"Supplemental Table 3. PCA, clustering, and GO enrichment analysis results. Note GO enrichment was not performed on the pale turquoise clade because this clade did not show temperature differences.",,,,,,,,,,,,,
protein_ID,PC1_loadings,PC2_loadings,PC_threshold_pass,ClusterColor,SimpleClusterColor,UniprotID,Protein_names,Protein_fams,Gene_names,GO_terms,GO_bp_IDs,sig_bp_GO,sig_bp_GOslim
CHOYP_LOC581183.1.1.m.49767,-0.023979337,0.003600103,Yes,wheat1,pale yellow,Q7ZU45,Tetratricopeptide repeat protein 25 (TPR repeat protein 25),,ttc25,cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474],GO:0005737; GO:0005856; GO:0032474; GO:0042995; GO:0060271; GO:0061371,GO:0060271; GO:0061371,cellular component assembly; anatomical structure development
CHOYP_LOC100368885.1.1.m.7807,-0.02469691,0.000751647,Yes,wheat1,pale yellow,A0A0R4IFG5,Cilia- and flagella-associated protein 53,CFAP53 family,cfap53,axoneme [GO:0005930]; ciliary base [GO:0097546]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287],GO:0003341; GO:0005930; GO:0007368; GO:0060271; GO:0060287; GO:0097546,GO:0060271; GO:0060287,cellular component assembly; anatomical structure development
CHOYP_BRAFLDRAFT_117858.3.3.m.61651,-0.023875513,-0.0044848,Yes,wheat1,pale yellow,Q5PPV2,Tektin-4,Tektin family,tekt4,motile cilium [GO:0031514]; cell projection organization [GO:0030030],GO:0030030; GO:0031514,GO:0030030,NA
CHOYP_LOC100372889.1.2.m.37506,-0.02391979,0.003559774,Yes,wheat1,pale yellow,P54001,Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline;2-oxoglutarate-4-dioxygenase subunit alpha-1),P4HA family,P4ha1 P4ha,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity; acting on single donors with incorporation of molecular oxygen; incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401],GO:0004656; GO:0005506; GO:0005739; GO:0005783; GO:0005788; GO:0016222; GO:0016702; GO:0018401; GO:0030199; GO:0031418; GO:0042802,GO:0018401; GO:0030199,cellular protein modification process; cellular amino acid metabolic process; extracellular matrix organization; small molecule metabolic process
CHOYP_LOC100377024.2.2.m.63302,-0.023900964,-0.002625186,Yes,wheat1,pale yellow,E9Q7R9,Cilia- and flagella-associated protein 43,CFAP43 family,Cfap43,axoneme [GO:0005930]; motile cilium [GO:0031514]; sperm axoneme assembly [GO:0007288]; sperm motility [GO:0097722],GO:0005930; GO:0007288; GO:0031514; GO:0097722,GO:0007288,reproduction; cytoskeleton organization; cellular component assembly; cell differentiation; locomotion; anatomical structure development; cell motility
CHOYP_BRAFLDRAFT_125670.1.1.m.9555,-0.023650712,0.007403366,Yes,wheat1,pale yellow,Q96N23,Cilia- and flagella-associated protein 54,CFAP54 family,CFAP54 C12orf55 C12orf63,axoneme [GO:0005930]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; spermatogenesis [GO:0007283],GO:0005930; GO:0007283; GO:0030154; GO:0060271; GO:0060294,GO:0007283; GO:0060271; GO:0060294,reproduction; cellular component assembly; locomotion; cell motility
CHOYP_LOC100377392.3.4.m.26363,-0.023693922,0.007852843,Yes,wheat1,pale yellow,Q32KL8,Protein TBATA (Protein SPATIAL) (Stromal protein associated with thymii and lymph node homolog) (Thymus; brain and testes-associated protein),TBATA family,TBATA SPATIAL,cytosol [GO:0005829]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],GO:0005829; GO:0007275; GO:0007283; GO:0030154,GO:0007283,reproduction
CHOYP_LOC100366451.1.1.m.10500,-0.023748369,-0.000537843,Yes,wheat1,pale yellow,B2RW38,Cilia- and flagella-associated protein 58,CFAP58 family,Cfap58,cilium [GO:0005929],GO:0005929,NA,NA
CHOYP_LOC100372505.2.2.m.26614,-0.023933422,0.003532207,Yes,wheat1,pale yellow,P86854,Perlucin-like protein,,,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],GO:0005576; GO:0030246,NA,NA
CHOYP_NRP.1.4.m.29956,-0.023826631,0.003116081,Yes,wheat1,pale yellow,H2A0M0,Asparagine-rich protein (Prism uncharacterized shell protein 1) (PUSP1),,,extracellular region [GO:0005576],GO:0005576,NA,NA
CHOYP_TNNC2.1.1.m.32533,-0.002417055,0.025582234,Yes,wheat1,pale yellow,P02595,Calmodulin (CaM),Calmodulin family,,calcium ion binding [GO:0005509],GO:0005509,NA,NA
CHOYP_LOC100371332.1.6.m.7760,-0.023770597,-0.00558241,Yes,wheat1,pale yellow,Q28864,Tissue factor pathway inhibitor (TFPI) (Extrinsic pathway inhibitor) (EPI) (Lipoprotein-associated coagulation inhibitor) (LACI),,TFPI TFPI1,extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; blood coagulation [GO:0007596],GO:0004867; GO:0005615; GO:0007596,NA,NA
CHOYP_contig_005590.m.6345,-0.02439075,-0.000256306,Yes,wheat1,pale yellow,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024582.m.27943,-0.023940335,0.003451722,Yes,wheat1,pale yellow,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025827.m.29484,-0.023611615,0.007359308,Yes,wheat1,pale yellow,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMOJ_GI23261.2.2.m.30988,-0.023677269,0.007625539,Yes,wheat1,pale yellow,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DWIL_GK12566.1.1.m.26720,-0.023750461,0.008007123,Yes,wheat1,pale yellow,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100376426.1.3.m.28097,-0.023759939,0.003018142,Yes,wheat1,pale yellow,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100905544.1.3.m.6504,-0.023604993,0.009065952,Yes,wheat1,pale yellow,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DPSE_GA19599.1.1.m.64309,0.004550097,-0.027196262,Yes,salmon,salmon,P58365,Cadherin-23 (Otocadherin),,Cdh23,apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; calcium ion binding [GO:0005509]; protein N-terminus binding [GO:0047485]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; sensory perception of sound [GO:0007605],GO:0005509; GO:0005886; GO:0007156; GO:0007605; GO:0007626; GO:0016021; GO:0032420; GO:0045177; GO:0047485; GO:0060122,GO:0060122,cell differentiation; anatomical structure development
CHOYP_CRE_01395.2.2.m.44269,0.000408387,-0.026975914,Yes,salmon,salmon,P22105,Tenascin-X (TN-X) (Hexabrachion-like protein),Tenascin family,TNXB HXBL TNX TNXB1 TNXB2 XB,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],GO:0005178; GO:0005201; GO:0005576; GO:0005615; GO:0005622; GO:0007155; GO:0008201; GO:0030036; GO:0030199; GO:0031012; GO:0032963; GO:0048251; GO:0062023; GO:0070062; GO:0098633,GO:0048251,cellular component assembly; extracellular matrix organization
CHOYP_LOC100369620.1.1.m.13590,0.001300954,-0.027821632,Yes,salmon,salmon,Q5E9Z7,DNA-directed RNA polymerase III subunit RPC4 (RNA polymerase III subunit C4) (DNA-directed RNA polymerase III subunit D),Eukaryotic RPC4/POLR3D RNA polymerase subunit family,POLR3D,RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383],GO:0003677; GO:0003899; GO:0005666; GO:0006383; GO:0032728; GO:0045087; GO:0045089; GO:0051607,GO:0045089,immune system process; response to stress
CHOYP_LOC100552337.1.1.m.19614,-0.001893381,-0.026856462,Yes,salmon,salmon,Q6ZQ58,La-related protein 1 (La ribonucleoprotein domain family member 1),LARP family,Larp1 Kiaa0731 Larp,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; polysome [GO:0005844]; TORC1 complex [GO:0031931]; eukaryotic initiation factor 4E binding [GO:0008190]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA cap binding [GO:0000339]; translation activator activity [GO:0008494]; translation initiation factor binding [GO:0031369]; cell proliferation [GO:0008283]; cellular response to rapamycin [GO:0072752]; mRNA stabilization [GO:0048255]; negative regulation of translation [GO:0017148]; positive regulation of macroautophagy [GO:0016239]; positive regulation of viral genome replication [GO:0045070]; response to amino acid starvation [GO:1990928]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; translational initiation [GO:0006413],GO:0000339; GO:0003730; GO:0005737; GO:0005844; GO:0006413; GO:0008190; GO:0008283; GO:0008494; GO:0010494; GO:0016239; GO:0017148; GO:0031369; GO:0031929; GO:0031931; GO:0038202; GO:0045070; GO:0048027; GO:0048255; GO:0072752; GO:1990928,GO:0038202; GO:0048255,signal transduction; catabolic process; cellular nitrogen compound metabolic process; nucleobase-containing compound catabolic process
CHOYP_LOC753939.1.1.m.44379,-0.005329569,-0.026762438,Yes,salmon,salmon,Q9H845,Acyl-CoA dehydrogenase family member 9; mitochondrial (ACAD-9) (EC 1.3.99.-),Acyl-CoA dehydrogenase family,ACAD9,dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981],GO:0000062; GO:0001676; GO:0004466; GO:0005634; GO:0005739; GO:0005743; GO:0017099; GO:0030425; GO:0031966; GO:0032981; GO:0050660; GO:0051791; GO:0070991,GO:0032981; GO:0051791,lipid metabolic process; mitochondrion organization; cellular component assembly; small molecule metabolic process; protein-containing complex assembly
CHOYP_PI3R4.1.1.m.14910,5.22E-05,-0.027089143,Yes,salmon,salmon,Q99570,Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) (PI3-kinase p150 subunit) (Phosphoinositide 3-kinase adaptor protein),Protein kinase superfamily; Ser/Thr protein kinase family,PIK3R4 VPS15,autophagosome [GO:0005776]; axoneme [GO:0005930]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phagocytic vesicle membrane [GO:0030670]; phosphatidylinositol 3-kinase complex; class III [GO:0035032]; phosphatidylinositol 3-kinase complex; class III; type I [GO:0034271]; phosphatidylinositol 3-kinase complex; class III; type II [GO:0034272]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; toll-like receptor 9 signaling pathway [GO:0034162],GO:0004672; GO:0004674; GO:0005524; GO:0005770; GO:0005776; GO:0005829; GO:0005930; GO:0006468; GO:0006623; GO:0015630; GO:0016020; GO:0016236; GO:0016303; GO:0030242; GO:0030670; GO:0032465; GO:0032801; GO:0034162; GO:0034271; GO:0034272; GO:0035032; GO:0042149; GO:0043231; GO:0043552; GO:0045324; GO:0071561,GO:0032801; GO:0042149; GO:0045324,transport; response to stress; vacuolar transport; catabolic process; vesicle-mediated transport
CHOYP_SC24B.1.2.m.95,-0.004058983,-0.027790521,Yes,salmon,salmon,O95487,Protein transport protein Sec24B (SEC24-related protein B),SEC23/SEC24 family; SEC24 subfamily,SEC24B,COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; aorta morphogenesis [GO:0035909]; auditory receptor cell stereocilium organization [GO:0060088]; cargo loading into COPII-coated vesicle [GO:0090110]; cochlear nucleus development [GO:0021747]; COPII vesicle coating [GO:0048208]; coronary artery morphogenesis [GO:0060982]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lung lobe morphogenesis [GO:0060463]; neural tube closure [GO:0001843]; outflow tract morphogenesis [GO:0003151]; pulmonary artery morphogenesis [GO:0061156]; regulation of cargo loading into COPII-coated vesicle [GO:1901301]; regulation of establishment of planar polarity involved in neural tube closure [GO:0090178],GO:0000139; GO:0001843; GO:0002474; GO:0003151; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0019886; GO:0021747; GO:0030127; GO:0035909; GO:0048208; GO:0060088; GO:0060463; GO:0060982; GO:0061156; GO:0090110; GO:0090178; GO:1901301,GO:0019886; GO:0035909; GO:0060088; GO:0060982; GO:0061156,cell morphogenesis; immune system process; embryo development; cell differentiation; anatomical structure development
CHOYP_NDUFB9.1.2.m.37494,-0.008102218,-0.026251443,Yes,salmon,salmon,Q02369,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 (Complex I-B22) (CI-B22) (NADH-ubiquinone oxidoreductase B22 subunit),Complex I LYR family,NDUFB9 UQOR22,mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981],GO:0005747; GO:0006120; GO:0032981,GO:0006120; GO:0032981,generation of precursor metabolites and energy; mitochondrion organization; cellular component assembly; cellular nitrogen compound metabolic process; small molecule metabolic process; protein-containing complex assembly
CHOYP_ISCW_ISCW011108.1.1.m.13934,0.001610847,-0.02656805,Yes,salmon,salmon,P62944,AP-2 complex subunit beta (AP105B) (Adaptor protein complex AP-2 subunit beta) (Adaptor-related protein complex 2 subunit beta) (Beta-2-adaptin) (Beta-adaptin) (Clathrin assembly protein complex 2 beta large chain) (Plasma membrane adaptor HA2/AP2 adaptin beta subunit),Adaptor complexes large subunit family,Ap2b1 Clapb1,AP-2 adaptor complex [GO:0030122]; AP-type membrane coat adaptor complex [GO:0030119]; clathrin coat [GO:0030118]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; cargo receptor activity [GO:0038024]; clathrin binding [GO:0030276]; protein-containing complex binding [GO:0044877]; aorta development [GO:0035904]; clathrin coat assembly [GO:0048268]; coronary vasculature development [GO:0060976]; negative regulation of neuron death [GO:1901215]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein localization to membrane [GO:1905477]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; ventricular septum development [GO:0003281],GO:0003281; GO:0030118; GO:0030119; GO:0030122; GO:0030276; GO:0035904; GO:0038024; GO:0044877; GO:0045807; GO:0048268; GO:0060976; GO:0098794; GO:0098884; GO:0098978; GO:1901215; GO:1905477,GO:0003281; GO:0035904; GO:0048268; GO:0060976; GO:0098884,transport; vesicle-mediated transport; cellular component assembly; anatomical structure development; protein-containing complex assembly
CHOYP_LOC100377501.1.1.m.13155,-0.007245774,-0.02663064,Yes,salmon,salmon,Q7ZWS1,tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like (EC 1.3.1.-) (tRNA-dihydrouridine synthase 3-like),Dus family; Dus3 subfamily,dus3l,flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; tRNA dihydrouridine synthase activity [GO:0017150],GO:0017150; GO:0046872; GO:0050660,NA,NA
CHOYP_FABP6.2.2.m.59518,-0.000931459,-0.027026313,Yes,salmon,salmon,O01812,Fatty acid-binding protein homolog 6,Calycin superfamily; Fatty-acid binding protein (FABP) family,lbp-6 W02D3.5,lipid binding [GO:0008289],GO:0008289,NA,NA
CHOYP_BRAFLDRAFT_123969.1.1.m.15145,-0.002180587,-0.027589928,Yes,salmon,salmon,Q9QXT0,Protein canopy homolog 2 (MIR-interacting saposin-like protein) (Putative secreted protein ZSIG9) (Transmembrane protein 4),Canopy family,Cnpy2 Msap Tmem4 Zsig9,endoplasmic reticulum [GO:0005783]; negative regulation of gene expression [GO:0010629]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; regulation of low-density lipoprotein particle clearance [GO:0010988],GO:0005783; GO:0010629; GO:0010988; GO:0045716,NA,NA
CHOYP_IPO9.1.4.m.24013,0.005556116,-0.02670594,Yes,salmon,salmon,Q91YE6,Importin-9 (Imp9) (Importin-9a) (Imp9a) (Importin-9b) (Imp9b) (Ran-binding protein 9) (RanBP9),Importin beta family,Ipo9 Imp9 Ranbp9,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; histone binding [GO:0042393]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; ribosome biogenesis [GO:0042254],GO:0005635; GO:0005737; GO:0005829; GO:0006606; GO:0008536; GO:0008565; GO:0042254; GO:0042393; GO:0050821,NA,NA
CHOYP_BRAFLDRAFT_283981.1.1.m.7732,-0.005943698,-0.028598461,Yes,salmon,salmon,Q9YHY6,Condensin complex subunit 1 (Chromosome assembly protein XCAP-D2) (Chromosome condensation-related SMC-associated protein 1) (Chromosome-associated protein D2) (Eg7) (Non-SMC condensin I complex subunit D2),CND1 (condensin subunit 1) family,ncapd2 capd2 cnap1 eg7,chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076],GO:0005634; GO:0005694; GO:0005829; GO:0007076; GO:0051301,NA,NA
CHOYP_CLC10.2.5.m.4673,0.000972724,-0.027517497,Yes,salmon,salmon,Q66S03,Galactose-specific lectin nattectin (CTL),True venom lectin family,,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954],GO:0005576; GO:0006954; GO:0030246; GO:0046872; GO:0090729,NA,NA
CHOYP_ABCF2.1.2.m.28360,0.000159208,-0.02812737,Yes,salmon,salmon,Q99LE6,ATP-binding cassette sub-family F member 2,ABC transporter superfamily; ABCF family; EF3 subfamily,Abcf2,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887],GO:0005524; GO:0005739; GO:0016887,NA,NA
CHOYP_CALM.42.50.m.56135,0.003601835,-0.026479484,Yes,salmon,salmon,P0DP35,Calmodulin-2 B,Calmodulin family,calm2-b,calcium ion binding [GO:0005509]; signaling receptor binding [GO:0005102]; calcium-mediated signaling [GO:0019722],GO:0005102; GO:0005509; GO:0019722,NA,NA
CHOYP_XPO7.1.1.m.50167,-0.00530341,-0.027273905,Yes,salmon,salmon,Q5ZLT0,Exportin-7,Exportin family,XPO7 RCJMB04_4p4,cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]; protein export from nucleus [GO:0006611],GO:0005049; GO:0005643; GO:0005737; GO:0006611; GO:0008536,NA,NA
CHOYP_contig_007115.m.8183,0.002934593,-0.027633793,Yes,salmon,salmon,Q58DT4,Pyrroline-5-carboxylate reductase 1; mitochondrial (P5C reductase 1) (P5CR 1) (EC 1.5.1.2),Pyrroline-5-carboxylate reductase family,PYCR1,mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; pyrroline-5-carboxylate reductase activity [GO:0004735]; cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; proline biosynthetic process [GO:0006561]; regulation of mitochondrial membrane potential [GO:0051881],GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0042802; GO:0051881; GO:0055129; GO:1903206,NA,NA
CHOYP_ACSS3.1.1.m.64144,-0.005930805,-0.027678357,Yes,salmon,salmon,Q5REB8,Acyl-CoA synthetase short-chain family member 3; mitochondrial (EC 6.2.1.1),ATP-dependent AMP-binding enzyme family,ACSS3,mitochondrion [GO:0005739]; acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524],GO:0003987; GO:0005524; GO:0005739,NA,NA
CHOYP_AMPD2.1.2.m.1295,-0.007191096,-0.026369661,Yes,salmon,salmon,Q01433,AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L),Metallo-dependent hydrolases superfamily; Adenosine and AMP deaminases family,AMPD2,cytosol [GO:0005829]; AMP deaminase activity [GO:0003876]; metal ion binding [GO:0046872]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; purine-containing compound salvage [GO:0043101],GO:0003876; GO:0005829; GO:0006188; GO:0032264; GO:0043101; GO:0046872; GO:0052652; GO:0097009,NA,NA
CHOYP_LOC100379027.1.1.m.27022,-0.002619011,-0.026430149,Yes,salmon,salmon,Q5RK00,39S ribosomal protein L46; mitochondrial (L46mt) (MRP-L46),Mitochondrion-specific ribosomal protein mL46 family,Mrpl46,cell junction [GO:0030054]; mitochondrial large ribosomal subunit [GO:0005762]; nucleoplasm [GO:0005654]; hydrolase activity [GO:0016787]; structural constituent of ribosome [GO:0003735],GO:0003735; GO:0005654; GO:0005762; GO:0016787; GO:0030054,NA,NA
CHOYP_RRP5.1.1.m.7375,-0.001398244,-0.026490455,Yes,salmon,salmon,Q14690,Protein RRP5 homolog (NF-kappa-B-binding protein) (NFBP) (Programmed cell death protein 11),,PDCD11 KIAA0185,cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; mRNA processing [GO:0006397]; rRNA processing [GO:0006364],GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006397; GO:0008134; GO:0032040,NA,NA
CHOYP_BRAFLDRAFT_123736.1.1.m.48671,0.009542938,-0.026427673,Yes,salmon,salmon,A0A0R4IVV0,Microsomal triglyceride transfer protein large subunit,,mttp mtp,basolateral plasma membrane [GO:0016323]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; phospholipid transporter activity [GO:0005548]; cholesterol homeostasis [GO:0042632]; digestion [GO:0007586]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; sprouting angiogenesis [GO:0002040],GO:0001579; GO:0002040; GO:0005319; GO:0005548; GO:0005783; GO:0005794; GO:0006629; GO:0006869; GO:0007586; GO:0008289; GO:0015909; GO:0016323; GO:0042157; GO:0042158; GO:0042632,NA,NA
CHOYP_ZC3HF.1.1.m.39867,-0.003494569,-0.029430092,Yes,salmon,salmon,Q8WU90,Zinc finger CCCH domain-containing protein 15 (DRG family-regulatory protein 1) (Likely ortholog of mouse immediate early response erythropoietin 4),ZC3H15/TMA46 family,ZC3H15 DFRP1 LEREPO4 HSPC303 HT010 MSTP012 PP730,cytosol [GO:0005829]; nucleolus [GO:0005730]; cadherin binding [GO:0045296]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cytokine-mediated signaling pathway [GO:0019221]; cytoplasmic translation [GO:0002181],GO:0000981; GO:0002181; GO:0003723; GO:0005730; GO:0005829; GO:0019221; GO:0045296; GO:0046872,NA,NA
CHOYP_U520.1.1.m.7087,0.003487844,-0.029133366,Yes,salmon,salmon,O75643,U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD),Helicase family; SKI2 subfamily,SNRNP200 ASCC3L1 HELIC2 KIAA0788,catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; ATP-dependent helicase activity [GO:0008026]; ATP-dependent RNA helicase activity [GO:0004004]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing; via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388],GO:0000354; GO:0000388; GO:0000398; GO:0001649; GO:0003723; GO:0004004; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0008026; GO:0016020; GO:0042802; GO:0046540; GO:0071013; GO:0071014,NA,NA
CHOYP_BRAFLDRAFT_63281.2.2.m.46528,0.005852799,-0.027657332,Yes,salmon,salmon,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004705.m.5404,-0.005301011,-0.026492575,Yes,salmon,salmon,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039363.m.44567,0.006658103,-0.026337498,Yes,salmon,salmon,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039460.m.44676,0.001230004,-0.02786118,Yes,salmon,salmon,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_GACZ.1.1.m.42619,0.000196653,-0.027375882,Yes,salmon,salmon,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MEG10.78.91.m.58715,0.001737392,-0.026865774,Yes,salmon,salmon,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ASB3.1.1.m.51103,0.024007692,-0.002451118,Yes,paleturquoise3,paleturquoise3,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_103544.1.1.m.38439,0.023874603,-0.007349509,Yes,paleturquoise3,paleturquoise3,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CAH2.1.1.m.42306,0.023981719,0.003762454,Yes,paleturquoise3,paleturquoise3,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004572.m.5255,0.024056386,-0.003338312,Yes,paleturquoise3,paleturquoise3,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015692.m.18358,0.023792615,-0.00748669,Yes,paleturquoise3,paleturquoise3,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016567.m.19514,0.024212635,-0.004890714,Yes,paleturquoise3,paleturquoise3,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048541.m.57541,0.02427805,-0.005014606,Yes,paleturquoise3,paleturquoise3,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMBT1.13.34.m.27666,0.023753122,-0.000703315,Yes,paleturquoise3,paleturquoise3,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ISCW_ISCW012957.1.2.m.51659,0.023632736,-0.000683766,Yes,paleturquoise3,paleturquoise3,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100376308.1.1.m.60595,0.024446937,-0.00267996,Yes,paleturquoise3,paleturquoise3,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377364.2.2.m.52803,0.023713786,-0.006483069,Yes,paleturquoise3,paleturquoise3,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533447.2.3.m.44496,0.023941335,0.004437045,Yes,paleturquoise3,paleturquoise3,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101169658.1.3.m.18820,0.024477486,-0.004814915,Yes,paleturquoise3,paleturquoise3,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101169658.2.3.m.20752,0.024744369,-0.000405575,Yes,paleturquoise3,paleturquoise3,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LRRX1.6.11.m.41895,0.024082521,-0.00489286,Yes,paleturquoise3,paleturquoise3,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MATN1.3.5.m.46206,0.024877846,-0.002936201,Yes,paleturquoise3,paleturquoise3,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G97278.1.2.m.34546,0.023865632,0.002157994,Yes,paleturquoise3,paleturquoise3,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NOV.1.2.m.27550,0.024508665,-0.003549937,Yes,paleturquoise3,paleturquoise3,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101067833.2.3.m.25528,-0.009140701,0.024678463,Yes,lightsteelblue,pale purple,Q8TDB6,E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2) (Rhysin2),Deltex family,DTX3L BBAP,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process [GO:0006511],GO:0000209; GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006511; GO:0006974; GO:0007219; GO:0008047; GO:0008333; GO:0010390; GO:0015031; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0033522; GO:0033523; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0046872; GO:0051444; GO:0051607; GO:0051865; GO:0070936; GO:0097677; GO:1900182; GO:1901666; GO:1902966; GO:2000646; GO:2001034,GO:0070936; GO:1900182,cellular protein modification process
CHOYP_BRAFLDRAFT_109340.1.1.m.30107,0.00190697,0.026594259,Yes,lightsteelblue,pale purple,Q60769,Tumor necrosis factor alpha-induced protein 3 (TNF alpha-induced protein 3) (EC 2.3.2.-) (EC 3.4.19.12) (Putative DNA-binding protein A20) (Zinc finger protein A20),Peptidase C64 family,Tnfaip3 Tnfip3,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; kinase binding [GO:0019900]; Lys63-specific deubiquitinase activity [GO:0061578]; protease binding [GO:0002020]; protein self-association [GO:0043621]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; B-1 B cell homeostasis [GO:0001922]; cell migration [GO:0016477]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cytoskeleton organization [GO:0007010]; establishment of protein localization to vacuole [GO:0072666]; inflammatory response [GO:0006954]; marginal zone B cell differentiation [GO:0002315]; negative regulation of autophagy [GO:0010507]; negative regulation of B cell activation [GO:0050869]; negative regulation of CD40 signaling pathway [GO:2000349]; negative regulation of cell death [GO:0060548]; negative regulation of chronic inflammatory response [GO:0002677]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of granuloma formation [GO:0002632]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070429]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; negative regulation of toll-like receptor 5 signaling pathway [GO:0034148]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K48-linked deubiquitination [GO:0071108]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked deubiquitination [GO:0070536]; regulation of germinal center formation [GO:0002634]; regulation of immunoglobulin production [GO:0002637]; regulation of innate immune response [GO:0045088]; response to molecule of bacterial origin [GO:0002237]; response to muramyl dipeptide [GO:0032495]; response to wounding [GO:0009611]; tolerance induction to lipopolysaccharide [GO:0072573],GO:0001922; GO:0002020; GO:0002237; GO:0002315; GO:0002632; GO:0002634; GO:0002637; GO:0002677; GO:0003677; GO:0004842; GO:0004843; GO:0005634; GO:0005737; GO:0005764; GO:0006915; GO:0006954; GO:0007010; GO:0008270; GO:0009611; GO:0010507; GO:0016477; GO:0016579; GO:0019900; GO:0030177; GO:0031397; GO:0032088; GO:0032495; GO:0032691; GO:0032703; GO:0032715; GO:0032720; GO:0034115; GO:0034140; GO:0034148; GO:0035523; GO:0035871; GO:0036459; GO:0042802; GO:0043124; GO:0043130; GO:0043231; GO:0043621; GO:0045088; GO:0045732; GO:0045736; GO:0045824; GO:0048662; GO:0050713; GO:0050728; GO:0050869; GO:0060548; GO:0061578; GO:0070301; GO:0070429; GO:0070433; GO:0070530; GO:0070536; GO:0070936; GO:0071108; GO:0071222; GO:0071947; GO:0072573; GO:0072666; GO:1902042; GO:1903364; GO:1990168; GO:2000347; GO:2000349; GO:2000352,GO:0070936,cellular protein modification process
CHOYP_LOC100377460.1.1.m.38781,0.010331469,0.026967956,Yes,lightsteelblue,pale purple,Q3ZBD3,Pterin-4-alpha-carbinolamine dehydratase (PHS) (EC 4.2.1.96) (4-alpha-hydroxy-tetrahydropterin dehydratase) (Dimerization cofactor of hepatocyte nuclear factor 1-alpha) (DCoH) (Dimerization cofactor of HNF1) (Phenylalanine hydroxylase-stimulating protein) (Pterin carbinolamine dehydratase) (PCD),Pterin-4-alpha-carbinolamine dehydratase family,PCBD1,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; 4-alpha-hydroxytetrahydrobiopterin dehydratase activity [GO:0008124]; identical protein binding [GO:0042802]; phenylalanine 4-monooxygenase activity [GO:0004505]; protein heterooligomerization [GO:0051291]; protein homotetramerization [GO:0051289]; tetrahydrobiopterin biosynthetic process [GO:0006729],GO:0004505; GO:0005654; GO:0005829; GO:0006729; GO:0008124; GO:0042802; GO:0051289; GO:0051291,GO:0051289,cellular component assembly; protein-containing complex assembly
CHOYP_PHUM_PHUM536560.2.2.m.59367,-0.001380138,0.025117995,Yes,lightsteelblue,pale purple,P47856,Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 1) (Glutamine:fructose-6-phosphate amidotransferase 1) (GFAT 1) (GFAT1) (Hexosephosphate aminotransferase 1),,Gfpt1 Gfpt,amino acid binding [GO:0016597]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; circadian regulation of gene expression [GO:0032922]; fructose 6-phosphate metabolic process [GO:0006002]; glucosamine biosynthetic process [GO:0006042]; glutamine metabolic process [GO:0006541]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein homotetramerization [GO:0051289]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047],GO:0004360; GO:0006002; GO:0006042; GO:0006047; GO:0006048; GO:0006487; GO:0006541; GO:0016597; GO:0030246; GO:0032922; GO:0045719; GO:0051289; GO:0097367,GO:0051289,cellular component assembly; protein-containing complex assembly
CHOYP_PK3CD.1.1.m.53039,-0.000572857,0.02468862,Yes,lightsteelblue,pale purple,O00329,Phosphatidylinositol 4;5-bisphosphate 3-kinase catalytic subunit delta isoform (PI3-kinase subunit delta) (PI3K-delta) (PI3Kdelta) (PtdIns-3-kinase subunit delta) (EC 2.7.1.153) (Phosphatidylinositol 4;5-bisphosphate 3-kinase 110 kDa catalytic subunit delta) (PtdIns-3-kinase subunit p110-delta) (p110delta),PI3/PI4-kinase family,PIK3CD,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mast cell granule [GO:0042629]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol-4;5-bisphosphate 3-kinase activity [GO:0046934]; adaptive immune response [GO:0002250]; axon guidance [GO:0007411]; B cell activation [GO:0042113]; B cell chemotaxis [GO:0035754]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cytokine production [GO:0001816]; cytokine-mediated signaling pathway [GO:0019221]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; natural killer cell activation [GO:0030101]; natural killer cell chemotaxis [GO:0035747]; natural killer cell differentiation [GO:0001779]; negative regulation of gene expression [GO:0010629]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; protein phosphorylation [GO:0006468]; respiratory burst involved in defense response [GO:0002679]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852],GO:0001779; GO:0001816; GO:0002250; GO:0002551; GO:0002679; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0006468; GO:0006954; GO:0007165; GO:0007411; GO:0010628; GO:0010629; GO:0010818; GO:0014065; GO:0014068; GO:0016020; GO:0016301; GO:0016303; GO:0016310; GO:0016477; GO:0019221; GO:0030101; GO:0030168; GO:0030217; GO:0030335; GO:0030593; GO:0033031; GO:0035004; GO:0035005; GO:0035747; GO:0035754; GO:0036092; GO:0042110; GO:0042113; GO:0042629; GO:0043303; GO:0045087; GO:0046854; GO:0046934; GO:0048015; GO:0050852; GO:0050853; GO:0051897; GO:0060374; GO:0072672,GO:0043303,immune system process; transport; vesicle-mediated transport
CHOYP_LMNB2.1.1.m.55999,-0.008995145,0.025472062,Yes,lightsteelblue,pale purple,P08928,Lamin Dm0,Intermediate filament family,Lam CG6944,cytoplasm [GO:0005737]; lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nucleus [GO:0005634]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; adult locomotory behavior [GO:0008344]; cell aging [GO:0007569]; central nervous system development [GO:0007417]; chitin-based cuticle development [GO:0040003]; chromatin silencing [GO:0006342]; compound eye morphogenesis [GO:0001745]; digestive tract morphogenesis [GO:0048546]; gonad morphogenesis [GO:0035262]; heterochromatin maintenance involved in chromatin silencing [GO:0070870]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; mitotic nuclear envelope reassembly [GO:0007084]; negative regulation of cell proliferation [GO:0008285]; negative regulation of immune response [GO:0050777]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; nuclear migration [GO:0007097]; nuclear pore distribution [GO:0031081]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cytokinesis; actomyosin contractile ring assembly [GO:2000433]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of spindle assembly [GO:1905832]; protein localization to nuclear envelope [GO:0090435]; spermatocyte division [GO:0048137]; spermatogenesis [GO:0007283]; terminal branching; open tracheal system [GO:0007430],GO:0000922; GO:0001745; GO:0003682; GO:0005102; GO:0005198; GO:0005634; GO:0005635; GO:0005637; GO:0005638; GO:0005652; GO:0005737; GO:0006342; GO:0006997; GO:0006998; GO:0007084; GO:0007097; GO:0007110; GO:0007112; GO:0007283; GO:0007417; GO:0007430; GO:0007569; GO:0008285; GO:0008344; GO:0030838; GO:0031081; GO:0035262; GO:0040003; GO:0048137; GO:0048546; GO:0050777; GO:0070870; GO:0071763; GO:0090435; GO:1900182; GO:1905832; GO:2000433,GO:0030838; GO:1900182,cytoskeleton organization; cellular component assembly; protein-containing complex assembly
CHOYP_LOC100119086.1.1.m.55425,-0.001492974,0.026250402,Yes,lightsteelblue,pale purple,P16591,Tyrosine-protein kinase Fer (EC 2.7.10.2) (Feline encephalitis virus-related kinase FER) (Fujinami poultry sarcoma/Feline sarcoma-related protein Fer) (Proto-oncogene c-Fer) (Tyrosine kinase 3) (p94-Fer),Protein kinase superfamily; Tyr protein kinase family; Fes/fps subfamily,FER TYK3,cell cortex [GO:0005938]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634]; ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase 1 binding [GO:0008157]; protein tyrosine kinase activity [GO:0004713]; actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; cell-cell adhesion mediated by cadherin [GO:0044331]; cellular response to insulin stimulus [GO:0032869]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to reactive oxygen species [GO:0034614]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; diapedesis [GO:0050904]; extracellular matrix-cell signaling [GO:0035426]; Fc-epsilon receptor signaling pathway [GO:0038095]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; Kit signaling pathway [GO:0038109]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of mast cell activation involved in immune response [GO:0033007]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell proliferation [GO:0042127]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of fibroblast migration [GO:0010762]; regulation of lamellipodium assembly [GO:0010591]; regulation of mast cell degranulation [GO:0043304]; regulation of protein phosphorylation [GO:0001932]; response to lipopolysaccharide [GO:0032496]; response to platelet-derived growth factor [GO:0036119]; substrate adhesion-dependent cell spreading [GO:0034446]; tyrosine phosphorylation of STAT protein [GO:0007260],GO:0000226; GO:0000278; GO:0001932; GO:0004713; GO:0004715; GO:0005154; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005938; GO:0006468; GO:0006935; GO:0007155; GO:0007260; GO:0008157; GO:0008283; GO:0008284; GO:0008289; GO:0010591; GO:0010762; GO:0018108; GO:0019221; GO:0030054; GO:0030335; GO:0030838; GO:0031234; GO:0031532; GO:0032496; GO:0032869; GO:0033007; GO:0034446; GO:0034614; GO:0035426; GO:0035556; GO:0036006; GO:0036119; GO:0038028; GO:0038095; GO:0038109; GO:0042058; GO:0042127; GO:0042995; GO:0043304; GO:0044331; GO:0046777; GO:0048008; GO:0050904; GO:0051092; GO:0070102,GO:0030838,cytoskeleton organization; cellular component assembly; protein-containing complex assembly
CHOYP_MLE.1.9.m.15462,0.000791928,0.026895769,Yes,lightsteelblue,pale purple,P07291,Myosin essential light chain; striated adductor muscle (E-LC) (Sulfhydryl light chain) (SHLC),,,myosin complex [GO:0016459]; calcium ion binding [GO:0005509],GO:0005509; GO:0016459,NA,NA
CHOYP_CALM.49.50.m.63320,-0.008818015,0.026178479,Yes,lightsteelblue,pale purple,P02595,Calmodulin (CaM),Calmodulin family,,calcium ion binding [GO:0005509],GO:0005509,NA,NA
CHOYP_CPVL.1.2.m.2978,0.00628411,0.026499556,Yes,lightsteelblue,pale purple,Q9H3G5,Probable serine carboxypeptidase CPVL (EC 3.4.16.-) (Carboxypeptidase; vitellogenic-like) (Vitellogenic carboxypeptidase-like protein) (VCP-like protein) (hVLP),Peptidase S10 family,CPVL VLP PSEC0124 UNQ197/PRO223,extracellular exosome [GO:0070062]; serine-type carboxypeptidase activity [GO:0004185]; proteolysis involved in cellular protein catabolic process [GO:0051603],GO:0004185; GO:0051603; GO:0070062,NA,NA
CHOYP_SMP_078690.5.5.m.64878,0.010759409,0.025025664,Yes,lightsteelblue,pale purple,P37397,Calponin-3 (Calponin; acidic isoform) (Calponin; non-muscle isoform),Calponin family,Cnn3,actin filament [GO:0005884]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; protein binding; bridging [GO:0030674]; actomyosin structure organization [GO:0031032]; epithelial cell differentiation [GO:0030855]; negative regulation of ATPase activity [GO:0032780],GO:0003779; GO:0005516; GO:0005829; GO:0005874; GO:0005884; GO:0008017; GO:0014069; GO:0030425; GO:0030674; GO:0030855; GO:0031032; GO:0032780; GO:0043025; GO:0043197,NA,NA
CHOYP_MYS.7.7.m.44342,-0.001603885,0.025824441,Yes,lightsteelblue,pale purple,P24733,Myosin heavy chain; striated muscle,TRAFAC class myosin-kinesin ATPase superfamily; Myosin family,,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],GO:0003774; GO:0005516; GO:0005524; GO:0030016; GO:0032982; GO:0051015,NA,NA
CHOYP_contig_043818.m.50622,-0.00555956,0.027304901,Yes,lightsteelblue,pale purple,Q5TZA2,Rootletin (Ciliary rootlet coiled-coil protein),Rootletin family,CROCC KIAA0445,actin cytoskeleton [GO:0015629]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; kinesin binding [GO:0019894]; structural molecule activity [GO:0005198]; centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098]; ciliary basal body organization [GO:0032053]; epithelial structure maintenance [GO:0010669]; establishment of organelle localization [GO:0051656]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365],GO:0001917; GO:0003779; GO:0005198; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0007098; GO:0008104; GO:0010457; GO:0010669; GO:0015629; GO:0019894; GO:0032053; GO:0033365; GO:0035253; GO:0045494; GO:0045724; GO:0051656; GO:0070062; GO:1903566,NA,NA
CHOYP_LOC762871.1.1.m.37896,0.006729973,0.025931963,Yes,lightsteelblue,pale purple,Q5R8Z8,Ras-related protein Rab-14,Small GTPase superfamily; Rab family,RAB14,cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; defense response to bacterium [GO:0042742]; endocytic recycling [GO:0032456]; fibroblast growth factor receptor signaling pathway [GO:0008543]; Golgi to endosome transport [GO:0006895]; phagosome maturation [GO:0090382]; protein transport [GO:0015031]; regulation of embryonic development [GO:0045995]; regulation of protein localization [GO:0032880],GO:0000139; GO:0003924; GO:0005525; GO:0005802; GO:0005829; GO:0006895; GO:0008543; GO:0015031; GO:0019003; GO:0031901; GO:0032456; GO:0032880; GO:0042742; GO:0045335; GO:0045995; GO:0055037; GO:0090382,NA,NA
CHOYP_BICRD.1.1.m.11088,-0.005387123,0.027482251,Yes,lightsteelblue,pale purple,Q8SWR2,Bicaudal D-related protein homolog (BICD-related protein homolog),BICDR family,CG17365 CG32137,,,NA,NA
CHOYP_contig_025032.m.28479,-0.006354052,0.025167296,Yes,lightsteelblue,pale purple,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053582.m.64175,0.005548565,0.024742023,Yes,lightsteelblue,pale purple,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EATER.1.1.m.30042,-0.005574984,0.027642012,Yes,lightsteelblue,pale purple,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MIB1.2.4.m.35815,-0.003419964,0.029331765,Yes,lightsteelblue,pale purple,NA,NA,NA,NA,NA,NA,NA,NA
ALBU_BOVIN,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CAS1_BOVIN,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_14332.1.2.m.5643,0.005412856,0.00060302,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_14332.2.2.m.61737,-0.006103818,0.003419113,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_1433E.1.2.m.3638,0.011585364,-0.002383009,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_1433G.2.2.m.63450,0.016699559,0.004303802,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_1433G.2.2.m.63451,0.003639521,0.009803831,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_1433Z.1.1.m.17045,0.003906502,-0.0157177,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_2A5D.2.3.m.32240,-0.005349325,0.002695655,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_2A5D.3.3.m.37716,0.006465562,-0.001038247,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_2AAA.1.1.m.13306,0.019445427,0.007505973,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_2AAA.1.1.m.13307,0.003134349,0.000707885,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_3BP2.2.3.m.19302,-0.011784019,-0.001127856,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_41.2.3.m.31169,0.00679758,-0.001152664,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_4EBP1.1.1.m.12045,0.013999698,0.000366837,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_4ET.1.1.m.1941,-0.012631543,-0.019753842,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_5HTR.1.1.m.64867,0.007710813,-0.009139163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_5NT3.1.1.m.24925,-0.011035296,-0.009333558,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_A1CF.1.2.m.8145,0.002651531,-0.02544021,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_A2M.2.3.m.54214,-0.014018064,-0.005444898,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_A4.2.3.m.7550,-0.009317001,-0.015905793,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_A4.3.3.m.22262,-0.001918221,0.00514339,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AACS.1.1.m.66267,-0.01350383,0.004367606,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AADAT.1.1.m.12672,0.00868921,0.003475082,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL000057.1.1.m.36013,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL001424.1.1.m.40785,-0.012999954,-0.004960136,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL001503.1.1.m.10649,-0.006642051,0.007405318,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL001706.1.1.m.43821,-0.012843113,-0.021888849,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL002456.1.1.m.35591,0.018291121,-0.010659439,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL002467.1.2.m.47358,0.009662868,0.020703221,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL003539.1.1.m.16619,-0.011791832,0.017215294,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL003853.1.2.m.39529,0.007209515,0.000281821,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL004399.1.1.m.3003,-0.006578574,-0.009186853,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL004839.1.1.m.13815,-0.018282132,0.004118856,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL005197.1.1.m.59507,0.007940588,-0.00060655,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL006854.1.1.m.13363,-0.01368215,0.002774902,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL006988.1.1.m.49733,0.004359808,0.0036208,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL007173.1.1.m.41471,0.001212609,0.015331318,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL007437.1.1.m.29443,0.002028068,-0.014819625,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL007549.1.1.m.13827,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL007787.1.1.m.13188,-0.007322574,-0.01466425,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL008069.1.2.m.58164,0.018957128,-0.006224522,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL008069.2.2.m.60920,0.022537077,0.009677309,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL008069.2.2.m.60921,0.009362017,-0.003055818,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL008257.2.3.m.36861,0.009689466,0.01661803,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL009169.1.1.m.24699,-0.014709191,-0.003302282,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL009187.1.1.m.25730,2.07E-05,-0.012419637,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL009387.1.1.m.66163,-0.004084159,0.003291663,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL009414.1.1.m.639,-0.008942914,-0.001688592,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL010339.1.1.m.63259,-0.010941133,0.004888613,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL010626.1.1.m.52019,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL010939.1.1.m.64870,-0.012331182,0.01244619,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL011273.1.1.m.12717,0.010867898,-0.005491023,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL011391.1.1.m.10090,0.006182795,-0.01269818,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL011527.1.1.m.20909,0.013134536,-0.010452872,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL011814.1.1.m.48797,-0.001023306,-0.013444981,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL011979.1.1.m.59057,0.019601053,-0.008960271,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL012012.1.1.m.11873,0.022066718,-0.010234076,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL012950.1.1.m.1373,-0.011384478,-0.024436687,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL013229.1.2.m.30359,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL013229.2.2.m.57593,0.000439195,-0.001703459,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL014931.1.1.m.24932,0.014531362,-0.018434484,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL015271.1.1.m.56223,-0.012348046,0.00793002,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAK1.1.1.m.14768,-0.008406221,-0.023390392,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAK1.1.1.m.14769,0.001607265,0.009024712,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAKG2.1.1.m.55638,0.011292527,0.010362006,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAMP.1.1.m.13698,0.001665535,0.016716328,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AASI_1435.2.35.m.17918,0.005109573,-0.000770874,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AASI_1435.28.35.m.60443,-0.005008938,0.011848728,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AASI_1435.35.35.m.65339,0.002147847,-0.000872102,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AATF.1.1.m.34004,-2.08E-05,-0.013487854,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AATM.1.1.m.32176,0.018954106,-0.009601003,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ABCA1.1.3.m.6501,0.00426525,-0.013292649,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ABCA1.3.3.m.56453,0.001512533,-0.012949009,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ABCA3.2.6.m.4295,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ABCA3.5.6.m.54787,-0.006395946,-0.00422707,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ABCA4.1.1.m.31461,0.005697466,-0.000846254,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ABCB6.2.3.m.11344,0.001812863,0.01926542,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ABCB6.3.3.m.53101,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ABCE1.1.2.m.7437,0.004472226,0.013360982,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ABCE1.2.2.m.42246,-0.003873363,-0.003098378,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ABCF2.1.2.m.28362,0.00304676,-0.022636915,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ABCG8.1.1.m.3707,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ABHD2.2.2.m.32276,-0.005099327,-0.005295774,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ABI2.2.2.m.65629,-0.010835508,0.005986401,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ABL1.1.1.m.55647,-0.001269083,0.011524714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACA1_060860.1.1.m.52568,0.005534824,-0.001385451,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACA1_091870.1.1.m.43726,-0.014087636,-0.022602303,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACA1_394750.1.2.m.54181,0.011569763,0.015550017,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACAA2.1.1.m.30666,0.011439411,-0.008432089,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACAC.1.2.m.16888,0.00204835,-0.014183003,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACAC.2.2.m.58115,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACAD8.1.1.m.9135,-0.013199429,0.00754614,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACADL.1.1.m.5508,0.010793847,-0.015958523,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACBD5.1.2.m.16744,0.002857214,-0.016044225,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACBP.1.4.m.15501,0.003217696,-0.00592535,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACDOPBH.1.9.m.8787,-0.014181609,0.010040412,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACDOPBH.5.9.m.42992,0.022270473,-0.010739707,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACDOPBH.8.9.m.52946,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACDOPBH.9.9.m.63296,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACE.2.4.m.5302,0.017596014,0.014215675,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACE.4.4.m.17563,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACH5.1.1.m.3951,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACH7.2.2.m.66217,-0.007558489,-0.009867368,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACIN1A.2.2.m.51408,-0.006466123,-0.011917943,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACL6B.1.1.m.62588,-0.00138239,-0.022037577,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACLA_093460.1.1.m.41459,0.006155408,0.000977992,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACLY.1.1.m.65081,0.004410189,-0.000956248,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACO13.1.1.m.30659,-0.004221992,-0.000836489,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACON.1.1.m.61060,0.006092176,-0.006599537,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACOX1.3.3.m.26948,-0.004643439,0.000885919,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACOX3.1.1.m.60111,-0.002946668,-0.00078586,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACSA.1.1.m.61294,0.019426664,0.005703554,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACSF2.2.4.m.30204,-0.022664775,0.01033563,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACSF3.1.1.m.14825,-0.02265859,0.005656774,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACSL1.1.1.m.685,0.011854112,-0.018668542,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACSL1.1.1.m.686,-0.004544117,0.007862549,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACSL4.1.1.m.24576,-0.012051308,0.004379674,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACSM3.1.1.m.23686,0.012485305,0.01804261,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACT.13.27.m.39351,0.006576041,0.001404493,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACT.19.27.m.53936,0.014947175,0.007064053,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACT.22.27.m.58204,0.006576105,0.001405655,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACT.23.27.m.58454,0.00052837,0.004254064,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACT.4.27.m.14034,0.010958415,-0.015804395,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACT.5.27.m.15585,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACT.6.27.m.15622,0.004182846,-0.008259497,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACT1.3.7.m.25836,-0.00508213,-0.011379571,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACT1.4.7.m.29125,-0.003516349,-0.011392692,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACT3.1.3.m.23292,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACT3.3.3.m.66907,0.003859214,0.007924949,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACT3A.1.1.m.25941,-0.004852454,-0.010523446,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACT3A.1.1.m.25943,0.005626764,-0.004632954,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACT5.3.3.m.41147,0.005054575,-0.005796466,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACTC.2.6.m.15315,-0.009816463,0.001494198,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACTC.3.6.m.21571,0.000545636,-0.000655692,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACTN.1.2.m.15252,0.016778645,0.011187933,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACTN.2.2.m.63975,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACTP1.1.1.m.30455,0.006381573,-0.006215026,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACTZ.1.1.m.12877,0.01236816,0.022382791,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ADA.1.1.m.5625,0.022838707,0.000797031,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ADA17.1.3.m.798,-0.001133488,0.00883946,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ADA17.3.3.m.54971,0.009571768,-0.017797698,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ADAL.1.1.m.57556,-0.006227098,0.015639851,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ADAMTS12.1.2.m.29930,-0.017571831,0.00883633,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ADAMTS16.1.1.m.28149,-0.014811463,-0.013738985,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ADAMTS18.1.2.m.4932,0.010012091,-0.010021241,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ADAR.2.3.m.45677,-0.022355269,0.010633781,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ADD.2.5.m.15081,-0.009367583,-0.011075344,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ADD.3.5.m.17639,0.012412783,0.006074217,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ADHX.1.1.m.60159,0.01552019,-0.003109357,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AFG32.1.1.m.59372,0.015896865,-0.004447237,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AFG32.1.1.m.59373,0.023219201,-0.00567061,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AFUA_1G01020.33.50.m.43179,-0.004194137,-0.004706781,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AFUA_1G01020.7.50.m.19296,-0.022664385,0.010339565,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_AFURIN2.1.1.m.59865,-0.007629087,-0.007401208,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; anterior/posterior pattern specification [GO:0009952]; cardiac septum development [GO:0003279]; cell-cell signaling [GO:0007267]; coronary vasculature development [GO:0060976]; cytokine biosynthetic process [GO:0042089]; determination of left/right symmetry [GO:0007368]; embryo implantation [GO:0007566]; embryonic digestive tract development [GO:0048566]; embryonic skeletal system development [GO:0048706]; heart development [GO:0007507]; kidney development [GO:0001822]; limb morphogenesis [GO:0035108]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; regulation of lipoprotein lipase activity [GO:0051004]; renin secretion into blood stream [GO:0002001]; respiratory tube development [GO:0030323]; signal peptide processing [GO:0006465]; viral life cycle [GO:0019058],NA,NA,NA
CHOYP_AGAP_AGAP000232.1.1.m.1999,-0.013885388,0.020937498,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron differentiation [GO:0045666],NA,NA,NA
CHOYP_AGAP_AGAP000991.1.1.m.5123,-1.95E-05,-0.013487914,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434],NA,NA,NA
CHOYP_AGAP_AGAP002199.1.1.m.25337,-0.015702443,-0.014960819,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP002350.1.1.m.37286,0.019834408,-0.004963547,No,NA,NA,NA,NA,NA,NA,troponin complex [GO:0005861]; regulation of muscle contraction [GO:0006937],NA,NA,NA
CHOYP_AGAP_AGAP002350.1.1.m.37287,0.02097174,0.00717045,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; abscisic acid-activated signaling pathway [GO:0009738]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777],NA,NA,NA
CHOYP_AGAP_AGAP002739.1.5.m.19925,0.015306895,-0.017757208,No,NA,NA,NA,NA,NA,NA,apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_AGAP_AGAP002739.3.5.m.47030,0.012720961,0.021191412,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_AGAP_AGAP002739.4.5.m.55695,0.001267965,0.003279737,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793],NA,NA,NA
CHOYP_AGAP_AGAP002739.5.5.m.60925,0.007672487,-0.008113189,No,NA,NA,NA,NA,NA,NA,acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; Notch binding [GO:0005112]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle arrest [GO:0007050]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; regulation of transcription; DNA-templated [GO:0006355]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; transcription initiation from RNA polymerase II promoter [GO:0006367]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],NA,NA,NA
CHOYP_AGAP_AGAP004136.1.3.m.24172,-0.005242313,-0.008713227,No,NA,NA,NA,NA,NA,NA,cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; protein domain specific binding [GO:0019904]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; axial mesoderm development [GO:0048318]; axial mesoderm morphogenesis [GO:0048319]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ectoderm development [GO:0007398]; embryonic foregut morphogenesis [GO:0048617]; endoderm development [GO:0007492]; epithelial cell morphogenesis [GO:0003382]; epithelial to mesenchymal transition [GO:0001837]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mesoderm development [GO:0007498]; mesoderm migration involved in gastrulation [GO:0007509]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of protein binding [GO:0032091]; neural plate morphogenesis [GO:0001839]; paraxial mesoderm development [GO:0048339]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of protein binding [GO:0032092]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of establishment of protein localization [GO:0070201]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]; substrate-dependent cell migration; cell attachment to substrate [GO:0006931]; unidimensional cell growth [GO:0009826],NA,NA,NA
CHOYP_AGAP_AGAP004136.3.3.m.44418,-0.004610327,0.005176283,No,NA,NA,NA,NA,NA,NA,cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; protein domain specific binding [GO:0019904]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; axial mesoderm development [GO:0048318]; axial mesoderm morphogenesis [GO:0048319]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ectoderm development [GO:0007398]; embryonic foregut morphogenesis [GO:0048617]; endoderm development [GO:0007492]; epithelial cell morphogenesis [GO:0003382]; epithelial to mesenchymal transition [GO:0001837]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mesoderm development [GO:0007498]; mesoderm migration involved in gastrulation [GO:0007509]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of protein binding [GO:0032091]; neural plate morphogenesis [GO:0001839]; paraxial mesoderm development [GO:0048339]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of protein binding [GO:0032092]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of establishment of protein localization [GO:0070201]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]; substrate-dependent cell migration; cell attachment to substrate [GO:0006931]; unidimensional cell growth [GO:0009826],NA,NA,NA
CHOYP_AGAP_AGAP004136.3.3.m.44420,0.016592853,0.002485158,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_AGAP_AGAP004179.1.1.m.33303,-0.014785526,0.020184663,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; calcium ion binding [GO:0005509]; mitochondrial calcium ion transmembrane transport [GO:0006851],NA,NA,NA
CHOYP_AGAP_AGAP004481.1.1.m.8676,-0.007968752,-0.015907099,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP004499.1.1.m.13546,0.007705817,0.001928089,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_AGAP_AGAP004861.2.2.m.54567,0.001272508,-0.013013216,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body; internal vesicle [GO:0097487]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-containing complex binding [GO:0044877]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; epithelial cell differentiation [GO:0030855]; negative regulation of epithelial cell migration [GO:0010633]; pigment granule maturation [GO:0048757]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endocytosis [GO:0045807]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746],NA,NA,NA
CHOYP_AGAP_AGAP004868.1.1.m.60336,-0.00625662,-0.008759264,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; regulation of cell proliferation [GO:0042127],NA,NA,NA
CHOYP_AGAP_AGAP004885.1.1.m.29831,-0.004026827,-0.00081322,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; protein maturation by [2Fe-2S] cluster transfer [GO:0106034],NA,NA,NA
CHOYP_AGAP_AGAP005057.1.1.m.62428,0.012300072,-0.012963476,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP005942.1.3.m.3157,0.012604294,-0.018295221,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP006478.1.1.m.44472,-0.014179409,-0.004842616,No,NA,NA,NA,NA,NA,NA,oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_AGAP_AGAP006590.1.1.m.42108,-0.005645268,-0.003344616,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; synapse [GO:0045202]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; actin cytoskeleton organization [GO:0030036]; intracellular signal transduction [GO:0035556]; positive regulation of filopodium assembly [GO:0051491]; regulation of axonogenesis [GO:0050770]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synapse structure or activity [GO:0050803],NA,NA,NA
CHOYP_AGAP_AGAP006810.1.2.m.12514,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; NuA3a histone acetyltransferase complex [GO:1990467]; NuA3b histone acetyltransferase complex [GO:1990468]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; histone H2A acetylation [GO:0043968]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982],NA,NA,NA
CHOYP_AGAP_AGAP007120.1.1.m.57542,0.013436384,0.0202274,No,NA,NA,NA,NA,NA,NA,cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; lamellipodium [GO:0030027]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; G-quadruplex DNA binding [GO:0051880]; GDP binding [GO:0019003]; intermediate filament binding [GO:0019215]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein complex oligomerization [GO:0051259]; regulation of epidermis development [GO:0045682]; response to growth hormone [GO:0060416]; UTP biosynthetic process [GO:0006228],NA,NA,NA
CHOYP_AGAP_AGAP007340.1.2.m.2953,-0.005542678,-0.012456814,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female pronucleus [GO:0001939]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; melanosome [GO:0042470]; midbody [GO:0030496]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; glucose transmembrane transporter activity [GO:0005355]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein self-association [GO:0043621]; xenobiotic transmembrane transporter activity [GO:0042910]; cellular hyperosmotic response [GO:0071474]; cellular response to glucose starvation [GO:0042149]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; dehydroascorbic acid transport [GO:0070837]; female pregnancy [GO:0007565]; glucose transmembrane transport [GO:1904659]; protein-containing complex assembly [GO:0065003]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to osmotic stress [GO:0006970]; response to Thyroglobulin triiodothyronine [GO:1904016]; xenobiotic transport [GO:0042908],NA,NA,NA
CHOYP_AGAP_AGAP007368.1.1.m.8474,0.009499779,0.00026612,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP007681.1.1.m.36727,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,cytoplasmic side of plasma membrane [GO:0009898]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; cell surface receptor signaling pathway [GO:0007166]; chromosome organization [GO:0051276]; immune response [GO:0006955]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_AGAP_AGAP008046.1.1.m.58394,0.016410597,0.000887633,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; cytoskeletal protein binding [GO:0008092]; phospholipid binding [GO:0005543]; actin filament organization [GO:0007015]; auditory receptor cell stereocilium organization [GO:0060088]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; neuron projection morphogenesis [GO:0048812]; plasma membrane tubulation [GO:0097320]; positive regulation of dendrite development [GO:1900006],NA,NA,NA
CHOYP_AGAP_AGAP008287.1.1.m.58727,-0.005621483,0.000400122,No,NA,NA,NA,NA,NA,NA,Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_AGAP_AGAP010186.1.1.m.62503,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; response to stimulus [GO:0050896],NA,NA,NA
CHOYP_AGAP_AGAP010186.1.1.m.62505,0.006333941,-0.006822016,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP010490.1.1.m.51445,-0.009772766,0.012240384,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; extracellular space [GO:0005615]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; Rab GTPase binding [GO:0017137]; vacuolar acidification [GO:0007035],NA,NA,NA
CHOYP_AGAP_AGAP011617.1.2.m.29071,0.020963553,-0.012960161,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP013102.1.1.m.50186,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412],NA,NA,NA
CHOYP_AGO2.1.1.m.17145,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,integral component of endoplasmic reticulum membrane [GO:0030176]; protein transport [GO:0015031]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_AGPS.1.1.m.62910,-0.000918901,-0.009051615,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; peroxisome [GO:0005777]; alkylglycerone-phosphate synthase activity [GO:0008609]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; ether lipid biosynthetic process [GO:0008611],NA,NA,NA
CHOYP_AGRIN.2.5.m.5339,-0.011631152,-0.006341799,No,NA,NA,NA,NA,NA,NA,axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell junction [GO:0030054]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotetramerization [GO:0051290]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416],NA,NA,NA
CHOYP_AGRIN.3.5.m.5652,-0.001112766,-0.00096562,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGRIN.4.5.m.27580,-0.022589014,0.010504426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGSA.1.1.m.5200,0.007642739,-0.000286447,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; adenosine deaminase activity [GO:0004000]; metal ion binding [GO:0046872]; adenosine catabolic process [GO:0006154],NA,NA,NA
CHOYP_AHCTF1.1.1.m.17461,0.010217274,-0.008481081,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; cell cycle [GO:0007049]; cell division [GO:0051301]; hemopoiesis [GO:0030097]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_AIFM1.1.1.m.1582,0.013958619,0.003134407,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; NAD(P)H oxidase activity [GO:0016174]; oxidoreductase activity; acting on NAD(P)H [GO:0016651]; protein dimerization activity [GO:0046983]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitric oxide [GO:0071732]; cellular response to oxygen-glucose deprivation [GO:0090650]; chromosome condensation [GO:0030261]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to ischemia [GO:0002931]; response to L-glutamate [GO:1902065],NA,NA,NA
CHOYP_AIMP1.1.1.m.16360,0.002700762,-0.007304175,No,NA,NA,NA,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; cytokine activity [GO:0005125]; tRNA binding [GO:0000049]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; positive regulation of glucagon secretion [GO:0070094]; translation [GO:0006412],NA,NA,NA
CHOYP_AJL2.1.1.m.26431,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_AK5.1.2.m.7331,-0.01108405,-0.014029769,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; ATP metabolic process [GO:0046034]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142],NA,NA,NA
CHOYP_AKD1.2.3.m.49697,-0.014602003,0.010548372,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]; nucleoside monophosphate kinase activity [GO:0050145]; AMP phosphorylation [GO:0006756]; ATP generation from ADP [GO:0006757]; CDP phosphorylation [GO:0061508]; CMP phosphorylation [GO:0061566]; dADP phosphorylation [GO:0006174]; dAMP phosphorylation [GO:0061565]; dCDP phosphorylation [GO:0061570]; dCMP phosphorylation [GO:0061567]; dGDP phosphorylation [GO:0006186]; GDP phosphorylation [GO:0061568]; nucleobase-containing small molecule interconversion [GO:0015949]; TDP phosphorylation [GO:0061571]; UDP phosphorylation [GO:0061569],NA,NA,NA
CHOYP_AKD1.3.3.m.63103,-0.017920427,-0.011494484,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]; nucleoside monophosphate kinase activity [GO:0050145]; AMP phosphorylation [GO:0006756]; ATP generation from ADP [GO:0006757]; CDP phosphorylation [GO:0061508]; CMP phosphorylation [GO:0061566]; dADP phosphorylation [GO:0006174]; dAMP phosphorylation [GO:0061565]; dCDP phosphorylation [GO:0061570]; dCMP phosphorylation [GO:0061567]; dGDP phosphorylation [GO:0006186]; GDP phosphorylation [GO:0061568]; nucleobase-containing small molecule interconversion [GO:0015949]; TDP phosphorylation [GO:0061571]; UDP phosphorylation [GO:0061569],NA,NA,NA
CHOYP_AKP13.1.5.m.12951,-0.007906523,-0.00571637,No,NA,NA,NA,NA,NA,NA,actin filament [GO:0005884]; cell cortex [GO:0005938]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cAMP-dependent protein kinase activity [GO:0004691]; guanyl-nucleotide exchange factor activity [GO:0005085]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; protein kinase A binding [GO:0051018]; protein-containing complex scaffold activity [GO:0032947]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0086023]; adrenergic receptor signaling pathway [GO:0071875]; bone development [GO:0060348]; cardiac muscle cell differentiation [GO:0055007]; cell growth involved in cardiac muscle cell development [GO:0061049]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; nuclear export [GO:0051168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of glucocorticoid mediated signaling pathway [GO:1900169]; regulation of sarcomere organization [GO:0060297]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_AKT1.2.2.m.51125,-0.002975636,-0.01156709,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; cholesterol homeostasis [GO:0042632]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration; open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; long-term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of triglyceride catabolic process [GO:0010897]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of lipid storage [GO:0010884]; positive regulation of organ growth [GO:0046622]; positive regulation of TORC1 signaling [GO:1904263]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_AL1A1.1.1.m.24832,0.013693081,0.014944925,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; retinal dehydrogenase activity [GO:0001758]; oxidation-reduction process [GO:0055114]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572],NA,NA,NA
CHOYP_AL4A1.1.1.m.28988,-0.014935341,0.017322768,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; 1-pyrroline-5-carboxylate dehydrogenase activity [GO:0003842]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; identical protein binding [GO:0042802]; proline catabolic process to glutamate [GO:0010133],NA,NA,NA
CHOYP_AL8A1.1.1.m.13904,0.012248854,-0.004186275,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620]; liver development [GO:0001889],NA,NA,NA
CHOYP_ALAT2.1.1.m.15163,-0.003005697,0.008785751,No,NA,NA,NA,NA,NA,NA,L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851],NA,NA,NA
CHOYP_ALDH2.3.3.m.25044,0.01931268,0.006730635,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; ethanol catabolic process [GO:0006068],NA,NA,NA
CHOYP_ALDR.1.1.m.50075,0.020469365,-0.009137825,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; 1;5-anhydro-D-fructose reductase activity [GO:0050571]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_ALF.1.3.m.25601,0.011996049,-0.005372648,No,NA,NA,NA,NA,NA,NA,fructose-bisphosphate aldolase activity [GO:0004332]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_ALF.2.3.m.40474,0.008594956,-0.010512514,No,NA,NA,NA,NA,NA,NA,fructose-bisphosphate aldolase activity [GO:0004332]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_ALF.3.3.m.66837,0.018171469,0.013336052,No,NA,NA,NA,NA,NA,NA,fructose-bisphosphate aldolase activity [GO:0004332]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_ALG1.1.1.m.40067,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; chitobiosyldiphosphodolichol beta-mannosyltransferase activity [GO:0004578]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_ALKB8.1.2.m.27789,0.003424565,-0.005758671,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; oxidation-reduction process [GO:0055114]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098],NA,NA,NA
CHOYP_ALPHATUB84D.1.1.m.16562,0.006286625,-0.009978036,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281],NA,NA,NA
CHOYP_ALS2.1.3.m.33568,-0.006686849,0.005514751,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; cell death [GO:0008219]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Rac protein signal transduction [GO:0035022]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of Rho protein signal transduction [GO:0035023]; response to oxidative stress [GO:0006979]; synaptic transmission; glutamatergic [GO:0035249],NA,NA,NA
CHOYP_ALS2.2.3.m.37861,0.002078433,0.014334762,No,NA,NA,NA,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_AMACR.1.1.m.21950,-0.010601997,-0.00993008,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; alpha-methylacyl-CoA racemase activity [GO:0008111]; signaling receptor binding [GO:0005102]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; isoprenoid catabolic process [GO:0008300],NA,NA,NA
CHOYP_AMDHD2.2.2.m.52160,-0.006985156,-0.024575252,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; N-acetylgalactosamine-6-phosphate deacetylase activity [GO:0047419]; N-acetylglucosamine-6-phosphate deacetylase activity [GO:0008448]; carbohydrate metabolic process [GO:0005975]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262],NA,NA,NA
CHOYP_AMO.1.5.m.28337,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038]; amine metabolic process [GO:0009308],NA,NA,NA
CHOYP_AMO.5.5.m.66428,0.005802717,0.013162225,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038]; amine metabolic process [GO:0009308],NA,NA,NA
CHOYP_AMPL.1.1.m.27061,-0.01220312,-0.013820624,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aminopeptidase activity [GO:0004177]; disordered domain specific binding [GO:0097718]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]; peptidase activity [GO:0008233],NA,NA,NA
CHOYP_AMRP.1.1.m.36070,-0.011041551,-0.024529281,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; rough endoplasmic reticulum lumen [GO:0048237]; amyloid-beta binding [GO:0001540]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; signaling receptor binding [GO:0005102]; very-low-density lipoprotein particle receptor binding [GO:0070326]; amyloid-beta clearance by transcytosis [GO:0150093]; extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of cell death [GO:0060548]; negative regulation of protein binding [GO:0032091]; negative regulation of receptor internalization [GO:0002091]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; positive regulation of amyloid-beta clearance [GO:1900223]; regulation of receptor-mediated endocytosis [GO:0048259],NA,NA,NA
CHOYP_AMY.2.3.m.15473,0.008228398,-0.023072217,No,NA,NA,NA,NA,NA,NA,alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_AMY.3.3.m.64271,0.020074464,-0.007251887,No,NA,NA,NA,NA,NA,NA,alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_AN13B.1.1.m.15287,0.004597799,-0.010647973,No,NA,NA,NA,NA,NA,NA,late endosome [GO:0005770]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_ANGP4.3.7.m.24608,0.018087625,0.003636052,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extrinsic component of external side of plasma membrane [GO:0031232]; carbohydrate binding [GO:0030246]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; sialic acid binding [GO:0033691]; signaling pattern recognition receptor activity [GO:0008329]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation; lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 secretion [GO:2000484]; protein localization to cell surface [GO:0034394]; recognition of apoptotic cell [GO:0043654],NA,NA,NA
CHOYP_ANGP4.4.7.m.33574,0.009789872,0.004258549,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; receptor tyrosine kinase binding [GO:0030971]; angiogenesis [GO:0001525],NA,NA,NA
CHOYP_ANK.2.3.m.19487,-0.008393587,0.003580472,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein binding; bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_ANK3.3.9.m.6798,0.005361626,-0.001658656,No,NA,NA,NA,NA,NA,NA,A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding; bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005],NA,NA,NA
CHOYP_ANK3.7.9.m.43272,-0.003502997,-0.007829565,No,NA,NA,NA,NA,NA,NA,A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding; bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005],NA,NA,NA
CHOYP_ANKK1.1.1.m.56194,0.023376676,0.002654996,No,NA,NA,NA,NA,NA,NA,endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport; endosome to plasma membrane [GO:1990126],NA,NA,NA
CHOYP_ANKMY2.1.1.m.18238,0.005351931,0.008493602,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ANKRD27.1.1.m.12550,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; protein transport [GO:0015031],NA,NA,NA
CHOYP_ANKRD5.1.2.m.11711,-0.015307715,0.01337956,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_ANKY2.2.2.m.44213,0.009900991,-0.005986815,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ANLN.1.1.m.6530,0.007392243,0.004500022,No,NA,NA,NA,NA,NA,NA,bleb [GO:0032059]; cell cortex region [GO:0099738]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; actin binding [GO:0003779]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of bleb assembly [GO:1904172],NA,NA,NA
CHOYP_ANM12.1.1.m.53881,0.000463019,-0.018361709,No,NA,NA,NA,NA,NA,NA,methyltransferase activity [GO:0008168]; protein methylation [GO:0006479],NA,NA,NA
CHOYP_ANM3.1.1.m.376,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; histone-arginine N-methyltransferase activity [GO:0008469]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; ribosome binding [GO:0043022]; histone arginine methylation [GO:0034969]; negative regulation of protein ubiquitination [GO:0031397]; peptidyl-arginine methylation; to asymmetrical-dimethyl arginine [GO:0019919]; protein methylation [GO:0006479]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ANM5.1.1.m.1529,0.014369992,-0.011182037,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; E-box binding [GO:0070888]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; protein heterodimerization activity [GO:0046982]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; ribonucleoprotein complex binding [GO:0043021]; transcription corepressor activity [GO:0003714]; cell proliferation [GO:0008283]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription; termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; liver regeneration [GO:0097421]; negative regulation of cell differentiation [GO:0045596]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine N-methylation [GO:0035246]; positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:1904992]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of DNA methylation [GO:0044030]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of mitotic nuclear division [GO:0007088]; regulation of signal transduction by p53 class mediator [GO:1901796]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_ANR11.1.1.m.56842,-0.002965977,0.003484534,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_ANR17.1.2.m.772,-0.012426604,-0.019956719,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275],NA,NA,NA
CHOYP_ANR31.1.1.m.61075,-0.01428457,0.014168724,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_ANR40.1.1.m.1429,-0.005997329,0.003333784,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_ANS1B.1.1.m.46724,0.011348763,-0.006962352,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; regulation of synaptic plasticity by receptor localization to synapse [GO:1900383],NA,NA,NA
CHOYP_ANT_25430.1.2.m.613,-0.004724258,-0.021869938,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ANT_25430.2.2.m.5862,-0.015496007,0.00410925,No,NA,NA,NA,NA,NA,NA,extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; extracellular matrix organization [GO:0030198],NA,NA,NA
CHOYP_ANXA4.1.2.m.19913,-0.022803811,0.005570477,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; chondroitin sulfate binding [GO:0035374]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; epithelial cell differentiation [GO:0030855]; Notch signaling pathway [GO:0007219],NA,NA,NA
CHOYP_ANXA7.1.4.m.4514,-0.020180447,0.010947833,No,NA,NA,NA,NA,NA,NA,chromaffin granule membrane [GO:0042584]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176],NA,NA,NA
CHOYP_AOF.1.1.m.7109,0.002973436,0.006338787,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; primary amine oxidase activity [GO:0008131]; catecholamine metabolic process [GO:0006584]; cellular biogenic amine catabolic process [GO:0042402]; neurotransmitter catabolic process [GO:0042135],NA,NA,NA
CHOYP_AP1G1.1.1.m.13111,0.011319813,-0.012990805,No,NA,NA,NA,NA,NA,NA,AP-1 adaptor complex [GO:0030121]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; collagen binding [GO:0005518]; GTP-dependent protein binding [GO:0030742]; kinesin binding [GO:0019894]; protein C-terminus binding [GO:0008022]; Rab GTPase binding [GO:0017137]; endosome to melanosome transport [GO:0035646]; Golgi to lysosome transport [GO:0090160]; intracellular protein transport [GO:0006886]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_AP1M1.1.1.m.56248,0.005029698,-0.011250891,No,NA,NA,NA,NA,NA,NA,clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; trans-Golgi network membrane [GO:0032588]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; neutrophil degranulation [GO:0043312]; regulation of defense response to virus by virus [GO:0050690],NA,NA,NA
CHOYP_AP2A2.1.1.m.62726,0.003776662,-0.012468964,No,NA,NA,NA,NA,NA,NA,AP-2 adaptor complex [GO:0030122]; cytoplasmic vesicle [GO:0031410]; membrane coat [GO:0030117]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021]; clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; regulation of hematopoietic stem cell differentiation [GO:1902036]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_AP2M1.1.1.m.25996,0.019758316,-0.00251497,No,NA,NA,NA,NA,NA,NA,clathrin adaptor complex [GO:0030131]; clathrin-coated pit [GO:0005905]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_AP2S1.1.1.m.61530,-0.000340543,0.010317601,No,NA,NA,NA,NA,NA,NA,AP-2 adaptor complex [GO:0030122]; plasma membrane [GO:0005886]; protein transporter activity [GO:0008565]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_AP3M2.1.1.m.43706,0.011229896,-0.020381886,No,NA,NA,NA,NA,NA,NA,axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Rab GTPase binding [GO:0017137]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_APBP2.1.1.m.62244,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; nucleus [GO:0005634]; intracellular transport [GO:0046907]; protein transport [GO:0015031],NA,NA,NA
CHOYP_API5.1.1.m.17066,0.007990938,0.00936043,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; fibroblast growth factor binding [GO:0017134]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of fibroblast apoptotic process [GO:2000270],NA,NA,NA
CHOYP_APLA.1.2.m.191,0.006350068,-0.006694971,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to calcium ion [GO:0071277]; cellular response to forskolin [GO:1904322]; circadian rhythm [GO:0007623]; long-term memory [GO:0007616]; modulation of chemical synaptic transmission [GO:0050804]; neuroinflammatory response [GO:0150076]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of long-term synaptic potentiation [GO:1900273]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to lithium ion [GO:0010226],NA,NA,NA
CHOYP_APLP.1.2.m.5955,-0.010578619,-0.012462644,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_APLP.2.2.m.55987,-0.014368499,-0.009311182,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_APN.1.3.m.316,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_APPBP2.1.1.m.9093,-0.018947602,0.004752224,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nucleus [GO:0005634]; microtubule motor activity [GO:0003777]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907],NA,NA,NA
CHOYP_AQR.1.1.m.9127,-0.007233636,-0.0225935,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_ARALYDRAFT_472154.1.1.m.29819,0.019071846,-0.003050381,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_ARB_02478.1.1.m.29725,0.014332959,-0.001138575,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_ARC1A.1.1.m.56262,0.007790479,0.01508212,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; membrane organization [GO:0061024],NA,NA,NA
CHOYP_ARC1A.1.1.m.56263,0.012607118,0.017666016,No,NA,NA,NA,NA,NA,NA,Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; Arp2/3 complex-mediated actin nucleation [GO:0034314],NA,NA,NA
CHOYP_ARF2.1.3.m.10738,-0.005215938,-0.002983517,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_ARF4.1.2.m.8401,-0.007115648,-0.026103698,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_ARF6.1.2.m.3974,0.003943371,0.012571329,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; filopodium membrane [GO:0031527]; Flemming body [GO:0090543]; glutamatergic synapse [GO:0098978]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; ruffle [GO:0001726]; GTP binding [GO:0005525]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996]; actin cytoskeleton organization [GO:0030036]; cellular response to nerve growth factor stimulus [GO:1990090]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; establishment of epithelial cell polarity [GO:0090162]; hepatocyte apoptotic process [GO:0097284]; intracellular protein transport [GO:0006886]; liver development [GO:0001889]; maintenance of postsynaptic density structure [GO:0099562]; myeloid cell apoptotic process [GO:0033028]; negative regulation of dendrite development [GO:2000171]; negative regulation of protein localization to cell surface [GO:2000009]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to cell surface [GO:0034394]; protein localization to endosome [GO:0036010]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of presynapse assembly [GO:1905606]; regulation of Rac protein signal transduction [GO:0035020]; ruffle assembly [GO:0097178]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_ARGI.1.2.m.3263,-0.015015631,0.015225799,No,NA,NA,NA,NA,NA,NA,arginase activity [GO:0004053]; metal ion binding [GO:0046872]; arginine metabolic process [GO:0006525]; urea cycle [GO:0000050],NA,NA,NA
CHOYP_ARH.2.2.m.25884,-0.011089321,-0.008460152,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897],NA,NA,NA
CHOYP_ARHG7.3.5.m.37182,0.011885717,0.004069875,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; astrocyte cell migration [GO:0043615]; lamellipodium assembly [GO:0030032]; positive regulation of apoptotic process [GO:0043065]; postsynaptic actin cytoskeleton organization [GO:0098974]; presynaptic actin cytoskeleton organization [GO:0099140]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_ARHGAP12B.1.2.m.36731,0.016129508,-0.000592111,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; phagocytic cup [GO:0001891]; GTPase activator activity [GO:0005096]; actin filament organization [GO:0007015]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis; engulfment [GO:0006911]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_ARHGAP8.1.1.m.25503,-0.009669376,-0.011863261,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_ARHGEF3.1.1.m.13898,-0.007975142,0.006214521,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_ARI2.1.1.m.34963,0.007148441,-0.012517845,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_ARI4B.1.1.m.56056,-0.017416581,0.007262795,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_ARID3A.1.1.m.55743,0.008644863,-0.011918313,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_ARIP4.3.3.m.33366,0.013246886,0.017414203,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386],NA,NA,NA
CHOYP_ARL6.1.2.m.29833,-0.000364747,-0.002311462,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; gastrulation [GO:0007369]; intracellular protein transport [GO:0006886]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pectoral fin development [GO:0033339]; protein localization to cilium [GO:0061512]; regulation of Notch signaling pathway [GO:0008593]; response to stimulus [GO:0050896]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601],NA,NA,NA
CHOYP_ARL6IP1.1.1.m.13877,0.012498034,0.009415554,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]; identical protein binding [GO:0042802]; apoptotic process [GO:0006915]; cotranslational protein targeting to membrane [GO:0006613]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of L-glutamate import across plasma membrane [GO:0002038],NA,NA,NA
CHOYP_ARL8A.1.1.m.12151,-0.017347803,-0.002979746,No,NA,NA,NA,NA,NA,NA,late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774]; GTP binding [GO:0005525]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059],NA,NA,NA
CHOYP_ARMC6.1.1.m.28786,-0.009644346,-0.010847871,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; hematopoietic progenitor cell differentiation [GO:0002244],NA,NA,NA
CHOYP_ARMC9.1.1.m.57265,-0.001408737,-0.003538656,No,NA,NA,NA,NA,NA,NA,ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cilium assembly [GO:0060271],NA,NA,NA
CHOYP_ARNT.1.1.m.19078,-0.007726281,-0.010874937,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; myosin binding [GO:0017022]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; insulin receptor signaling pathway [GO:0008286]; limb development [GO:0060173]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of R7 cell differentiation [GO:0045676]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ARP2.1.1.m.43520,0.005162123,0.000244409,No,NA,NA,NA,NA,NA,NA,Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; ATP binding [GO:0005524]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_ARP3.1.1.m.6867,0.009093524,-0.006506832,No,NA,NA,NA,NA,NA,NA,Arp2/3 protein complex [GO:0005885]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; asymmetric cell division [GO:0008356]; cellular response to interferon-gamma [GO:0071346]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; meiotic chromosome movement towards spindle pole [GO:0016344]; meiotic cytokinesis [GO:0033206]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spindle localization [GO:0051653],NA,NA,NA
CHOYP_ARP6.1.1.m.17920,-0.011787814,-0.002095714,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; chromatin remodeling [GO:0006338],NA,NA,NA
CHOYP_ARP8.1.1.m.10729,-2.87E-05,-0.016607355,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281],NA,NA,NA
CHOYP_ARPC2.1.1.m.50573,0.010999298,0.015977837,No,NA,NA,NA,NA,NA,NA,Arp2/3 protein complex [GO:0005885]; cell junction [GO:0030054]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; synapse [GO:0045202]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314],NA,NA,NA
CHOYP_ARPC4.2.2.m.35677,-0.003286588,0.012131974,No,NA,NA,NA,NA,NA,NA,Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; protein binding; bridging [GO:0030674]; structural constituent of cytoskeleton [GO:0005200]; actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314],NA,NA,NA
CHOYP_ARRB.1.2.m.25932,0.013490534,0.010084859,No,NA,NA,NA,NA,NA,NA,clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_ARRD.6.1.1.m.9470,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ARRD3.2.2.m.64983,0.00778017,0.002705549,No,NA,NA,NA,NA,NA,NA,early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; beta-3 adrenergic receptor binding [GO:0031699]; fat pad development [GO:0060613]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; skin development [GO:0043588]; temperature homeostasis [GO:0001659],NA,NA,NA
CHOYP_ASCC1.1.1.m.39863,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ASCC2.1.1.m.34978,0.006227006,-0.014852185,No,NA,NA,NA,NA,NA,NA,activating signal cointegrator 1 complex [GO:0099053]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA dealkylation involved in DNA repair [GO:0006307]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ASCC3.1.1.m.51755,-0.004134512,-0.004222553,No,NA,NA,NA,NA,NA,NA,activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; ATP-dependent helicase activity [GO:0008026]; nucleic acid binding [GO:0003676]; cell proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508],NA,NA,NA
CHOYP_ASGR2.3.4.m.47793,0.004307408,-0.013198708,No,NA,NA,NA,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_ASK1.1.2.m.586,0.00070503,-0.023933414,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; activation of MAPKK activity [GO:0000186],NA,NA,NA
CHOYP_ASM.1.1.m.21521,-0.012003871,-0.012205499,No,NA,NA,NA,NA,NA,NA,endosome [GO:0005768]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021],NA,NA,NA
CHOYP_ASMTL.1.1.m.20115,0.003518038,-0.013589608,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171],NA,NA,NA
CHOYP_ASNA.1.1.m.52208,-0.012889914,-0.002458474,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; protein insertion into ER membrane [GO:0045048],NA,NA,NA
CHOYP_ASPH.1.2.m.35319,-0.000432045,-0.023137187,No,NA,NA,NA,NA,NA,NA,cortical endoplasmic reticulum [GO:0032541]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; calcium ion binding [GO:0005509]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; face morphogenesis [GO:0060325]; limb morphogenesis [GO:0035108]; negative regulation of cell proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of inositol 1;4;5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021],NA,NA,NA
CHOYP_ASPM.1.4.m.6650,0.006490569,0.004201896,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ASSY.2.4.m.43713,0.001294794,-0.011744209,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; urea cycle [GO:0000050],NA,NA,NA
CHOYP_ASUN.1.1.m.6333,0.012162711,0.02229032,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell division [GO:0051301]; centrosome localization [GO:0051642]; flagellated sperm motility [GO:0030317]; mitotic spindle organization [GO:0007052]; protein localization to nuclear envelope [GO:0090435]; regulation of fertilization [GO:0080154]; regulation of mitotic cell cycle [GO:0007346]; snRNA transcription by RNA polymerase II [GO:0042795],NA,NA,NA
CHOYP_AT1.1.1.m.66793,-0.008527134,-0.017735663,No,NA,NA,NA,NA,NA,NA,glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_AT10A.1.1.m.56662,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AT1A.1.1.m.18017,0.016871156,-0.015143746,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391],NA,NA,NA
CHOYP_AT5F1.1.1.m.12896,0.003939494,0.01249855,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex; coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proton transmembrane transporter activity [GO:0015078]; transmembrane transporter activity [GO:0022857]; ATP biosynthetic process [GO:0006754]; ATP hydrolysis coupled cation transmembrane transport [GO:0099132]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; substantia nigra development [GO:0021762],NA,NA,NA
CHOYP_ATC1.1.1.m.5160,0.017110096,0.014519985,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; calcium-transporting ATPase activity [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity; phosphorylative mechanism [GO:0008553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874],NA,NA,NA
CHOYP_ATC1.1.1.m.5161,-0.009924107,0.005939186,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_ATE1.1.3.m.6901,-0.016330162,0.000749568,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; arginyltransferase activity [GO:0004057]; proteasomal protein catabolic process [GO:0010498]; protein arginylation [GO:0016598],NA,NA,NA
CHOYP_ATG2A.1.1.m.57169,0.004342809,-0.012410104,No,NA,NA,NA,NA,NA,NA,extrinsic component of membrane [GO:0019898]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422],NA,NA,NA
CHOYP_ATG3.1.1.m.25570,0.012069261,-0.006202849,No,NA,NA,NA,NA,NA,NA,cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]; Atg12 transferase activity [GO:0019777]; Atg8 ligase activity [GO:0019776]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; protein transport [GO:0015031],NA,NA,NA
CHOYP_ATG7.1.1.m.34175,0.005322527,-0.016762239,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407]; Atg12 activating enzyme activity [GO:0019778]; Atg8 activating enzyme activity [GO:0019779]; protein homodimerization activity [GO:0042803]; transcription factor binding [GO:0008134]; adult walking behavior [GO:0007628]; amino acid homeostasis [GO:0080144]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of host cells involved in interaction with symbiont [GO:0075044]; autophagy of mitochondrion [GO:0000422]; C-terminal protein lipidation [GO:0006501]; cardiac muscle cell development [GO:0055013]; cellular homeostasis [GO:0019725]; cellular response to hyperoxia [GO:0071455]; cellular response to nitrogen starvation [GO:0006995]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system neuron axonogenesis [GO:0021955]; cerebellar Purkinje cell layer development [GO:0021680]; cerebral cortex development [GO:0021987]; defense response to virus [GO:0051607]; late nucleophagy [GO:0044805]; liver development [GO:0001889]; macroautophagy [GO:0016236]; membrane organization [GO:0061024]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of mitochondrial DNA replication [GO:0090298]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of phagocytosis [GO:0050765]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; negative stranded viral RNA replication [GO:0039689]; nervous system process [GO:0050877]; neuron projection development [GO:0031175]; organelle organization [GO:0006996]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of mucus secretion [GO:0070257]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein modification process [GO:0031401]; post-embryonic development [GO:0009791]; protein catabolic process [GO:0030163]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]; pyramidal neuron development [GO:0021860]; regulation of cell development [GO:0060284]; regulation of circadian rhythm [GO:0042752]; regulation of hemopoiesis [GO:1903706]; regulation of neuron death [GO:1901214]; regulation of protein ubiquitination [GO:0031396]; response to starvation [GO:0042594]; suppression by virus of host autophagy [GO:0039521],NA,NA,NA
CHOYP_ATIC.1.1.m.17816,-0.003196387,-0.020739835,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; protein homodimerization activity [GO:0042803]; 'de novo' IMP biosynthetic process [GO:0006189],NA,NA,NA
CHOYP_ATP13A.1.1.m.10161,-0.001983235,-0.019614859,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874],NA,NA,NA
CHOYP_ATP2B3.1.1.m.6573,-0.001843126,0.004494281,No,NA,NA,NA,NA,NA,NA,extracellular vesicle [GO:1903561]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; ATP binding [GO:0005524]; calcium ion transmembrane transporter activity [GO:0015085]; calcium-transporting ATPase activity [GO:0005388]; calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; calcium ion export across plasma membrane [GO:1990034]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480],NA,NA,NA
CHOYP_ATP5B.1.1.m.22321,0.01454692,-0.013800564,No,NA,NA,NA,NA,NA,NA,mitochondrial proton-transporting ATP synthase complex; catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_ATP5C1.1.1.m.16222,0.004038133,-0.004826145,No,NA,NA,NA,NA,NA,NA,mitochondrial proton-transporting ATP synthase complex; catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_ATP5H.1.1.m.22927,0.007132744,-0.004425298,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ATP6AP1.1.1.m.18150,-0.011016877,-0.019177721,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting V-type ATPase; V1 domain [GO:0033180]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; Rab GTPase binding [GO:0017137]; transporter activity [GO:0005215]; ATP hydrolysis coupled proton transport [GO:0015991]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; establishment of organelle localization [GO:0051656]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; pH reduction [GO:0045851]; positive regulation of bone resorption [GO:0045780]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast development [GO:2001206]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]; transferrin transport [GO:0033572],NA,NA,NA
CHOYP_ATP7A.1.1.m.23099,0.001657093,-0.007478462,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane raft [GO:0045121]; microvillus [GO:0005902]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; copper-dependent protein binding [GO:0032767]; copper-exporting ATPase activity [GO:0004008]; copper-transporting ATPase activity [GO:0043682]; cuprous ion binding [GO:1903136]; Rac GTPase binding [GO:0048365]; cellular copper ion homeostasis [GO:0006878]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cobalt ion [GO:0071279]; cellular response to copper ion [GO:0071280]; cellular response to hypoxia [GO:0071456]; cellular response to iron ion [GO:0071281]; cellular response to lead ion [GO:0071284]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; copper ion export [GO:0060003]; in utero embryonic development [GO:0001701]; lactation [GO:0007595]; liver development [GO:0001889]; negative regulation of iron ion transmembrane transport [GO:0034760]; positive regulation of cell size [GO:0045793]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of response to wounding [GO:1903036]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of gene expression [GO:0010468]; response to copper ion [GO:0046688]; response to iron(III) ion [GO:0010041]; response to lead ion [GO:0010288]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043],NA,NA,NA
CHOYP_ATPA.1.1.m.50245,0.002325697,-0.008939525,No,NA,NA,NA,NA,NA,NA,mitochondrial proton-transporting ATP synthase complex; catalytic core F(1) [GO:0000275]; plasma membrane [GO:0005886]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; electron transport chain [GO:0022900]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_ATPB.1.1.m.21960,-0.007840682,-0.005833668,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex; catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986],NA,NA,NA
CHOYP_ATRIP.1.1.m.15992,0.009613848,-0.003653614,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; DNA damage checkpoint [GO:0000077]; DNA replication [GO:0006260]; interstrand cross-link repair [GO:0036297],NA,NA,NA
CHOYP_ATRP.1.1.m.22451,-0.009462601,-0.009997114,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ATRX.1.1.m.14705,0.000319746,-0.000117074,No,NA,NA,NA,NA,NA,NA,condensed nuclear chromosome; centromeric region [GO:0000780]; nuclear chromosome; telomeric region [GO:0000784]; nuclear pericentric heterochromatin [GO:0031618]; nuclear subtelomeric heterochromatin [GO:1990707]; PML body [GO:0016605]; telomeric heterochromatin [GO:0031933]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; DNA translocase activity [GO:0015616]; helicase activity [GO:0004386]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; cellular response to hydroxyurea [GO:0072711]; chromatin remodeling [GO:0006338]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA damage response; signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; DNA replication-independent nucleosome assembly [GO:0006336]; forebrain development [GO:0030900]; meiotic spindle organization [GO:0000212]; multicellular organism growth [GO:0035264]; negative regulation of maintenance of mitotic sister chromatid cohesion; telomeric [GO:1904908]; negative regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901581]; nucleosome assembly [GO:0006334]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic forelimb morphogenesis [GO:0035128]; protein localization to chromosome; telomeric region [GO:0070198]; regulation of histone H3-K9 trimethylation [GO:1900112]; replication fork processing [GO:0031297]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_ATS10.1.1.m.43473,0.004844055,-0.017718739,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; eye development [GO:0001654]; negative regulation of platelet aggregation [GO:0090331],NA,NA,NA
CHOYP_ATS16.2.4.m.14579,-0.000222455,-0.000403097,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; branching involved in ureteric bud morphogenesis [GO:0001658]; male gamete generation [GO:0048232]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],NA,NA,NA
CHOYP_ATS2.1.2.m.39791,0.022050895,-0.007915582,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; branching involved in ureteric bud morphogenesis [GO:0001658]; male gamete generation [GO:0048232]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],NA,NA,NA
CHOYP_ATS20.2.2.m.52571,0.003882557,-0.003133451,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573],NA,NA,NA
CHOYP_ATS6.3.3.m.56109,-0.012833457,-0.016352844,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; branching involved in ureteric bud morphogenesis [GO:0001658]; male gamete generation [GO:0048232]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],NA,NA,NA
CHOYP_ATXN10.1.1.m.33209,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471],NA,NA,NA
CHOYP_AUHM.1.2.m.28847,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; itaconyl-CoA hydratase activity [GO:0050011]; methylglutaconyl-CoA hydratase activity [GO:0004490]; mRNA 3'-UTR binding [GO:0003730]; fatty acid beta-oxidation [GO:0006635]; leucine catabolic process [GO:0006552],NA,NA,NA
CHOYP_AUHM.2.2.m.44102,0.003386666,0.022475881,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635],NA,NA,NA
CHOYP_B3GT2.1.1.m.35771,0.004975149,-0.012698606,No,NA,NA,NA,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_BACH1.3.17.m.6935,0.010854693,0.01391998,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; Cul3-RING ubiquitin ligase complex [GO:0031463]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BACH1.8.17.m.18006,-0.018198802,0.00352248,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BACOIKO003_21.1.1.m.44123,0.014320872,0.001377473,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BAG1.2.2.m.60616,0.014332343,0.013916446,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of apoptotic process [GO:0043066]; regulation of cellular response to heat [GO:1900034],NA,NA,NA
CHOYP_BAG3.1.1.m.15160,-0.005005639,0.000983584,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of phosphatidylinositol-3;4;5-trisphosphate 5-phosphatase activity [GO:2001145]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion [GO:0045785]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; regulation of cellular response to heat [GO:1900034]; ruffle assembly [GO:0097178]; tumor necrosis factor-mediated signaling pathway [GO:0033209],NA,NA,NA
CHOYP_BAG6A.1.1.m.25802,-0.013032892,-0.020842499,No,NA,NA,NA,NA,NA,NA,BAT3 complex [GO:0071818]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ribosome binding [GO:0043022]; brain development [GO:0007420]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ER-associated misfolded protein catabolic process [GO:0071712]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; proteasomal protein catabolic process [GO:0010498]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of embryonic development [GO:0045995]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BAI1.1.2.m.4434,-0.003669478,0.006102674,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416],NA,NA,NA
CHOYP_BAP18.1.1.m.48944,-0.010734643,-0.011561332,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; NURF complex [GO:0016589]; DNA binding [GO:0003677]; chromatin organization [GO:0006325],NA,NA,NA
CHOYP_BAP31.1.1.m.62939,-0.003293511,-0.005161397,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BARBAKC583_0145.1.1.m.10555,0.003591359,0.007685583,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BAT1.4.4.m.32273,0.004294958,-0.007963358,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-amino acid transmembrane transporter activity [GO:0015179]; L-cystine transmembrane transporter activity [GO:0015184]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; L-cystine transport [GO:0015811]; leukocyte migration [GO:0050900]; neutral amino acid transport [GO:0015804]; protein-containing complex assembly [GO:0065003],NA,NA,NA
CHOYP_BAX.1.1.m.30787,-0.008268048,-0.016281495,No,NA,NA,NA,NA,NA,NA,BAX complex [GO:0097144]; Bcl-2 family protein complex [GO:0097136]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pore complex [GO:0046930]; BH3 domain binding [GO:0051434]; channel activity [GO:0015267]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; lipid binding [GO:0008289]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; apoptotic mitochondrial changes [GO:0008637]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell homeostatic proliferation [GO:0002358]; B cell negative selection [GO:0002352]; B cell receptor apoptotic signaling pathway [GO:1990117]; blood vessel remodeling [GO:0001974]; cellular response to organic substance [GO:0071310]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; development of secondary sexual characteristics [GO:0045136]; ectopic germ cell programmed cell death [GO:0035234]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; fertilization [GO:0009566]; germ cell development [GO:0007281]; glycosphingolipid metabolic process [GO:0006687]; homeostasis of number of cells within a tissue [GO:0048873]; hypothalamus development [GO:0021854]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein binding [GO:0032091]; neuron apoptotic process [GO:0051402]; neuron migration [GO:0001764]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of developmental pigmentation [GO:0048087]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein homooligomerization [GO:0051260]; protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:0001844]; regulation of cell cycle [GO:0051726]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of nitrogen utilization [GO:0006808]; regulation of protein heterodimerization activity [GO:0043497]; regulation of protein homodimerization activity [GO:0043496]; release of cytochrome c from mitochondria [GO:0001836]; release of matrix enzymes from mitochondria [GO:0032976]; response to axon injury [GO:0048678]; response to gamma radiation [GO:0010332]; response to salt stress [GO:0009651]; response to toxic substance [GO:0009636]; retina development in camera-type eye [GO:0060041]; retinal cell programmed cell death [GO:0046666]; Sertoli cell proliferation [GO:0060011]; spermatid differentiation [GO:0048515]; T cell homeostatic proliferation [GO:0001777]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068],NA,NA,NA
CHOYP_BAZ1A.1.1.m.9485,-0.005540669,-0.002108313,No,NA,NA,NA,NA,NA,NA,ACF complex [GO:0016590]; CHRAC [GO:0008623]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; DNA-dependent DNA replication [GO:0006261]; histone acetylation [GO:0016573]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_BAZ1B.1.1.m.24480,-0.008693406,-0.008928521,No,NA,NA,NA,NA,NA,NA,condensed chromosome [GO:0000793]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]; ATP binding [GO:0005524]; histone binding [GO:0042393]; histone kinase activity [GO:0035173]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; histone phosphorylation [GO:0016572]; positive regulation of gene expression; epigenetic [GO:0045815]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_BBOV_II003210.5.13.m.30678,-0.008530693,-0.001854242,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BBS4.1.1.m.50943,-0.009617481,0.011561597,No,NA,NA,NA,NA,NA,NA,BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; microtubule motor activity [GO:0003777]; RNA polymerase II repressing transcription factor binding [GO:0001103]; adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; heart looping [GO:0001947]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; maintenance of protein location in nucleus [GO:0051457]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of systemic arterial blood pressure [GO:0003085]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cilium assembly [GO:0045724]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to organelle [GO:0033365]; protein localization to photoreceptor outer segment [GO:1903546]; protein transport [GO:0015031]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of cytokinesis [GO:0032465]; regulation of lipid metabolic process [GO:0019216]; regulation of non-motile cilium assembly [GO:1902855]; regulation of stress fiber assembly [GO:0051492]; retina homeostasis [GO:0001895]; retinal rod cell development [GO:0046548]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BBS5.1.1.m.56560,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; phosphatidylinositol-3-phosphate binding [GO:0032266]; compound eye development [GO:0048749]; compound eye photoreceptor development [GO:0042051]; gastrulation [GO:0007369]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pigment granule aggregation in cell center [GO:0051877]; pronephros formation [GO:0072116],NA,NA,NA
CHOYP_BCAS0157.2.2.m.53484,0.01900448,-0.00600352,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BCAS3.1.1.m.6968,-0.00454436,-0.008152151,No,NA,NA,NA,NA,NA,NA,cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; intermediate filament cytoskeleton [GO:0045111]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone binding [GO:0042393]; nuclear hormone receptor binding [GO:0035257]; transcription factor binding [GO:0008134]; activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; cellular response to estrogen stimulus [GO:0071391]; Golgi organization [GO:0007030]; microtubule organizing center organization [GO:0031023]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of catalytic activity [GO:0043085]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of establishment of cell polarity [GO:2000114]; response to starvation [GO:0042594]; tube formation [GO:0035148],NA,NA,NA
CHOYP_BCAT1.1.1.m.54127,0.011295882,0.002806491,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; branched-chain-amino-acid transaminase activity [GO:0004084]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-valine transaminase activity [GO:0052655]; cellular response to leukemia inhibitory factor [GO:1990830]; isoleucine catabolic process [GO:0006550]; leucine biosynthetic process [GO:0009098]; regulation of hormone levels [GO:0010817]; valine biosynthetic process [GO:0009099],NA,NA,NA
CHOYP_BCKD.2.2.m.60038,-0.014743463,0.003729844,No,NA,NA,NA,NA,NA,NA,mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; [3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; branched-chain amino acid catabolic process [GO:0009083]; cellular amino acid catabolic process [GO:0009063]; phosphorylation [GO:0016310],NA,NA,NA
CHOYP_BCL3.1.2.m.56007,0.009876239,0.019905784,No,NA,NA,NA,NA,NA,NA,Bcl3-Bcl10 complex [GO:0032996]; Bcl3/NF-kappaB2 complex [GO:0033257]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein binding; bridging [GO:0030674]; transcription factor binding [GO:0008134]; antimicrobial humoral response [GO:0019730]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response; signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; maintenance of protein location in nucleus [GO:0051457]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-8 biosynthetic process [GO:0045415]; negative regulation of JAK-STAT cascade [GO:0046426]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 biosynthetic process [GO:0045082]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; protein import into nucleus; translocation [GO:0000060]; regulation of apoptotic process [GO:0042981]; regulation of DNA binding [GO:0051101]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_BCL3.2.2.m.57485,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,Bcl3/NF-kappaB2 complex [GO:0033257]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; aging [GO:0007568]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; lymph node development [GO:0048535]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription; DNA-templated [GO:0006355]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; rhythmic process [GO:0048511]; spleen development [GO:0048536],NA,NA,NA
CHOYP_BCL7A.1.1.m.29528,0.003737865,0.012562438,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BDH2.1.2.m.30737,0.010088676,0.018291297,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; oxidoreductase activity; acting on the CH-CH group of donors; NAD or NADP as acceptor [GO:0016628]; heme metabolic process [GO:0042168]; iron ion homeostasis [GO:0055072]; siderophore biosynthetic process [GO:0019290],NA,NA,NA
CHOYP_BDH2.2.2.m.57286,0.007879957,0.003150465,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; oxidoreductase activity; acting on the CH-CH group of donors; NAD or NADP as acceptor [GO:0016628]; heme metabolic process [GO:0042168]; iron ion homeostasis [GO:0055072]; siderophore biosynthetic process [GO:0019290],NA,NA,NA
CHOYP_BDHB.1.1.m.9128,-0.022561485,0.009982919,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BET1L.1.1.m.8210,-0.013077332,-0.016910755,No,NA,NA,NA,NA,NA,NA,integral component of Golgi membrane [GO:0030173]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BGAL.2.2.m.41942,-0.010055025,-0.00792649,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_BH13620.1.1.m.41020,-0.022659421,0.010370991,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II; core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; ubiquitin protein ligase binding [GO:0031625]; 7-methylguanosine mRNA capping [GO:0006370]; DNA-templated transcription; termination [GO:0006353]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of RNA splicing [GO:0033120]; regulation of gene silencing by miRNA [GO:0060964]; regulation of transcription; DNA-templated [GO:0006355]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_BICD2.1.1.m.9177,-0.008112092,-0.023790449,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; host cell viral assembly compartment [GO:0072517]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; cytoskeletal adaptor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; dynein intermediate chain binding [GO:0045505]; protein kinase binding [GO:0019901]; proteinase activated receptor binding [GO:0031871]; Rab GTPase binding [GO:0017137]; microtubule anchoring at microtubule organizing center [GO:0072393]; minus-end-directed organelle transport along microtubule [GO:0072385]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900737]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein localization to organelle [GO:0033365]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of proteinase activated receptor activity [GO:1900276]; stress granule assembly [GO:0034063]; viral process [GO:0016032],NA,NA,NA
CHOYP_BIG1.1.3.m.6444,0.00985767,0.00436875,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; small nuclear ribonucleoprotein complex [GO:0030532]; trans-Golgi network [GO:0005802]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237]; endomembrane system organization [GO:0010256]; Golgi organization [GO:0007030]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; neuron projection development [GO:0031175]; positive regulation of protein glycosylation in Golgi [GO:0090284]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of establishment of cell polarity [GO:2000114]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BIG1.3.3.m.34442,0.003731622,-0.020689451,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; small nuclear ribonucleoprotein complex [GO:0030532]; trans-Golgi network [GO:0005802]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237]; endomembrane system organization [GO:0010256]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein glycosylation in Golgi [GO:0090284]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of establishment of cell polarity [GO:2000114]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BIG3.1.1.m.51447,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; negative regulation of phosphatase activity [GO:0010923]; regulation of ARF protein signal transduction [GO:0032012],NA,NA,NA
CHOYP_BIG3.1.1.m.51448,-0.00187495,0.016933576,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_BIR7B.2.2.m.60973,-0.006746172,0.004523331,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BIRA.1.1.m.18343,-0.010454421,-0.010983573,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; biotin-[acetyl-CoA-carboxylase] ligase activity [GO:0004077]; DNA binding [GO:0003677]; protein biotinylation [GO:0009305]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_BIRC6.1.2.m.51516,-0.006353686,3.05E-05,No,NA,NA,NA,NA,NA,NA,endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BIRC7.3.5.m.22702,-0.001030045,0.01322559,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BL1S2.1.1.m.11618,0.016238087,-0.004454809,No,NA,NA,NA,NA,NA,NA,axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; gamma-tubulin complex [GO:0000930]; lysosomal membrane [GO:0005765]; gamma-tubulin binding [GO:0043015]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosomal transport [GO:0016197]; lysosome localization [GO:0032418]; negative regulation of lymphoid progenitor cell differentiation [GO:1905457]; negative regulation of Notch signaling pathway [GO:0045746]; neuron projection development [GO:0031175]; positive regulation of hematopoietic stem cell differentiation [GO:1902038]; positive regulation of myeloid progenitor cell differentiation [GO:1905455],NA,NA,NA
CHOYP_BLIMP.1.1.1.m.55502,0.009556219,0.013450546,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BLMH.1.1.m.66065,0.002996077,-0.016010981,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; carboxypeptidase activity [GO:0004180]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; homocysteine catabolic process [GO:0043418]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; response to drug [GO:0042493]; response to toxic substance [GO:0009636],NA,NA,NA
CHOYP_BLOC1S4.1.1.m.22903,-0.009309176,0.005872529,No,NA,NA,NA,NA,NA,NA,axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cytoplasm [GO:0005737]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; melanosome organization [GO:0032438]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]; platelet aggregation [GO:0070527],NA,NA,NA
CHOYP_BLVRA.1.1.m.17904,-0.010892988,-0.005993312,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; biliverdin reductase activity [GO:0004074]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270]; heme catabolic process [GO:0042167]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_BM1_00205.2.4.m.5170,0.003791581,-0.025625328,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BM1_05690.1.1.m.23253,-0.004139763,-0.023812731,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BM1_24035.1.1.m.40152,0.018804557,-0.008983443,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of collagen fibril organization [GO:1904027]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_BM1_57400.5.7.m.58033,-0.002227197,0.001554352,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_BM8F.1.2.m.3009,0.005449302,-0.010190051,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BM8F.2.2.m.35731,0.023261541,-0.007443827,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BMS1.1.1.m.17619,-0.002301192,-0.020142998,No,NA,NA,NA,NA,NA,NA,90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_BN6_64710.1.1.m.52168,-0.022560925,0.009981935,No,NA,NA,NA,NA,NA,NA,3-hydroxybutyrate dehydrogenase activity [GO:0003858],NA,NA,NA
CHOYP_BOP1.1.1.m.66373,-0.006738963,-0.020428634,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome; large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463]; regulation of cell cycle [GO:0051726],NA,NA,NA
CHOYP_BPHL.1.1.m.55822,-0.006179879,0.006304013,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_BPTF.1.1.m.25244,-0.006340335,0.005021967,No,NA,NA,NA,NA,NA,NA,NURF complex [GO:0016589]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; nuclear receptor binding [GO:0016922]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; hemopoiesis [GO:0030097]; negative regulation of innate immune response [GO:0045824]; negative regulation of JAK-STAT cascade [GO:0046426]; nucleosome mobilization [GO:0042766]; positive regulation of Notch signaling pathway [GO:0045747]; pupariation [GO:0035073]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid differentiation [GO:0048515]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_BRAF.2.3.m.21192,-0.013256675,-0.009597134,No,NA,NA,NA,NA,NA,NA,cell body [GO:0044297]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; animal organ morphogenesis [GO:0009887]; CD4-positive or CD8-positive; alpha-beta T cell lineage commitment [GO:0043369]; CD4-positive; alpha-beta T cell differentiation [GO:0043367]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of protein localization to membrane [GO:0090150]; face development [GO:0060324]; head morphogenesis [GO:0060323]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; positive regulation of axon regeneration [GO:0048680]; positive regulation of axonogenesis [GO:0050772]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein heterooligomerization [GO:0051291]; protein phosphorylation [GO:0006468]; regulation of cell proliferation [GO:0042127]; regulation of T cell differentiation [GO:0045580]; response to cAMP [GO:0051591]; response to peptide hormone [GO:0043434]; somatic stem cell population maintenance [GO:0035019]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trehalose metabolism in response to stress [GO:0070413]; visual learning [GO:0008542],NA,NA,NA
CHOYP_BRAFLDRAFT_100614.1.1.m.31700,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; sphingomyelin phosphodiesterase activator activity [GO:0016230]; ceramide metabolic process [GO:0006672]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ceramide biosynthetic process [GO:2000304]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_BRAFLDRAFT_100695.1.1.m.47761,-0.014327665,-0.005703915,No,NA,NA,NA,NA,NA,NA,phosphatase binding [GO:0019902],NA,NA,NA
CHOYP_BRAFLDRAFT_101346.1.1.m.1028,-0.004166964,-0.003631055,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; cysteamine dioxygenase activity [GO:0047800]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_102226.1.1.m.48829,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; enzyme binding [GO:0019899]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251]; signaling receptor binding [GO:0005102]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; bile acid biosynthetic process [GO:0006699]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; methyl-branched fatty acid metabolic process [GO:0097089]; neutrophil degranulation [GO:0043312]; protein targeting to peroxisome [GO:0006625]; very long-chain fatty acid catabolic process [GO:0042760],NA,NA,NA
CHOYP_BRAFLDRAFT_102424.4.6.m.51652,-0.007410949,-0.011519683,No,NA,NA,NA,NA,NA,NA,azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosome [GO:0005764]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; RNA binding [GO:0003723]; neutrophil degranulation [GO:0043312]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_BRAFLDRAFT_104092.10.11.m.53767,-0.011356423,-0.0003766,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_104160.1.1.m.29524,0.007611124,0.00374756,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]; protein complex oligomerization [GO:0051259],NA,NA,NA
CHOYP_BRAFLDRAFT_104267.1.1.m.52332,0.009291507,0.003199624,No,NA,NA,NA,NA,NA,NA,proteasome complex [GO:0000502],NA,NA,NA
CHOYP_BRAFLDRAFT_104472.1.1.m.16220,-0.004759611,-0.006793953,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243],NA,NA,NA
CHOYP_BRAFLDRAFT_104488.3.3.m.2973,-0.007687231,-0.011785557,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; nucleobase-containing compound metabolic process [GO:0006139]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384],NA,NA,NA
CHOYP_BRAFLDRAFT_105037.1.1.m.17483,-0.01958089,-0.00308662,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_105238.1.1.m.18657,-0.002805117,0.0015678,No,NA,NA,NA,NA,NA,NA,autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; regulation of vacuole fusion; non-autophagic [GO:0032889]; vacuole organization [GO:0007033],NA,NA,NA
CHOYP_BRAFLDRAFT_106560.10.14.m.46985,-0.003771733,-0.009233318,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_106560.13.14.m.62780,-0.02093894,0.004871245,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_106560.13.14.m.62781,-0.018180532,-0.005851484,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_106560.4.14.m.5053,0.005559103,-0.017268115,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_107506.1.1.m.15759,0.009815404,-0.005990587,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_108193.2.2.m.37878,0.01342654,0.009093779,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; NF-kappaB binding [GO:0051059]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription; DNA-templated [GO:0045892]; tumor necrosis factor-mediated signaling pathway [GO:0033209],NA,NA,NA
CHOYP_BRAFLDRAFT_108792.2.5.m.31493,-0.017825495,0.000623586,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_BRAFLDRAFT_108792.3.5.m.34514,-0.015001857,0.009726335,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_BRAFLDRAFT_108792.4.5.m.45892,-0.000204349,-0.024364056,No,NA,NA,NA,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_BRAFLDRAFT_109077.1.1.m.7494,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_BRAFLDRAFT_109688.1.1.m.59704,-0.011275952,0.000967198,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; poly-hydroxybutyrate biosynthetic process [GO:0042619],NA,NA,NA
CHOYP_BRAFLDRAFT_113534.1.1.m.10828,-0.004730355,0.008620499,No,NA,NA,NA,NA,NA,NA,carbohydrate binding [GO:0030246]; glucose-6-phosphate 1-epimerase activity [GO:0047938]; cellular carbohydrate metabolic process [GO:0044262],NA,NA,NA
CHOYP_BRAFLDRAFT_113552.1.1.m.29171,0.018027623,0.01601442,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; phosphomannomutase activity [GO:0004615]; GDP-mannose biosynthetic process [GO:0009298],NA,NA,NA
CHOYP_BRAFLDRAFT_113596.1.1.m.53557,-1.49E-05,0.014568988,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; intracellular [GO:0005622]; nucleus [GO:0005634]; Hsp70 protein binding [GO:0030544]; protein transporter activity [GO:0008565]; cellular response to heat [GO:0034605]; protein import into nucleus [GO:0006606]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_113696.1.1.m.54166,0.001083767,-0.000348361,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II sequence-specific DNA-binding transcription factor binding [GO:0061629]; glial cell proliferation [GO:0014009]; muscle cell differentiation [GO:0042692]; neuroblast proliferation [GO:0007405]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_BRAFLDRAFT_113849.1.1.m.53398,0.009216195,0.015523444,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear proteasome complex [GO:0031595]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; lid subcomplex [GO:0008541]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_BRAFLDRAFT_113849.1.1.m.53400,0.009106741,0.013013787,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_113892.1.1.m.44055,0.000458507,-0.006518986,No,NA,NA,NA,NA,NA,NA,glutamate-cysteine ligase complex [GO:0017109]; enzyme regulator activity [GO:0030234]; glutamate-cysteine ligase activity [GO:0004357]; glutamate-cysteine ligase catalytic subunit binding [GO:0035226]; protein heterodimerization activity [GO:0046982]; aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_BRAFLDRAFT_114006.1.1.m.49056,-0.009311305,0.003773977,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_114106.1.1.m.28307,-0.007322563,-0.019461686,No,NA,NA,NA,NA,NA,NA,glutamatergic synapse [GO:0098978]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]; terminal bouton [GO:0043195]; vacuolar membrane [GO:0005774]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]; apical protein localization [GO:0045176]; brain development [GO:0007420]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; neuron differentiation [GO:0030182]; positive regulation of ATPase activity [GO:0032781]; protein-containing complex disassembly [GO:0032984]; regulation of synaptic vesicle priming [GO:0010807]; SNARE complex disassembly [GO:0035494]; synaptic transmission; glutamatergic [GO:0035249]; synaptic vesicle priming [GO:0016082],NA,NA,NA
CHOYP_BRAFLDRAFT_114158.1.1.m.24733,0.020931827,0.00048065,No,NA,NA,NA,NA,NA,NA,dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi stack [GO:0005795]; synaptic vesicle [GO:0008021]; TRAPP complex [GO:0030008]; dendrite development [GO:0016358]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_114204.1.1.m.15168,-0.013948585,-0.010462445,No,NA,NA,NA,NA,NA,NA,oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_BRAFLDRAFT_114350.1.1.m.14176,-0.01664036,-0.015851931,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]; mRNA (adenine-N1-)-methyltransferase activity [GO:0061953]; tRNA (adenine-N1-)-methyltransferase activity [GO:0016429]; mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_BRAFLDRAFT_114379.1.1.m.57424,-0.016700521,0.012304501,No,NA,NA,NA,NA,NA,NA,microtubule [GO:0005874]; microtubule bundle [GO:0097427]; perinuclear region of cytoplasm [GO:0048471]; tubulin binding [GO:0015631]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273],NA,NA,NA
CHOYP_BRAFLDRAFT_114488.1.1.m.6260,0.001461827,-0.020340592,No,NA,NA,NA,NA,NA,NA,nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_BRAFLDRAFT_114510.1.1.m.52252,-0.009594643,-0.012238593,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_114633.1.1.m.49577,0.007010346,-0.005561136,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697],NA,NA,NA
CHOYP_BRAFLDRAFT_114709.1.1.m.17347,0.020837816,0.000902244,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_BRAFLDRAFT_114843.2.2.m.57232,0.004256847,-0.018377997,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; U2AF [GO:0089701]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_BRAFLDRAFT_114859.1.1.m.37271,-0.014067685,0.001416197,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cellular response to nutrient [GO:0031670]; cellular response to reactive oxygen species [GO:0034614]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cellular ketone metabolic process [GO:0010565]; regulation of gluconeogenesis [GO:0006111]; regulation of glucose metabolic process [GO:0010906]; regulation of pH [GO:0006885],NA,NA,NA
CHOYP_BRAFLDRAFT_114866.1.5.m.6859,0.014049422,0.014327636,No,NA,NA,NA,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_114866.4.5.m.35626,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_114866.4.5.m.35627,-0.003723988,-0.010491373,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_114978.1.1.m.43775,0.01265706,-0.000142262,No,NA,NA,NA,NA,NA,NA,proteasome accessory complex [GO:0022624]; proteasome assembly [GO:0043248],NA,NA,NA
CHOYP_BRAFLDRAFT_115029.1.2.m.8365,0.018019424,-0.000751903,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_115040.1.1.m.28389,0.018391455,0.006707132,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; FAD-AMP lyase (cyclizing) activity [GO:0034012]; glycerone kinase activity [GO:0004371]; metal ion binding [GO:0046872]; triokinase activity [GO:0050354]; carbohydrate phosphorylation [GO:0046835]; cellular carbohydrate metabolic process [GO:0044262]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; glycerol catabolic process [GO:0019563]; glycolytic process through fructose-1-phosphate [GO:0061625]; negative regulation of MDA-5 signaling pathway [GO:0039534]; regulation of innate immune response [GO:0045088],NA,NA,NA
CHOYP_BRAFLDRAFT_115113.1.2.m.31023,-0.013132016,0.010860389,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; regulation of transcription; DNA-templated [GO:0006355]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_115208.1.1.m.52467,0.012803124,0.007383857,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020],NA,NA,NA
CHOYP_BRAFLDRAFT_115265.1.1.m.5158,-0.009299554,-0.002384939,No,NA,NA,NA,NA,NA,NA,autophagosome [GO:0005776]; axoneme [GO:0005930]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; phagophore assembly site membrane [GO:0034045]; aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; autophagy of host cells involved in interaction with symbiont [GO:0075044]; autophagy of mitochondrion [GO:0000422]; blood vessel remodeling [GO:0001974]; cellular homeostasis [GO:0019725]; cellular response to nitrosative stress [GO:0071500]; cellular response to starvation [GO:0009267]; heart contraction [GO:0060047]; negative regulation of apoptotic process [GO:0043066]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; positive regulation of mucus secretion [GO:0070257]; protein lipidation involved in autophagosome assembly [GO:0061739]; regulation of cilium assembly [GO:1902017]; regulation of cytokine secretion involved in immune response [GO:0002739]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to drug [GO:0042493]; response to fungus [GO:0009620]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015],NA,NA,NA
CHOYP_BRAFLDRAFT_115608.1.1.m.25984,0.02057045,-0.001160293,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_BRAFLDRAFT_115611.1.1.m.33392,0.00857074,-0.009043986,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NAD+ diphosphatase activity [GO:0000210]; NADH pyrophosphatase activity [GO:0035529]; NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742],NA,NA,NA
CHOYP_BRAFLDRAFT_115639.1.1.m.11373,-0.01090599,-0.010120317,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; DNA replication factor A complex [GO:0005662]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_BRAFLDRAFT_115687.1.1.m.4876,0.018090766,0.008503366,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; protein kinase binding [GO:0019901]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_BRAFLDRAFT_115743.1.1.m.61177,0.013600409,-0.01276693,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; sperm mitochondrial sheath [GO:0097226]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060],NA,NA,NA
CHOYP_BRAFLDRAFT_115771.2.2.m.30817,-0.016327118,-0.002847351,No,NA,NA,NA,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; 2 iron; 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; NADH dehydrogenase activity [GO:0003954]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120],NA,NA,NA
CHOYP_BRAFLDRAFT_115951.1.1.m.22622,0.01552949,0.02087889,No,NA,NA,NA,NA,NA,NA,iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505]; tryptophan 5-monooxygenase activity [GO:0004510]; eye pigment biosynthetic process [GO:0006726]; L-phenylalanine catabolic process [GO:0006559]; long-term memory [GO:0007616]; serotonin biosynthetic process [GO:0042427]; tyrosine biosynthetic process [GO:0006571],NA,NA,NA
CHOYP_BRAFLDRAFT_116041.1.1.m.3962,-0.018016015,-0.004233051,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_BRAFLDRAFT_116053.1.1.m.63017,-0.021298722,1.74E-05,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_116088.2.2.m.27531,0.000968382,-0.002842238,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634],NA,NA,NA
CHOYP_BRAFLDRAFT_116394.1.1.m.57079,0.016600542,-0.00018621,No,NA,NA,NA,NA,NA,NA,COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; protein deneddylation [GO:0000338],NA,NA,NA
CHOYP_BRAFLDRAFT_116913.1.1.m.43886,0.00659527,0.004580829,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; brain development [GO:0007420]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_BRAFLDRAFT_116988.1.3.m.3947,-0.003035869,-0.011777746,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_BRAFLDRAFT_117028.1.1.m.26596,-0.011457815,-0.020926821,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_117068.1.1.m.36193,0.018078933,-0.012141428,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117083.3.3.m.59001,-0.019731619,-0.00174362,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_BRAFLDRAFT_117106.1.1.m.49365,0.005128314,-0.001145257,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; actin binding [GO:0003779]; actin filament polymerization [GO:0030041]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_117157.1.3.m.7944,-0.017065751,-0.00234851,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_BRAFLDRAFT_117158.2.2.m.42430,0.019844064,0.003674203,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; recycling endosome membrane [GO:0055038]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612],NA,NA,NA
CHOYP_BRAFLDRAFT_117187.2.4.m.3553,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117216.1.1.m.25201,-0.020009781,-0.004929205,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514]; lipid binding [GO:0008289]; phospholipid transporter activity [GO:0005548]; bile acid secretion [GO:0032782]; phospholipid transport [GO:0015914]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360],NA,NA,NA
CHOYP_BRAFLDRAFT_117231.1.1.m.4966,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; enzyme activator activity [GO:0008047]; nuclear receptor activity [GO:0004879]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sterol response element binding [GO:0032810]; aging [GO:0007568]; cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; cholesterol metabolic process [GO:0008203]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of insulin secretion [GO:0046676]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by chemical signal [GO:0003062]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to food [GO:0032094]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526],NA,NA,NA
CHOYP_BRAFLDRAFT_117263.1.1.m.28027,-0.002365254,0.00258053,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; phosphatidylinositol binding [GO:0035091]; negative regulation of autophagy [GO:0010507]; regulation of apoptotic process [GO:0042981],NA,NA,NA
CHOYP_BRAFLDRAFT_117275.1.1.m.9900,-0.001526811,0.012233857,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117282.2.6.m.13259,-0.004766072,-0.011228989,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117283.2.2.m.37544,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117284.5.7.m.53216,-0.011443747,-0.003529911,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117292.1.1.m.19637,0.006066002,0.013949926,No,NA,NA,NA,NA,NA,NA,chromosome; centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; chromosome segregation [GO:0007059]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; regulation of mitotic cytokinesis [GO:1902412],NA,NA,NA
CHOYP_BRAFLDRAFT_117315.1.2.m.7247,-0.018610551,0.005470413,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117365.1.2.m.12413,0.005709658,-0.011543234,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_117365.2.2.m.31681,-0.019530385,0.009344169,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_117560.1.1.m.18467,-0.013626308,-0.022326599,No,NA,NA,NA,NA,NA,NA,AP-5 adaptor complex [GO:0044599]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-strand break repair via homologous recombination [GO:0000724]; endosomal transport [GO:0016197]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_117612.1.1.m.28286,0.021537376,-0.012319515,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; 5-amino-4-imidazole carboxylate lyase activity [GO:0043727]; ATP binding [GO:0005524]; phosphoribosylaminoimidazole carboxylase activity [GO:0004638]; phosphoribosylaminoimidazolesuccinocarboxamide synthase activity [GO:0004639]; 'de novo' IMP biosynthetic process [GO:0006189],NA,NA,NA
CHOYP_BRAFLDRAFT_117629.2.2.m.31330,-0.009772859,-0.007908988,No,NA,NA,NA,NA,NA,NA,ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; cardiac septum development [GO:0003279]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; coronary vasculature development [GO:0060976]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; heart development [GO:0007507]; kidney development [GO:0001822]; protein localization to ciliary transition zone [GO:1904491]; roof of mouth development [GO:0060021]; ventricular septum development [GO:0003281],NA,NA,NA
CHOYP_BRAFLDRAFT_117631.1.1.m.45793,-0.016020159,-0.000487045,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_117675.1.1.m.33772,-0.002391239,-0.001239622,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472],NA,NA,NA
CHOYP_BRAFLDRAFT_117737.1.1.m.4255,-0.003630999,-0.002834114,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117750.1.1.m.12162,-0.010070489,0.005462132,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_117811.1.1.m.27127,0.00562443,-0.012725331,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; glucose homeostasis [GO:0042593]; multicellular organism development [GO:0007275]; negative regulation of aggregate size involved in sorocarp development [GO:0031158]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cGMP-mediated signaling [GO:0010754]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of glucose-6-phosphatase activity [GO:0032114]; regulation of glycolytic process [GO:0006110]; response to UV-C [GO:0010225],NA,NA,NA
CHOYP_BRAFLDRAFT_117811.1.1.m.27128,0.013051159,0.003539564,No,NA,NA,NA,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_BRAFLDRAFT_117821.1.1.m.16201,-5.03E-05,-0.003417583,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]; chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein targeting to vacuole [GO:0006623]; regulation of protein localization to plasma membrane [GO:1903076]; retrograde transport; endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280],NA,NA,NA
CHOYP_BRAFLDRAFT_117849.1.3.m.2806,-0.00693652,0.004936047,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117849.2.3.m.4489,-0.004525394,0.007158247,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117849.3.3.m.5503,0.005154612,-0.009261837,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117858.2.3.m.48274,0.008357937,-0.004271299,No,NA,NA,NA,NA,NA,NA,commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA 5'-splice site recognition [GO:0000395],NA,NA,NA
CHOYP_BRAFLDRAFT_117875.1.1.m.48427,0.006856084,0.00740298,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117937.1.1.m.18686,-0.001183174,-0.010980287,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; nucleus [GO:0005634]; H4 histone acetyltransferase activity [GO:0010485]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptidyl-lysine acetyltransferase activity [GO:0052858]; establishment of mitotic sister chromatid cohesion [GO:0034087]; histone acetylation [GO:0016573]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid cohesion; centromeric [GO:0071962]; N-terminal protein amino acid acetylation [GO:0006474]; somitogenesis [GO:0001756],NA,NA,NA
CHOYP_BRAFLDRAFT_117940.1.1.m.59223,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,GTP binding [GO:0005525],NA,NA,NA
CHOYP_BRAFLDRAFT_117976.1.3.m.22767,0.004304797,-0.019613088,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_117976.2.3.m.49156,-0.019418904,-0.009703645,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_118043.1.1.m.26278,0.003707659,-0.004357285,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118054.1.1.m.18488,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity; acting on NAD(P)H; oxygen as acceptor [GO:0050664],NA,NA,NA
CHOYP_BRAFLDRAFT_118099.2.6.m.3049,0.008611782,-0.018223754,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; WASH complex [GO:0071203]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; retromer complex binding [GO:1905394]; protein transport [GO:0015031]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_BRAFLDRAFT_118099.6.6.m.45150,-0.003968072,0.016660544,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; plasma membrane [GO:0005886]; WASH complex [GO:0071203]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_BRAFLDRAFT_118103.1.1.m.41767,0.007315905,0.011550406,No,NA,NA,NA,NA,NA,NA,cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; insulin binding [GO:0043559]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transporter activity [GO:0008526]; phospholipid transporter activity [GO:0005548]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774],NA,NA,NA
CHOYP_BRAFLDRAFT_118108.1.1.m.58962,-0.003338519,0.001706742,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; aspartic-type endopeptidase activity [GO:0004190]; endopeptidase activity [GO:0004175]; amyloid-beta formation [GO:0034205]; amyloid-beta metabolic process [GO:0050435]; brain development [GO:0007420]; calcium ion transport [GO:0006816]; melanocyte differentiation [GO:0030318]; membrane protein ectodomain proteolysis [GO:0006509]; neurogenesis [GO:0022008]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; protein processing [GO:0016485]; somite development [GO:0061053],NA,NA,NA
CHOYP_BRAFLDRAFT_118210.1.1.m.51280,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_BRAFLDRAFT_118250.1.1.m.11178,-0.004172758,0.023211765,No,NA,NA,NA,NA,NA,NA,axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; cell junction [GO:0030054]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; secretory granule [GO:0030141]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; SNARE binding [GO:0000149]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; autophagosome maturation [GO:0097352]; cellular protein-containing complex localization [GO:0034629]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; lysosomal lumen acidification [GO:0007042]; lysosome localization [GO:0032418]; melanosome organization [GO:0032438]; negative regulation of neuron projection development [GO:0010977]; neuron projection development [GO:0031175]; neurotransmitter secretion [GO:0007269]; positive regulation of late endosome to lysosome transport [GO:1902824]; protein maturation [GO:0051604]; regulation of protein binding [GO:0043393]; regulation of synaptic vesicle exocytosis [GO:2000300]; retrograde axonal transport [GO:0008090]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle transport [GO:0048489]; terminal button organization [GO:0072553]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_118260.1.1.m.13621,-0.003611151,-0.007813519,No,NA,NA,NA,NA,NA,NA,cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265],NA,NA,NA
CHOYP_BRAFLDRAFT_118294.2.2.m.15439,-0.005168845,-0.014672786,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; cell differentiation [GO:0030154]; establishment of protein localization to plasma membrane [GO:0061951]; Golgi organization [GO:0007030]; organelle organization [GO:0006996]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_118310.1.1.m.8287,-0.002317342,-0.024531386,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; neuromuscular junction [GO:0031594]; neuromuscular junction of somatic muscle [GO:0098527]; presynaptic cytosol [GO:0099523]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; autophagy [GO:0006914]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neurotransmitter secretion [GO:0007269]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; SNARE complex disassembly [GO:0035494]; synaptic vesicle cycle [GO:0099504]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082],NA,NA,NA
CHOYP_BRAFLDRAFT_118365.1.1.m.44334,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118423.1.3.m.29148,0.003238621,-0.002415315,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118423.2.3.m.29362,0.01272908,-0.012583627,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118423.3.3.m.30322,-0.002691666,-0.012576758,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118430.2.2.m.44188,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118500.1.1.m.46374,-0.003058921,-0.009511598,No,NA,NA,NA,NA,NA,NA,azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; transporter activity [GO:0005215]; cellular response to calcium ion [GO:0071277]; cellular response to growth factor stimulus [GO:0071363]; ERBB2 signaling pathway [GO:0038128]; glycerophospholipid biosynthetic process [GO:0046474]; lipid metabolic process [GO:0006629]; neutrophil degranulation [GO:0043312]; positive regulation of cell migration [GO:0030335]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_118535.3.8.m.35521,0.008872123,0.003654027,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],NA,NA,NA
CHOYP_BRAFLDRAFT_118535.6.8.m.55199,0.009418194,0.020400805,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],NA,NA,NA
CHOYP_BRAFLDRAFT_118535.8.8.m.61819,-0.015245941,0.004954575,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],NA,NA,NA
CHOYP_BRAFLDRAFT_118545.2.2.m.54585,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sterol binding [GO:0032934]; cholesterol metabolic process [GO:0008203]; SREBP signaling pathway [GO:0032933],NA,NA,NA
CHOYP_BRAFLDRAFT_118602.2.5.m.17419,0.017463853,0.005524142,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_BRAFLDRAFT_118602.3.5.m.19626,0.013160342,0.022022762,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118602.4.5.m.26803,0.004565129,-0.012991866,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118619.2.2.m.4663,-0.00737848,-0.00135946,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118645.1.1.m.30629,0.009701584,-0.016664362,No,NA,NA,NA,NA,NA,NA,FMN binding [GO:0010181]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_BRAFLDRAFT_118680.1.1.m.14225,3.36E-05,0.002720734,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_BRAFLDRAFT_118709.2.4.m.41225,0.000137925,0.011807598,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_118709.3.4.m.52468,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_118718.1.1.m.14739,0.000778467,-0.023084815,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle lumen [GO:0097013]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; peptidoglycan receptor activity [GO:0016019]; zinc ion binding [GO:0008270]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; antimicrobial humoral response [GO:0019730]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; growth of symbiont in host [GO:0044117]; innate immune response [GO:0045087]; killing of cells of other organism [GO:0031640]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of natural killer cell differentiation involved in immune response [GO:0032827]; neutrophil degranulation [GO:0043312]; peptidoglycan catabolic process [GO:0009253]; positive regulation of cytolysis in other organism [GO:0051714],NA,NA,NA
CHOYP_BRAFLDRAFT_118735.1.1.m.6990,0.007843577,-0.004174086,No,NA,NA,NA,NA,NA,NA,molybdopterin synthase complex [GO:0019008]; 4 iron; 4 sulfur cluster binding [GO:0051539]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; GTP 3';8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324],NA,NA,NA
CHOYP_BRAFLDRAFT_118736.1.1.m.17458,0.004467038,-0.005554518,No,NA,NA,NA,NA,NA,NA,FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; nuclease activity [GO:0004518]; interstrand cross-link repair [GO:0036297]; positive regulation of protein monoubiquitination [GO:1902527]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712],NA,NA,NA
CHOYP_BRAFLDRAFT_118756.1.2.m.16721,0.014112356,-0.003221222,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118772.1.1.m.59465,-0.012052563,0.018170142,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_118789.2.3.m.59829,-0.016088871,0.002484386,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; peroxisome [GO:0005777]; deaminase activity [GO:0019239]; endoribonuclease activity; producing 3'-phosphomonoesters [GO:0016892]; long-chain fatty acid binding [GO:0036041]; platinum binding [GO:1904012]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; transition metal ion binding [GO:0046914]; xenon atom binding [GO:1904013]; brain development [GO:0007420]; G1 to G0 transition [GO:0070314]; kidney development [GO:0001822]; L-threonine catabolic process to glycine [GO:0019518]; lung development [GO:0030324]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of translation [GO:0017148]; organonitrogen compound catabolic process [GO:1901565]; response to lipid [GO:0033993]; response to salt [GO:1902074],NA,NA,NA
CHOYP_BRAFLDRAFT_118790.1.1.m.29970,0.021141705,-0.011082929,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; phosphoethanolamine N-methyltransferase activity [GO:0000234]; phosphatidylcholine biosynthetic process [GO:0006656],NA,NA,NA
CHOYP_BRAFLDRAFT_118793.1.1.m.20795,-0.001836431,-0.004573384,No,NA,NA,NA,NA,NA,NA,CCR4-NOT complex [GO:0030014]; mRNA catabolic process [GO:0006402]; negative regulation of translation [GO:0017148],NA,NA,NA
CHOYP_BRAFLDRAFT_118803.1.1.m.14069,-0.00096817,0.007155028,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; extracellular space [GO:0005615]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; glucose homeostasis [GO:0042593]; negative regulation of insulin receptor signaling pathway [GO:0046627],NA,NA,NA
CHOYP_BRAFLDRAFT_118819.1.2.m.29565,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,AIP1-IRE1 complex [GO:1990597]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Ire1 complex [GO:1990332]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]; activation of JUN kinase activity [GO:0007257]; cell cycle arrest [GO:0007050]; cellular response to glucose stimulus [GO:0071333]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA catabolic process [GO:0006402]; mRNA cleavage [GO:0006379]; mRNA cleavage involved in mRNA processing [GO:0098787]; mRNA splicing; via endonucleolytic cleavage and ligation [GO:0070054]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine trans-autophosphorylation [GO:1990579]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of macroautophagy [GO:0016241]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_BRAFLDRAFT_118867.1.1.m.27944,0.006884397,0.004705582,No,NA,NA,NA,NA,NA,NA,cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245],NA,NA,NA
CHOYP_BRAFLDRAFT_118961.1.1.m.8363,-0.020961671,0.003315019,No,NA,NA,NA,NA,NA,NA,CIA complex [GO:0097361]; 4 iron; 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_BRAFLDRAFT_119035.1.3.m.6973,-0.003352347,-0.003003029,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_119036.1.1.m.18576,-0.010304938,-0.000787028,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intracellular membrane-bounded organelle [GO:0043231]; intraciliary transport particle B [GO:0030992]; nucleoplasm [GO:0005654]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; floor plate formation [GO:0021508]; heart looping [GO:0001947]; intraciliary transport [GO:0042073]; left/right pattern formation [GO:0060972]; neural tube closure [GO:0001843]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_BRAFLDRAFT_119209.1.1.m.4850,-0.020274202,-0.000716812,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_119350.1.1.m.50169,-0.004393913,0.006229562,No,NA,NA,NA,NA,NA,NA,cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; P-body [GO:0000932]; ATP binding [GO:0005524]; ATP-dependent 5'-3' RNA helicase activity [GO:0032575]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; gene silencing by miRNA [GO:0035195]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of transposition; RNA-mediated [GO:0010526]; positive regulation of mRNA catabolic process [GO:0061014]; posttranscriptional gene silencing by RNA [GO:0035194]; regulation of neuron projection arborization [GO:0150011],NA,NA,NA
CHOYP_BRAFLDRAFT_119363.1.1.m.41627,0.002110776,0.017379314,No,NA,NA,NA,NA,NA,NA,exocyst [GO:0000145]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; presynaptic membrane [GO:0042734]; secretory granule membrane [GO:0030667]; SNARE binding [GO:0000149]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_119367.1.1.m.59963,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; zinc ion binding [GO:0008270]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; midbrain development [GO:0030901]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_BRAFLDRAFT_119424.1.1.m.15350,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_119484.2.3.m.60445,0.010158973,-0.002294606,No,NA,NA,NA,NA,NA,NA,CCR4-NOT complex [GO:0030014]; nuclear speck [GO:0016607]; P-body [GO:0000932]; PML body [GO:0016605]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290],NA,NA,NA
CHOYP_BRAFLDRAFT_119491.1.1.m.58761,-0.005067248,0.009936004,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_119549.1.1.m.56597,-0.022662613,0.010353421,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_119616.1.1.m.31670,0.013384467,0.000933146,No,NA,NA,NA,NA,NA,NA,oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620]; structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_BRAFLDRAFT_119617.1.1.m.50138,-0.004758924,-0.011238285,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; 3'-nucleotidase activity [GO:0008254]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; metal ion binding [GO:0046872]; inositol biosynthetic process [GO:0006021]; phosphatidylinositol phosphorylation [GO:0046854],NA,NA,NA
CHOYP_BRAFLDRAFT_119774.4.4.m.33349,-0.010689042,-0.002655493,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_119799.1.1.m.23765,-0.01383881,0.016238486,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; antioxidant activity [GO:0016209]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; peroxynitrite reductase activity [GO:0072541]; protein dimerization activity [GO:0046983]; RNA polymerase III regulatory region DNA binding [GO:0001016]; signaling receptor binding [GO:0005102]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription by RNA polymerase III [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_BRAFLDRAFT_119901.1.1.m.7089,0.007420167,-0.010168603,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270]; base-excision repair; DNA ligation [GO:0006288]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial DNA replication [GO:0090298]; nucleotide-excision repair; DNA gap filling [GO:0006297]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_BRAFLDRAFT_119906.1.1.m.45319,-0.009037727,0.006509439,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; non-motile cilium [GO:0097730]; negative regulation of canonical Wnt signaling pathway [GO:0090090],NA,NA,NA
CHOYP_BRAFLDRAFT_119906.1.1.m.45320,-0.009540403,0.007445505,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein N-terminus binding [GO:0047485]; negative regulation of apoptotic process [GO:0043066]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_BRAFLDRAFT_119955.1.1.m.16485,-0.006378886,0.014970379,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; tRNA (guanine-N7-)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049]; tRNA modification [GO:0006400],NA,NA,NA
CHOYP_BRAFLDRAFT_119982.1.1.m.62398,-0.008906867,-0.009581508,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; endodeoxyribonuclease activity [GO:0004520]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; satellite DNA binding [GO:0003696]; depyrimidination [GO:0045008]; DNA repair [GO:0006281]; response to estradiol [GO:0032355]; response to radiation [GO:0009314],NA,NA,NA
CHOYP_BRAFLDRAFT_120041.1.1.m.6386,-0.022653081,0.010395392,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_120058.1.1.m.9895,-0.018797495,6.61E-05,No,NA,NA,NA,NA,NA,NA,Set1C/COMPASS complex [GO:0048188]; histone H3-K4 methylation [GO:0051568],NA,NA,NA
CHOYP_BRAFLDRAFT_120093.2.2.m.51468,-0.006290691,0.010373545,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_120139.4.5.m.50713,-0.02256957,0.009997355,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; phagocytic vesicle membrane [GO:0030670]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589]; extracellular matrix structural constituent [GO:0005201]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]; blastocyst development [GO:0001824]; cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; inner cell mass cell proliferation [GO:0001833]; positive regulation of epithelial cell differentiation [GO:0030858]; protein transport [GO:0015031]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_BRAFLDRAFT_120431.1.1.m.49038,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_120433.1.1.m.66614,-0.00907234,-0.007450956,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; cytochrome-b5 reductase activity; acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; response to yeast [GO:0001878]; sterol biosynthetic process [GO:0016126],NA,NA,NA
CHOYP_BRAFLDRAFT_120586.1.1.m.41856,0.004838825,0.006264442,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; regulation of extrinsic apoptotic signaling pathway [GO:2001236],NA,NA,NA
CHOYP_BRAFLDRAFT_120588.1.1.m.22993,-0.022648951,0.01018528,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_120607.1.3.m.8455,-0.023226999,-0.001837925,No,NA,NA,NA,NA,NA,NA,axonemal central apparatus [GO:1990716]; microtubule [GO:0005874]; motile cilium [GO:0031514]; axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement [GO:0003351],NA,NA,NA
CHOYP_BRAFLDRAFT_120767.1.1.m.16005,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to UV [GO:0034644]; DNA replication [GO:0006260]; protein processing [GO:0016485]; protein ubiquitination [GO:0016567]; regulation of cell cycle arrest [GO:0071156],NA,NA,NA
CHOYP_BRAFLDRAFT_120826.1.1.m.56321,-0.014356994,-0.002780161,No,NA,NA,NA,NA,NA,NA,cytoplasmic dynein complex [GO:0005868]; early endosome membrane [GO:0031901]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; transferrin receptor binding [GO:1990459]; endocytic recycling [GO:0032456]; positive regulation of histamine secretion by mast cell [GO:1903595]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_120908.1.1.m.5866,0.004984573,0.022662628,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; lipid binding [GO:0008289]; hibernation [GO:0042750],NA,NA,NA
CHOYP_BRAFLDRAFT_120923.3.3.m.58916,0.020943761,0.008746758,No,NA,NA,NA,NA,NA,NA,zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_BRAFLDRAFT_120970.1.1.m.63798,0.006182105,-0.011295173,No,NA,NA,NA,NA,NA,NA,azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; transporter activity [GO:0005215]; cellular response to calcium ion [GO:0071277]; cellular response to growth factor stimulus [GO:0071363]; ERBB2 signaling pathway [GO:0038128]; glycerophospholipid biosynthetic process [GO:0046474]; lipid metabolic process [GO:0006629]; neutrophil degranulation [GO:0043312]; positive regulation of cell migration [GO:0030335]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_120990.1.18.m.2376,-0.008079203,-0.003341683,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_120990.10.18.m.51025,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_120993.1.2.m.41307,0.009600505,0.000276293,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],NA,NA,NA
CHOYP_BRAFLDRAFT_121045.1.1.m.55827,-0.014653692,0.004509544,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; chemorepellent activity [GO:0045499]; peptidase activity [GO:0008233]; signaling receptor binding [GO:0005102]; cell cycle [GO:0007049]; negative chemotaxis [GO:0050919]; negative regulation of asexual reproduction [GO:1903665]; protein localization to plasma membrane [GO:0072659]; regulation of aggregate size involved in sorocarp development [GO:0031157]; sporulation resulting in formation of a cellular spore [GO:0030435],NA,NA,NA
CHOYP_BRAFLDRAFT_121105.1.1.m.41883,-0.01943234,-0.001641995,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_121138.1.1.m.787,-0.004216183,-0.007907705,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; IkappaB kinase complex [GO:0008385]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; linear polyubiquitin binding [GO:1990450]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; cellular response to DNA damage stimulus [GO:0006974]; establishment of vesicle localization [GO:0051650]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_BRAFLDRAFT_121151.1.1.m.59381,-0.00419139,0.002534936,No,NA,NA,NA,NA,NA,NA,brush border [GO:0005903]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of endosome membrane [GO:0031313]; macropinocytic cup [GO:0070685]; phagocytic cup [GO:0001891]; retromer complex [GO:0030904]; retromer; tubulation complex [GO:0030905]; ruffle [GO:0001726]; tubular endosome [GO:0097422]; cadherin binding [GO:0045296]; D1 dopamine receptor binding [GO:0031748]; dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protein heterodimerization activity [GO:0046982]; epidermal growth factor catabolic process [GO:0007174]; intracellular protein transport [GO:0006886]; negative regulation of blood pressure [GO:0045776]; pinocytosis [GO:0006907]; positive regulation of renal sodium excretion [GO:0035815]; regulation of macroautophagy [GO:0016241]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_BRAFLDRAFT_121259.1.1.m.2411,-0.005868131,0.004930395,No,NA,NA,NA,NA,NA,NA,clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; clathrin heavy chain binding [GO:0032050]; clathrin-dependent endocytosis [GO:0072583],NA,NA,NA
CHOYP_BRAFLDRAFT_121459.1.1.m.21810,0.002134482,-0.01385483,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_121480.1.1.m.48790,0.021953463,-0.009644427,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_121507.1.2.m.30603,-0.018855208,-0.013613551,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; cilium [GO:0005929]; kinocilium [GO:0060091]; motile cilium [GO:0031514]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; motile cilium assembly [GO:0044458],NA,NA,NA
CHOYP_BRAFLDRAFT_121562.1.1.m.37267,-0.000354443,0.02160398,No,NA,NA,NA,NA,NA,NA,dipeptidyl-peptidase activity [GO:0008239]; endopeptidase activity [GO:0004175]; serine-type peptidase activity [GO:0008236]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_BRAFLDRAFT_121562.1.1.m.37268,0.014605452,-0.001329764,No,NA,NA,NA,NA,NA,NA,postsynaptic density [GO:0014069]; ribosome [GO:0005840]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_BRAFLDRAFT_121667.1.2.m.12193,-0.017710371,-0.008478802,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_121824.1.1.m.37419,-0.017661033,0.009676727,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_121887.1.1.m.59668,0.000301157,-0.023367896,No,NA,NA,NA,NA,NA,NA,chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomere maintenance via recombination [GO:0000722],NA,NA,NA
CHOYP_BRAFLDRAFT_121902.1.1.m.64757,0.020257004,-0.007965837,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_121927.1.1.m.47211,-0.021023008,-0.007626481,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_122018.1.1.m.21774,-0.006323349,-0.022081896,No,NA,NA,NA,NA,NA,NA,nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; structural constituent of nuclear pore [GO:0017056]; mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056],NA,NA,NA
CHOYP_BRAFLDRAFT_122339.1.1.m.58748,-0.017624223,0.009070373,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_122376.1.1.m.49446,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_122381.3.4.m.23140,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_122389.1.1.m.15498,0.001538974,-0.022104357,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; cell cycle [GO:0007049]; chaperone-mediated protein complex assembly [GO:0051131]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457],NA,NA,NA
CHOYP_BRAFLDRAFT_122422.1.2.m.52874,-0.011017834,0.004012694,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188]; activating transcription factor binding [GO:0033613]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; identical protein binding [GO:0042802]; protein binding; bridging [GO:0030674]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator activity [GO:0003713]; blastocyst hatching [GO:0001835]; cell cycle [GO:0007049]; cellular response to organic cyclic compound [GO:0071407]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; mitochondrion organization [GO:0007005]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription; DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of protein complex assembly [GO:0043254]; regulation of transcription; DNA-templated [GO:0006355]; release from viral latency [GO:0019046],NA,NA,NA
CHOYP_BRAFLDRAFT_122572.1.1.m.29320,-0.02199337,0.001139331,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_122634.2.2.m.43678,0.018671781,0.003965281,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062],NA,NA,NA
CHOYP_BRAFLDRAFT_122687.1.1.m.47713,-0.008641879,0.005990129,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_122791.1.6.m.8640,0.007796315,-0.013831113,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_BRAFLDRAFT_122807.1.1.m.3729,0.018517777,0.005582482,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; protein disulfide oxidoreductase activity [GO:0015035]; thioredoxin-disulfide reductase activity [GO:0004791]; blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_122887.1.1.m.62170,0.016293009,-0.00183958,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; cilium assembly [GO:0060271]; Golgi ribbon formation [GO:0090161]; stress fiber assembly [GO:0043149],NA,NA,NA
CHOYP_BRAFLDRAFT_122922.1.1.m.17746,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; cell death [GO:0008219]; cellular response to menadione [GO:0036245]; iron-sulfur cluster assembly [GO:0016226]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_BRAFLDRAFT_122927.1.1.m.51870,-0.006536748,-0.016385884,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; MLL1 complex [GO:0071339]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_BRAFLDRAFT_122970.1.1.m.52022,-0.011594949,-0.003711424,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955],NA,NA,NA
CHOYP_BRAFLDRAFT_123087.1.2.m.6329,-0.016699146,0.002988571,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_123087.2.2.m.27308,0.005219109,-0.015289506,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_123202.1.1.m.17267,-0.004154627,-0.020444117,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; dimethylallyltranstransferase activity [GO:0004161]; geranyltranstransferase activity [GO:0004337]; metal ion binding [GO:0046872]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384],NA,NA,NA
CHOYP_BRAFLDRAFT_123291.1.1.m.11923,-0.017537403,0.009514343,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_BRAFLDRAFT_123298.1.1.m.483,-0.009149007,-0.014912613,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; Rab-protein geranylgeranyltransferase complex [GO:0005968]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab geranylgeranyltransferase activity [GO:0004663]; Rab GTPase binding [GO:0017137]; post-translational protein modification [GO:0043687]; protein geranylgeranylation [GO:0018344]; protein targeting to membrane [GO:0006612]; regulation of apoptotic process [GO:0042981]; small GTPase mediated signal transduction [GO:0007264]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_123304.1.1.m.29231,0.00673765,0.00523782,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_BRAFLDRAFT_123389.1.1.m.57156,-0.005253486,-0.010329124,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; GID complex [GO:0034657]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_BRAFLDRAFT_123397.1.1.m.42218,-0.014455414,-0.000882679,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; myosin complex [GO:0016459]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; ATP binding [GO:0005524]; motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]; cochlea morphogenesis [GO:0090103]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_123537.1.2.m.28822,0.001317367,-0.003217005,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_BRAFLDRAFT_123537.2.2.m.50531,-0.017783262,-0.007987066,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159],NA,NA,NA
CHOYP_BRAFLDRAFT_123540.1.1.m.10582,-0.011836243,-0.01203787,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_BRAFLDRAFT_123636.1.1.m.16162,0.013399842,0.005798758,No,NA,NA,NA,NA,NA,NA,autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; phagophore assembly site membrane [GO:0034045]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; autophagosome assembly [GO:0000045]; negative stranded viral RNA replication [GO:0039689]; positive regulation of autophagy [GO:0010508]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; xenophagy [GO:0098792],NA,NA,NA
CHOYP_BRAFLDRAFT_123642.2.2.m.55471,0.010523168,-0.004817657,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; Golgi membrane [GO:0000139]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of endocytosis [GO:0030100]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_BRAFLDRAFT_123741.1.1.m.31088,0.023165593,-0.009312229,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],NA,NA,NA
CHOYP_BRAFLDRAFT_123768.1.1.m.7223,-0.018448812,0.017577311,No,NA,NA,NA,NA,NA,NA,signal transduction [GO:0007165],NA,NA,NA
CHOYP_BRAFLDRAFT_123909.1.1.m.24337,-0.014162285,0.010142489,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; nucleolus [GO:0005730]; nucleus [GO:0005634]; deacetylase activity [GO:0019213]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_BRAFLDRAFT_123986.1.1.m.47284,-0.00711763,-0.026070282,No,NA,NA,NA,NA,NA,NA,MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; regulation of DNA-dependent DNA replication initiation [GO:0030174],NA,NA,NA
CHOYP_BRAFLDRAFT_124020.1.1.m.22574,0.015507425,0.007533496,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; arsenite methyltransferase activity [GO:0030791]; methylarsonite methyltransferase activity [GO:0030792]; arsonoacetate metabolic process [GO:0018872]; methylation [GO:0032259]; toxin metabolic process [GO:0009404],NA,NA,NA
CHOYP_BRAFLDRAFT_124027.1.2.m.22812,0.013596497,-0.000889849,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dorsal/ventral pattern formation [GO:0009953],NA,NA,NA
CHOYP_BRAFLDRAFT_124027.2.2.m.50286,-0.011561039,-0.003749224,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dorsal/ventral pattern formation [GO:0009953],NA,NA,NA
CHOYP_BRAFLDRAFT_124064.1.6.m.5120,-0.007759425,0.007800948,No,NA,NA,NA,NA,NA,NA,N-acyltransferase activity [GO:0016410]; protein acetylation [GO:0006473],NA,NA,NA
CHOYP_BRAFLDRAFT_124064.3.6.m.38212,0.009423987,0.006729157,No,NA,NA,NA,NA,NA,NA,high-density lipoprotein particle [GO:0034364]; acute-phase response [GO:0006953],NA,NA,NA
CHOYP_BRAFLDRAFT_124064.5.6.m.41252,0.011585385,0.001289868,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_124069.1.1.m.14145,-0.004558051,-0.002066596,No,NA,NA,NA,NA,NA,NA,cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_BRAFLDRAFT_124130.2.3.m.30247,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_124233.1.1.m.26105,-0.002641423,-0.001946348,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; electron transfer activity [GO:0009055]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_BRAFLDRAFT_124240.1.1.m.8573,-0.004022038,-0.00877344,No,NA,NA,NA,NA,NA,NA,dendrite [GO:0030425]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; cerebellar granule cell differentiation [GO:0021707]; positive regulation of protein phosphorylation [GO:0001934]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_BRAFLDRAFT_124260.1.1.m.8355,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_124275.1.1.m.8900,0.012889019,0.017329259,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; succinate-CoA ligase complex (GDP-forming) [GO:0045244]; cofactor binding [GO:0048037]; GDP binding [GO:0019003]; nucleoside diphosphate kinase activity [GO:0004550]; protein heterodimerization activity [GO:0046982]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; nucleoside triphosphate biosynthetic process [GO:0009142]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_BRAFLDRAFT_124284.1.1.m.33673,-0.004819868,-1.15E-05,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; xylulokinase activity [GO:0004856]; D-xylose metabolic process [GO:0042732]; phosphorylation [GO:0016310]; xylulose metabolic process [GO:0005997],NA,NA,NA
CHOYP_BRAFLDRAFT_124476.1.4.m.1812,0.00347095,0.000536916,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_BRAFLDRAFT_124476.3.4.m.48503,0.007745455,-0.002406094,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_BRAFLDRAFT_124523.1.1.m.18960,0.006594069,0.000115121,No,NA,NA,NA,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475],NA,NA,NA
CHOYP_BRAFLDRAFT_124526.1.1.m.25228,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; nucleoplasm [GO:0005654]; preribosome; small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; maturation of SSU-rRNA [GO:0030490]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274],NA,NA,NA
CHOYP_BRAFLDRAFT_124536.1.2.m.10835,-0.008703718,-0.006314835,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509]; blastocyst hatching [GO:0001835]; regulation of amyloid precursor protein biosynthetic process [GO:0042984],NA,NA,NA
CHOYP_BRAFLDRAFT_124611.1.1.m.34341,0.006076597,-0.008745818,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795],NA,NA,NA
CHOYP_BRAFLDRAFT_124637.1.1.m.26435,-0.005983071,8.10E-05,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; micro-ribonucleoprotein complex [GO:0035068]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC-loading complex [GO:0070578]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; ATP-dependent 3'-5' DNA/RNA helicase activity [GO:0033681]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; ATP-dependent DNA helicase activity [GO:0004003]; ATP-dependent RNA helicase activity [GO:0004004]; ATPase activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded DNA binding [GO:0003697]; single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity [GO:1990518]; single-stranded RNA binding [GO:0003727]; transcription coactivator activity [GO:0003713]; triplex DNA binding [GO:0045142]; alternative mRNA splicing; via spliceosome [GO:0000380]; cellular response to tumor necrosis factor [GO:0071356]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription; termination [GO:0006353]; G-quadruplex DNA unwinding [GO:0044806]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423],NA,NA,NA
CHOYP_BRAFLDRAFT_124675.1.1.m.61945,0.003608783,0.0140582,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein kinase binding [GO:0019901]; apoptotic process [GO:0006915]; CD40 signaling pathway [GO:0023035]; cellular response to lipopolysaccharide [GO:0071222]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of B cell activation [GO:0050871]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macrophage activation [GO:0043032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 9 signaling pathway [GO:0034162],NA,NA,NA
CHOYP_BRAFLDRAFT_124686.1.1.m.18409,0.016322833,0.018505299,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-cysteine:2-oxoglutarate aminotransferase activity [GO:0047801]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate metabolic process [GO:0006531]; cellular amino acid metabolic process [GO:0006520]; gluconeogenesis [GO:0006094]; glutamate metabolic process [GO:0006536]; glycerol biosynthetic process [GO:0006114],NA,NA,NA
CHOYP_BRAFLDRAFT_124878.1.1.m.55561,0.005816919,0.004015845,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; insulin receptor complex [GO:0005899]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; aging [GO:0007568]; cellular response to angiotensin [GO:1904385]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to radiation [GO:0071478]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of insulin secretion [GO:0046676]; negative regulation of somatostatin secretion [GO:0090275]; positive regulation of glucagon secretion [GO:0070094]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphorylation [GO:0042327]; protein heterooligomerization [GO:0051291]; response to activity [GO:0014823]; response to caffeine [GO:0031000]; response to peptide hormone [GO:0043434],NA,NA,NA
CHOYP_BRAFLDRAFT_124950.1.1.m.8139,-7.18E-05,0.020090112,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; condensin complex [GO:0000796]; cytosol [GO:0005829]; nuclear condensin complex [GO:0000799]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA topoisomerase (ATP-hydrolyzing) activator activity [GO:0072587]; DNA topoisomerase binding [GO:0044547]; cell division [GO:0051301]; female meiosis chromosome separation [GO:0051309]; female meiotic nuclear division [GO:0007143]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076],NA,NA,NA
CHOYP_BRAFLDRAFT_124962.1.1.m.57433,-0.002650593,-0.021308125,No,NA,NA,NA,NA,NA,NA,anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072],NA,NA,NA
CHOYP_BRAFLDRAFT_124972.1.5.m.3843,0.02199039,-0.007490192,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_124972.1.5.m.3844,0.009659701,-0.010106031,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; ganglioside catabolic process [GO:0006689],NA,NA,NA
CHOYP_BRAFLDRAFT_124972.2.5.m.4101,-0.020666633,-0.005953729,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; ganglioside catabolic process [GO:0006689],NA,NA,NA
CHOYP_BRAFLDRAFT_125037.1.3.m.2939,0.011404732,-0.015737335,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; piRNA binding [GO:0034584]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_125037.2.3.m.13981,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_125073.1.1.m.1752,-0.006271924,0.013161899,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; adenyl-nucleotide exchange factor activity [GO:0000774]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398],NA,NA,NA
CHOYP_BRAFLDRAFT_125104.1.1.m.31139,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_BRAFLDRAFT_125119.1.1.m.57550,-0.019980648,0.013413325,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; motile cilium [GO:0031514],NA,NA,NA
CHOYP_BRAFLDRAFT_125234.2.2.m.19033,-0.011349663,0.003221153,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_BRAFLDRAFT_125263.1.9.m.7394,-0.015561765,0.003548562,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125265.2.4.m.18968,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125270.1.1.m.2429,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced ascorbate as one donor; and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589],NA,NA,NA
CHOYP_BRAFLDRAFT_125327.1.1.m.29699,-0.0015766,0.024229313,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047],NA,NA,NA
CHOYP_BRAFLDRAFT_125356.3.3.m.35009,-0.009382738,-0.011229122,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_125389.1.1.m.62938,-0.011200712,-0.012286777,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_125403.1.1.m.30476,-0.020165523,0.004010295,No,NA,NA,NA,NA,NA,NA,COPII vesicle coat [GO:0030127]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; zinc ion binding [GO:0008270]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_BRAFLDRAFT_125405.1.1.m.5741,0.021106666,0.000546726,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125481.1.1.m.4369,-0.002216748,-0.004172312,No,NA,NA,NA,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; nucleus [GO:0005634]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic cell cycle [GO:0051321],NA,NA,NA
CHOYP_BRAFLDRAFT_125501.1.1.m.30916,0.015889477,-0.012104927,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125516.1.1.m.13150,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125550.1.5.m.9080,-0.022311804,0.00964087,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule lumen [GO:0034774]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; defense response to bacterium [GO:0042742]; defense response to nematode [GO:0002215]; eosinophil migration [GO:0072677]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-5 production [GO:0032714]; neutrophil degranulation [GO:0043312]; positive regulation of interleukin-4 production [GO:0032753]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_BRAFLDRAFT_125634.1.1.m.14767,0.011222578,-0.003140683,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022],NA,NA,NA
CHOYP_BRAFLDRAFT_125658.1.1.m.27104,0.013757659,0.016114103,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; exocyst [GO:0000145]; midbody [GO:0030496]; protein N-terminus binding [GO:0047485]; Ral GTPase binding [GO:0017160]; epithelial cell apoptotic process [GO:1904019]; establishment of planar polarity [GO:0001736]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; homeostasis of number of cells within a tissue [GO:0048873]; non-motile cilium assembly [GO:1905515]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle docking [GO:0048278],NA,NA,NA
CHOYP_BRAFLDRAFT_125701.1.3.m.18477,0.007272464,-0.003485683,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125724.1.1.m.30781,0.007358848,-0.011029756,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125729.1.1.m.50316,-0.007525892,-0.002511397,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; mRNA 5'-UTR binding [GO:0048027]; myosin binding [GO:0017022]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_BRAFLDRAFT_125731.1.1.m.6261,-0.016262518,-0.002929482,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125735.1.3.m.26333,-0.006820485,0.017152488,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; Lsm2-8 complex [GO:0120115]; nucleolus [GO:0005730]; nucleus [GO:0005634]; P-body [GO:0000932]; small nucleolar ribonucleoprotein complex [GO:0005732]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; maturation of SSU-rRNA [GO:0030490]; mRNA catabolic process [GO:0006402]; mRNA splicing; via spliceosome [GO:0000398]; tRNA processing [GO:0008033],NA,NA,NA
CHOYP_BRAFLDRAFT_125780.1.1.m.60450,-0.003193329,0.00137608,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; Golgi apparatus [GO:0005794]; folic acid binding [GO:0005542]; formimidoyltetrahydrofolate cyclodeaminase activity [GO:0030412]; glutamate formimidoyltransferase activity [GO:0030409]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; tetrahydrofolate interconversion [GO:0035999],NA,NA,NA
CHOYP_BRAFLDRAFT_125840.1.1.m.58396,-0.016016121,0.011912045,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234],NA,NA,NA
CHOYP_BRAFLDRAFT_125862.1.1.m.27159,-0.012018628,-0.014099015,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125880.1.3.m.7081,-0.004072031,-0.017740705,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125880.3.3.m.26918,-0.009560444,-0.025869204,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125998.1.1.m.63211,-0.021013155,0.003128615,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_125999.1.1.m.24819,0.005598049,-0.00454993,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_126058.1.1.m.1201,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]; response to retinoic acid [GO:0032526],NA,NA,NA
CHOYP_BRAFLDRAFT_126152.2.2.m.42694,0.018936009,0.009676582,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transferase activity [GO:0016740]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_126227.1.1.m.24340,0.004924244,0.006915408,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; intracellular [GO:0005622]; pyridoxal phosphate binding [GO:0030170],NA,NA,NA
CHOYP_BRAFLDRAFT_126338.1.1.m.59058,-0.00142636,0.002824544,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_126352.2.2.m.64882,-0.007978544,0.00366532,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; regulation of erythrocyte differentiation [GO:0045646],NA,NA,NA
CHOYP_BRAFLDRAFT_126371.3.3.m.66053,-0.003399727,-0.002282386,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; protein-disulfide reductase activity [GO:0047134]; immune system process [GO:0002376],NA,NA,NA
CHOYP_BRAFLDRAFT_126378.2.2.m.11826,-0.023356522,0.006583015,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_126379.1.3.m.5102,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_126411.1.1.m.49664,0.004932176,-0.007412125,No,NA,NA,NA,NA,NA,NA,chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; dense body [GO:0097433]; nucleus [GO:0005634]; P granule [GO:0043186]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA cap binding complex binding [GO:0140262]; piRNA binding [GO:0034584]; polysome binding [GO:1905538]; protein kinase binding [GO:0019901]; single-stranded RNA binding [GO:0003727]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; regulation of translation [GO:0006417]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; spermatogenesis; exchange of chromosomal proteins [GO:0035093],NA,NA,NA
CHOYP_BRAFLDRAFT_126506.1.1.m.60629,0.006830317,-0.010138717,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]; chondroitin sulfate biosynthetic process [GO:0030206]; epithelial cell migration; open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process; polysaccharide chain biosynthetic process [GO:0015014]; mesoderm migration involved in gastrulation [GO:0007509]; segment polarity determination [GO:0007367]; UDP-glucuronate biosynthetic process [GO:0006065]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_BRAFLDRAFT_126555.2.6.m.5075,0.01823167,-0.004106154,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]; lipid metabolic process [GO:0006629]; pancreas development [GO:0031016]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434],NA,NA,NA
CHOYP_BRAFLDRAFT_126555.6.6.m.54234,-0.022564414,0.0099881,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; intestinal cholesterol absorption [GO:0030299]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; positive regulation of triglyceride lipase activity [GO:0061365]; post-embryonic development [GO:0009791],NA,NA,NA
CHOYP_BRAFLDRAFT_126596.1.1.m.64385,-0.008712572,-0.00898138,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; macropinocytosis [GO:0044351]; mitotic cytokinesis [GO:0000281]; negative regulation of endocytosis [GO:0045806]; negative regulation of protein localization to cell surface [GO:2000009]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein localization to cell surface [GO:2000010]; protein import [GO:0017038],NA,NA,NA
CHOYP_BRAFLDRAFT_126603.1.1.m.31078,-0.021672862,-0.008870835,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; ciliary base [GO:0097546]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_BRAFLDRAFT_126700.1.2.m.17811,-0.009028697,0.000120851,No,NA,NA,NA,NA,NA,NA,nucleoplasmic periphery of the nuclear pore complex [GO:1990826]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; deaminase binding [GO:1990827]; enzyme inhibitor activity [GO:0004857]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; protein domain specific binding [GO:0019904]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of mRNA modification [GO:0090367],NA,NA,NA
CHOYP_BRAFLDRAFT_126750.1.1.m.40768,0.010000102,-0.005561143,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_126756.1.1.m.29611,-0.017991503,-5.55E-05,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_126767.1.3.m.6394,0.016160462,-0.00412032,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_126822.1.1.m.14626,-0.014239208,-0.013220386,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; nuclear inclusion body [GO:0042405]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; RNA polymerase II regulatory region DNA binding [GO:0001012]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin protein ligase binding [GO:0031625]; actin cytoskeleton organization [GO:0030036]; cellular response to heat [GO:0034605]; cellular response to misfolded protein [GO:0071218]; exploration behavior [GO:0035640]; histone H3 deacetylation [GO:0070932]; intermediate filament cytoskeleton organization [GO:0045104]; microtubule cytoskeleton organization [GO:0000226]; monoubiquitinated protein deubiquitination [GO:0035520]; positive regulation of ERAD pathway [GO:1904294]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein localization to cytosolic proteasome complex involved in ERAD pathway [GO:1904379]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cell-substrate adhesion [GO:0010810],NA,NA,NA
CHOYP_BRAFLDRAFT_126826.1.1.m.14796,0.006548773,0.008451819,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285],NA,NA,NA
CHOYP_BRAFLDRAFT_126856.1.3.m.24519,-0.007969698,-0.006182801,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; carbohydrate binding [GO:0030246]; galactoside binding [GO:0016936],NA,NA,NA
CHOYP_BRAFLDRAFT_126856.2.3.m.30577,-0.008261811,0.000163227,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; immune system process [GO:0002376],NA,NA,NA
CHOYP_BRAFLDRAFT_126923.1.1.m.5580,-0.01588319,-0.012528776,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815],NA,NA,NA
CHOYP_BRAFLDRAFT_126943.1.3.m.6839,0.009852676,-0.012075588,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_127028.1.1.m.18415,-0.002629586,-0.006369639,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; 4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; amine binding [GO:0043176]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620]; protein homodimerization activity [GO:0042803]; carnitine biosynthetic process [GO:0045329]; carnitine metabolic process [GO:0009437]; cellular aldehyde metabolic process [GO:0006081]; neurotransmitter biosynthetic process [GO:0042136]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_BRAFLDRAFT_127065.1.7.m.4586,-0.002284826,-0.007624257,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_127065.2.7.m.5835,-0.006543857,0.018893328,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_127065.3.7.m.15669,-0.012752515,0.016241,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_127065.4.7.m.28277,-0.009726625,-0.015340172,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198],NA,NA,NA
CHOYP_BRAFLDRAFT_127065.5.7.m.28848,-0.015072207,-0.018730022,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198],NA,NA,NA
CHOYP_BRAFLDRAFT_127065.6.7.m.30727,-0.020958287,-0.00762839,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; tissue development [GO:0009888],NA,NA,NA
CHOYP_BRAFLDRAFT_127065.7.7.m.57708,0.000981284,0.011767221,No,NA,NA,NA,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_BRAFLDRAFT_127100.1.2.m.2218,0.00230467,0.001472763,No,NA,NA,NA,NA,NA,NA,clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]; clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; cell cycle [GO:0007049]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_BRAFLDRAFT_127100.2.2.m.42594,0.014125294,-0.003958395,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_127105.1.1.m.21922,0.014726804,0.007205759,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084],NA,NA,NA
CHOYP_BRAFLDRAFT_127252.1.1.m.16242,0.008319783,-0.010019771,No,NA,NA,NA,NA,NA,NA,NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; protein antigen binding [GO:1990405]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967],NA,NA,NA
CHOYP_BRAFLDRAFT_127356.1.2.m.8691,0.000453655,-0.009870848,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_127466.1.1.m.62415,-0.017845056,-0.016740607,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_127486.1.1.m.57687,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein domain specific binding [GO:0019904]; cell cycle arrest [GO:0007050]; myeloid progenitor cell differentiation [GO:0002318]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_BRAFLDRAFT_127497.1.1.m.35445,-0.006781299,0.003104826,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; regulation of translational fidelity [GO:0006450]; translation [GO:0006412]; tRNA aminoacylation [GO:0043039],NA,NA,NA
CHOYP_BRAFLDRAFT_127510.1.1.m.48935,-0.022458628,0.009824892,No,NA,NA,NA,NA,NA,NA,apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission; GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903],NA,NA,NA
CHOYP_BRAFLDRAFT_127851.1.1.m.10499,0.008291444,-0.023210973,No,NA,NA,NA,NA,NA,NA,COPI-coated vesicle [GO:0030137]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; Golgi organization [GO:0007030]; negative regulation of GTPase activity [GO:0034260]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_128029.1.1.m.63515,-0.015796021,0.000180463,No,NA,NA,NA,NA,NA,NA,ciliary basal body [GO:0036064]; cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; cell projection organization [GO:0030030]; positive regulation of kinase activity [GO:0033674]; regulation of cell projection organization [GO:0031344],NA,NA,NA
CHOYP_BRAFLDRAFT_128033.2.2.m.54293,0.005729771,-0.00807758,No,NA,NA,NA,NA,NA,NA,isomerase activity [GO:0016853]; ligase activity [GO:0016874]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; antibiotic biosynthetic process [GO:0017000],NA,NA,NA
CHOYP_BRAFLDRAFT_128100.1.1.m.10153,0.008081111,-0.020063822,No,NA,NA,NA,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; granular component [GO:0001652]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal small subunit biogenesis [GO:0042274]; ribosome assembly [GO:0042255]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_BRAFLDRAFT_128129.1.1.m.63237,-0.016668576,0.005819633,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784],NA,NA,NA
CHOYP_BRAFLDRAFT_128345.1.1.m.9897,-0.022642387,0.010424214,No,NA,NA,NA,NA,NA,NA,motile cilium [GO:0031514],NA,NA,NA
CHOYP_BRAFLDRAFT_128432.1.1.m.8945,0.019817089,-0.015646187,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_128459.1.3.m.21899,-0.016830246,0.006258232,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_128460.1.2.m.7232,-0.012321804,0.007030536,No,NA,NA,NA,NA,NA,NA,ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; nuclear chromatin [GO:0000790]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; protein localization to cilium [GO:0061512]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_BRAFLDRAFT_128562.2.4.m.33663,-0.019205855,0.002135562,No,NA,NA,NA,NA,NA,NA,chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomere maintenance via recombination [GO:0000722],NA,NA,NA
CHOYP_BRAFLDRAFT_128749.1.1.m.56605,-0.00451144,-0.012369835,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]; palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl-CoA hydrolase activity [GO:0016290]; cofactor metabolic process [GO:0051186]; cofactor transport [GO:0051181]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_128799.1.1.m.29183,-0.013296493,0.016427622,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_128825.1.1.m.10785,-0.012995481,0.005820152,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_128828.1.2.m.7356,-0.010777641,-0.01283418,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; glycerol-1-phosphatase activity [GO:0000121]; glycerol-3-phosphatase activity [GO:0043136]; magnesium ion binding [GO:0000287]; nucleotide phosphatase activity; acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; phosphoglycolate phosphatase activity [GO:0008967]; protein tyrosine phosphatase activity [GO:0004725]; dephosphorylation [GO:0016311]; glycerol biosynthetic process [GO:0006114]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of gluconeogenesis [GO:0045721]; peptidyl-tyrosine dephosphorylation [GO:0035335],NA,NA,NA
CHOYP_BRAFLDRAFT_128878.1.1.m.42339,0.00632957,-0.008164186,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; vesicle [GO:0031982]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_BRAFLDRAFT_128887.2.2.m.46965,-0.005180299,0.009906771,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_128944.1.2.m.19981,-0.013859929,-0.018900655,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; katanin complex [GO:0008352]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule severing [GO:0051013],NA,NA,NA
CHOYP_BRAFLDRAFT_129004.15.15.m.60150,-0.002384036,-0.006503157,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_129034.1.1.m.17626,0.000133463,-0.012525172,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; spindle [GO:0005819]; cell division [GO:0051301]; mitotic spindle assembly [GO:0090307]; regulation of centriole replication [GO:0046599],NA,NA,NA
CHOYP_BRAFLDRAFT_129048.1.1.m.1769,0.007697823,0.008387458,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_129063.1.1.m.15419,0.007203352,0.000240874,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_129074.1.1.m.25032,-0.00743295,-0.003929713,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone demethylase activity (H3-K36 specific) [GO:0051864]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_BRAFLDRAFT_129108.1.2.m.2456,0.005355306,-0.006508604,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_BRAFLDRAFT_129234.1.1.m.10468,0.012478985,-0.021624674,No,NA,NA,NA,NA,NA,NA,dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; hemopoiesis [GO:0030097]; protein lipoylation [GO:0009249],NA,NA,NA
CHOYP_BRAFLDRAFT_129259.1.1.m.9267,0.022924416,-0.008218822,No,NA,NA,NA,NA,NA,NA,amyloplast [GO:0009501]; 3 iron; 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; iron ion binding [GO:0005506]; glutamine metabolic process [GO:0006541]; L-glutamate biosynthetic process [GO:0097054],NA,NA,NA
CHOYP_BRAFLDRAFT_129513.1.1.m.51276,0.015525106,-0.000258369,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; 4 iron; 4 sulfur cluster binding [GO:0051539]; dihydropyrimidine dehydrogenase (NADP+) activity [GO:0017113]; dihydrouracil dehydrogenase (NAD+) activity [GO:0004159]; FAD binding [GO:0071949]; iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]; NADH dehydrogenase activity [GO:0003954]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; uracil binding [GO:0002058]; aging [GO:0007568]; beta-alanine biosynthetic process [GO:0019483]; circadian rhythm [GO:0007623]; pyrimidine nucleobase catabolic process [GO:0006208]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; thymidine catabolic process [GO:0006214]; thymine catabolic process [GO:0006210]; uracil catabolic process [GO:0006212]; uracil metabolic process [GO:0019860],NA,NA,NA
CHOYP_BRAFLDRAFT_129759.2.2.m.30082,-0.022746219,0.001212823,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_BRAFLDRAFT_129885.1.2.m.24564,-0.005256761,-0.0021048,No,NA,NA,NA,NA,NA,NA,actomyosin [GO:0042641]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; proteinase activated receptor binding [GO:0031871]; actomyosin contractile ring assembly [GO:0000915]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; multivesicular body assembly [GO:0036258]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of extracellular exosome assembly [GO:1903551]; regulation of membrane permeability [GO:0090559]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058],NA,NA,NA
CHOYP_BRAFLDRAFT_129885.2.2.m.34895,-0.001903436,0.012774263,No,NA,NA,NA,NA,NA,NA,actomyosin [GO:0042641]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; proteinase activated receptor binding [GO:0031871]; actomyosin contractile ring assembly [GO:0000915]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; multivesicular body assembly [GO:0036258]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of extracellular exosome assembly [GO:1903551]; regulation of membrane permeability [GO:0090559]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058],NA,NA,NA
CHOYP_BRAFLDRAFT_129914.1.3.m.8213,-0.007976806,0.006215313,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_BRAFLDRAFT_129932.1.1.m.30332,-0.014012132,-0.006961351,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_129967.1.4.m.4020,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_BRAFLDRAFT_129967.3.4.m.41916,0.004643979,-0.012366114,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_BRAFLDRAFT_129967.4.4.m.64315,0.013316629,0.007522864,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_BRAFLDRAFT_130097.1.1.m.12458,-0.022638753,-0.007348122,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_130131.1.1.m.11020,0.005801317,-0.008490565,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_130395.1.1.m.38394,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_130685.1.1.m.63499,-0.022840144,0.00645029,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; artery morphogenesis [GO:0048844]; cell aging [GO:0007569]; developmental growth [GO:0048589]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; vasculogenesis [GO:0001570]; vitellogenesis [GO:0007296],NA,NA,NA
CHOYP_BRAFLDRAFT_130809.1.1.m.5127,0.016452046,0.014816158,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_130974.1.1.m.28374,0.007218874,-0.014422901,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235],NA,NA,NA
CHOYP_BRAFLDRAFT_131134.3.3.m.16643,-0.000445931,-0.021778209,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_131151.3.4.m.57848,0.004993158,0.002427278,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; plasma membrane [GO:0005886]; GTP-dependent protein binding [GO:0030742]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidic acid binding [GO:0070300]; Ras GTPase binding [GO:0017016]; microvillus assembly [GO:0030033]; positive regulation of GTPase activity [GO:0043547]; protein localization to plasma membrane [GO:0072659]; Ras protein signal transduction [GO:0007265]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_BRAFLDRAFT_131151.4.4.m.58019,-0.006974292,-0.004083455,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; plasma membrane [GO:0005886]; GTP-dependent protein binding [GO:0030742]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidic acid binding [GO:0070300]; Ras GTPase binding [GO:0017016]; microvillus assembly [GO:0030033]; positive regulation of GTPase activity [GO:0043547]; protein localization to plasma membrane [GO:0072659]; Ras protein signal transduction [GO:0007265]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_BRAFLDRAFT_131216.1.1.m.8822,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,chromosome; telomeric region [GO:0000781]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; telomere maintenance via recombination [GO:0000722],NA,NA,NA
CHOYP_BRAFLDRAFT_131227.1.1.m.24973,0.011052174,0.010392938,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; endoplasmic reticulum tubular network organization [GO:0071786]; endosomal transport [GO:0016197]; establishment of neuroblast polarity [GO:0045200]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; polarized epithelial cell differentiation [GO:0030859]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_131414.1.1.m.9300,-0.00685284,-0.000842769,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_131608.1.1.m.44249,0.003865725,-0.002935397,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_131621.1.1.m.56341,0.01659405,0.000505074,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; TRAF2-GSTP1 complex [GO:0097057]; dinitrosyl-iron complex binding [GO:0035731]; drug binding [GO:0008144]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; protein kinase binding [GO:0019901]; S-nitrosoglutathione binding [GO:0035730]; glutathione metabolic process [GO:0006749],NA,NA,NA
CHOYP_BRAFLDRAFT_131834.1.1.m.29489,-0.011919764,0.003412277,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; integrin activation [GO:0033622]; positive regulation of cell proliferation [GO:0008284]; positive regulation of immunoglobulin biosynthetic process [GO:0002642]; regulation of B cell proliferation [GO:0030888]; regulation of cell proliferation [GO:0042127]; regulation of insulin receptor signaling pathway [GO:0046626],NA,NA,NA
CHOYP_BRAFLDRAFT_132233.1.4.m.13687,0.001844136,-0.000612318,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; manchette [GO:0002177]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017],NA,NA,NA
CHOYP_BRAFLDRAFT_132336.1.1.m.26677,-0.006758735,-0.016207468,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_132957.1.1.m.51287,-0.017715504,0.003253634,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_BRAFLDRAFT_133135.1.1.m.18788,-0.02265634,0.010383964,No,NA,NA,NA,NA,NA,NA,MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; negative regulation of cell proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of transcription; DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of signal transduction by p53 class mediator [GO:1901796],NA,NA,NA
CHOYP_BRAFLDRAFT_136434.1.1.m.33244,-0.003352079,0.001509422,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; cellular response to interleukin-7 [GO:0098761]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_140951.1.1.m.40225,0.002740418,0.010589431,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; vacuole [GO:0005773]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; exocytosis [GO:0006887]; protein transport [GO:0015031]; response to salt stress [GO:0009651]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_BRAFLDRAFT_150340.1.4.m.7435,0.002568707,0.017533599,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_151236.1.1.m.30653,-0.021855297,-0.000355551,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_153908.1.2.m.1377,-0.006881657,-0.008354686,No,NA,NA,NA,NA,NA,NA,cell [GO:0005623]; calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_BRAFLDRAFT_154839.1.1.m.13878,-0.001868246,-0.004370785,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein homodimerization activity [GO:0042803]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport; vesicle recycling within Golgi [GO:0000301],NA,NA,NA
CHOYP_BRAFLDRAFT_161161.1.1.m.39447,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_165799.1.1.m.33332,-0.013157792,-0.001847213,No,NA,NA,NA,NA,NA,NA,eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; RNA cap binding [GO:0000339]; translation initiation factor activity [GO:0003743]; positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_194931.1.1.m.46966,-0.009745192,-0.016697421,No,NA,NA,NA,NA,NA,NA,CD95 death-inducing signaling complex [GO:0031265]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; ripoptosome [GO:0097342]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type peptidase activity [GO:0008234]; death effector domain binding [GO:0035877]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; B cell activation [GO:0042113]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic cyclic compound [GO:0071407]; death-inducing signaling complex assembly [GO:0071550]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; macrophage differentiation [GO:0030225]; natural killer cell activation [GO:0030101]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of neuron death [GO:1901216]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of proteolysis [GO:0045862]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of necroptotic process [GO:0060544]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to cobalt ion [GO:0032025]; response to cold [GO:0009409]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process [GO:0039650]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]; T cell activation [GO:0042110]; toll-like receptor 3 signaling pathway [GO:0034138]; TRAIL-activated apoptotic signaling pathway [GO:0036462]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666],NA,NA,NA
CHOYP_BRAFLDRAFT_199108.1.2.m.24078,0.011189627,0.007841667,No,NA,NA,NA,NA,NA,NA,cell projection membrane [GO:0031253]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; podosome [GO:0002102]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; cilium assembly [GO:0060271]; positive regulation of membrane tubulation [GO:1903527]; positive regulation of podosome assembly [GO:0071803],NA,NA,NA
CHOYP_BRAFLDRAFT_199346.1.3.m.11369,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; Golgi to plasma membrane transport [GO:0006893]; protein localization to organelle [GO:0033365]; protein targeting to membrane [GO:0006612],NA,NA,NA
CHOYP_BRAFLDRAFT_200206.1.1.m.35419,-0.009379464,0.016993403,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; adult locomotory behavior [GO:0008344]; memory [GO:0007613]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_200527.1.1.m.601,0.011065426,0.007941661,No,NA,NA,NA,NA,NA,NA,cytoplasmic microtubule [GO:0005881]; carbonyl reductase (NADPH) activity [GO:0004090]; erythrulose reductase activity [GO:0047880]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity; acting on NAD(P)H; quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997],NA,NA,NA
CHOYP_BRAFLDRAFT_201924.1.1.m.30855,-0.023470102,0.002441627,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_BRAFLDRAFT_202318.1.1.m.4330,-0.014836369,-0.001227249,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_BRAFLDRAFT_202721.1.2.m.18687,-0.008085075,0.000979859,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; trans-Golgi network [GO:0005802]; histone-lysine N-methyltransferase activity [GO:0018024]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; endosomal transport [GO:0016197]; histone H3-K4 methylation [GO:0051568]; regulation of megakaryocyte differentiation [GO:0045652],NA,NA,NA
CHOYP_BRAFLDRAFT_202783.1.2.m.21505,0.00465486,-0.002611007,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; cellular response to peptide [GO:1901653],NA,NA,NA
CHOYP_BRAFLDRAFT_203026.1.1.m.61263,0.007449225,0.005552163,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; mRNA transport [GO:0051028]; small GTPase mediated signal transduction [GO:0007264]; stress granule assembly [GO:0034063],NA,NA,NA
CHOYP_BRAFLDRAFT_203057.1.1.m.47437,-0.007962307,0.001690321,No,NA,NA,NA,NA,NA,NA,integrator complex [GO:0032039]; snRNA processing [GO:0016180],NA,NA,NA
CHOYP_BRAFLDRAFT_203393.1.2.m.16760,-0.005208317,-0.014760108,No,NA,NA,NA,NA,NA,NA,histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL3/4 complex [GO:0044666]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; histone-lysine N-methyltransferase activity [GO:0018024]; methylated histone binding [GO:0035064]; transcription regulatory region DNA binding [GO:0044212]; beta-catenin-TCF complex assembly [GO:1904837]; cellular response to DNA damage stimulus [GO:0006974]; histone H3-K4 methylation [GO:0051568]; post-translational protein modification [GO:0043687]; regulation of megakaryocyte differentiation [GO:0045652]; response to estrogen [GO:0043627],NA,NA,NA
CHOYP_BRAFLDRAFT_203655.1.2.m.10,-0.021721438,0.004905043,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; nucleolus [GO:0005730]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; catalytic activity [GO:0003824]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; negative regulation of telomerase RNA reverse transcriptase activity [GO:1905662]; positive regulation of DNA ligation [GO:0051106]; protein ADP-ribosylation [GO:0006471]; protein localization to site of double-strand break [GO:1990166]; protein poly-ADP-ribosylation [GO:0070212]; regulation of mitotic spindle organization [GO:0060236]; telomere maintenance [GO:0000723],NA,NA,NA
CHOYP_BRAFLDRAFT_203655.2.2.m.20185,-0.012051952,0.003151314,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; nucleolus [GO:0005730]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; catalytic activity [GO:0003824]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; negative regulation of telomerase RNA reverse transcriptase activity [GO:1905662]; positive regulation of DNA ligation [GO:0051106]; protein ADP-ribosylation [GO:0006471]; protein localization to site of double-strand break [GO:1990166]; protein poly-ADP-ribosylation [GO:0070212]; regulation of mitotic spindle organization [GO:0060236]; telomere maintenance [GO:0000723],NA,NA,NA
CHOYP_BRAFLDRAFT_204357.1.1.m.62329,-0.017704824,0.000735923,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; regulation of transcription; DNA-templated [GO:0006355]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_204501.1.1.m.910,-0.002134471,-0.004965767,No,NA,NA,NA,NA,NA,NA,methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_BRAFLDRAFT_204736.1.2.m.27864,-0.014608772,-0.008513583,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; cellular response to DNA damage stimulus [GO:0006974]; mitochondrial protein catabolic process [GO:0035694]; mitophagy by induced vacuole formation [GO:0035695]; response to steroid hormone [GO:0048545],NA,NA,NA
CHOYP_BRAFLDRAFT_204736.2.2.m.63327,0.007806209,-0.015401698,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; cellular response to DNA damage stimulus [GO:0006974]; mitochondrial protein catabolic process [GO:0035694]; mitophagy by induced vacuole formation [GO:0035695]; response to steroid hormone [GO:0048545],NA,NA,NA
CHOYP_BRAFLDRAFT_204871.1.1.m.66069,0.010866629,-0.002180931,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_204923.1.2.m.1690,-0.00460748,-0.01692325,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_BRAFLDRAFT_204923.2.2.m.63877,-0.016475749,0.00317845,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008],NA,NA,NA
CHOYP_BRAFLDRAFT_205095.2.2.m.62915,-0.01454184,-0.015452671,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_BRAFLDRAFT_205939.3.3.m.64021,0.008341892,-0.000246764,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_206799.1.23.m.3242,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_206907.11.11.m.60959,-0.004557894,-0.012084912,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],NA,NA,NA
CHOYP_BRAFLDRAFT_206907.11.11.m.60961,0.019093039,-0.006625581,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; P granule [GO:0043186]; P-body [GO:0000932]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; mRNA 3'-UTR binding [GO:0003730]; phosphatase binding [GO:0019902]; intracellular signal transduction [GO:0035556]; regulation of mRNA stability [GO:0043488],NA,NA,NA
CHOYP_BRAFLDRAFT_206907.5.11.m.19273,-0.006256911,0.010459699,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376],NA,NA,NA
CHOYP_BRAFLDRAFT_206907.6.11.m.30690,0.001569867,0.013057548,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],NA,NA,NA
CHOYP_BRAFLDRAFT_208090.1.1.m.45354,-0.013933575,0.006226954,No,NA,NA,NA,NA,NA,NA,acrosomal membrane [GO:0002080]; axonemal basal plate [GO:0097541]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; kinocilium [GO:0060091]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; outer acrosomal membrane [GO:0002081]; photoreceptor connecting cilium [GO:0032391]; sperm flagellum [GO:0036126]; trans-Golgi network [GO:0005802]; kinesin binding [GO:0019894]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endothelial cell morphogenesis [GO:0001886]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; primary palate development [GO:1903929]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; sperm axoneme assembly [GO:0007288]; spermatid nucleus elongation [GO:0007290]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537],NA,NA,NA
CHOYP_BRAFLDRAFT_208117.3.3.m.56788,0.012590794,-0.003851674,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; protein C-terminus binding [GO:0008022]; Ras GTPase binding [GO:0017016]; adherens junction organization [GO:0034332]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell signaling [GO:0007267]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; negative regulation of cell migration [GO:0030336]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of GTPase activity [GO:0043547]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_BRAFLDRAFT_208160.1.2.m.4498,-0.005324954,-0.013098367,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_BRAFLDRAFT_208197.18.21.m.59194,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208197.2.21.m.9816,-0.000210635,-0.003691143,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208197.5.21.m.21756,-2.00E-07,-0.01501926,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208293.10.20.m.53518,0.004663383,0.006545299,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208293.15.20.m.61604,-0.009060854,0.003772444,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208293.6.20.m.36168,-0.009303321,0.007788458,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.1.32.m.14239,-0.005609703,0.017582757,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.11.32.m.42955,0.004014289,-0.005231198,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.18.32.m.58763,-0.009931399,0.003850205,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.22.32.m.59131,0.013764386,0.003999482,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.25.32.m.60144,-0.005711947,0.003470316,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.27.32.m.61232,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.28.32.m.61328,-0.004067082,0.0114847,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.29.32.m.61624,-0.000632038,0.013278465,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.30.32.m.61782,-0.007223266,0.014826909,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.4.32.m.22687,0.000171686,0.0002634,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.4.32.m.22689,-0.004111805,0.016940645,No,NA,NA,NA,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; synapse [GO:0045202]; 5.8S rRNA binding [GO:1990932]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.8.32.m.36574,0.003558142,0.007133524,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208819.1.1.m.61941,-0.005445293,0.004257549,No,NA,NA,NA,NA,NA,NA,cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]; 3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]; cGMP-mediated signaling [GO:0019934],NA,NA,NA
CHOYP_BRAFLDRAFT_208819.1.1.m.61942,-0.016191396,-0.00243288,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_209304.2.2.m.63768,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear membrane [GO:0031965]; Hsp70 protein binding [GO:0030544]; cellular protein-containing complex assembly [GO:0034622]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_BRAFLDRAFT_209933.1.1.m.29283,0.01586781,0.003168765,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_210874.1.1.m.28596,-0.009281686,-0.003111494,No,NA,NA,NA,NA,NA,NA,heme binding [GO:0020037]; metal ion binding [GO:0046872]; tryptophan 2;3-dioxygenase activity [GO:0004833]; compound eye pigmentation [GO:0048072]; kynurenine metabolic process [GO:0070189]; ommochrome biosynthetic process [GO:0006727]; positive regulation of neuron death [GO:1901216]; protein homotetramerization [GO:0051289]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to acetyl-CoA [GO:0019442]; tryptophan catabolic process to kynurenine [GO:0019441],NA,NA,NA
CHOYP_BRAFLDRAFT_211853.1.1.m.18681,-0.00457285,0.005114776,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; growth factor activity [GO:0008083]; metal ion binding [GO:0046872]; negative regulation of appetite [GO:0032099]; positive regulation of MAPK cascade [GO:0043410],NA,NA,NA
CHOYP_BRAFLDRAFT_212086.1.11.m.20083,0.001061351,0.006130504,No,NA,NA,NA,NA,NA,NA,cell [GO:0005623]; ADP-ribosylarginine hydrolase activity [GO:0003875]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cellular protein modification process [GO:0006464]; intracellular protein transport [GO:0006886]; protein de-ADP-ribosylation [GO:0051725],NA,NA,NA
CHOYP_BRAFLDRAFT_212086.4.11.m.42448,-0.008717137,0.006236896,No,NA,NA,NA,NA,NA,NA,cell [GO:0005623]; ADP-ribosylarginine hydrolase activity [GO:0003875]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cellular protein modification process [GO:0006464]; intracellular protein transport [GO:0006886]; protein de-ADP-ribosylation [GO:0051725],NA,NA,NA
CHOYP_BRAFLDRAFT_212086.9.11.m.60590,-0.007383598,0.005009488,No,NA,NA,NA,NA,NA,NA,cell [GO:0005623]; ADP-ribosylarginine hydrolase activity [GO:0003875]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cellular protein modification process [GO:0006464]; intracellular protein transport [GO:0006886]; protein de-ADP-ribosylation [GO:0051725],NA,NA,NA
CHOYP_BRAFLDRAFT_212438.1.1.m.29117,0.005667298,-0.001539219,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; cellular response to dsRNA [GO:0071359]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-gamma [GO:0071346]; mitochondrial mRNA catabolic process [GO:0000958]; mRNA processing [GO:0006397]; negative regulation of cell death [GO:0060548]; negative regulation of oxidative phosphorylation [GO:0090324]; nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:0000288]; positive regulation of viral genome replication [GO:0045070]; regulation of mitochondrial mRNA stability [GO:0044528],NA,NA,NA
CHOYP_BRAFLDRAFT_214346.1.1.m.56462,-0.007624594,-0.02497282,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex III [GO:0005750]; electron transporter; transferring electrons within CoQH2-cytochrome c reductase complex activity [GO:0045153]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; mitochondrial electron transport; ubiquinol to cytochrome c [GO:0006122],NA,NA,NA
CHOYP_BRAFLDRAFT_214348.1.2.m.42797,-0.007481243,0.019749657,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; 5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749],NA,NA,NA
CHOYP_BRAFLDRAFT_214348.2.2.m.59996,-0.008226242,0.019443241,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_214790.1.1.m.15955,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_BRAFLDRAFT_215087.1.1.m.66618,0.003994777,0.008958144,No,NA,NA,NA,NA,NA,NA,apical part of cell [GO:0045177]; azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; pseudopodium [GO:0031143]; SNARE complex [GO:0031201]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; calcium ion regulated exocytosis [GO:0017156]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosome to lysosome transport [GO:0008333]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; natural killer cell degranulation [GO:0043320]; neutrophil degranulation [GO:0043312]; phagocytosis; engulfment [GO:0006911]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of histamine secretion by mast cell [GO:1903595]; regulation of protein targeting to vacuolar membrane [GO:1900483]; SNARE complex assembly [GO:0035493]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_215208.1.1.m.40012,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_BRAFLDRAFT_215283.1.1.m.1467,0.001093425,0.000722495,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H2A-R3 specific) [GO:0070612]; histone methyltransferase activity (H3-R2 specific) [GO:0070611]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; DNA repair [GO:0006281]; histone H3-R2 methylation [GO:0034970]; negative regulation of transcription; DNA-templated [GO:0045892]; peptidyl-arginine methylation; to asymmetrical-dimethyl arginine [GO:0019919]; peptidyl-arginine N-methylation [GO:0035246],NA,NA,NA
CHOYP_BRAFLDRAFT_215361.1.1.m.55455,-0.008449778,0.020888325,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; leukotriene-A4 hydrolase activity [GO:0004463]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]; cellular lipid metabolic process [GO:0044255]; cellular protein metabolic process [GO:0044267]; leukotriene biosynthetic process [GO:0019370]; peptide catabolic process [GO:0043171],NA,NA,NA
CHOYP_BRAFLDRAFT_215413.1.1.m.2004,0.007531446,0.011888463,No,NA,NA,NA,NA,NA,NA,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462],NA,NA,NA
CHOYP_BRAFLDRAFT_215789.1.1.m.60401,-0.000977037,-0.016687125,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_BRAFLDRAFT_215789.1.1.m.60405,-0.007940768,-0.000674292,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cell cycle [GO:0007049]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response; signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; mRNA processing [GO:0006397]; negative regulation of cell proliferation [GO:0008285]; regulation of myotube differentiation [GO:0010830]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_216204.1.1.m.30654,-0.00205262,-0.016119107,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],NA,NA,NA
CHOYP_BRAFLDRAFT_216893.1.1.m.18940,-0.013084155,-0.003454384,No,NA,NA,NA,NA,NA,NA,ACF complex [GO:0016590]; CHRAC [GO:0008623]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; DNA-dependent DNA replication [GO:0006261]; histone acetylation [GO:0016573]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_BRAFLDRAFT_217332.2.2.m.51240,-0.010808558,0.011771099,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; sialate O-acetylesterase activity [GO:0001681]; carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682],NA,NA,NA
CHOYP_BRAFLDRAFT_217424.2.2.m.44576,-0.003383999,-0.007795056,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; aliphatic-amine oxidase activity [GO:0052595]; aminoacetone:oxygen oxidoreductase(deaminating) activity [GO:0052594]; copper ion binding [GO:0005507]; phenethylamine:oxygen oxidoreductase (deaminating) activity [GO:0052596]; primary amine oxidase activity [GO:0008131]; protein homodimerization activity [GO:0042803]; quinone binding [GO:0048038]; tryptamine:oxygen oxidoreductase (deaminating) activity [GO:0052593]; aging [GO:0007568]; amine metabolic process [GO:0009308]; cell adhesion [GO:0007155]; eating behavior [GO:0042755]; leukocyte migration involved in inflammatory response [GO:0002523]; negative regulation of primary amine oxidase activity [GO:1902283]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of leukocyte migration [GO:0002687]; regulation of blood pressure [GO:0008217]; response to antibiotic [GO:0046677]; response to immobilization stress [GO:0035902],NA,NA,NA
CHOYP_BRAFLDRAFT_217516.1.1.m.18628,-0.004107867,-0.008211759,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822]; histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; transcription factor binding [GO:0008134]; chromatin organization [GO:0006325]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_BRAFLDRAFT_218889.2.2.m.58058,-0.010185452,-0.010519257,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription factor complex [GO:0005667]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region DNA binding [GO:0001012]; transcription factor binding [GO:0008134]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of cellular senescence [GO:2000773]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell division [GO:0051302]; regulation of lipid kinase activity [GO:0043550]; regulation of mitotic cell cycle [GO:0007346]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_219059.1.1.m.40577,-0.004841769,-0.001705448,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; adenosine deaminase activity [GO:0004000]; adenosine receptor binding [GO:0031685]; heparin binding [GO:0008201]; proteoglycan binding [GO:0043394]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154],NA,NA,NA
CHOYP_BRAFLDRAFT_219059.1.1.m.40578,-0.002106841,0.012392803,No,NA,NA,NA,NA,NA,NA,ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; motor neuron axon guidance [GO:0008045]; regulation of axonogenesis [GO:0050770]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_BRAFLDRAFT_219160.1.1.m.58567,-0.006568844,-0.004109478,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_BRAFLDRAFT_220284.1.1.m.29545,-0.00317989,0.008475749,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; mannose binding [GO:0005537]; glycosylation [GO:0070085]; positive regulation of GTP binding [GO:1904426]; retrograde transport; endosome to Golgi [GO:0042147]; signal peptide processing [GO:0006465],NA,NA,NA
CHOYP_BRAFLDRAFT_220356.5.6.m.38505,0.013723176,0.011087645,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_221105.1.2.m.172,0.014175972,0.01035169,No,NA,NA,NA,NA,NA,NA,cysteine-type peptidase activity [GO:0008234]; NEDD8-specific protease activity [GO:0019784],NA,NA,NA
CHOYP_BRAFLDRAFT_221105.2.2.m.18318,-0.005017445,-0.00752528,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829],NA,NA,NA
CHOYP_BRAFLDRAFT_221115.1.1.m.28512,-0.006929145,-0.000316258,No,NA,NA,NA,NA,NA,NA,early endosome [GO:0005769]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_221294.2.2.m.52722,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_221898.1.2.m.28353,-0.013567198,0.005527327,No,NA,NA,NA,NA,NA,NA,axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; thromboxane A2 receptor binding [GO:0031870]; camera-type eye development [GO:0043010]; cerebellum development [GO:0021549]; ciliary basal body-plasma membrane docking [GO:0097711]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589],NA,NA,NA
CHOYP_BRAFLDRAFT_223290.2.2.m.30918,0.001847246,-0.017672426,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_BRAFLDRAFT_223429.1.2.m.30136,-0.000522694,0.019934582,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded RNA binding [GO:0003727]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_BRAFLDRAFT_223429.2.2.m.38659,0.009274261,0.0154984,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; double-stranded DNA binding [GO:0003690]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_223476.1.1.m.30983,0.005685781,-0.025104408,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829],NA,NA,NA
CHOYP_BRAFLDRAFT_223573.1.1.m.4526,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_BRAFLDRAFT_223623.1.1.m.11202,-0.010299592,-0.019373636,No,NA,NA,NA,NA,NA,NA,Cul3-RING ubiquitin ligase complex [GO:0031463]; midbody [GO:0030496]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_BRAFLDRAFT_223894.1.1.m.7024,-0.004416554,-0.013812753,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; embryo implantation [GO:0007566]; nucleologenesis [GO:0017126]; positive regulation of gene expression; epigenetic [GO:0045815]; rRNA transcription [GO:0009303]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation from RNA polymerase I promoter [GO:0006361],NA,NA,NA
CHOYP_BRAFLDRAFT_224325.1.3.m.26136,-0.010771485,0.000997405,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; histone binding [GO:0042393]; glucose homeostasis [GO:0042593]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; regulation of fatty acid metabolic process [GO:0019217]; response to ethanol [GO:0045471]; triglyceride metabolic process [GO:0006641],NA,NA,NA
CHOYP_BRAFLDRAFT_224325.3.3.m.52906,0.00444297,0.0088406,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641],NA,NA,NA
CHOYP_BRAFLDRAFT_224574.18.18.m.65591,0.007479131,0.009156757,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_224574.3.18.m.20799,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],NA,NA,NA
CHOYP_BRAFLDRAFT_224716.1.2.m.41344,0.002962156,-0.01457436,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_225253.1.1.m.9264,-0.005391157,-0.023308264,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; transporter activity [GO:0005215]; atrial cardiac muscle cell action potential [GO:0086014]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_225290.1.1.m.5737,-0.000282411,-0.002527856,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen [GO:0016705]; icosanoid metabolic process [GO:0006690],NA,NA,NA
CHOYP_BRAFLDRAFT_226345.1.1.m.55555,0.021258727,-0.013516335,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; fat cell differentiation [GO:0045444]; positive regulation of sequestering of triglyceride [GO:0010890],NA,NA,NA
CHOYP_BRAFLDRAFT_226416.1.1.m.56984,-0.008024811,0.009043318,No,NA,NA,NA,NA,NA,NA,actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cytoskeletal protein binding [GO:0008092]; actin filament polymerization [GO:0030041]; cell migration [GO:0016477],NA,NA,NA
CHOYP_BRAFLDRAFT_226506.1.3.m.1062,-0.005753445,-0.022624212,No,NA,NA,NA,NA,NA,NA,dense core granule [GO:0031045]; extrinsic component of membrane [GO:0019898]; autophagy [GO:0006914]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; social behavior [GO:0035176],NA,NA,NA
CHOYP_BRAFLDRAFT_226506.3.3.m.53203,-0.002189279,0.02118879,No,NA,NA,NA,NA,NA,NA,dense core granule [GO:0031045]; extrinsic component of membrane [GO:0019898]; autophagy [GO:0006914]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; social behavior [GO:0035176],NA,NA,NA
CHOYP_BRAFLDRAFT_226942.1.1.m.49751,0.009559241,0.01344853,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of muscle organ development [GO:0048635]; negative regulation of transcription; DNA-templated [GO:0045892]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_227287.1.1.m.14669,-0.015682234,0.00239565,No,NA,NA,NA,NA,NA,NA,hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_227771.1.2.m.60606,0.020210386,0.002019589,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_BRAFLDRAFT_228853.1.1.m.9833,-0.003958573,-0.011141884,No,NA,NA,NA,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; mRNA cap binding [GO:0098808]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_BRAFLDRAFT_230143.1.1.m.15015,-0.010108546,0.004552977,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; proline-rich region binding [GO:0070064]; protein kinase binding [GO:0019901]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; CD4-positive or CD8-positive; alpha-beta T cell lineage commitment [GO:0043369]; homeostasis of number of cells [GO:0048872]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of B cell differentiation [GO:0045577]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of necroptotic process [GO:0060544]; regulation of protein binding [GO:0043393]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ripoptosome assembly involved in necroptotic process [GO:1901026]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_BRAFLDRAFT_230181.1.1.m.61583,0.003118578,-0.010572987,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phospholipid binding [GO:0005543]; ceramide metabolic process [GO:0006672]; fatty acid catabolic process [GO:0009062]; glycerophospholipid metabolic process [GO:0006650]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phospholipid metabolic process [GO:0006644],NA,NA,NA
CHOYP_BRAFLDRAFT_232705.1.2.m.13912,-0.019835326,-0.006865981,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; NAD biosynthetic process [GO:0009435]; quinolinate catabolic process [GO:0034213],NA,NA,NA
CHOYP_BRAFLDRAFT_233674.1.1.m.66738,0.007228574,-0.001272248,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; protein histidine phosphatase activity [GO:0101006]; dephosphorylation [GO:0016311]; phosphate-containing compound metabolic process [GO:0006796]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_BRAFLDRAFT_234513.1.1.m.9581,-0.008272366,-0.002326893,No,NA,NA,NA,NA,NA,NA,Mon1-Ccz1 complex [GO:0035658]; guanyl-nucleotide exchange factor activity [GO:0005085],NA,NA,NA
CHOYP_BRAFLDRAFT_234854.2.2.m.58013,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,chromosome; centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048],NA,NA,NA
CHOYP_BRAFLDRAFT_235412.2.2.m.58139,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_BRAFLDRAFT_236936.2.6.m.17168,0.001798664,0.008955946,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_BRAFLDRAFT_236936.3.6.m.29228,0.003493241,-0.019566725,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_237339.1.1.m.15256,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_238139.1.1.m.12224,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_BRAFLDRAFT_239751.2.3.m.36889,-0.018265433,0.01781581,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_240825.1.1.m.43452,0.004706975,-0.0019557,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2B complex [GO:0005851]; guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; hippocampus development [GO:0021766]; myelination [GO:0042552]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_BRAFLDRAFT_240864.1.1.m.24434,0.005736272,0.014317888,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; phosphatidylinositol binding [GO:0035091]; intracellular protein transport [GO:0006886]; retrograde transport; endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_BRAFLDRAFT_240914.2.3.m.29586,0.017776224,-0.005142352,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_BRAFLDRAFT_241287.1.1.m.5544,-0.000739841,0.003239962,No,NA,NA,NA,NA,NA,NA,axon terminus [GO:0043679]; axonal growth cone [GO:0044295]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; synaptic membrane [GO:0097060]; chemorepellent activity [GO:0045499]; fibroblast growth factor receptor binding [GO:0005104]; protein homodimerization activity [GO:0042803]; axon guidance [GO:0007411]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; embryonic morphogenesis [GO:0048598]; fibroblast growth factor receptor signaling pathway [GO:0008543]; head development [GO:0060322]; heart development [GO:0007507]; neuron projection development [GO:0031175]; neuron projection extension [GO:1990138]; positive regulation of synapse assembly [GO:0051965]; proepicardium cell migration involved in pericardium morphogenesis [GO:0003345]; response to axon injury [GO:0048678]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560],NA,NA,NA
CHOYP_BRAFLDRAFT_241400.1.1.m.44544,0.005304324,0.020450855,No,NA,NA,NA,NA,NA,NA,hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_241420.1.1.m.61408,0.002042606,-0.013721714,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; cellular response to superoxide [GO:0071451],NA,NA,NA
CHOYP_BRAFLDRAFT_241726.22.22.m.52736,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_241726.4.22.m.3766,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_244533.1.2.m.40480,0.009183721,-0.007379812,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; phosphorylase activity [GO:0004645]; protein homodimerization activity [GO:0042803]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969],NA,NA,NA
CHOYP_BRAFLDRAFT_244533.2.2.m.53951,-0.00860984,-0.002630161,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; phosphorylase activity [GO:0004645]; protein homodimerization activity [GO:0042803]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969],NA,NA,NA
CHOYP_BRAFLDRAFT_245349.1.1.m.45479,-0.015763226,-0.019098806,No,NA,NA,NA,NA,NA,NA,motile cilium [GO:0031514]; nucleus [GO:0005634]; cilium organization [GO:0044782]; meiotic cell cycle [GO:0051321],NA,NA,NA
CHOYP_BRAFLDRAFT_246447.1.1.m.30255,-0.018770623,0.005495471,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],NA,NA,NA
CHOYP_BRAFLDRAFT_246510.1.1.m.27433,-0.022662793,0.010253392,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_246978.1.1.m.6916,-0.021373576,-0.004562724,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_247007.1.1.m.15096,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; protein disulfide oxidoreductase activity [GO:0015035]; superoxide dismutase activity [GO:0004784]; superoxide dismutase copper chaperone activity [GO:0016532]; zinc ion binding [GO:0008270]; cellular response to oxidative stress [GO:0034599]; metal ion transport [GO:0030001]; positive regulation of oxidoreductase activity [GO:0051353]; protein maturation by copper ion transfer [GO:0015680]; removal of superoxide radicals [GO:0019430]; superoxide metabolic process [GO:0006801],NA,NA,NA
CHOYP_BRAFLDRAFT_247063.1.1.m.17671,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannosyl-oligosaccharide glucosidase activity [GO:0004573]; oligosaccharide metabolic process [GO:0009311]; protein N-linked glycosylation [GO:0006487],NA,NA,NA
CHOYP_BRAFLDRAFT_249141.1.1.m.6974,-0.01148044,-0.002234225,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_249506.2.2.m.60314,-0.011410571,0.004326688,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_BRAFLDRAFT_251578.1.1.m.15566,-0.007596668,0.001067772,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; establishment of pole plasm mRNA localization [GO:0046595]; germarium-derived oocyte fate determination [GO:0007294]; microtubule cytoskeleton organization [GO:0000226]; mRNA splicing; via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of transposition; DNA-mediated [GO:0000335]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of pole plasm oskar mRNA localization [GO:0007317]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_251779.1.2.m.6830,-0.004352697,0.015673093,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; single-stranded DNA-dependent ATPase activity [GO:0043142]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein homooligomerization [GO:0051260]; somatic hypermutation of immunoglobulin genes [GO:0016446],NA,NA,NA
CHOYP_BRAFLDRAFT_251802.1.1.m.66483,0.01426646,0.00430104,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; biosynthetic process [GO:0009058]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512],NA,NA,NA
CHOYP_BRAFLDRAFT_255736.1.1.m.62027,-0.010858788,0.008777234,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_258021.1.1.m.6099,-0.011056995,-0.01284259,No,NA,NA,NA,NA,NA,NA,external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; acute-phase response [GO:0006953],NA,NA,NA
CHOYP_BRAFLDRAFT_259692.1.1.m.44099,-0.000927229,-0.014181811,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; deoxyribose-phosphate aldolase activity [GO:0004139]; carbohydrate catabolic process [GO:0016052]; deoxyribonucleoside catabolic process [GO:0046121]; deoxyribonucleotide catabolic process [GO:0009264]; deoxyribose phosphate catabolic process [GO:0046386],NA,NA,NA
CHOYP_BRAFLDRAFT_259734.1.1.m.23051,-0.0107385,-0.020523466,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743],NA,NA,NA
CHOYP_BRAFLDRAFT_259980.1.1.m.17608,-0.009844744,-0.007589834,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; kinase activator activity [GO:0019209]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein kinase activator activity [GO:0030295]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; activation of MAPKKK activity [GO:0000185]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; positive regulation of MAP kinase activity [GO:0043406]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_BRAFLDRAFT_260197.1.1.m.8081,-0.011020528,-0.023742891,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ER membrane protein complex [GO:0072546]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634],NA,NA,NA
CHOYP_BRAFLDRAFT_260828.1.1.m.16250,0.005133965,-0.010688086,No,NA,NA,NA,NA,NA,NA,spliceosomal complex [GO:0005681]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_BRAFLDRAFT_260946.1.2.m.54464,-0.022440939,0.010603036,No,NA,NA,NA,NA,NA,NA,dioxygenase activity [GO:0051213],NA,NA,NA
CHOYP_BRAFLDRAFT_261406.1.1.m.46291,-0.017179045,-0.004102213,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_261932.1.1.m.23690,-0.005999249,0.003019876,No,NA,NA,NA,NA,NA,NA,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940],NA,NA,NA
CHOYP_BRAFLDRAFT_261940.2.2.m.53422,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,cell wall [GO:0005618]; cytosol [GO:0005829]; alpha;alpha-trehalase activity [GO:0004555]; protein-glucosylgalactosylhydroxylysine glucosidase activity [GO:0047402]; carbohydrate metabolic process [GO:0005975]; trehalose catabolic process [GO:0005993],NA,NA,NA
CHOYP_BRAFLDRAFT_262219.2.2.m.65564,-0.008717063,-0.017892392,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; cellular amino acid metabolic process [GO:0006520],NA,NA,NA
CHOYP_BRAFLDRAFT_262219.2.2.m.65565,-0.010959004,0.003697589,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_263599.1.1.m.59010,-0.014272133,0.001649215,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017]; Rab GTPase binding [GO:0017137]; axoneme assembly [GO:0035082]; brain development [GO:0007420]; cellular protein localization [GO:0034613]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement [GO:0003351]; flagellated sperm motility [GO:0030317]; negative regulation of cell proliferation [GO:0008285]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of microtubule binding [GO:1904526],NA,NA,NA
CHOYP_BRAFLDRAFT_263599.1.1.m.59011,-0.002002599,0.011800075,No,NA,NA,NA,NA,NA,NA,cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Grb2-EGFR complex [GO:0070436]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; neurotrophin TRKA receptor binding [GO:0005168]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; SH3 domain binding [GO:0017124]; SH3/SH2 adaptor activity [GO:0005070]; aging [GO:0007568]; anatomical structure formation involved in morphogenesis [GO:0048646]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell differentiation [GO:0030154]; cellular response to ionizing radiation [GO:0071479]; insulin receptor signaling pathway [GO:0008286]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein heterooligomerization [GO:0051291]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; signal transduction in response to DNA damage [GO:0042770],NA,NA,NA
CHOYP_BRAFLDRAFT_263840.1.1.m.51673,-0.018347713,-0.004824075,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929],NA,NA,NA
CHOYP_BRAFLDRAFT_264234.1.2.m.5174,0.018540389,-0.011436456,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; alpha-subunit complex [GO:0019773]; synapse [GO:0045202]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; ubiquitin protein ligase binding [GO:0031625]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of endopeptidase activity [GO:0052548],NA,NA,NA
CHOYP_BRAFLDRAFT_264234.2.2.m.7063,-0.000867655,0.00649478,No,NA,NA,NA,NA,NA,NA,cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_BRAFLDRAFT_264304.1.1.m.35625,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_BRAFLDRAFT_264316.1.1.m.29655,-0.004554628,-0.018659503,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; catalytic activity [GO:0003824],NA,NA,NA
CHOYP_BRAFLDRAFT_264461.1.1.m.51481,-0.015682094,-7.25E-05,No,NA,NA,NA,NA,NA,NA,acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; microtubule binding [GO:0008017]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_265162.1.3.m.58969,-0.014252044,-0.003850443,No,NA,NA,NA,NA,NA,NA,tRNA 2'-phosphotransferase activity [GO:0000215]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_BRAFLDRAFT_265162.3.3.m.64003,-0.008979969,-0.002081824,No,NA,NA,NA,NA,NA,NA,tRNA 2'-phosphotransferase activity [GO:0000215]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_BRAFLDRAFT_265208.3.7.m.10791,0.006509178,-0.006021257,No,NA,NA,NA,NA,NA,NA,brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; amino acid transport [GO:0006865]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_BRAFLDRAFT_265208.6.7.m.52336,0.016163771,-0.00199686,No,NA,NA,NA,NA,NA,NA,brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; amino acid transport [GO:0006865]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_BRAFLDRAFT_265208.7.7.m.62510,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; amino acid transport [GO:0006865]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_BRAFLDRAFT_265613.1.2.m.14785,0.013392646,-0.000133692,No,NA,NA,NA,NA,NA,NA,eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]; ubiquitin protein ligase binding [GO:0031625]; in utero embryonic development [GO:0001701]; negative regulation of translation [GO:0017148],NA,NA,NA
CHOYP_BRAFLDRAFT_265991.1.1.m.58765,-0.00900091,-0.003653573,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270]; peptidyl-pyroglutamic acid biosynthetic process; using glutaminyl-peptide cyclotransferase [GO:0017186],NA,NA,NA
CHOYP_BRAFLDRAFT_266349.1.1.m.9217,0.009386702,-0.023677686,No,NA,NA,NA,NA,NA,NA,methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552],NA,NA,NA
CHOYP_BRAFLDRAFT_266781.1.2.m.24880,0.009865513,-0.003416559,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_BRAFLDRAFT_266781.1.2.m.24881,0.016636258,0.00868705,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; kinetochore microtubule [GO:0005828]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; postsynaptic recycling endosome [GO:0098837]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; myosin V binding [GO:0031489]; amyloid-beta clearance by transcytosis [GO:0150093]; astral microtubule organization [GO:0030953]; establishment of protein localization to organelle [GO:0072594]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; intracellular cholesterol transport [GO:0032367]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; multivesicular body assembly [GO:0036258]; neuron projection development [GO:0031175]; neurotransmitter receptor transport; endosome to postsynaptic membrane [GO:0098887]; positive regulation of axon extension [GO:0045773]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; Rab protein signal transduction [GO:0032482]; regulation of cytokinesis [GO:0032465]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of multivesicular body size [GO:0010796]; regulation of protein transport [GO:0051223]; regulation of vesicle-mediated transport [GO:0060627]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003],NA,NA,NA
CHOYP_BRAFLDRAFT_268308.1.1.m.17043,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; dihydrofolate reductase activity [GO:0004146]; drug binding [GO:0008144]; mRNA binding [GO:0003729]; NADP binding [GO:0050661]; dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; one-carbon metabolic process [GO:0006730]; response to methotrexate [GO:0031427]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653],NA,NA,NA
CHOYP_BRAFLDRAFT_268354.1.1.m.57510,-0.011346664,-0.013762299,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_BRAFLDRAFT_268591.1.1.m.59744,0.001500004,0.000644547,No,NA,NA,NA,NA,NA,NA,oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_BRAFLDRAFT_268929.1.1.m.35239,0.008234003,0.016515199,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_268929.1.1.m.35240,-0.002982002,0.012127679,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_269194.1.1.m.53515,0.004304436,-0.015209603,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406],NA,NA,NA
CHOYP_BRAFLDRAFT_269209.1.1.m.4681,0.021478318,0.014229789,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_BRAFLDRAFT_270293.1.3.m.8709,-0.010681687,-0.017193525,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phospholipid transporter activity [GO:0005548]; phospholipid transport [GO:0015914],NA,NA,NA
CHOYP_BRAFLDRAFT_270300.1.1.m.59680,0.003046528,-0.001374844,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; 3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; valine catabolic process [GO:0006574],NA,NA,NA
CHOYP_BRAFLDRAFT_270517.1.1.m.27028,-0.022012725,-0.001211726,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; sperm midpiece [GO:0097225]; cell differentiation [GO:0030154]; olfactory behavior [GO:0042048]; positive regulation of fertilization [GO:1905516]; positive regulation of flagellated sperm motility [GO:1902093]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_270672.1.1.m.25768,0.010742725,-0.016004673,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615],NA,NA,NA
CHOYP_BRAFLDRAFT_271463.1.1.m.62869,-0.02030755,-0.009697877,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; centrosome [GO:0005813]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; spindle pole [GO:0000922]; alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022]; cerebral cortex cell migration [GO:0021795]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; regulation of cell division [GO:0051302],NA,NA,NA
CHOYP_BRAFLDRAFT_272416.1.1.m.56641,0.014929715,0.000309396,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]; intracellular transport [GO:0046907]; positive regulation of mitotic centrosome separation [GO:0046604]; signal transduction [GO:0007165]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_273508.1.4.m.5528,0.019835369,0.00547313,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840],NA,NA,NA
CHOYP_BRAFLDRAFT_273832.1.1.m.56325,0.00318715,-0.017876682,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]; 4 iron; 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137],NA,NA,NA
CHOYP_BRAFLDRAFT_274539.3.3.m.49552,-0.015232805,-0.000931298,No,NA,NA,NA,NA,NA,NA,tRNA 2'-phosphotransferase activity [GO:0000215]; regulation of protein kinase activity [GO:0045859]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_BRAFLDRAFT_274974.1.1.m.56783,0.011204693,-0.005662713,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SRP-dependent cotranslational protein targeting to membrane; translocation [GO:0006616],NA,NA,NA
CHOYP_BRAFLDRAFT_275083.2.2.m.66604,-0.020554218,0.002792737,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_BRAFLDRAFT_275293.1.1.m.16192,-0.009538079,-0.004846007,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_BRAFLDRAFT_275517.1.1.m.9720,-0.00310664,0.009650991,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; H4K20me3 modified histone binding [GO:1990889]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033140]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_BRAFLDRAFT_275527.1.1.m.12579,0.011397613,0.006160528,No,NA,NA,NA,NA,NA,NA,nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_275580.2.2.m.40924,-0.006632068,0.021404168,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; amino acid binding [GO:0016597]; L-tyrosine:2-oxoglutarate aminotransferase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; glutamate metabolic process [GO:0006536]; L-phenylalanine catabolic process [GO:0006559]; response to glucocorticoid [GO:0051384]; response to mercury ion [GO:0046689]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; tyrosine catabolic process [GO:0006572],NA,NA,NA
CHOYP_BRAFLDRAFT_275667.1.1.m.17353,-0.017454043,-0.007207692,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; bone morphogenesis [GO:0060349]; chondrocyte differentiation [GO:0002062]; intraciliary transport involved in cilium assembly [GO:0035735]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; non-motile cilium assembly [GO:1905515]; osteoblast differentiation [GO:0001649]; positive regulation of smoothened signaling pathway [GO:0045880]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_BRAFLDRAFT_275724.1.1.m.54178,0.003453471,-0.006312593,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitinyl hydrolase activity [GO:0101005]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; regulation of circadian rhythm [GO:0042752]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_BRAFLDRAFT_275787.1.2.m.15360,0.010942961,-0.022620365,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_BRAFLDRAFT_275787.2.2.m.62313,-0.008856674,0.01605419,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_BRAFLDRAFT_275793.1.1.m.9519,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; disulfide oxidoreductase activity [GO:0015036]; cell redox homeostasis [GO:0045454]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_BRAFLDRAFT_275870.1.1.m.12895,0.00231218,-0.023287143,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; N-terminal protein myristoylation [GO:0006499]; negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; peptidyl-threonine dephosphorylation [GO:0035970]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_BRAFLDRAFT_276131.1.1.m.46672,0.014967151,-0.000107111,No,NA,NA,NA,NA,NA,NA,condensed chromosome [GO:0000793]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleosome [GO:0000786]; pericentric heterochromatin [GO:0005721]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; chromatin organization [GO:0006325]; dosage compensation [GO:0007549]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression; epigenetic [GO:0045814]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of protein localization to chromosome; telomeric region [GO:1904815]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of gene expression; epigenetic [GO:0045815]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; regulation of lipid metabolic process [GO:0019216]; regulation of response to oxidative stress [GO:1902882],NA,NA,NA
CHOYP_BRAFLDRAFT_276226.1.2.m.21725,0.008447267,0.012428478,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_276226.2.2.m.64449,-0.011603841,9.60E-05,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; prostaglandin metabolic process [GO:0006693],NA,NA,NA
CHOYP_BRAFLDRAFT_276229.1.1.m.37508,-0.005142397,0.006846984,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_276474.1.1.m.6793,-0.006203823,-0.015813167,No,NA,NA,NA,NA,NA,NA,peroxisome [GO:0005777]; 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity [GO:0051997]; carboxy-lyase activity [GO:0016831]; allantoin biosynthetic process [GO:0019428]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628],NA,NA,NA
CHOYP_BRAFLDRAFT_276592.1.1.m.8046,-0.007061553,0.002644086,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; regulation of axon extension [GO:0030516]; response to stimulus [GO:0050896]; retina homeostasis [GO:0001895]; rRNA processing [GO:0006364]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_276662.1.1.m.52846,-0.003839055,-0.009956336,No,NA,NA,NA,NA,NA,NA,autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_276868.1.1.m.27780,-0.003203452,0.008068514,No,NA,NA,NA,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; syntaxin binding [GO:0019905]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_BRAFLDRAFT_276908.1.1.m.28793,-0.005198182,-0.011363952,No,NA,NA,NA,NA,NA,NA,AP-3 adaptor complex [GO:0030123]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation [GO:0019882]; antigen processing and presentation; exogenous lipid antigen via MHC class Ib [GO:0048007]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport; postsynaptic endosome to lysosome [GO:0098943]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to membrane [GO:0072657]; protein localization to organelle [GO:0033365]; protein targeting to vacuole [GO:0006623]; regulation of sequestering of zinc ion [GO:0061088]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle membrane organization [GO:0048499]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]; zinc ion transport [GO:0006829],NA,NA,NA
CHOYP_BRAFLDRAFT_277055.1.2.m.3095,-0.001052324,-0.014518125,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_BRAFLDRAFT_277055.2.2.m.18714,-0.004762058,-0.011234263,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_277091.1.3.m.1103,-0.007295338,0.004278346,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_277269.1.1.m.51636,0.004331642,-0.012123239,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide metabolic process [GO:0006518]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_BRAFLDRAFT_277494.2.3.m.57496,-0.006649829,0.01273777,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation factor activity; RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446],NA,NA,NA
CHOYP_BRAFLDRAFT_277494.3.3.m.62602,0.011554799,-0.007483532,No,NA,NA,NA,NA,NA,NA,eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; RNA cap binding [GO:0000339]; translation initiation factor activity [GO:0003743]; positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_277528.1.1.m.10120,-0.01996192,0.002412119,No,NA,NA,NA,NA,NA,NA,intracellular [GO:0005622]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_277744.1.2.m.5416,-0.002132296,0.001273641,No,NA,NA,NA,NA,NA,NA,brush border [GO:0005903]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252],NA,NA,NA
CHOYP_BRAFLDRAFT_277775.1.1.m.12736,0.00370895,-0.009321941,No,NA,NA,NA,NA,NA,NA,6-phosphofructo-2-kinase/fructose-2;6-biphosphatase complex [GO:0043540]; cytosol [GO:0005829]; 6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2;6-bisphosphate 2-phosphatase activity [GO:0004331]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; animal organ regeneration [GO:0031100]; carbohydrate phosphorylation [GO:0046835]; fructose 2;6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; positive regulation of glucokinase activity [GO:0033133]; response to cAMP [GO:0051591]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; response to starvation [GO:0042594],NA,NA,NA
CHOYP_BRAFLDRAFT_277775.1.1.m.12737,-0.002908626,0.007737802,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport; ER to cytosol [GO:1904265]; endoplasmic reticulum unfolded protein response [GO:0030968]; macroautophagy [GO:0016236]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K27-linked deubiquitination [GO:1990167]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_BRAFLDRAFT_277797.1.1.m.26394,-0.001198455,0.00491021,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; hydrolase activity [GO:0016787]; regulation of cell proliferation [GO:0042127],NA,NA,NA
CHOYP_BRAFLDRAFT_277920.1.1.m.28845,0.001074373,-0.003530583,No,NA,NA,NA,NA,NA,NA,apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome; small subunit precursor [GO:0030688]; snoRNA binding [GO:0030515]; cell proliferation [GO:0008283]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364]; trophectodermal cell differentiation [GO:0001829],NA,NA,NA
CHOYP_BRAFLDRAFT_278091.1.1.m.7340,-0.014170886,-0.006447164,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]; 'de novo' IMP biosynthetic process [GO:0006189]; anterior head development [GO:0097065]; glutamine metabolic process [GO:0006541]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to drug [GO:0042493],NA,NA,NA
CHOYP_BRAFLDRAFT_278625.1.2.m.53120,0.006203777,-0.015587038,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; protein kinase A regulatory subunit binding [GO:0034237]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_BRAFLDRAFT_278777.1.1.m.1970,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_BRAFLDRAFT_278832.1.1.m.13624,0.003620467,0.018961146,No,NA,NA,NA,NA,NA,NA,peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; palmitoyl-CoA oxidase activity [GO:0016401]; protein homodimerization activity [GO:0042803]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]; very long-chain fatty acid metabolic process [GO:0000038],NA,NA,NA
CHOYP_BRAFLDRAFT_278918.1.5.m.13792,0.002494146,-0.009660353,No,NA,NA,NA,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661],NA,NA,NA
CHOYP_BRAFLDRAFT_278918.2.5.m.16457,-0.004966068,-0.01217194,No,NA,NA,NA,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; defense response to fungus [GO:0050832],NA,NA,NA
CHOYP_BRAFLDRAFT_278918.3.5.m.38481,-0.00309461,-0.014623665,No,NA,NA,NA,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661],NA,NA,NA
CHOYP_BRAFLDRAFT_278918.4.5.m.39356,0.007922351,-0.006143773,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_BRAFLDRAFT_278918.5.5.m.48881,-0.023511586,0.002569676,No,NA,NA,NA,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661],NA,NA,NA
CHOYP_BRAFLDRAFT_278938.1.1.m.38684,-0.005512692,0.004641825,No,NA,NA,NA,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; early endosome [GO:0005769]; ESCRT III complex [GO:0000815]; microtubule organizing center [GO:0005815]; nuclear matrix [GO:0016363]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; gene silencing [GO:0016458]; midbody abscission [GO:0061952]; mitotic chromosome condensation [GO:0007076]; mitotic metaphase plate congression [GO:0007080]; negative regulation of cell cycle [GO:0045786]; negative regulation of transcription; DNA-templated [GO:0045892]; nucleus organization [GO:0006997]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; vacuolar transport [GO:0007034]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_279143.1.1.m.50630,0.003255303,-0.014324172,No,NA,NA,NA,NA,NA,NA,fibrillar center [GO:0001650]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; rRNA primary transcript binding [GO:0042134]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_BRAFLDRAFT_279226.1.1.m.24471,-0.006752747,-0.005712347,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; dipeptidase activity [GO:0016805]; serine-type peptidase activity [GO:0008236],NA,NA,NA
CHOYP_BRAFLDRAFT_279360.1.1.m.11115,0.013104093,-0.020319525,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; maternal process involved in female pregnancy [GO:0060135]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_BRAFLDRAFT_279625.1.1.m.51890,0.021344284,-0.009556811,No,NA,NA,NA,NA,NA,NA,4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698],NA,NA,NA
CHOYP_BRAFLDRAFT_279668.1.1.m.21404,0.004418293,-0.004817137,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TRAPP complex [GO:0030008]; ion channel binding [GO:0044325]; transcription factor binding [GO:0008134]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; regulation of transcription; DNA-templated [GO:0006355]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_279789.3.3.m.48128,0.017967899,-0.0085468,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; ribosome [GO:0005840]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_279923.1.1.m.65663,-0.001714092,-0.016039387,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle; lid subcomplex [GO:0008541]; structural molecule activity [GO:0005198]; meiosis I [GO:0007127]; proteasome assembly [GO:0043248]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_279937.1.1.m.49979,0.019185087,-0.009621263,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; inclusion body [GO:0016234]; aldo-keto reductase (NADP) activity [GO:0004033]; ferric iron binding [GO:0008199]; inositol oxygenase activity [GO:0050113]; NADP binding [GO:0050661]; oxidoreductase activity [GO:0016491]; oxidoreductase activity; acting on NAD(P)H [GO:0016651]; oxidoreductase activity; acting on single donors with incorporation of molecular oxygen [GO:0016701]; inositol catabolic process [GO:0019310],NA,NA,NA
CHOYP_BRAFLDRAFT_279949.1.1.m.54415,-0.022568513,0.009995443,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; MKS complex [GO:0036038]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac septum morphogenesis [GO:0060411]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; common bile duct development [GO:0061009]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial structure maintenance [GO:0010669]; head development [GO:0060322]; inner ear receptor cell stereocilium organization [GO:0060122]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901620]; regulation of Wnt signaling pathway; planar cell polarity pathway [GO:2000095]; smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003271],NA,NA,NA
CHOYP_BRAFLDRAFT_279978.1.1.m.30960,-0.020190531,-0.00781743,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_280249.1.1.m.26508,-0.013549993,0.013445762,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_280343.1.1.m.41317,-0.008812575,-0.008232679,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network transport vesicle [GO:0030140]; CD4 receptor binding [GO:0042609],NA,NA,NA
CHOYP_BRAFLDRAFT_280861.1.2.m.5389,-0.010365853,-0.00340408,No,NA,NA,NA,NA,NA,NA,COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; molecular adaptor activity [GO:0060090]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein membrane anchor [GO:0043495]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324],NA,NA,NA
CHOYP_BRAFLDRAFT_281070.1.1.m.1319,0.005519679,0.02218739,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular [GO:0005622]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; protein disulfide oxidoreductase activity [GO:0015035]; signaling receptor binding [GO:0005102]; epithelial cell differentiation [GO:0030855]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_BRAFLDRAFT_281217.1.1.m.15677,0.00288836,-0.020162538,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_BRAFLDRAFT_281480.1.1.m.22697,-0.021020983,-0.008313707,No,NA,NA,NA,NA,NA,NA,cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_BRAFLDRAFT_281490.1.1.m.53995,0.009548794,-0.004890774,No,NA,NA,NA,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore outer ring [GO:0031080]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mRNA export from nucleus [GO:0006406]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_281651.2.8.m.5909,-0.00232177,0.00299735,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532],NA,NA,NA
CHOYP_BRAFLDRAFT_281651.5.8.m.25278,-0.022453724,0.00047297,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532],NA,NA,NA
CHOYP_BRAFLDRAFT_281658.1.1.m.6266,-0.01194835,-0.012016843,No,NA,NA,NA,NA,NA,NA,Ku70:Ku80 complex [GO:0043564]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome; telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; damaged DNA binding [GO:0003684]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; cellular response to gamma radiation [GO:0071480]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of transcription; DNA-templated [GO:0045892]; telomere maintenance [GO:0000723],NA,NA,NA
CHOYP_BRAFLDRAFT_281754.1.1.m.27604,-0.004714675,-0.006924893,No,NA,NA,NA,NA,NA,NA,mitochondrial envelope [GO:0005740]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290],NA,NA,NA
CHOYP_BRAFLDRAFT_282065.1.2.m.590,0.004415696,-0.004833333,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_282105.1.2.m.43460,-0.002574959,0.00305617,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_282135.1.1.m.55919,-0.010695341,-0.003565224,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; phosphopantothenate--cysteine ligase activity [GO:0004632]; coenzyme A biosynthetic process [GO:0015937]; coenzyme biosynthetic process [GO:0009108],NA,NA,NA
CHOYP_BRAFLDRAFT_282200.1.1.m.18115,-0.006995506,0.013980345,No,NA,NA,NA,NA,NA,NA,mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; 5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; snoRNA 3'-end processing [GO:0031126]; snoRNA splicing [GO:0034247]; termination of RNA polymerase II transcription [GO:0006369],NA,NA,NA
CHOYP_BRAFLDRAFT_282752.2.2.m.17526,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412],NA,NA,NA
CHOYP_BRAFLDRAFT_283093.1.1.m.15039,-0.014126848,-0.020153101,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_283789.1.1.m.40987,-0.012567658,0.001008574,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; protein N-linked glycosylation via asparagine [GO:0018279],NA,NA,NA
CHOYP_BRAFLDRAFT_284130.1.1.m.27065,-0.005699438,-0.001132418,No,NA,NA,NA,NA,NA,NA,membrane raft [GO:0045121]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; innate immune response [GO:0045087]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_BRAFLDRAFT_284242.1.1.m.13711,-0.007670503,0.00607777,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; protein localization to Golgi membrane [GO:1903292]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_284412.1.1.m.37396,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tetrahydrofolylpolyglutamate synthase activity [GO:0004326]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell proliferation [GO:0008283]; folic acid metabolic process [GO:0046655]; folic acid-containing compound metabolic process [GO:0006760]; glutamate metabolic process [GO:0006536]; liver development [GO:0001889]; nucleobase-containing compound metabolic process [GO:0006139]; one-carbon metabolic process [GO:0006730]; tetrahydrofolylpolyglutamate biosynthetic process [GO:0046901],NA,NA,NA
CHOYP_BRAFLDRAFT_284508.1.1.m.4587,-0.012330232,-0.00742325,No,NA,NA,NA,NA,NA,NA,Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H3 acetylation [GO:0043966],NA,NA,NA
CHOYP_BRAFLDRAFT_284587.1.3.m.284,-0.00050328,-0.001172366,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_BRAFLDRAFT_284587.2.3.m.15867,-0.002998284,-0.012978804,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_BRAFLDRAFT_284587.3.3.m.26954,0.012740196,0.016391584,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_BRAFLDRAFT_284774.2.3.m.15260,-0.002501843,0.013877776,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719],NA,NA,NA
CHOYP_BRAFLDRAFT_284784.1.1.m.12397,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; NatB complex [GO:0031416]; nucleus [GO:0005634]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196],NA,NA,NA
CHOYP_BRAFLDRAFT_284846.2.2.m.60100,-0.005415248,0.002186451,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; Sec62/Sec63 complex [GO:0031207]; protein transporter activity [GO:0008565]; liver development [GO:0001889]; multicellular organism aging [GO:0010259]; nitrogen compound metabolic process [GO:0006807]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; posttranslational protein targeting to membrane; translocation [GO:0031204]; renal system development [GO:0072001]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614],NA,NA,NA
CHOYP_BRAFLDRAFT_284971.1.1.m.8607,-0.005656579,0.002662795,No,NA,NA,NA,NA,NA,NA,Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA-dependent ATPase activity [GO:0043142]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264],NA,NA,NA
CHOYP_BRAFLDRAFT_284971.1.1.m.8608,-0.006190582,-0.008043278,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; transcription factor TFIIF complex [GO:0005674]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; TFIIF-class transcription factor complex binding [GO:0001096]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_BRAFLDRAFT_285193.1.1.m.63396,-0.007699494,0.005381739,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; SNARE complex [GO:0031201]; synapse [GO:0045202]; vacuolar membrane [GO:0005774]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_285264.1.1.m.52913,-0.009898364,-0.015004758,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; 3'(2');5'-bisphosphate nucleotidase activity [GO:0008441]; metal ion binding [GO:0046872]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; phosphatidylinositol phosphorylation [GO:0046854],NA,NA,NA
CHOYP_BRAFLDRAFT_285738.1.1.m.21025,0.006917372,0.017262262,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; magnesium ion binding [GO:0000287]; phosphoacetylglucosamine mutase activity [GO:0004610]; phosphoglucomutase activity [GO:0004614]; carbohydrate metabolic process [GO:0005975]; glucosamine metabolic process [GO:0006041]; glucose 1-phosphate metabolic process [GO:0019255]; hemopoiesis [GO:0030097]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; spermatogenesis [GO:0007283]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],NA,NA,NA
CHOYP_BRAFLDRAFT_285971.1.1.m.18286,-0.000286201,-0.013415071,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; transferase activity [GO:0016740]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_BRAFLDRAFT_286243.1.1.m.11085,-0.004114672,0.005576304,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein localization to membrane [GO:0072657],NA,NA,NA
CHOYP_BRAFLDRAFT_287019.1.1.m.36911,-0.018763108,-0.014730204,No,NA,NA,NA,NA,NA,NA,lysosomal lumen [GO:0043202]; hydrolase activity [GO:0016787]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_BRAFLDRAFT_287353.1.1.m.46293,0.010106446,0.017186574,No,NA,NA,NA,NA,NA,NA,oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620],NA,NA,NA
CHOYP_BRAFLDRAFT_287356.1.1.m.25008,-0.016958723,-0.004185189,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_287444.3.5.m.17688,-0.002682871,0.013444046,No,NA,NA,NA,NA,NA,NA,chloroplast inner membrane [GO:0009706]; calmodulin binding [GO:0005516]; oxidoreductase activity [GO:0016491]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_287716.1.1.m.51443,-0.008681588,0.008817871,No,NA,NA,NA,NA,NA,NA,argininosuccinate lyase activity [GO:0004056]; arginine biosynthetic process via ornithine [GO:0042450]; urea cycle [GO:0000050],NA,NA,NA
CHOYP_BRAFLDRAFT_287844.1.1.m.63253,-0.017778393,0.005000773,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929],NA,NA,NA
CHOYP_BRAFLDRAFT_290492.1.1.m.21887,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; organelle membrane [GO:0031090]; alcohol dehydrogenase (NAD) activity [GO:0004022]; racemase and epimerase activity [GO:0016854]; retinol dehydrogenase activity [GO:0004745]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; androgen metabolic process [GO:0008209]; epithelial cell differentiation [GO:0030855]; progesterone metabolic process [GO:0042448]; retinol metabolic process [GO:0042572],NA,NA,NA
CHOYP_BRAFLDRAFT_291364.1.1.m.47990,-0.022560265,0.009980778,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 7-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0047022]; acetoacetyl-CoA reductase activity [GO:0018454]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; steroid dehydrogenase activity [GO:0016229]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; acyl-CoA metabolic process [GO:0006637]; androgen metabolic process [GO:0008209]; ecdysone metabolic process [GO:0008205]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; mitochondrial tRNA processing [GO:0090646]; RNA phosphodiester bond hydrolysis; endonucleolytic [GO:0090502]; steroid metabolic process [GO:0008202],NA,NA,NA
CHOYP_BRAFLDRAFT_57028.1.1.m.55583,-0.012858991,0.00258699,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_BRAFLDRAFT_57175.1.1.m.7616,0.009141434,-0.002246145,No,NA,NA,NA,NA,NA,NA,core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; ATPase activator activity [GO:0001671]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_BRAFLDRAFT_57176.3.5.m.23440,-0.006578804,-0.012419505,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; ciliary basal body-plasma membrane docking [GO:0097711]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; G2/M transition of mitotic cell cycle [GO:0000086]; intraciliary transport [GO:0042073]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],NA,NA,NA
CHOYP_BRAFLDRAFT_57176.5.5.m.54727,-0.008737674,0.01019155,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_57258.1.3.m.43523,0.021190617,0.001633706,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_57258.2.3.m.48328,0.012333328,-0.008382958,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; protein homodimerization activity [GO:0042803]; quinone binding [GO:0048038]; NADP metabolic process [GO:0006739]; regulation of apoptotic process [GO:0042981],NA,NA,NA
CHOYP_BRAFLDRAFT_57395.1.1.m.9938,0.004789325,0.010088866,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]; signaling receptor binding [GO:0005102]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_BRAFLDRAFT_57407.1.1.m.28838,-0.014161783,-0.017615309,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrion [GO:0005739]; cellular response to vitamin D [GO:0071305]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; mitochondrion organization [GO:0007005]; protein targeting to mitochondrion [GO:0006626]; response to retinoic acid [GO:0032526],NA,NA,NA
CHOYP_BRAFLDRAFT_57459.1.1.m.61613,-0.010568207,-0.00693503,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; cilium assembly [GO:0060271]; immune system development [GO:0002520]; response to UV [GO:0009411]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_BRAFLDRAFT_57552.1.1.m.8199,-0.002558726,-0.0247811,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA cis splicing; via spliceosome [GO:0045292]; mRNA splicing; via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_BRAFLDRAFT_57788.3.10.m.31620,-0.013827582,0.012794213,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_57788.6.10.m.45495,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_57788.8.10.m.49717,0.009414024,0.020300336,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_58035.2.2.m.65814,0.009232014,-0.000166543,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial respiratory chain complex I assembly [GO:0032981]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_BRAFLDRAFT_58194.1.1.m.27050,0.020956437,-0.007335011,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; L-cysteine catabolic process to hypotaurine [GO:0019449]; L-cysteine catabolic process to taurine [GO:0019452]; taurine biosynthetic process [GO:0042412],NA,NA,NA
CHOYP_BRAFLDRAFT_58684.1.1.m.13006,0.009328433,-0.025316256,No,NA,NA,NA,NA,NA,NA,AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin-coated vesicle membrane [GO:0030665]; COPI-coated vesicle [GO:0030137]; Golgi apparatus [GO:0005794]; transporter activity [GO:0005215]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; post-Golgi vesicle-mediated transport [GO:0006892],NA,NA,NA
CHOYP_BRAFLDRAFT_59014.1.1.m.59709,-0.02073367,-0.006922082,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542],NA,NA,NA
CHOYP_BRAFLDRAFT_59154.3.3.m.53255,0.000787617,-0.002902541,No,NA,NA,NA,NA,NA,NA,cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; SCF ubiquitin ligase complex [GO:0019005]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; histone binding [GO:0042393]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130]; cell division [GO:0051301]; cell proliferation [GO:0008283]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_BRAFLDRAFT_59647.1.1.m.25700,-0.002228393,0.016777391,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084],NA,NA,NA
CHOYP_BRAFLDRAFT_59863.1.1.m.24545,-0.011066577,0.008826769,No,NA,NA,NA,NA,NA,NA,azurophil granule [GO:0042582]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; tertiary granule [GO:0070820]; vesicle [GO:0031982]; chloride channel inhibitor activity [GO:0019869]; protein-containing complex binding [GO:0044877]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; organelle localization [GO:0051640]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_BRAFLDRAFT_60200.1.3.m.22201,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; preribosome; large subunit precursor [GO:0030687]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_BRAFLDRAFT_60200.1.3.m.22202,0.006596893,0.00043685,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488],NA,NA,NA
CHOYP_BRAFLDRAFT_60200.2.3.m.33251,0.006037538,-0.007092313,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_BRAFLDRAFT_60329.1.1.m.18239,0.012708653,-0.005088898,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; synapse [GO:0045202]; cellular response to lipopolysaccharide [GO:0071222]; macroautophagy [GO:0016236]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; positive regulation of dendrite extension [GO:1903861]; positive regulation of neuron migration [GO:2001224]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of synaptic vesicle recycling [GO:1903423]; prostaglandin metabolic process [GO:0006693]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],NA,NA,NA
CHOYP_BRAFLDRAFT_60331.1.1.m.34512,-0.018191547,-0.014925236,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; intraciliary transport particle B binding [GO:0120170]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; manchette assembly [GO:1905198]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell morphogenesis [GO:0008594]; protein localization to cilium [GO:0061512]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_BRAFLDRAFT_61250.5.14.m.37733,0.001829057,0.009023665,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen [GO:0016705]; icosanoid metabolic process [GO:0006690],NA,NA,NA
CHOYP_BRAFLDRAFT_61250.8.14.m.44214,0.001890009,0.001907984,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen [GO:0016705]; icosanoid metabolic process [GO:0006690],NA,NA,NA
CHOYP_BRAFLDRAFT_61507.1.1.m.52347,-0.007144525,0.013399644,No,NA,NA,NA,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleoside triphosphate adenylate kinase activity [GO:0046899]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; AMP phosphorylation [GO:0006756]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; protein homooligomerization [GO:0051260]; UTP metabolic process [GO:0046051],NA,NA,NA
CHOYP_BRAFLDRAFT_61845.1.1.m.37831,-0.0178689,0.00145763,No,NA,NA,NA,NA,NA,NA,sperm flagellum [GO:0036126]; nucleoside diphosphate kinase activity [GO:0004550]; cilium assembly [GO:0060271]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_BRAFLDRAFT_62156.1.1.m.47958,0.009474996,-0.012763097,No,NA,NA,NA,NA,NA,NA,lyase activity [GO:0016829],NA,NA,NA
CHOYP_BRAFLDRAFT_63199.1.5.m.9045,-0.005439107,0.000216453,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_63199.2.5.m.21288,0.006038437,0.014263723,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_63281.1.2.m.28725,-0.003265404,0.022786639,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_63397.6.8.m.48804,0.005117278,-0.000741859,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_BRAFLDRAFT_63459.2.3.m.27933,-0.021077673,-0.002201599,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_63471.1.1.m.25619,-0.001624954,0.016595601,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_63652.1.1.m.8021,0.00429186,-0.007971994,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]; cilium assembly [GO:0060271]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_BRAFLDRAFT_63676.1.1.m.37146,-0.008034358,0.006242707,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of striated muscle cell differentiation [GO:0051155],NA,NA,NA
CHOYP_BRAFLDRAFT_63907.1.1.m.14584,0.007197177,-0.022197227,No,NA,NA,NA,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; negative regulation of autophagy [GO:0010507]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TORC1 signaling [GO:1904263]; protein targeting to lysosome [GO:0006622]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418],NA,NA,NA
CHOYP_BRAFLDRAFT_64071.9.35.m.13313,-0.008917531,-0.00014471,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_64737.1.1.m.40499,-0.005903272,-0.00224625,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; polysome [GO:0005844]; metal ion binding [GO:0046872]; mRNA CDS binding [GO:1990715]; polysome binding [GO:1905538]; RNA binding [GO:0003723]; cell morphogenesis involved in neuron differentiation [GO:0048667]; negative regulation of cytoplasmic translation [GO:2000766]; neuron migration [GO:0001764],NA,NA,NA
CHOYP_BRAFLDRAFT_64948.1.1.m.17321,-0.007222616,-0.02162802,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; dynein intermediate chain binding [GO:0045505]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_BRAFLDRAFT_64962.1.1.m.59737,-0.00383257,0.006440453,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_65137.1.1.m.64534,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; early endosome [GO:0005769]; endosome [GO:0005768]; midbody [GO:0030496]; recycling endosome [GO:0055037]; retromer complex [GO:0030904]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell projection organization [GO:0030030]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; retrograde transport; endosome to plasma membrane [GO:1990126],NA,NA,NA
CHOYP_BRAFLDRAFT_65518.1.1.m.29803,0.007662282,-0.000186122,No,NA,NA,NA,NA,NA,NA,DNA binding [GO:0003677]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803],NA,NA,NA
CHOYP_BRAFLDRAFT_65562.1.1.m.14267,0.006619351,-0.004353756,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; inflammatory response [GO:0006954]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_BRAFLDRAFT_65681.1.1.m.445,-0.014199236,0.000640487,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor cell maintenance [GO:0045494]; protein localization to photoreceptor connecting cilium [GO:1903621]; protein localization to photoreceptor outer segment [GO:1903546]; response to stimulus [GO:0050896]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_65711.1.1.m.18159,0.012506513,0.010304152,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_65861.1.1.m.24624,-0.002846645,-0.023851004,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886]; endocytosis [GO:0006897]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_65994.1.1.m.40535,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,azurophil granule membrane [GO:0035577]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; beta-mannosidase activity [GO:0004567]; mannose binding [GO:0005537]; cellular protein modification process [GO:0006464]; glycoprotein catabolic process [GO:0006516]; mannan catabolic process [GO:0046355]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313],NA,NA,NA
CHOYP_BRAFLDRAFT_66204.1.3.m.2589,0.008723608,-0.00318098,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062],NA,NA,NA
CHOYP_BRAFLDRAFT_66627.1.1.m.40620,0.019039888,-0.011689112,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; valyl-tRNA aminoacylation [GO:0006438],NA,NA,NA
CHOYP_BRAFLDRAFT_66688.1.2.m.2447,0.001087156,-0.007883486,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_66688.2.2.m.10883,-0.01810801,-0.000745807,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_BRAFLDRAFT_66705.1.1.m.47148,-0.022406268,0.010616872,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; endopeptidase activity [GO:0004175]; apoptotic process [GO:0006915]; cornification [GO:0070268]; epidermis development [GO:0008544]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; keratinization [GO:0031424],NA,NA,NA
CHOYP_BRAFLDRAFT_67226.1.1.m.38034,0.015768801,0.005810802,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_67258.9.18.m.34120,-0.017970467,0.004734837,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_67261.1.2.m.16694,0.021045742,0.000108072,No,NA,NA,NA,NA,NA,NA,cell [GO:0005623]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; female germ cell nucleus [GO:0001674]; NLS-dependent protein nuclear import complex [GO:0042564]; galactose binding [GO:0005534]; melibiose binding [GO:1903777]; protein homodimerization activity [GO:0042803]; rhamnose binding [GO:0033296],NA,NA,NA
CHOYP_BRAFLDRAFT_67264.4.6.m.42082,-0.000312187,-0.002561088,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_67459.2.2.m.56116,-0.01056244,0.010785317,No,NA,NA,NA,NA,NA,NA,chromosome; centromeric core domain [GO:0034506]; early endosome membrane [GO:0031901]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; Rac GTPase binding [GO:0048365]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to kinetochore [GO:0072356]; establishment of protein localization [GO:0045184]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; regulation of cell migration [GO:0030334]; regulation of fibroblast migration [GO:0010762]; regulation of ruffle assembly [GO:1900027],NA,NA,NA
CHOYP_BRAFLDRAFT_67483.1.1.m.55096,0.006240721,0.00306614,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; WW domain binding [GO:0050699]; aging [GO:0007568]; cell proliferation [GO:0008283]; chromatin remodeling [GO:0006338]; cloacal septation [GO:0060197]; cranial skeletal system development [GO:1904888]; ectoderm and mesoderm interaction [GO:0007499]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; epidermal cell division [GO:0010481]; epithelial cell development [GO:0002064]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; female genitalia morphogenesis [GO:0048807]; hair follicle morphogenesis [GO:0031069]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; keratinocyte differentiation [GO:0030216]; multicellular organism aging [GO:0010259]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mesoderm development [GO:2000381]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of somatic stem cell population maintenance [GO:1904674]; post-anal tail morphogenesis [GO:0036342]; prostatic bud formation [GO:0060513]; protein homotetramerization [GO:0051289]; proximal/distal pattern formation [GO:0009954]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of epidermal cell division [GO:0010482]; replicative cell aging [GO:0001302]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; spermatogenesis [GO:0007283]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; sympathetic nervous system development [GO:0048485],NA,NA,NA
CHOYP_BRAFLDRAFT_67520.1.2.m.16093,0.005596462,0.00782128,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_BRAFLDRAFT_67520.2.2.m.34594,-0.006486941,-0.023055342,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_BRAFLDRAFT_67662.1.1.m.3006,-0.011313127,0.001889823,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; L-galactose dehydrogenase activity [GO:0010349]; oxidoreductase activity [GO:0016491]; galactose metabolic process [GO:0006012]; L-ascorbic acid biosynthetic process [GO:0019853],NA,NA,NA
CHOYP_BRAFLDRAFT_67696.3.3.m.54584,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_67741.2.2.m.37743,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_67911.1.1.m.4174,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401],NA,NA,NA
CHOYP_BRAFLDRAFT_67999.1.1.m.44535,0.00982428,0.01896529,No,NA,NA,NA,NA,NA,NA,anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685],NA,NA,NA
CHOYP_BRAFLDRAFT_68004.1.1.m.24323,0.011350058,-0.007747958,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA repair [GO:0006281]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_BRAFLDRAFT_68242.2.3.m.26345,0.007455185,-0.014493465,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_68488.1.1.m.58466,-0.016687828,0.012404017,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936],NA,NA,NA
CHOYP_BRAFLDRAFT_68592.1.1.m.53611,0.009452412,0.004487921,No,NA,NA,NA,NA,NA,NA,early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; protein tyrosine phosphatase activity [GO:0004725]; actin cytoskeleton reorganization [GO:0031532]; endoplasmic reticulum unfolded protein response [GO:0030968]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of endocytosis [GO:0030100]; regulation of signal transduction [GO:0009966],NA,NA,NA
CHOYP_BRAFLDRAFT_68766.4.4.m.38248,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_68867.1.1.m.4095,0.005116499,-0.000744796,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; enzyme binding [GO:0019899]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251]; signaling receptor binding [GO:0005102]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; bile acid biosynthetic process [GO:0006699]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; methyl-branched fatty acid metabolic process [GO:0097089]; neutrophil degranulation [GO:0043312]; protein targeting to peroxisome [GO:0006625]; very long-chain fatty acid catabolic process [GO:0042760],NA,NA,NA
CHOYP_BRAFLDRAFT_68915.2.7.m.3908,0.009465941,0.016579076,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; peptidase activity [GO:0008233]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638],NA,NA,NA
CHOYP_BRAFLDRAFT_68917.1.3.m.16606,0.018671727,-0.005879466,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_68917.2.3.m.28554,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; intracellular [GO:0005622]; extracellular matrix binding [GO:0050840]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; scavenger receptor activity [GO:0005044]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterial lipoprotein [GO:0042494]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; negative regulation of interleukin-8 secretion [GO:2000483],NA,NA,NA
CHOYP_BRAFLDRAFT_68934.1.2.m.57609,-0.015477221,0.007899641,No,NA,NA,NA,NA,NA,NA,Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; negative cofactor 2 complex [GO:0017054]; core promoter binding [GO:0001047]; protein heterodimerization activity [GO:0046982]; TBP-class protein binding [GO:0017025]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045898]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_BRAFLDRAFT_68997.1.1.m.56357,-0.011225973,-0.008537826,No,NA,NA,NA,NA,NA,NA,CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; IRE1-TRAF2-ASK1 complex [GO:1990604]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; TRAF2-GSTP1 complex [GO:0097057]; ubiquitin ligase complex [GO:0000151]; vesicle membrane [GO:0012506]; CD40 receptor binding [GO:0005174]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; sphingolipid binding [GO:0046625]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; cellular protein-containing complex assembly [GO:0034622]; cellular response to nitric oxide [GO:0071732]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glial cell apoptotic process [GO:0034351]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein heterooligomerization [GO:0051291]; protein homotrimerization [GO:0070207]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of immunoglobulin secretion [GO:0051023]; regulation of JNK cascade [GO:0046328]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209],NA,NA,NA
CHOYP_BRAFLDRAFT_69005.1.1.m.26462,0.0128773,0.01518914,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_BRAFLDRAFT_69120.3.3.m.40386,0.013249704,0.022032444,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_69134.2.13.m.10914,0.003800378,0.01239606,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147],NA,NA,NA
CHOYP_BRAFLDRAFT_69505.3.4.m.52485,-0.015652652,-0.018014014,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_69729.1.1.m.683,-0.006314895,0.003290158,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; eye development [GO:0001654]; head development [GO:0060322]; liver development [GO:0001889]; pharynx development [GO:0060465]; rRNA processing [GO:0006364]; spleen development [GO:0048536]; thymus development [GO:0048538],NA,NA,NA
CHOYP_BRAFLDRAFT_69798.11.22.m.42042,-0.017573155,0.003138298,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_70742.1.1.m.8525,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_70868.1.1.m.55081,0.004127528,0.00297653,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; telomeric DNA binding [GO:0042162]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727],NA,NA,NA
CHOYP_BRAFLDRAFT_70886.1.1.m.53762,0.007919859,0.000851293,No,NA,NA,NA,NA,NA,NA,early endosome [GO:0005769]; vesicle [GO:0031982]; metal ion binding [GO:0046872]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein phosphorylation [GO:0001934],NA,NA,NA
CHOYP_BRAFLDRAFT_70987.2.2.m.58284,-0.013724931,0.0013075,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; detection of temperature stimulus [GO:0016048]; protein tetramerization [GO:0051262]; sensory perception of temperature stimulus [GO:0050951],NA,NA,NA
CHOYP_BRAFLDRAFT_71030.1.1.m.31477,-0.018973516,-0.000958341,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_71616.2.3.m.27171,-0.021142123,0.003986788,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_71629.1.1.m.65970,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_72035.1.1.m.48832,-0.010586746,0.00305386,No,NA,NA,NA,NA,NA,NA,clathrin-coated vesicle membrane [GO:0030665]; plasma membrane [GO:0005886]; endocytosis [GO:0006897]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_72273.1.2.m.34499,0.0077915,0.00441913,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_72357.1.1.m.59063,0.0010113,0.009082958,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; epinephrine binding [GO:0051379]; monoamine oxidase activity [GO:0097621]; NADH binding [GO:0070404]; oxidoreductase activity; acting on NAD(P)H [GO:0016651]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of blood pressure [GO:0045776]; negative regulation of heart rate [GO:0010459]; oxidation-reduction process [GO:0055114]; response to epinephrine [GO:0071871]; response to ischemia [GO:0002931]; response to salt [GO:1902074],NA,NA,NA
CHOYP_BRAFLDRAFT_72541.1.2.m.13652,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]; protein folding in endoplasmic reticulum [GO:0034975],NA,NA,NA
CHOYP_BRAFLDRAFT_72611.1.1.m.61108,0.001403859,-0.01298458,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_72748.1.1.m.27724,0.016619486,0.014261097,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_BRAFLDRAFT_73177.1.1.m.61488,0.015969934,0.008840694,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ion channel binding [GO:0044325]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; protein localization to phagophore assembly site [GO:0034497]; protein localization to plasma membrane [GO:0072659]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_73486.1.1.m.16417,0.000295498,0.019577037,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; homogentisate 1;2-dioxygenase activity [GO:0004411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cellular amino acid metabolic process [GO:0006520]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572],NA,NA,NA
CHOYP_BRAFLDRAFT_73991.2.2.m.60726,0.023103129,0.000694183,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_74063.1.5.m.2740,0.021960822,0.012709379,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_74063.2.5.m.9454,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_BRAFLDRAFT_74063.4.5.m.43367,0.007809373,-0.010920881,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of BMP signaling pathway [GO:0030513],NA,NA,NA
CHOYP_BRAFLDRAFT_74469.3.3.m.53818,-0.005343961,0.002520555,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_74594.1.3.m.1187,0.018092857,-0.008789938,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_BRAFLDRAFT_74594.2.3.m.1285,0.007579821,-0.004791687,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_BRAFLDRAFT_74594.3.3.m.1992,0.000112308,-0.012531798,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_BRAFLDRAFT_74861.1.1.m.16599,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; SCF ubiquitin ligase complex [GO:0019005]; Schaffer collateral - CA1 synapse [GO:0098685]; ubiquitin-protein transferase activity [GO:0004842]; behavioral fear response [GO:0001662]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; regulation of protein catabolic process at presynapse; modulating synaptic transmission [GO:0099575]; regulation of synaptic vesicle exocytosis [GO:2000300]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_74874.1.9.m.3545,-0.014686091,0.017905301,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_BRAFLDRAFT_74874.3.9.m.37096,-0.015648973,-0.013569983,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_74874.5.9.m.47033,0.006370227,0.010308965,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_74879.1.6.m.21111,0.005354547,-0.006047039,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_BRAFLDRAFT_74879.3.6.m.24658,0.003226216,0.001220664,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_BRAFLDRAFT_75094.1.2.m.24898,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_75616.1.2.m.9949,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_75632.1.1.m.60676,-0.001049777,0.015823763,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; inflammatory response [GO:0006954]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_BRAFLDRAFT_75707.1.1.m.8533,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_75823.1.2.m.2870,-0.002175454,-0.006902852,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_76126.1.1.m.8736,-0.010043393,0.00841575,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_76176.1.1.m.55550,-0.018460389,-0.004284779,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674],NA,NA,NA
CHOYP_BRAFLDRAFT_76402.1.5.m.22765,0.014743116,-0.007907157,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_76662.3.3.m.61577,-0.014598236,0.004880057,No,NA,NA,NA,NA,NA,NA,plasma membrane [GO:0005886]; catalytic activity [GO:0003824],NA,NA,NA
CHOYP_BRAFLDRAFT_76728.1.1.m.17486,0.015419151,0.009146467,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; transferase activity [GO:0016740]; immune response [GO:0006955]; positive regulation of transcription; DNA-templated [GO:0045893]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_BRAFLDRAFT_76825.1.1.m.2818,-0.021723925,0.004160672,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198],NA,NA,NA
CHOYP_BRAFLDRAFT_76885.1.1.m.20259,0.015973517,-0.011877825,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_76943.1.1.m.58001,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_77063.1.1.m.8252,-0.009078547,-0.013640218,No,NA,NA,NA,NA,NA,NA,2-aminoethylphosphonate-pyruvate transaminase activity [GO:0047304]; organic phosphonate catabolic process [GO:0019700],NA,NA,NA
CHOYP_BRAFLDRAFT_77132.1.2.m.5217,-0.002914315,-0.018173841,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular [GO:0005622]; nucleus [GO:0005634]; retromer complex [GO:0030904]; retromer; tubulation complex [GO:0030905]; tubular endosome [GO:0097422]; dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; intracellular protein transport [GO:0006886]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of macroautophagy [GO:0016241]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_BRAFLDRAFT_77225.1.2.m.29845,0.004735288,-0.012104194,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; hyperosmotic response [GO:0006972]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_BRAFLDRAFT_77483.1.1.m.56627,-0.000163344,-0.023943037,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_78229.1.1.m.52210,0.0108616,0.020720316,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_BRAFLDRAFT_79044.2.2.m.62650,0.004175596,0.004670737,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; carboxylic ester hydrolase activity [GO:0052689]; S-formylglutathione hydrolase activity [GO:0018738]; formaldehyde catabolic process [GO:0046294],NA,NA,NA
CHOYP_BRAFLDRAFT_79377.5.30.m.21330,-0.018545237,0.00421659,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_79602.1.1.m.42298,-0.001724676,0.015289793,No,NA,NA,NA,NA,NA,NA,cytoskeleton [GO:0005856]; endocytic vesicle membrane [GO:0030666]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; endocytosis [GO:0006897]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of nitric-oxide synthase activity [GO:0050999],NA,NA,NA
CHOYP_BRAFLDRAFT_79734.1.1.m.15409,-0.006397315,-0.006937933,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_80039.1.1.m.2568,0.021033601,0.000409961,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; kinetochore [GO:0000776]; late endosome [GO:0005770]; lysosome [GO:0005764]; microtubule [GO:0005874]; ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; microtubule motor activity [GO:0003777]; cellular response to nerve growth factor stimulus [GO:1990090]; centrosome localization [GO:0051642]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_BRAFLDRAFT_80064.1.1.m.40175,-0.009830567,-0.000909455,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; endosome membrane [GO:0010008]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; receptor complex [GO:0043235]; ripoptosome [GO:0097342]; ATP binding [GO:0005524]; death domain binding [GO:0070513]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of JUN kinase activity [GO:0007257]; amyloid fibril formation [GO:1990000]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular protein catabolic process [GO:0044257]; cellular response to growth factor stimulus [GO:0071363]; cellular response to tumor necrosis factor [GO:0071356]; death-inducing signaling complex assembly [GO:0071550]; extrinsic apoptotic signaling pathway [GO:0097191]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; MAPK cascade [GO:0000165]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; peptidyl-serine autophosphorylation [GO:0036289]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of hydrogen peroxide-induced cell death [GO:1905206]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of necroptotic process [GO:0060545]; positive regulation of necrotic cell death [GO:0010940]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein deubiquitination [GO:0016579]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of ATP:ADP antiporter activity [GO:0070926]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to tumor necrosis factor [GO:0034612]; ripoptosome assembly [GO:0097343]; ripoptosome assembly involved in necroptotic process [GO:1901026]; T cell apoptotic process [GO:0070231]; toll-like receptor 3 signaling pathway [GO:0034138]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_80311.1.3.m.18963,0.011613286,0.014546876,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_BRAFLDRAFT_80311.3.3.m.30251,-0.005336416,-0.018631061,No,NA,NA,NA,NA,NA,NA,carbohydrate binding [GO:0030246]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_BRAFLDRAFT_80394.4.9.m.33604,0.006710656,-0.006272214,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_80432.2.2.m.18322,-0.013852535,-0.001042197,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_80496.1.10.m.12618,0.003082333,-0.010052663,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_BRAFLDRAFT_80496.3.10.m.22837,0.004613993,0.000204697,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_BRAFLDRAFT_80496.6.10.m.29014,0.00558151,-0.020300921,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_BRAFLDRAFT_80496.8.10.m.49028,0.002458174,-0.006531358,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_BRAFLDRAFT_80577.2.6.m.24330,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_BRAFLDRAFT_80919.1.1.m.62047,-0.013922713,-0.005335817,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_BRAFLDRAFT_80934.1.2.m.23714,-0.00800848,-0.010618816,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_81321.3.10.m.34305,-0.01156416,0.003468757,No,NA,NA,NA,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; transferase activity [GO:0016740]; adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; intracellular signal transduction [GO:0035556]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of T cell activation [GO:0050863],NA,NA,NA
CHOYP_BRAFLDRAFT_81321.5.10.m.45062,-0.00855273,0.006148365,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; chloroplast organization [GO:0009658],NA,NA,NA
CHOYP_BRAFLDRAFT_81321.6.10.m.48025,0.007851896,0.007289335,No,NA,NA,NA,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368],NA,NA,NA
CHOYP_BRAFLDRAFT_81322.1.2.m.17860,0.00918697,0.010914717,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289],NA,NA,NA
CHOYP_BRAFLDRAFT_81364.2.3.m.30348,-0.02131408,-0.001028563,No,NA,NA,NA,NA,NA,NA,cell wall [GO:0005618]; extracellular region [GO:0005576]; endo-1;4-beta-xylanase activity [GO:0031176]; xylan catabolic process [GO:0045493],NA,NA,NA
CHOYP_BRAFLDRAFT_81364.3.3.m.30607,0.00322153,-0.005780259,No,NA,NA,NA,NA,NA,NA,endo-1;4-beta-xylanase activity [GO:0031176]; xylan catabolic process [GO:0045493],NA,NA,NA
CHOYP_BRAFLDRAFT_81509.1.1.m.31565,0.012428505,0.012266472,No,NA,NA,NA,NA,NA,NA,actin filament [GO:0005884]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cellular response to interferon-gamma [GO:0071346]; inflammatory response [GO:0006954]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell proliferation [GO:0048662]; phagocytosis; engulfment [GO:0006911]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; Rac protein signal transduction [GO:0016601]; ruffle assembly [GO:0097178],NA,NA,NA
CHOYP_BRAFLDRAFT_81532.1.1.m.58865,0.013392397,0.024204738,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to iron ion [GO:0071281]; ethylene-activated signaling pathway [GO:0009873]; gibberellin biosynthetic process [GO:0009686]; negative regulation of ethylene-activated signaling pathway [GO:0010105]; protein autophosphorylation [GO:0046777]; regulation of post-embryonic root development [GO:2000069]; regulation of stem cell division [GO:2000035]; regulation of timing of transition from vegetative to reproductive phase [GO:0048510]; response to ethylene [GO:0009723]; response to fructose [GO:0009750]; response to hypoxia [GO:0001666]; response to sucrose [GO:0009744]; sugar mediated signaling pathway [GO:0010182],NA,NA,NA
CHOYP_BRAFLDRAFT_81609.1.1.m.94,0.019559178,0.000269636,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation; using sulfide:quinone oxidoreductase [GO:0070221],NA,NA,NA
CHOYP_BRAFLDRAFT_81733.1.1.m.213,-0.009894359,-0.014293999,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; proteasome binding [GO:0070628]; proteasome assembly [GO:0043248]; proteasome core complex assembly [GO:0080129],NA,NA,NA
CHOYP_BRAFLDRAFT_82353.1.1.m.13454,0.010624225,0.002497325,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transketolase activity [GO:0004802],NA,NA,NA
CHOYP_BRAFLDRAFT_82426.1.20.m.8067,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_82868.3.5.m.48837,0.003954882,-0.017292867,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_83096.1.1.m.27011,0.000936749,-0.006065059,No,NA,NA,NA,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_BRAFLDRAFT_83552.1.1.m.55255,0.001055711,-0.018308159,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; carnitine O-acetyltransferase activity [GO:0004092]; carnitine metabolic process; CoA-linked [GO:0019254]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_BRAFLDRAFT_84054.1.2.m.8523,-0.006731823,-0.008829594,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; microtubule binding [GO:0008017]; establishment of spindle orientation [GO:0051294]; microtubule-based movement [GO:0007018]; negative regulation of mitotic centrosome separation [GO:0046603]; nucleus localization [GO:0051647]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_BRAFLDRAFT_84207.2.2.m.36438,-0.012022037,-0.000831053,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_84237.1.1.m.1879,-0.010335056,-0.018313527,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; E-box binding [GO:0070888]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cellular response to glucose starvation [GO:0042149]; circadian regulation of gene expression [GO:0032922]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of transcription; DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of anoikis [GO:2000210]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of gene expression; epigenetic [GO:0045815]; regulation of transcription; DNA-templated [GO:0006355]; respiratory electron transport chain [GO:0022904]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_BRAFLDRAFT_84245.2.2.m.53621,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,BLOC-3 complex [GO:0031085]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; platelet dense granule [GO:0042827]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; blood coagulation [GO:0007596]; hemostasis [GO:0007599]; lysosome organization [GO:0007040]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; positive regulation of eye pigmentation [GO:0048075]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein stabilization [GO:0050821]; protein targeting [GO:0006605],NA,NA,NA
CHOYP_BRAFLDRAFT_84494.2.5.m.30751,-0.02094749,-0.001445396,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_84494.3.5.m.41159,0.006414599,0.006667275,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_84494.4.5.m.44543,0.006961484,-0.018710193,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_84664.1.7.m.3969,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_84838.3.6.m.42355,-0.005066773,-0.002509552,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_BRAFLDRAFT_84941.1.1.m.53224,0.007586027,0.006007114,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor connecting cilium [GO:0032391]; GTPase activity [GO:0003924]; tubulin binding [GO:0015631]; cell morphogenesis [GO:0000902]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021],NA,NA,NA
CHOYP_BRAFLDRAFT_85170.1.1.m.8699,0.009874829,0.019940601,No,NA,NA,NA,NA,NA,NA,microtubule [GO:0005874]; protein-containing complex [GO:0032991]; multicellular organism development [GO:0007275]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_BRAFLDRAFT_85206.1.1.m.49234,0.002908932,-0.003381879,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_85506.1.1.m.54726,0.013790782,0.018676241,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_85511.15.23.m.46769,0.006572892,0.001555629,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_85511.17.23.m.55470,-0.01066065,-0.004353378,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_BRAFLDRAFT_85511.3.23.m.14160,0.011095867,0.015407301,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_BRAFLDRAFT_85664.10.10.m.45430,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_85664.3.10.m.26597,-0.006386361,-0.002199418,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_85664.6.10.m.30553,-0.002593193,-0.006315839,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_85822.1.1.m.10102,0.012689267,0.0062716,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]; ribonucleoprotein complex binding [GO:0043021]; mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_85896.1.1.m.38692,-0.011213924,-0.002844305,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764],NA,NA,NA
CHOYP_BRAFLDRAFT_85994.3.10.m.7126,0.010883072,-0.017115801,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_85994.7.10.m.36866,0.007438907,0.013863173,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_86052.1.1.m.25460,-0.008057039,-0.014706712,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; protein homodimerization activity [GO:0042803]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374],NA,NA,NA
CHOYP_BRAFLDRAFT_86765.1.1.m.54066,-0.006408773,-0.011897791,No,NA,NA,NA,NA,NA,NA,iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; antibiotic biosynthetic process [GO:0017000]; antibiotic metabolic process [GO:0016999],NA,NA,NA
CHOYP_BRAFLDRAFT_86801.1.1.m.27107,0.016817951,-0.014017431,No,NA,NA,NA,NA,NA,NA,blood microparticle [GO:0072562]; cell cortex [GO:0005938]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; adaptive immune response [GO:0002250]; blood coagulation [GO:0007596]; blood coagulation; common pathway [GO:0072377]; blood coagulation; fibrin clot formation [GO:0072378]; cell-matrix adhesion [GO:0007160]; cellular protein-containing complex assembly [GO:0034622]; fibrinolysis [GO:0042730]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; plasminogen activation [GO:0031639]; platelet aggregation [GO:0070527]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein secretion [GO:0050714]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of vasoconstriction [GO:0045907]; protein polymerization [GO:0051258]; protein-containing complex assembly [GO:0065003]; response to calcium ion [GO:0051592],NA,NA,NA
CHOYP_BRAFLDRAFT_86801.1.1.m.27108,-0.004010439,-0.015978497,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_86827.2.4.m.9197,-0.000144915,-0.000876925,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_86827.3.4.m.27276,-0.009236099,-0.004879749,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_86827.4.4.m.61859,-0.015161614,-0.020968802,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_86846.1.3.m.13594,-0.016651651,0.012232729,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; spindle [GO:0005819]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507]; adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure; amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance; open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cell proliferation [GO:0008284]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; tube morphogenesis [GO:0035239]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218],NA,NA,NA
CHOYP_BRAFLDRAFT_86846.3.3.m.53453,-0.000655963,0.020391593,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; spindle [GO:0005819]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507]; adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure; amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance; open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cell proliferation [GO:0008284]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; tube morphogenesis [GO:0035239]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218],NA,NA,NA
CHOYP_BRAFLDRAFT_86890.2.4.m.23914,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_BRAFLDRAFT_87283.1.1.m.46768,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_87294.6.6.m.64622,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_87336.4.9.m.23926,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_87429.1.1.m.43808,-0.010193089,-0.009993728,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi organization [GO:0007030]; lipid homeostasis [GO:0055088]; liver development [GO:0001889]; protein N-linked glycosylation [GO:0006487]; protein secretion [GO:0009306]; regulation of response to endoplasmic reticulum stress [GO:1905897]; retina development in camera-type eye [GO:0060041]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_87630.1.1.m.30352,0.010902063,-0.000442899,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen [GO:0016709]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; kidney development [GO:0001822]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; oxidation-reduction process [GO:0055114]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; sterol metabolic process [GO:0016125]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_BRAFLDRAFT_87634.1.1.m.39992,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_87662.1.1.m.5474,-0.003409895,0.004608349,No,NA,NA,NA,NA,NA,NA,N-acylglucosamine 2-epimerase activity [GO:0050121]; peptidase inhibitor activity [GO:0030414]; N-acetylglucosamine metabolic process [GO:0006044]; N-acetylmannosamine metabolic process [GO:0006051]; N-acetylneuraminate catabolic process [GO:0019262],NA,NA,NA
CHOYP_BRAFLDRAFT_87806.1.1.m.28308,0.002635878,-0.001841684,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922]; angiogenesis [GO:0001525]; fucose metabolic process [GO:0006004]; heart development [GO:0007507]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; protein O-linked glycosylation [GO:0006493]; regulation of Notch signaling pathway [GO:0008593]; somitogenesis [GO:0001756],NA,NA,NA
CHOYP_BRAFLDRAFT_88012.1.1.m.12815,-0.017844602,0.004916895,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; NADPH-adrenodoxin reductase activity [GO:0015039]; cholesterol metabolic process [GO:0008203],NA,NA,NA
CHOYP_BRAFLDRAFT_88018.1.1.m.50147,-0.014642752,-0.011457665,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; multicellular organism development [GO:0007275]; positive regulation of cell-substrate adhesion [GO:0010811],NA,NA,NA
CHOYP_BRAFLDRAFT_88218.8.8.m.64733,0.000514616,0.002493788,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_BRAFLDRAFT_88219.1.5.m.37187,0.005218096,-0.002181987,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_88223.10.22.m.35410,-0.007739808,0.000642056,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_88223.5.22.m.23899,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_88223.9.22.m.34933,0.005694786,-0.006482599,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_BRAFLDRAFT_88224.2.11.m.3212,0.005429046,0.012139597,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; nervous system development [GO:0007399]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_88506.1.1.m.64174,0.003090299,-0.018170619,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_88543.1.2.m.54473,-0.014626066,-0.006049572,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_88566.3.11.m.5108,0.005029166,-0.005201334,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_88570.1.2.m.55232,-0.004737122,-0.013941275,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_88583.1.1.m.56300,0.000849183,-0.005875164,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_BRAFLDRAFT_88596.1.2.m.24206,0.008270134,-0.009127376,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; chitin binding [GO:0008061]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_89105.1.1.m.2234,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89330.1.1.m.23864,0.00059236,-0.009654855,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89362.1.1.m.49683,0.005397541,0.001488221,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_BRAFLDRAFT_89535.1.1.m.6232,-0.011390081,-0.003739039,No,NA,NA,NA,NA,NA,NA,ciliary transition zone [GO:0035869]; lipid binding [GO:0008289]; cilium assembly [GO:0060271]; lipoprotein transport [GO:0042953]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_BRAFLDRAFT_89536.1.1.m.26678,-0.010697249,0.003147204,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822]; transcriptional repressor complex [GO:0017053]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_BRAFLDRAFT_89744.1.1.m.29497,-0.005121222,0.009922145,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; brain development [GO:0007420]; cell differentiation [GO:0030154]; spinal cord development [GO:0021510],NA,NA,NA
CHOYP_BRAFLDRAFT_89746.1.2.m.29425,-0.011948394,-0.024131902,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of transcription; DNA-templated [GO:0006355]; tissue regeneration [GO:0042246]; wound healing [GO:0042060],NA,NA,NA
CHOYP_BRAFLDRAFT_89869.1.3.m.28871,-0.014828775,0.007677995,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89869.3.3.m.37644,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89870.1.1.m.15447,0.004351553,0.008608005,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89920.1.1.m.13963,0.007185529,-0.022178619,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_BRAFLDRAFT_89952.1.1.m.59629,0.004328349,-0.012409853,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]; synapse [GO:0045202]; brain development [GO:0007420]; neuronal signal transduction [GO:0023041],NA,NA,NA
CHOYP_BRAFLDRAFT_89952.1.1.m.59630,0.010042649,0.013928152,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89961.1.3.m.5717,0.020667017,-0.00821474,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89961.3.3.m.49198,0.01658802,-0.006083345,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_90098.1.4.m.3841,-0.010018881,-0.024759014,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]; amino-acid betaine catabolic process [GO:0006579]; methionine biosynthetic process [GO:0009086],NA,NA,NA
CHOYP_BRAFLDRAFT_90098.4.4.m.28113,0.00981593,0.008314837,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086],NA,NA,NA
CHOYP_BRAFLDRAFT_90187.1.1.m.30393,-0.022224428,-0.00814433,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_90196.2.2.m.42787,-0.001954688,0.002635786,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-ascorbate:sodium symporter activity [GO:0008520]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904],NA,NA,NA
CHOYP_BRAFLDRAFT_90332.3.4.m.18933,0.021156863,-0.013124529,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_BRAFLDRAFT_90405.1.1.m.44167,0.004185384,-0.021309988,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase [NAD(P)] activity [GO:0032440],NA,NA,NA
CHOYP_BRAFLDRAFT_90471.1.2.m.30257,-0.010602285,-0.006845473,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; filamentous actin [GO:0031941]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; vascular endothelial growth factor receptor binding [GO:0005172]; actin filament organization [GO:0007015]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of transforming growth factor beta1 production [GO:0032911]; positive regulation of protein localization to nucleus [GO:1900182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of receptor-mediated endocytosis [GO:0048259]; vesicle organization [GO:0016050],NA,NA,NA
CHOYP_BRAFLDRAFT_90679.1.1.m.33411,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771],NA,NA,NA
CHOYP_BRAFLDRAFT_90706.2.2.m.29119,-0.022561061,0.009982174,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_90929.1.1.m.54454,-0.00749408,0.004201238,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear receptor transcription coactivator activity [GO:0030374]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_BRAFLDRAFT_90953.1.1.m.48786,-0.011667777,0.019639523,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; galactose binding [GO:0005534]; galactitol metabolic process [GO:0019402]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623],NA,NA,NA
CHOYP_BRAFLDRAFT_91062.1.1.m.77,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytoskeleton [GO:0005856]; Golgi stack [GO:0005795]; synapse [GO:0045202]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; aging [GO:0007568]; intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_BRAFLDRAFT_91068.1.1.m.9955,-0.003992852,-0.003017466,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; kinocilium [GO:0060091]; stereocilium [GO:0032420]; positive regulation of GTPase activity [GO:0043547],NA,NA,NA
CHOYP_BRAFLDRAFT_91316.1.1.m.46558,-0.001571145,0.024265163,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_91321.1.10.m.20278,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_91321.10.10.m.59301,-0.00693698,0.001671668,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_BRAFLDRAFT_91321.5.10.m.37054,0.004416559,-0.004827965,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_91321.7.10.m.56158,-0.004809497,-0.005296709,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_BRAFLDRAFT_91394.1.1.m.16068,-0.010984738,-0.016092937,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361]; chloride-transporting ATPase activity [GO:0008555]; prenylcysteine oxidase activity [GO:0001735]; chloride transport [GO:0006821]; prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328],NA,NA,NA
CHOYP_BRAFLDRAFT_91441.1.1.m.47971,0.020623744,-0.010469209,No,NA,NA,NA,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_BRAFLDRAFT_91636.1.11.m.28449,-0.014765317,0.001413114,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955],NA,NA,NA
CHOYP_BRAFLDRAFT_91636.4.11.m.45350,-0.008903235,0.006450285,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_BRAFLDRAFT_91636.6.11.m.49144,0.00510569,0.018694644,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_BRAFLDRAFT_91636.8.11.m.58992,0.005312238,-0.006192895,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615],NA,NA,NA
CHOYP_BRAFLDRAFT_91695.1.1.m.31423,-0.012677287,-0.016357529,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_91870.3.3.m.62762,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,mitochondrial envelope [GO:0005740]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; cholesterol 26-hydroxylase activity [GO:0031073]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen [GO:0016705]; vitamin D3 25-hydroxylase activity [GO:0030343]; cholesterol metabolic process [GO:0008203]; steroid catabolic process [GO:0006706],NA,NA,NA
CHOYP_BRAFLDRAFT_92024.1.1.m.49813,0.007473334,-0.01076928,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; glial cell migration [GO:0008347]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; response to axon injury [GO:0048678],NA,NA,NA
CHOYP_BRAFLDRAFT_92063.1.2.m.677,-0.00363862,-0.001788222,No,NA,NA,NA,NA,NA,NA,early endosome [GO:0005769]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_92084.1.1.m.10643,-0.0134928,0.000991906,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462],NA,NA,NA
CHOYP_BRAFLDRAFT_92365.3.3.m.51160,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_BRAFLDRAFT_92367.1.4.m.29492,-0.000232007,0.02319008,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_92398.1.2.m.15178,-0.008043435,0.005854311,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_92410.1.1.m.36946,0.006574523,0.001537556,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_BRAFLDRAFT_92601.1.1.m.56157,0.015882093,-0.009396365,No,NA,NA,NA,NA,NA,NA,Golgi membrane [GO:0000139]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_92908.1.1.m.36182,-0.00427848,0.002599584,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236],NA,NA,NA
CHOYP_BRAFLDRAFT_93030.1.1.m.29276,0.008913944,0.012517901,No,NA,NA,NA,NA,NA,NA,axolemma [GO:0030673]; cortical cytoskeleton [GO:0030863]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; common-partner SMAD protein phosphorylation [GO:0007182]; Golgi to plasma membrane protein transport [GO:0043001]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 secretion [GO:1900042]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390],NA,NA,NA
CHOYP_BRAFLDRAFT_93247.1.1.m.7558,-0.022566055,0.009991026,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_93411.1.3.m.13317,0.00610648,0.010124003,No,NA,NA,NA,NA,NA,NA,bicellular tight junction [GO:0005923]; nucleus [GO:0005634]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_BRAFLDRAFT_93411.3.3.m.54402,0.006118156,0.006057288,No,NA,NA,NA,NA,NA,NA,bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; gap junction [GO:0005921]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; bicellular tight junction assembly [GO:0070830]; cellular response to calcium ion [GO:0071277],NA,NA,NA
CHOYP_BRAFLDRAFT_93856.2.6.m.20593,0.007227574,-0.012454723,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_93876.1.1.m.8885,0.005200295,0.01204735,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of protein import into nucleus [GO:0042307]; regulation of growth [GO:0040008]; response to ethanol [GO:0045471],NA,NA,NA
CHOYP_BRAFLDRAFT_94906.1.1.m.59345,0.012457882,0.014068496,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein deglycase activity [GO:0036524]; cellular response to glyoxal [GO:0036471]; cellular response to methylglyoxal [GO:0097238]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation; glyoxal removal [GO:0106046]; lactate biosynthetic process [GO:0019249]; methylglyoxal metabolic process [GO:0009438]; negative regulation of neuron death [GO:1901215]; protein deglycation; glyoxal removal [GO:0036529]; response to toxic substance [GO:0009636],NA,NA,NA
CHOYP_BRAFLDRAFT_95073.3.9.m.27326,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_95739.1.2.m.53575,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hair cycle process [GO:0022405]; innervation [GO:0060384]; otolith morphogenesis [GO:0032474]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_BRAFLDRAFT_95739.2.2.m.57592,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_95868.1.2.m.56034,0.003730459,-0.017448087,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_96254.1.1.m.47860,-0.012465888,0.010917311,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_96598.1.1.m.54770,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166],NA,NA,NA
CHOYP_BRAFLDRAFT_97410.1.3.m.34739,-0.001743206,0.015928959,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_97676.1.1.m.62102,-0.011996785,-0.014830219,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588]; Rab GTPase binding [GO:0017137]; syntaxin binding [GO:0019905]; ectodermal cell differentiation [GO:0010668]; embryonic ectodermal digestive tract development [GO:0048611]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_BRAFLDRAFT_97881.1.1.m.46581,-0.011856878,0.004547552,No,NA,NA,NA,NA,NA,NA,autosome [GO:0030849]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; X chromosome [GO:0000805]; XY body [GO:0001741]; Y chromosome [GO:0000806]; chromatin binding [GO:0003682]; transcription corepressor activity [GO:0003714]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid metabolic process [GO:0019216],NA,NA,NA
CHOYP_BRAFLDRAFT_98499.1.1.m.5718,-0.008962308,0.012031064,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_98740.3.7.m.46571,-0.010662804,-0.003796435,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; glycosaminoglycan binding [GO:0005539]; integrin binding [GO:0005178]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta-activated receptor activity [GO:0005024]; growth hormone secretion [GO:0030252]; multicellular organism development [GO:0007275]; protein folding [GO:0006457]; regulation of cell differentiation [GO:0045595]; regulation of cell growth [GO:0001558]; regulation of proteolysis [GO:0030162]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_BRAFLDRAFT_98740.4.7.m.53694,0.01854008,0.006759234,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583],NA,NA,NA
CHOYP_BRAFLDRAFT_98740.5.7.m.58200,0.008140856,0.003135876,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; negative regulation of osteoclast development [GO:2001205]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_98740.6.7.m.59350,-0.01077203,0.010586158,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_98740.6.7.m.59351,0.011150075,0.00235758,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular protein metabolic process [GO:0044267]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; post-translational protein modification [GO:0043687]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_98740.7.7.m.65348,0.016500265,-0.00738384,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular protein metabolic process [GO:0044267]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; post-translational protein modification [GO:0043687]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_98895.2.2.m.39575,-0.005280033,-0.012468399,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_98992.1.1.m.62815,0.007895072,-0.005475839,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; medium-chain fatty acid catabolic process [GO:0051793]; protein homotetramerization [GO:0051289]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; response to hormone [GO:0009725]; response to nutrient [GO:0007584],NA,NA,NA
CHOYP_BRAFLDRAFT_99018.1.1.m.14650,-0.007183356,-0.013462145,No,NA,NA,NA,NA,NA,NA,hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_BRAFLDRAFT_99073.1.1.m.18282,-0.000625998,0.008140151,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_99083.1.1.m.11705,-0.013305943,0.018708101,No,NA,NA,NA,NA,NA,NA,cell body [GO:0044297]; cilium [GO:0005929]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; ubiquitin protein ligase binding [GO:0031625]; cellular response to unfolded protein [GO:0034620]; negative regulation of cell death [GO:0060548]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_BRAFLDRAFT_99539.1.1.m.55866,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_99630.3.9.m.20020,0.003246136,0.022009668,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; apoptotic process [GO:0006915]; positive regulation of cell proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_BRAFLDRAFT_99630.5.9.m.36500,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; apoptotic process [GO:0006915]; positive regulation of cell proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_BRAFLDRAFT_99630.9.9.m.62562,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_99641.1.1.m.63666,-0.007223637,-0.005393631,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_BRAFLDRAFT_99974.1.1.m.25083,0.014686978,0.003053423,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; beta-carotene 15;15'-monooxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; retinal isomerase activity [GO:0004744]; beta-carotene metabolic process [GO:1901810]; carotene catabolic process [GO:0016121]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; vitamin A biosynthetic process [GO:0035238],NA,NA,NA
CHOYP_BRAP.1.1.m.47862,-0.005763956,0.010226572,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265],NA,NA,NA
CHOYP_BRCA2.1.2.m.17660,-0.00862626,-0.012746709,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; chromatin binding [GO:0003682]; cellular response to DNA damage stimulus [GO:0006974]; centrosome cycle [GO:0007098]; DNA replication [GO:0006260]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; translesion synthesis [GO:0019985],NA,NA,NA
CHOYP_BRCC3.1.1.m.66615,0.004961936,-0.006998926,No,NA,NA,NA,NA,NA,NA,BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle pole [GO:0000922]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425],NA,NA,NA
CHOYP_BRD4.1.1.m.55245,-0.007680542,0.012967514,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; cell differentiation [GO:0030154]; chromatin remodeling [GO:0006338]; histone displacement [GO:0001207]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; mRNA processing [GO:0006397]; positive regulation of transcription involved in meiotic cell cycle [GO:0051039]; regulation of RNA splicing [GO:0043484]; regulation of transcription; DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRD8.1.1.m.244,0.000854706,0.009284683,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; Swr1 complex [GO:0000812]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008],NA,NA,NA
CHOYP_BRX1.1.1.m.30421,-0.002153474,-0.005035591,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; ribosomal large subunit assembly [GO:0000027],NA,NA,NA
CHOYP_BT3L4.1.1.m.2144,-0.002675038,0.000627682,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_BTAF1.2.2.m.55086,-0.007633711,-0.008945937,No,NA,NA,NA,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_BTKL.1.1.m.55270,0.0189468,-0.018461722,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; neuron projection [GO:0043005]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; regulation of synaptic transmission; glutamatergic [GO:0051966],NA,NA,NA
CHOYP_BTKL.1.1.m.55271,0.006049139,0.004622881,No,NA,NA,NA,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phospholipid binding [GO:0005543]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; cytokine-mediated signaling pathway [GO:0019221]; Fc-epsilon receptor signaling pathway [GO:0038095]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein phosphorylation [GO:0006468]; regulation of platelet activation [GO:0010543]; T cell receptor signaling pathway [GO:0050852]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_BTRC.1.1.m.816,-0.002488129,-0.009310706,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; SCF ubiquitin ligase complex [GO:0019005]; small-subunit processome [GO:0032040]; beta-catenin binding [GO:0008013]; ligase activity [GO:0016874]; protein dimerization activity [GO:0046983]; protein phosphorylated amino acid binding [GO:0045309]; snoRNA binding [GO:0030515]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to organic cyclic compound [GO:0071407]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; mammary gland epithelial cell proliferation [GO:0033598]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription; DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription; DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of circadian rhythm [GO:0042752]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_BTZ.1.1.m.45914,0.019502595,-0.014672302,No,NA,NA,NA,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; intracellular mRNA localization [GO:0008298]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BUCC.1.2.m.10972,0.002992972,-0.003581735,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218],NA,NA,NA
CHOYP_BUD31.3.3.m.64519,0.011084481,0.014283023,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_BUP1.1.1.m.13641,-0.008898112,-0.004842956,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; beta-ureidopropionase activity [GO:0003837]; metal ion binding [GO:0046872]; beta-alanine biosynthetic process via 3-ureidopropionate [GO:0033396]; beta-alanine metabolic process [GO:0019482]; pyrimidine nucleoside catabolic process [GO:0046135],NA,NA,NA
CHOYP_BZW1.1.1.m.44089,0.001353633,-0.008031218,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_C10.1.2.m.23678,-0.012657542,0.002027847,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; camera-type eye morphogenesis [GO:0048593]; cognition [GO:0050890]; corpus callosum morphogenesis [GO:0021540]; post-embryonic development [GO:0009791]; psychomotor behavior [GO:0036343]; regulation of skeletal muscle contraction [GO:0014819]; third ventricle development [GO:0021678],NA,NA,NA
CHOYP_C102A.1.1.m.23591,-0.007521808,0.020500417,No,NA,NA,NA,NA,NA,NA,myosin complex [GO:0016459]; motor activity [GO:0003774],NA,NA,NA
CHOYP_C124A.1.1.m.61913,-0.022214541,0.000802589,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; cell cycle [GO:0007049]; cell division [GO:0051301],NA,NA,NA
CHOYP_C19L1.1.1.m.13954,0.00488431,0.013072903,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_C1QL2.19.32.m.29743,-0.005166275,-0.020040699,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_C1QL2.32.32.m.64434,0.012092001,0.013988943,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_C1QL4.7.10.m.49245,0.004199976,-0.002867472,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_C1QL4L.3.7.m.5967,-0.006303589,-0.005277267,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of translation [GO:0017148]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000055]; regulation of growth [GO:0040008],NA,NA,NA
CHOYP_C1QL4L.3.7.m.5968,-0.003164954,0.003061732,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147],NA,NA,NA
CHOYP_C1QL4L.6.7.m.26358,0.006921599,-0.000519967,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_C1QT3.4.8.m.22821,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_C1QT4.2.5.m.28767,0.019860501,0.00206224,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; cytokine activity [GO:0005125]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of tumor necrosis factor secretion [GO:1904469],NA,NA,NA
CHOYP_C1QT4.3.5.m.46406,0.011736938,0.000160682,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147],NA,NA,NA
CHOYP_C1TC.1.1.m.28294,0.021239769,0.007792472,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO:0004486]; 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; nucleotide metabolic process [GO:0009117]; one-carbon metabolic process [GO:0006730]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]; response to nitrogen dioxide [GO:0035713]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653],NA,NA,NA
CHOYP_C2CD5.1.1.m.9675,-0.004670866,-0.004516643,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340],NA,NA,NA
CHOYP_C2D1.1.1.m.8807,0.019592474,-0.007228482,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; phospholipid binding [GO:0005543]; compound eye development [GO:0048749]; endosomal transport [GO:0016197]; female germ-line stem cell asymmetric division [GO:0048132]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; multivesicular body organization [GO:0036257]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of protein catabolic process [GO:0045732]; regulation of endocytosis [GO:0030100]; regulation of Notch signaling pathway [GO:0008593]; sensory organ development [GO:0007423]; sensory organ precursor cell division [GO:0045035]; wing disc morphogenesis [GO:0007472],NA,NA,NA
CHOYP_C3ORF38.1.1.m.59043,-0.007050286,-0.004543328,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065],NA,NA,NA
CHOYP_C43BP.1.1.m.62099,-0.007278188,-0.007607885,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intermembrane ceramide transfer activity [GO:0120017]; phosphatidylinositol-4-phosphate binding [GO:0070273]; ER to Golgi ceramide transport [GO:0035621],NA,NA,NA
CHOYP_CA050.1.2.m.10226,0.000151224,-0.023692943,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_CA14.1.1.m.30677,-0.005150952,-0.022541461,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; bicarbonate transport [GO:0015701],NA,NA,NA
CHOYP_CA2.1.1.m.27846,-0.017712354,-0.004463779,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_CAB32.1.1.m.52444,-0.00772321,-0.00223656,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; type II terminal bouton [GO:0061175]; type III terminal bouton [GO:0097467]; calcium ion binding [GO:0005509]; negative regulation of response to wounding [GO:1903035]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509],NA,NA,NA
CHOYP_CAD1.2.2.m.61448,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_CAD89.1.1.m.14552,0.003473121,0.016114531,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; apical protein localization [GO:0045176]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-mediated signaling [GO:0019722]; cell-cell adhesion mediated by cadherin [GO:0044331]; chorion-containing eggshell formation [GO:0007304]; follicle cell microvillus organization [GO:0032529]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mucosal immune response [GO:0002385]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; regulation of follicle cell microvillus length [GO:0032533]; tube morphogenesis [GO:0035239]; vitelline membrane formation involved in chorion-containing eggshell formation [GO:0007305],NA,NA,NA
CHOYP_CADM3.4.4.m.45272,-0.005535845,0.002216301,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_CADM4.1.1.m.60661,0.004007583,-0.011687225,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_CADM4.1.1.m.60662,-0.000916158,0.014316968,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; midbody [GO:0030496]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; cytoskeleton-dependent cytokinesis [GO:0061640]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_CADN.2.3.m.19237,0.01329358,0.000211232,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290],NA,NA,NA
CHOYP_CAH1.1.2.m.24247,0.006791854,-0.004569098,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_CAHD1.5.6.m.53893,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,voltage-gated calcium channel complex [GO:0005891]; voltage-gated calcium channel activity [GO:0005245],NA,NA,NA
CHOYP_CAL6303_3579.1.1.m.59031,0.00297084,-0.02018932,No,NA,NA,NA,NA,NA,NA,caffeoyl-CoA O-methyltransferase activity [GO:0042409]; metal ion binding [GO:0046872]; lignin biosynthetic process [GO:0009809],NA,NA,NA
CHOYP_CAL7507_4591.1.1.m.49532,0.005981485,0.012056909,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CALCR.1.6.m.856,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcitonin receptor activity [GO:0004948]; cell surface receptor signaling pathway [GO:0007166],NA,NA,NA
CHOYP_CALM.11.50.m.28106,0.011184321,0.00446714,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALM.15.50.m.30007,0.014685802,-0.002883478,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; spindle pole body organization [GO:0051300],NA,NA,NA
CHOYP_CALM.22.50.m.31010,0.004266998,0.011868441,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALM.31.50.m.48469,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; DNA binding [GO:0003677]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_CALM.32.50.m.48894,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cell periphery [GO:0071944]; centrosome [GO:0005813]; mitotic spindle [GO:0072686]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; apoptotic cell clearance [GO:0043277]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of meiotic spindle orientation [GO:0051296]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]; spindle pole body organization [GO:0051300],NA,NA,NA
CHOYP_CALM.35.50.m.49987,-0.012043622,0.001203338,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_CALM.37.50.m.52385,0.000382153,-0.013371578,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_CALM.44.50.m.56751,0.010739481,-0.015526976,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALM.45.50.m.57163,0.000502961,-0.01080102,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALM.50.50.m.67046,0.007070138,-0.010723165,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALM.7.50.m.12029,0.001713906,-0.011874136,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_CALMB.1.1.m.41570,-0.007551754,0.014040088,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALRL.2.3.m.42463,0.008702515,0.000909019,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; corticotrophin-releasing factor receptor activity [GO:0015056]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; corticotropin secretion [GO:0051458]; regulation of corticosterone secretion [GO:2000852],NA,NA,NA
CHOYP_CALUB.1.2.m.57842,0.003492736,0.00692177,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALUB.2.2.m.58007,0.011288755,0.020529399,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALX.1.1.m.12010,-0.005359391,0.001991387,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; clathrin-dependent endocytosis [GO:0072583]; protein folding [GO:0006457]; synaptic vesicle endocytosis [GO:0048488],NA,NA,NA
CHOYP_CAMK4.1.1.m.30431,-0.020871005,0.004714048,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; adaptive immune response [GO:0002250]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; myeloid dendritic cell differentiation [GO:0043011]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of osteoclast differentiation [GO:0045670]; regulation of T cell differentiation in thymus [GO:0033081]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_CAN5.1.1.m.42242,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_CAN5.1.1.m.42243,-0.016854414,0.008147266,No,NA,NA,NA,NA,NA,NA,4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate transaminase activity [GO:0003867]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]; aging [GO:0007568]; behavioral response to cocaine [GO:0048148]; cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of platelet aggregation [GO:0090331]; neurotransmitter catabolic process [GO:0042135]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094],NA,NA,NA
CHOYP_CAN8.1.2.m.21091,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; digestion [GO:0007586]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CAOG_00801.1.2.m.1579,-0.013752644,0.003316326,No,NA,NA,NA,NA,NA,NA,melanocyte differentiation [GO:0030318],NA,NA,NA
CHOYP_CAOG_01182.1.1.m.8019,-0.022662004,0.010357286,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_CAOG_01521.1.1.m.28103,0.016155482,0.011142624,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CAOG_02976.1.2.m.41292,-0.001878235,-0.0101215,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177],NA,NA,NA
CHOYP_CAOG_02976.2.2.m.56777,-0.007901368,0.005634945,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177],NA,NA,NA
CHOYP_CAOG_03463.1.1.m.16746,0.022523816,-0.002398103,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; otolith morphogenesis [GO:0032474],NA,NA,NA
CHOYP_CAOG_04006.1.1.m.5403,-0.002456849,0.00638549,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; amino acid binding [GO:0016597]; L-threonine 3-dehydrogenase activity [GO:0008743]; NAD+ binding [GO:0070403]; zinc ion binding [GO:0008270]; L-threonine catabolic process to glycine [GO:0019518]; protein homotetramerization [GO:0051289]; threonine metabolic process [GO:0006566],NA,NA,NA
CHOYP_CAOG_04643.2.2.m.50992,-0.008071212,-0.018333437,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CAOG_04686.2.2.m.28117,0.012392355,-0.006826796,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CAOG_05733.1.2.m.29878,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CAP.1.2.m.22123,0.012981968,-0.009396762,No,NA,NA,NA,NA,NA,NA,plasma membrane [GO:0005886]; actin binding [GO:0003779]; cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010],NA,NA,NA
CHOYP_CAPLA.1.2.m.51979,0.002937694,0.003769641,No,NA,NA,NA,NA,NA,NA,cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine/threonine kinase activity [GO:0004674]; anesthesia-resistant memory [GO:0007615]; anterior/posterior pattern specification; imaginal disc [GO:0007448]; behavioral response to ethanol [GO:0048149]; cAMP-mediated signaling [GO:0019933]; cellular response to ethanol [GO:0071361]; compound eye development [GO:0048749]; imaginal disc-derived wing morphogenesis [GO:0007476]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of nucleocytoplasmic transport [GO:0046823]; negative regulation of smoothened signaling pathway [GO:0045879]; olfactory learning [GO:0008355]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oogenesis [GO:0048477]; positive regulation of gene expression [GO:0010628]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of bicoid mRNA localization [GO:0008359]; regulation of circadian sleep/wake cycle; sleep [GO:0045187]; regulation of pole plasm oskar mRNA localization [GO:0007317]; rhythmic behavior [GO:0007622]; sprouting of injured axon [GO:0048682]; thermosensory behavior [GO:0040040],NA,NA,NA
CHOYP_CAPSLB.1.1.m.58887,0.00757925,-0.008037337,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CAPZB.1.1.m.5762,-0.010279337,0.001546088,No,NA,NA,NA,NA,NA,NA,actin filament [GO:0005884]; dendritic spine [GO:0043197]; F-actin capping protein complex [GO:0008290]; neuronal cell body [GO:0043025]; sarcomere [GO:0030017]; WASH complex [GO:0071203]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010]; negative regulation of filopodium assembly [GO:0051490]; regulation of cell morphogenesis [GO:0022604]; regulation of lamellipodium assembly [GO:0010591],NA,NA,NA
CHOYP_CARNS1.1.6.m.2227,0.012670671,0.005538085,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; carnosine synthase activity [GO:0047730]; FMN binding [GO:0010181]; homocarnosine synthase activity [GO:0102102]; metal ion binding [GO:0046872]; carnosine biosynthetic process [GO:0035499]; histidine catabolic process [GO:0006548],NA,NA,NA
CHOYP_CARNS1.2.6.m.3531,-0.00889665,-0.012271783,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; fatty acid metabolic process [GO:0006631]; regulation of lipid storage [GO:0010883]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445],NA,NA,NA
CHOYP_CARNS1.4.6.m.40244,-0.022453467,0.001742241,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; carnosine synthase activity [GO:0047730]; FMN binding [GO:0010181]; homocarnosine synthase activity [GO:0102102]; metal ion binding [GO:0046872]; carnosine biosynthetic process [GO:0035499]; histidine catabolic process [GO:0006548],NA,NA,NA
CHOYP_CARNS1.5.6.m.63614,-0.007975895,-0.002830611,No,NA,NA,NA,NA,NA,NA,histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; PML body [GO:0016605]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; cerebellum development [GO:0021549]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_CASP10.4.7.m.45631,-0.014217086,0.009510271,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CASP10.5.7.m.49889,-0.012295505,0.010277394,No,NA,NA,NA,NA,NA,NA,CD95 death-inducing signaling complex [GO:0031265]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ripoptosome [GO:0097342]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; death effector domain binding [GO:0035877]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell surface receptor signaling pathway [GO:0007166]; execution phase of apoptosis [GO:0097194]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of apoptotic process [GO:0042981],NA,NA,NA
CHOYP_CASP2.5.5.m.35953,-0.003027192,0.007030965,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; aging [GO:0007568]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; brain development [GO:0007420]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; ectopic germ cell programmed cell death [GO:0035234]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; luteolysis [GO:0001554]; negative regulation of apoptotic process [GO:0043066]; neural retina development [GO:0003407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485],NA,NA,NA
CHOYP_CASP3.1.3.m.23354,-0.011905461,0.008868883,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CASP3.2.3.m.24896,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; death receptor binding [GO:0005123]; peptidase activity [GO:0008233]; phospholipase A2 activator activity [GO:0016005]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic substance [GO:0071310]; cellular response to staurosporine [GO:0072734]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; leukocyte apoptotic process [GO:0071887]; luteolysis [GO:0001554]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; response to amino acid [GO:0043200]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; striated muscle cell differentiation [GO:0051146]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060],NA,NA,NA
CHOYP_CASP7.11.23.m.26574,-0.013770242,-0.000804333,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146],NA,NA,NA
CHOYP_CASP7.16.23.m.50828,-0.008567996,0.012382411,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CASP7.17.23.m.52767,-0.009979042,-0.019550487,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146],NA,NA,NA
CHOYP_CASP7.18.23.m.52787,0.004105293,-0.022969752,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],NA,NA,NA
CHOYP_CASP7.2.23.m.5415,-0.014123216,0.000544696,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_CASP7.21.23.m.63852,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146],NA,NA,NA
CHOYP_CASP7.22.23.m.66704,0.002308417,-0.000502404,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146],NA,NA,NA
CHOYP_CASP7.5.23.m.12847,-0.001379642,0.001044813,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CASP7.8.23.m.23670,0.006491775,0.001851337,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; peptidase activity [GO:0008233]; apoptotic process [GO:0006915]; cornification [GO:0070268]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630],NA,NA,NA
CHOYP_CASP7.9.23.m.25523,-0.010378812,-0.023244392,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CAT.1.1.m.57038,0.018247121,-0.019143052,No,NA,NA,NA,NA,NA,NA,peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; aminoacylase activity [GO:0004046]; catalase activity [GO:0004096]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; aerobic respiration [GO:0009060]; cholesterol metabolic process [GO:0008203]; hemoglobin metabolic process [GO:0020027]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; oxidation-reduction process [GO:0055114]; positive regulation of cell division [GO:0051781]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein homotetramerization [GO:0051289]; response to hydrogen peroxide [GO:0042542]; triglyceride metabolic process [GO:0006641]; UV protection [GO:0009650],NA,NA,NA
CHOYP_CATA.1.3.m.11120,-0.000545041,0.00137286,No,NA,NA,NA,NA,NA,NA,peroxisome [GO:0005777]; catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_CATA.2.3.m.18454,0.013192329,-0.015033322,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; aminoacylase activity [GO:0004046]; antioxidant activity [GO:0016209]; catalase activity [GO:0004096]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; oxidoreductase activity; acting on peroxide as acceptor [GO:0016684]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; aerobic respiration [GO:0009060]; aging [GO:0007568]; cellular response to growth factor stimulus [GO:0071363]; cellular response to oxidative stress [GO:0034599]; cholesterol metabolic process [GO:0008203]; hemoglobin metabolic process [GO:0020027]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; positive regulation of cell division [GO:0051781]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein homotetramerization [GO:0051289]; protein targeting to peroxisome [GO:0006625]; protein tetramerization [GO:0051262]; response to activity [GO:0014823]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to inactivity [GO:0014854]; response to insulin [GO:0032868]; response to L-ascorbic acid [GO:0033591]; response to lead ion [GO:0010288]; response to light intensity [GO:0009642]; response to ozone [GO:0010193]; response to phenylpropanoid [GO:0080184]; response to reactive oxygen species [GO:0000302]; response to vitamin A [GO:0033189]; response to vitamin E [GO:0033197]; triglyceride metabolic process [GO:0006641]; ureteric bud development [GO:0001657]; UV protection [GO:0009650],NA,NA,NA
CHOYP_CATA.3.3.m.21642,0.021421899,-0.013106449,No,NA,NA,NA,NA,NA,NA,peroxisome [GO:0005777]; catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_CATB.1.2.m.5440,-0.016707453,0.013774018,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of catalytic activity [GO:0050790],NA,NA,NA
CHOYP_CATL1.1.1.m.56906,-0.008666152,0.009541867,No,NA,NA,NA,NA,NA,NA,cysteine-type peptidase activity [GO:0008234],NA,NA,NA
CHOYP_CATS.1.1.m.45218,-0.008198668,0.011539075,No,NA,NA,NA,NA,NA,NA,apical part of cell [GO:0045177]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; microvillus [GO:0005902]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; secretory granule [GO:0030141]; aminopeptidase activity [GO:0004177]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; kininogen binding [GO:0030984]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; autophagic cell death [GO:0048102]; cellular response to starvation [GO:0009267]; decidualization [GO:0046697]; extracellular matrix disassembly [GO:0022617]; multicellular organism aging [GO:0010259]; nerve development [GO:0021675]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of keratinocyte differentiation [GO:0045616]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to odorant [GO:1990834]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_CB044.1.1.m.53539,0.00929722,-0.003703865,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_CBG09799.1.1.m.44038,0.001572977,-0.013249771,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBG11254.1.1.m.9107,-0.021388849,0.003776716,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBG11292.1.1.m.12957,-0.008776601,-0.016919737,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]; neuropeptide signaling pathway [GO:0007218],NA,NA,NA
CHOYP_CBG18730.1.1.m.2611,-3.27E-05,0.00143539,No,NA,NA,NA,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],NA,NA,NA
CHOYP_CBG20816.1.1.m.49333,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBG22657.2.2.m.28802,0.001220451,-0.015672155,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBLN3.1.2.m.29253,-0.002738837,-0.025422089,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBP.2.4.m.11401,-0.005345341,0.004537321,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; acetyltransferase activity [GO:0016407]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; histone acetyltransferase activity [GO:0004402]; MRF binding [GO:0043426]; peroxisome proliferator activated receptor binding [GO:0042975]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; cell proliferation [GO:0008283]; cellular response to UV [GO:0034644]; histone acetylation [GO:0016573]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; protein destabilization [GO:0031648]; regulation of transcription; DNA-templated [GO:0006355]; response to interleukin-1 [GO:0070555]; rhythmic process [GO:0048511],NA,NA,NA
CHOYP_CBPC1.1.1.m.30713,0.006759928,-0.00146215,No,NA,NA,NA,NA,NA,NA,Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; U6 snRNA binding [GO:0017070]; U6atac snRNA binding [GO:0030624]; mRNA splicing; via spliceosome [GO:0000398]; nucleosome assembly [GO:0006334]; positive regulation of histone deubiquitination [GO:1903586]; spliceosomal snRNP assembly [GO:0000387]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_CBPQ.1.1.m.58629,-0.014584089,-0.00099496,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CBR.GLY.5.1.1.m.26441,0.004294197,0.013085223,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBR.LET.2.2.2.m.44681,-0.012690499,-0.019924213,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBR.LET.2.2.2.m.44682,0.009008569,0.012279799,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBR.LIN.24.1.1.m.5076,-0.014783634,-0.004435582,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBS.2.2.m.65898,-0.005490361,-0.002571971,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; carbon monoxide binding [GO:0070025]; cystathionine beta-synthase activity [GO:0004122]; cysteine synthase activity [GO:0004124]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; modified amino acid binding [GO:0072341]; nitric oxide binding [GO:0070026]; nitrite reductase (NO-forming) activity [GO:0050421]; oxygen binding [GO:0019825]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; S-adenosyl-L-methionine binding [GO:1904047]; ubiquitin protein ligase binding [GO:0031625]; blood vessel remodeling [GO:0001974]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to hypoxia [GO:0071456]; cerebellum morphogenesis [GO:0021587]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; endochondral ossification [GO:0001958]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; L-serine metabolic process [GO:0006563]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of apoptotic process [GO:0043066]; regulation of blood vessel size [GO:0050880]; regulation of JUN kinase activity [GO:0043506]; regulation of nitric oxide mediated signal transduction [GO:0010749]; response to folic acid [GO:0051593]; superoxide metabolic process [GO:0006801]; transsulfuration [GO:0019346],NA,NA,NA
CHOYP_CBWD1.1.1.m.6825,-0.011833033,-0.00924818,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_CBX1.1.4.m.5390,0.002238279,-0.003088692,No,NA,NA,NA,NA,NA,NA,chromocenter [GO:0010369]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; kinetochore [GO:0000776]; nuclear chromosome; telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein binding; bridging [GO:0030674]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; repressing transcription factor binding [GO:0070491]; ribonucleoprotein complex binding [GO:0043021]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_CBX1.3.4.m.27106,0.009811661,0.011349155,No,NA,NA,NA,NA,NA,NA,chromocenter [GO:0010369]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; kinetochore [GO:0000776]; nuclear chromosome; telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein binding; bridging [GO:0030674]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; repressing transcription factor binding [GO:0070491]; ribonucleoprotein complex binding [GO:0043021]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_CC136.1.1.m.64302,-0.008537142,-0.013818342,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_CC171.1.1.m.55237,-0.008679037,-0.002885929,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_CC1G_13336.1.3.m.23079,-0.001749891,-0.016084251,No,NA,NA,NA,NA,NA,NA,mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrial respiratory chain complex IV assembly [GO:0033617],NA,NA,NA
CHOYP_CCAR1.1.1.m.25430,-0.013087987,0.005015619,No,NA,NA,NA,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; cell cycle [GO:0007049]; regulation of transcription; DNA-templated [GO:0006355]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_CCBL1.1.1.m.30637,-0.016137703,0.001914134,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; kynurenine metabolic process [GO:0070189],NA,NA,NA
CHOYP_CCD22.1.1.m.6639,0.00043177,0.012238063,No,NA,NA,NA,NA,NA,NA,cullin family protein binding [GO:0097602]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060],NA,NA,NA
CHOYP_CCD43.1.1.m.63636,-0.006295398,-0.010026815,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_CCD53.1.1.m.6684,0.001339178,0.011203404,No,NA,NA,NA,NA,NA,NA,WASH complex [GO:0071203]; actin filament polymerization [GO:0030041]; exocytosis [GO:0006887],NA,NA,NA
CHOYP_CCD73.1.2.m.21485,-0.003114829,-0.010325374,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CCDC146.1.1.m.11347,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814],NA,NA,NA
CHOYP_CCDC150.1.1.m.58800,-0.001490696,-0.010646561,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_CCDC6.1.1.m.13918,0.009875761,-0.001951995,No,NA,NA,NA,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200],NA,NA,NA
CHOYP_CCHCR1.1.1.m.59142,-0.008901326,0.008834191,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; arylformamidase activity [GO:0004061]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; tryptophan catabolic process to kynurenine [GO:0019441],NA,NA,NA
CHOYP_CCHL.2.2.m.66608,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]; cytochrome c-heme linkage [GO:0018063],NA,NA,NA
CHOYP_CCKAR.4.6.m.43964,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930],NA,NA,NA
CHOYP_CCNB.2.2.m.16936,-0.022566559,0.009991929,No,NA,NA,NA,NA,NA,NA,phosphoprotein phosphatase activity [GO:0004721],NA,NA,NA
CHOYP_CCNL1.1.2.m.9018,-0.00942479,-0.00954345,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of transcription; DNA-templated [GO:0006355]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_CD033.1.1.m.25350,0.003085797,0.00059912,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_CD109.1.2.m.7033,-0.004620222,-0.011587735,No,NA,NA,NA,NA,NA,NA,anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616],NA,NA,NA
CHOYP_CD11B.1.1.m.51509,-0.002801277,-0.014518687,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; cell proliferation [GO:0008283]; mitotic cell cycle [GO:0000278]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of mRNA processing [GO:0050684]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_CD36_40650.1.1.m.47015,-0.001685393,0.013135458,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; immune response [GO:0006955]; integrin-mediated signaling pathway [GO:0007229]; protein localization to plasma membrane [GO:0072659]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_CDC14A.1.1.m.18068,0.002979832,0.003147595,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinociliary basal body [GO:1902636]; kinocilium [GO:0060091]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; stereocilium tip [GO:0032426]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cell division [GO:0051301]; cell proliferation [GO:0008283]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; mitotic cell cycle arrest [GO:0071850]; positive regulation of cytokinesis [GO:0032467]; regulation of exit from mitosis [GO:0007096]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_CDC23.1.1.m.6463,-0.00831899,-0.004187571,No,NA,NA,NA,NA,NA,NA,anaphase-promoting complex [GO:0005680]; cell division [GO:0051301]; mitotic metaphase plate congression [GO:0007080]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic metaphase/anaphase transition [GO:0030071],NA,NA,NA
CHOYP_CDC42.1.11.m.324,0.018947054,0.006056283,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CDC42.11.11.m.60002,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CDC42.11.11.m.60004,-0.015751064,0.01146812,No,NA,NA,NA,NA,NA,NA,adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; axon extension [GO:0048675]; branching involved in open tracheal system development [GO:0060446]; cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; establishment of neuroblast polarity [GO:0045200]; exocyst localization [GO:0051601]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair outgrowth [GO:0035318]; maintenance of cell polarity [GO:0030011]; maintenance of protein location [GO:0045185]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; nephrocyte filtration [GO:0097206]; neuromuscular synaptic transmission [GO:0007274]; ommatidial rotation [GO:0016318]; phagocytosis [GO:0006909]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of wound healing [GO:0090303]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; Rho protein signal transduction [GO:0007266]; sensory perception of touch [GO:0050975]; spermatid development [GO:0007286]; wound healing [GO:0042060],NA,NA,NA
CHOYP_CDC5L.1.1.m.25107,-0.020455635,-0.008757381,No,NA,NA,NA,NA,NA,NA,DNA replication factor A complex [GO:0005662]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-DNA complex [GO:0032993]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; leucine zipper domain binding [GO:0043522]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; WD40-repeat domain binding [GO:0071987]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interleukin-2 [GO:0071352]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to prolactin [GO:1990646]; cellular response to wortmannin [GO:1904568]; DNA repair [GO:0006281]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; mRNA splicing; via spliceosome [GO:0000398]; regulation of transcription; DNA-templated [GO:0006355]; signal transduction involved in DNA damage checkpoint [GO:0072422],NA,NA,NA
CHOYP_CDC73.1.1.m.36157,-0.007775184,-0.001797973,No,NA,NA,NA,NA,NA,NA,Cdc73/Paf1 complex [GO:0016593]; nucleus [GO:0005634]; RNA polymerase II complex binding [GO:0000993]; cell cycle [GO:0007049]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone modification [GO:0016570]; mRNA polyadenylation [GO:0006378]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of cell growth [GO:0001558]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_CDK13.1.1.m.59965,-0.001934087,-0.005856904,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; cyclin K-CDK12 complex [GO:0002944]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; fibrillar center [GO:0001650]; nuclear chromatin [GO:0000790]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; mRNA processing [GO:0006397]; negative regulation of stem cell differentiation [GO:2000737]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of MAP kinase activity [GO:0043405]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_CDK5.1.1.m.25495,-0.012216539,-0.004678053,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule [GO:0005874]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533]; Schaffer collateral - CA1 synapse [GO:0098685]; acetylcholine receptor activator activity [GO:0030549]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cytoskeletal protein binding [GO:0008092]; ephrin receptor binding [GO:0046875]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; Hsp90 protein binding [GO:0051879]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635]; apoptotic process [GO:0006915]; associative learning [GO:0008306]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; central nervous system neuron development [GO:0021954]; cerebellar cortex development [GO:0021695]; cerebellar cortex formation [GO:0021697]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; corpus callosum development [GO:0022038]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; exocytosis [GO:0006887]; forebrain development [GO:0030900]; hippocampus development [GO:0021766]; histone phosphorylation [GO:0016572]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; mitochondrion organization [GO:0007005]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of cell cycle [GO:0045786]; negative regulation of neuron death [GO:1901215]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; negative regulation of transcription; DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; nucleocytoplasmic transport [GO:0006913]; oligodendrocyte differentiation [GO:0048709]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of glial cell apoptotic process [GO:0034352]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; protein autophosphorylation [GO:0046777]; protein localization to synapse [GO:0035418]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulated exocytosis [GO:0045055]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission; glutamatergic [GO:0051966]; response to cocaine [GO:0042220]; response to wounding [GO:0009611]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; serine phosphorylation of STAT protein [GO:0042501]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synapse pruning [GO:0098883]; synaptic transmission; dopaminergic [GO:0001963]; synaptic transmission; glutamatergic [GO:0035249]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]; telencephalon development [GO:0021537]; visual learning [GO:0008542],NA,NA,NA
CHOYP_CDO1.1.4.m.26663,0.01228816,0.016517612,No,NA,NA,NA,NA,NA,NA,cysteine dioxygenase activity [GO:0017172]; iron ion binding [GO:0005506]; taurine biosynthetic process [GO:0042412],NA,NA,NA
CHOYP_CDPK5.1.1.m.6214,0.019294406,0.000615309,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; spindle pole body organization [GO:0051300],NA,NA,NA
CHOYP_CDPKM.1.1.m.58179,0.010198906,-9.11E-05,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_CE112.1.2.m.11508,0.007980862,0.000714341,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; receptor localization to synapse [GO:0097120],NA,NA,NA
CHOYP_CE120.1.2.m.19214,-0.014518735,-0.007972817,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; protein C-terminus binding [GO:0008022]; astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; neurogenesis [GO:0022008]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of cilium assembly [GO:0045724]; positive regulation of establishment of protein localization [GO:1904951],NA,NA,NA
CHOYP_CEBPZ.1.1.m.12869,-0.014710793,-0.018274081,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_CECR2.2.3.m.13613,0.007263315,-0.012394661,No,NA,NA,NA,NA,NA,NA,CERF complex [GO:0090537]; nucleus [GO:0005634]; apoptotic DNA fragmentation [GO:0006309]; ATP-dependent chromatin remodeling [GO:0043044]; cytoskeleton organization [GO:0007010]; cytoskeleton-dependent cytokinesis [GO:0061640]; execution phase of apoptosis [GO:0097194]; neural tube development [GO:0021915]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_CECR2.3.3.m.59311,0.005751867,-0.015550424,No,NA,NA,NA,NA,NA,NA,CERF complex [GO:0090537]; nucleus [GO:0005634]; apoptotic DNA fragmentation [GO:0006309]; ATP-dependent chromatin remodeling [GO:0043044]; cytoskeleton organization [GO:0007010]; cytoskeleton-dependent cytokinesis [GO:0061640]; execution phase of apoptosis [GO:0097194]; neural tube development [GO:0021915]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_CED1.20.29.m.45054,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CED1.22.29.m.48193,0.004419624,-0.005120342,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CED1.26.29.m.53629,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CED1.9.29.m.29470,-0.022383392,0.010624911,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_CEG1A.1.6.m.815,0.010285728,-0.00320177,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein transport [GO:0015031],NA,NA,NA
CHOYP_CEL.2.3.m.27351,-0.00305735,-0.012148987,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; zymogen granule [GO:0042588]; carboxylic ester hydrolase activity [GO:0052689]; glycosphingolipid binding [GO:0043208]; lysophospholipase activity [GO:0004622]; neurexin family protein binding [GO:0042043]; protein-containing complex binding [GO:0044877]; retinyl-palmitate esterase activity [GO:0050253]; signaling receptor activity [GO:0038023]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; synaptic vesicle endocytosis [GO:0048488],NA,NA,NA
CHOYP_CELA1.1.3.m.14531,0.002023134,-0.01482498,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CELA1.2.3.m.27287,-0.003575922,0.002903022,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],NA,NA,NA
CHOYP_CELE_F01D5.5.1.1.m.4263,0.018371339,0.013119511,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CELE_F01D5.5.1.1.m.4265,0.016860255,0.017918467,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CELE_Y64G10A.7.3.4.m.53262,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_CELF2.2.4.m.22506,0.016236791,-0.003316356,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_CELF4.1.1.m.22429,-0.010201456,0.001110878,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_CELR2.3.8.m.29505,-0.013158378,-0.001846578,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CENPJ.1.1.m.49318,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; tubulin binding [GO:0015631]; astral microtubule nucleation [GO:0030954]; cell division [GO:0051301]; centriole assembly [GO:0098534]; centriole elongation [GO:0061511]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; microtubule polymerization [GO:0046785]; mitotic spindle pole body duplication [GO:1903087]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; positive regulation of centriole elongation [GO:1903724]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of centriole replication [GO:0046599]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_CENTRIN.1.1.m.59526,0.017780877,0.014412497,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CEP164.1.1.m.40330,-0.002694274,0.010378875,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; DNA repair [GO:0006281]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],NA,NA,NA
CHOYP_CEP192.1.2.m.7869,0.007746293,0.002079283,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; pericentriolar material [GO:0000242]; phosphatase binding [GO:0019902]; centrosome duplication [GO:0051298]; centrosome-templated microtubule nucleation [GO:0090222]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic spindle assembly [GO:0090307]; negative regulation of phosphatase activity [GO:0010923]; protein localization to centrosome [GO:0071539]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_CEP290.1.1.m.58767,-0.002277848,-0.011944066,No,NA,NA,NA,NA,NA,NA,centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580]; identical protein binding [GO:0042802]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; G2/M transition of mitotic cell cycle [GO:0000086]; hindbrain development [GO:0030902]; neutrophil degranulation [GO:0043312]; otic vesicle formation [GO:0030916]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of transcription; DNA-templated [GO:0045893]; pronephros development [GO:0048793]; protein transport [GO:0015031]; regulation of establishment of protein localization [GO:0070201]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],NA,NA,NA
CHOYP_CEP350.1.1.m.4119,-0.000638204,0.003388771,No,NA,NA,NA,NA,NA,NA,cell projection [GO:0042995]; centriole [GO:0005814]; centrosome [GO:0005813]; nucleus [GO:0005634]; spindle [GO:0005819]; microtubule binding [GO:0008017]; microtubule anchoring [GO:0034453],NA,NA,NA
CHOYP_CEP63.2.2.m.35716,-0.000526983,0.004882099,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_CEP76.1.1.m.6264,0.001704335,0.011578493,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; regulation of centriole replication [GO:0046599],NA,NA,NA
CHOYP_CEP89.1.2.m.14339,-0.004349983,-0.008551717,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; chemical synaptic transmission [GO:0007268]; cilium assembly [GO:0060271]; mitochondrion organization [GO:0007005]; non-motile cilium assembly [GO:1905515],NA,NA,NA
CHOYP_CERS6.1.1.m.5214,0.022230728,-0.013064622,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; DNA binding [GO:0003677]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148],NA,NA,NA
CHOYP_CETN1.1.3.m.15199,-0.010177063,0.002092268,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; XPC complex [GO:0071942]; calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; heterotrimeric G-protein binding [GO:0032795]; microtubule binding [GO:0008017]; calcium-mediated signaling [GO:0019722]; centriole replication [GO:0007099]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; nucleotide-excision repair [GO:0006289]; regulation of centrosome duplication [GO:0010824]; regulation of cytokinesis [GO:0032465]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_CF106.1.1.m.14354,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,autophagosome [GO:0005776]; phagophore assembly site [GO:0000407]; ubiquitin binding [GO:0043130]; macroautophagy [GO:0016236],NA,NA,NA
CHOYP_CG057.1.1.m.45912,-0.009947072,0.00166492,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CG14207.1.1.m.41523,0.013097239,0.022218396,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_CG17147.1.1.m.28107,-0.015123489,0.005825003,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CG34417.1.2.m.18203,-0.00269406,0.012086044,No,NA,NA,NA,NA,NA,NA,contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; I band [GO:0031674]; M band [GO:0031430]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; protein phosphatase 1 binding [GO:0008157]; tropomyosin binding [GO:0005523]; actin cytoskeleton organization [GO:0030036]; negative regulation of blood vessel diameter [GO:0097756]; positive regulation of vasoconstriction [GO:0045907],NA,NA,NA
CHOYP_CG42749.1.1.m.30138,0.017421695,-0.014299687,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CGD4_750.1.1.m.29180,0.009660872,0.010314717,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CGL.1.2.m.31960,0.006998606,0.022280603,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]; cystathionine gamma-lyase activity [GO:0004123]; L-cysteine desulfhydrase activity [GO:0080146]; L-cystine L-cysteine-lyase (deaminating) [GO:0044540]; pyridoxal phosphate binding [GO:0030170]; cysteine biosynthetic process [GO:0019344]; hydrogen sulfide biosynthetic process [GO:0070814]; negative regulation of apoptotic process [GO:0043066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein sulfhydration [GO:0044524]; protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine [GO:0018272],NA,NA,NA
CHOYP_CH60.1.1.m.26967,0.013234537,-0.008840567,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; apoptotic mitochondrial changes [GO:0008637]; cellular response to heat [GO:0034605]; mitochondrion organization [GO:0007005]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]; protein targeting to mitochondrion [GO:0006626],NA,NA,NA
CHOYP_CHCHD1.1.1.m.25210,-0.001194256,0.022681918,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CHD2.1.1.m.36132,0.001536404,-0.009886069,No,NA,NA,NA,NA,NA,NA,chromosome; centromeric region [GO:0000775]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386],NA,NA,NA
CHOYP_CHD5.2.2.m.28708,-0.017040269,0.000713008,No,NA,NA,NA,NA,NA,NA,heterochromatin [GO:0000792]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; H3K27me3 modified histone binding [GO:0061628]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K27 trimethylation [GO:0098532]; histone H4 acetylation [GO:0043967]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of transcription involved in cell fate commitment [GO:0060850]; spermatogenesis; exchange of chromosomal proteins [GO:0035093]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_CHD7.2.2.m.14418,-0.005986024,-0.014450468,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; chromatin organization [GO:0006325],NA,NA,NA
CHOYP_CHER.1.1.m.63350,-0.000540787,0.011637347,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport; nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation; actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_CHERP.1.1.m.22401,0.000103988,-0.009447387,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum membrane [GO:0033017]; ion channel binding [GO:0044325]; RNA binding [GO:0003723]; cellular calcium ion homeostasis [GO:0006874]; negative regulation of cell proliferation [GO:0008285]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; release of sequestered calcium ion into cytosol [GO:0051209]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_CHGG_10233.1.1.m.39238,0.017339148,0.013129993,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; actin binding [GO:0003779]; actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301],NA,NA,NA
CHOYP_CHI1.1.1.m.40259,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_CHKA.1.1.m.25454,-0.000871085,-0.006679604,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646],NA,NA,NA
CHOYP_CHL1.2.2.m.65829,0.005420929,-0.006089073,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CHM2A.1.1.m.59752,-0.004246869,0.018477271,No,NA,NA,NA,NA,NA,NA,ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; nuclear envelope [GO:0005635]; endosome transport via multivesicular body sorting pathway [GO:0032509]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; nuclear envelope reassembly [GO:0031468]; protein transport [GO:0015031],NA,NA,NA
CHOYP_CHM4B.1.1.m.19057,0.001623101,0.006379205,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; nuclear envelope reassembly [GO:0031468]; protein transport [GO:0015031]; vacuolar transport [GO:0007034],NA,NA,NA
CHOYP_CHMP3.1.1.m.65684,8.66E-05,-0.007173482,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; ESCRT III complex [GO:0000815]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; multivesicular body [GO:0005771]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; positive regulation of cytokinesis [GO:0032467]; protein transport [GO:0015031]; regulation of endosome size [GO:0051036],NA,NA,NA
CHOYP_CHMP5.1.1.m.66827,-0.014733726,-0.006455727,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body sorting pathway [GO:0071985]; nucleus organization [GO:0006997]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of receptor recycling [GO:0001919]; viral budding [GO:0046755],NA,NA,NA
CHOYP_CHMP7.1.1.m.15221,0.00370641,0.016637418,No,NA,NA,NA,NA,NA,NA,ESCRT III complex [GO:0000815]; nuclear envelope [GO:0005635]; protein transporter activity [GO:0008565]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; nuclear envelope reassembly [GO:0031468],NA,NA,NA
CHOYP_CHRD1.1.1.m.42143,0.016235342,-0.007954924,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; regulation of centrosome duplication [GO:0010824],NA,NA,NA
CHOYP_CHRO_0413.1.2.m.16023,-0.018362304,0.005509926,No,NA,NA,NA,NA,NA,NA,3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; DNA catabolic process; exonucleolytic [GO:0000738]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000467],NA,NA,NA
CHOYP_CHS.2.1.1.m.37794,0.00784462,-0.011400277,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CHS1.1.4.m.4755,-0.013957428,-0.001721391,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063],NA,NA,NA
CHOYP_CHS2.1.1.m.63783,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063],NA,NA,NA
CHOYP_CHSS2.1.1.m.19314,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; transferase activity; transferring glycosyl groups [GO:0016757]; chondroitin sulfate biosynthetic process [GO:0030206],NA,NA,NA
CHOYP_CHTOP.1.1.m.35404,-0.007515434,-0.003165967,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CI064.1.1.m.9517,-0.008782315,-0.017927364,No,NA,NA,NA,NA,NA,NA,tRNA-guanine transglycosylation [GO:0101030],NA,NA,NA
CHOYP_CIAO1.1.1.m.48324,0.009861165,-0.000984089,No,NA,NA,NA,NA,NA,NA,CIA complex [GO:0097361]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_CIC.1.2.m.57436,0.005594023,-0.006352486,No,NA,NA,NA,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; brain development [GO:0007420]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; social behavior [GO:0035176],NA,NA,NA
CHOYP_CIR1.1.2.m.16126,-0.01041817,-0.008885332,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CIR1A.1.1.m.11568,0.004136259,-0.000495014,No,NA,NA,NA,NA,NA,NA,90S preribosome [GO:0030686]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455]; RNA binding [GO:0003723]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; regulation of transcription; DNA-templated [GO:0006355]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_CISD2.1.1.m.26823,-0.009229329,-0.017807059,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; 2 iron; 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; autophagy of mitochondrion [GO:0000422]; multicellular organism aging [GO:0010259]; regulation of autophagy [GO:0010506],NA,NA,NA
CHOYP_CISY.1.1.m.36666,-0.007289018,-0.016600083,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; citrate (Si)-synthase activity [GO:0004108]; carbohydrate metabolic process [GO:0005975]; response to activity [GO:0014823]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_CKAP5.1.1.m.10679,-0.015548442,0.004306756,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; microtubule plus-end binding [GO:0051010]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule depolymerization [GO:0007019]; microtubule polymerization [GO:0046785]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; RNA transport [GO:0050658]; spindle organization [GO:0007051],NA,NA,NA
CHOYP_CKLF4.1.1.m.55295,-0.007695213,-0.001444408,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_CLAP1.4.6.m.39950,-0.001287679,0.001963949,No,NA,NA,NA,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore microtubule [GO:0005828]; microtubule organizing center [GO:0005815]; kinetochore binding [GO:0043515]; microtubule plus-end binding [GO:0051010]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023],NA,NA,NA
CHOYP_CLAP1.6.6.m.57823,0.001879146,0.001718514,No,NA,NA,NA,NA,NA,NA,basal cortex [GO:0045180]; cell cortex [GO:0005938]; centrosomal corona [GO:0031592]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule plus-end [GO:0035371]; spindle microtubule [GO:0005876]; dystroglycan binding [GO:0002162]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of epithelial cell polarity [GO:0090162]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing; spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of microtubule polymerization [GO:0031116]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]; vesicle targeting [GO:0006903],NA,NA,NA
CHOYP_CLASR.1.2.m.27688,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_CLCN3.1.1.m.21245,-0.009331509,-0.005244603,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of synaptic vesicle membrane [GO:0030285]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; specific granule [GO:0042581]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride ion binding [GO:0031404]; ion channel activity [GO:0005216]; PDZ domain binding [GO:0030165]; protein heterodimerization activity [GO:0046982]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247]; voltage-gated ion channel activity [GO:0005244]; adult locomotory behavior [GO:0008344]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transport [GO:0006811]; negative regulation of cell volume [GO:0045794]; neuron cellular homeostasis [GO:0070050]; phagocytosis; engulfment [GO:0006911]; photoreceptor cell maintenance [GO:0045494]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; synaptic transmission; GABAergic [GO:0051932]; synaptic transmission; glutamatergic [GO:0035249]; synaptic vesicle lumen acidification [GO:0097401],NA,NA,NA
CHOYP_CLCN7.2.3.m.47039,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; voltage-gated chloride channel activity [GO:0005247]; chloride transmembrane transport [GO:1902476]; response to pH [GO:0009268],NA,NA,NA
CHOYP_CLCN7.3.3.m.51894,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; voltage-gated chloride channel activity [GO:0005247]; chloride transmembrane transport [GO:1902476]; response to pH [GO:0009268],NA,NA,NA
CHOYP_CLEC10A.3.3.m.27236,-0.011707461,-0.019681173,No,NA,NA,NA,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_CLEC17A.1.1.m.28486,0.018783527,0.008846394,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; fucose binding [GO:0042806]; mannose binding [GO:0005537]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_CLH1.2.2.m.22327,0.021537081,-0.004665851,No,NA,NA,NA,NA,NA,NA,clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; melanosome [GO:0042470]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; spindle [GO:0005819]; arrestin family protein binding [GO:1990763]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; structural molecule activity [GO:0005198]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_CLK2.1.1.m.3081,0.010438589,-0.011350439,No,NA,NA,NA,NA,NA,NA,nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; negative regulation of gluconeogenesis [GO:0045721]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212]; response to retinoic acid [GO:0032526],NA,NA,NA
CHOYP_CLK2.1.1.m.3082,-0.001433018,-0.001041227,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658],NA,NA,NA
CHOYP_CLP1.1.1.m.11641,0.008826336,-0.012428888,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; tRNA-intron endonuclease complex [GO:0000214]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity [GO:0051736]; polydeoxyribonucleotide kinase activity [GO:0051733]; cerebellar cortex development [GO:0021695]; mRNA polyadenylation [GO:0006378]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_CLPB.1.3.m.14233,0.005790385,-0.009329687,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cellular response to heat [GO:0034605],NA,NA,NA
CHOYP_CLPT1.1.1.m.50172,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_CLPX.1.2.m.12748,-0.004229056,-0.019125168,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endopeptidase Clp complex [GO:0009368]; mitochondrial endopeptidase Clp complex [GO:0009841]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; unfolded protein binding [GO:0051082]; ATP metabolic process [GO:0046034]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_CLPX.2.2.m.49273,-0.003829021,-0.006727688,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endopeptidase Clp complex [GO:0009368]; mitochondrial endopeptidase Clp complex [GO:0009841]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; unfolded protein binding [GO:0051082]; ATP metabolic process [GO:0046034]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_CLSTN1.1.1.m.55323,0.011102074,0.016437703,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of postsynaptic density membrane [GO:0099061]; integral component of spine apparatus membrane [GO:0099065]; nucleus [GO:0005634]; postsynaptic endosome [GO:0098845]; postsynaptic membrane [GO:0045211]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; regulation of cell growth [GO:0001558]; regulation of synapse maturation [GO:0090128]; vesicle-mediated transport in synapse [GO:0099003],NA,NA,NA
CHOYP_CLU.1.1.m.8566,0.012177592,-0.020646912,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; intracellular distribution of mitochondria [GO:0048312],NA,NA,NA
CHOYP_CML1.1.1.m.30763,-0.022666135,0.010297751,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_CML8.1.1.m.37436,-0.012950016,-0.013715951,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_CN166.1.1.m.14529,-0.0079578,-0.009390163,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; tRNA-splicing ligase complex [GO:0072669]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_CNA1.1.1.m.65403,-0.003307758,-0.023592854,No,NA,NA,NA,NA,NA,NA,calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; Z disc [GO:0030018]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; cyclosporin A binding [GO:0016018]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]; brain development [GO:0007420]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endocytosis [GO:0045807]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883],NA,NA,NA
CHOYP_CNDP2.1.4.m.11722,0.010929017,-0.002627845,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; glutathione biosynthetic process [GO:0006750],NA,NA,NA
CHOYP_CNDP2.3.4.m.30467,0.015657634,0.011271957,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CNDP2.4.4.m.56870,-0.014146203,-0.015613029,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237],NA,NA,NA
CHOYP_CNE_1C34780.3.3.m.30615,0.007859757,-0.023701908,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CNOT1.1.1.m.12104,-0.008177378,-0.020660182,No,NA,NA,NA,NA,NA,NA,CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; protein domain specific binding [GO:0019904]; protein-containing complex scaffold activity [GO:0032947]; retinoic acid receptor binding [GO:0042974]; gene silencing by miRNA [GO:0035195]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis; exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829],NA,NA,NA
CHOYP_CNOT1.1.1.m.12106,-0.003251919,0.0168685,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA binding; bending [GO:0008301]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; innate immune response [GO:0045087]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_CNOT2.1.2.m.47530,-0.007579284,-0.018213038,No,NA,NA,NA,NA,NA,NA,CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription coregulator activity [GO:0003712]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA phosphodiester bond hydrolysis; exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829],NA,NA,NA
CHOYP_CNOT3.1.1.m.62322,-0.000279009,0.001264382,No,NA,NA,NA,NA,NA,NA,CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of translation [GO:0017148]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription; DNA-templated [GO:0006355]; trophectodermal cell differentiation [GO:0001829],NA,NA,NA
CHOYP_CNOT7.1.2.m.7497,-0.011168824,-0.012486847,No,NA,NA,NA,NA,NA,NA,CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; host cell PML body [GO:0075341]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; gene silencing by RNA [GO:0031047]; negative regulation of cell proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell proliferation [GO:0008284]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509],NA,NA,NA
CHOYP_CNOT7.2.2.m.35718,0.003444609,-0.019431564,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; ESCRT I complex [GO:0000813]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; endosome transport via multivesicular body sorting pathway [GO:0032509]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],NA,NA,NA
CHOYP_CNTN5.4.5.m.44639,-0.004713263,0.002011286,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; response to stimulus [GO:0050896],NA,NA,NA
CHOYP_CNTN6.1.2.m.781,-0.007354778,0.002657019,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; response to stimulus [GO:0050896],NA,NA,NA
CHOYP_CNTRL.1.1.m.8381,-0.013937259,-0.008237822,No,NA,NA,NA,NA,NA,NA,centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]; cytoskeletal protein binding [GO:0008092]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; cell division [GO:0051301]; coronary vasculature development [GO:0060976]; mitotic cell cycle [GO:0000278]; regulation of cytoskeleton organization [GO:0051493]; ventricular septum development [GO:0003281],NA,NA,NA
CHOYP_CNTROB.1.1.m.11584,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein domain specific binding [GO:0019904]; centriole replication [GO:0007099]; centrosome separation [GO:0051299]; mitotic cytokinetic process [GO:1902410]; regulation of cilium assembly [GO:1902017],NA,NA,NA
CHOYP_CO1A1.1.1.m.32133,0.022643324,-0.005794493,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; extracellular matrix organization [GO:0030198]; hematopoietic progenitor cell differentiation [GO:0002244],NA,NA,NA
CHOYP_CO2A1.1.1.m.62996,0.021314661,-0.006665216,No,NA,NA,NA,NA,NA,NA,collagen type I trimer [GO:0005584]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; cellular response to organic substance [GO:0071310]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; extracellular matrix organization [GO:0030198]; response to norepinephrine [GO:0071873],NA,NA,NA
CHOYP_CO4A1.1.2.m.36472,0.000943118,0.0142265,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; collagen trimer [GO:0005581]; extracellular matrix structural constituent [GO:0005201],NA,NA,NA
CHOYP_CO4A2.1.2.m.14631,-0.017625015,-0.0028714,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; cardiac muscle cell development [GO:0055013]; dorsal closure [GO:0007391]; extracellular matrix organization [GO:0030198]; intestinal epithelial structure maintenance [GO:0060729]; oviduct morphogenesis [GO:0035848]; post-embryonic digestive tract morphogenesis [GO:0048621],NA,NA,NA
CHOYP_CO5A2.1.1.m.28030,-0.023279881,0.001898657,No,NA,NA,NA,NA,NA,NA,virion [GO:0019012],NA,NA,NA
CHOYP_CO6A3.2.5.m.39533,0.011449904,0.010999904,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_CO6A3.3.5.m.39796,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; sarcolemma [GO:0042383]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; muscle organ development [GO:0007517],NA,NA,NA
CHOYP_CO6A5.1.6.m.5838,0.023449583,-0.003959545,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_CO6A5.1.6.m.5840,0.0038604,-0.024162783,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857],NA,NA,NA
CHOYP_CO9A1.1.1.m.62338,-0.000321047,-0.002570964,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; collagen trimer [GO:0005581]; extracellular matrix structural constituent [GO:0005201],NA,NA,NA
CHOYP_COCA1.3.6.m.49360,-0.023182697,0.006222836,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_COG2.1.2.m.12604,0.016917761,-0.0030576,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588]; protein transporter activity [GO:0008565]; protein-containing complex binding [GO:0044877]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891],NA,NA,NA
CHOYP_COG3.1.1.m.35921,0.009827778,0.003522772,No,NA,NA,NA,NA,NA,NA,cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; protein transporter activity [GO:0008565]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; protein glycosylation [GO:0006486]; protein localization to organelle [GO:0033365]; protein stabilization [GO:0050821]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_COG5.1.1.m.13833,-0.004329512,0.005348502,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031],NA,NA,NA
CHOYP_COG6.1.1.m.57008,0.006350827,0.01103786,No,NA,NA,NA,NA,NA,NA,Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; glycosylation [GO:0070085]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031],NA,NA,NA
CHOYP_COG8.1.1.m.10907,0.004215301,-0.002208023,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031],NA,NA,NA
CHOYP_COIL.1.1.m.18070,-0.009860282,-0.001786566,No,NA,NA,NA,NA,NA,NA,sphere organelle [GO:0071601],NA,NA,NA
CHOYP_COL4A4.1.1.m.30919,-0.021185888,0.003563646,No,NA,NA,NA,NA,NA,NA,virion [GO:0019012],NA,NA,NA
CHOYP_COL6A6.1.2.m.39071,0.007043001,-0.006885945,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cellulose binding [GO:0030248]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_contig_000003.m.1,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_000121.m.127,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_000189.m.198,0.001079125,-0.014647607,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_000227.m.218,-0.007088528,-0.006291127,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_000437.m.416,-0.004108452,0.017905993,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001114.m.1165,-0.009421522,-0.018442886,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001129.m.1188,-0.010972899,-0.010794175,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001251.m.1283,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001305.m.1337,0.00106275,0.014596847,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001317.m.1351,-0.013945141,-0.014149702,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001413.m.1466,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001477.m.1562,0.007698886,0.002093058,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001544.m.1660,0.001911659,0.011724834,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001740.m.1863,0.007486502,0.00917933,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001932.m.2147,-0.003049348,0.001858592,No,NA,NA,NA,NA,NA,NA,nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074],NA,NA,NA
CHOYP_contig_002228.m.2410,-0.000278592,-0.002523589,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002245.m.2431,0.017453517,-0.006532083,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002279.m.2484,0.021393406,-0.013909893,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_contig_002305.m.2519,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002327.m.2549,0.007896933,-0.006050726,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_contig_002369.m.2605,0.007169342,-0.01708045,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002417.m.2661,0.0124299,0.005149737,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002558.m.2814,-0.018621426,-0.001024047,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002568.m.2819,-0.010771189,0.013688755,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002597.m.2856,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002691.m.2966,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002715.m.2994,0.005893314,0.013818826,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002718.m.2999,0.009616738,-0.005531076,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002734.m.3017,-0.011525495,-0.000264517,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002762.m.3056,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002806.m.3116,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002826.m.3144,0.020886539,0.005666119,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002896.m.3210,-0.009293516,0.000178914,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002989.m.3291,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002999.m.3300,0.005870653,-0.016478356,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003050.m.3358,0.002462713,-0.01605914,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003161.m.3509,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003213.m.3589,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003275.m.3667,0.006046675,0.004596516,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003319.m.3735,0.006085816,0.000155284,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003356.m.3782,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003460.m.3916,0.009444115,0.011040741,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003549.m.4007,0.00992669,-0.016514929,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003595.m.4058,0.009548807,0.013314496,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003670.m.4147,0.016929325,-0.00921729,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003695.m.4176,-0.010976853,0.000160029,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003840.m.4375,-0.003508339,0.017033828,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003882.m.4416,0.008300384,-0.014629558,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003956.m.4511,0.006707657,-0.026109642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004011.m.4571,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004045.m.4615,0.003612593,-0.018631156,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004193.m.4802,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004202.m.4814,-0.008722471,-0.000782846,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004338.m.4955,-0.00104396,-0.014523137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004401.m.5025,0.012909318,0.009655333,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004461.m.5117,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004474.m.5130,-0.01631918,-0.009312038,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004504.m.5173,1.09E-05,-0.012773784,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004513.m.5183,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004594.m.5279,0.019750985,-0.01475411,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004609.m.5296,0.017729942,0.012207014,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004652.m.5338,-0.009151222,0.006767301,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004751.m.5446,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004756.m.5453,0.000360952,-0.015104262,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004795.m.5507,0.018042347,0.010079317,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004820.m.5529,0.009986443,-0.014264142,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004853.m.5555,0.016001884,0.006359952,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004869.m.5573,-0.005846955,-0.008180497,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004890.m.5604,-0.01388509,-0.008042423,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004925.m.5642,0.014344536,0.004958705,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004972.m.5699,-0.005506649,-0.006869419,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004987.m.5716,0.004304531,-0.021868772,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004993.m.5721,0.020698023,-0.001360287,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005029.m.5761,-0.007066149,-0.004251242,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005134.m.5869,0.005104168,0.007555773,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005396.m.6126,0.012069403,0.006226945,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005454.m.6186,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005583.m.6332,0.018242263,-0.000152595,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; 3 iron; 4 sulfur cluster binding [GO:0051538]; 4 iron; 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cellular iron ion homeostasis [GO:0006879]; citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; post-embryonic development [GO:0009791]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_contig_005659.m.6448,-0.002594265,0.007016851,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005830.m.6680,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005858.m.6708,-0.000760863,0.016695871,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005908.m.6759,-0.021991252,0.009306696,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005913.m.6764,-0.012009112,-0.000845946,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006063.m.6910,-0.001037737,0.002840132,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006084.m.6928,-0.001834469,-0.019660865,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006214.m.7057,0.002532246,0.006878066,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006293.m.7131,-0.022643757,0.010167277,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006299.m.7138,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077],NA,NA,NA
CHOYP_contig_006359.m.7206,0.006032156,-0.007110816,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006364.m.7211,-0.023281878,0.006672085,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006560.m.7472,-0.015551118,-0.013786312,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006640.m.7557,-0.009074837,-0.001909891,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006758.m.7690,0.003561813,-0.020089506,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006775.m.7711,-0.01418271,0.000619577,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_007032.m.8066,0.003422875,-0.005765768,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_007082.m.8119,0.003696404,0.015671661,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_007164.m.8244,0.011979836,-0.003337937,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_007754.m.8963,0.000126483,-0.012527431,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_007858.m.9121,-0.015663049,0.002899442,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_007998.m.9259,-0.022503322,0.000548195,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008002.m.9263,-0.022808927,0.001052919,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008016.m.9273,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008030.m.9291,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008101.m.9378,0.007254738,0.013104355,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008102.m.9380,0.007255585,0.01310772,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008114.m.9394,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008181.m.9453,0.010536877,-0.007393596,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008261.m.9575,-0.022565769,0.009990515,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008262.m.9576,-0.00268771,-0.01258033,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008307.m.9640,-0.022006209,0.004506806,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008452.m.9831,-0.014368585,-0.006238656,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008503.m.9899,-0.022757808,0.005507792,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008795.m.10231,-0.001807184,0.006368441,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008923.m.10388,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008926.m.10391,0.007641086,-0.000294801,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008975.m.10444,-0.007011228,0.009142737,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009176.m.10652,0.001322721,0.020834189,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell-cell adherens junction [GO:0005913]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; ruffle [GO:0001726]; stress fiber [GO:0001725]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; ossification [GO:0001503]; positive regulation of osteoblast differentiation [GO:0045669]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_contig_009196.m.10701,-0.020854342,0.007134631,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009315.m.10833,-0.00842698,0.011718833,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009651.m.11212,-0.008703174,0.004491325,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009697.m.11280,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009806.m.11429,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009817.m.11438,0.003104211,0.000640315,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009870.m.11509,0.0043998,0.012536493,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009887.m.11524,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010011.m.11666,0.010112695,0.001574812,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010154.m.11827,0.009639797,-0.007046647,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010181.m.11866,-0.01907204,0.005359734,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010226.m.11916,0.016591433,-0.019865551,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010233.m.11921,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010276.m.11960,-0.007157553,-0.00274361,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010354.m.12065,-0.009518571,0.001982632,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; hydroxyisourate hydrolase activity [GO:0033971]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628],NA,NA,NA
CHOYP_contig_010487.m.12180,-0.022632219,0.010132803,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010532.m.12231,-0.01557667,0.012901283,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010639.m.12333,0.021192546,-0.013608721,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010659.m.12347,-0.001520295,-0.010639661,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010674.m.12365,-0.022448054,0.009810443,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010687.m.12382,-0.011993139,-0.014976822,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010861.m.12544,-0.001345728,0.007818089,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_011170.m.12887,-0.012212033,0.002376038,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_011268.m.13012,0.007430417,-0.005053238,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_011571.m.13308,-0.001571455,-0.000916933,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012045.m.13814,-0.019072127,-0.003074725,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012068.m.13831,-0.00820024,0.014702941,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012079.m.13839,-0.007707474,0.011663535,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_contig_012255.m.14080,-0.005955885,0.009944655,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012395.m.14264,-0.005301793,-0.009340954,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012437.m.14312,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012819.m.14744,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012962.m.14885,0.009864991,0.006641481,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013437.m.15402,0.007802282,0.015647037,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013551.m.15499,-0.002004967,-0.007712635,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013622.m.15553,-0.013465703,-0.016480521,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013738.m.15666,0.022477308,-0.010593929,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013751.m.15674,-0.015069326,0.011118681,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013806.m.15731,0.011523516,-0.010625645,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013837.m.15768,0.005597985,0.001291195,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014109.m.16087,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014152.m.16145,0.017726337,-0.008249559,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014205.m.16198,-0.00446024,-0.019282504,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014279.m.16311,0.009875623,0.019922054,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014296.m.16345,0.016539892,-0.018198259,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014354.m.16426,-0.005055699,-0.006146228,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014357.m.16429,-0.016234139,0.005286026,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014469.m.16593,-0.022563184,0.009985916,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014479.m.16604,0.022556953,-0.01063516,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014529.m.16671,0.008141574,0.006248295,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014863.m.17135,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014867.m.17143,0.007648902,-0.000255109,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014877.m.17157,0.006569408,0.001585584,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014947.m.17245,0.016687178,-0.006996786,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014958.m.17266,0.01589928,-0.013349468,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015023.m.17360,-0.00791763,0.008660853,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015209.m.17650,0.009640082,-0.010230571,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015341.m.17864,-0.012913714,0.002982537,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015391.m.17937,0.000499014,0.003201048,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015430.m.17979,-0.004726788,-0.012769334,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015439.m.17989,-0.011010389,-0.008511855,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015543.m.18138,0.022922813,-0.008399047,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015712.m.18387,0.011086389,-0.007195206,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015857.m.18578,0.008885164,0.007703827,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015918.m.18639,-0.022256108,0.009577848,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015923.m.18643,-0.013774118,-0.014833469,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015931.m.18654,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016010.m.18750,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016017.m.18760,-0.006499429,0.002414146,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016020.m.18768,-0.013314474,0.004699624,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016120.m.18916,-0.010012497,0.006680437,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016292.m.19158,0.006554986,0.002363674,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016370.m.19270,0.018034998,0.01168249,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016375.m.19279,0.007284475,-0.008596997,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016405.m.19312,0.01546483,-0.018470348,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016540.m.19484,0.009875711,0.019919854,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016554.m.19499,0.016648038,-0.014536025,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016559.m.19503,-0.006211247,-0.022386878,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016589.m.19530,0.00090575,0.004271527,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016628.m.19586,-0.004391915,0.003081162,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016637.m.19603,0.006320276,0.014297492,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016752.m.19715,0.007945652,0.008683343,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016762.m.19724,-0.022591895,0.010039831,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016854.m.19834,-0.000378004,0.009600186,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_017060.m.20058,-0.004394518,0.018129577,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_017672.m.20677,-0.008322017,-0.004185064,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_017941.m.21005,0.022027201,-0.013960364,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_contig_018098.m.21196,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_018118.m.21239,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_018645.m.21889,0.023036703,-0.007564766,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_018676.m.21920,-0.012593226,-0.00667859,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_018822.m.22082,-0.011321859,-0.020353662,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_018956.m.22217,0.015666254,-0.008006466,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_018978.m.22243,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_019122.m.22406,0.00312625,-0.012850722,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_019189.m.22478,-0.014154518,0.000584017,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_019238.m.22546,0.002845731,0.008404995,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_019263.m.22580,0.005865497,-0.003276629,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_019436.m.22745,0.004384893,0.01043243,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_019571.m.22867,0.017774848,-0.00269932,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; bone mineralization [GO:0030282]; extracellular matrix organization [GO:0030198]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_contig_019914.m.23170,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_020023.m.23276,0.007303466,0.015573335,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_020370.m.23576,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_020390.m.23600,-0.015467506,-0.015528445,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_020392.m.23606,-0.004759079,0.000171574,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_020442.m.23651,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021278.m.24464,-0.001561315,-0.00774103,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021455.m.24647,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021478.m.24670,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021494.m.24691,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021632.m.24849,0.002136518,-0.013850512,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021664.m.24884,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021811.m.25040,-0.006756441,-0.019826772,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021858.m.25098,0.011275574,-0.007165205,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_022142.m.25369,-0.002404889,-0.014475263,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_022641.m.25871,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_022643.m.25874,0.001389954,-0.019864089,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell-cell adherens junction [GO:0005913]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; actin binding [GO:0003779]; actinin binding [GO:0042805]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; protein kinase C binding [GO:0005080]; protein N-terminus binding [GO:0047485]; cell growth involved in cardiac muscle cell development [GO:0061049]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of synapse assembly [GO:0051963],NA,NA,NA
CHOYP_contig_022826.m.26063,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_022851.m.26077,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_contig_022855.m.26082,-0.003091623,0.011280702,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_022863.m.26088,0.006377073,0.011234868,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023043.m.26235,0.001892875,0.001911888,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023172.m.26349,-0.022466119,0.010591507,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023259.m.26467,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023399.m.26635,0.006379531,-0.006287067,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023445.m.26685,0.00585316,-0.010190737,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_contig_023474.m.26716,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023538.m.26787,-0.022647109,0.006334021,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023655.m.26913,-0.022594625,0.010045345,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023660.m.26915,0.007282618,-0.013567905,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023673.m.26924,0.016560153,0.013615795,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023675.m.26925,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023710.m.26965,0.013999004,-0.016476508,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023723.m.26983,0.004236084,-0.013324145,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023724.m.26984,-0.012019767,-0.015267281,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023752.m.27015,0.019666304,-0.002277704,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023763.m.27021,-0.00246124,0.004891563,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023792.m.27044,0.004193598,0.001044634,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023811.m.27063,0.021443397,-0.001174409,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023814.m.27068,-0.00200822,-0.010501767,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023887.m.27194,0.005433455,-0.013616142,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023888.m.27197,-0.02263709,0.01014663,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023897.m.27203,-0.018777384,-0.000874046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023932.m.27233,0.012322059,0.022453205,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023945.m.27245,-0.02250976,0.000568957,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023964.m.27264,0.009559201,0.013448562,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024012.m.27306,-0.021457061,-0.006964561,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024035.m.27331,0.010076958,0.004194287,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024046.m.27342,-0.006419044,0.005461573,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024156.m.27442,-0.022665141,0.010331377,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024166.m.27453,-0.008502299,-0.020784738,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024175.m.27461,0.016346593,-0.004179011,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024218.m.27505,0.007584201,-0.005104198,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024219.m.27509,-0.001011203,-0.014807261,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024342.m.27673,0.013193208,0.021573679,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024357.m.27696,-0.006189577,-0.008531876,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024372.m.27722,-0.023204122,0.00627366,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024418.m.27769,-0.021872069,-0.002128051,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024424.m.27774,-0.018195364,0.014190258,No,NA,NA,NA,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_contig_024498.m.27853,-0.02259145,0.01003894,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024504.m.27855,-0.022867305,0.005680305,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024602.m.27966,-0.00467855,-0.004090539,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024605.m.27976,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024653.m.28033,-0.005666928,-0.023621628,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024662.m.28044,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024665.m.28048,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024679.m.28057,0.016093611,0.008287079,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024697.m.28081,-0.013240872,-0.016694174,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024706.m.28101,-0.007018114,0.008096636,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024730.m.28114,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024739.m.28119,-0.022642505,0.010163218,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024742.m.28122,0.003632047,-0.010884575,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024846.m.28258,0.006618624,-0.007760435,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024858.m.28270,0.022572062,-0.007961323,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024935.m.28365,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025014.m.28472,-0.022556534,0.009974284,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025058.m.28495,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025076.m.28535,-0.014601967,-0.02230489,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025149.m.28635,-0.021800344,0.000131486,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025167.m.28650,0.015002662,-0.00814165,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025192.m.28699,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025210.m.28720,-0.016804973,0.010398613,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025272.m.28780,-0.020484684,-0.008064045,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025311.m.28826,-0.022630429,0.010127933,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025377.m.28903,-0.005750573,-0.022525949,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025391.m.28934,-0.022242218,0.009562549,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025398.m.28945,-0.012191763,8.26E-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025411.m.28960,-0.022558619,0.009977903,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025422.m.28978,0.000515966,-0.017518538,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025639.m.29255,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,virion [GO:0019012],NA,NA,NA
CHOYP_contig_025679.m.29295,-0.023032342,0.001502645,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025684.m.29301,-0.016727682,-0.013915766,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025702.m.29329,-0.021993268,-0.00016779,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025725.m.29348,0.003950105,0.018725909,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025759.m.29400,-0.015546795,-0.005208912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025810.m.29463,-0.003243064,-0.016577029,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025861.m.29521,-0.022655862,0.010385762,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025862.m.29523,-0.021810587,0.004474584,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025865.m.29527,-0.019857176,0.00557353,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025897.m.29562,0.012867749,-0.009411015,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025962.m.29619,-0.002031576,-0.014123841,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026106.m.29754,-0.022598515,0.010053344,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026129.m.29781,-0.021755688,-0.000436298,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026140.m.29796,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026147.m.29805,0.002134129,-0.013855571,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026238.m.29873,0.003621228,-0.020107226,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026328.m.29985,-0.02328617,0.006429761,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026389.m.30064,-0.022650229,0.010190061,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026398.m.30077,-0.022660763,0.010239443,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026477.m.30166,-0.023368795,0.002522423,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026494.m.30182,-0.022578293,0.00073821,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026567.m.30260,0.020699959,0.00798686,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026627.m.30320,-0.008326256,-0.012273122,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026644.m.30335,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026676.m.30376,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026679.m.30379,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026684.m.30387,-0.000668896,-0.010541142,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026696.m.30395,-0.021458091,0.011288628,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026700.m.30399,-0.020913524,-0.011302383,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular protein metabolic process [GO:0044267]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; post-translational protein modification [GO:0043687]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_contig_026723.m.30427,-0.022716005,0.000916406,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026816.m.30541,0.014639108,-0.009885057,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026852.m.30581,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026871.m.30597,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026910.m.30632,-0.005060154,0.011709805,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026915.m.30635,-0.02312812,0.00617564,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026949.m.30663,0.004871042,-0.002338248,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026959.m.30676,-0.02281111,0.001221327,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026975.m.30698,-0.022604908,-0.004554721,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027060.m.30790,0.017273875,0.013530249,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027196.m.30937,0.003486808,0.003608376,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027213.m.30953,-0.019347754,-0.002464369,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027260.m.31007,0.012854434,-0.005560032,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027304.m.31034,-0.022530971,0.000606816,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027327.m.31055,-0.022387413,0.009731669,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027342.m.31071,-0.022566593,0.01052615,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027379.m.31113,-0.022583758,0.010023848,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027593.m.31285,0.023360498,-0.006996088,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_contig_027703.m.31406,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027730.m.31434,0.008231774,-0.008356918,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027976.m.31727,-0.007862033,0.015967507,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028013.m.31792,0.006965149,-0.001012873,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028016.m.31798,0.003862751,-0.004787032,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028143.m.32002,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028227.m.32131,0.012238683,0.023732694,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028345.m.32285,0.018515702,0.001452788,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028370.m.32304,0.005175581,-0.005089094,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028488.m.32431,0.00162055,-0.010540835,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028566.m.32498,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028737.m.32661,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_029139.m.33073,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_029222.m.33159,0.00855999,-0.010405466,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_029279.m.33207,0.005454789,-0.008349565,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_029445.m.33401,0.009186578,-0.00014097,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_029710.m.33698,-0.000864646,-0.010184648,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030340.m.34527,-0.015661794,0.0023701,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030366.m.34550,0.006971395,-0.014376503,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030528.m.34754,-0.022605074,0.010485873,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030621.m.34884,0.005762476,0.012540502,No,NA,NA,NA,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],NA,NA,NA
CHOYP_contig_030692.m.34979,-0.004493874,0.005457973,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030744.m.35041,0.00987688,0.019886243,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030748.m.35048,-0.011040872,-0.010029475,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030819.m.35130,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030869.m.35200,0.000930847,-0.019339123,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030888.m.35216,-0.004377407,-0.001204954,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030959.m.35312,-0.005270141,0.010341861,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031003.m.35364,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031126.m.35509,-0.022593204,0.000684272,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031244.m.35665,-0.022604336,0.010486795,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031272.m.35693,0.009558955,0.013448754,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031279.m.35700,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031433.m.35919,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031485.m.35969,-0.002220215,-0.002429729,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031486.m.35972,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031630.m.36105,-0.022559725,0.009979833,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031802.m.36287,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031987.m.36469,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_032098.m.36603,0.011507866,0.016235288,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_032567.m.37185,-0.006743877,-0.00823282,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_032576.m.37192,-0.006123769,-0.020308916,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; Z disc [GO:0030018]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; protein kinase C binding [GO:0005080]; protein N-terminus binding [GO:0047485]; cell growth involved in cardiac muscle cell development [GO:0061049]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of synapse assembly [GO:0051963],NA,NA,NA
CHOYP_contig_032616.m.37244,0.002051883,0.012307122,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_032666.m.37309,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_032690.m.37333,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_032916.m.37612,0.011018535,0.019189534,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of insulin receptor signaling pathway [GO:0046627]; regulation of mast cell activation [GO:0033003]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185],NA,NA,NA
CHOYP_contig_032947.m.37658,-0.010746212,-0.010578057,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033072.m.37776,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033090.m.37804,0.00495918,0.011869461,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033147.m.37856,-0.022663412,0.010347774,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033179.m.37880,-0.012697902,-0.007993314,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033285.m.37973,0.01577239,-0.003030807,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033346.m.38026,-0.022665901,0.0102897,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033356.m.38032,0.020355694,-0.004958652,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033663.m.38288,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033740.m.38360,0.015406707,0.015546592,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033822.m.38452,0.00766775,0.015372011,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033899.m.38537,0.018255946,0.004497646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033976.m.38613,0.009323876,-0.018215481,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034345.m.39015,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034390.m.39050,0.003537246,8.62E-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034410.m.39066,0.019322367,-0.010400594,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034686.m.39375,-0.004810721,0.016471249,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034695.m.39383,-0.006191723,0.005263664,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034750.m.39458,0.022971552,0.002186871,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034847.m.39553,0.021086683,0.002561821,No,NA,NA,NA,NA,NA,NA,amidase activity [GO:0004040]; indoleacetamide hydrolase activity [GO:0043864],NA,NA,NA
CHOYP_contig_034890.m.39584,0.013203434,0.01465883,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034934.m.39632,0.007319251,-0.017681428,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034987.m.39710,0.007378685,0.013608449,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035123.m.39896,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035291.m.40069,0.010273147,0.006999045,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035372.m.40130,-0.000955214,-0.004223064,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035380.m.40136,0.012407268,0.018186224,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035493.m.40257,-0.002122828,0.00828468,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035545.m.40311,0.020353126,-0.015407149,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035578.m.40341,-0.01218984,0.01142951,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035697.m.40446,0.001935509,-0.014852407,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035767.m.40509,-0.004069407,-0.02537561,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035889.m.40603,-0.01235501,0.003935135,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035951.m.40680,0.019399262,0.003576085,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036103.m.40829,0.007802045,0.015645625,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036280.m.40985,-0.015348022,-0.010511051,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036283.m.40992,0.002563729,-0.021747932,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036657.m.41264,-0.002489286,-0.014436312,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036790.m.41410,0.022214281,-0.010921654,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036886.m.41498,0.021031048,-0.00546506,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036899.m.41515,0.001531788,-0.021939079,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036935.m.41573,-0.019335352,0.005642382,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036974.m.41637,0.006753664,0.00904026,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037000.m.41674,0.012912741,-0.009869374,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; de-etiolation [GO:0009704]; response to far red light [GO:0010218]; seed germination [GO:0009845],NA,NA,NA
CHOYP_contig_037038.m.41727,0.007972427,-0.007845555,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037467.m.42206,-0.011488564,-0.012269621,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037561.m.42354,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037644.m.42447,0.011752394,-0.014676193,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037727.m.42549,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037785.m.42603,0.007500219,-0.022842683,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037938.m.42800,0.003156677,0.011894942,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037956.m.42826,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037959.m.42830,0.017325391,-0.01633732,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038058.m.42964,0.002024327,-0.01482373,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038126.m.43051,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038160.m.43103,-0.018957996,0.008690638,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038218.m.43194,-0.015783257,-0.009903163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038370.m.43386,0.022005819,-0.009419295,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038408.m.43447,0.002023103,-0.014825012,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038478.m.43530,0.015753118,-0.015922117,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038486.m.43547,-0.002269952,0.011919892,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; axon ensheathment [GO:0008366]; regulation of RNA splicing [GO:0043484],NA,NA,NA
CHOYP_contig_038513.m.43619,0.019191084,0.00737238,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038550.m.43669,0.006463952,-0.001571342,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038579.m.43695,0.021973222,-0.00913261,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038691.m.43809,-0.006623488,0.008647068,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038703.m.43817,-0.009184589,-0.012149395,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038765.m.43871,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038766.m.43872,0.009415708,0.020334031,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038806.m.43911,0.010626352,-0.011703513,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038817.m.43926,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038859.m.43982,-0.014810157,-0.008987921,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038869.m.43996,0.018405391,-0.000184611,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038921.m.44081,0.016990877,-0.014072782,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038946.m.44119,0.000198256,0.002109638,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039058.m.44237,0.019920354,0.007995461,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039068.m.44246,0.006561465,-0.000277104,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039097.m.44266,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039100.m.44268,0.007401361,-0.011871558,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039169.m.44357,0.018522196,-0.018925489,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039208.m.44410,0.008024423,0.002465864,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039283.m.44494,-0.022685094,0.005391859,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039285.m.44499,0.022824837,0.000224242,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039330.m.44540,0.021986966,-0.010718715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039366.m.44569,0.021660707,-0.012221087,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039465.m.44679,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039575.m.44801,-0.004058164,-0.000149854,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039595.m.44817,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039638.m.44850,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039715.m.44911,0.021561704,-0.012932602,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039741.m.44927,-0.003353529,-0.001743843,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039966.m.45203,0.018913355,-0.010907084,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040048.m.45313,-0.010978061,0.00016123,No,NA,NA,NA,NA,NA,NA,aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074],NA,NA,NA
CHOYP_contig_040238.m.45604,0.0059632,0.000457588,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040334.m.45722,-0.009100685,1.23E-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040433.m.45856,-0.006085951,-0.019973284,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040481.m.45927,0.009876043,0.019911185,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040503.m.45959,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040577.m.46077,-0.014303755,-0.020616039,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040623.m.46145,-0.003814796,-0.01790422,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040750.m.46306,-0.004244355,-0.013667968,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040887.m.46494,0.003396078,-0.005876765,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040962.m.46595,0.010706591,0.006034394,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040975.m.46616,0.001120071,-0.004660439,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_contig_040978.m.46621,-0.022645306,0.010172438,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041025.m.46710,4.58E-06,-0.013488603,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041068.m.46778,0.009974736,0.01227565,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041073.m.46786,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041193.m.46961,0.010919116,0.013009009,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041218.m.46991,0.002516248,-0.015420781,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041288.m.47081,0.002820649,-0.017871653,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041298.m.47095,0.014439151,0.004434237,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041336.m.47149,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041380.m.47215,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041554.m.47492,0.004949287,-0.003559761,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041605.m.47590,0.007475146,-0.000546266,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041673.m.47688,-0.008848748,0.005746915,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041706.m.47739,-0.022665886,0.010319093,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041712.m.47757,0.005766558,-0.005731343,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041717.m.47768,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041765.m.47848,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041782.m.47874,0.001451974,0.006828094,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041876.m.48001,-0.01475307,-0.002338466,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041950.m.48134,-0.004429121,-0.001943076,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041958.m.48141,0.020948496,-0.007970013,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042054.m.48295,-0.010465977,-0.013695943,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042130.m.48414,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042244.m.48592,-0.003893387,0.005404251,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042249.m.48611,-0.022560561,0.009981297,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042362.m.48774,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042378.m.48796,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042449.m.48875,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042540.m.49007,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042557.m.49033,0.020594437,-0.001687556,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042616.m.49103,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042690.m.49166,-0.013118372,-0.015726874,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042697.m.49175,0.013417647,0.014941516,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042766.m.49278,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042815.m.49366,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042864.m.49442,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042901.m.49495,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043041.m.49677,-0.022615298,0.010090188,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043053.m.49693,0.0068554,0.012130287,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043057.m.49706,0.004123091,0.012171085,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043072.m.49721,-0.000949387,0.00384394,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043212.m.49892,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043231.m.49931,0.012480545,0.017312071,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043238.m.49940,0.022922477,-0.008269786,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043280.m.49983,0.00729502,0.003863367,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043301.m.50018,0.003092273,0.0006136,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043488.m.50266,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043510.m.50295,0.015394591,-0.01982681,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043576.m.50359,0.010908006,0.018973719,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043813.m.50619,-0.000735586,0.005693044,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043845.m.50665,-0.02266224,0.010249279,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043862.m.50684,0.019596897,-0.014853986,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043874.m.50696,-0.003260928,0.017312359,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043898.m.50728,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043909.m.50738,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044078.m.50900,0.008861896,-0.005395155,No,NA,NA,NA,NA,NA,NA,A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding; bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005],NA,NA,NA
CHOYP_contig_044225.m.51129,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044310.m.51269,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044503.m.51534,-0.002428004,0.002941323,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044612.m.51675,0.000757514,-0.00490973,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044629.m.51700,-0.000304669,-0.011153806,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044640.m.51719,-0.001565202,0.023050594,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044678.m.51771,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044692.m.51797,-0.01840854,0.005323753,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044795.m.51952,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044803.m.51967,-0.004337791,0.022037518,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044824.m.51993,-0.001812473,0.023225866,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045072.m.52344,-0.003707347,0.009213027,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; negative regulation of viral genome replication [GO:0045071]; plasma membrane phospholipid scrambling [GO:0017121]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of innate immune response [GO:0045089]; response to interferon-beta [GO:0035456],NA,NA,NA
CHOYP_contig_045193.m.52491,-0.017077817,0.01421732,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045205.m.52522,0.00387628,0.007469562,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045248.m.52574,-0.007175677,-0.022106544,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045427.m.52825,-0.000310606,-0.011152423,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045550.m.53021,0.022805692,-0.012238306,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045552.m.53024,-0.001850772,0.007043569,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045655.m.53199,0.006240271,-0.018531288,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045662.m.53210,-0.015916155,-0.003908434,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; nuclear receptor transcription coactivator activity [GO:0030374]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-templated transcription; initiation [GO:0006352]; glucocorticoid receptor signaling pathway [GO:0042921]; heart development [GO:0007507]; intracellular estrogen receptor signaling pathway [GO:0030520]; myeloid cell differentiation [GO:0030099]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of lipid metabolic process [GO:0019216]; response to hormone [GO:0009725],NA,NA,NA
CHOYP_contig_045946.m.53656,-0.003326069,-0.003082903,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046319.m.54200,-0.005741885,-0.001329907,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046503.m.54505,0.009508188,0.015663692,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046530.m.54559,-0.021965161,0.004465656,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046551.m.54588,0.002838779,-0.001269915,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046706.m.54827,-0.016452408,0.008542826,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046854.m.55054,0.008135544,0.006212111,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046883.m.55107,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047016.m.55305,-0.000811414,-0.000532221,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047066.m.55375,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020],NA,NA,NA
CHOYP_contig_047135.m.55497,0.009417142,0.020368596,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047190.m.55575,0.020994369,-4.18E-07,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047214.m.55631,0.011450896,0.010668094,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047294.m.55755,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047333.m.55799,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047394.m.55871,-0.009579316,0.009233262,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047449.m.55959,-0.014359072,-0.001330237,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047498.m.56019,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047569.m.56118,0.008450515,-0.009115417,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047668.m.56271,0.002162548,0.009402789,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047685.m.56291,-0.021863603,0.000253365,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047707.m.56320,-0.013738019,0.009099641,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047731.m.56360,-0.016901885,0.005218709,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047828.m.56501,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047907.m.56621,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047908.m.56622,0.00856165,-0.009090617,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047916.m.56635,0.009528073,0.006266864,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047982.m.56715,0.00239295,0.017022287,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048122.m.56947,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048134.m.56964,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048148.m.56980,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048267.m.57131,-0.012373608,0.013027963,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048274.m.57147,0.007802344,0.015647409,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048277.m.57151,-0.019746836,-0.010051221,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048369.m.57273,-0.009851978,-0.001903806,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048457.m.57397,0.001491768,0.002480353,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048495.m.57473,0.021350103,0.001996656,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048603.m.57625,0.008077097,0.00590472,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048626.m.57669,-0.014123528,0.000545086,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048667.m.57735,0.002319619,-0.005687456,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048706.m.57793,0.00225248,-0.015516504,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048721.m.57810,0.021199379,0.000419515,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048781.m.57879,-0.009589006,0.009236371,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048805.m.57897,-0.019709976,-0.004630735,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048887.m.57987,-0.00756023,0.005484758,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048930.m.58050,-0.015002187,0.014561798,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048973.m.58107,-0.018420078,-0.005666109,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048994.m.58122,0.007940823,0.008673173,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049099.m.58219,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049136.m.58269,-0.019835802,0.004588591,No,NA,NA,NA,NA,NA,NA,calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; oxygen binding [GO:0019825],NA,NA,NA
CHOYP_contig_049345.m.58557,0.01061292,0.005599525,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049353.m.58568,-0.000573992,-0.011980075,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049367.m.58596,-0.00482458,0.016461976,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049413.m.58667,-0.007075708,0.005020012,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049548.m.58834,0.008480931,-0.007021867,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049586.m.58876,-0.007205971,0.013994716,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049619.m.58908,-0.023221916,0.006302604,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050044.m.59512,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050158.m.59641,-0.009714162,0.007026304,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050222.m.59713,-0.009321688,0.000203377,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050253.m.59761,-0.012967834,-0.004765211,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050301.m.59822,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050355.m.59899,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050388.m.59942,0.001825581,0.009015924,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050483.m.60085,-0.010700773,-0.005515846,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050507.m.60115,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_contig_050515.m.60136,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050645.m.60289,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050710.m.60376,-0.001394181,-0.002091682,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050842.m.60581,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050863.m.60613,-0.004741791,0.016517077,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050942.m.60734,-0.002103779,0.017861841,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051171.m.61058,0.012326218,0.00604976,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051254.m.61184,-0.012463137,0.008225864,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051254.m.61185,-0.022664413,0.010267776,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051311.m.61287,0.000118757,-0.001635301,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051346.m.61337,0.00781575,0.015728407,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051433.m.61487,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051499.m.61590,0.005355488,0.008906456,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051534.m.61634,0.009800636,0.008026608,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051787.m.61994,-0.004979646,0.022096758,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051794.m.62013,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051943.m.62221,0.003263058,-0.017605758,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052015.m.62309,-0.013702989,-0.002376575,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052081.m.62393,0.000243254,-0.006655178,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052083.m.62396,0.019992772,-0.016037271,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052147.m.62461,0.010747585,0.013138523,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052383.m.62773,0.010398231,-0.019483436,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052396.m.62799,-0.005036657,-0.005576298,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052416.m.62821,0.004853063,-0.012928393,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052441.m.62852,-0.013915459,0.005973964,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052658.m.63135,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052729.m.63227,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052748.m.63243,-0.010833158,0.016986955,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052993.m.63573,-0.002714655,0.013327316,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053017.m.63597,0.011483985,0.007238951,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053024.m.63605,0.003512045,0.00179443,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053133.m.63737,-0.007618444,0.014042065,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053329.m.63915,0.001163098,0.013045987,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053371.m.63972,-0.012220711,-0.016942158,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053627.m.64220,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053683.m.64287,0.021842377,0.005300669,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053687.m.64290,0.007481243,0.017195409,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053787.m.64362,0.023119351,-0.009717513,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053912.m.64506,0.008066,-0.006276274,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053977.m.64571,0.017382257,-0.003329369,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053989.m.64582,0.009447473,0.013406028,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053995.m.64585,-0.000666186,0.012086116,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_054223.m.64734,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_054409.m.64895,0.020253344,-0.010490576,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_054622.m.65176,-0.009680445,-0.001853491,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_054868.m.65463,-0.00847509,0.010372262,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_054901.m.65508,-0.003304173,0.014486528,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; ATPase binding [GO:0051117]; ATPase inhibitor activity [GO:0042030]; heme biosynthetic process [GO:0006783]; negative regulation of ATPase activity [GO:0032780],NA,NA,NA
CHOYP_contig_055102.m.65741,0.005982381,-0.014906267,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055225.m.65857,0.002560135,-0.012462661,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055303.m.65981,-0.008402229,-0.00411831,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055335.m.66005,0.004967775,-0.01272104,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055359.m.66029,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055404.m.66082,-0.007520237,-0.000225133,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055406.m.66084,-0.012871375,-0.009308816,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055822.m.66445,0.00621274,-0.013667118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055842.m.66464,0.003552455,0.000116719,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055984.m.66583,0.014987971,-0.000298485,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_056008.m.66602,0.009475494,-0.024019463,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301],NA,NA,NA
CHOYP_contig_056033.m.66621,-0.015759547,0.006820468,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_056499.m.66997,0.001123906,-0.017006647,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_COPA.1.1.m.31888,0.004397272,-0.008853636,No,NA,NA,NA,NA,NA,NA,COPI vesicle coat [GO:0030126]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; hormone activity [GO:0005179]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_COPA.1.1.m.31889,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; SRP-dependent cotranslational protein targeting to membrane; translocation [GO:0006616],NA,NA,NA
CHOYP_COPB.1.1.m.16988,0.020629089,-0.002308672,No,NA,NA,NA,NA,NA,NA,COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_COPB2.1.1.m.11046,0.011350301,-0.022932396,No,NA,NA,NA,NA,NA,NA,COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_COPD.1.1.m.37389,0.006215131,0.004423518,No,NA,NA,NA,NA,NA,NA,COPI vesicle coat [GO:0030126]; COPI-coated vesicle [GO:0030137]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi localization [GO:0051645]; protein transport [GO:0015031]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_COPD.1.1.m.37390,-0.014732036,0.006952423,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity; plus-end-directed [GO:2000582],NA,NA,NA
CHOYP_COPE.1.1.m.48265,0.01851652,0.005117679,No,NA,NA,NA,NA,NA,NA,COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_COPG2.1.1.m.60836,0.020009348,-0.002800294,No,NA,NA,NA,NA,NA,NA,COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; structural molecule activity [GO:0005198]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_COQ4.1.1.m.6843,-0.010048811,-0.003545252,No,NA,NA,NA,NA,NA,NA,extrinsic component of mitochondrial inner membrane [GO:0031314]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_COQ9.1.2.m.4620,-0.010472846,-0.005540051,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_CORIN.2.2.m.40858,0.012868675,0.00368322,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; female pregnancy [GO:0007565]; peptide hormone processing [GO:0016486]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of renal sodium excretion [GO:0035813]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050],NA,NA,NA
CHOYP_COX1.1.15.m.3193,-0.019935975,-0.004120711,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_COX1.5.15.m.24406,-0.005587536,0.01378287,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_COX1.6.15.m.25748,-0.004727599,-0.005478953,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; N6-methyladenosine-containing RNA binding [GO:1990247]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948],NA,NA,NA
CHOYP_COX5B.1.3.m.20245,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_COX5B.3.3.m.38557,0.000680492,-0.018466501,No,NA,NA,NA,NA,NA,NA,mitochondrial respiratory chain complex IV [GO:0005751]; respiratory chain complex IV [GO:0045277]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport; cytochrome c to oxygen [GO:0006123],NA,NA,NA
CHOYP_CP080.1.1.m.24911,-0.021223565,-0.010536478,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; microtubule [GO:0005874]; nucleus [GO:0005634]; cilium assembly [GO:0060271]; positive regulation of cell motility [GO:2000147]; positive regulation of feeding behavior [GO:2000253]; protein polyglutamylation [GO:0018095]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296],NA,NA,NA
CHOYP_CP096.1.1.m.35853,0.008437959,-0.005388253,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_CP2BA.1.1.m.38084,0.014617852,0.00152321,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced flavin or flavoprotein as one donor; and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; arachidonic acid metabolic process [GO:0019369]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_CP3AB.4.4.m.47872,-0.006742194,-0.008088622,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; testosterone 6-beta-hydroxylase activity [GO:0050649]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_CP3AO.1.1.m.63459,0.003432663,0.007189941,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; steroid hydroxylase activity [GO:0008395]; female pregnancy [GO:0007565]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to zinc ion [GO:0010043]; sensory perception of smell [GO:0007608],NA,NA,NA
CHOYP_CP4F2.1.1.m.7803,-0.013802725,-0.005428488,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CPE.1.1.m.53041,-0.008739397,-0.010670789,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; transport vesicle membrane [GO:0030658]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_CPIB.2.3.m.44557,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CPIB.3.3.m.46138,-0.012133531,-0.016373066,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CPIPJ_CPIJ000723.1.1.m.7190,-0.022654296,0.010206539,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; collagen trimer [GO:0005581]; extracellular matrix structural constituent [GO:0005201],NA,NA,NA
CHOYP_CPIPJ_CPIJ001623.1.1.m.19531,0.012811884,0.013043163,No,NA,NA,NA,NA,NA,NA,early endosome [GO:0005769]; membrane [GO:0016020]; enzyme binding [GO:0019899]; phosphatidylinositol binding [GO:0035091]; negative regulation of early endosome to late endosome transport [GO:2000642]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein processing [GO:0010955]; negative regulation of protein transport [GO:0051224]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_CPIPJ_CPIJ003599.1.1.m.61267,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; myeloid cell differentiation [GO:0030099]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_CPIPJ_CPIJ003871.1.1.m.147,0.011784913,-0.002684535,No,NA,NA,NA,NA,NA,NA,cell [GO:0005623]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; metal ion binding [GO:0046872]; vinculin binding [GO:0017166]; cell-matrix adhesion [GO:0007160]; response to muscle stretch [GO:0035994],NA,NA,NA
CHOYP_CPIPJ_CPIJ004440.1.1.m.62518,-0.005669826,0.000395559,No,NA,NA,NA,NA,NA,NA,early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; cellular calcium ion homeostasis [GO:0006874]; Golgi calcium ion transport [GO:0032472]; protein N-linked glycosylation [GO:0006487]; regulation of lysosomal lumen pH [GO:0035751],NA,NA,NA
CHOYP_CPIPJ_CPIJ004536.3.3.m.52790,0.0048605,0.010681769,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CPIPJ_CPIJ004840.1.1.m.3309,-0.006736121,-0.003934533,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; oxidoreductase activity [GO:0016491]; mitochondrial respiratory chain complex I assembly [GO:0032981],NA,NA,NA
CHOYP_CPIPJ_CPIJ005489.1.1.m.43655,0.006155694,0.000979245,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; neuron projection [GO:0043005]; tubulin binding [GO:0015631]; axonogenesis [GO:0007409]; brain development [GO:0007420]; establishment of skin barrier [GO:0061436]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; intracellular signal transduction [GO:0035556]; microtubule depolymerization [GO:0007019]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; neuron projection development [GO:0031175]; positive regulation of cellular component movement [GO:0051272]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule polymerization or depolymerization [GO:0031110]; response to virus [GO:0009615],NA,NA,NA
CHOYP_CPIPJ_CPIJ007723.1.4.m.5854,-0.001611575,0.013730375,No,NA,NA,NA,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_CPIPJ_CPIJ007723.3.4.m.30316,0.018347997,-0.016170673,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_CPIPJ_CPIJ007723.4.4.m.64973,-0.017666468,-0.018178454,No,NA,NA,NA,NA,NA,NA,Cdc73/Paf1 complex [GO:0016593]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; transcriptionally active chromatin [GO:0035327]; chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome positioning [GO:0016584]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of histone methylation [GO:0031062]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein localization to nucleus [GO:0034504]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_CPIPJ_CPIJ007907.1.1.m.45771,0.004928214,-0.009744665,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CPIPJ_CPIJ008112.1.1.m.51524,0.011316003,-0.006448899,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; axon guidance receptor activity [GO:0008046]; PDZ domain binding [GO:0030165]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to thyroxine stimulus [GO:0097069]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dopaminergic neuron differentiation [GO:0071542]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; modulation of chemical synaptic transmission [GO:0050804]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to activity [GO:0014823]; response to thyroid hormone [GO:0097066]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_CPIPJ_CPIJ008190.1.1.m.21761,0.013548855,0.022626094,No,NA,NA,NA,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_CPIPJ_CPIJ008492.1.1.m.6934,-0.010921782,0.008171036,No,NA,NA,NA,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761],NA,NA,NA
CHOYP_CPIPJ_CPIJ011304.2.2.m.43130,-0.010934358,-0.002549559,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CPIPJ_CPIJ011346.2.2.m.44999,0.007342799,0.001378897,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CPIPJ_CPIJ012408.1.1.m.10724,-0.013912686,0.000646723,No,NA,NA,NA,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; defense response to bacterium [GO:0042742],NA,NA,NA
CHOYP_CPIPJ_CPIJ015079.1.1.m.39675,-0.007336746,-0.018739057,No,NA,NA,NA,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; protein-containing complex binding [GO:0044877]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981],NA,NA,NA
CHOYP_CPIPJ_CPIJ016910.1.1.m.62713,-0.014696485,0.000694292,No,NA,NA,NA,NA,NA,NA,acrosomal vesicle [GO:0001669]; azurophil granule [GO:0042582]; azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; astrocyte cell migration [GO:0043615]; cellular calcium ion homeostasis [GO:0006874]; cellular protein metabolic process [GO:0044267]; chondroitin sulfate catabolic process [GO:0030207]; ganglioside catabolic process [GO:0006689]; glycosphingolipid metabolic process [GO:0006687]; hyaluronan catabolic process [GO:0030214]; keratan sulfate catabolic process [GO:0042340]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; male courtship behavior [GO:0008049]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]; oogenesis [GO:0048477]; penetration of zona pellucida [GO:0007341]; phospholipid biosynthetic process [GO:0008654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_CPNE8.2.2.m.58380,0.008384772,-0.015092342,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; nucleosome binding [GO:0031491]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_CPSF1.1.1.m.27767,-0.014646094,-0.00392596,No,NA,NA,NA,NA,NA,NA,mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA polyadenylation [GO:0006378],NA,NA,NA
CHOYP_CPSF2.1.1.m.13908,-0.012428255,0.005289734,No,NA,NA,NA,NA,NA,NA,mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378],NA,NA,NA
CHOYP_CPSF5.1.2.m.59012,-0.005616777,0.007333883,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; AU-rich element binding [GO:0017091]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; cell differentiation [GO:0030154]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; positive regulation of mRNA cleavage [GO:0031439]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; posttranscriptional regulation of gene expression [GO:0010608]; protein heterotetramerization [GO:0051290],NA,NA,NA
CHOYP_CPT1A.1.1.m.53985,-0.015178263,-0.008384934,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; serine-type peptidase activity [GO:0008236]; signal peptide processing [GO:0006465],NA,NA,NA
CHOYP_CPT2.1.1.m.16349,-0.007752373,0.005718563,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; carnitine O-palmitoyltransferase activity [GO:0004095]; carnitine shuttle [GO:0006853]; fatty acid beta-oxidation [GO:0006635]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of lipid metabolic process [GO:0019216],NA,NA,NA
CHOYP_CPVL.2.2.m.62669,-0.016652761,-0.014248459,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; serine-type carboxypeptidase activity [GO:0004185]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_CRADD.1.2.m.27800,0.008462799,-0.009088004,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE_02254.1.1.m.12455,-0.001088111,-0.00522824,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; L-malate dehydrogenase activity [GO:0030060]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_CRE_06881.1.1.m.62783,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE_13958.1.1.m.31239,0.00572009,-0.00590059,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE_16884.1.1.m.28203,-0.00477919,-0.00113945,No,NA,NA,NA,NA,NA,NA,copper ion binding [GO:0005507]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; another compound as one donor; and incorporation of one atom of oxygen [GO:0016716]; melanin biosynthetic process [GO:0042438],NA,NA,NA
CHOYP_CRE_18961.1.1.m.30942,-0.002100996,-0.015056571,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; oxidoreductase activity [GO:0016491]; retinal dehydrogenase activity [GO:0001758]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_CRE_20365.1.3.m.20889,0.010445375,-0.00668906,No,NA,NA,NA,NA,NA,NA,integral component of mitochondrial inner membrane [GO:0031305]; pyruvate transmembrane transporter activity [GO:0050833]; mitochondrial pyruvate transmembrane transport [GO:0006850],NA,NA,NA
CHOYP_CRE_21950.1.1.m.55,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204],NA,NA,NA
CHOYP_CRE_25145.1.1.m.8177,-0.020374514,-0.014765953,No,NA,NA,NA,NA,NA,NA,Set1C/COMPASS complex [GO:0048188]; histone H3-K4 methylation [GO:0051568],NA,NA,NA
CHOYP_CRE_29942.1.1.m.48587,0.005677241,0.001738638,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; axon guidance receptor activity [GO:0008046]; PDZ domain binding [GO:0030165]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to thyroxine stimulus [GO:0097069]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dopaminergic neuron differentiation [GO:0071542]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; modulation of chemical synaptic transmission [GO:0050804]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to activity [GO:0014823]; response to thyroid hormone [GO:0097066]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_CRE.DIG.1.1.1.m.26794,0.020515713,-0.006950961,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE.GST.7.1.1.m.30139,-0.019359522,-0.008929109,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE.HIM.4.1.1.m.55343,-0.00014614,-0.004797717,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE.UNC.89.1.3.m.20277,0.010198659,0.00689523,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE.UNC.89.3.3.m.61234,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CREM.1.1.m.12267,0.002484011,0.000614548,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; glycosphingolipid metabolic process [GO:0006687]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_CRI9333_2800.1.1.m.5332,0.007689555,0.009972267,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cell differentiation involved in metanephros development [GO:0072202]; circadian regulation of gene expression [GO:0032922]; digestive tract development [GO:0048565]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; hair follicle development [GO:0001942]; hormone-mediated signaling pathway [GO:0009755]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; male genitalia development [GO:0030539]; metanephric glomerulus development [GO:0072224]; metanephric nephron tubule morphogenesis [GO:0072282]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription; DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription; DNA-templated [GO:0045893]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_CRIM1.1.3.m.5078,0.019486032,-0.011004391,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRIM1.2.3.m.5811,0.018538821,0.015689105,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRLF3.1.2.m.8760,0.013861575,0.004412861,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677],NA,NA,NA
CHOYP_CRNL1.1.1.m.2792,-0.006558923,-0.002430295,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_CRYAB.1.5.m.2659,-0.009299428,-0.021952101,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_CRYAB.5.5.m.49919,-0.006544517,-0.007083242,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_CRYM.1.1.m.8544,0.022194352,-0.006224353,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; hormone binding [GO:0042562]; NADP binding [GO:0050661]; oxidoreductase activity; acting on the CH-NH2 group of donors; NAD or NADP as acceptor [GO:0016639]; protein homodimerization activity [GO:0042803]; thiomorpholine-carboxylate dehydrogenase activity [GO:0047127]; thyroid hormone binding [GO:0070324]; transcription corepressor activity [GO:0003714]; mitochondrial transport [GO:0006839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; sensory perception of sound [GO:0007605]; thyroid hormone metabolic process [GO:0042403]; thyroid hormone transport [GO:0070327],NA,NA,NA
CHOYP_CRYZ.2.2.m.65927,0.018049616,-0.004411779,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mRNA 3'-UTR binding [GO:0003730]; NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; zinc ion binding [GO:0008270]; protein homotetramerization [GO:0051289]; visual perception [GO:0007601]; xenobiotic catabolic process [GO:0042178],NA,NA,NA
CHOYP_CS066.1.3.m.44165,-0.012848273,0.013499192,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; negative regulation of viral genome replication [GO:0045071]; response to interferon-gamma [GO:0034341]; response to type I interferon [GO:0034340]; response to type III interferon [GO:0034342],NA,NA,NA
CHOYP_CS081.1.1.m.48577,0.00212937,-0.013865324,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CSAD.1.1.m.40056,0.021453694,-0.007495551,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; L-cysteine catabolic process to hypotaurine [GO:0019449]; L-cysteine catabolic process to taurine [GO:0019452]; taurine biosynthetic process [GO:0042412],NA,NA,NA
CHOYP_CSK.1.1.m.55145,-0.000145511,0.011228894,No,NA,NA,NA,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368],NA,NA,NA
CHOYP_CSK21.1.2.m.19313,-0.015111993,-0.019679198,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_CSK2B.1.1.m.37285,-0.002576637,-0.024212585,No,NA,NA,NA,NA,NA,NA,protein kinase CK2 complex [GO:0005956]; metal ion binding [GO:0046872]; protein kinase regulator activity [GO:0019887]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_CSKI2.1.1.m.29327,3.94E-06,-0.013488598,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; protein domain specific binding [GO:0019904]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_CSKP.1.2.m.20832,0.007588995,-0.000948029,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; guanylate kinase activity [GO:0004385]; neurexin family protein binding [GO:0042043]; protein serine/threonine kinase activity [GO:0004674]; calcium ion import [GO:0070509]; cell adhesion [GO:0007155]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion import [GO:0090280]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of synaptic vesicle exocytosis [GO:2000300],NA,NA,NA
CHOYP_CSN2.1.1.m.28636,0.005983455,0.008994448,No,NA,NA,NA,NA,NA,NA,COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_CSN3.1.1.m.10996,-0.012406273,0.003279052,No,NA,NA,NA,NA,NA,NA,COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_CSN4.1.1.m.18561,-0.000843013,-0.011196126,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; synaptic vesicle [GO:0008021]; protein deneddylation [GO:0000338],NA,NA,NA
CHOYP_CSN5.1.1.m.52330,0.00967855,0.010576673,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; NEDD8-specific protease activity [GO:0019784]; negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; protein deneddylation [GO:0000338]; vestibular receptor cell development [GO:0060118],NA,NA,NA
CHOYP_CSN8.1.1.m.14798,-0.011406733,0.003494107,No,NA,NA,NA,NA,NA,NA,COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; COP9 signalosome assembly [GO:0010387]; protein deneddylation [GO:0000338],NA,NA,NA
CHOYP_CSPA_C15740.1.1.m.59258,-0.010726715,-0.009099639,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; patched binding [GO:0005113]; unfolded protein binding [GO:0051082]; mitochondrion organization [GO:0007005]; multicellular organism development [GO:0007275]; negative regulation of smoothened signaling pathway [GO:0045879]; protein folding [GO:0006457]; response to heat [GO:0009408],NA,NA,NA
CHOYP_CSPP1.11.14.m.54546,-0.000122795,-0.023711469,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922]; positive regulation of cell division [GO:0051781]; positive regulation of cytokinesis [GO:0032467],NA,NA,NA
CHOYP_CSTA.1.3.m.6422,-0.022559268,0.009979035,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869],NA,NA,NA
CHOYP_CSTF3.1.1.m.10636,-0.005180975,-0.004682381,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; mRNA splicing; via spliceosome [GO:0000398]; RNA 3'-end processing [GO:0031123]; termination of RNA polymerase II transcription [GO:0006369],NA,NA,NA
CHOYP_CTBL1.1.1.m.22983,0.008865999,0.005344695,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; apoptotic process [GO:0006915]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_CTBS.1.1.m.54468,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313],NA,NA,NA
CHOYP_CTK2.3.3.m.51999,0.008753878,-7.79E-05,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein homodimerization activity [GO:0042803]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; distributive segregation [GO:0032837]; meiotic spindle organization [GO:0000212]; microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; minus-end directed microtubule sliding [GO:0031534]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle elongation [GO:0000022]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; regulation of mitotic spindle assembly [GO:1901673]; regulation of mitotic spindle elongation [GO:0032888]; spindle assembly involved in female meiosis [GO:0007056]; spindle assembly involved in meiosis [GO:0090306]; spindle organization [GO:0007051],NA,NA,NA
CHOYP_CTL2.1.2.m.3858,-0.001643021,-0.002819186,No,NA,NA,NA,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; brain development [GO:0007420]; chordate embryonic development [GO:0043009]; translation [GO:0006412],NA,NA,NA
CHOYP_CTND2.1.1.m.12206,-0.007345336,0.001682294,No,NA,NA,NA,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_CTR1.2.4.m.39987,0.006425013,0.002040257,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to iron ion [GO:0071281]; ethylene-activated signaling pathway [GO:0009873]; gibberellin biosynthetic process [GO:0009686]; negative regulation of ethylene-activated signaling pathway [GO:0010105]; protein autophosphorylation [GO:0046777]; regulation of post-embryonic root development [GO:2000069]; regulation of stem cell division [GO:2000035]; regulation of timing of transition from vegetative to reproductive phase [GO:0048510]; response to ethylene [GO:0009723]; response to fructose [GO:0009750]; response to hypoxia [GO:0001666]; response to sucrose [GO:0009744]; sugar mediated signaling pathway [GO:0010182],NA,NA,NA
CHOYP_CTR9.1.1.m.18832,-0.005739432,-0.01540201,No,NA,NA,NA,NA,NA,NA,Cdc73/Paf1 complex [GO:0016593]; transcriptionally active chromatin [GO:0035327]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968],NA,NA,NA
CHOYP_CTRA.1.2.m.26705,-0.022095883,0.010680838,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586],NA,NA,NA
CHOYP_CTRL.1.1.m.48654,0.008634904,-0.005567724,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252],NA,NA,NA
CHOYP_CTSL2.1.2.m.2936,-0.001231606,0.008928115,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_CTTN.1.1.m.22042,0.005961937,0.005954352,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; mitotic spindle midzone [GO:1990023]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; voltage-gated potassium channel complex [GO:0008076]; cadherin binding [GO:0045296]; profilin binding [GO:0005522]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; membrane organization [GO:0061024]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of axon extension [GO:0030516]; substrate-dependent cell migration; cell extension [GO:0006930],NA,NA,NA
CHOYP_CTU2.1.1.m.43200,0.003275866,-0.014304297,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098],NA,NA,NA
CHOYP_CTXA.1.2.m.31637,0.002360667,-0.006661296,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CUL1.1.1.m.13087,0.008585377,-0.003615566,No,NA,NA,NA,NA,NA,NA,cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; cell proliferation [GO:0008283]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_CUL2.1.1.m.59278,-0.01245232,-0.019696227,No,NA,NA,NA,NA,NA,NA,Cul2-RING ubiquitin ligase complex [GO:0031462]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_CUL3B.1.1.m.61643,0.003755406,-0.009151646,No,NA,NA,NA,NA,NA,NA,Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; polar microtubule [GO:0005827]; ubiquitin protein ligase binding [GO:0031625]; cell migration [GO:0016477]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; integrin-mediated signaling pathway [GO:0007229]; mitotic metaphase plate congression [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149],NA,NA,NA
CHOYP_CUL3B.1.1.m.61644,0.002618032,-0.011118752,No,NA,NA,NA,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],NA,NA,NA
CHOYP_CUL4B.1.1.m.6652,0.005292127,0.013523473,No,NA,NA,NA,NA,NA,NA,Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response; detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of cell proliferation [GO:0008285]; negative regulation of granulocyte differentiation [GO:0030853]; nucleotide-excision repair; DNA damage recognition [GO:0000715]; nucleotide-excision repair; DNA incision [GO:0033683]; nucleotide-excision repair; DNA incision; 5'-to lesion [GO:0006296]; nucleotide-excision repair; preincision complex assembly [GO:0006294]; nucleotide-excision repair; preincision complex stabilization [GO:0006293]; positive regulation of cell proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_CUX1.1.2.m.10448,0.009849348,-0.000350961,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; intra-Golgi vesicle-mediated transport [GO:0006891],NA,NA,NA
CHOYP_CWC22.1.1.m.29270,-0.007831251,-0.010809098,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_CX6A2.1.1.m.47963,0.001167852,-0.022965774,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CYB5.1.2.m.2195,0.009229274,-0.022657883,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; organelle membrane [GO:0031090]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; stearoyl-CoA 9-desaturase activity [GO:0004768]; fatty acid metabolic process [GO:0006631]; response to cadmium ion [GO:0046686],NA,NA,NA
CHOYP_CYC.1.5.m.5663,0.018805976,0.000661166,No,NA,NA,NA,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_CYH1.1.1.m.66676,0.008917582,-0.005371389,No,NA,NA,NA,NA,NA,NA,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]; establishment of epithelial cell polarity [GO:0090162]; regulation of ARF protein signal transduction [GO:0032012]; regulation of cell adhesion [GO:0030155]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_CYIIB.2.2.m.64544,0.011012025,0.00776919,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CYIIB.2.2.m.64545,0.005265049,-0.008270551,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_CYPL.1.1.m.25000,0.018814338,0.006118601,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; cyclosporin A binding [GO:0016018]; disordered domain specific binding [GO:0097718]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing; via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413],NA,NA,NA
CHOYP_CYT5.1.1.m.29960,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CYT5.1.1.m.29962,0.007356356,0.007379254,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CYTA.1.1.m.10540,-0.023380825,0.006694311,No,NA,NA,NA,NA,NA,NA,cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]; protein binding; bridging [GO:0030674]; structural molecule activity [GO:0005198]; cell-cell adhesion [GO:0098609]; cornification [GO:0070268]; keratinocyte differentiation [GO:0030216]; negative regulation of peptidase activity [GO:0010466]; negative regulation of proteolysis [GO:0045861]; peptide cross-linking [GO:0018149],NA,NA,NA
CHOYP_CYTB.1.6.m.7874,-0.0127538,0.008102213,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; motile cilium assembly [GO:0044458]; pronephros development [GO:0048793]; pronephros morphogenesis [GO:0072114]; regulation of cilium movement [GO:0003352],NA,NA,NA
CHOYP_CZH5ORF51.1.1.m.25147,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_D39U1.1.1.m.29364,-0.001105533,0.008464029,No,NA,NA,NA,NA,NA,NA,coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_DAB2.1.1.m.22396,0.012206634,-0.010012318,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cytosol [GO:0005829]; presynapse [GO:0098793]; sevenless binding [GO:0005118]; SH3 domain binding [GO:0017124]; cellularization [GO:0007349]; clathrin-dependent endocytosis [GO:0072583]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; motor neuron axon guidance [GO:0008045]; positive regulation of sevenless signaling pathway [GO:0045874]; synaptic vesicle endocytosis [GO:0048488],NA,NA,NA
CHOYP_DANA_GF10165.1.1.m.59230,-0.011229945,0.000927505,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_DANA_GF10776.1.1.m.18533,-0.005219762,-0.017823674,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735],NA,NA,NA
CHOYP_DANA_GF14191.1.1.m.11942,0.019558973,0.001118619,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DANA_GF15280.1.2.m.4538,0.011829192,0.016222174,No,NA,NA,NA,NA,NA,NA,early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_DANA_GF15955.1.1.m.44177,0.009614759,0.015153952,No,NA,NA,NA,NA,NA,NA,response to metal ion [GO:0010038],NA,NA,NA
CHOYP_DANA_GF15955.1.1.m.44178,0.005289937,-0.007930763,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DANA_GF16638.1.1.m.10255,-0.002109824,-0.024735434,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289],NA,NA,NA
CHOYP_DANA_GF18010.1.1.m.6864,0.00719152,-0.01085988,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DANA_GF20914.1.1.m.14747,-0.011080386,0.001386143,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333],NA,NA,NA
CHOYP_DANA_GF24303.1.1.m.33639,0.000767914,-0.008643553,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; heme binding [GO:0020037]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; antimicrobial humoral response [GO:0019730]; cell differentiation [GO:0030154]; ecdysis; chitin-based cuticle [GO:0018990]; hormone-mediated signaling pathway [GO:0009755]; molting cycle; chitin-based cuticle [GO:0007591]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of ecdysteroid metabolic process [GO:0007553]; regulation of gene expression [GO:0010468]; response to ecdysone [GO:0035075]; response to lipid [GO:0033993],NA,NA,NA
CHOYP_DAR1.2.4.m.29583,-0.012180256,-0.002303558,No,NA,NA,NA,NA,NA,NA,apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; D-serine ammonia-lyase activity [GO:0008721]; glycine binding [GO:0016594]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114]; aging [GO:0007568]; brain development [GO:0007420]; D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; protein homotetramerization [GO:0051289]; pyruvate biosynthetic process [GO:0042866]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; serine family amino acid metabolic process [GO:0009069],NA,NA,NA
CHOYP_DARS2.1.1.m.43847,0.002519251,0.013143459,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; mitochondrial asparaginyl-tRNA aminoacylation [GO:0070145],NA,NA,NA
CHOYP_DBP2.2.2.m.55820,0.007554802,0.000273844,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_DBT.1.1.m.4866,-0.011814344,-0.013219355,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; acetyltransferase activity [GO:0016407]; dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity [GO:0043754]; lipoic acid binding [GO:0031405]; ubiquitin protein ligase binding [GO:0031625],NA,NA,NA
CHOYP_DC1I2.1.3.m.25743,-0.007105166,-0.010303506,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]; vesicle [GO:0031982]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; protein-containing complex binding [GO:0044877]; microtubule-based movement [GO:0007018]; negative regulation of neuron projection development [GO:0010977],NA,NA,NA
CHOYP_DC1I2.2.3.m.54049,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]; vesicle [GO:0031982]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DCA15.1.1.m.11376,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_DCAF7.1.1.m.51583,0.006570355,0.001578227,No,NA,NA,NA,NA,NA,NA,Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_DCDC2.3.7.m.36589,0.010340493,-0.004498954,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; kinocilium [GO:0060091]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; kinesin binding [GO:0019894]; cilium assembly [GO:0060271]; dendrite morphogenesis [GO:0048813]; intracellular signal transduction [GO:0035556]; neuron migration [GO:0001764]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of cilium assembly [GO:1902017]; regulation of Wnt signaling pathway [GO:0030111]; sensory perception of sound [GO:0007605]; visual learning [GO:0008542],NA,NA,NA
CHOYP_DCDC2.7.7.m.46807,-0.011852744,-0.013307815,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinocilium [GO:0060091]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; kinesin binding [GO:0019894]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; dendrite morphogenesis [GO:0048813]; intracellular signal transduction [GO:0035556]; neuron migration [GO:0001764]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of cilium assembly [GO:1902017]; regulation of Wnt signaling pathway [GO:0030111]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_DCNL4.1.2.m.36826,0.017126577,-0.003332978,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116],NA,NA,NA
CHOYP_DCTN1.2.2.m.40900,-0.002169368,-0.002557439,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; intermediate filament cytoskeleton [GO:0045111]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; spindle [GO:0005819]; spindle pole [GO:0000922]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; protein kinase binding [GO:0019901]; tau protein binding [GO:0048156]; tubulin binding [GO:0015631]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; ciliary basal body-plasma membrane docking [GO:0097711]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; IRE1-mediated unfolded protein response [GO:0036498]; maintenance of synapse structure [GO:0099558]; microtubule anchoring at centrosome [GO:0034454]; mitotic cell cycle [GO:0000278]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; non-motile cilium assembly [GO:1905515]; nuclear envelope disassembly [GO:0051081]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuromuscular junction development [GO:1904398]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport; endosome to Golgi [GO:0042147]; transport along microtubule [GO:0010970]; ventral spinal cord development [GO:0021517],NA,NA,NA
CHOYP_DCTN2.1.1.m.1084,-0.008844606,-0.01697105,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; growth cone [GO:0030426]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; vesicle [GO:0031982]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; cell proliferation [GO:0008283]; melanosome transport [GO:0032402]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; protein localization to centrosome [GO:0071539],NA,NA,NA
CHOYP_DCTN4.1.1.m.29541,0.014162407,0.005293147,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleus [GO:0005634]; sarcomere [GO:0030017]; spindle pole [GO:0000922]; stress fiber [GO:0001725]; protein N-terminus binding [GO:0047485]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; nuclear migration [GO:0007097],NA,NA,NA
CHOYP_DCUP.1.1.m.7527,0.001442992,-0.025552912,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; uroporphyrinogen decarboxylase activity [GO:0004853]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782],NA,NA,NA
CHOYP_DD19A.1.1.m.57641,-0.014267167,0.01140692,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; mRNA transport [GO:0051028]; protein transport [GO:0015031],NA,NA,NA
CHOYP_DDB_G0275195.1.1.m.47584,-0.015551652,-0.005259634,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DDB1.1.1.m.59135,-0.015071819,-0.009804519,No,NA,NA,NA,NA,NA,NA,Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; damaged DNA binding [GO:0003684]; protein binding; bridging [GO:0030674]; protein-containing complex binding [GO:0044877]; WD40-repeat domain binding [GO:0071987]; DNA repair [GO:0006281]; histone H2A monoubiquitination [GO:0035518]; interaction with symbiont [GO:0051702]; negative regulation of apoptotic process [GO:0043066]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral release from host cell [GO:1902188]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of mitotic cell cycle phase transition [GO:1901990]; UV-damage excision repair [GO:0070914]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_DDX1.1.1.m.46908,-0.014255637,-0.020094947,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; ATP binding [GO:0005524]; ATP-dependent helicase activity [GO:0008026]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA/RNA helicase activity [GO:0033677]; exonuclease activity [GO:0004527]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; transcription coregulator activity [GO:0003712]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; mRNA processing [GO:0006397]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_DDX10.1.1.m.17783,0.017544195,-0.004547178,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; lysosome [GO:0005764]; hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; transcription factor binding [GO:0008134]; lipid metabolic process [GO:0006629],NA,NA,NA
CHOYP_DDX18.1.2.m.12567,-0.011978941,-0.005595077,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; cellular response to estradiol stimulus [GO:0071392],NA,NA,NA
CHOYP_DDX18.2.2.m.51768,-0.005775154,-0.009815118,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; cellular response to estradiol stimulus [GO:0071392],NA,NA,NA
CHOYP_DDX21.1.2.m.3695,-0.004793152,-0.011412085,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_DDX23.1.1.m.20195,-0.008228299,0.006895634,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing; via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_DDX23.1.1.m.20196,-0.003561214,-0.009673568,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; catalytic activity [GO:0003824],NA,NA,NA
CHOYP_DDX24.1.1.m.6330,-0.013356511,-0.011526136,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA metabolic process [GO:0016070],NA,NA,NA
CHOYP_DDX3Y.1.1.m.3679,-0.003905809,-0.008959685,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_DDX41.1.1.m.16719,0.000187268,0.018329245,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; cellular response to interferon-beta [GO:0035458]; defense response to virus [GO:0051607]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_DDX42.2.2.m.54450,0.003043604,-0.022061068,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_DDX46.1.1.m.52473,-0.010283758,-0.003540315,No,NA,NA,NA,NA,NA,NA,Cajal body [GO:0015030]; nuclear speck [GO:0016607]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; brain development [GO:0007420]; definitive hemopoiesis [GO:0060216]; digestive tract morphogenesis [GO:0048546]; exocrine pancreas development [GO:0031017]; liver morphogenesis [GO:0072576]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell differentiation [GO:1902038]; positive regulation of lymphocyte differentiation [GO:0045621],NA,NA,NA
CHOYP_DDX47.1.1.m.11144,-0.010315581,-0.004324477,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_DDX58.1.9.m.822,-0.006615498,-0.005860175,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_DDX58.7.9.m.58168,-0.016154942,0.000183366,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_DDX58.9.9.m.62757,-0.016089041,0.019884966,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; negative regulation of type I interferon production [GO:0032480]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein deubiquitination [GO:0016579]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529]; viral process [GO:0016032],NA,NA,NA
CHOYP_DDX58.9.9.m.62758,-0.009579385,-2.20E-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DECR2.1.2.m.29687,0.001723692,-0.005023084,No,NA,NA,NA,NA,NA,NA,peroxisome [GO:0005777]; 2;4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_DEK.1.1.m.40646,0.012264047,-0.017581366,No,NA,NA,NA,NA,NA,NA,contractile fiber [GO:0043292]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; chromatin organization [GO:0006325]; regulation of double-strand break repair [GO:2000779]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032],NA,NA,NA
CHOYP_DENND4A.1.1.m.342,0.008354736,-0.005782106,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_DEP1A.1.1.m.50111,0.01078604,0.013558733,No,NA,NA,NA,NA,NA,NA,GTPase activator activity [GO:0005096]; intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_DERE_GG18317.1.1.m.44727,0.000324588,-0.014182563,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013],NA,NA,NA
CHOYP_DERE_GG18317.1.1.m.44730,-0.022404122,0.009752756,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DFA_00978.1.1.m.17875,0.003774794,-0.003936627,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DFA_05420.1.1.m.25051,0.003868947,0.006201367,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_DFA_06569.1.1.m.9782,-0.022673831,0.006229742,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DFER_5601.1.1.m.49215,0.012345206,-0.016175834,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; glucan endo-1;6-beta-glucosidase activity [GO:0046557]; glucosylceramidase activity [GO:0004348]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; polysaccharide metabolic process [GO:0005976]; sphingolipid metabolic process [GO:0006665],NA,NA,NA
CHOYP_DFPA.1.1.m.29402,-0.00446598,-0.025641682,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509]; diisopropyl-fluorophosphatase activity [GO:0047862],NA,NA,NA
CHOYP_DGKD.2.2.m.9520,0.004357833,-0.007781842,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol binding [GO:0019992]; diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; glycerolipid metabolic process [GO:0046486]; lipid phosphorylation [GO:0046834]; multicellular organism development [GO:0007275]; platelet activation [GO:0030168]; protein homooligomerization [GO:0051260]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein transport [GO:0015031]; response to organic substance [GO:0010033]; second-messenger-mediated signaling [GO:0019932]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_DGKZA.1.2.m.29620,0.007628252,-0.00035906,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0090216]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205],NA,NA,NA
CHOYP_DGRI_GH10893.1.1.m.27211,-0.009596391,-0.02216804,No,NA,NA,NA,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium channel activity [GO:0005262]; calcium ion transmembrane transport [GO:0070588]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983],NA,NA,NA
CHOYP_DGRI_GH12278.1.1.m.5056,-0.010266862,0.000512322,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; L-gulonate 3-dehydrogenase activity [GO:0050104]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; fatty acid metabolic process [GO:0006631]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640],NA,NA,NA
CHOYP_DGRI_GH13197.1.1.m.35578,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; rhythmic process [GO:0048511],NA,NA,NA
CHOYP_DGRI_GH14833.1.1.m.14206,-0.00483695,-0.01825707,No,NA,NA,NA,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleotide binding [GO:0000166]; structural constituent of ribosome [GO:0003735]; gene silencing by RNA [GO:0031047]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]; translation [GO:0006412],NA,NA,NA
CHOYP_DGRI_GH14972.1.1.m.64210,0.006525842,0.001129954,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development; heterochronic [GO:0040034],NA,NA,NA
CHOYP_DGRI_GH15313.1.1.m.5763,0.008314485,0.011255974,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289],NA,NA,NA
CHOYP_DGRI_GH15575.1.1.m.49170,0.009074519,-0.014855932,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DGRI_GH19122.1.1.m.1378,0.004810898,-0.009053437,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_DGRI_GH20300.1.1.m.57587,0.013273041,0.00951673,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_DGRI_GH22804.1.1.m.12160,-0.003230914,-0.014999708,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; LBD domain binding [GO:0050693]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; negative regulation of amyloid-beta formation [GO:1902430]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of protein binding [GO:0032092]; positive regulation of protein processing [GO:0010954],NA,NA,NA
CHOYP_DGRI_GH22876.2.3.m.54068,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,glycinergic synapse [GO:0098690]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_DGRI_GH23100.1.1.m.44142,-0.001619695,0.005066515,No,NA,NA,NA,NA,NA,NA,cell projection [GO:0042995]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; myosin binding [GO:0017022]; cell adhesion [GO:0007155]; excretion [GO:0007588]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_DGRI_GH24618.1.2.m.1995,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; photoreceptor activity [GO:0009881]; small conductance calcium-activated potassium channel activity [GO:0016286]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of membrane potential in photoreceptor cell [GO:0016057],NA,NA,NA
CHOYP_DHB12.1.1.m.62534,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 3-oxo-arachidoyl-CoA reductase activity [GO:0102339]; 3-oxo-behenoyl-CoA reductase activity [GO:0102340]; 3-oxo-cerotoyl-CoA reductase activity [GO:0102342]; 3-oxo-lignoceroyl-CoA reductase activity [GO:0102341]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633],NA,NA,NA
CHOYP_DHB14.1.1.m.13441,-0.001108287,0.021400566,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; identical protein binding [GO:0042802]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; steroid catabolic process [GO:0006706],NA,NA,NA
CHOYP_DHB4.1.2.m.13985,0.010605627,0.003892002,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3alpha;7alpha;12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; isomerase activity [GO:0016853]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; alpha-linolenic acid metabolic process [GO:0036109]; androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; protein targeting to peroxisome [GO:0006625]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111],NA,NA,NA
CHOYP_DHB4.2.2.m.19618,-0.000492474,-0.011945924,No,NA,NA,NA,NA,NA,NA,peroxisome [GO:0005777]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3alpha;7alpha;12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; isomerase activity [GO:0016853]; protein homodimerization activity [GO:0042803]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; aging [GO:0007568]; cellular response to organic cyclic compound [GO:0071407]; cholesterol metabolic process [GO:0008203]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to steroid hormone [GO:0048545],NA,NA,NA
CHOYP_DHC6.1.1.m.22887,-0.022322949,0.009653837,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DHE4.1.1.m.48536,-0.021172989,0.003674769,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; leucine binding [GO:0070728]; NAD+ binding [GO:0070403]; cellular amino acid biosynthetic process [GO:0008652]; glutamate biosynthetic process [GO:0006537]; glutamate catabolic process [GO:0006538]; glutamine metabolic process [GO:0006541]; positive regulation of insulin secretion [GO:0032024]; substantia nigra development [GO:0021762]; tricarboxylic acid metabolic process [GO:0072350],NA,NA,NA
CHOYP_DHPS.1.1.m.55870,0.003129376,-0.020726768,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; deoxyhypusine synthase activity [GO:0034038]; identical protein binding [GO:0042802]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]; positive regulation of cell proliferation [GO:0008284]; spermidine metabolic process [GO:0008216]; translation [GO:0006412],NA,NA,NA
CHOYP_DHR.1.1.1.m.43819,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DHR11.2.2.m.36445,-0.022646772,0.010177475,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703],NA,NA,NA
CHOYP_DHSAB.1.1.m.25026,-0.002518109,-0.012601504,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; flavin adenine dinucleotide binding [GO:0050660]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; electron transport chain [GO:0022900]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_DHSB.1.1.m.3993,-0.015111131,-0.013834172,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex II; succinate dehydrogenase complex (ubiquinone) [GO:0005749]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; 2 iron; 2 sulfur cluster binding [GO:0051537]; 3 iron; 4 sulfur cluster binding [GO:0051538]; 4 iron; 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; ubiquinone binding [GO:0048039]; aerobic respiration [GO:0009060]; respiratory electron transport chain [GO:0022904]; succinate metabolic process [GO:0006105]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_DHSO.1.2.m.5409,-0.014557105,-0.008053719,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]; flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; L-xylitol catabolic process [GO:0051160]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to nutrient levels [GO:0031667]; response to osmotic stress [GO:0006970]; sorbitol catabolic process [GO:0006062],NA,NA,NA
CHOYP_DHSO.2.2.m.29745,0.010747595,-0.002759723,No,NA,NA,NA,NA,NA,NA,mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; protein-containing complex [GO:0032991]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]; fructose biosynthetic process [GO:0046370]; fructose metabolic process [GO:0006000]; NADH oxidation [GO:0006116]; NADH regeneration [GO:0006735]; sorbitol biosynthetic process [GO:0006061]; sorbitol catabolic process [GO:0006062],NA,NA,NA
CHOYP_DHTK1.1.1.m.8425,0.005182557,0.001244366,No,NA,NA,NA,NA,NA,NA,tRNA 2'-phosphotransferase activity [GO:0000215]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_DHX15.2.2.m.62441,-0.002949756,-0.001708218,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; ATP binding [GO:0005524]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_DHX57.2.2.m.45703,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914],NA,NA,NA
CHOYP_DHX8.2.3.m.55112,-0.011487706,-0.025364513,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; ATP binding [GO:0005524]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; ATP-dependent RNA helicase activity [GO:0004004]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; spliceosomal complex disassembly [GO:0000390],NA,NA,NA
CHOYP_DHX8.2.3.m.55114,0.011071195,-0.005274169,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031],NA,NA,NA
CHOYP_DI3L2.1.1.m.61980,0.0001274,0.016539026,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301]; miRNA catabolic process [GO:0010587]; nuclear-transcribed mRNA catabolic process; exonucleolytic [GO:0000291]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_DIAP2.1.1.m.25706,0.010846711,-0.007324553,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cytoskeleton organization [GO:0007010]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_DIAPH1.1.1.m.55416,0.019770414,-0.000834207,No,NA,NA,NA,NA,NA,NA,actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; actin filament polymerization [GO:0030041]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477],NA,NA,NA
CHOYP_DICER.1.3.m.9936,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; micro-ribonucleoprotein complex [GO:0035068]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; ATP binding [GO:0005524]; bidentate ribonuclease III activity [GO:0016443]; deoxyribonuclease I activity [GO:0004530]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; pre-miRNA binding [GO:0070883]; ribonuclease III activity [GO:0004525]; single-stranded RNA binding [GO:0003727]; apoptotic DNA fragmentation [GO:0006309]; dendrite morphogenesis [GO:0048813]; dsRNA transport [GO:0033227]; germ-line stem cell division [GO:0042078]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; mitotic cell cycle; embryonic [GO:0045448]; pole cell formation [GO:0007279]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; response to starvation [GO:0042594]; RNA interference [GO:0016246]; segment polarity determination [GO:0007367]; siRNA loading onto RISC involved in RNA interference [GO:0035087],NA,NA,NA
CHOYP_DICPUDRAFT_147269.1.1.m.34818,-0.000277582,-0.00828462,No,NA,NA,NA,NA,NA,NA,cysteine-type peptidase activity [GO:0008234],NA,NA,NA
CHOYP_DICPUDRAFT_81027.1.1.m.5425,0.015015214,-0.007861935,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DICPUDRAFT_93011.1.1.m.30650,-0.023307911,0.006602933,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_DIS3.1.1.m.6724,-5.19E-05,0.00646533,No,NA,NA,NA,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_DJC13.1.1.m.46117,-0.000420243,-0.007646065,No,NA,NA,NA,NA,NA,NA,azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954],NA,NA,NA
CHOYP_DKC1.1.1.m.10978,-0.006172725,-0.005951606,No,NA,NA,NA,NA,NA,NA,box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; Cajal body [GO:0015030]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; box H/ACA snoRNA binding [GO:0034513]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; box H/ACA snoRNA 3'-end processing [GO:0000495]; box H/ACA snoRNA metabolic process [GO:0033979]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of cell proliferation [GO:0008284]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; rRNA pseudouridine synthesis [GO:0031118]; scaRNA localization to Cajal body [GO:0090666]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; snRNA pseudouridine synthesis [GO:0031120]; telomerase RNA stabilization [GO:0090669]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_DLAT.1.1.m.64812,0.009003107,-0.002592063,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; pyruvate dehydrogenase complex [GO:0045254]; dihydrolipoyllysine-residue acetyltransferase activity [GO:0004742]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_DLDH.1.1.m.31018,-0.000606635,0.009053945,No,NA,NA,NA,NA,NA,NA,acrosomal vesicle [GO:0001669]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; dihydrolipoyl dehydrogenase activity [GO:0004148]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; cell redox homeostasis [GO:0045454]; histone succinylation [GO:0106077],NA,NA,NA
CHOYP_DLGP1.3.3.m.44296,0.018469031,-0.003414219,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; protein-containing complex binding [GO:0044877]; chemical synaptic transmission [GO:0007268],NA,NA,NA
CHOYP_DLL1.1.1.m.4589,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; Notch binding [GO:0005112]; phospholipid binding [GO:0005543]; structural molecule activity [GO:0005198]; angiogenesis [GO:0001525]; aorta morphogenesis [GO:0035909]; aortic valve morphogenesis [GO:0003180]; blood vessel remodeling [GO:0001974]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum morphogenesis [GO:0060411]; cell fate determination [GO:0001709]; ciliary body morphogenesis [GO:0061073]; distal tubule development [GO:0072017]; endocardial cushion cell development [GO:0061444]; endothelial cell differentiation [GO:0045446]; glomerular visceral epithelial cell development [GO:0072015]; hemopoiesis [GO:0030097]; inner ear auditory receptor cell differentiation [GO:0042491]; keratinocyte differentiation [GO:0030216]; loop of Henle development [GO:0072070]; morphogenesis of an epithelial sheet [GO:0002011]; myoblast differentiation [GO:0045445]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of stem cell differentiation [GO:2000737]; nephron development [GO:0072006]; nervous system development [GO:0007399]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell proliferation [GO:0042127]; response to muramyl dipeptide [GO:0032495]; T cell mediated immunity [GO:0002456],NA,NA,NA
CHOYP_DLL4.1.1.m.40197,0.021878224,-0.004621576,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; blood vessel lumenization [GO:0072554]; blood vessel remodeling [GO:0001974]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac atrium morphogenesis [GO:0003209]; dorsal aorta morphogenesis [GO:0035912]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; pericardium morphogenesis [GO:0003344]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; T cell differentiation [GO:0030217]; ventricular trabecula myocardium morphogenesis [GO:0003222],NA,NA,NA
CHOYP_DLP.1.1.m.31353,0.013256133,-0.010498283,No,NA,NA,NA,NA,NA,NA,actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; actin filament binding [GO:0051015]; dystroglycan binding [GO:0002162]; zinc ion binding [GO:0008270]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639],NA,NA,NA
CHOYP_DLP1.1.1.m.40279,-0.009450492,-0.010007973,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]; isoprenoid biosynthetic process [GO:0008299]; protein heterotetramerization [GO:0051290]; regulation of body fluid levels [GO:0050878]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_DMBT1.11.34.m.22620,0.007487332,0.009181896,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_DMBT1.15.34.m.29008,-0.00887917,-0.025782555,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_DMBT1.3.34.m.3602,0.001750412,0.012029093,No,NA,NA,NA,NA,NA,NA,endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; acute-phase response [GO:0006953]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_DMOJ_GI11203.1.1.m.24977,-0.011061978,-0.003771003,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_DMOJ_GI12418.1.1.m.49398,-0.017944357,0.002570855,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMOJ_GI12939.1.3.m.5732,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMOJ_GI12939.2.3.m.20888,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMOJ_GI17052.1.1.m.4566,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMOJ_GI17690.1.1.m.48369,-0.003465483,-0.005625651,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; 3';5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; calcium- and calmodulin-regulated 3';5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; male mating behavior [GO:0060179]; multicellular organism reproduction [GO:0032504]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_DMOJ_GI18492.1.1.m.8902,-2.89E-05,-0.011275956,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243],NA,NA,NA
CHOYP_DMOJ_GI18492.1.1.m.8903,0.015432112,0.010979996,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243],NA,NA,NA
CHOYP_DMOJ_GI18925.1.1.m.37775,-0.00948494,0.001539452,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_DMOJ_GI19977.1.1.m.66449,-0.010304814,0.009457787,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMOJ_GI23261.1.2.m.12269,-0.017071174,0.004469424,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DNAH12.2.3.m.32353,-0.014938164,0.00402325,No,NA,NA,NA,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DNAH12.3.3.m.63246,-0.005280464,-0.01106102,No,NA,NA,NA,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DNAH5.1.2.m.56799,0.011647251,0.017418778,No,NA,NA,NA,NA,NA,NA,9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_DNAH5.2.2.m.61452,-0.022055251,-0.005221319,No,NA,NA,NA,NA,NA,NA,9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_DNAH6.2.3.m.21512,-0.020673967,-0.007276319,No,NA,NA,NA,NA,NA,NA,axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DNAH7.1.2.m.19685,-0.009608721,-0.008411217,No,NA,NA,NA,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DNAH7.2.2.m.46648,-0.02087336,-0.007782951,No,NA,NA,NA,NA,NA,NA,axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytosol [GO:0005829]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DNAJ.11.1.1.m.18882,0.021533036,-0.008697554,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DNAJB6B.1.2.m.1265,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_DNAL1.1.1.m.11822,-0.006335014,0.013677597,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; alpha-tubulin binding [GO:0043014]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_DNER.1.1.m.28378,0.000117159,-0.012530337,No,NA,NA,NA,NA,NA,NA,acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; Notch binding [GO:0005112]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac vascular smooth muscle cell development [GO:0060948]; cell cycle arrest [GO:0007050]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart looping [GO:0001947]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell proliferation [GO:0042127]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],NA,NA,NA
CHOYP_DNJA2.2.2.m.51791,0.018838873,0.012846792,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]; response to heat [GO:0009408],NA,NA,NA
CHOYP_DNJA3.1.1.m.15026,-0.014171604,-0.017192876,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077],NA,NA,NA
CHOYP_DNJC2.1.1.m.8941,-0.013354545,-0.005167013,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; ubiquitin modification-dependent histone binding [GO:0061649]; chromatin organization [GO:0006325]; negative regulation of cell growth [GO:0030308]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_DNJC3.1.1.m.52309,-0.011177288,-0.008000105,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; chaperone binding [GO:0051087]; misfolded protein binding [GO:0051787]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; unfolded protein binding [GO:0051082]; cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; protein folding in endoplasmic reticulum [GO:0034975]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_DNJC5.1.1.m.52453,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020],NA,NA,NA
CHOYP_DNJC7.1.1.m.8987,-0.013434381,-0.005940455,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATPase activator activity [GO:0001671]; heat shock protein binding [GO:0031072]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034],NA,NA,NA
CHOYP_DNJC9.1.1.m.12688,-0.00494753,-0.014618207,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; heat shock protein binding [GO:0031072]; positive regulation of ATPase activity [GO:0032781]; social behavior [GO:0035176],NA,NA,NA
CHOYP_DNLI1.1.2.m.19123,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_DNMT1.1.1.m.54990,-0.001434232,-0.016355521,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]; DNA methylation on cytosine within a CG sequence [GO:0010424]; maintenance of DNA methylation [GO:0010216]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; Ras protein signal transduction [GO:0007265],NA,NA,NA
CHOYP_DNPH1.1.1.m.28418,-0.003623921,-0.003621042,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; deoxyribonucleoside 5'-monophosphate N-glycosidase activity [GO:0070694]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; deoxyribonucleoside monophosphate catabolic process [GO:0009159]; epithelial cell differentiation [GO:0030855]; nucleoside metabolic process [GO:0009116]; nucleotide metabolic process [GO:0009117]; positive regulation of cell growth [GO:0030307],NA,NA,NA
CHOYP_DOCK1.2.2.m.61345,-0.003220834,0.005478523,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; integrin-mediated signaling pathway [GO:0007229]; phagocytosis; engulfment [GO:0006911]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_DOCK3.1.2.m.49353,0.002141863,-0.013838788,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; Rac GTPase binding [GO:0048365]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; cell chemotaxis [GO:0060326]; negative regulation of vascular smooth muscle contraction [GO:1904694]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_DOCK7.1.3.m.1197,0.01313917,-0.007704261,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; basal part of cell [GO:0045178]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; neuron projection [GO:0043005]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rac GTPase binding [GO:0048365]; activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_DOCK9.1.2.m.7649,-0.008368368,-0.006876163,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]; blood coagulation [GO:0007596]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_DOME.2.2.m.62360,-0.011783485,0.008829536,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DP13A.2.3.m.10746,-0.00600363,-0.001689128,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; vesicle membrane [GO:0012506]; identical protein binding [GO:0042802]; protein kinase B binding [GO:0043422]; protein-containing complex binding [GO:0044877]; cell cycle [GO:0007049]; cell proliferation [GO:0008283]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; insulin receptor signaling pathway [GO:0008286]; regulation of glucose import [GO:0046324]; regulation of protein localization to plasma membrane [GO:1903076]; signal transduction [GO:0007165]; signaling [GO:0023052],NA,NA,NA
CHOYP_DPER_GL17438.1.1.m.11680,0.007782533,0.017777666,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_DPER_GL17448.1.1.m.54836,0.000912783,-0.004805232,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; carbohydrate binding [GO:0030246]; CD4 receptor binding [GO:0042609]; IgM binding [GO:0001791]; protein phosphatase binding [GO:0019903]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; B cell activation [GO:0042113]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of immunoglobulin secretion [GO:0051025]; regulation of B cell proliferation [GO:0030888]; regulation of endocytosis [GO:0030100]; regulation of immune response [GO:0050776],NA,NA,NA
CHOYP_DPER_GL24378.1.1.m.64285,0.001644243,0.01717144,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DPER_GL26275.1.2.m.885,0.011875054,0.005363132,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DPER_GL26275.2.2.m.17886,-0.003400984,0.002753855,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DPF2.1.2.m.6678,0.000638505,-0.001215081,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; H3K9me3 modified histone binding [GO:0062072]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; apoptotic process [GO:0006915]; negative regulation of myeloid progenitor cell differentiation [GO:1905454]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_DPOLB.1.1.m.15375,-0.011884334,0.004751325,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_DPOLZ.1.1.m.49299,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; zeta DNA polymerase complex [GO:0016035]; 4 iron; 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleic acid phosphodiester bond hydrolysis [GO:0090305],NA,NA,NA
CHOYP_DPSE_GA10259.1.1.m.36297,0.014602351,-0.016896816,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_DPSE_GA10675.1.1.m.23860,0.00685649,0.009943174,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; phagophore assembly site [GO:0000407]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic cell clearance [GO:0043277]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cell migration [GO:0016477]; dauer larval development [GO:0040024]; determination of adult lifespan [GO:0008340]; embryo development ending in birth or egg hatching [GO:0009792]; nematode male tail tip morphogenesis [GO:0045138]; programmed cell death [GO:0012501]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of axon extension [GO:0030516]; regulation of cell size [GO:0008361]; regulation of multicellular organism growth [GO:0040014]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_DPSE_GA15574.1.1.m.62967,-0.005103919,-0.003753075,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013],NA,NA,NA
CHOYP_DPSE_GA16367.1.1.m.22618,-0.005520651,0.007782403,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_DPSE_GA17283.3.3.m.59446,0.00355468,-0.001528504,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_DPSE_GA25136.1.1.m.66680,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493],NA,NA,NA
CHOYP_DPSE_GA27121.1.1.m.6089,0.022366464,-0.002065868,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DPSE_GA28568.3.9.m.19206,-0.017729157,0.014908296,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; spindle pole [GO:0000922]; alpha-actinin binding [GO:0051393]; ciliary basal body-plasma membrane docking [GO:0097711]; endosomal transport [GO:0016197]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of centriole replication [GO:0046599]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of stress fiber assembly [GO:0051492],NA,NA,NA
CHOYP_DPSE_GA28568.5.9.m.33670,-0.007688676,0.004325938,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DPSE_GA30097.1.1.m.24050,0.007544215,-0.004803023,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_DPSE_GA30464.1.1.m.65390,-0.00754696,-0.008046046,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; hydrolase activity; acting on ester bonds [GO:0016788]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]; glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813],NA,NA,NA
CHOYP_DPY19L3.1.1.m.7532,0.003126892,-0.017757099,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406],NA,NA,NA
CHOYP_DRE2.2.2.m.41479,-0.011270604,-0.010490143,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 2 iron; 2 sulfur cluster binding [GO:0051537]; 4 iron; 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915]; hemopoiesis [GO:0030097]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of apoptotic process [GO:0043066],NA,NA,NA
CHOYP_DRG1.1.1.m.28901,0.002452425,-0.018412805,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_DRG2.1.1.m.14009,0.005208812,-0.021814358,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; cytoplasmic translation [GO:0002181]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_DRPR.1.2.m.58255,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis; engulfment [GO:0006911]; positive regulation of phagocytosis; engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_DRPR.2.2.m.62931,-0.002693012,-0.012575538,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis; engulfment [GO:0006911]; positive regulation of phagocytosis; engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_DS.1.1.m.62106,0.001593907,-0.012915104,No,NA,NA,NA,NA,NA,NA,apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell morphogenesis involved in differentiation [GO:0000904]; cell proliferation [GO:0008283]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of hippo signaling [GO:0035331]; peptide cross-linking [GO:0018149]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; Wnt signaling pathway; planar cell polarity pathway [GO:0060071],NA,NA,NA
CHOYP_DSCAM.3.3.m.65848,0.004928745,0.000337813,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_DSEC_GM10209.1.1.m.49171,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell surface receptor signaling pathway [GO:0007166],NA,NA,NA
CHOYP_DSEC_GM12928.1.1.m.11933,0.007023388,-0.014930434,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DSEC_GM16292.1.1.m.12184,-0.014940651,-0.004720083,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_DSEC_GM19691.1.1.m.30070,0.004699986,0.006676798,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; immunological synapse [GO:0001772]; membrane [GO:0016020]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; Rho GDP-dissociation inhibitor activity [GO:0005094]; regulation of protein localization [GO:0032880]; Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526],NA,NA,NA
CHOYP_DSEC_GM21767.1.1.m.63020,0.017477596,-0.007123819,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; H zone [GO:0031673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; compound eye photoreceptor cell differentiation [GO:0001751]; eye development [GO:0001654]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of female receptivity [GO:0045924]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; rhabdomere development [GO:0042052]; visual perception [GO:0007601],NA,NA,NA
CHOYP_DSIM_GD11682.1.1.m.30804,0.00283739,0.003852201,No,NA,NA,NA,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; regulation of growth [GO:0040008]; translation [GO:0006412],NA,NA,NA
CHOYP_DSIM_GD13062.1.1.m.3175,0.011062811,0.00471286,No,NA,NA,NA,NA,NA,NA,SH3 domain binding [GO:0017124],NA,NA,NA
CHOYP_DSIM_GD13354.1.1.m.6235,-0.009971117,-0.002297414,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nuclear body [GO:0016604]; electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; reactive oxygen species metabolic process [GO:0072593]; substantia nigra development [GO:0021762],NA,NA,NA
CHOYP_DSIM_GD24875.1.1.m.66201,-0.011465229,-0.011672005,No,NA,NA,NA,NA,NA,NA,axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; identical protein binding [GO:0042802]; protein binding involved in protein folding [GO:0044183]; protein homodimerization activity [GO:0042803]; anterograde axonal protein transport [GO:0099641]; chaperone-mediated protein folding [GO:0061077]; regulation of protein phosphorylation [GO:0001932],NA,NA,NA
CHOYP_DSIM_GD25210.1.1.m.29275,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transporter activity [GO:1902388]; intermembrane lipid transfer activity [GO:0120013]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543]; phospholipid transporter activity [GO:0005548]; ceramide 1-phosphate transport [GO:1902389]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009]; negative regulation of autophagy [GO:0010507]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226],NA,NA,NA
CHOYP_DSPP.5.8.m.37255,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_DSPP.6.8.m.47723,-0.002995655,-0.009322826,No,NA,NA,NA,NA,NA,NA,AP-1 adaptor complex [GO:0030121]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; trans-Golgi network membrane [GO:0032588]; clathrin binding [GO:0030276]; protein transporter activity [GO:0008565]; intracellular transport [GO:0046907],NA,NA,NA
CHOYP_DSPP.8.8.m.65419,0.009735999,0.005795541,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DSRAD.1.4.m.4228,-0.017757764,0.00482247,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; mRNA processing [GO:0006397]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RNA processing [GO:0006396]; type I interferon signaling pathway [GO:0060337],NA,NA,NA
CHOYP_DSRAD.2.4.m.5410,-0.011343848,0.007752246,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; mRNA processing [GO:0006397]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RNA processing [GO:0006396]; type I interferon signaling pathway [GO:0060337],NA,NA,NA
CHOYP_DSRAD.3.4.m.24850,0.013430898,0.012269694,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; left-handed Z-DNA binding [GO:0003692]; metal ion binding [GO:0046872]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of RNA interference [GO:1900369]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RNA processing [GO:0006396]; somatic diversification of immune receptors via somatic mutation [GO:0002566],NA,NA,NA
CHOYP_DTNBP1.1.1.m.66644,0.007715682,0.008624445,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; melanosome membrane [GO:0033162]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle membrane [GO:0030672]; actin cytoskeleton reorganization [GO:0031532]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; blood coagulation [GO:0007596]; dendrite morphogenesis [GO:0048813]; melanosome organization [GO:0032438]; negative regulation of protein binding [GO:0032091]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; platelet dense granule organization [GO:0060155]; positive regulation of gene expression [GO:0010628]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of dopamine secretion [GO:0014059]; regulation of JUN kinase activity [GO:0043506]; regulation of synaptic vesicle exocytosis [GO:2000300],NA,NA,NA
CHOYP_DTX3.3.3.m.64703,-0.008019367,0.007013802,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_DTX3L.2.4.m.51200,-0.007065841,0.008134284,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_DUOX1.1.4.m.14284,-0.005426458,0.007293622,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; piRNA binding [GO:0034584]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_DUOX1.1.4.m.14285,-0.016684759,0.010384875,No,NA,NA,NA,NA,NA,NA,apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase activity [GO:0016174]; peroxidase activity [GO:0004601]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590],NA,NA,NA
CHOYP_DUOX1.2.4.m.33964,-0.013590955,0.009629235,No,NA,NA,NA,NA,NA,NA,apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase activity [GO:0016174]; peroxidase activity [GO:0004601]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590],NA,NA,NA
CHOYP_DUOX1.3.4.m.34160,0.007678584,-0.011029485,No,NA,NA,NA,NA,NA,NA,endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase activity [GO:0016174]; peroxidase activity [GO:0004601]; adult chitin-based cuticle development [GO:0008365]; adult chitin-containing cuticle pigmentation [GO:0048085]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response to bacterium [GO:0042742]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; imaginal disc-derived wing morphogenesis [GO:0007476]; mucosal immune response [GO:0002385]; negative regulation of apoptotic process [GO:0043066]; reactive oxygen species metabolic process [GO:0072593]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; wing disc development [GO:0035220],NA,NA,NA
CHOYP_DUOX1.4.4.m.44613,-0.007907509,-0.024068736,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; DNA replication [GO:0006260]; negative regulation of histone acetylation [GO:0035067]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription; DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; regulation of mRNA stability [GO:0043488]; viral process [GO:0016032],NA,NA,NA
CHOYP_DVIR_GJ11008.1.1.m.11917,0.004757602,-0.019115537,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; RNA binding [GO:0003723]; autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176],NA,NA,NA
CHOYP_DVIR_GJ11267.1.1.m.29991,-0.016867896,0.002526737,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; oxidoreductase activity [GO:0016491]; retinal dehydrogenase activity [GO:0001758]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_DVIR_GJ13593.1.1.m.18124,-0.006407095,-0.00874225,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; positive regulation of ecdysteroid biosynthetic process [GO:0045998],NA,NA,NA
CHOYP_DVIR_GJ14588.1.1.m.25420,-0.005540883,0.002567933,No,NA,NA,NA,NA,NA,NA,pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455],NA,NA,NA
CHOYP_DVIR_GJ17679.2.3.m.46443,-0.000174047,-0.004354899,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; hydroxylysine kinase activity [GO:0047992]; lysine catabolic process [GO:0006554],NA,NA,NA
CHOYP_DVIR_GJ20612.1.1.m.14542,0.001601658,-0.013899704,No,NA,NA,NA,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; ribonucleoprotein complex [GO:1990904]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_DVIR_GJ21252.1.1.m.10086,-0.000524085,0.01609473,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063]; unfolded protein binding [GO:0051082]; bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of multicellular organism growth [GO:0040018]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_DVIR_GJ22204.1.1.m.17270,0.018468947,-0.007622919,No,NA,NA,NA,NA,NA,NA,D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1;2-dihydrobenzene-1;2-diol dehydrogenase activity [GO:0047115],NA,NA,NA
CHOYP_DVIR_GJ23521.1.1.m.2757,-0.013811517,-0.002304928,No,NA,NA,NA,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_DVL.2.2.m.40553,-0.000402371,-0.020983924,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; beta-catenin binding [GO:0008013]; ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_DWIL_GK10341.1.1.m.21304,-0.015688165,-0.005779175,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_DWIL_GK10525.1.1.m.56074,0.009861011,0.012177964,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; subsynaptic reticulum [GO:0071212]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; high mobility group box 1 binding [GO:0070379]; identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; defense response [GO:0006952]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; ectodermal cell fate specification [GO:0001715]; gastrulation involving germ band extension [GO:0010004]; germ cell migration [GO:0008354]; heart development [GO:0007507]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; melanization defense response [GO:0035006]; mesoderm development [GO:0007498]; mesodermal cell fate specification [GO:0007501]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system neuron development [GO:0048935]; plasmatocyte differentiation [GO:0042387]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of hemocyte proliferation [GO:0035206]; regulation of transcription; DNA-templated [GO:0006355]; response to cytokine [GO:0034097]; Toll signaling pathway [GO:0008063]; ventral cord development [GO:0007419],NA,NA,NA
CHOYP_DWIL_GK11849.1.1.m.12344,0.004465318,-0.004407144,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DWIL_GK15715.1.1.m.52399,-0.008391315,-0.007433597,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; potassium ion transmembrane transporter activity [GO:0015079]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; cell volume homeostasis [GO:0006884]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573],NA,NA,NA
CHOYP_DWIL_GK17319.1.1.m.58968,-0.014790299,0.015219214,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; ubiquitin conjugating enzyme activity [GO:0061631]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534],NA,NA,NA
CHOYP_DWIL_GK23042.1.1.m.38792,0.007100733,-0.017560539,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432],NA,NA,NA
CHOYP_DWIL_GK24328.1.1.m.16490,0.014771663,-4.99E-05,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_DWIL_GK25045.1.2.m.9225,0.015906453,0.013949849,No,NA,NA,NA,NA,NA,NA,apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; nucleus [GO:0005634]; chloride channel activity [GO:0005254]; voltage-gated ion channel activity [GO:0005244]; epithelial cell development [GO:0002064]; regulation of ion transmembrane transport [GO:0034765]; regulation of tube size [GO:0035150],NA,NA,NA
CHOYP_DWIL_GK25256.1.1.m.7275,-0.008439006,-0.010877654,No,NA,NA,NA,NA,NA,NA,endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_DX39B.2.3.m.18241,-0.003538599,-0.021810949,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; ATP-dependent RNA helicase activity [GO:0004004]; identical protein binding [GO:0042802]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; mRNA export from nucleus [GO:0006406]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; RNA secondary structure unwinding [GO:0010501]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784],NA,NA,NA
CHOYP_DYAK_GE11656.1.2.m.34706,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; H zone [GO:0031673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; compound eye photoreceptor cell differentiation [GO:0001751]; eye development [GO:0001654]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of female receptivity [GO:0045924]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; rhabdomere development [GO:0042052]; visual perception [GO:0007601],NA,NA,NA
CHOYP_DYAK_GE21870.1.1.m.28467,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DYAK_GE25081.2.3.m.43232,0.017453185,-0.012696003,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DYAK_GE25484.1.1.m.6273,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DYH1.1.1.m.46156,-0.022757164,-0.000653621,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]; sperm axoneme assembly [GO:0007288],NA,NA,NA
CHOYP_DYH2.1.1.m.28905,-0.021443055,-0.003146865,No,NA,NA,NA,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DYH8.2.2.m.45091,0.007846589,0.016269158,No,NA,NA,NA,NA,NA,NA,dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; sperm principal piece [GO:0097228]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_DYHC.1.3.m.10664,-0.021608968,-0.003464385,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DYHC1.1.1.m.2432,0.007298062,-0.014783058,No,NA,NA,NA,NA,NA,NA,azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; RNA binding [GO:0003723]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; cytoplasmic mRNA processing body assembly [GO:0033962]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic spindle organization [GO:0007052]; neutrophil degranulation [GO:0043312]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; stress granule assembly [GO:0034063],NA,NA,NA
CHOYP_DYHC2.2.2.m.31941,-0.016464312,-0.012301868,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_DYN1.2.3.m.30771,-0.003031285,-0.002355158,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane coat [GO:0030117]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynaptic endocytic zone membrane [GO:0098835]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; varicosity [GO:0043196]; D2 dopamine receptor binding [GO:0031749]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; clathrin-dependent endocytosis [GO:0072583]; endosome organization [GO:0007032]; G protein-coupled receptor internalization [GO:0002031]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle recycling [GO:1903423]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of synapse structure or activity [GO:0050803]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to amyloid-beta [GO:1904645]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_DYNLL2.2.2.m.37356,-0.008671284,0.011384512,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; myosin V complex [GO:0031475]; postsynaptic density [GO:0014069]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity; plus-end-directed [GO:2000582],NA,NA,NA
CHOYP_E_R_.1.1.m.63122,-0.004846754,0.002720281,No,NA,NA,NA,NA,NA,NA,cell cycle [GO:0007049]; positive regulation of Notch signaling pathway [GO:0045747]; pyrimidine nucleotide biosynthetic process [GO:0006221],NA,NA,NA
CHOYP_E2F4.1.1.m.25398,-0.013608848,0.001107054,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; centriole assembly [GO:0098534]; mitotic cell cycle [GO:0000278]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_E41L3.2.2.m.57999,-0.003513214,-0.025229075,No,NA,NA,NA,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; juxtaparanode region of axon [GO:0044224]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; cytoskeletal anchoring at plasma membrane [GO:0007016]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_EBNA1BP2.1.1.m.63216,-0.01124568,-0.008376219,No,NA,NA,NA,NA,NA,NA,nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_ECD.1.1.m.61798,0.0132634,-0.019507604,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_ECH1.1.1.m.29110,0.000438245,-0.006384573,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; peroxisome [GO:0005777]; delta3;5-delta2;4-dienoyl-CoA isomerase activity [GO:0051750]; signaling receptor binding [GO:0005102]; fatty acid beta-oxidation [GO:0006635],NA,NA,NA
CHOYP_ECHM.1.1.m.38462,0.002258817,0.005675414,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635],NA,NA,NA
CHOYP_ECHVI_0367.2.2.m.16808,0.017982598,-0.002387456,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ECM29.1.1.m.48083,0.000158514,-0.024083574,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; late endosome [GO:0005770]; multivesicular body [GO:0005771]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome binding [GO:0070628]; protein-containing complex scaffold activity [GO:0032947]; proteasome assembly [GO:0043248]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_ECMB.1.3.m.2566,5.19E-05,-0.00267162,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ECR.1.1.m.28368,-0.005509687,0.01419895,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; ecdysone binding [GO:0035100]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; ecdysone receptor-mediated signaling pathway [GO:0035076],NA,NA,NA
CHOYP_EDEM1.1.1.m.12175,0.004490181,0.010549208,No,NA,NA,NA,NA,NA,NA,aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1;2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport; ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466],NA,NA,NA
CHOYP_EDI_002780.1.1.m.31041,-0.02255948,0.009979405,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EDI_048910.1.2.m.31504,0.009333877,0.004073543,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EDRF1.2.2.m.45353,0.003235244,-0.005880739,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_EEA1.1.1.m.9573,0.008064512,0.004290819,No,NA,NA,NA,NA,NA,NA,axonal spine [GO:0044308]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extrinsic component of plasma membrane [GO:0019897]; recycling endosome [GO:0055037]; serine-pyruvate aminotransferase complex [GO:0005969]; 1-phosphatidylinositol binding [GO:0005545]; GTP-dependent protein binding [GO:0030742]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; endocytosis [GO:0006897]; vesicle fusion [GO:0006906]; viral RNA genome replication [GO:0039694],NA,NA,NA
CHOYP_EEF1A.2.3.m.20692,-0.00907727,0.013979717,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EEF1A.3.3.m.37430,-0.002292085,-0.002293863,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EEF2.1.2.m.44023,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_EEF2.1.2.m.44025,-0.009165684,-0.019877032,No,NA,NA,NA,NA,NA,NA,beta-catenin binding [GO:0008013]; response to ionizing radiation [GO:0010212],NA,NA,NA
CHOYP_EF.1A.6.9.m.43621,-0.004831766,0.006320068,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EF.1A.9.9.m.63037,-0.014294055,-0.001002528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EF1A.2.4.m.50858,0.020394774,0.005431303,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_EF1A.3.4.m.63413,0.014438564,0.001070093,No,NA,NA,NA,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; translation initiation factor activity [GO:0003743]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of RNA-directed 5'-3' RNA polymerase activity [GO:1900260],NA,NA,NA
CHOYP_EF1A.3.4.m.63416,-0.009154195,-0.015605006,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134]; positive regulation of protein ubiquitination [GO:0031398]; regulation of locomotor rhythm [GO:1904059],NA,NA,NA
CHOYP_EF1A.4.4.m.65743,-0.017945457,-0.004239879,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein phosphorylation [GO:0006468]; regulation of signal transduction by p53 class mediator [GO:1901796]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_EF1A2.1.3.m.30022,-0.003142641,0.002600513,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_EF1A2.2.3.m.37043,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EF1B.1.7.m.26504,0.013826603,-0.009842226,No,NA,NA,NA,NA,NA,NA,eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EF1B.2.7.m.30853,0.010910177,-0.021164164,No,NA,NA,NA,NA,NA,NA,eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EF1B.3.7.m.35082,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EF1G.1.3.m.12909,-0.007402613,-0.016634452,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; sarcolemma [GO:0042383]; calcium ion binding [GO:0005509]; phosphoprotein phosphatase activity [GO:0004721]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_EF1G.2.3.m.50676,0.016290482,-0.002714917,No,NA,NA,NA,NA,NA,NA,translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EF1G.3.3.m.63510,0.022032067,0.005168593,No,NA,NA,NA,NA,NA,NA,translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EF2.1.5.m.1541,-0.008679443,-0.021205612,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020]; mitochondrion [GO:0005739]; cellular response to hypoxia [GO:0071456]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_EF2.4.5.m.30185,-0.006167229,0.010217082,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; brain development [GO:0007420]; positive regulation of protein ubiquitination [GO:0031398]; progesterone receptor signaling pathway [GO:0050847]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_EF2.4.5.m.30186,0.021177369,-0.006962278,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_EF2.5.5.m.39855,-0.014087231,-0.02190294,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_EF2.5.5.m.39856,-0.016293135,-0.01475318,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573],NA,NA,NA
CHOYP_EFCAB1.1.1.m.43342,0.011899029,-0.000423959,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_EFCAB7.1.1.m.17862,-0.013190907,-0.010446799,No,NA,NA,NA,NA,NA,NA,ciliary membrane [GO:0060170]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_EFGM.1.1.m.16632,0.002317234,-0.017200145,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125],NA,NA,NA
CHOYP_EFHD2.1.1.m.22844,-0.009253265,0.012424344,No,NA,NA,NA,NA,NA,NA,membrane raft [GO:0045121]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_EFTS.2.2.m.66393,0.002556718,-0.015350119,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EGF1.1.2.m.46366,0.008447233,0.012428174,No,NA,NA,NA,NA,NA,NA,apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_EGFR.1.3.m.30285,0.011256117,-0.011381349,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; multicellular organism development [GO:0007275]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_EGFR.2.3.m.61781,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body; internal vesicle lumen [GO:0097489]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; synapse [GO:0045202]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; epidermal growth factor binding [GO:0048408]; epidermal growth factor-activated receptor activity [GO:0005006]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; kinase activity [GO:0016301]; nitric-oxide synthase regulator activity [GO:0030235]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]; activation of MAPKK activity [GO:0000186]; astrocyte activation [GO:0048143]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to amino acid stimulus [GO:0071230]; cellular response to cadmium ion [GO:0071276]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to growth factor stimulus [GO:0071363]; cellular response to mechanical stimulus [GO:0071260]; cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; circadian rhythm [GO:0007623]; digestive tract morphogenesis [GO:0048546]; diterpenoid metabolic process [GO:0016101]; embryonic placenta development [GO:0001892]; epidermal growth factor receptor signaling pathway [GO:0007173]; epidermis development [GO:0008544]; eyelid development in camera-type eye [GO:0061029]; hair follicle development [GO:0001942]; hydrogen peroxide metabolic process [GO:0042743]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; liver regeneration [GO:0097421]; lung development [GO:0030324]; magnesium ion homeostasis [GO:0010960]; midgut development [GO:0007494]; morphogenesis of an epithelial fold [GO:0060571]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiocyte differentiation [GO:1905208]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein catabolic process [GO:0042177]; neuron projection morphogenesis [GO:0048812]; ovulation cycle [GO:0042698]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of bone resorption [GO:0045780]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of inflammatory response [GO:0050729]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphorylation [GO:0042327]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of synaptic transmission; glutamatergic [GO:0051968]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of vasoconstriction [GO:0045907]; protein autophosphorylation [GO:0046777]; receptor-mediated endocytosis [GO:0006898]; regulation of cell proliferation [GO:0042127]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; response to calcium ion [GO:0051592]; response to cobalamin [GO:0033590]; response to hydroxyisoflavone [GO:0033594]; response to osmotic stress [GO:0006970]; response to UV-A [GO:0070141]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]; tongue development [GO:0043586]; translation [GO:0006412]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060],NA,NA,NA
CHOYP_EHHADH.1.1.m.26459,-0.009856444,-0.01849749,No,NA,NA,NA,NA,NA,NA,peroxisome [GO:0005777]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635],NA,NA,NA
CHOYP_EHI_072050.2.8.m.16931,-0.014708415,-0.0042397,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EHI_072050.5.8.m.47580,-0.004271163,0.004878859,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EHI_072050.7.8.m.61373,0.001329141,-0.013002763,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EHI_153670.1.2.m.21885,-0.010906258,0.004017755,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EHMT2.1.1.m.263,0.00315311,0.000750041,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; histone methylation [GO:0016571]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of embryonic development [GO:0045995]; response to fungicide [GO:0060992],NA,NA,NA
CHOYP_EIF1A.1.1.m.30303,0.007439734,0.013426819,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EIF1A.1.1.m.30304,0.011036848,-0.011300635,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; translation initiation factor activity [GO:0003743],NA,NA,NA
CHOYP_EIF1B.1.3.m.29107,-0.011518421,-0.001180095,No,NA,NA,NA,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_EIF2A.1.1.m.12752,0.007546416,0.002907933,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; eukaryotic translation initiation factor 2 complex [GO:0005850]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049]; regulation of translation [GO:0006417]; ribosome assembly [GO:0042255],NA,NA,NA
CHOYP_EIF3B.1.1.m.12232,0.017458752,-0.0108629,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex; eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; synapse [GO:0045202]; protein-containing complex scaffold activity [GO:0032947]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525],NA,NA,NA
CHOYP_EIF3C.1.1.m.7991,0.015290864,-0.012154136,No,NA,NA,NA,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_EIF3E.1.1.m.27167,-0.008073941,-0.017838622,No,NA,NA,NA,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex; eIF3e [GO:0071540]; nucleus [GO:0005634]; PML body [GO:0016605]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_EIF3G.1.1.m.29464,-0.002363437,0.015690068,No,NA,NA,NA,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_EIF3I.1.1.m.56504,0.013224819,0.005944812,No,NA,NA,NA,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_EIF3K.1.1.m.59650,-0.003381521,-0.011177296,No,NA,NA,NA,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleus [GO:0005634]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_EIF3L.1.1.m.7542,-0.003937865,-0.025277763,No,NA,NA,NA,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525],NA,NA,NA
CHOYP_EIF4BB.1.1.m.51065,-0.014297001,-0.017570805,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EIF4BB.1.1.m.51066,0.017564738,-0.003246481,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; polysome [GO:0005844]; postsynapse [GO:0098794]; ribosomal small subunit binding [GO:0043024]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation initiation factor activity [GO:0003743]; cytoplasmic translation [GO:0002181]; eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731],NA,NA,NA
CHOYP_EIF4H.3.3.m.57962,0.01035041,-0.005085672,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; cadherin binding [GO:0045296]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation factor activity; RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; cytoplasmic translation [GO:0002181]; developmental growth [GO:0048589]; eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446]; sexual reproduction [GO:0019953]; translational initiation [GO:0006413]; viral process [GO:0016032],NA,NA,NA
CHOYP_EIF5A.1.3.m.22684,0.000930592,-0.001271689,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; nuclear pore [GO:0005643]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; mRNA transport [GO:0051028]; positive regulation of translation [GO:0045727]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031]; translational frameshifting [GO:0006452],NA,NA,NA
CHOYP_EIN_155680.4.6.m.52358,-0.012588967,0.010034611,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EIN_155680.6.6.m.56323,-0.007231134,0.020600476,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EIN_201030.1.3.m.20334,0.019155022,0.007915567,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; positive regulation of smoothened signaling pathway [GO:0045880]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_ELDP2.1.2.m.39081,0.021224234,-0.01138965,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_ELDP2.2.2.m.40194,0.018823927,-0.012095918,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_ELMO1.1.1.m.59285,0.001049191,0.009467668,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; cell chemotaxis [GO:0060326]; cell-cell adhesion [GO:0098609]; cytoskeleton organization [GO:0007010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_ELOB.1.1.m.56270,0.012443693,-0.00050538,No,NA,NA,NA,NA,NA,NA,elongin complex [GO:0070449]; transcription factor complex [GO:0005667]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_ELOC.1.1.m.1299,-0.004601951,-0.003704175,No,NA,NA,NA,NA,NA,NA,elongin complex [GO:0070449]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_ELOV4.3.3.m.64203,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; transferase activity; transferring acyl groups other than amino-acyl groups [GO:0016747]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation; monounsaturated fatty acid [GO:0034625]; fatty acid elongation; polyunsaturated fatty acid [GO:0034626]; fatty acid elongation; saturated fatty acid [GO:0019367]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]; very long-chain fatty acid metabolic process [GO:0000038],NA,NA,NA
CHOYP_ELP1.2.2.m.29114,-0.000882737,-0.01320729,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Elongator holoenzyme complex [GO:0033588]; nucleolus [GO:0005730]; transcription elongation factor complex [GO:0008023]; phosphorylase kinase regulator activity [GO:0008607]; immune response [GO:0006955]; positive regulation of cell migration [GO:0030335]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098],NA,NA,NA
CHOYP_ELP2.1.1.m.18394,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; proteasome complex [GO:0000502]; transcription elongation factor complex [GO:0008023]; endopeptidase activator activity [GO:0061133]; proteasome assembly [GO:0043248]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098],NA,NA,NA
CHOYP_EMAL1.1.1.m.58030,-0.002446278,0.011100257,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]; brain development [GO:0007420]; hematopoietic progenitor cell differentiation [GO:0002244]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neuroblast proliferation [GO:0007405],NA,NA,NA
CHOYP_EMAL6.1.1.m.6370,-0.018761418,0.004097641,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule binding [GO:0008017],NA,NA,NA
CHOYP_EMC2.2.2.m.21018,-0.007317223,-0.019605817,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; ER membrane protein complex [GO:0072546]; nucleus [GO:0005634]; protein folding in endoplasmic reticulum [GO:0034975],NA,NA,NA
CHOYP_ENGASE.1.1.m.54655,0.010713756,-0.0011355,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [GO:0033925]; protein deglycosylation [GO:0006517],NA,NA,NA
CHOYP_ENO.1.2.m.7680,-0.006368025,-0.005204009,No,NA,NA,NA,NA,NA,NA,endosome membrane [GO:0010008]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456],NA,NA,NA
CHOYP_ENO.1.2.m.7681,0.014989948,0.015051857,No,NA,NA,NA,NA,NA,NA,phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_ENOPH.1.4.m.8576,0.011177055,0.008503275,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_ENOPH.3.4.m.51956,-0.015897646,-0.012801072,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; 2;3-diketo-5-methylthiopentyl-1-phosphate enolase activity [GO:0043715]; 2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity [GO:0043716]; acireductone synthase activity [GO:0043874]; magnesium ion binding [GO:0000287]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284],NA,NA,NA
CHOYP_ENOX2.1.1.m.7197,-0.001852055,-0.015214154,No,NA,NA,NA,NA,NA,NA,external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; oxidoreductase activity [GO:0016491]; ultradian rhythm [GO:0007624],NA,NA,NA
CHOYP_ENPEP.1.1.m.12765,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; angiotensin maturation [GO:0002003]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081],NA,NA,NA
CHOYP_ENPL.3.4.m.39476,0.003714701,-0.025150147,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; perinuclear region of cytoplasm [GO:0048471]; smooth endoplasmic reticulum [GO:0005790]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; cellular response to manganese ion [GO:0071287]; protein folding [GO:0006457]; response to hypoxia [GO:0001666]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_ENPL.4.4.m.47194,-0.001016179,0.024311072,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; perinuclear region of cytoplasm [GO:0048471]; smooth endoplasmic reticulum [GO:0005790]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; cellular response to manganese ion [GO:0071287]; protein folding [GO:0006457]; response to hypoxia [GO:0001666]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_ENPP3.1.1.m.13519,0.008143421,0.00213744,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleic acid binding [GO:0003676]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; toxin activity [GO:0090729]; immune response [GO:0006955],NA,NA,NA
CHOYP_ENS.1.3.m.25925,0.00799618,0.007595913,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ENTPD4.1.1.m.15533,-0.004815509,0.006365913,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_EP15R.1.1.m.14260,0.005943771,-0.005940484,No,NA,NA,NA,NA,NA,NA,clathrin coat of coated pit [GO:0030132]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059],NA,NA,NA
CHOYP_EPDR2.1.1.m.33988,0.017145183,-0.000256791,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EPN2.1.1.m.23660,-0.011083129,0.010391496,No,NA,NA,NA,NA,NA,NA,clathrin coat of endocytic vesicle [GO:0030128]; lipid binding [GO:0008289]; endocytosis [GO:0006897]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_EPN4.1.3.m.10807,-0.010217774,-0.016216128,No,NA,NA,NA,NA,NA,NA,clathrin-coated vesicle [GO:0030136]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; clathrin binding [GO:0030276]; lipid binding [GO:0008289]; endocytosis [GO:0006897],NA,NA,NA
CHOYP_EPN4.2.3.m.66030,0.012666506,0.001234326,No,NA,NA,NA,NA,NA,NA,clathrin-coated vesicle [GO:0030136]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; clathrin binding [GO:0030276]; lipid binding [GO:0008289]; endocytosis [GO:0006897],NA,NA,NA
CHOYP_EPRS.1.1.m.35443,0.004862777,0.003197021,No,NA,NA,NA,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proline-tRNA ligase activity [GO:0004827]; protein homodimerization activity [GO:0042803]; RNA stem-loop binding [GO:0035613]; zinc ion binding [GO:0008270]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; long-chain fatty acid import [GO:0044539]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433],NA,NA,NA
CHOYP_EPS.8.1.1.m.17522,0.00649687,0.00667333,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ER.1.2.m.14189,-0.022649945,0.010188984,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; estrogen receptor activity [GO:0030284]; sequence-specific DNA binding [GO:0043565]; steroid binding [GO:0005496]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_ERD22.1.1.m.12383,0.001556359,-0.01846577,No,NA,NA,NA,NA,NA,NA,cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; ER retention sequence binding [GO:0046923]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031],NA,NA,NA
CHOYP_ERF1.1.1.m.37539,0.01076472,0.006588367,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; translation release factor activity [GO:0003747],NA,NA,NA
CHOYP_ERF1.1.1.m.37540,-0.004212531,-0.024933661,No,NA,NA,NA,NA,NA,NA,mitochondrial outer membrane [GO:0005741]; pore complex [GO:0046930]; nucleotide binding [GO:0000166]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308],NA,NA,NA
CHOYP_ERF3A.1.1.m.57282,0.006759996,-0.020236333,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; translation release factor complex [GO:0018444]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation release factor activity [GO:0003747]; cytoplasmic translational termination [GO:0002184]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; translation [GO:0006412],NA,NA,NA
CHOYP_ERGI1.1.1.m.9684,0.003703902,-0.024541623,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_ERL2B.1.1.m.187,-0.013330774,-0.010223803,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase binding [GO:0031625]; cholesterol metabolic process [GO:0008203]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_ERP44.1.1.m.3853,0.00796738,-0.025362324,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_ERR3.1.1.m.25316,0.006864741,0.000564693,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; AF-2 domain binding [GO:0050682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription; DNA-templated [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384],NA,NA,NA
CHOYP_ES1.1.1.m.66406,-0.004764448,0.003981065,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_ESF1.1.1.m.15088,-0.000265388,0.019811948,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_EST1A.1.1.m.59161,0.010739077,-0.017414157,No,NA,NA,NA,NA,NA,NA,chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleolus [GO:0005730]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; DNA polymerase binding [GO:0070182]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; negative regulation of telomere capping [GO:1904354]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of RNA stability [GO:0043487]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_ETFD.1.1.m.6881,-0.003139415,-0.017193459,No,NA,NA,NA,NA,NA,NA,integral component of mitochondrial inner membrane [GO:0031305]; membrane [GO:0016020]; mitochondrial electron transfer flavoprotein complex [GO:0017133]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; 4 iron; 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxidoreductase activity; oxidizing metal ions with flavin as acceptor [GO:0043783]; quinone binding [GO:0048038]; ubiquinone binding [GO:0048039]; electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_EVI1.1.1.m.62064,0.006085703,-0.017263117,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726],NA,NA,NA
CHOYP_EVL.1.1.m.57134,0.000473402,0.000947338,No,NA,NA,NA,NA,NA,NA,bicellular tight junction [GO:0005923]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; actin cytoskeleton organization [GO:0030036]; actin polymerization or depolymerization [GO:0008154]; axon guidance [GO:0007411]; neural tube closure [GO:0001843]; positive regulation of actin filament polymerization [GO:0030838]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_EXC6B.1.1.m.38489,0.009415474,0.020328991,No,NA,NA,NA,NA,NA,NA,exocyst [GO:0000145]; membrane [GO:0016020]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_EXOC1.1.2.m.60,-0.001388067,0.013622762,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTP-Rho binding [GO:0017049]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; defense response to virus [GO:0051607]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of protein secretion [GO:0050714]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; viral process [GO:0016032],NA,NA,NA
CHOYP_EXOC2.1.3.m.360,0.003276447,-0.014303706,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; Ral GTPase binding [GO:0017160]; exocyst assembly [GO:0001927]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535],NA,NA,NA
CHOYP_EXOC4.1.2.m.4421,0.019696034,-0.007877067,No,NA,NA,NA,NA,NA,NA,cell leading edge [GO:0031252]; dendritic shaft [GO:0043198]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone [GO:0030426]; growth cone membrane [GO:0032584]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; chemical synaptic transmission [GO:0007268]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; Golgi to transport vesicle transport [GO:0055108]; membrane biogenesis [GO:0044091]; oligodendrocyte differentiation [GO:0048709]; positive regulation of calcium-mediated signaling [GO:0050850]; protein targeting to membrane [GO:0006612]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903]; vesicle tethering involved in exocytosis [GO:0090522],NA,NA,NA
CHOYP_EXOS3.1.1.m.10596,-0.017547906,-0.015722513,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; 3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; DNA deamination [GO:0045006]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000467]; isotype switching [GO:0045190]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; regulation of mRNA stability [GO:0043488]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475],NA,NA,NA
CHOYP_EXOS7.1.1.m.3323,0.002893509,-0.015650565,No,NA,NA,NA,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 3'-5'-exoribonuclease activity [GO:0000175]; AU-rich element binding [GO:0017091]; RNA binding [GO:0003723]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476],NA,NA,NA
CHOYP_EXOS9.1.1.m.12468,0.015796519,0.003236791,No,NA,NA,NA,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; nuclear exosome (RNase complex) [GO:0000176]; AU-rich element binding [GO:0017091]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476],NA,NA,NA
CHOYP_EXOSC10.1.1.m.39774,-0.017613992,-0.002783326,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; CUT catabolic process [GO:0071034]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_EXOSC2.1.1.m.9530,-0.009891945,-0.010715101,No,NA,NA,NA,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000467]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; U4 snRNA 3'-end processing [GO:0034475],NA,NA,NA
CHOYP_EZH2.1.1.m.47916,-0.002269895,-0.007153072,No,NA,NA,NA,NA,NA,NA,ESC/E(Z) complex [GO:0035098]; histone-lysine N-methyltransferase activity [GO:0018024]; promoter-specific chromatin binding [GO:1990841]; negative regulation of gene expression; epigenetic [GO:0045814]; rhythmic process [GO:0048511],NA,NA,NA
CHOYP_F10A1.2.4.m.11805,0.011471938,-0.008036794,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; protein dimerization activity [GO:0046983]; chaperone cofactor-dependent protein refolding [GO:0051085],NA,NA,NA
CHOYP_F10A1.4.4.m.44752,-0.004727982,0.011423193,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; protein dimerization activity [GO:0046983]; chaperone cofactor-dependent protein refolding [GO:0051085],NA,NA,NA
CHOYP_F172A.2.2.m.58797,-0.018280968,-0.002362837,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; chromatin silencing by small RNA [GO:0031048]; mRNA processing [GO:0006397]; neural crest cell development [GO:0014032]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_F179B.1.1.m.45817,0.007700139,-0.011914984,No,NA,NA,NA,NA,NA,NA,early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; ADP-ribosylation factor binding [GO:0030306]; ubiquitin binding [GO:0043130]; endocytic recycling [GO:0032456]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; negative regulation of amyloid-beta formation [GO:1902430]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein localization to cell surface [GO:0034394]; protein localization to lysosome [GO:0061462]; regulation of protein stability [GO:0031647],NA,NA,NA
CHOYP_F188B.1.1.m.8460,-0.003006888,0.022893349,No,NA,NA,NA,NA,NA,NA,thiol-dependent ubiquitinyl hydrolase activity [GO:0036459],NA,NA,NA
CHOYP_F48E3.8.1.1.m.46349,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_F91A1.1.1.m.52980,0.004889992,-0.014116582,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041],NA,NA,NA
CHOYP_FA13A.1.2.m.296,0.00656899,-0.000247561,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_FA13A.1.2.m.297,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,cleavage furrow [GO:0032154]; endosome [GO:0005768]; membrane [GO:0016020]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536],NA,NA,NA
CHOYP_FA49B.1.1.m.294,0.004963149,0.021358104,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; MHC class Ib protein binding; via antigen binding groove [GO:0023030]; platelet degranulation [GO:0002576]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916],NA,NA,NA
CHOYP_FA63B.1.1.m.52872,-0.014879512,0.003257568,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; cysteine-type carboxypeptidase activity [GO:0016807]; K11-linked polyubiquitin modification-dependent protein binding [GO:0071795]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K6-linked polyubiquitin modification-dependent protein binding [GO:0071796]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein K48-linked deubiquitination [GO:0071108],NA,NA,NA
CHOYP_FA65A.1.1.m.24019,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_FAAA.1.1.m.7653,-0.011196042,-0.005900993,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; fumarylacetoacetase activity [GO:0004334]; metal ion binding [GO:0046872]; homogentisate catabolic process [GO:1902000]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572],NA,NA,NA
CHOYP_FABP.1.2.m.51611,0.009048175,0.004945656,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; fatty acid binding [GO:0005504],NA,NA,NA
CHOYP_FABP2.1.2.m.5800,-0.001204782,-0.01328655,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FABP6.1.2.m.49858,0.014164621,0.01669321,No,NA,NA,NA,NA,NA,NA,lipid binding [GO:0008289],NA,NA,NA
CHOYP_FABP7.1.2.m.22674,0.003965394,0.009545785,No,NA,NA,NA,NA,NA,NA,cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; lipid binding [GO:0008289]; cell proliferation in forebrain [GO:0021846]; neurogenesis [GO:0022008]; prepulse inhibition [GO:0060134],NA,NA,NA
CHOYP_FABP7.2.2.m.29096,0.022824045,-0.003053348,No,NA,NA,NA,NA,NA,NA,cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; lipid binding [GO:0008289]; cell proliferation in forebrain [GO:0021846]; neurogenesis [GO:0022008]; prepulse inhibition [GO:0060134],NA,NA,NA
CHOYP_FACE1.1.1.m.13875,0.005534925,-0.001385126,No,NA,NA,NA,NA,NA,NA,integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; protein-containing complex [GO:0032991]; double-stranded DNA binding [GO:0003690]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; adult walking behavior [GO:0007628]; bone mineralization [GO:0030282]; CAAX-box protein processing [GO:0071586]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; CAMKK-AMPK signaling cascade [GO:0061762]; cardiac conduction [GO:0061337]; cardiac muscle fiber development [GO:0048739]; cardiac ventricle development [GO:0003231]; cellular lipid metabolic process [GO:0044255]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; epidermis development [GO:0008544]; growth plate cartilage development [GO:0003417]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; histone H2A phosphorylation [GO:1990164]; histone H2B acetylation [GO:0043969]; histone H2B-K5 acetylation [GO:0043979]; hypomethylation of CpG island [GO:0044029]; inflammatory cell apoptotic process [GO:0006925]; kidney morphogenesis [GO:0060993]; liver development [GO:0001889]; maintenance of rDNA [GO:0043007]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; neuromuscular process [GO:0050905]; nuclear envelope organization [GO:0006998]; nucleus organization [GO:0006997]; positive regulation of gene expression [GO:0010628]; prenylated protein catabolic process [GO:0030327]; protein processing [GO:0016485]; regulation of autophagy [GO:0010506]; regulation of blood circulation [GO:1903522]; regulation of bone mineralization [GO:0030500]; regulation of cell shape [GO:0008360]; regulation of cellular senescence [GO:2000772]; regulation of defense response to virus [GO:0050688]; regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043516]; regulation of DNA methylation [GO:0044030]; regulation of fibroblast proliferation [GO:0048145]; regulation of glucose metabolic process [GO:0010906]; regulation of heart contraction [GO:0008016]; regulation of histone H4 acetylation [GO:0090239]; regulation of histone H4-K16 acetylation [GO:2000618]; regulation of hormone metabolic process [GO:0032350]; regulation of lipid metabolic process [GO:0019216]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic cell cycle DNA replication [GO:1903463]; regulation of multicellular organism growth [GO:0040014]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of stress-activated protein kinase signaling cascade [GO:0070302]; regulation of termination of RNA polymerase I transcription [GO:2000730]; regulation of TOR signaling [GO:0032006]; regulation of transcription; DNA-templated [GO:0006355]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to DNA damage checkpoint signaling [GO:0072423]; thymus development [GO:0048538]; ventricular cardiac muscle tissue development [GO:0003229],NA,NA,NA
CHOYP_FAF1.1.1.m.35621,0.012051441,0.014348404,No,NA,NA,NA,NA,NA,NA,CD95 death-inducing signaling complex [GO:0031265]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; heat shock protein binding [GO:0031072]; NF-kappaB binding [GO:0051059]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of DNA replication [GO:0045740]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of protein complex assembly [GO:0031334]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell adhesion [GO:0030155]; regulation of protein catabolic process [GO:0042176],NA,NA,NA
CHOYP_FAF1.1.1.m.35623,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_FAF2.1.1.m.54271,0.002975876,0.018426919,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_FAIM1.1.1.m.36651,-0.005380564,-0.00113329,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066],NA,NA,NA
CHOYP_FAM122B.1.1.m.7361,-0.000169862,-0.006725195,No,NA,NA,NA,NA,NA,NA,protein serine/threonine phosphatase inhibitor activity [GO:0004865]; positive regulation of cell growth [GO:0030307]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436],NA,NA,NA
CHOYP_FAM193A.1.1.m.66343,-0.002457643,-0.004390659,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_FAM50.1.1.m.17123,-0.000894753,0.003163971,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_FANCJ.1.1.m.17513,0.004365423,-0.005738864,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; chiasma assembly [GO:0051026]; DNA repair [GO:0006281]; double-strand break repair involved in meiotic recombination [GO:1990918]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284],NA,NA,NA
CHOYP_FARP2.1.1.m.9404,-0.015692718,-0.008311282,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; cytoskeletal protein binding [GO:0008092]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; hair cycle process [GO:0022405]; neuron remodeling [GO:0016322]; osteoclast differentiation [GO:0030316]; podosome assembly [GO:0071800]; Rac protein signal transduction [GO:0016601]; regulation of integrin activation [GO:0033623]; regulation of Rho protein signal transduction [GO:0035023]; semaphorin-plexin signaling pathway [GO:0071526],NA,NA,NA
CHOYP_FAS2.1.1.m.41201,0.020753219,0.008043113,No,NA,NA,NA,NA,NA,NA,glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; cytoskeletal protein binding [GO:0008092]; fibroblast growth factor receptor binding [GO:0005104]; heparin binding [GO:0008201]; LRR domain binding [GO:0030275]; phosphatase binding [GO:0019902]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; axonal fasciculation [GO:0007413]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; response to activity [GO:0014823]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794],NA,NA,NA
CHOYP_FASN.3.4.m.60278,-0.003928611,-0.019769938,No,NA,NA,NA,NA,NA,NA,cell [GO:0005623]; (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; enoyl-[acyl-carrier-protein] reductase (NADPH; A-specific) activity [GO:0047117]; fatty acid synthase activity [GO:0004312]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]; single-stranded DNA binding [GO:0003697]; fatty acid biosynthetic process [GO:0006633]; lactate metabolic process [GO:0006089]; positive regulation of appetite [GO:0032100],NA,NA,NA
CHOYP_FAT1.2.4.m.36735,0.006412337,0.006653342,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; camera-type eye morphogenesis [GO:0048593]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; epithelial cell morphogenesis [GO:0003382]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],NA,NA,NA
CHOYP_FAT1.4.4.m.63315,-0.002592611,-0.010487927,No,NA,NA,NA,NA,NA,NA,apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],NA,NA,NA
CHOYP_FAT4.8.10.m.44748,0.009820998,-0.01890912,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; camera-type eye morphogenesis [GO:0048593]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; epithelial cell morphogenesis [GO:0003382]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],NA,NA,NA
CHOYP_FBLN2.1.1.m.25187,0.019325621,-0.017357565,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811],NA,NA,NA
CHOYP_FBX22.1.1.m.35385,-0.017487575,0.000761597,No,NA,NA,NA,NA,NA,NA,Z disc [GO:0030018],NA,NA,NA
CHOYP_FBX42.1.1.m.11569,-0.009535255,-0.002183823,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_FBX9.1.1.m.49865,-0.002772967,0.004369292,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin-protein transferase activity [GO:0004842]; fat cell differentiation [GO:0045444]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of TOR signaling [GO:0032006]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],NA,NA,NA
CHOYP_FCHO2.1.1.m.46242,-0.002605194,0.00884719,No,NA,NA,NA,NA,NA,NA,AP-2 adaptor complex [GO:0030122]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; presynaptic endocytic zone membrane [GO:0098835]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; phospholipid binding [GO:0005543]; tubulin binding [GO:0015631]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; plasma membrane tubulation [GO:0097320]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488],NA,NA,NA
CHOYP_FCL.1.1.m.13504,-0.009834621,0.004353159,No,NA,NA,NA,NA,NA,NA,coenzyme binding [GO:0050662]; GDP-L-fucose synthase activity [GO:0050577]; GDP-mannose 3;5-epimerase activity [GO:0047918]; identical protein binding [GO:0042802]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; T cell mediated cytotoxicity [GO:0001913],NA,NA,NA
CHOYP_FEN1.1.1.m.66181,-0.003818722,-0.007503833,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; DNA binding [GO:0003677]; flap endonuclease activity [GO:0048256]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; apoptotic DNA fragmentation [GO:0006309]; base-excision repair [GO:0006284]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication; removal of RNA primer [GO:0043137]; positive regulation of sister chromatid cohesion [GO:0045876],NA,NA,NA
CHOYP_FGD1.1.2.m.11030,0.011945024,0.014773033,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; animal organ morphogenesis [GO:0009887]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; G protein-coupled receptor signaling pathway [GO:0007186]; multicellular organism development [GO:0007275]; positive regulation of apoptotic process [GO:0043065]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_FGFR2.1.3.m.20151,-0.002532576,-0.001038122,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; alveolar secondary septum development [GO:0061144]; cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glucose homeostasis [GO:0042593]; lung development [GO:0030324]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; organ induction [GO:0001759]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphate ion homeostasis [GO:0055062]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of proteolysis [GO:0045862]; protein autophosphorylation [GO:0046777]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of lipid metabolic process [GO:0019216]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vitamin D3 metabolic process [GO:0070640],NA,NA,NA
CHOYP_FGFR2.2.3.m.53947,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; apoptotic process [GO:0006915]; cell proliferation in midbrain [GO:0033278]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; digestive tract development [GO:0048565]; midbrain development [GO:0030901]; positive regulation of cell proliferation [GO:0008284]; regulation of hematopoietic stem cell differentiation [GO:1902036]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_FGL1.1.6.m.30450,0.008436678,0.012334334,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615],NA,NA,NA
CHOYP_FHOD3.2.2.m.44837,-0.020381001,0.014889888,No,NA,NA,NA,NA,NA,NA,striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_FIBP.1.1.m.36402,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,endomembrane system [GO:0012505]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; fibroblast growth factor binding [GO:0017134],NA,NA,NA
CHOYP_FKBP12.1.1.m.32709,-0.003881272,-0.007134135,No,NA,NA,NA,NA,NA,NA,calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018]; calcium channel inhibitor activity [GO:0019855]; cyclic nucleotide binding [GO:0030551]; FK506 binding [GO:0005528]; ion channel binding [GO:0044325]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; signaling receptor binding [GO:0005102]; chaperone-mediated protein folding [GO:0061077]; insulin secretion [GO:0030073]; negative regulation of heart rate [GO:0010459]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; neuronal action potential propagation [GO:0019227]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of sequestering of calcium ion [GO:0051284]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; release of sequestered calcium ion into cytosol [GO:0051209]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to redox state [GO:0051775]; response to vitamin E [GO:0033197]; smooth muscle contraction [GO:0006939]; T cell proliferation [GO:0042098],NA,NA,NA
CHOYP_FKBP13.1.1.m.43694,0.019205974,-0.013858163,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_FKBP14.1.1.m.7244,-0.01234506,-0.000339852,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_FKBP1AA.1.1.m.26101,0.012193623,0.00928459,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic side of membrane [GO:0098562]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of organelle membrane [GO:0031312]; membrane [GO:0016020]; ryanodine receptor complex [GO:1990425]; sarcoplasmic reticulum membrane [GO:0033017]; terminal cisterna [GO:0014802]; Z disc [GO:0030018]; activin binding [GO:0048185]; calcium channel inhibitor activity [GO:0019855]; drug binding [GO:0008144]; FK506 binding [GO:0005528]; ion channel binding [GO:0044325]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]; amyloid fibril formation [GO:1990000]; cytokine-mediated signaling pathway [GO:0019221]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; muscle contraction [GO:0006936]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of immune response [GO:0050776]; regulation of protein localization [GO:0032880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; release of sequestered calcium ion into cytosol [GO:0051209]; response to caffeine [GO:0031000]; SMAD protein complex assembly [GO:0007183]; supramolecular fiber organization [GO:0097435]; T cell proliferation [GO:0042098]; ventricular cardiac muscle tissue morphogenesis [GO:0055010],NA,NA,NA
CHOYP_FKBP4.1.1.m.15147,0.008872906,-0.000777616,No,NA,NA,NA,NA,NA,NA,axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]; protein peptidyl-prolyl isomerization [GO:0000413],NA,NA,NA
CHOYP_FL2D.1.1.m.62439,-0.006646415,0.006059658,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; cell cycle [GO:0007049]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_FLELI_3104.1.1.m.46432,0.017808855,-0.008216214,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphotransferase activity; alcohol group as acceptor [GO:0016773]; 1;6-anhydro-N-acetyl-beta-muramic acid catabolic process [GO:0097175]; amino sugar metabolic process [GO:0006040]; carbohydrate metabolic process [GO:0005975]; peptidoglycan turnover [GO:0009254],NA,NA,NA
CHOYP_FLNA.1.6.m.11089,-0.001808934,-0.009184915,No,NA,NA,NA,NA,NA,NA,brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; actin cytoskeleton organization [GO:0030036]; cellular response to interferon-gamma [GO:0071346]; epithelial cell morphogenesis [GO:0003382]; keratinocyte development [GO:0003334]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_FLNA.2.6.m.11845,0.013182849,0.000160821,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport; nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation; actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_FLNA.6.6.m.37383,-0.00857286,0.011200849,No,NA,NA,NA,NA,NA,NA,brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; actin cytoskeleton organization [GO:0030036]; cellular response to interferon-gamma [GO:0071346]; epithelial cell morphogenesis [GO:0003382]; keratinocyte development [GO:0003334]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_FLNC.2.5.m.37450,-0.003902429,-0.004994315,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; defense response to virus [GO:0051607]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; wound healing; spreading of cells [GO:0044319],NA,NA,NA
CHOYP_FLNC.3.5.m.38669,0.004097038,0.006441769,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; defense response to virus [GO:0051607]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; wound healing; spreading of cells [GO:0044319],NA,NA,NA
CHOYP_FLNC.5.5.m.40834,0.009417346,0.02060036,No,NA,NA,NA,NA,NA,NA,costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; muscle fiber development [GO:0048747],NA,NA,NA
CHOYP_FLOT1.1.2.m.21435,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; flotillin complex [GO:0016600]; structural molecule activity [GO:0005198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_FLOT1.2.2.m.59727,-0.010159472,0.014216474,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; flotillin complex [GO:0016600]; structural molecule activity [GO:0005198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_FMRF.1.4.m.26285,0.007667938,-0.002446202,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218],NA,NA,NA
CHOYP_FMRF.2.4.m.37051,0.010725798,0.011248262,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FMRF.4.4.m.62077,-0.009257872,-0.001478001,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FMRP.1.2.m.37742,-0.014355031,-0.00364266,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; dendritic spine [GO:0043197]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; ribonucleoprotein granule [GO:0035770]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA strand annealing activity [GO:0033592]; translation regulator activity [GO:0045182]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; negative regulation of translation [GO:0017148]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of translation [GO:0045727]; regulation of mRNA stability [GO:0043488],NA,NA,NA
CHOYP_FND2.1.4.m.8542,-0.008743982,-0.024877552,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_FND2.3.4.m.40482,0.022499976,-0.010538524,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_FND2.4.4.m.44570,0.012476671,0.000313819,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_FNTA.1.1.m.40996,-0.004473299,-0.001634316,No,NA,NA,NA,NA,NA,NA,CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; protein farnesyltransferase complex [GO:0005965]; acetylcholine receptor regulator activity [GO:0030548]; alpha-tubulin binding [GO:0043014]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; microtubule binding [GO:0008017]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661]; Rab geranylgeranyltransferase activity [GO:0004663]; receptor tyrosine kinase binding [GO:0030971]; neurotransmitter receptor metabolic process [GO:0045213]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of tubulin deacetylation [GO:0090044]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_FNTB.1.1.m.45546,0.01630256,-0.009569913,No,NA,NA,NA,NA,NA,NA,protein farnesyltransferase complex [GO:0005965]; farnesyltranstransferase activity [GO:0004311]; protein farnesyltransferase activity [GO:0004660]; zinc ion binding [GO:0008270]; negative regulation of cell proliferation [GO:0008285]; positive regulation of fibroblast proliferation [GO:0048146]; protein farnesylation [GO:0018343]; protein prenylation [GO:0018342]; wound healing [GO:0042060],NA,NA,NA
CHOYP_FOCAD.2.2.m.52366,-0.010245297,-0.008952796,No,NA,NA,NA,NA,NA,NA,focal adhesion [GO:0005925]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_FOXF1.1.1.m.4194,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region DNA binding [GO:0044212]; animal organ morphogenesis [GO:0009887]; blood vessel development [GO:0001568]; cardiac left ventricle morphogenesis [GO:0003214]; cell-cell adhesion [GO:0098609]; cellular response to cytokine stimulus [GO:0071345]; cellular response to organic cyclic compound [GO:0071407]; detection of wounding [GO:0014822]; determination of left/right symmetry [GO:0007368]; digestive tract development [GO:0048565]; ductus arteriosus closure [GO:0097070]; embryonic digestive tract development [GO:0048566]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic ectodermal digestive tract morphogenesis [GO:0048613]; embryonic foregut morphogenesis [GO:0048617]; endocardial cushion development [GO:0003197]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lateral mesodermal cell differentiation [GO:0048371]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; lung morphogenesis [GO:0060425]; lung vasculature development [GO:0060426]; mesenchyme migration [GO:0090131]; mesoderm development [GO:0007498]; midgut development [GO:0007494]; morphogenesis of a branching structure [GO:0001763]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of smooth muscle cell differentiation [GO:0051150]; renal system development [GO:0072001]; respiratory tube development [GO:0030323]; right lung morphogenesis [GO:0060461]; smooth muscle cell differentiation [GO:0051145]; smoothened signaling pathway [GO:0007224]; somitogenesis [GO:0001756]; trachea development [GO:0060438]; ureter development [GO:0072189]; vasculogenesis [GO:0001570]; venous blood vessel development [GO:0060841],NA,NA,NA
CHOYP_FOXK2.1.1.m.56318,-0.009507642,0.014193251,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; magnesium ion binding [GO:0000287]; sequence-specific DNA binding [GO:0043565]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_FOXN2_3.1.1.m.8518,0.000263176,0.003449034,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; cell cycle [GO:0007049],NA,NA,NA
CHOYP_FREM1.1.1.m.55119,0.003606978,-0.006287989,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cell communication [GO:0007154]; cell-matrix adhesion [GO:0007160]; craniofacial suture morphogenesis [GO:0097094],NA,NA,NA
CHOYP_FREM2.1.1.m.31430,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cell communication [GO:0007154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_FRIS.10.11.m.66055,0.003025972,0.003463021,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826],NA,NA,NA
CHOYP_FRIS.6.11.m.44036,-0.001936392,-0.003868827,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826],NA,NA,NA
CHOYP_FRIS.9.11.m.53958,-0.0034231,0.004395436,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FRIY.1.1.m.5052,0.01760453,-0.018564016,No,NA,NA,NA,NA,NA,NA,cell [GO:0005623]; extracellular region [GO:0005576]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826],NA,NA,NA
CHOYP_FRM4B.1.1.m.2249,-0.003449302,-0.024679758,No,NA,NA,NA,NA,NA,NA,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein binding; bridging [GO:0030674]; establishment of epithelial cell polarity [GO:0090162],NA,NA,NA
CHOYP_FRRS1.2.3.m.41025,0.021765177,-0.002974215,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_FUCL1.1.1.m.28893,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; regulation of cellular defense response [GO:0010185]; regulation of complement activation; lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088],NA,NA,NA
CHOYP_FUCO.1.2.m.58756,0.003143404,-0.016006358,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_FUCO.2.2.m.58905,-0.002356016,-0.012479435,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_FUCO2.1.1.m.64139,-0.00191524,-0.020225974,No,NA,NA,NA,NA,NA,NA,azurophil granule lumen [GO:0035578]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; cellular protein metabolic process [GO:0044267]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]; neutrophil degranulation [GO:0043312]; post-translational protein modification [GO:0043687]; regulation of entry of bacterium into host cell [GO:2000535]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_FUK.1.1.m.17020,-0.0005206,-0.006511987,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; fucokinase activity [GO:0050201]; carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352]; response to dopamine [GO:1903350],NA,NA,NA
CHOYP_FUMH.2.2.m.55401,-0.004809145,-0.004998095,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_FUT2.4.5.m.54048,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_FUT8.1.1.m.9231,-0.00955084,-0.0026986,No,NA,NA,NA,NA,NA,NA,Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]; GDP-L-fucose metabolic process [GO:0046368]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279],NA,NA,NA
CHOYP_FUTSC.1.4.m.10187,-0.013034584,-0.001977611,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FUTSC.3.4.m.18545,-0.018707391,0.004543444,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FUTSC.4.4.m.59503,-0.010003371,-0.023076437,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FYN.1.1.m.44312,0.005386817,0.014546256,No,NA,NA,NA,NA,NA,NA,Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; endosome [GO:0005768]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; actin filament network formation [GO:0051639]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cell migration [GO:0016477]; lamellipodium organization [GO:0097581]; maintenance of cell polarity [GO:0030011]; microtubule organizing center localization [GO:0061842]; orbitofrontal cortex development [GO:0021769]; smooth muscle cell migration [GO:0014909],NA,NA,NA
CHOYP_FYNA.1.1.m.63901,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; connexin binding [GO:0071253]; growth factor receptor binding [GO:0070851]; heme binding [GO:0020037]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; progesterone receptor signaling pathway [GO:0050847]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_FYV1.1.1.m.41923,0.006474501,0.007392787,No,NA,NA,NA,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; vesicle membrane [GO:0012506]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556]; myelin assembly [GO:0032288]; protein localization to nucleus [GO:0034504]; regulation of autophagosome assembly [GO:2000785]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_FZD7A.1.1.m.29589,0.006962163,-0.004409691,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_G6PD.1.2.m.38380,-0.001143321,-0.010075664,No,NA,NA,NA,NA,NA,NA,cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; glucose binding [GO:0005536]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADP metabolic process [GO:0006739]; NADPH regeneration [GO:0006740]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt; oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390],NA,NA,NA
CHOYP_G6PD.2.2.m.46923,-0.008844456,0.009415428,No,NA,NA,NA,NA,NA,NA,cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; glucose binding [GO:0005536]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADP metabolic process [GO:0006739]; NADPH regeneration [GO:0006740]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt; oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390],NA,NA,NA
CHOYP_GABPA.1.1.m.15077,-0.002855445,0.005353338,No,NA,NA,NA,NA,NA,NA,nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cellular response to dopamine [GO:1903351]; mitochondrion organization [GO:0007005]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_GADL1.1.1.m.14433,0.001996645,0.000996589,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; L-cysteine catabolic process to hypotaurine [GO:0019449]; L-cysteine catabolic process to taurine [GO:0019452]; taurine biosynthetic process [GO:0042412],NA,NA,NA
CHOYP_GAK.1.1.m.7017,-0.009546609,0.002962239,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; vesicle [GO:0031982]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; cyclin binding [GO:0030332]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; chaperone cofactor-dependent protein refolding [GO:0051085]; clathrin coat disassembly [GO:0072318]; clathrin-coated pit assembly [GO:1905224]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum organization [GO:0007029]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; membrane organization [GO:0061024]; negative regulation of neuron projection development [GO:0010977]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle uncoating [GO:0016191],NA,NA,NA
CHOYP_GALK2.1.2.m.5222,0.007923374,0.019129276,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; galactose binding [GO:0005534]; N-acetylgalactosamine kinase activity [GO:0033858]; galactose catabolic process via UDP-galactose [GO:0033499],NA,NA,NA
CHOYP_GALNS.1.1.m.66165,-0.021945266,0.000415799,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; metal ion binding [GO:0046872]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890],NA,NA,NA
CHOYP_GALT1.1.1.m.33853,0.006533858,-0.000384222,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation [GO:0006493],NA,NA,NA
CHOYP_GALT2.1.1.m.54493,-0.004168502,0.017462998,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; immunoglobulin biosynthetic process [GO:0002378]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243],NA,NA,NA
CHOYP_GAR1.1.2.m.9449,-0.011758024,0.003968357,No,NA,NA,NA,NA,NA,NA,box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; Cajal body [GO:0015030]; dense fibrillar component [GO:0001651]; fibrillar center [GO:0001650]; nuclear chromosome; telomeric region [GO:0000784]; telomerase holoenzyme complex [GO:0005697]; box H/ACA snoRNA binding [GO:0034513]; snoRNA binding [GO:0030515]; telomerase RNA binding [GO:0070034]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_GATA1.1.2.m.16576,0.00612084,0.000320295,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; blastoderm segmentation [GO:0007350]; cardioblast cell fate determination [GO:0007510]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cell differentiation [GO:0030154]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; digestive tract development [GO:0048565]; dorsal closure [GO:0007391]; ectoderm development [GO:0007398]; embryonic heart tube development [GO:0035050]; endoderm development [GO:0007492]; heart contraction [GO:0060047]; heart development [GO:0007507]; lymph gland development [GO:0048542]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; pattern specification process [GO:0007389]; pericardial nephrocyte differentiation [GO:0061320]; pigment metabolic process [GO:0042440]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of antimicrobial peptide biosynthetic process [GO:0002805]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_GATAD1.1.1.m.50020,0.022138201,-0.002751411,No,NA,NA,NA,NA,NA,NA,I band [GO:0031674]; nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_GATC.1.2.m.2975,-0.007168355,-0.007209288,No,NA,NA,NA,NA,NA,NA,glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of translational fidelity [GO:0006450],NA,NA,NA
CHOYP_GBB.2.2.m.35274,-0.004189863,0.008328755,No,NA,NA,NA,NA,NA,NA,nuclear envelope [GO:0005635]; 3'-5' exonuclease activity [GO:0008408]; nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_GBLP.3.7.m.20931,0.016862217,-0.016202428,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_GBLP.6.7.m.57427,0.019702342,0.014143647,No,NA,NA,NA,NA,NA,NA,actin cortical patch [GO:0030479]; apical plasma membrane [GO:0016324]; dynactin complex [GO:0005869]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]; actin filament binding [GO:0051015]; protein heterodimerization activity [GO:0046982]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; germarium-derived oocyte fate determination [GO:0007294]; microtubule-based movement [GO:0007018]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of JNK cascade [GO:0046329]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; wing disc development [GO:0035220],NA,NA,NA
CHOYP_GCC2.1.1.m.17251,-0.010152062,-0.002939584,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]; identical protein binding [GO:0042802]; Golgi ribbon formation [GO:0090161]; late endosome to Golgi transport [GO:0034499]; microtubule anchoring [GO:0034453]; microtubule organizing center organization [GO:0031023]; protein localization to Golgi apparatus [GO:0034067]; protein targeting to lysosome [GO:0006622]; recycling endosome to Golgi transport [GO:0071955]; regulation of protein exit from endoplasmic reticulum [GO:0070861]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_GCKR.1.1.m.51743,-0.004402161,-0.019821401,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; fructose-6-phosphate binding [GO:0070095]; carbohydrate derivative metabolic process [GO:1901135]; carbohydrate metabolic process [GO:0005975]; negative regulation of glucokinase activity [GO:0033132],NA,NA,NA
CHOYP_GCN1L.1.1.m.1352,0.012944484,-0.015726988,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; polysome [GO:0005844]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_GCP2.1.1.m.23103,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225],NA,NA,NA
CHOYP_GCSP.1.1.m.46644,-0.021183857,0.00438417,No,NA,NA,NA,NA,NA,NA,glycine cleavage complex [GO:0005960]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; lyase activity [GO:0016829]; protein homodimerization activity [GO:0042803]; pyridoxal binding [GO:0070280]; pyridoxal phosphate binding [GO:0030170]; cellular response to leukemia inhibitory factor [GO:1990830]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255],NA,NA,NA
CHOYP_GCST.1.1.m.16047,-0.0058286,0.018147446,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464],NA,NA,NA
CHOYP_GCY.2.4.m.33243,-1.44E-06,-0.013488523,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood vessel size [GO:0050880]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_GD1L1.1.1.m.11963,0.008054703,-0.004441034,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrion [GO:0005739]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; mitochondrion organization [GO:0007005]; protein targeting to mitochondrion [GO:0006626]; response to retinoic acid [GO:0032526],NA,NA,NA
CHOYP_GDAP2.1.1.m.57049,-0.015685763,0.002400071,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_GDE.1.1.m.54948,0.004183317,-0.003681757,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; inclusion body [GO:0016234]; isoamylase complex [GO:0043033]; nucleus [GO:0005634]; sarcoplasmic reticulum [GO:0016529]; secretory granule lumen [GO:0034774]; 4-alpha-glucanotransferase activity [GO:0004134]; amylo-alpha-1;6-glucosidase activity [GO:0004135]; beta-maltose 4-alpha-glucanotransferase activity [GO:0102500]; glycogen debranching enzyme activity [GO:0004133]; polysaccharide binding [GO:0030247]; polyubiquitin modification-dependent protein binding [GO:0031593]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; neutrophil degranulation [GO:0043312]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584],NA,NA,NA
CHOYP_GDS1B.1.1.m.52257,0.013374584,-4.29E-05,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; GTPase activator activity [GO:0005096]; Ral GTPase binding [GO:0017160]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_GEK.1.1.m.4939,0.01880335,-0.011372945,No,NA,NA,NA,NA,NA,NA,actomyosin [GO:0042641]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_GELS2.2.2.m.30443,0.014550012,0.022092926,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; actin filament capping [GO:0051693],NA,NA,NA
CHOYP_GEMIN5.2.2.m.59078,0.005851636,-0.00753338,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622]; regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412],NA,NA,NA
CHOYP_GEPH.1.2.m.49093,-0.015397334,-0.005520795,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; postsynaptic specialization membrane [GO:0099634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin cofactor binding [GO:0043546]; molybdopterin molybdotransferase activity [GO:0061599]; nitrate reductase activity [GO:0008940]; establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdenum incorporation into molybdenum-molybdopterin complex [GO:0018315]; molybdopterin cofactor biosynthetic process [GO:0032324]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; response to metal ion [GO:0010038],NA,NA,NA
CHOYP_GFM2.1.1.m.18396,-0.01809841,-0.014745894,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translation [GO:0032543]; ribosome disassembly [GO:0032790],NA,NA,NA
CHOYP_GGPPS.1.1.m.12124,0.009677365,0.011318501,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; dimethylallyltranstransferase activity [GO:0004161]; farnesyltranstransferase activity [GO:0004311]; geranyltranstransferase activity [GO:0004337]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid metabolic process [GO:0006720]; regulation of cholesterol biosynthetic process [GO:0045540],NA,NA,NA
CHOYP_GIGA2.1.1.m.44916,0.021640234,-0.011153148,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_GIGA3.1.1.m.42774,0.021383601,0.003826549,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_GIGA4.1.3.m.10521,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_GIGA4.2.3.m.41265,0.001878171,-0.017731603,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_GIGA5.3.4.m.17227,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_GIGA5.4.4.m.39598,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_GIGA6.1.1.m.38687,0.020900212,-0.009922087,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_GIMA4.4.7.m.42250,0.012929198,-0.012727448,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; GTP binding [GO:0005525],NA,NA,NA
CHOYP_GINS3.1.1.m.18574,-0.015473984,-0.015435394,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_GIPC1.1.1.m.60630,0.007871762,-0.020064599,No,NA,NA,NA,NA,NA,NA,brush border [GO:0005903]; cell cortex [GO:0005938]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506]; actin binding [GO:0003779]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; cellular response to interleukin-7 [GO:0098761]; chemical synaptic transmission [GO:0007268]; endothelial cell migration [GO:0043542]; glutamate secretion [GO:0014047]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cytokinesis [GO:0032467]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting [GO:0006605]; regulation of protein stability [GO:0031647]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle exocytosis [GO:2000300],NA,NA,NA
CHOYP_GIT1.1.2.m.26059,0.015935458,-0.000998573,No,NA,NA,NA,NA,NA,NA,calyx of Held [GO:0044305]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ephrin receptor signaling pathway [GO:0048013]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of cytokinesis [GO:0032465]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of synaptic vesicle exocytosis [GO:2000300],NA,NA,NA
CHOYP_GKAP1.1.1.m.18792,0.008684872,-0.01889866,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_GLB1L2.1.1.m.5029,0.016529719,0.014048359,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_GLCM.2.3.m.40511,-0.006545888,0.016822804,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; glucosylceramidase activity [GO:0004348]; hydrolase activity [GO:0016787]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; autophagosome organization [GO:1905037]; beta-glucoside catabolic process [GO:1901805]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; glucosylceramide catabolic process [GO:0006680]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein complex disassembly [GO:0043243]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; regulation of cellular protein metabolic process [GO:0032268]; regulation of protein metabolic process [GO:0051246]; regulation of water loss via skin [GO:0033561]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin morphogenesis [GO:0043589]; sphingosine biosynthetic process [GO:0046512]; termination of signal transduction [GO:0023021],NA,NA,NA
CHOYP_GLIPR1L1.1.1.m.41745,0.022844529,-0.001408731,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; peptidase inhibitor activity [GO:0030414]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_GLMN.1.1.m.17085,-0.014136098,0.000560858,No,NA,NA,NA,NA,NA,NA,Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; hepatocyte growth factor receptor binding [GO:0005171]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase inhibitor activity [GO:0055105]; cell surface receptor signaling pathway [GO:0007166]; circulatory system development [GO:0072359]; muscle cell differentiation [GO:0042692]; negative regulation of cell proliferation [GO:0008285]; negative regulation of T cell proliferation [GO:0042130]; neural tube closure [GO:0001843]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of phosphorylation [GO:0042327]; regulation of gene expression; epigenetic [GO:0040029]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; vasculogenesis [GO:0001570],NA,NA,NA
CHOYP_GLNA.1.5.m.1591,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; neurotransmitter receptor metabolic process [GO:0045213]; synapse assembly [GO:0007416],NA,NA,NA
CHOYP_GLNA2.1.4.m.4133,0.019668662,0.006777938,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; neurotransmitter receptor metabolic process [GO:0045213]; synapse assembly [GO:0007416],NA,NA,NA
CHOYP_GLNA2.1.4.m.4134,0.009580562,-0.00336283,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_GLO1.1.1.m.32382,-0.010405545,-0.016799235,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_GLOD5.1.1.m.25831,-0.008285193,0.006361698,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_GLRX2.1.1.m.19246,-0.009115928,0.005628835,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_GLRX3.1.1.m.63529,0.000265712,0.006244497,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; [2Fe-2S] cluster assembly [GO:0044571]; cell redox homeostasis [GO:0045454]; cellular iron ion homeostasis [GO:0006879]; protein maturation by iron-sulfur cluster transfer [GO:0097428],NA,NA,NA
CHOYP_GLT13.2.2.m.10604,-0.002666188,-0.004750438,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243],NA,NA,NA
CHOYP_GM2A.2.3.m.19346,0.009980875,0.013558147,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; beta-N-acetylgalactosaminidase activity [GO:0032428]; beta-N-acetylhexosaminidase activity [GO:0004563]; enzyme activator activity [GO:0008047]; lipid transporter activity [GO:0005319]; phospholipase activator activity [GO:0016004]; ganglioside catabolic process [GO:0006689]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; nervous system process [GO:0050877]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313]; positive regulation of hydrolase activity [GO:0051345],NA,NA,NA
CHOYP_GMCLL.1.1.m.15031,0.007197402,0.000201824,No,NA,NA,NA,NA,NA,NA,nuclear matrix [GO:0016363]; identical protein binding [GO:0042802]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_GMDS.1.1.m.28602,-0.0087609,-0.000710437,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; GDP-mannose 4;6-dehydratase activity [GO:0008446]; identical protein binding [GO:0042802]; NADP+ binding [GO:0070401]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; Notch signaling pathway [GO:0007219],NA,NA,NA
CHOYP_GMEB1.1.1.m.8284,-0.000753788,-0.023183127,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_GMFB.2.2.m.54955,0.004344722,-0.021936324,No,NA,NA,NA,NA,NA,NA,actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; growth factor activity [GO:0008083]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316],NA,NA,NA
CHOYP_GMPAA.1.1.m.1432,0.01770089,-0.019149801,No,NA,NA,NA,NA,NA,NA,GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]; GDP-mannose biosynthetic process [GO:0009298],NA,NA,NA
CHOYP_GMPR2.1.1.m.63274,0.004904378,-0.011523135,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; GMP reductase complex [GO:1902560]; GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]; GMP metabolic process [GO:0046037]; purine nucleobase metabolic process [GO:0006144]; purine ribonucleotide interconversion [GO:0015951]; purine-containing compound salvage [GO:0043101],NA,NA,NA
CHOYP_GNA1.1.1.m.39198,-0.012273313,0.003864615,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; glucosamine 6-phosphate N-acetyltransferase activity [GO:0004343]; monosaccharide binding [GO:0048029]; N-acetylglucosamine biosynthetic process [GO:0006045]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],NA,NA,NA
CHOYP_GNAI.1.1.m.26096,-0.003563544,0.013708001,No,NA,NA,NA,NA,NA,NA,G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188],NA,NA,NA
CHOYP_GNAO.1.1.m.37355,-0.002699208,0.016407278,No,NA,NA,NA,NA,NA,NA,G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188],NA,NA,NA
CHOYP_GNAQ.1.1.m.20698,-0.011645447,-0.012747387,No,NA,NA,NA,NA,NA,NA,G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186],NA,NA,NA
CHOYP_GNAS.3.3.m.55756,0.001427587,-0.015363863,No,NA,NA,NA,NA,NA,NA,G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186],NA,NA,NA
CHOYP_GNBPB3.1.1.m.55379,0.021747178,0.003988956,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; (1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_GNPI2.1.1.m.55897,-0.018137333,-0.015845276,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; glucosamine-6-phosphate deaminase activity [GO:0004342]; identical protein binding [GO:0042802]; carbohydrate metabolic process [GO:0005975]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],NA,NA,NA
CHOYP_GOGB1.1.2.m.26408,-0.006177608,0.00367003,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_GOGB1.2.2.m.66418,0.009531851,0.007847925,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_GOLGA4.1.3.m.4761,-0.013318052,-0.000960242,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; GTPase binding [GO:0051020]; Golgi to plasma membrane protein transport [GO:0043001]; positive regulation of axon extension [GO:0045773],NA,NA,NA
CHOYP_GOLGA4.3.3.m.55461,0.007063841,-0.020494463,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]; GTPase binding [GO:0051020]; Golgi to plasma membrane protein transport [GO:0043001]; positive regulation of axon extension [GO:0045773]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_GOLI4.2.4.m.15493,0.013463637,0.000570797,No,NA,NA,NA,NA,NA,NA,cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133],NA,NA,NA
CHOYP_GOLI4.3.4.m.29146,-0.002427437,0.003026004,No,NA,NA,NA,NA,NA,NA,cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133],NA,NA,NA
CHOYP_GOLP3.1.1.m.52389,-0.005895412,0.010713642,No,NA,NA,NA,NA,NA,NA,cleavage furrow [GO:0032154]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; Rab GTPase binding [GO:0017137]; actomyosin contractile ring assembly [GO:0000915]; cleavage furrow formation [GO:0036089]; Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly [GO:0090307]; retrograde transport; vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; spindle assembly [GO:0051225]; spindle assembly involved in male meiosis [GO:0007053],NA,NA,NA
CHOYP_GOPC.1.1.m.45489,0.003224149,-0.003224496,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; trans-Golgi network transport vesicle [GO:0030140]; frizzled binding [GO:0005109]; GTPase regulator activity [GO:0030695]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; syntaxin binding [GO:0019905]; autophagy [GO:0006914]; cytoplasmic sequestering of CFTR protein [GO:0043004]; negative regulation of anion channel activity [GO:0010360]; negative regulation of protein localization to cell surface [GO:2000009]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; spermatid nucleus differentiation [GO:0007289],NA,NA,NA
CHOYP_GPAT4.1.1.m.56178,-0.007733071,0.014044892,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432],NA,NA,NA
CHOYP_GPC6.1.1.m.64926,-0.005705549,-0.013892931,No,NA,NA,NA,NA,NA,NA,anchored component of plasma membrane [GO:0046658]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; cell migration [GO:0016477]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of signal transduction [GO:0009966],NA,NA,NA
CHOYP_GPCP1.1.1.m.11490,-0.008924,0.000432683,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; glycerophosphocholine phosphodiesterase activity [GO:0047389]; starch binding [GO:2001070]; glycerophospholipid catabolic process [GO:0046475]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_GPDA.1.2.m.6967,-0.006848005,0.008924273,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; glycerol-3-phosphate dehydrogenase complex [GO:0009331]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368]; glycerol-3-phosphate dehydrogenase [NAD(P)+] activity [GO:0047952]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; carbohydrate metabolic process [GO:0005975]; cellular response to cAMP [GO:0071320]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerolipid metabolic process [GO:0046486]; glycerophosphate shuttle [GO:0006127]; NADH metabolic process [GO:0006734]; NADH oxidation [GO:0006116]; positive regulation of glycolytic process [GO:0045821],NA,NA,NA
CHOYP_GPDA.2.2.m.30755,0.010320046,-0.004116041,No,NA,NA,NA,NA,NA,NA,glycerol-3-phosphate dehydrogenase complex [GO:0009331]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; carbohydrate metabolic process [GO:0005975]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerophospholipid metabolic process [GO:0006650],NA,NA,NA
CHOYP_GPM6A.1.1.m.41817,0.004337159,0.011657813,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; extracellular matrix assembly [GO:0085029]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of serotonin uptake [GO:0051612]; neuron projection development [GO:0031175]; ossification [GO:0001503]; positive regulation of bone mineralization [GO:0030501]; protein transport [GO:0015031]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of focal adhesion assembly [GO:0051893],NA,NA,NA
CHOYP_GPMA.1.1.m.35689,9.67E-06,0.021665305,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; phagocytic vesicle [GO:0045335]; bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_GPN3.1.2.m.6649,0.003437029,-0.006689324,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; growth cone leading edge [GO:0061850]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actin polymerization-dependent cell motility [GO:0070358]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cellular response to nerve growth factor stimulus [GO:1990090]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; membrane organization [GO:0061024],NA,NA,NA
CHOYP_GPR98.4.5.m.21296,0.007941026,0.0086736,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_GPSM2.1.1.m.58301,-0.020601009,-0.008838809,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]; dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236],NA,NA,NA
CHOYP_GPSM2.1.1.m.58302,0.0086277,-0.016682244,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_GPX1.1.4.m.11300,0.016373169,-0.000830212,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; glutathione peroxidase activity [GO:0004602]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_GPX3.1.2.m.24838,-0.009953772,-0.010283155,No,NA,NA,NA,NA,NA,NA,glutathione peroxidase activity [GO:0004602]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_GPX4.A.1.1.m.257,0.000286889,0.009388828,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_GR101.3.3.m.43507,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930],NA,NA,NA
CHOYP_GRAP1.1.1.m.45768,0.007147463,0.004240657,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; neurotransmitter receptor transport; endosome to postsynaptic membrane [GO:0098887]; regulation of modification of synaptic structure [GO:1905244]; regulation of neurotransmitter receptor transport; endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158],NA,NA,NA
CHOYP_GRDN.1.5.m.12675,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; dynein light intermediate chain binding [GO:0051959]; microtubule binding [GO:0008017]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; activation of protein kinase B activity [GO:0032148]; cell migration [GO:0016477]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; DNA replication [GO:0006260]; lamellipodium assembly [GO:0030032]; membrane organization [GO:0061024]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell proliferation [GO:0042127]; regulation of DNA replication [GO:0006275]; regulation of neuron projection development [GO:0010975]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929],NA,NA,NA
CHOYP_GRIA3.1.1.m.44173,0.002000069,-0.016391505,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; ionotropic glutamate receptor activity [GO:0004970],NA,NA,NA
CHOYP_GRK5.1.1.m.6617,0.002787227,-0.002897343,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; lipid binding [GO:0008289]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; fat cell differentiation [GO:0045444]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; regulation of cell cycle [GO:0051726]; tachykinin receptor signaling pathway [GO:0007217]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_GRM1.2.2.m.65835,0.018941917,-0.013492165,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; negative regulation of adenylate cyclase activity [GO:0007194]; regulation of synaptic transmission; glutamatergic [GO:0051966],NA,NA,NA
CHOYP_GRP75.1.1.m.11678,0.010314736,-0.019169312,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled [GO:0042623]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; erythrocyte differentiation [GO:0030218]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_GRP78.2.5.m.33058,0.011875924,-0.006291935,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_GSH1.1.1.m.8927,-0.003912678,0.006528685,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; coenzyme binding [GO:0050662]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410],NA,NA,NA
CHOYP_GSHB.1.1.m.27512,0.004646008,-0.010437183,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803],NA,NA,NA
CHOYP_GSK3B.1.1.m.62139,-0.010109474,-0.020521782,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; cell body [GO:0044297]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; membrane raft [GO:0045121]; membrane-bounded organelle [GO:0043227]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; Schaffer collateral - CA1 synapse [GO:0098685]; Wnt signalosome [GO:1990909]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; integrin binding [GO:0005178]; ionotropic glutamate receptor binding [GO:0035255]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II transcription factor binding [GO:0001085]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; animal organ morphogenesis [GO:0009887]; axonogenesis [GO:0007409]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway [GO:0060070]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to amyloid-beta [GO:1904646]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to interleukin-3 [GO:0036016]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; establishment or maintenance of cell polarity [GO:0007163]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hepatic stellate cell activation [GO:0035733]; hepatocyte apoptotic process [GO:0097284]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; maintenance of cell polarity [GO:0030011]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite development [GO:2000171]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of protein localization to centrosome [GO:1904780]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of TOR signaling [GO:0032007]; neuron projection development [GO:0031175]; neuron projection retraction [GO:0106028]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of osteoclast proliferation [GO:0090290]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of apoptotic process [GO:0042981]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of dendrite morphogenesis [GO:0048814]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule-based process [GO:0032886]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of neuron projection development [GO:0010975]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of osteoblast differentiation [GO:0045667]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to zinc ion [GO:0010043]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_GSLG1.3.3.m.66468,-0.002227038,-0.002116458,No,NA,NA,NA,NA,NA,NA,extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; fibroblast growth factor binding [GO:0017134]; bone morphogenesis [GO:0060349]; negative regulation of protein processing [GO:0010955]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of chondrocyte differentiation [GO:0032330],NA,NA,NA
CHOYP_GSPATT00009499001.1.1.m.34366,0.000763595,-0.0049057,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_GSPATT00037947001.1.1.m.24620,-0.006624501,0.013459209,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_GST7.1.1.m.59335,-0.020463008,-0.011150331,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_GSTO1.1.2.m.14745,-0.000727085,-0.000907445,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]; cellular response to arsenic-containing substance [GO:0071243]; glutathione derivative biosynthetic process [GO:1901687]; interleukin-12-mediated signaling pathway [GO:0035722]; L-ascorbic acid metabolic process [GO:0019852]; methylation [GO:0032259]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; oxidation-reduction process [GO:0055114]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178],NA,NA,NA
CHOYP_GSTO1.2.2.m.26202,0.001170993,-0.005515651,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; pyrimidodiazepine synthase activity [GO:0004734]; transferase activity; transferring sulfur-containing groups [GO:0016782]; eye pigment biosynthetic process [GO:0006726]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114]; pteridine biosynthetic process [GO:0006728],NA,NA,NA
CHOYP_GSTO2.1.1.m.36486,0.001181187,0.018722352,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]; cellular response to arsenic-containing substance [GO:0071243]; glutathione derivative biosynthetic process [GO:1901687]; interleukin-12-mediated signaling pathway [GO:0035722]; L-ascorbic acid metabolic process [GO:0019852]; methylation [GO:0032259]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; oxidation-reduction process [GO:0055114]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178],NA,NA,NA
CHOYP_GSTP1.1.2.m.29677,-0.001023705,0.001248154,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; TRAF2-GSTP1 complex [GO:0097057]; dinitrosyl-iron complex binding [GO:0035731]; drug binding [GO:0008144]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; JUN kinase binding [GO:0008432]; kinase regulator activity [GO:0019207]; protein kinase binding [GO:0019901]; S-nitrosoglutathione binding [GO:0035730]; animal organ regeneration [GO:0031100]; cellular response to cell-matrix adhesion [GO:0071460]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; common myeloid progenitor cell proliferation [GO:0035726]; glutathione metabolic process [GO:0006749]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of leukocyte proliferation [GO:0070664]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of neutrophil aggregation [GO:2000429]; negative regulation of nitric-oxide synthase biosynthetic process [GO:0051771]; negative regulation of peroxidase activity [GO:2000469]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of tumor necrosis factor production [GO:0032720]; oligodendrocyte development [GO:0014003]; positive regulation of superoxide anion generation [GO:0032930]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of stress-activated MAPK cascade [GO:0032872]; response to amino acid [GO:0043200]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to L-ascorbic acid [GO:0033591]; response to nutrient levels [GO:0031667]; response to reactive oxygen species [GO:0000302]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_GSTP1.2.2.m.30099,-0.003937265,-0.016605386,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; nucleus [GO:0005634]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_GSTS8.1.1.m.12434,-0.00242969,-0.00653901,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693],NA,NA,NA
CHOYP_GSTUL.1.1.m.35986,-0.002484293,-0.008434598,No,NA,NA,NA,NA,NA,NA,chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; peroxidase activity [GO:0004601]; cellular response to water deprivation [GO:0042631]; glutathione metabolic process [GO:0006749]; response to cadmium ion [GO:0046686]; response to oxidative stress [GO:0006979]; toxin catabolic process [GO:0009407],NA,NA,NA
CHOYP_GSTZ1.1.1.m.56540,0.007490591,-0.010486045,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; glutathione transferase activity [GO:0004364]; maleylacetoacetate isomerase activity [GO:0016034]; glutathione metabolic process [GO:0006749]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572],NA,NA,NA
CHOYP_GTPB1.1.1.m.66453,-0.011584726,-0.016725642,No,NA,NA,NA,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_GTR1.1.1.m.25509,0.006566684,0.001604568,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; female pronucleus [GO:0001939]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane raft [GO:0045121]; midbody [GO:0030496]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; glucose transmembrane transporter activity [GO:0005355]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; cellular response to glucose starvation [GO:0042149]; glucose import [GO:0046323]; glucose transmembrane transport [GO:1904659]; protein-containing complex assembly [GO:0065003],NA,NA,NA
CHOYP_GUAA.1.1.m.18809,0.000681323,0.001363758,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; pyrophosphatase activity [GO:0016462]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177],NA,NA,NA
CHOYP_GUAD.1.1.m.33511,-0.00725531,0.017800698,No,NA,NA,NA,NA,NA,NA,guanine deaminase activity [GO:0008892]; zinc ion binding [GO:0008270]; guanine catabolic process [GO:0006147],NA,NA,NA
CHOYP_GUK1.1.1.m.48140,0.003091596,-0.003171317,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; GDP biosynthetic process [GO:0046711]; purine nucleotide metabolic process [GO:0006163],NA,NA,NA
CHOYP_GULP1.1.1.m.44407,-0.009871604,-0.00619066,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; phagocytosis [GO:0006909],NA,NA,NA
CHOYP_GUN.1.2.m.26883,-0.013353283,-0.000907601,No,NA,NA,NA,NA,NA,NA,cellulase activity [GO:0008810]; cellulose catabolic process [GO:0030245],NA,NA,NA
CHOYP_GUN.2.2.m.46462,0.023582428,-0.000107768,No,NA,NA,NA,NA,NA,NA,cellulase activity [GO:0008810]; cellulose catabolic process [GO:0030245],NA,NA,NA
CHOYP_GZF1.1.2.m.7747,0.012405204,-0.00032242,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_H2AV.1.7.m.12182,-0.012670371,0.000404565,No,NA,NA,NA,NA,NA,NA,nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325],NA,NA,NA
CHOYP_H2BL3.1.1.m.16594,0.00752714,0.000151848,No,NA,NA,NA,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_H3.1.2.m.3829,-0.014855832,-0.007970447,No,NA,NA,NA,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982],NA,NA,NA
CHOYP_HAAF.11.13.m.44366,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_HAAF.3.13.m.8849,-0.011566153,-0.003743543,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_HACE1.1.2.m.24806,-0.0084239,-0.012428812,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell migration [GO:0030334]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_HACL1.1.1.m.6578,0.017877537,-0.013900271,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; carbon-carbon lyase activity [GO:0016830]; cofactor binding [GO:0048037]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; signaling receptor binding [GO:0005102]; thiamine pyrophosphate binding [GO:0030976]; fatty acid alpha-oxidation [GO:0001561]; protein complex oligomerization [GO:0051259]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_HAND1.1.1.m.10874,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; cardiac muscle cell differentiation [GO:0055007]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cardiogenic plate morphogenesis [GO:0003142]; determination of intestine left/right asymmetry [GO:0071908]; embryonic heart tube formation [GO:0003144]; embryonic pectoral fin morphogenesis [GO:0035118]; embryonic viscerocranium morphogenesis [GO:0048703]; heart contraction [GO:0060047]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; noradrenergic neuron differentiation [GO:0003357]; polarized epithelial cell differentiation [GO:0030859]; proepicardium development [GO:0003342]; sympathetic nervous system development [GO:0048485]; thyroid gland development [GO:0030878],NA,NA,NA
CHOYP_HBS1L.1.2.m.14311,-0.012716925,-0.020272181,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; signal transduction [GO:0007165]; translation [GO:0006412],NA,NA,NA
CHOYP_HBX5.1.1.m.11081,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_HD.1.1.m.56119,0.004205004,-0.010926504,No,NA,NA,NA,NA,NA,NA,autophagosome [GO:0005776]; axon [GO:0030424]; centriole [GO:0005814]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991]; synaptic membrane [GO:0097060]; beta-tubulin binding [GO:0048487]; diazepam binding [GO:0050809]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; profilin binding [GO:0005522]; signaling receptor binding [GO:0005102]; transcription factor binding [GO:0008134]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; associative learning [GO:0008306]; axo-dendritic transport [GO:0008088]; brain development [GO:0007420]; cell aging [GO:0007569]; central nervous system development [GO:0007417]; citrulline metabolic process [GO:0000052]; determination of adult lifespan [GO:0008340]; dopamine receptor signaling pathway [GO:0007212]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; establishment of mitotic spindle orientation [GO:0000132]; gastrulation [GO:0007369]; Golgi organization [GO:0007030]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insulin secretion [GO:0030073]; iron ion homeostasis [GO:0055072]; L-glutamate import [GO:0051938]; lactate biosynthetic process from pyruvate [GO:0019244]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; mRNA transport [GO:0051028]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; neural plate formation [GO:0021990]; neurogenesis [GO:0022008]; neuron apoptotic process [GO:0051402]; neuron development [GO:0048666]; olfactory lobe development [GO:0021988]; paraxial mesoderm formation [GO:0048341]; peptide hormone secretion [GO:0030072]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1;4;5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; positive regulation of motile cilium assembly [GO:1905505]; positive regulation of non-motile cilium assembly [GO:1902857]; postsynapse to nucleus signaling pathway [GO:0099527]; protein destabilization [GO:0031648]; protein localization to centrosome [GO:0071539]; protein localization to nucleus [GO:0034504]; quinolinate biosynthetic process [GO:0019805]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of gene expression [GO:0010468]; regulation of intracellular mRNA localization [GO:1904580]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of protein localization to nucleus [GO:1900180]; regulation of synaptic plasticity [GO:0048167]; response to calcium ion [GO:0051592]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; social behavior [GO:0035176]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; urea cycle [GO:0000050]; vesicle transport along microtubule [GO:0047496]; visual learning [GO:0008542]; vocal learning [GO:0042297],NA,NA,NA
CHOYP_HEAT1.1.1.m.11228,0.011867213,-0.013145065,No,NA,NA,NA,NA,NA,NA,90S preribosome [GO:0030686]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of RNA stability [GO:0043487],NA,NA,NA
CHOYP_HEATR3.1.1.m.33423,-0.004560455,0.005440576,No,NA,NA,NA,NA,NA,NA,cell [GO:0005623]; unfolded protein binding [GO:0051082]; protein import into nucleus [GO:0006606]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_HECD1.1.1.m.27759,-0.001399238,0.006036192,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein K63-linked ubiquitination [GO:0070534],NA,NA,NA
CHOYP_HELZ.2.2.m.43303,-0.002818168,-0.015130253,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; posttranscriptional gene silencing by RNA [GO:0035194],NA,NA,NA
CHOYP_HEM2.1.1.m.6789,-0.00154299,0.005584762,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; identical protein binding [GO:0042802]; porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270]; cellular response to interleukin-4 [GO:0071353]; heme biosynthetic process [GO:0006783]; negative regulation of proteasomal protein catabolic process [GO:1901799]; protein homooligomerization [GO:0051260]; protoporphyrinogen IX biosynthetic process [GO:0006782],NA,NA,NA
CHOYP_HEM3.1.1.m.28414,-0.006735444,0.00567472,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; hydroxymethylbilane synthase activity [GO:0004418]; heme biosynthetic process [GO:0006783]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; protoporphyrinogen IX biosynthetic process [GO:0006782],NA,NA,NA
CHOYP_HEM6.1.1.m.17205,0.004205848,-0.010961338,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; coproporphyrinogen oxidase activity [GO:0004109]; protein homodimerization activity [GO:0042803]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process from glutamate [GO:0019353],NA,NA,NA
CHOYP_HERC1.2.2.m.51367,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]; cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175],NA,NA,NA
CHOYP_HERC2.1.1.m.65153,0.011040717,-0.005749932,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_HES1.2.3.m.27001,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; BMP signaling pathway [GO:0030509]; cell proliferation [GO:0008283]; floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; neural crest formation [GO:0014029]; prechordal plate formation [GO:0021501],NA,NA,NA
CHOYP_HEX.1.1.m.43068,0.022103852,-0.006236577,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; polysaccharide binding [GO:0030247]; carbohydrate metabolic process [GO:0005975]; chitin catabolic process [GO:0006032],NA,NA,NA
CHOYP_HGFAC.1.1.m.5902,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_HHEX.2.2.m.19527,-0.01314443,-0.001861631,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; condensed chromosome kinetochore [GO:0000777]; cell adhesion [GO:0007155]; multicellular organism development [GO:0007275]; negative regulation of fibroblast apoptotic process [GO:2000270]; regulation of cell proliferation [GO:0042127]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_HIF1N.1.1.m.53726,0.00500645,0.016828245,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; ankyrin repeat binding [GO:0071532]; carboxylic acid binding [GO:0031406]; cofactor binding [GO:0048037]; hypoxia-inducible factor-asparagine oxygenase activity [GO:0102113]; iron ion binding [GO:0005506]; NF-kappaB binding [GO:0051059]; Notch binding [GO:0005112]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; oxygen sensor activity [GO:0019826]; peptidyl-asparagine 3-dioxygenase activity [GO:0036140]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; oxidation-reduction process [GO:0055114]; peptidyl-asparagine hydroxylation [GO:0042265]; peptidyl-aspartic acid hydroxylation [GO:0042264]; peptidyl-histidine hydroxylation [GO:0036138]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of vasculogenesis [GO:2001214]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418],NA,NA,NA
CHOYP_HINT1.1.1.m.53526,-0.003158518,0.005473339,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; purine ribonucleotide catabolic process [GO:0009154]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_HIP1.1.1.m.31791,0.00069286,0.013652653,No,NA,NA,NA,NA,NA,NA,actin cortical patch [GO:0030479]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of postsynaptic membrane [GO:0098890]; extrinsic component of presynaptic membrane [GO:0098888]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]; actin filament binding [GO:0051015]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; epidermal growth factor receptor binding [GO:0005154]; glutamate receptor binding [GO:0035254]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]; actin filament organization [GO:0007015]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane organization [GO:0061024]; neurotransmitter receptor transport [GO:0099637]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_HIRA.1.1.m.19212,-0.002243054,0.018325461,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; chromatin organization [GO:0006325]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_HMBS.1.1.m.31422,-0.012749418,0.011004614,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; hydroxymethylbilane synthase activity [GO:0004418]; heme biosynthetic process [GO:0006783]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; protoporphyrinogen IX biosynthetic process [GO:0006782],NA,NA,NA
CHOYP_HMCN1.19.44.m.39500,0.011737696,-0.025048626,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_HMCN1.23.44.m.42684,0.022056831,-0.012172853,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_HMCN1.28.44.m.47379,0.020751648,0.008859323,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_HMCN1.32.44.m.58935,0.008069164,0.004581125,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_HMCN1.33.44.m.58938,0.013796427,0.010221407,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_HMCN1.39.44.m.61047,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_HMCN1.5.44.m.7236,-0.010519769,0.017621102,No,NA,NA,NA,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_HMCN2.10.12.m.49343,-0.022659412,0.010231495,No,NA,NA,NA,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity; open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991],NA,NA,NA
CHOYP_HMCN2.11.12.m.51619,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; cell adhesion [GO:0007155]; response to stimulus [GO:0050896]; visual perception [GO:0007601],NA,NA,NA
CHOYP_HMCN2.3.12.m.26811,0.014533919,-0.007802712,No,NA,NA,NA,NA,NA,NA,virion [GO:0019012],NA,NA,NA
CHOYP_HMCN2.6.12.m.33452,-0.003374521,-0.012981161,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_HMCN2.8.12.m.39297,0.001769022,-0.009762324,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; response to stimulus [GO:0050896],NA,NA,NA
CHOYP_HMCN2.9.12.m.44986,0.01993645,-0.016258034,No,NA,NA,NA,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_HN1L.2.2.m.9837,-0.009733866,0.013723625,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_HNRPR.1.2.m.44125,0.017441698,0.015570402,No,NA,NA,NA,NA,NA,NA,axon terminus [GO:0043679]; catalytic step 2 spliceosome [GO:0071013]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; circadian rhythm [GO:0007623]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of catalytic activity [GO:0043086]; RNA metabolic process [GO:0016070],NA,NA,NA
CHOYP_HNRPR.1.2.m.44126,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,myosin complex [GO:0016459]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_HOIL1.2.3.m.54310,0.011622031,-0.009356668,No,NA,NA,NA,NA,NA,NA,LUBAC complex [GO:0071797]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; embryonic cranial skeleton morphogenesis [GO:0048701]; otic vesicle morphogenesis [GO:0071600]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039],NA,NA,NA
CHOYP_HOOK3.1.1.m.14456,-0.008339063,-0.019268027,No,NA,NA,NA,NA,NA,NA,centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; microtubule [GO:0005874]; pericentriolar material [GO:0000242]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi localization [GO:0051645]; interkinetic nuclear migration [GO:0022027]; lysosome organization [GO:0007040]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuronal stem cell population maintenance [GO:0097150]; protein localization to centrosome [GO:0071539]; protein transport [GO:0015031],NA,NA,NA
CHOYP_HOW.5.5.m.58452,0.016911052,-0.006460458,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon ensheathment [GO:0008366]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; germ-line stem cell population maintenance [GO:0030718]; glial cell migration [GO:0008347]; mesoderm development [GO:0007498]; mesodermal cell migration [GO:0008078]; muscle attachment [GO:0016203]; muscle cell fate determination [GO:0007521]; muscle organ development [GO:0007517]; oenocyte development [GO:0007438]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of embryonic development [GO:0045995]; regulation of heart contraction [GO:0008016]; regulation of translation [GO:0006417]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]; spermatogonial cell division [GO:0007284],NA,NA,NA
CHOYP_HPGD.1.3.m.50258,0.021368084,0.004231084,No,NA,NA,NA,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_HPRT.1.1.m.61881,0.019663698,-0.012972946,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]; GMP catabolic process [GO:0046038]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; positive regulation of dopamine metabolic process [GO:0045964]; protein homotetramerization [GO:0051289]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166],NA,NA,NA
CHOYP_HS12A.10.33.m.38139,-0.003936055,0.013577209,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12A.12.33.m.39763,-0.003031441,0.005817392,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12A.14.33.m.41988,0.006108685,0.004141914,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12A.20.33.m.55554,-0.001028837,-0.020944189,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12A.24.33.m.60051,0.01422716,-0.001177844,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12A.25.33.m.60352,-0.001174502,0.000134165,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12B.10.14.m.59859,-0.015861447,0.007524361,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12B.2.14.m.19896,-0.001032349,0.01702207,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12B.7.14.m.40600,0.005834751,0.01126107,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12B.7.14.m.40601,0.008817707,-0.005327636,No,NA,NA,NA,NA,NA,NA,death domain binding [GO:0070513]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; negative regulation of autophagy [GO:0010507],NA,NA,NA
CHOYP_HS74L.1.1.m.24610,0.017557088,-0.006999941,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_HS90A.1.3.m.7725,0.022993092,0.000757932,No,NA,NA,NA,NA,NA,NA,cadherin binding [GO:0045296]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_HS90A.3.3.m.28299,0.000915846,-0.013139456,No,NA,NA,NA,NA,NA,NA,A band [GO:0031672]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; melanosome [GO:0042470]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Z disc [GO:0030018]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; disordered domain specific binding [GO:0097718]; nitric-oxide synthase regulator activity [GO:0030235]; protein homodimerization activity [GO:0042803]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to metal ion [GO:0010038]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_HS90A.3.3.m.28300,0.011027792,-0.02099337,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex; coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proton transmembrane transporter activity [GO:0015078]; transmembrane transporter activity [GO:0022857]; ATP biosynthetic process [GO:0006754]; ATP hydrolysis coupled cation transmembrane transport [GO:0099132]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; substantia nigra development [GO:0021762],NA,NA,NA
CHOYP_HSC70.1.1.m.335,0.008649412,0.005425047,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_HSF1.2.2.m.38636,-0.013623041,0.002031215,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; chromatin DNA binding [GO:0031490]; core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; heat shock protein binding [GO:0031072]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cellular response to cadmium ion [GO:0071276]; cellular response to gamma radiation [GO:0071480]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of cell proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of protein heterodimerization activity [GO:0043497]; response to heat [GO:0009408]; response to light stimulus [GO:0009416],NA,NA,NA
CHOYP_HSP21.4.1.1.m.8171,-0.010664776,0.005668125,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_HSP70.1.1.m.61727,-0.013140325,-0.001866046,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSP7D.2.3.m.34782,0.01963873,0.003450819,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSP7D.2.3.m.34785,-0.017382058,-0.01439791,No,NA,NA,NA,NA,NA,NA,ASAP complex [GO:0061574]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_HSP7D.3.3.m.41778,0.007115405,0.011699637,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; selenide; water dikinase activity [GO:0004756]; cell cycle [GO:0007049]; cell proliferation [GO:0008283]; glutamine metabolic process [GO:0006541]; imaginal disc development [GO:0007444]; mitochondrion organization [GO:0007005]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of cell proliferation [GO:0008284]; selenium compound metabolic process [GO:0001887]; selenocysteine biosynthetic process [GO:0016260]; tRNA seleno-modification [GO:0070329],NA,NA,NA
CHOYP_HSP7E.1.1.m.13730,-0.000632986,-0.002269816,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; polysome [GO:0005844]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; cytoplasmic translation [GO:0002181]; protein refolding [GO:0042026]; regulation of translational fidelity [GO:0006450]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_HSP90AA1.1.1.m.14867,0.020265856,0.006451109,No,NA,NA,NA,NA,NA,NA,A band [GO:0031672]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; melanosome [GO:0042470]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Z disc [GO:0030018]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; disordered domain specific binding [GO:0097718]; nitric-oxide synthase regulator activity [GO:0030235]; protein homodimerization activity [GO:0042803]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to metal ion [GO:0010038]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_HSPA12A.10.27.m.35252,0.014202219,0.017796087,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPA12A.15.27.m.45635,0.010765793,0.019272611,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPA12A.16.27.m.48207,0.003783299,0.00438709,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPA12A.2.27.m.15188,-0.004370246,0.002442692,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_HSPA12A.21.27.m.57005,-0.008286726,0.0110669,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPA12A.5.27.m.21251,0.006555585,0.001247222,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPA12A.9.27.m.34375,-0.001213936,0.014091768,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPA12B.1.1.m.36165,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPG2.1.4.m.1496,-0.004215092,-0.008643912,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766],NA,NA,NA
CHOYP_HTF4.1.5.m.16262,-0.006563592,0.012914141,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; transcription factor complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; enhancer binding [GO:0035326]; HMG box domain binding [GO:0071837]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]; immune response [GO:0006955]; muscle organ development [GO:0007517]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_HTR2B.1.1.m.121,-0.00627637,0.00908831,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]; drug binding [GO:0008144]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; activation of phospholipase C activity [GO:0007202]; behavior [GO:0007610]; calcium-mediated signaling [GO:0019722]; cardiac muscle hypertrophy [GO:0003300]; cellular calcium ion homeostasis [GO:0006874]; cellular response to temperature stimulus [GO:0071502]; cGMP-mediated signaling [GO:0019934]; chemical synaptic transmission [GO:0007268]; embryonic morphogenesis [GO:0048598]; ERK1 and ERK2 cascade [GO:0070371]; G protein-coupled receptor internalization [GO:0002031]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway; coupled to cyclic nucleotide second messenger [GO:0007187]; heart morphogenesis [GO:0003007]; intestine smooth muscle contraction [GO:0014827]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cell death [GO:0060548]; neural crest cell differentiation [GO:0014033]; neural crest cell migration [GO:0001755]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphorylation [GO:0016310]; positive regulation of cell division [GO:0051781]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of behavior [GO:0050795]; release of sequestered calcium ion into cytosol [GO:0051209]; response to drug [GO:0042493]; serotonin receptor signaling pathway [GO:0007210]; vasoconstriction [GO:0042310],NA,NA,NA
CHOYP_HTR5B.1.1.m.39330,-0.00790617,-0.014825384,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_HTT.1.1.m.33803,0.011589488,0.000761122,No,NA,NA,NA,NA,NA,NA,autophagosome [GO:0005776]; axon [GO:0030424]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; profilin binding [GO:0005522]; apoptotic process [GO:0006915]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1;4;5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; protein destabilization [GO:0031648]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of phosphoprotein phosphatase activity [GO:0043666]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; vesicle transport along microtubule [GO:0047496]; vocal learning [GO:0042297],NA,NA,NA
CHOYP_HUTH.1.1.m.30350,0.004230902,-0.004709625,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; histidine ammonia-lyase activity [GO:0004397]; histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; histidine metabolic process [GO:0006547],NA,NA,NA
CHOYP_HUWE1.1.2.m.566,0.002582338,-0.025252302,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; histone ubiquitination [GO:0016574]; neutrophil degranulation [GO:0043312]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_HVCN1.1.4.m.8888,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; voltage-gated proton channel activity [GO:0030171]; cellular response to pH [GO:0071467]; cellular response to zinc ion [GO:0071294]; proton transmembrane transport [GO:1902600]; regulation of ion transmembrane transport [GO:0034765]; response to pH [GO:0009268]; response to zinc ion [GO:0010043],NA,NA,NA
CHOYP_HVCN1.2.4.m.29334,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_HX1.1.1.m.23716,0.007975943,0.001820818,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_HXD3.1.1.m.40287,0.006570061,0.001580557,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_HYI.1.1.m.10528,-0.007828537,-0.021064795,No,NA,NA,NA,NA,NA,NA,hydroxypyruvate isomerase activity [GO:0008903]; racemase and epimerase activity; acting on carbohydrates and derivatives [GO:0016857],NA,NA,NA
CHOYP_HYOU1.1.3.m.163,0.003332206,-0.008447926,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]; cellular response to hypoxia [GO:0071456]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298],NA,NA,NA
CHOYP_HYOU1.2.3.m.12568,0.019658689,-0.014058592,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]; cellular response to hypoxia [GO:0071456]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298],NA,NA,NA
CHOYP_IARS.1.1.m.27559,0.012913458,-0.016418948,No,NA,NA,NA,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418],NA,NA,NA
CHOYP_IDE.1.3.m.8450,-0.004846044,-0.015474727,No,NA,NA,NA,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; beta-endorphin binding [GO:0031626]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ubiquitin-dependent protein binding [GO:0140036]; zinc ion binding [GO:0008270]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein oligomerization [GO:0032461]; protein heterooligomerization [GO:0051291]; protein homotetramerization [GO:0051289]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992],NA,NA,NA
CHOYP_IDHC.1.1.m.7041,0.015666868,0.002858678,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_IDLC.1.1.m.63624,-0.015600455,-0.012334388,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; filopodium [GO:0030175]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]; inner dynein arm assembly [GO:0036159],NA,NA,NA
CHOYP_IF122.2.2.m.59794,-0.017580198,0.003416283,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; multicellular organism development [GO:0007275]; negative regulation of smoothened signaling pathway [GO:0045879]; protein localization to cilium [GO:0061512],NA,NA,NA
CHOYP_IF2A.1.1.m.13279,-0.009634783,0.007486659,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2 complex [GO:0005850]; eukaryotic translation initiation factor 2B complex [GO:0005851]; glial limiting end-foot [GO:0097451]; multi-eIF complex [GO:0043614]; nucleus [GO:0005634]; synapse [GO:0045202]; translation initiation ternary complex [GO:0044207]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; stress granule assembly [GO:0034063],NA,NA,NA
CHOYP_IF2H.1.1.m.18253,0.009961044,-0.001932373,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731],NA,NA,NA
CHOYP_IF4A3.1.1.m.30424,-0.003766097,-0.016623689,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_IF4E.1.1.m.56823,0.013833975,-0.01857756,No,NA,NA,NA,NA,NA,NA,eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; protein-containing complex [GO:0032991]; translation initiation factor activity [GO:0003743]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_IF4G2.1.1.m.62766,-0.012553058,-0.018981054,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; postsynaptic density [GO:0014069]; mRNA binding [GO:0003729]; translation factor activity; RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; cellular macromolecule biosynthetic process [GO:0034645]; negative regulation of autophagy [GO:0010507]; positive regulation of axon extension [GO:0045773]; positive regulation of cell growth [GO:0030307]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446],NA,NA,NA
CHOYP_IF6.1.1.m.22685,-0.007364219,0.009536555,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; lamin filament [GO:0005638]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; assembly of large subunit precursor of preribosome [GO:1902626]; gene silencing by miRNA [GO:0035195]; mature ribosome assembly [GO:0042256]; miRNA mediated inhibition of translation [GO:0035278]; positive regulation of translation [GO:0045727]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glycolytic process [GO:0006110]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to insulin [GO:0032868]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal subunit export from nucleus [GO:0000054],NA,NA,NA
CHOYP_IFIH1.10.14.m.60393,-0.012188615,0.001552689,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein sumoylation [GO:0016925]; response to virus [GO:0009615],NA,NA,NA
CHOYP_IFIH1.3.14.m.24387,-0.003034319,0.001583172,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_IFIH1.7.14.m.46974,-0.008975448,0.004345991,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_IFIH1.9.14.m.54678,-0.002304872,0.005797923,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_IFT140.1.1.m.61053,-0.017159662,0.001474569,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589]; renal system development [GO:0072001]; retina development in camera-type eye [GO:0060041]; skeletal system morphogenesis [GO:0048705],NA,NA,NA
CHOYP_IFT57.1.1.m.13249,-0.017033273,-0.004193805,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]; photoreceptor connecting cilium [GO:0032391]; DNA binding [GO:0003677]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; heart looping [GO:0001947]; intraciliary transport [GO:0042073]; left/right pattern formation [GO:0060972]; motile cilium assembly [GO:0044458]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of apoptotic process [GO:0042981]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_IKBZ.1.1.m.23083,0.016724947,0.000861076,No,NA,NA,NA,NA,NA,NA,transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_IKZF.1.1.m.55498,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterooligomerization [GO:0051291],NA,NA,NA
CHOYP_IMA2.1.2.m.35753,-0.001321454,0.017277687,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; NLS-bearing protein import into nucleus [GO:0006607],NA,NA,NA
CHOYP_IMA2.2.2.m.49279,-0.001006381,-0.023602299,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; protein transporter activity [GO:0008565]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_IMDH3.1.1.m.51789,-0.000752457,-0.018145961,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; circadian rhythm [GO:0007623]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183],NA,NA,NA
CHOYP_IMG5_109580.1.1.m.27791,-0.022486745,0.010580945,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_IMG5_163910.1.1.m.46747,-0.003438574,0.004160956,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_IMSP5.1.2.m.5157,-0.011845733,-0.024310147,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_IMSP5.2.2.m.17779,0.014259995,0.005304657,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_INF2.3.5.m.13728,0.005263855,-0.006932366,No,NA,NA,NA,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]; regulation of mitochondrial fission [GO:0090140],NA,NA,NA
CHOYP_INO1A.1.1.m.91,-0.005453057,-0.014552834,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; inositol-3-phosphate synthase activity [GO:0004512]; inositol biosynthetic process [GO:0006021]; phospholipid biosynthetic process [GO:0008654],NA,NA,NA
CHOYP_INO80.1.2.m.1270,-0.008251772,-0.007513448,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; intermediate filament cytoskeleton [GO:0045111]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mitotic sister chromatid segregation [GO:0000070]; nucleosome mobilization [GO:0042766]; positive regulation of cell growth [GO:0030307]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; spindle assembly [GO:0051225]; transcription; DNA-templated [GO:0006351]; UV-damage excision repair [GO:0070914],NA,NA,NA
CHOYP_INSI2.1.1.m.59456,0.005015629,0.014585058,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779],NA,NA,NA
CHOYP_INT11.1.1.m.29494,-0.014036655,-0.004194797,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; integrator complex [GO:0032039]; hydrolase activity [GO:0016787]; regulation of RNA splicing [GO:0043484]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180],NA,NA,NA
CHOYP_INT2.1.1.m.52909,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; intracellular [GO:0005622]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795],NA,NA,NA
CHOYP_INT6.1.1.m.13005,-0.001691356,-0.015382415,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180],NA,NA,NA
CHOYP_INT7.1.1.m.14480,0.004199556,-0.010964407,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; integrator complex [GO:0032039]; cellular response to DNA damage stimulus [GO:0006974]; snRNA 3'-end processing [GO:0034472],NA,NA,NA
CHOYP_INT9.1.1.m.11703,-0.010837329,-0.008265501,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795],NA,NA,NA
CHOYP_INVS.2.6.m.8331,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_IP6K1.1.1.m.54347,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; fibrillar center [GO:0001650]; ATP binding [GO:0005524]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol phosphate biosynthetic process [GO:0032958]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol phosphorylation [GO:0046854],NA,NA,NA
CHOYP_IPO11.1.1.m.10815,0.005347475,-0.006550444,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; fibrillar center [GO:0001650]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610],NA,NA,NA
CHOYP_IPO5.1.1.m.25693,0.017536175,-0.017904547,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleus [GO:0005634]; GTPase inhibitor activity [GO:0005095]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; cellular response to amino acid stimulus [GO:0071230]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; ribosomal protein import into nucleus [GO:0006610]; viral process [GO:0016032],NA,NA,NA
CHOYP_IPO7.1.1.m.16806,0.009889843,-0.024230369,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; SMAD binding [GO:0046332]; innate immune response [GO:0045087]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_IQCA1.1.3.m.4290,-0.019488189,-0.005563939,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_IQGA1.1.1.m.47731,0.012541888,-0.007918143,No,NA,NA,NA,NA,NA,NA,actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; mitogen-activated protein kinase binding [GO:0051019]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; protein-containing complex scaffold activity [GO:0032947]; Rac GTPase binding [GO:0048365]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of dendrite development [GO:1900006]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; response to angiotensin [GO:1990776]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_IRAK4.1.1.m.23405,-0.005288747,0.005653403,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cytokine production [GO:0001816]; cytokine-mediated signaling pathway [GO:0019221]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of smooth muscle cell proliferation [GO:0048661],NA,NA,NA
CHOYP_IRF1.1.3.m.52606,-0.012440638,-0.022758063,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]; cell proliferation [GO:0008283],NA,NA,NA
CHOYP_IRF5.1.1.m.58123,-0.004455193,-0.000394804,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; myeloid cell differentiation [GO:0030099]; negative regulation of growth of symbiont in host [GO:0044130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phagocytosis [GO:0006909]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_IRO.4.4.m.24034,0.00605986,-0.014750805,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; compound eye morphogenesis [GO:0001745]; equator specification [GO:0045317]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell fate commitment [GO:0042693]; negative regulation of growth [GO:0045926]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346],NA,NA,NA
CHOYP_ISCA1.1.2.m.17578,0.00529048,-0.006261564,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]; endocrine process [GO:0050886]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428],NA,NA,NA
CHOYP_ISCU.1.1.m.37414,0.012433767,-0.008403147,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ferrous iron binding [GO:0008198]; iron-sulfur transferase activity [GO:0036455]; protein-containing complex scaffold activity [GO:0032947]; cellular iron ion homeostasis [GO:0006879]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_ISCW_ISCW000210.4.4.m.38490,0.010967917,0.019490258,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ISCW_ISCW000642.1.1.m.4065,0.009394503,0.004765243,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_ISCW_ISCW000704.1.1.m.38250,-0.009636963,-0.018638574,No,NA,NA,NA,NA,NA,NA,actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; actin cytoskeleton reorganization [GO:0031532]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; exocytosis [GO:0006887]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; wound healing [GO:0042060],NA,NA,NA
CHOYP_ISCW_ISCW001190.1.1.m.26579,-0.009299928,0.018324239,No,NA,NA,NA,NA,NA,NA,Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_ISCW_ISCW001487.2.2.m.61505,-0.001396936,-3.48E-05,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; endothelial cell morphogenesis [GO:0001886]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; ruffle assembly [GO:0097178],NA,NA,NA
CHOYP_ISCW_ISCW001592.1.2.m.20852,-0.007881513,-0.01934312,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial processing peptidase complex [GO:0017087]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; aerobic respiration [GO:0009060]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial electron transport; ubiquinol to cytochrome c [GO:0006122]; protein processing involved in protein targeting to mitochondrion [GO:0006627],NA,NA,NA
CHOYP_ISCW_ISCW003477.1.1.m.37800,0.013014306,-0.014968722,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; filopodium [GO:0030175]; membrane [GO:0016020]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; ruffle [GO:0001726]; sperm midpiece [GO:0097225]; chloride channel regulator activity [GO:0017081]; protein-containing complex scaffold activity [GO:0032947]; bile acid secretion [GO:0032782]; glutathione transport [GO:0034635]; negative regulation of cell motility [GO:2000146]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; regulation of protein kinase activity [GO:0045859]; renal absorption [GO:0070293]; renal phosphate ion absorption [GO:0097291]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_ISCW_ISCW003928.1.1.m.18079,-0.011603249,0.016310533,No,NA,NA,NA,NA,NA,NA,adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytoskeletal protein binding [GO:0008092]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; actomyosin structure organization [GO:0031032]; negative regulation of cell motility [GO:2000146]; positive regulation of cell adhesion [GO:0045785]; regulation of cell migration [GO:0030334],NA,NA,NA
CHOYP_ISCW_ISCW004420.1.8.m.5439,-0.003770038,-0.010877482,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ISCW_ISCW004725.1.1.m.9722,-0.000377625,0.009277889,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_ISCW_ISCW005083.2.2.m.40343,0.004326057,-0.005841051,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ISCW_ISCW005292.1.1.m.11066,0.00504612,0.002116097,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; AMP binding [GO:0016208]; fructose 1;6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; carbohydrate metabolic process [GO:0005975]; cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 1;6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein homotetramerization [GO:0051289]; regulation of gluconeogenesis [GO:0006111]; sucrose biosynthetic process [GO:0005986],NA,NA,NA
CHOYP_ISCW_ISCW005596.1.1.m.60561,-0.005662462,0.007068607,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of dense core granule exocytosis [GO:1905413]; regulation of synaptic transmission; GABAergic [GO:0032228]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_ISCW_ISCW005651.1.1.m.49000,-0.015186814,-0.017483092,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; DNA replication factor A complex [GO:0005662]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; double-stranded telomeric DNA binding [GO:0003691]; purine-rich negative regulatory element binding [GO:0032422]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]; translation repressor activity; mRNA regulatory element binding [GO:0000900]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; DNA unwinding involved in DNA replication [GO:0006268]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell proliferation [GO:0008284],NA,NA,NA
CHOYP_ISCW_ISCW005791.1.1.m.53514,-0.000852483,0.011689296,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; positive regulation of establishment of cell polarity regulating cell shape [GO:2000784]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346],NA,NA,NA
CHOYP_ISCW_ISCW005878.1.1.m.39374,0.006095188,0.000198974,No,NA,NA,NA,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412],NA,NA,NA
CHOYP_ISCW_ISCW006091.2.2.m.61313,-0.017388169,-0.004693945,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; spindle [GO:0005819]; DNA binding [GO:0003677]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_ISCW_ISCW006277.2.2.m.66212,0.004319609,-0.012408117,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_ISCW_ISCW006831.1.1.m.23820,0.001430496,-0.017657045,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_ISCW_ISCW007151.1.2.m.41781,0.013290746,0.005521065,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; morphogenesis of a branching structure [GO:0001763]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287],NA,NA,NA
CHOYP_ISCW_ISCW007151.2.2.m.41979,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; anterior commissure morphogenesis [GO:0021960]; chemorepulsion of branchiomotor axon [GO:0021793]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644],NA,NA,NA
CHOYP_ISCW_ISCW007158.2.2.m.53689,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of cell cycle arrest [GO:0071157]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; Ras protein signal transduction [GO:0007265]; regulation of microtubule cytoskeleton organization [GO:0070507],NA,NA,NA
CHOYP_ISCW_ISCW007158.2.2.m.53690,-0.006791123,0.006680336,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; cell cycle [GO:0007049]; negative regulation of cell proliferation [GO:0008285]; positive regulation of transcription; DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; regulation of cell death [GO:0010941],NA,NA,NA
CHOYP_ISCW_ISCW007303.1.1.m.42263,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027],NA,NA,NA
CHOYP_ISCW_ISCW008174.1.2.m.8360,-0.008810456,0.000916954,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II; core complex [GO:0005665]; DNA binding [GO:0003677]; LRR domain binding [GO:0030275]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_ISCW_ISCW008219.1.2.m.46822,0.007555718,0.022928032,No,NA,NA,NA,NA,NA,NA,axon cytoplasm [GO:1904115]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dense core granule [GO:0031045]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein phosphatase 2B binding [GO:0030346]; Rac GTPase binding [GO:0048365]; superoxide dismutase activity [GO:0004784]; superoxide dismutase copper chaperone activity [GO:0016532]; zinc ion binding [GO:0008270]; activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226],NA,NA,NA
CHOYP_ISCW_ISCW008316.1.3.m.11997,0.010973799,0.018958942,No,NA,NA,NA,NA,NA,NA,transcription elongation factor complex [GO:0008023]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; chromatin-mediated maintenance of transcription [GO:0048096]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_ISCW_ISCW008555.1.1.m.40873,0.01174718,-0.009459933,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cell projection [GO:0042995]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; podosome [GO:0002102]; presynapse [GO:0098793]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; synaptic vesicle uncoating [GO:0016191],NA,NA,NA
CHOYP_ISCW_ISCW008596.2.2.m.44077,0.003961155,-0.014203919,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_ISCW_ISCW008669.1.1.m.20227,0.001804344,-0.010585102,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; rDNA heterochromatin [GO:0033553]; 5S rRNA binding [GO:0008097]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; protein localization to nucleolus [GO:1902570]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein phosphorylation [GO:0001932]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_ISCW_ISCW009103.1.1.m.24140,-0.000272868,0.011735408,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; micro-ribonucleoprotein complex [GO:0035068]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; RISC-loading complex [GO:0070578]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; ATP-dependent 3'-5' DNA/RNA helicase activity [GO:0033681]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; ATP-dependent DNA helicase activity [GO:0004003]; ATP-dependent RNA helicase activity [GO:0004004]; ATPase activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded DNA binding [GO:0003697]; single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity [GO:1990518]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; triplex DNA binding [GO:0045142]; alternative mRNA splicing; via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to heat [GO:0034605]; cellular response to tumor necrosis factor [GO:0071356]; circadian rhythm [GO:0007623]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA-templated transcription; termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; pyroptosis [GO:0070269]; regulation of cytoplasmic translation [GO:2000765]; regulation of defense response to virus by host [GO:0050691]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423],NA,NA,NA
CHOYP_ISCW_ISCW009328.2.2.m.65633,0.017555461,-0.000352037,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; calcitriol binding [GO:1902098]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; vitamin D binding [GO:0005499]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inner ear receptor cell development [GO:0060119]; multicellular organism development [GO:0007275]; otic vesicle development [GO:0071599]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_ISCW_ISCW010143.1.3.m.17397,-0.007139271,0.00495743,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; satellite DNA binding [GO:0003696]; siRNA binding [GO:0035197]; aging [GO:0007568]; ATP-dependent chromatin remodeling [GO:0043044]; cellular protein-containing complex assembly [GO:0034622]; cellular response to organic cyclic compound [GO:0071407]; chromatin silencing at rDNA [GO:0000183]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; maternal behavior [GO:0042711]; methylation-dependent chromatin silencing [GO:0006346]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell proliferation [GO:0042127]; regulation of DNA methylation [GO:0044030]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667],NA,NA,NA
CHOYP_ISCW_ISCW010143.3.3.m.61542,0.008205174,-0.011188613,No,NA,NA,NA,NA,NA,NA,protein phosphatase inhibitor activity [GO:0004864]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of signal transduction [GO:0009966],NA,NA,NA
CHOYP_ISCW_ISCW010532.1.4.m.11493,0.000683548,-0.017763497,No,NA,NA,NA,NA,NA,NA,cell [GO:0005623]; antioxidant activity [GO:0016209]; peroxidase activity [GO:0004601]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_ISCW_ISCW010532.2.4.m.35454,0.002300732,0.018636369,No,NA,NA,NA,NA,NA,NA,cell [GO:0005623]; antioxidant activity [GO:0016209]; peroxidase activity [GO:0004601]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_ISCW_ISCW011328.1.1.m.8861,0.001899723,0.001921215,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; brain development [GO:0007420]; chromatin organization [GO:0006325]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462],NA,NA,NA
CHOYP_ISCW_ISCW011341.1.1.m.18728,-0.014938553,-0.008149745,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; conversion of ds siRNA to ss siRNA involved in RNA interference [GO:0033168]; defense response to Gram-negative bacterium [GO:0050829]; mRNA processing [GO:0006397]; negative regulation of viral genome replication [GO:0045071]; primary miRNA processing [GO:0031053]; RNA interference [GO:0016246],NA,NA,NA
CHOYP_ISCW_ISCW012010.1.1.m.27251,0.010025735,-0.015348783,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539],NA,NA,NA
CHOYP_ISCW_ISCW012036.1.1.m.27987,0.00106147,0.004236165,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; small nucleolar ribonucleoprotein complex [GO:0005732]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_ISCW_ISCW012228.1.2.m.57884,-0.014397151,-0.011014516,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; organelle membrane [GO:0031090]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629],NA,NA,NA
CHOYP_ISCW_ISCW012232.1.1.m.38746,-0.003029948,0.000117223,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412],NA,NA,NA
CHOYP_ISCW_ISCW012366.1.1.m.3690,-0.00772992,-0.007539576,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; centrosome [GO:0005813]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; postsynapse [GO:0098794]; presynapse [GO:0098793]; synaptic vesicle membrane [GO:0030672]; BH domain binding [GO:0051400]; clathrin binding [GO:0030276]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; GTPase binding [GO:0051020]; MDM2/MDM4 family protein binding [GO:0097371]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to astaxanthin [GO:1905218]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to erythropoietin [GO:0036018]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to prolactin [GO:1990646]; cellular response to thapsigargin [GO:1904579]; cellular response to tumor necrosis factor [GO:0071356]; cerebral cortex development [GO:0021987]; endocytosis [GO:0006897]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; regulation of apoptotic process [GO:0042981]; regulation of cytokinesis [GO:0032465]; regulation of long-term synaptic depression [GO:1900452]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to erythropoietin [GO:0036017]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to ischemia [GO:0002931]; response to lead ion [GO:0010288]; response to lipopolysaccharide [GO:0032496]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to oxidative stress [GO:0006979]; response to peptide hormone [GO:0043434]; synaptic vesicle recycling via endosome [GO:0036466],NA,NA,NA
CHOYP_ISCW_ISCW012366.1.1.m.3691,0.003896199,-0.023342157,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nuclear body [GO:0016604]; electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; reactive oxygen species metabolic process [GO:0072593]; substantia nigra development [GO:0021762],NA,NA,NA
CHOYP_ISCW_ISCW012442.1.1.m.8441,0.019179339,0.002716545,No,NA,NA,NA,NA,NA,NA,signal recognition particle; endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614],NA,NA,NA
CHOYP_ISCW_ISCW012623.1.1.m.26452,0.00317131,-0.014645571,No,NA,NA,NA,NA,NA,NA,COPI-coated vesicle [GO:0030137]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein transport [GO:0015031],NA,NA,NA
CHOYP_ISCW_ISCW013289.2.2.m.18741,-0.004531067,-0.018481359,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; response to cold [GO:0009409]; response to water deprivation [GO:0009414],NA,NA,NA
CHOYP_ISCW_ISCW013378.2.3.m.11858,-0.000725867,0.001531992,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; micro-ribonucleoprotein complex [GO:0035068]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter binding [GO:0001047]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity; cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity; cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087],NA,NA,NA
CHOYP_ISCW_ISCW013378.3.3.m.20296,-0.004710785,0.001797472,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; micro-ribonucleoprotein complex [GO:0035068]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter binding [GO:0001047]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity; cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity; cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087],NA,NA,NA
CHOYP_ISCW_ISCW013556.1.1.m.26406,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; chromatin assembly or disassembly [GO:0006333],NA,NA,NA
CHOYP_ISCW_ISCW013767.1.1.m.29335,0.003141753,0.020018292,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; smooth endoplasmic reticulum [GO:0005790]; protein homodimerization activity [GO:0042803]; thioredoxin peroxidase activity [GO:0008379]; 4-hydroxyproline metabolic process [GO:0019471]; cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; oxidation-reduction process [GO:0055114]; protein maturation by protein folding [GO:0022417]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_ISCW_ISCW013795.1.1.m.12153,-0.01536722,-0.009739688,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ISCW_ISCW013810.2.2.m.19882,-0.002258385,0.01758248,No,NA,NA,NA,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_ISCW_ISCW014398.1.3.m.15838,0.002064273,0.019371127,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA cis splicing; via spliceosome [GO:0045292]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_ISCW_ISCW014398.1.3.m.15839,0.001705518,-0.004524841,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA cis splicing; via spliceosome [GO:0045292]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_ISCW_ISCW014481.1.1.m.61217,0.003808622,-0.004849543,No,NA,NA,NA,NA,NA,NA,A band [GO:0031672]; actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; Z disc [GO:0030018]; activating transcription factor binding [GO:0033613]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; potassium ion binding [GO:0030955]; promoter-specific chromatin binding [GO:1990841]; protein deacetylase activity [GO:0033558]; protein kinase binding [GO:0019901]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO transferase activity [GO:0019789]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to mechanical stimulus [GO:0071260]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; inflammatory response [GO:0006954]; negative regulation of cell proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; osteoblast development [GO:0002076]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; protein deacetylation [GO:0006476]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of gene expression; epigenetic [GO:0040029]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle fiber development [GO:0048742]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to drug [GO:0042493]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_ISCW_ISCW014579.2.2.m.5327,0.00082037,-0.008186357,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; establishment of cell polarity [GO:0030010]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_ISCW_ISCW014726.5.5.m.47210,-0.011250558,0.00651901,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ISCW_ISCW014880.1.1.m.27977,-0.000108471,-0.020706797,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; kinase activity [GO:0016301]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transferase activity [GO:0016740]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; execution phase of apoptosis [GO:0097194]; microtubule cytoskeleton organization [GO:0000226]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of microtubule depolymerization [GO:0007026]; neuron cellular homeostasis [GO:0070050]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein acetylation [GO:1901985]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule cytoskeleton organization [GO:0070507]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_ISCW_ISCW015061.1.1.m.51,-0.011207333,-0.005806934,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015],NA,NA,NA
CHOYP_ISCW_ISCW015295.1.1.m.22192,-0.014895288,0.000630743,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; glycine C-acetyltransferase activity [GO:0008890]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]; L-threonine catabolic process to glycine [GO:0019518],NA,NA,NA
CHOYP_ISCW_ISCW016148.3.6.m.54385,-0.00346089,0.013085194,No,NA,NA,NA,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],NA,NA,NA
CHOYP_ISCW_ISCW016212.1.2.m.2539,0.001560776,-0.007520741,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272],NA,NA,NA
CHOYP_ISCW_ISCW016212.2.2.m.46221,-0.006866637,-0.001956836,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272],NA,NA,NA
CHOYP_ISCW_ISCW016254.2.5.m.38599,-0.011284205,0.004985022,No,NA,NA,NA,NA,NA,NA,mitochondrial proton-transporting ATP synthase complex; coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; ATP biosynthetic process [GO:0006754]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_ISCW_ISCW016289.1.1.m.12312,-0.011531286,-0.007995021,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; mRNA metabolic process [GO:0016071],NA,NA,NA
CHOYP_ISCW_ISCW016328.1.1.m.10256,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205],NA,NA,NA
CHOYP_ISCW_ISCW017188.1.1.m.23179,-0.010163678,0.007113109,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome; centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; regulation of mitotic spindle assembly [GO:1901673],NA,NA,NA
CHOYP_ISCW_ISCW017350.1.1.m.11950,-0.005429122,0.016118951,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; DNA binding; bending [GO:0008301]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; DNA recombination [GO:0006310]; DNA unwinding involved in DNA replication [GO:0006268]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379],NA,NA,NA
CHOYP_ISCW_ISCW017474.1.1.m.18280,0.003259641,-0.014320149,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; protein localization [GO:0008104],NA,NA,NA
CHOYP_ISCW_ISCW017519.1.2.m.935,0.011755219,-0.011280975,No,NA,NA,NA,NA,NA,NA,focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674],NA,NA,NA
CHOYP_ISCW_ISCW017526.2.2.m.57044,0.010710919,0.001374455,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; SH2 domain binding [GO:0042169]; anterior/posterior axis specification; embryo [GO:0008595]; antimicrobial humoral response [GO:0019730]; photoreceptor cell development [GO:0042461]; R7 cell fate commitment [GO:0007465]; regulation of Ras protein signal transduction [GO:0046578]; sevenless signaling pathway [GO:0045500]; torso signaling pathway [GO:0008293],NA,NA,NA
CHOYP_ISCW_ISCW017652.1.1.m.49306,-0.003637822,-0.025700139,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; mitochondrial ribosome binding [GO:0097177]; rRNA binding [GO:0019843]; tRNA binding [GO:0000049]; cell proliferation [GO:0008283]; positive regulation of mitochondrial translation [GO:0070131],NA,NA,NA
CHOYP_ISCW_ISCW017655.1.1.m.22914,0.006745278,0.001778531,No,NA,NA,NA,NA,NA,NA,large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_ISCW_ISCW017707.1.1.m.58329,0.012840156,-0.005697584,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; actin binding [GO:0003779]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cellular component organization [GO:0051128],NA,NA,NA
CHOYP_ISCW_ISCW017709.1.1.m.30040,-0.012645826,-0.023635815,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020],NA,NA,NA
CHOYP_ISCW_ISCW017872.2.2.m.60293,0.005070053,0.012745123,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; aryl hydrocarbon receptor binding [GO:0017162]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone acetyltransferase activity [GO:0004402]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor binding [GO:0016922]; nuclear receptor transcription coactivator activity [GO:0030374]; progesterone receptor binding [GO:0033142]; protein dimerization activity [GO:0046983]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; RNA polymerase II regulatory region DNA binding [GO:0001012]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; cellular response to hormone stimulus [GO:0032870]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; estrous cycle [GO:0044849]; hippocampus development [GO:0021766]; histone H4 acetylation [GO:0043967]; hypothalamus development [GO:0021854]; labyrinthine layer morphogenesis [GO:0060713]; lactation [GO:0007595]; male gonad development [GO:0008584]; male mating behavior [GO:0060179]; positive regulation of apoptotic process [GO:0043065]; positive regulation of female receptivity [GO:0045925]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by galactose [GO:0000435]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of cellular response to drug [GO:2001038]; regulation of RNA biosynthetic process [GO:2001141]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]; response to estradiol [GO:0032355]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_ISCW_ISCW018108.1.1.m.43365,-0.006086229,-0.011602663,No,NA,NA,NA,NA,NA,NA,Cul2-RING ubiquitin ligase complex [GO:0031462]; ubiquitin-protein transferase activity [GO:0004842]; regulation of ubiquitin-protein transferase activity [GO:0051438],NA,NA,NA
CHOYP_ISCW_ISCW018298.1.1.m.741,-0.001927289,0.000351755,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of cell proliferation [GO:0008285]; protein glycosylation [GO:0006486]; protein transport [GO:0015031]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_ISCW_ISCW018425.1.1.m.35608,0.021179556,-0.001755284,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; activation of MAPK activity [GO:0000187]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235],NA,NA,NA
CHOYP_ISCW_ISCW018501.2.2.m.61797,-0.010495137,-0.021268347,No,NA,NA,NA,NA,NA,NA,nuclear envelope [GO:0005635]; phosphatidylinositol-3;5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of autophagy [GO:0010506],NA,NA,NA
CHOYP_ISCW_ISCW018536.1.1.m.56336,0.007466067,-0.003491613,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; late endosome [GO:0005770]; phagocytic vesicle [GO:0045335]; retromer complex [GO:0030904]; protein transporter activity [GO:0008565]; cellular response to interferon-gamma [GO:0071346]; intracellular protein transport [GO:0006886]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_ISCW_ISCW018656.1.1.m.51893,-0.015815609,-0.016604512,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_ISCW_ISCW019027.2.2.m.66984,0.013417563,0.011823651,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_ISCW_ISCW019130.1.2.m.10722,-0.00233035,-0.006793607,No,NA,NA,NA,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412],NA,NA,NA
CHOYP_ISCW_ISCW019177.2.4.m.56600,-0.01582725,0.002004517,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; protein homodimerization activity [GO:0042803]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374],NA,NA,NA
CHOYP_ISCW_ISCW019177.4.4.m.63940,-0.022666186,0.010306836,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; protein homodimerization activity [GO:0042803]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374],NA,NA,NA
CHOYP_ISCW_ISCW019590.1.1.m.30707,-0.000184157,0.012718504,No,NA,NA,NA,NA,NA,NA,apicolateral plasma membrane [GO:0016327]; basolateral part of cell [GO:1990794]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; postsynaptic density [GO:0014069]; septate junction [GO:0005918]; synapse [GO:0045202]; ionotropic glutamate receptor binding [GO:0035255]; anterior/posterior axis specification; follicular epithelium [GO:0030714]; basal protein localization [GO:0045175]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; cell proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; Malpighian tubule development [GO:0072002]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of cell proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport; endosome to postsynaptic membrane [GO:0098887]; olfactory behavior [GO:0042048]; ovarian follicle cell development [GO:0030707]; pole plasm protein localization [GO:0007318]; R3/R4 cell fate commitment [GO:0007464]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of JAK-STAT cascade [GO:0046425]; regulation of Notch signaling pathway [GO:0008593]; regulation of synapse structure or activity [GO:0050803]; sensory perception of smell [GO:0007608]; septate junction assembly [GO:0019991]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186],NA,NA,NA
CHOYP_ISCW_ISCW019991.1.5.m.8713,-0.00841904,-0.015239853,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_ISCW_ISCW020028.1.1.m.57937,0.019359841,-0.011428259,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; dorsal closure; amnioserosa morphology change [GO:0046664]; head involution [GO:0008258]; myosin filament assembly [GO:0031034]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_ISCW_ISCW020302.1.1.m.37564,0.00799069,-0.012592483,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; pyrroline-5-carboxylate reductase activity [GO:0004735]; cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561],NA,NA,NA
CHOYP_ISCW_ISCW020550.2.2.m.18099,0.014703586,-0.001114272,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; adrenergic receptor binding [GO:0031690]; complement component C1q binding [GO:0001849]; hyaluronic acid binding [GO:0005540]; kininogen binding [GO:0030984]; mitochondrial ribosome binding [GO:0097177]; mRNA binding [GO:0003729]; protein kinase C binding [GO:0005080]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; translation activator activity [GO:0008494]; apoptotic process [GO:0006915]; complement activation; classical pathway [GO:0006958]; immune response [GO:0006955]; innate immune response [GO:0045087]; mature ribosome assembly [GO:0042256]; mRNA processing [GO:0006397]; negative regulation of defense response to virus [GO:0050687]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of trophoblast cell migration [GO:1901165]; regulation of complement activation [GO:0030449]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_ISCW_ISCW021350.1.1.m.10332,-0.009684355,0.009582176,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; DNA replication [GO:0006260]; negative regulation of histone acetylation [GO:0035067]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription; DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; regulation of mRNA stability [GO:0043488]; viral process [GO:0016032],NA,NA,NA
CHOYP_ISCW_ISCW021457.1.1.m.31134,-0.012681582,-0.021916905,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; cellular response to hypoxia [GO:0071456]; cellular response to retinoic acid [GO:0071300]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription; DNA-templated [GO:0045892]; response to wounding [GO:0009611],NA,NA,NA
CHOYP_ISCW_ISCW021476.1.1.m.29578,-0.007352952,-0.001337746,No,NA,NA,NA,NA,NA,NA,mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; pre-mRNA cleavage required for polyadenylation [GO:0098789],NA,NA,NA
CHOYP_ISCW_ISCW021545.1.1.m.25379,0.001806561,0.00897355,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular protein metabolic process [GO:0044267]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; post-translational protein modification [GO:0043687]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_ISCW_ISCW021591.1.1.m.13969,0.003430668,0.01245444,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; SOSS complex [GO:0070876]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic cell cycle checkpoint [GO:0007093]; response to ionizing radiation [GO:0010212],NA,NA,NA
CHOYP_ISCW_ISCW021591.1.1.m.13970,0.011542498,-0.015766199,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; asparaginyl-tRNA aminoacylation [GO:0006421],NA,NA,NA
CHOYP_ISCW_ISCW021601.2.2.m.20304,0.017174643,-0.017017124,No,NA,NA,NA,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732],NA,NA,NA
CHOYP_ISCW_ISCW022021.1.1.m.53168,0.016293225,0.013535491,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_ISCW_ISCW022029.1.1.m.9014,0.000590823,-0.012375054,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; chromatin [GO:0000785]; nuclear body [GO:0016604]; nuclear replication fork [GO:0043596]; PCNA complex [GO:0043626]; PCNA-p21 complex [GO:0070557]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide insertion or deletion binding [GO:0032139]; DNA polymerase binding [GO:0070182]; DNA polymerase processivity factor activity [GO:0030337]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; MutLalpha complex binding [GO:0032405]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; receptor tyrosine kinase binding [GO:0030971]; cellular response to UV [GO:0034644]; DNA replication [GO:0006260]; epithelial cell differentiation [GO:0030855]; mismatch repair [GO:0006298]; positive regulation of deoxyribonuclease activity [GO:0032077]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; translesion synthesis [GO:0019985],NA,NA,NA
CHOYP_ISCW_ISCW022189.1.1.m.8227,-0.001119775,0.016638214,No,NA,NA,NA,NA,NA,NA,troponin complex [GO:0005861]; regulation of muscle contraction [GO:0006937],NA,NA,NA
CHOYP_ISCW_ISCW022609.1.1.m.26988,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857]; carnitine transmembrane transport [GO:1902603],NA,NA,NA
CHOYP_ISCW_ISCW022842.1.1.m.5648,0.008913586,-0.003851252,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection terminus [GO:0044306]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein phosphorylation [GO:0001934],NA,NA,NA
CHOYP_ISCW_ISCW022925.1.2.m.61535,0.011520276,-0.012564554,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; maintenance of lens transparency [GO:0036438]; negative regulation of creatine transmembrane transporter activity [GO:1905408]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; signal transduction by protein phosphorylation [GO:0023014]; signal transduction by trans-phosphorylation [GO:0023016]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_ISCW_ISCW023153.1.1.m.10480,-0.010732872,0.002024301,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]; positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116],NA,NA,NA
CHOYP_ISCW_ISCW023180.1.2.m.31255,-0.010682457,-0.018818446,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; unfolded protein binding [GO:0051082]; mRNA 5'-splice site recognition [GO:0000395]; mRNA cis splicing; via spliceosome [GO:0045292]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_ISCW_ISCW023297.1.1.m.11833,0.008633615,-0.024004376,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing; via spliceosome [GO:0000398]; transcription; DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_ISCW_ISCW023591.1.1.m.9921,0.010896263,0.001354266,No,NA,NA,NA,NA,NA,NA,transferase activity [GO:0016740]; acetyl-CoA metabolic process [GO:0006084],NA,NA,NA
CHOYP_ISCW_ISCW023973.1.2.m.6506,0.007054192,-0.012319228,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; N-methyltransferase activity [GO:0008170]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; S-adenosyl-L-methionine binding [GO:1904047]; transcription coactivator activity [GO:0003713]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; histone methylation [GO:0016571]; metamorphosis [GO:0007552]; negative regulation of megakaryocyte differentiation [GO:0045653]; neurogenesis [GO:0022008]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation; to asymmetrical-dimethyl arginine [GO:0019919]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription; DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of histone modification [GO:0031056]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ISL1.1.1.m.10993,-0.007334894,0.020566544,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; enhancer sequence-specific DNA binding [GO:0001158]; estrogen receptor binding [GO:0030331]; metal ion binding [GO:0046872]; nuclear receptor binding [GO:0016922]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; atrial septum morphogenesis [GO:0060413]; axon regeneration [GO:0031103]; cardiac cell fate determination [GO:0060913]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to glucocorticoid stimulus [GO:0071385]; endocardial cushion morphogenesis [GO:0003203]; heart development [GO:0007507]; innervation [GO:0060384]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inflammatory response [GO:0050728]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein homodimerization activity [GO:0090074]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; outflow tract septum morphogenesis [GO:0003148]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; pharyngeal system development [GO:0060037]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of histone acetylation [GO:0035066]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of transcription; DNA-templated [GO:0006355]; retinal ganglion cell axon guidance [GO:0031290]; secondary heart field specification [GO:0003139]; sensory system development [GO:0048880]; spinal cord motor neuron cell fate specification [GO:0021520]; trigeminal nerve development [GO:0021559]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral motor neuron differentiation [GO:0021524],NA,NA,NA
CHOYP_ISY1.1.1.m.53545,-0.019448982,0.008333861,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; post-mRNA release spliceosomal complex [GO:0071014]; post-spliceosomal complex [GO:0071020]; Prp19 complex [GO:0000974]; generation of catalytic spliceosome for second transesterification step [GO:0000350]; mRNA 3'-splice site recognition [GO:0000389],NA,NA,NA
CHOYP_ITA5.1.1.m.55930,-0.008139822,0.009800759,No,NA,NA,NA,NA,NA,NA,integrin complex [GO:0008305]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; integrin-mediated signaling pathway [GO:0007229]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_ITA7.1.1.m.1060,-0.015007939,-6.74E-05,No,NA,NA,NA,NA,NA,NA,basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell surface [GO:0009986]; cell-cell adherens junction [GO:0005913]; external side of plasma membrane [GO:0009897]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; integrin alpha6-beta4 complex [GO:0034676]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; insulin-like growth factor I binding [GO:0031994]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; neuregulin binding [GO:0038132]; protein-containing complex binding [GO:0044877]; amelogenesis [GO:0097186]; brown fat cell differentiation [GO:0050873]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; cellular response to extracellular stimulus [GO:0031668]; cellular response to organic cyclic compound [GO:0071407]; digestive tract development [GO:0048565]; ectodermal cell differentiation [GO:0010668]; extracellular matrix organization [GO:0030198]; filopodium assembly [GO:0046847]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; nail development [GO:0035878]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; renal system development [GO:0072001]; skin development [GO:0043588],NA,NA,NA
CHOYP_ITB1.2.4.m.24270,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,alpha9-beta1 integrin-ADAM8 complex [GO:0071133]; alphav-beta3 integrin-HMGB1 complex [GO:0035868]; alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; alphav-beta3 integrin-PKCalpha complex [GO:0035866]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of synaptic membrane [GO:0099699]; integrin alpha9-beta1 complex [GO:0034679]; integrin alphav-beta3 complex [GO:0034683]; integrin complex [GO:0008305]; lamellipodium membrane [GO:0031258]; melanosome [GO:0042470]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; cell adhesion molecule binding [GO:0050839]; enzyme binding [GO:0019899]; extracellular matrix binding [GO:0050840]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protease binding [GO:0002020]; protein disulfide isomerase activity [GO:0003756]; protein kinase C binding [GO:0005080]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; activation of protein kinase activity [GO:0032147]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; apoptotic cell clearance [GO:0043277]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell projection morphogenesis [GO:0048858]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; cellular response to drug [GO:0035690]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; embryo implantation [GO:0007566]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; negative chemotaxis [GO:0050919]; negative regulation of cell death [GO:0060548]; negative regulation of lipid storage [GO:0010888]; negative regulation of lipid transport [GO:0032369]; negative regulation of lipoprotein metabolic process [GO:0050748]; negative regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045715]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:1900731]; positive regulation of angiogenesis [GO:0045766]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of T cell migration [GO:2000406]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of extracellular matrix organization [GO:1903053]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to activity [GO:0014823]; response to radiation [GO:0009314]; smooth muscle cell migration [GO:0014909]; substrate adhesion-dependent cell spreading [GO:0034446]; viral entry into host cell [GO:0046718],NA,NA,NA
CHOYP_ITB1.3.4.m.28565,-0.010339472,0.006269303,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth; open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity; open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration; cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601],NA,NA,NA
CHOYP_ITB1B.1.1.m.59423,-0.001979205,0.012732667,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; recycling endosome [GO:0055037]; ruffle membrane [GO:0032587]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of protein localization to plasma membrane [GO:1903078]; receptor internalization [GO:0031623]; regulation of collagen catabolic process [GO:0010710],NA,NA,NA
CHOYP_ITF2.1.1.m.1446,0.007017691,-0.012158284,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; transcription factor complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_ITIH3.1.3.m.21736,-0.022560296,0.009980832,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; germinal vesicle [GO:0042585]; male pronucleus [GO:0001940]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; C-5 methylation of cytosine [GO:0090116]; chromatin organization [GO:0006325]; DNA demethylation of male pronucleus [GO:0044727]; positive regulation of DNA demethylation [GO:1901537],NA,NA,NA
CHOYP_ITPA.1.1.m.13655,-0.006128959,0.001145473,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166]; deoxyribonucleoside triphosphate catabolic process [GO:0009204]; nucleoside triphosphate catabolic process [GO:0009143]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_ITSN1.4.4.m.35131,-0.005270566,0.001245836,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; membrane [GO:0016020]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; endocytosis [GO:0006897]; intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_IVBI.2.2.m.67049,-0.02256156,0.009983051,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867],NA,NA,NA
CHOYP_IVD.1.2.m.5213,-0.008247562,0.011868706,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; leucine catabolic process [GO:0006552],NA,NA,NA
CHOYP_IVD.2.2.m.14522,-0.009350836,0.000605485,No,NA,NA,NA,NA,NA,NA,plasma membrane [GO:0005886]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; leucine catabolic process [GO:0006552],NA,NA,NA
CHOYP_IWS1.1.1.m.13972,-0.004400382,-0.005252793,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; regulation of histone H3-K36 trimethylation [GO:2001253]; regulation of histone H4 acetylation [GO:0090239]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_IWS1.1.1.m.13973,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_JIP3.1.1.m.25162,-0.001448173,-0.024764822,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase p38 binding [GO:0048273]; receptor signaling complex scaffold activity [GO:0030159]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; negative regulation of protein homodimerization activity [GO:0090074]; positive regulation of cell migration [GO:0030335]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; protein homooligomerization [GO:0051260]; retrograde transport; endosome to Golgi [GO:0042147]; striated muscle cell differentiation [GO:0051146]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_JNK.1.1.m.1540,-0.011641454,-0.010987024,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to organic substance [GO:0071310]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; chorion micropyle formation [GO:0046844]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure; spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc fusion; thorax closure [GO:0046529]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing [GO:0042060]; wound healing; spreading of epidermal cells [GO:0035313],NA,NA,NA
CHOYP_K0020.1.1.m.1673,-0.002837258,0.003753908,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; regulation of protein ADP-ribosylation [GO:0010835],NA,NA,NA
CHOYP_K11G12.5.1.1.m.55605,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; antiporter activity [GO:0015297]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; dicarboxylic acid transport [GO:0006835]; gluconeogenesis [GO:0006094]; ion transport [GO:0006811]; malate transmembrane transport [GO:0071423]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; sulfide oxidation; using sulfide:quinone oxidoreductase [GO:0070221]; thiosulfate transport [GO:0015709],NA,NA,NA
CHOYP_K1239.3.3.m.45453,-0.009126726,0.001474077,No,NA,NA,NA,NA,NA,NA,unfolded protein binding [GO:0051082]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_K1468.1.1.m.24917,0.003519736,-0.020184821,No,NA,NA,NA,NA,NA,NA,recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; intracellular cholesterol transport [GO:0032367],NA,NA,NA
CHOYP_K1609.1.1.m.17775,0.023284981,-0.008260914,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020],NA,NA,NA
CHOYP_K6PF.1.1.m.46882,0.009638504,0.004958384,No,NA,NA,NA,NA,NA,NA,6-phosphofructokinase complex [GO:0005945]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; canonical glycolysis [GO:0061621]; fructose 1;6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; myoblast fusion [GO:0007520]; protein complex oligomerization [GO:0051259]; response to sucrose [GO:0009744]; somatic muscle development [GO:0007525],NA,NA,NA
CHOYP_KAL1.1.1.m.60996,0.01791388,-0.017146536,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KALRN.1.2.m.891,0.009830094,0.004680783,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; adult locomotory behavior [GO:0008344]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_KAPR.1.3.m.8246,0.00582317,0.002719935,No,NA,NA,NA,NA,NA,NA,cAMP-dependent protein kinase complex [GO:0005952]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603],NA,NA,NA
CHOYP_KAPR.2.3.m.56519,-0.007269493,-0.018444008,No,NA,NA,NA,NA,NA,NA,cAMP-dependent protein kinase complex [GO:0005952]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603],NA,NA,NA
CHOYP_KARG.11.11.m.50800,0.003020221,-0.005901118,No,NA,NA,NA,NA,NA,NA,arginine kinase activity [GO:0004054]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_KARG.2.11.m.2196,-0.003457771,0.016597942,No,NA,NA,NA,NA,NA,NA,arginine kinase activity [GO:0004054]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_KARG.3.11.m.2494,-0.016190716,-0.001268212,No,NA,NA,NA,NA,NA,NA,arginine kinase activity [GO:0004054]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_KARG.4.11.m.5401,0.007689261,0.008279482,No,NA,NA,NA,NA,NA,NA,arginine kinase activity [GO:0004054]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_KARG.9.11.m.50527,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,arginine kinase activity [GO:0004054]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_KAT3.1.1.m.49207,-0.005805863,0.00616369,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; kynurenine metabolic process [GO:0070189],NA,NA,NA
CHOYP_KAT5.1.1.m.9015,-0.001517311,-0.010640379,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; protein-containing complex [GO:0032991]; Swr1 complex [GO:0000812]; chromatin binding [GO:0003682]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; phospholipase binding [GO:0043274]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to X-ray [GO:0071481]; DNA damage response; signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; histone acetylation [GO:0016573]; histone H4 acetylation [GO:0043967]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; response to heat [GO:0009408],NA,NA,NA
CHOYP_KAT6B.1.2.m.10955,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleosome [GO:0000786]; acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; negative regulation of transcription; DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_KAT8.1.1.m.28310,0.000822122,0.006825048,No,NA,NA,NA,NA,NA,NA,histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; MLL1 complex [GO:0071339]; MSL complex [GO:0072487]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acetyltransferase activity [GO:0016407]; enzyme binding [GO:0019899]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription factor binding [GO:0008134]; histone acetylation [GO:0016573]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of autophagy [GO:0010506],NA,NA,NA
CHOYP_KBP.1.1.m.16212,-0.014864728,0.003598919,No,NA,NA,NA,NA,NA,NA,cytoskeleton [GO:0005856]; mitochondrion [GO:0005739]; cell differentiation [GO:0030154]; mitochondrial transport [GO:0006839]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_KC1A.1.2.m.14719,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; peptide binding [GO:0042277]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell morphogenesis [GO:0000902]; Golgi organization [GO:0007030]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of GTP binding [GO:1904424]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_KC1A.2.2.m.64030,-0.012599675,0.001485523,No,NA,NA,NA,NA,NA,NA,ciliary basal body [GO:0036064]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; intermediate filament cytoskeleton organization [GO:0045104]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_KC1D.1.3.m.12297,0.00076408,-0.006023715,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; cellular response to nerve growth factor stimulus [GO:1990090]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; microtubule nucleation [GO:0007020]; non-motile cilium assembly [GO:1905515]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to Golgi apparatus [GO:0034067]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_KC1D.3.3.m.61498,0.010767156,0.013506951,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583],NA,NA,NA
CHOYP_KC1G3.1.2.m.18974,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; peptide binding [GO:0042277]; phosphoprotein binding [GO:0051219]; protein serine/threonine kinase activity [GO:0004674]; endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_KCIP4.1.1.m.46682,0.016396147,-0.009150989,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KCMF1.1.1.m.62675,-0.004210284,-0.024084544,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312],NA,NA,NA
CHOYP_KCP.10.13.m.44423,0.007204235,0.000246706,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cellular response to virus [GO:0098586],NA,NA,NA
CHOYP_KCP.3.13.m.17018,0.019131891,-0.010332442,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KCP.6.13.m.26127,0.011120244,-0.004214291,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KCP.7.13.m.40006,-0.007166425,-0.015004084,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KCP.8.13.m.40457,0.022310865,-0.010568193,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_KCP.9.13.m.43409,0.023213427,-0.008936205,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KCY.1.1.m.29973,0.01290591,0.009172893,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; uridylate kinase activity [GO:0009041]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine nucleotide biosynthetic process [GO:0006221],NA,NA,NA
CHOYP_KDEL1.1.1.m.62729,0.005250553,-0.00702769,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]; protein O-linked glycosylation via serine [GO:0018242],NA,NA,NA
CHOYP_KDM1A.1.1.m.60229,-0.002074889,-0.025419323,No,NA,NA,NA,NA,NA,NA,DNA repair complex [GO:1990391]; nuclear chromatin [GO:0000790]; nuclear chromosome; telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; histone deacetylase activity [GO:0004407]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-K9 specific) [GO:0032454]; MRF binding [GO:0043426]; nuclear receptor transcription coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; telomeric DNA binding [GO:0042162]; telomeric repeat-containing RNA binding [GO:0061752]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; alternative mRNA splicing; via spliceosome [GO:0000380]; blood coagulation [GO:0007596]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; guanine metabolic process [GO:0046098]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of histone ubiquitination [GO:0033184]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of cellular protein localization [GO:1903827]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992],NA,NA,NA
CHOYP_KDM1A.1.1.m.60230,0.00542768,0.001640287,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytosol [GO:0005829]; nucleus [GO:0005634]; synapse [GO:0045202]; actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell motility [GO:0048870]; stress fiber assembly [GO:0043149],NA,NA,NA
CHOYP_KDM1B.1.1.m.15843,-0.02136616,-0.000965503,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-monomethyl-K4 specific) [GO:0034649]; oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]; DNA methylation involved in gamete generation [GO:0043046]; histone H3-K4 demethylation [GO:0034720]; multicellular organism development [GO:0007275]; protein deubiquitination [GO:0016579]; regulation of DNA methylation [GO:0044030]; regulation of gene expression by genetic imprinting [GO:0006349],NA,NA,NA
CHOYP_KDM2B.1.1.m.58689,-3.89E-05,-0.013486654,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_KDM5A.1.1.m.51935,-0.009893482,-0.015738639,No,NA,NA,NA,NA,NA,NA,histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; core promoter sequence-specific DNA binding [GO:0001046]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_KHDR1.1.1.m.8878,-0.016182578,0.001005778,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_KI11A.1.1.m.14576,-0.010094608,-0.002834717,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; regulation of mitotic centrosome separation [GO:0046602]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; spindle organization [GO:0007051],NA,NA,NA
CHOYP_KI16B.1.3.m.42636,0.001794536,0.001778011,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; phagocytic vesicle [GO:0045335]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; Rab GTPase binding [GO:0017137]; cellular response to interferon-gamma [GO:0071346]; early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; microtubule-based movement [GO:0007018]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919],NA,NA,NA
CHOYP_KI21A.1.2.m.43900,0.000978185,-0.005314094,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_KIAA1143.1.1.m.1249,-0.001329457,0.007378624,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_KIF2A.2.2.m.62686,-0.004331709,0.009377943,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_KIF2A.2.2.m.62687,0.007800272,-0.008684083,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase activity [GO:0004738]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_KIF2A.2.2.m.62688,-0.011268917,-0.005740008,No,NA,NA,NA,NA,NA,NA,integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; inorganic phosphate transmembrane transporter activity [GO:0005315]; protein-containing complex binding [GO:0044877]; symporter activity [GO:0015293]; phosphate ion transmembrane transport [GO:0035435],NA,NA,NA
CHOYP_KIF3A.1.1.m.51746,-0.009624088,0.008010215,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; cilium [GO:0005929]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_KINH.1.9.m.1032,0.014249409,-0.000451732,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_KINH.6.9.m.42394,-0.001663074,0.00899279,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_KIZ.1.1.m.57618,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cell projection [GO:0042995]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; protein kinase binding [GO:0019901]; spindle organization [GO:0007051],NA,NA,NA
CHOYP_KLC.2.3.m.40314,-0.008235813,0.00734586,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule motor activity [GO:0003777],NA,NA,NA
CHOYP_KLH26.1.2.m.8792,-0.022665727,0.010285809,No,NA,NA,NA,NA,NA,NA,Cul3-RING ubiquitin ligase complex [GO:0031463]; midbody [GO:0030496]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_KLH36.1.2.m.12244,0.010127094,0.002541682,No,NA,NA,NA,NA,NA,NA,Cul3-RING ubiquitin ligase complex [GO:0031463]; midbody [GO:0030496]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_KLHDB.3.5.m.46662,0.008331609,-0.009815189,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_KLHL24.1.4.m.8833,0.009556324,0.013450487,No,NA,NA,NA,NA,NA,NA,adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204]; intermediate filament organization [GO:0045109]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of kainate selective glutamate receptor activity [GO:2000312],NA,NA,NA
CHOYP_KLHL24.2.4.m.18433,-0.01930104,-0.014584469,No,NA,NA,NA,NA,NA,NA,B cell receptor signaling pathway [GO:0050853]; germinal center formation [GO:0002467]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_KLHL7.1.1.m.9444,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]; distal tubule morphogenesis [GO:0072156]; ion homeostasis [GO:0050801]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; renal sodium ion absorption [GO:0070294]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_KLLA0E01035G.1.1.m.13451,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KMO.1.2.m.17496,0.006006081,-0.012577856,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase activity [GO:0016174]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; glomerular visceral epithelial cell development [GO:0072015]; kynurenine metabolic process [GO:0070189]; NAD metabolic process [GO:0019674]; quinolinate biosynthetic process [GO:0019805]; response to yeast [GO:0001878]; tryptophan catabolic process [GO:0006569],NA,NA,NA
CHOYP_KNOP1.1.1.m.11909,0.004244857,-0.013316558,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730],NA,NA,NA
CHOYP_KPC1.1.2.m.30648,-0.002018842,-0.02496364,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein kinase C activity [GO:0004697]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_KPC1.2.2.m.37402,0.007222496,-0.007634108,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein kinase C activity [GO:0004697]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_KPC2.1.3.m.22368,0.001823135,-0.000632692,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_KPCD3.1.1.m.10808,-0.000897297,-0.001999601,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148],NA,NA,NA
CHOYP_KPOL_1058P4.2.2.m.61989,-0.001456983,0.023092573,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KPRB.1.1.m.17501,-0.00549411,-0.001417042,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; ribose phosphate diphosphokinase complex [GO:0002189]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; bone development [GO:0060348]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164],NA,NA,NA
CHOYP_KPYK.2.4.m.19753,0.016162237,0.004314815,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_KPYK.3.4.m.47446,0.005552868,0.003880066,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; pyruvate kinase complex [GO:1902912]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; thyroid hormone binding [GO:0070324]; animal organ regeneration [GO:0031100]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; liver development [GO:0001889]; neutrophil degranulation [GO:0043312]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; protein homotetramerization [GO:0051289]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403],NA,NA,NA
CHOYP_KPYK.4.4.m.48513,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; pyruvate kinase complex [GO:1902912]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; thyroid hormone binding [GO:0070324]; animal organ regeneration [GO:0031100]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; liver development [GO:0001889]; neutrophil degranulation [GO:0043312]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; protein homotetramerization [GO:0051289]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403],NA,NA,NA
CHOYP_KPYM.1.1.m.33498,0.022807392,0.000710718,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; pyruvate kinase complex [GO:1902912]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; thyroid hormone binding [GO:0070324]; animal organ regeneration [GO:0031100]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; liver development [GO:0001889]; neutrophil degranulation [GO:0043312]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; protein homotetramerization [GO:0051289]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403],NA,NA,NA
CHOYP_KRP95.1.1.m.13582,-0.017465705,-0.004878183,No,NA,NA,NA,NA,NA,NA,axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; Rho GTPase binding [GO:0017048]; anterograde axonal transport [GO:0008089]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; determination of left/right symmetry [GO:0007368]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_KS6A1.1.1.m.38386,0.021083139,-0.003768725,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]; cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224],NA,NA,NA
CHOYP_KS6A1.1.1.m.38387,0.00248801,0.00488481,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; peroxisome [GO:0005777]; lipid binding [GO:0008289]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; lipid transport [GO:0006869]; positive regulation of intracellular cholesterol transport [GO:0032385],NA,NA,NA
CHOYP_KS6A5.1.1.m.51330,-0.011103644,-0.024702723,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; histone H2A-S1 phosphorylation [GO:0043990]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-S28 phosphorylation [GO:0043988]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_KS6B1.1.1.m.8274,-0.012859681,0.000611545,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; aging [GO:0007568]; apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cell migration [GO:0016477]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; long-chain fatty acid import [GO:0044539]; long-term memory [GO:0007616]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of glucose import [GO:0046324]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to electrical stimulus involved in regulation of muscle adaptation [GO:0014878]; response to ethanol [GO:0045471]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to insulin [GO:0032868]; response to leucine [GO:0043201]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; response to peptide hormone [GO:0043434]; response to testosterone [GO:0033574]; response to toxic substance [GO:0009636]; response to tumor necrosis factor [GO:0034612]; response to wounding [GO:0009611]; skeletal muscle atrophy [GO:0014732]; skeletal muscle contraction [GO:0003009]; TOR signaling [GO:0031929],NA,NA,NA
CHOYP_KSR2.1.1.m.9852,-0.008179924,-0.004917803,No,NA,NA,NA,NA,NA,NA,Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA-dependent ATPase activity [GO:0043142]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264],NA,NA,NA
CHOYP_KTNA1.1.2.m.16373,0.001277596,0.013132558,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122],NA,NA,NA
CHOYP_KTNA1.2.2.m.63437,0.001502792,-0.017307699,No,NA,NA,NA,NA,NA,NA,aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; late endosome [GO:0005770]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; cell differentiation [GO:0030154]; endosome organization [GO:0007032]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; negative regulation of growth of symbiont in host [GO:0044130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; protein heterooligomerization [GO:0051291]; protein localization to perinuclear region of cytoplasm [GO:1905719]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of protein complex stability [GO:0061635]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; selective autophagy [GO:0061912],NA,NA,NA
CHOYP_L1CAM.2.2.m.49542,2.88E-05,0.008509059,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; axon guidance receptor activity [GO:0008046]; PDZ domain binding [GO:0030165]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to thyroxine stimulus [GO:0097069]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dopaminergic neuron differentiation [GO:0071542]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; modulation of chemical synaptic transmission [GO:0050804]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to activity [GO:0014823]; response to thyroid hormone [GO:0097066]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_LA.1.1.m.65962,-0.0008322,-0.015409268,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; poly(U) RNA binding [GO:0008266]; sequence-specific mRNA binding [GO:1990825]; tRNA binding [GO:0000049]; IRES-dependent viral translational initiation [GO:0075522]; nuclear histone mRNA catabolic process [GO:0071045]; protein localization to cytoplasmic stress granule [GO:1903608]; tRNA 3'-end processing [GO:0042780]; tRNA 5'-leader removal [GO:0001682]; tRNA export from nucleus [GO:0006409],NA,NA,NA
CHOYP_LACB2.1.1.m.31957,-0.007079318,-0.006353382,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; endoribonuclease activity [GO:0004521]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; RNA phosphodiester bond hydrolysis; endonucleolytic [GO:0090502],NA,NA,NA
CHOYP_LACBIDRAFT_295117.3.10.m.29879,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LACH.1.1.m.62529,0.00087524,-0.022930588,No,NA,NA,NA,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity; open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991],NA,NA,NA
CHOYP_LAMA2.1.1.m.10439,0.002646561,-0.00905183,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; sarcolemma [GO:0042383]; synaptic cleft [GO:0043083]; extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; positive regulation of synaptic transmission; cholinergic [GO:0032224]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; Schwann cell differentiation [GO:0014037],NA,NA,NA
CHOYP_LAMC1.1.1.m.36098,-0.016186231,-0.016033895,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-11 complex [GO:0043260]; extracellular matrix structural constituent [GO:0005201]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; endoderm development [GO:0007492]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; hemidesmosome assembly [GO:0031581]; positive regulation of epithelial cell proliferation [GO:0050679]; post-translational protein modification [GO:0043687]; protein-containing complex assembly [GO:0065003]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_LAMP1.2.3.m.16422,0.000697488,-0.009722713,No,NA,NA,NA,NA,NA,NA,endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_LAMP1.3.3.m.16600,0.009118981,-0.011952217,No,NA,NA,NA,NA,NA,NA,endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_LAR.1.2.m.30133,-0.008624996,-0.007048385,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LARP4.1.1.m.14987,-0.008467368,-0.010214482,No,NA,NA,NA,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; positive regulation of translation [GO:0045727],NA,NA,NA
CHOYP_LARP7.1.1.m.35019,0.003120811,0.000773616,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; cardiac muscle tissue regeneration [GO:0061026]; regulation of cardiac muscle cell proliferation [GO:0060043]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_LC7L3.1.1.m.20705,-0.011817713,0.002949765,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LCAZH_2403.1.1.m.47655,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LCP2.12.14.m.40093,0.012333201,0.010505788,No,NA,NA,NA,NA,NA,NA,cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane raft [GO:0044853]; TCR signalosome [GO:0036398]; cytokine secretion [GO:0050663]; Fc-epsilon receptor signaling pathway [GO:0038095]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; mast cell activation [GO:0045576]; platelet activation [GO:0030168]; positive regulation of protein kinase activity [GO:0045860]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LCP2.3.14.m.8968,-0.007792243,-0.009766227,No,NA,NA,NA,NA,NA,NA,cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane raft [GO:0044853]; TCR signalosome [GO:0036398]; cytokine secretion [GO:0050663]; intracellular signal transduction [GO:0035556]; mast cell activation [GO:0045576]; positive regulation of protein kinase activity [GO:0045860]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LDB3.1.1.m.371,-0.006332654,-0.001443052,No,NA,NA,NA,NA,NA,NA,cytoskeleton [GO:0005856]; transcription factor complex [GO:0005667]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LDBPK_300810.1.1.m.29406,0.008724187,0.006624821,No,NA,NA,NA,NA,NA,NA,adherens junction [GO:0005912]; basal cortex [GO:0045180]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; alpha-catenin binding [GO:0045294]; cell adhesion [GO:0007155]; cell motility [GO:0048870]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; culmination involved in sorocarp development [GO:0031154]; epithelial cell morphogenesis [GO:0003382]; establishment or maintenance of bipolar cell polarity [GO:0061245]; Golgi localization [GO:0051645]; multicellular organism development [GO:0007275]; positive regulation of cytoskeleton organization [GO:0051495]; protein secretion [GO:0009306]; regulation of gene expression [GO:0010468]; sorocarp spore cell differentiation [GO:0044671]; sorocarp stalk development [GO:0031150]; sorocarp stalk morphogenesis [GO:0036360],NA,NA,NA
CHOYP_LDLR.6.7.m.57984,0.018334541,-0.006388282,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LECG.3.4.m.29627,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954],NA,NA,NA
CHOYP_LEG4.1.1.m.22079,-0.011595878,0.000954908,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; spliceosomal complex [GO:0005681]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LEMD3.1.1.m.56975,0.019407518,-0.00791099,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; DNA binding [GO:0003677]; angiogenesis [GO:0001525]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; nuclear envelope organization [GO:0006998]; regulation of intracellular signal transduction [GO:1902531],NA,NA,NA
CHOYP_LEO1.1.1.m.41626,-0.011163221,-0.020458213,No,NA,NA,NA,NA,NA,NA,Cdc73/Paf1 complex [GO:0016593]; nucleus [GO:0005634]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; embryonic cranial skeleton morphogenesis [GO:0048701]; glial cell development [GO:0021782]; heart development [GO:0007507]; histone modification [GO:0016570]; melanocyte differentiation [GO:0030318]; neural crest cell development [GO:0014032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; transcription elongation from RNA polymerase II promoter [GO:0006368]; xanthophore differentiation [GO:0050936],NA,NA,NA
CHOYP_LGR4.1.2.m.27343,0.018239717,-0.000362984,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cell differentiation involved in metanephros development [GO:0072202]; circadian regulation of gene expression [GO:0032922]; digestive tract development [GO:0048565]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; hair follicle development [GO:0001942]; hormone-mediated signaling pathway [GO:0009755]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; male genitalia development [GO:0030539]; metanephric glomerulus development [GO:0072224]; metanephric nephron tubule morphogenesis [GO:0072282]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription; DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription; DNA-templated [GO:0045893]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LIAS.1.1.m.21693,-0.018664658,-0.006528645,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; 4 iron; 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; metal ion binding [GO:0046872]; protein lipoylation [GO:0009249],NA,NA,NA
CHOYP_LIG4.1.1.m.6295,-0.01172471,0.009669451,No,NA,NA,NA,NA,NA,NA,condensed chromosome [GO:0000793]; cytoplasmic ribonucleoprotein granule [GO:0036464]; DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; ligase activity [GO:0016874]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell proliferation [GO:0008283]; cellular response to ionizing radiation [GO:0071479]; cellular response to lithium ion [GO:0071285]; central nervous system development [GO:0007417]; chromosome organization [GO:0051276]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA ligation involved in DNA recombination [GO:0051102]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; in utero embryonic development [GO:0001701]; isotype switching [GO:0045190]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; nucleotide-excision repair; DNA gap filling [GO:0006297]; positive regulation of chromosome organization [GO:2001252]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neurogenesis [GO:0050769]; pro-B cell differentiation [GO:0002328]; response to gamma radiation [GO:0010332]; response to ionizing radiation [GO:0010212]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; somatic stem cell population maintenance [GO:0035019]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; V(D)J recombination [GO:0033151],NA,NA,NA
CHOYP_LIGO2.1.2.m.3525,0.007725219,-0.007399351,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of cell migration [GO:0030335]; receptor-mediated virion attachment to host cell [GO:0046813],NA,NA,NA
CHOYP_LIN9.1.1.m.12005,0.006504297,-0.000261074,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; DNA biosynthetic process [GO:0071897]; regulation of cell cycle [GO:0051726]; reproduction [GO:0000003]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_LINJ_09_0950.1.1.m.64023,0.005623091,-0.005340524,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LIPA1.1.1.m.10892,0.000413263,-0.0091258,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]; cell-matrix adhesion [GO:0007160]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LIPB1.1.1.m.35961,-0.009253286,-0.016028143,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular [GO:0005622]; presynapse [GO:0098793]; identical protein binding [GO:0042802],NA,NA,NA
CHOYP_LIPR1.2.3.m.4679,-0.004764924,-0.011230512,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]; lipid metabolic process [GO:0006629]; pancreas development [GO:0031016]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434],NA,NA,NA
CHOYP_LIS1.1.1.m.56212,0.003175367,-0.001950755,No,NA,NA,NA,NA,NA,NA,axon cytoplasm [GO:1904115]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010]; brain morphogenesis [GO:0048854]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; nuclear migration [GO:0007097]; regulation of microtubule motor activity [GO:2000574]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496],NA,NA,NA
CHOYP_LMBL3.1.1.m.14251,-0.009249378,0.006697683,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325],NA,NA,NA
CHOYP_LMO7.1.1.m.27803,0.003921451,0.008142896,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; stress fiber [GO:0001725]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; myosin II head/neck binding [GO:0032034]; actomyosin structure organization [GO:0031032]; negative regulation of cell migration [GO:0030336]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; regulation of focal adhesion assembly [GO:0051893],NA,NA,NA
CHOYP_LNTL.1.1.2.m.10782,-0.013218213,0.013093385,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOAG_00377.2.4.m.54574,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; gonad morphogenesis [GO:0035262]; protein autoprocessing [GO:0016540]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of distal tip cell migration [GO:1903354]; zymogen activation [GO:0031638],NA,NA,NA
CHOYP_LOAG_00625.1.1.m.34418,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOAG_01021.1.4.m.1826,-0.019969375,-0.000317171,No,NA,NA,NA,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; ATP binding [GO:0005524]; MATH domain binding [GO:0090736]; phosphatase binding [GO:0019902]; protein kinase activity [GO:0004672]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; cellular protein localization [GO:0034613]; myosin filament assembly [GO:0031034]; pharyngeal gland morphogenesis [GO:1905905]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion [GO:0040017]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; regulation of Rho protein signal transduction [GO:0035023]; regulation of skeletal muscle contraction by calcium ion signaling [GO:0014722]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_LOAG_05095.2.2.m.58023,0.004782968,0.007618979,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOAG_05718.1.1.m.48540,-0.012468416,-0.000595918,No,NA,NA,NA,NA,NA,NA,chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; voltage-gated ion channel activity [GO:0005244]; regulation of ion transmembrane transport [GO:0034765],NA,NA,NA
CHOYP_LOAG_05814.1.1.m.56611,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine phosphatase activity [GO:0004725],NA,NA,NA
CHOYP_LOC100005182.1.1.m.53007,0.000598896,0.01187521,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; GTP binding [GO:0005525],NA,NA,NA
CHOYP_LOC100005318.1.1.m.30043,0.008345732,-0.000235341,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100007585.5.7.m.51610,-0.006149773,0.004684568,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100008030.1.1.m.10817,0.005978422,-0.007349214,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; negative regulation of cell proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100013725.1.2.m.12740,-0.004871942,-0.010197316,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; cofactor binding [GO:0048037]; drug binding [GO:0008144]; folic acid binding [GO:0005542]; mRNA binding [GO:0003729]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]; sequence-specific mRNA binding [GO:1990825]; thymidylate synthase activity [GO:0004799]; translation repressor activity; mRNA regulatory element binding [GO:0000900]; aging [GO:0007568]; cartilage development [GO:0051216]; circadian rhythm [GO:0007623]; developmental growth [GO:0048589]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; dUMP metabolic process [GO:0046078]; immortalization of host cell by virus [GO:0019088]; intestinal epithelial cell maturation [GO:0060574]; liver regeneration [GO:0097421]; negative regulation of translation [GO:0017148]; regulation of translation [GO:0006417]; response to cytokine [GO:0034097]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to organophosphorus [GO:0046683]; response to progesterone [GO:0032570]; response to vitamin A [GO:0033189]; tetrahydrofolate interconversion [GO:0035999]; uracil metabolic process [GO:0019860],NA,NA,NA
CHOYP_LOC100017222.1.1.m.19930,0.003487696,0.007361521,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100017224.1.1.m.26828,-0.003615427,0.004619186,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; omega-amidase activity [GO:0050152]; asparagine metabolic process [GO:0006528]; glutamine metabolic process [GO:0006541]; oxaloacetate metabolic process [GO:0006107],NA,NA,NA
CHOYP_LOC100023660.1.1.m.30865,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; hepatocyte differentiation [GO:0070365]; lipid homeostasis [GO:0055088]; regulation of insulin secretion [GO:0050796]; type B pancreatic cell development [GO:0003323],NA,NA,NA
CHOYP_LOC100024134.1.1.m.61877,0.007123686,0.00666226,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; iron ion binding [GO:0005506]; oxidoreductase activity; acting on single donors with incorporation of molecular oxygen; incorporation of two atoms of oxygen [GO:0016702]; trimethyllysine dioxygenase activity [GO:0050353]; carnitine biosynthetic process [GO:0045329],NA,NA,NA
CHOYP_LOC100024935.1.1.m.2615,0.005417628,-0.016936897,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; nucleolus [GO:0005730]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662],NA,NA,NA
CHOYP_LOC100027252.1.1.m.30045,-0.001710404,-0.016561323,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; pseudouridine 5'-phosphatase activity [GO:1990738]; nucleotide metabolic process [GO:0009117]; pyrimidine nucleoside salvage [GO:0043097],NA,NA,NA
CHOYP_LOC100027962.1.1.m.48278,0.011205224,0.004785278,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nuclear membrane [GO:0031965]; identical protein binding [GO:0042802]; omega peptidase activity [GO:0008242]; serine-type endopeptidase activity [GO:0004252]; amyloid-beta metabolic process [GO:0050435]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100028654.1.1.m.62088,0.019369953,-0.007504374,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100030437.1.3.m.5994,0.008098635,-0.019221425,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_LOC100030710.2.4.m.13432,0.006319943,0.002919147,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100030710.4.4.m.20819,0.004996275,-0.004254236,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100049762.1.1.m.1777,0.003126217,-0.012851339,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100061302.1.1.m.47172,-0.004925978,0.005650917,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cilium assembly [GO:0060271]; DNA damage response; detection of DNA damage [GO:0042769]; protein phosphorylation [GO:0006468]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100068494.1.1.m.8733,-0.004899101,-0.004624172,No,NA,NA,NA,NA,NA,NA,Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_LOC100072802.1.1.m.27280,-0.001225109,-0.014715913,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; adrenergic receptor binding [GO:0031690]; complement component C1q binding [GO:0001849]; hyaluronic acid binding [GO:0005540]; kininogen binding [GO:0030984]; mitochondrial ribosome binding [GO:0097177]; mRNA binding [GO:0003729]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; translation activator activity [GO:0008494]; apoptotic process [GO:0006915]; complement activation; classical pathway [GO:0006958]; innate immune response [GO:0045087]; mature ribosome assembly [GO:0042256]; mRNA processing [GO:0006397]; negative regulation of defense response to virus [GO:0050687]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of trophoblast cell migration [GO:1901165]; regulation of complement activation [GO:0030449]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100079978.1.1.m.18519,0.004241104,-0.01331998,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; nuclear receptor transcription coactivator activity [GO:0030374]; pseudouridine synthase activity [GO:0009982]; steroid receptor RNA activator RNA binding [GO:0002153]; tRNA binding [GO:0000049]; tRNA pseudouridine synthase activity [GO:0106029]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tRNA pseudouridine synthesis [GO:0031119],NA,NA,NA
CHOYP_LOC100080726.1.1.m.59048,0.00712819,-0.004280105,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; endoribonuclease activity [GO:0004521]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; nuclease activity [GO:0004518]; ribosome binding [GO:0043022]; RNA stem-loop binding [GO:0035613]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to chemokine [GO:1990869]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-1 [GO:0071347]; cellular response to ionomycin [GO:1904637]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cellular response to sodium arsenite [GO:1903936]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; immune response-activating signal transduction [GO:0002757]; inflammatory response [GO:0006954]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma secretion [GO:1902714]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of tumor necrosis factor secretion [GO:1904468]; nervous system development [GO:0007399]; nuclear-transcribed mRNA catabolic process; endonucleolytic cleavage-dependent decay [GO:0000294]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of cell death [GO:0010942]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of lipid storage [GO:0010884]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein complex oligomerization [GO:0051259]; protein deubiquitination [GO:0016579]; RNA phosphodiester bond hydrolysis [GO:0090501]; RNA phosphodiester bond hydrolysis; endonucleolytic [GO:0090502]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_LOC100081619.1.1.m.33744,-0.009295114,0.011703258,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; integral component of presynaptic endosome membrane [GO:0099067]; integral component of synaptic vesicle membrane [GO:0030285]; phagocytic vesicle [GO:0045335]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; cellular response to interferon-gamma [GO:0071346]; Golgi ribbon formation [GO:0090161]; Golgi to plasma membrane protein transport [GO:0043001]; microtubule cytoskeleton organization [GO:0000226]; regulation of Golgi to plasma membrane protein transport [GO:0042996]; regulation of synaptic vesicle endocytosis [GO:1900242]; SNARE complex assembly [GO:0035493]; synaptic vesicle to endosome fusion [GO:0016189]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100081920.1.4.m.1772,-0.015313606,-0.001746528,No,NA,NA,NA,NA,NA,NA,heterotrimeric G-protein complex [GO:0005834]; GTPase activity [GO:0003924]; PDZ domain binding [GO:0030165]; phosphate ion binding [GO:0042301]; cerebral cortex development [GO:0021987]; G protein-coupled receptor signaling pathway [GO:0007186]; response to lipopolysaccharide [GO:0032496],NA,NA,NA
CHOYP_LOC100083076.1.1.m.35327,0.006130579,0.000870261,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; cellular protein catabolic process [GO:0044257]; endosome to lysosome transport [GO:0008333],NA,NA,NA
CHOYP_LOC100089326.1.1.m.19184,-0.002632702,-0.010495011,No,NA,NA,NA,NA,NA,NA,nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; protein-containing complex [GO:0032991]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein heterooligomerization [GO:0051291]; protein heterotetramerization [GO:0051290]; protein heterotrimerization [GO:0070208]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of protein import into nucleus [GO:0042306],NA,NA,NA
CHOYP_LOC100113561.1.1.m.37903,-0.005435052,-0.005346898,No,NA,NA,NA,NA,NA,NA,proton-transporting V-type ATPase; V1 domain [GO:0033180]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991],NA,NA,NA
CHOYP_LOC100113671.1.1.m.18491,-0.018881519,-0.00242166,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; negative regulation of protein dephosphorylation [GO:0035308]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100114159.1.1.m.53867,0.009196771,0.000103915,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100114171.1.1.m.50280,0.003739283,0.021776659,No,NA,NA,NA,NA,NA,NA,CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; translation regulator activity [GO:0045182]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610],NA,NA,NA
CHOYP_LOC100114247.1.1.m.30717,0.011983322,-0.008446312,No,NA,NA,NA,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; tRNA binding [GO:0000049]; activation of MAPK activity [GO:0000187]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; negative regulation of cell proliferation [GO:0008285]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription; DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tumor necrosis factor-mediated signaling pathway [GO:0033209],NA,NA,NA
CHOYP_LOC100114310.1.2.m.39843,0.003075044,-0.001078231,No,NA,NA,NA,NA,NA,NA,axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 secretion [GO:1900042]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390],NA,NA,NA
CHOYP_LOC100114310.2.2.m.64227,0.019332163,0.002153411,No,NA,NA,NA,NA,NA,NA,apicolateral plasma membrane [GO:0016327]; axon [GO:0030424]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; photoreceptor cell axon guidance [GO:0072499]; plasma membrane organization [GO:0007009]; regulation of synapse organization [GO:0050807],NA,NA,NA
CHOYP_LOC100114310.2.2.m.64228,0.006042732,0.020931515,No,NA,NA,NA,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_LOC100114433.2.4.m.6343,0.01540201,-0.008044201,No,NA,NA,NA,NA,NA,NA,A band [GO:0031672]; actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018]; 14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]; cellular response to drug [GO:0035690]; centrosome cycle [GO:0007098]; mitotic cell cycle [GO:0000278]; negative regulation of catalytic activity [GO:0043086]; positive regulation of myosin-light-chain-phosphatase activity [GO:0035508]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of nucleocytoplasmic transport [GO:0046822]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100114636.1.1.m.11052,0.009930365,-0.006758021,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; disulfide oxidoreductase activity [GO:0015036]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_LOC100114736.1.1.m.18266,-0.00473936,0.010315851,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 7-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0047022]; acetoacetyl-CoA reductase activity [GO:0018454]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; steroid dehydrogenase activity [GO:0016229]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; acyl-CoA metabolic process [GO:0006637]; androgen metabolic process [GO:0008209]; ecdysone metabolic process [GO:0008205]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; mitochondrial tRNA processing [GO:0090646]; RNA phosphodiester bond hydrolysis; endonucleolytic [GO:0090502]; steroid metabolic process [GO:0008202],NA,NA,NA
CHOYP_LOC100115002.1.1.m.45844,-0.000280342,-0.003713179,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; identical protein binding [GO:0042802]; MIT domain binding [GO:0090541]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; abscission [GO:0009838]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; establishment of protein localization [GO:0045184]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein localization [GO:0008104]; protein transport [GO:0015031]; viral capsid secondary envelopment [GO:0046745]; viral release from host cell [GO:0019076],NA,NA,NA
CHOYP_LOC100115298.1.1.m.39207,0.007288284,-0.003974847,No,NA,NA,NA,NA,NA,NA,COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100115467.1.1.m.51329,0.016564567,0.011022562,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; histone pre-mRNA DCP binding [GO:0071208]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LOC100115577.1.1.m.21791,0.010946129,0.011065954,No,NA,NA,NA,NA,NA,NA,chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; ovarian follicle cell development [GO:0030707]; protein folding [GO:0006457],NA,NA,NA
CHOYP_LOC100115776.1.1.m.24729,-0.009778434,-0.005968492,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100115939.1.1.m.28155,-0.014471924,-0.015406321,No,NA,NA,NA,NA,NA,NA,NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; protein antigen binding [GO:1990405]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967],NA,NA,NA
CHOYP_LOC100116049.1.1.m.54372,-0.012401492,-0.001480114,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]; photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100116717.2.2.m.30034,-0.014701297,-0.008054722,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1;2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1;2-dioleoylphosphatidylethanolamine) [GO:0102568]; arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644],NA,NA,NA
CHOYP_LOC100116719.1.1.m.58,0.018866679,-0.005311133,No,NA,NA,NA,NA,NA,NA,90S preribosome [GO:0030686]; nucleolus [GO:0005730]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; maturation of LSU-rRNA [GO:0000470]; regulation of apoptotic process [GO:0042981]; regulation of cellular senescence [GO:2000772]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_LOC100116878.1.1.m.11654,-0.000345103,-0.010176076,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; cell cycle [GO:0007049]; negative regulation of cell proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100116878.1.1.m.11655,-0.012799698,-0.001873572,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]; mRNA binding [GO:0003729]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; protein heterotetramerization [GO:0051290],NA,NA,NA
CHOYP_LOC100117365.1.1.m.37817,0.011522268,-0.009820017,No,NA,NA,NA,NA,NA,NA,translation initiation factor activity [GO:0003743],NA,NA,NA
CHOYP_LOC100117425.1.1.m.1256,-0.007688944,0.01404389,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; postsynaptic density [GO:0014069]; tetraspanin-enriched microdomain [GO:0097197]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; constitutive protein ectodomain proteolysis [GO:0051089]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; response to tumor necrosis factor [GO:0034612],NA,NA,NA
CHOYP_LOC100117775.2.2.m.59969,-0.011320233,-0.022987382,No,NA,NA,NA,NA,NA,NA,catalytic activity [GO:0003824],NA,NA,NA
CHOYP_LOC100117917.1.1.m.21225,-0.005664431,0.013456526,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100118048.1.1.m.62637,-0.004607931,0.018453205,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715],NA,NA,NA
CHOYP_LOC100118048.1.1.m.62638,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation factor activity; RNA binding [GO:0008135]; translation [GO:0006412]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_LOC100118063.2.4.m.29108,-0.004849286,-0.001302433,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity; acting on CH-OH group of donors [GO:0016614],NA,NA,NA
CHOYP_LOC100118098.1.1.m.14795,-0.002235923,-0.017174385,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; signaling receptor binding [GO:0005102]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LOC100118291.1.1.m.54817,0.007287879,0.005128932,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Shc-EGFR complex [GO:0070435]; epidermal growth factor receptor binding [GO:0005154]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; actin cytoskeleton organization [GO:0030036]; activation of MAPK activity [GO:0000187]; aging [GO:0007568]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of cell proliferation [GO:0008284]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of vasoconstriction [GO:0045907]; regulation of growth [GO:0040008]; regulation of smooth muscle contraction [GO:0006940]; response to endothelin [GO:1990839]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636],NA,NA,NA
CHOYP_LOC100118354.1.4.m.27048,-0.007592779,-0.024272957,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100118354.2.4.m.44636,-0.019661232,-0.009346303,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100118464.1.1.m.33259,0.013158114,-0.019628917,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cytoplasmic microtubule organization [GO:0031122]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100118502.1.1.m.57420,0.008743938,0.007878143,No,NA,NA,NA,NA,NA,NA,AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle membrane [GO:0030659]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100118811.1.1.m.57633,-0.00592121,-0.016173932,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; cerebral cortex development [GO:0021987]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of protein kinase activity [GO:0006469]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of neuron differentiation [GO:0045664]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; Schwann cell differentiation [GO:0014037]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100119008.1.1.m.43229,0.015795828,0.005972251,No,NA,NA,NA,NA,NA,NA,L-phenylalanine:2-oxoglutarate aminotransferase activity [GO:0080130]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058],NA,NA,NA
CHOYP_LOC100119236.1.1.m.22785,-0.00580694,0.002979808,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100119310.1.1.m.22031,0.004798617,0.007099617,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; bile acid:sodium symporter activity [GO:0008508]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC100119310.1.1.m.22032,0.014294243,0.006382918,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100119577.1.1.m.47861,-0.016364658,-0.005797019,No,NA,NA,NA,NA,NA,NA,cell periphery [GO:0071944]; chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723]; cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; histone dephosphorylation [GO:0016576]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; protein complex oligomerization [GO:0051259]; protein dephosphorylation [GO:0006470]; protein heterooligomerization [GO:0051291]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278],NA,NA,NA
CHOYP_LOC100119750.1.1.m.7019,-0.006864018,0.00129669,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; ribosome binding [GO:0043022]; ubiquitin protein ligase activity [GO:0061630]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344],NA,NA,NA
CHOYP_LOC100120123.1.1.m.12979,-0.014158069,-0.021799007,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; delta1-pyrroline-5-carboxylate synthetase activity [GO:0017084]; glutamate 5-kinase activity [GO:0004349]; glutamate-5-semialdehyde dehydrogenase activity [GO:0004350]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; cellular amino acid biosynthetic process [GO:0008652]; citrulline biosynthetic process [GO:0019240]; glutamate metabolic process [GO:0006536]; L-proline biosynthetic process [GO:0055129]; ornithine biosynthetic process [GO:0006592]; proline biosynthetic process [GO:0006561],NA,NA,NA
CHOYP_LOC100120260.1.1.m.41887,0.005025561,-0.003389567,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100120260.1.1.m.41888,-0.002355336,0.009695051,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; nuclear receptor transcription coactivator activity [GO:0030374]; protein heterodimerization activity [GO:0046982]; retinoid X receptor binding [GO:0046965]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol homeostasis [GO:0042632]; insulin receptor signaling pathway [GO:0008286]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; multicellular organism development [GO:0007275]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of nuclear receptor transcription coactivator activity [GO:2000325],NA,NA,NA
CHOYP_LOC100120440.1.1.m.15371,0.010750913,-0.013152475,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100120677.1.1.m.16799,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,CAF-1 complex [GO:0033186]; nucleus [GO:0005634]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_LOC100120994.1.1.m.54109,0.003101119,-0.006215612,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle; wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480],NA,NA,NA
CHOYP_LOC100121360.1.1.m.56328,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition; RNA-mediated [GO:0032197],NA,NA,NA
CHOYP_LOC100121363.1.1.m.46369,-0.000125634,0.007459234,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1;2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1;2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171]; antibacterial humoral response [GO:0019731]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; lipid catabolic process [GO:0016042]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission; glutamatergic [GO:0051967]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832],NA,NA,NA
CHOYP_LOC100121425.1.1.m.10532,-0.014253538,0.006019798,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; mRNA binding [GO:0003729]; snRNA stem-loop binding [GO:0035614]; chemical synaptic transmission [GO:0007268]; dormancy process [GO:0022611]; mRNA splicing; via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; regulation of hemocyte proliferation [GO:0035206],NA,NA,NA
CHOYP_LOC100121687.1.1.m.57141,-0.012766754,-0.010188392,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_LOC100121788.1.1.m.28436,0.022691947,-0.005119882,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005]; hydrolase activity [GO:0016787]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353],NA,NA,NA
CHOYP_LOC100121969.1.1.m.52130,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; exocytosis [GO:0006887]; phosphatidylinositol-mediated signaling [GO:0048015],NA,NA,NA
CHOYP_LOC100121991.1.1.m.13778,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I activity [GO:0003917]; zinc ion binding [GO:0008270]; developmental growth [GO:0048589]; DNA topological change [GO:0006265]; double-strand break repair via homologous recombination [GO:0000724]; mitochondrial genome maintenance [GO:0000002]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_LOC100121999.3.4.m.54805,0.003333746,0.012149635,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]; actin binding [GO:0003779]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; hippo signaling [GO:0035329]; hyperosmotic response [GO:0006972]; positive regulation of cell division [GO:0051781]; positive regulation of mitotic cytokinetic process [GO:1903438]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of sorocarp development [GO:0031156]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100122037.1.1.m.12516,-0.010716922,-0.012247793,No,NA,NA,NA,NA,NA,NA,CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100122067.1.1.m.49811,-0.005518451,-0.012880375,No,NA,NA,NA,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA [GO:0000470]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100122208.1.1.m.58545,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]; mitochondrial respiratory chain complex III assembly [GO:0034551]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_LOC100122211.1.1.m.56146,0.007941629,-0.002279473,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nucleus [GO:0005634]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; response to virus [GO:0009615]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100122269.1.1.m.8408,0.017115847,-0.015535913,No,NA,NA,NA,NA,NA,NA,DNA binding [GO:0003677]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_LOC100122293.2.2.m.61265,0.021355063,0.007910334,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; endocytosis [GO:0006897]; membrane organization [GO:0061024],NA,NA,NA
CHOYP_LOC100122438.2.2.m.60108,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100122904.1.1.m.45984,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; early endosome to Golgi transport [GO:0034498]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein complex oligomerization [GO:0051259],NA,NA,NA
CHOYP_LOC100123075.1.1.m.8128,0.009918103,0.006525373,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; endomembrane system [GO:0012505]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_LOC100123216.1.1.m.28671,0.014991576,0.004154787,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; tRNA aminoacylation for protein translation [GO:0006418],NA,NA,NA
CHOYP_LOC100123238.1.1.m.27155,-0.001762476,0.009312732,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (guanine(9)-N(1))-methyltransferase activity [GO:0052905]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA binding [GO:0000049]; magnesium ion homeostasis [GO:0010960]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_LOC100123307.1.1.m.13647,-0.001486232,-0.010647559,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100123521.1.2.m.20656,0.009812078,0.011813412,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; saccharopine dehydrogenase (NAD+; L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NADP+; L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554]; protein tetramerization [GO:0051262],NA,NA,NA
CHOYP_LOC100123521.2.2.m.52492,-0.009789944,0.019144211,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; saccharopine dehydrogenase (NAD+; L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NADP+; L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554]; protein tetramerization [GO:0051262],NA,NA,NA
CHOYP_LOC100123553.1.1.m.34041,-0.008444866,-0.012603583,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; SAGA complex [GO:0000124]; transcription coregulator activity [GO:0003712]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H3 acetylation [GO:0043966]; mitotic cytokinesis [GO:0000281]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351]; wing disc pattern formation [GO:0035222],NA,NA,NA
CHOYP_LOC100123595.1.2.m.63353,0.003147285,0.011387901,No,NA,NA,NA,NA,NA,NA,cyclin K-CDK12 complex [GO:0002944]; cyclin K-CDK13 complex [GO:0002945]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; in utero embryonic development [GO:0001701]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues [GO:2001165]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_LOC100123629.1.1.m.841,0.009398042,0.016191476,No,NA,NA,NA,NA,NA,NA,adherens junction [GO:0005912]; basal plasma membrane [GO:0009925]; M band [GO:0031430]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; striated muscle dense body [GO:0055120]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; cell-cell junction organization [GO:0045216]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; sensory perception of mechanical stimulus [GO:0050954],NA,NA,NA
CHOYP_LOC100123667.1.1.m.22353,-0.010979461,0.000162622,No,NA,NA,NA,NA,NA,NA,Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; striated muscle dense body [GO:0055120]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; muscle organ development [GO:0007517]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100123810.2.2.m.52182,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100123890.1.1.m.11450,0.001609796,-0.003979854,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; glucose homeostasis [GO:0042593]; multicellular organism aging [GO:0010259]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100123907.1.1.m.2987,-0.012266441,-0.011528574,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; uridylate kinase activity [GO:0009041]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine nucleotide biosynthetic process [GO:0006221],NA,NA,NA
CHOYP_LOC100136190.1.1.m.9460,-0.01479617,-0.01504708,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; U2-type spliceosomal complex [GO:0005684]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; DNA repair [GO:0006281]; isopeptide cross-linking via N6-glycyl-L-lysine [GO:0018276]; mRNA processing [GO:0006397]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; protein ubiquitination [GO:0016567]; snoRNA splicing [GO:0034247],NA,NA,NA
CHOYP_LOC100142119.1.2.m.2339,0.006860693,-0.01275821,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; negative regulation of myoblast differentiation [GO:0045662]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100142249.1.1.m.55762,0.014440308,-0.00031801,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic endocytic zone [GO:0098843]; Schaffer collateral - CA1 synapse [GO:0098685]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process; modulating synaptic transmission [GO:0099546]; protein K48-linked ubiquitination [GO:0070936]; regulation of defense response to virus by host [GO:0050691]; regulation of interferon-beta production [GO:0032648],NA,NA,NA
CHOYP_LOC100145215.1.1.m.6904,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; Gi/o-coupled serotonin receptor activity [GO:0001586]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; anesthesia-resistant memory [GO:0007615]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway; coupled to cyclic nucleotide second messenger [GO:0007187]; inter-male aggressive behavior [GO:0002121]; male courtship behavior [GO:0008049]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; regulation of circadian sleep/wake cycle; sleep [GO:0045187]; serotonin receptor signaling pathway [GO:0007210],NA,NA,NA
CHOYP_LOC100146233.1.1.m.36400,0.003126635,-0.012839131,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983],NA,NA,NA
CHOYP_LOC100148223.1.1.m.10633,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100150876.1.1.m.61100,-0.014077584,-0.010989542,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; execution phase of apoptosis [GO:0097194],NA,NA,NA
CHOYP_LOC100158931.1.1.m.8283,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,bicellular tight junction [GO:0005923]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]; bicellular tight junction assembly [GO:0070830]; establishment of epithelial cell polarity [GO:0090162],NA,NA,NA
CHOYP_LOC100160077.1.1.m.62645,0.021026229,0.004341198,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; activation of protein kinase activity [GO:0032147]; axonogenesis [GO:0007409]; cell migration [GO:0016477]; cellular response to organic cyclic compound [GO:0071407]; dendrite development [GO:0016358]; dendritic spine morphogenesis [GO:0060997]; intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron apoptotic process [GO:0043525]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; regulation of neuron projection development [GO:0010975]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100160385.1.2.m.40193,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100160412.2.2.m.56352,0.020240491,-0.003692137,No,NA,NA,NA,NA,NA,NA,M band [GO:0031430]; nucleus [GO:0005634]; Z disc [GO:0030018]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015],NA,NA,NA
CHOYP_LOC100161158.1.1.m.14383,-0.004052911,-0.024189947,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; GTP binding [GO:0005525]; uridine kinase activity [GO:0004849],NA,NA,NA
CHOYP_LOC100161360.1.1.m.65809,-0.007719428,0.00205318,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; messenger ribonucleoprotein complex [GO:1990124]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; P granule [GO:0043186]; P-body [GO:0000932]; postsynapse [GO:0098794]; sensory dendrite [GO:0071683]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; cytoplasmic mRNA processing body assembly [GO:0033962]; gene silencing by miRNA [GO:0035195]; habituation [GO:0046959]; messenger ribonucleoprotein complex assembly [GO:1990120]; negative regulation of cytoplasmic translation [GO:2000766]; ovarian follicle cell development [GO:0030707]; pole cell formation [GO:0007279]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of posttranscriptional gene silencing [GO:0060148]; regulation of defense response to virus [GO:0050688]; regulation of neuron projection arborization [GO:0150011]; regulation of olfactory learning [GO:0090328],NA,NA,NA
CHOYP_LOC100162380.1.1.m.23942,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166],NA,NA,NA
CHOYP_LOC100162439.1.1.m.19182,-0.022575894,0.010008967,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677],NA,NA,NA
CHOYP_LOC100164363.1.1.m.61731,0.021204753,-0.00018719,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; magnesium ion binding [GO:0000287]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; phosphate ion binding [GO:0042301]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653],NA,NA,NA
CHOYP_LOC100164899.1.1.m.59665,0.019685309,0.005082787,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851],NA,NA,NA
CHOYP_LOC100165317.1.1.m.8504,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; intracellular [GO:0005622]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; metal ion binding [GO:0046872]; nervous system development [GO:0007399]; proteolysis [GO:0006508]; response to stimulus [GO:0050896]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100165581.1.1.m.18008,-0.012770128,-0.007513094,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741],NA,NA,NA
CHOYP_LOC100165685.1.1.m.13583,0.011358692,-0.017482913,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; animal organ morphogenesis [GO:0009887]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100165703.1.1.m.48642,-0.004333126,0.014843931,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100166052.1.1.m.46867,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; nucleus [GO:0005634]; presynapse [GO:0098793]; adipose tissue development [GO:0060612]; fat cell differentiation [GO:0045444]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; nucleus localization [GO:0051647]; regulation of cell growth [GO:0001558]; spermatogenesis [GO:0007283]; synaptic vesicle endocytosis [GO:0048488],NA,NA,NA
CHOYP_LOC100166353.1.1.m.4625,-0.001521429,0.006170277,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],NA,NA,NA
CHOYP_LOC100166368.1.1.m.44709,0.01824656,-4.86E-05,No,NA,NA,NA,NA,NA,NA,actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; stereocilium [GO:0032420]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; inner ear auditory receptor cell differentiation [GO:0042491],NA,NA,NA
CHOYP_LOC100167728.1.2.m.2289,0.016461543,-0.006388067,No,NA,NA,NA,NA,NA,NA,clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; phosphatidylinositol phosphate binding [GO:1901981]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; positive regulation of GTPase activity [GO:0043547]; protein transport [GO:0015031]; regulation of immune response [GO:0050776]; T cell receptor signaling pathway [GO:0050852]; T-helper 2 cell cytokine production [GO:0035745],NA,NA,NA
CHOYP_LOC100168017.1.1.m.40316,0.008141574,0.006248295,No,NA,NA,NA,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100168209.1.1.m.26697,-0.015682547,-0.014137471,No,NA,NA,NA,NA,NA,NA,plasma membrane [GO:0005886]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; cellular aldehyde metabolic process [GO:0006081]; ethanol catabolic process [GO:0006068],NA,NA,NA
CHOYP_LOC100168368.1.1.m.18551,-0.01720893,-0.000470195,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; adrenal gland development [GO:0030325]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; branching involved in ureteric bud morphogenesis [GO:0001658]; embryonic hemopoiesis [GO:0035162]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; embryonic skeletal system development [GO:0048706]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of cell proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of cell proliferation [GO:0042127]; regulation of ossification [GO:0030278]; sex differentiation [GO:0007548]; spleen development [GO:0048536]; steroid biosynthetic process [GO:0006694]; thymus development [GO:0048538]; urogenital system development [GO:0001655],NA,NA,NA
CHOYP_LOC100168569.1.2.m.11752,0.006902769,-0.00524139,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein dimerization activity [GO:0046983]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cell differentiation involved in embryonic placenta development [GO:0060706]; central nervous system development [GO:0007417]; endocardium development [GO:0003157]; hepatocyte apoptotic process [GO:0097284]; hippo signaling [GO:0035329]; intracellular signal transduction [GO:0035556]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation [GO:0008285]; negative regulation of organ growth [GO:0046621]; neural tube formation [GO:0001841]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase B signaling [GO:0051897]; primitive hemopoiesis [GO:0060215]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cell differentiation involved in embryonic placenta development [GO:0060800]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100168620.4.4.m.40081,-0.023389972,0.006813375,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC100168796.1.1.m.4672,0.011878017,-0.008611729,No,NA,NA,NA,NA,NA,NA,synapse [GO:0045202]; RNA binding [GO:0003723]; cellular response to leukemia inhibitory factor [GO:1990830],NA,NA,NA
CHOYP_LOC100168945.1.1.m.37004,0.007200219,-0.007480763,No,NA,NA,NA,NA,NA,NA,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; myelin sheath [GO:0043209]; secretory granule lumen [GO:0034774]; synapse [GO:0045202]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_LOC100169229.1.1.m.25981,0.013428941,-0.008456102,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; negative regulation of cell migration [GO:0030336]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100169297.1.1.m.48433,0.0056281,-0.009201121,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_LOC100169460.1.1.m.41302,-0.01033366,-0.016082882,No,NA,NA,NA,NA,NA,NA,cytoskeleton [GO:0005856]; extrinsic component of plasma membrane [GO:0019897]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; cardiolipin binding [GO:1901612]; GTPase binding [GO:0051020]; signaling receptor binding [GO:0005102]; CD4-positive; alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; interleukin-2 production [GO:0032623]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein complex oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_LOC100174996.1.1.m.27300,-0.011638478,0.016386183,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100175021.11.11.m.63958,-0.022519518,0.010561608,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100175021.7.11.m.58378,-0.022620923,0.010463939,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100175702.1.1.m.56240,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100175722.1.3.m.11427,-0.022836308,0.00110576,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100175867.1.1.m.48982,0.022029772,-0.003984861,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC100175959.1.7.m.1896,0.005926505,0.017029499,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_LOC100175959.4.7.m.28172,0.015884127,0.003783866,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_LOC100176099.1.1.m.40368,-0.022666073,0.010313637,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; modulation of chemical synaptic transmission [GO:0050804]; regulation of protein kinase A signaling [GO:0010738],NA,NA,NA
CHOYP_LOC100176232.1.1.m.24645,-0.011116773,0.012704454,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density; intracellular component [GO:0099092]; Schaffer collateral - CA1 synapse [GO:0098685]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; inner ear morphogenesis [GO:0042472]; intracellular signal transduction [GO:0035556]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular extravasation [GO:0002692]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neutrophil degranulation [GO:0043314]; neuromuscular process controlling balance [GO:0050885]; positive regulation of phagocytosis [GO:0050766]; regulation of Rho protein signal transduction [GO:0035023]; regulation of vascular permeability [GO:0043114]; response to lipopolysaccharide [GO:0032496],NA,NA,NA
CHOYP_LOC100176461.1.1.m.63236,0.003896971,-0.018237163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100176721.6.6.m.66056,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_LOC100176799.1.1.m.3132,0.007321473,0.007575365,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013],NA,NA,NA
CHOYP_LOC100177459.1.2.m.48730,-0.016614043,-0.002553466,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100177679.1.1.m.54177,0.01706195,-0.001050963,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100177909.1.1.m.29356,-0.00825871,-0.005694934,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; [2Fe-2S] cluster assembly [GO:0044571]; iron-sulfur cluster assembly [GO:0016226]; protein complex oligomerization [GO:0051259]; protein maturation by iron-sulfur cluster transfer [GO:0097428],NA,NA,NA
CHOYP_LOC100178034.1.2.m.13282,0.003693897,-0.022158227,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100178081.1.1.m.56365,-0.011016305,-0.00626005,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202]; vesicle [GO:0031982]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; axon guidance [GO:0007411]; compound eye morphogenesis [GO:0001745]; defense response to fungus [GO:0050832]; exocytosis [GO:0006887]; germarium-derived egg chamber formation [GO:0007293]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; oocyte microtubule cytoskeleton polarization [GO:0008103]; phototransduction [GO:0007602]; pole plasm oskar mRNA localization [GO:0045451]; R7 cell development [GO:0045467]; Rab protein signal transduction [GO:0032482]; regulation of postsynaptic membrane potential [GO:0060078]; retrograde transport; endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100178400.1.1.m.4321,0.012172702,0.005665149,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100178700.1.1.m.37554,1.22E-05,-0.015018977,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone demethylase activity (H3-K36 specific) [GO:0051864]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_LOC100178916.1.1.m.26391,0.001445046,0.002410149,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_LOC100179134.1.1.m.23870,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,fibrillar center [GO:0001650]; intercellular bridge [GO:0045171]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; nucleotide phosphatase activity; acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; RNA binding [GO:0003723]; polynucleotide 5' dephosphorylation [GO:0098507]; protein dephosphorylation [GO:0006470]; RNA metabolic process [GO:0016070],NA,NA,NA
CHOYP_LOC100179300.1.2.m.22734,0.002341576,-0.022632651,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100179357.5.6.m.45322,-0.009336075,-0.013176392,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100179448.1.1.m.8298,0.014545081,-0.015914947,No,NA,NA,NA,NA,NA,NA,small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100179516.1.2.m.45110,-0.006192052,0.014000503,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100179516.2.2.m.49937,-0.018807025,-0.011186417,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100180023.1.7.m.11060,0.018713537,0.008355405,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100180023.4.7.m.33650,0.006936172,-0.004373632,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100180023.5.7.m.56825,-0.001407159,0.018485876,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100180543.1.1.m.4746,0.011608061,0.000655134,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; agmatinase activity [GO:0008783]; metal ion binding [GO:0046872]; putrescine biosynthetic process from arginine [GO:0033388]; spermidine biosynthetic process [GO:0008295],NA,NA,NA
CHOYP_LOC100180636.1.1.m.66440,-0.007072569,-0.024459613,No,NA,NA,NA,NA,NA,NA,ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; heart development [GO:0007507]; protein phosphorylation [GO:0006468]; regulation of cilium assembly [GO:1902017],NA,NA,NA
CHOYP_LOC100180716.1.2.m.860,0.008337874,0.013477192,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100180855.2.4.m.46097,-0.005540956,0.004900693,No,NA,NA,NA,NA,NA,NA,plasma membrane [GO:0005886]; AMP binding [GO:0016208],NA,NA,NA
CHOYP_LOC100180855.4.4.m.66721,0.000333889,-0.017478697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100180883.1.1.m.46611,-0.015381465,-0.009261491,No,NA,NA,NA,NA,NA,NA,cytoplasmic dynein complex [GO:0005868]; dynein intermediate chain binding [GO:0045505]; cilium assembly [GO:0060271]; regulation of cilium assembly [GO:1902017]; regulation of intraciliary retrograde transport [GO:1905799],NA,NA,NA
CHOYP_LOC100181095.1.1.m.8314,-0.016151739,-0.013687061,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100181159.1.1.m.6127,0.016405023,0.01167396,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100181343.1.1.m.59214,-0.001444642,0.01094202,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; mRNA binding [GO:0003729]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100181350.1.1.m.2782,0.01072765,-0.004219979,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; purine nucleotide catabolic process [GO:0006195]; xanthine catabolic process [GO:0009115],NA,NA,NA
CHOYP_LOC100181355.1.1.m.48652,-0.000870294,0.010175578,No,NA,NA,NA,NA,NA,NA,acrosomal membrane [GO:0002080]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378],NA,NA,NA
CHOYP_LOC100181607.1.2.m.36709,0.005148559,0.015030361,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100181826.1.1.m.16288,0.016468709,-0.013400699,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100181873.1.2.m.45633,-0.016180734,0.005750619,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100182131.1.1.m.26023,-0.010497241,-0.006133337,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; endocytosis [GO:0006897]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of sprouting angiogenesis [GO:1903671]; regulation of Notch signaling pathway [GO:0008593],NA,NA,NA
CHOYP_LOC100182237.2.2.m.33734,0.005333271,-0.006623147,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_LOC100182352.2.2.m.64092,0.009218548,-0.000385159,No,NA,NA,NA,NA,NA,NA,intracellular [GO:0005622]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384],NA,NA,NA
CHOYP_LOC100182585.1.2.m.2597,-0.011580021,0.013893848,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; negative regulation of ERBB signaling pathway [GO:1901185]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; vacuolar protein processing [GO:0006624],NA,NA,NA
CHOYP_LOC100182585.2.2.m.24665,-0.012439476,-0.010535819,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100183353.1.1.m.54920,-0.020826554,-0.006331152,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100183535.2.2.m.10350,0.006475326,-0.022261441,No,NA,NA,NA,NA,NA,NA,lyase activity [GO:0016829],NA,NA,NA
CHOYP_LOC100183583.1.2.m.3863,0.002332627,0.003819888,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; glycerophospholipid biosynthetic process [GO:0046474],NA,NA,NA
CHOYP_LOC100183682.1.1.m.61630,-0.004358491,-0.00200182,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100183847.1.2.m.12797,0.00877478,-0.010838743,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; dUTP diphosphatase activity [GO:0004170]; magnesium ion binding [GO:0000287]; peroxisome proliferator activated receptor binding [GO:0042975]; pyrimidine deoxyribonucleotide binding [GO:0032556]; receptor inhibitor activity [GO:0030547]; RNA binding [GO:0003723]; DNA replication [GO:0006260]; dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081]; liver development [GO:0001889]; nucleobase-containing compound metabolic process [GO:0006139]; nucleobase-containing small molecule interconversion [GO:0015949]; protein homotrimerization [GO:0070207]; regulation of protein heterodimerization activity [GO:0043497]; response to organic cyclic compound [GO:0014070],NA,NA,NA
CHOYP_LOC100184284.2.2.m.21644,-0.013569999,0.001095858,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_LOC100184451.1.8.m.30146,-0.019338095,-0.005002615,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100184874.1.1.m.41851,0.00285648,-0.011869674,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; signaling receptor binding [GO:0005102],NA,NA,NA
CHOYP_LOC100185060.2.2.m.18100,-0.020659011,0.002910369,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100185271.1.1.m.19210,-0.016043233,-0.002050265,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100185431.1.1.m.43063,-0.004931786,0.000978119,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_LOC100185443.1.1.m.60976,-0.013658017,-0.012571015,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cilium organization [GO:0044782],NA,NA,NA
CHOYP_LOC100185472.1.1.m.66178,-0.019121699,0.003825781,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100185473.1.1.m.5316,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100185549.1.6.m.31232,-0.014158833,0.018064355,No,NA,NA,NA,NA,NA,NA,plasma membrane [GO:0005886]; AMP binding [GO:0016208],NA,NA,NA
CHOYP_LOC100185549.5.6.m.62694,-0.013631841,0.000735247,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100185846.1.1.m.37884,0.004509794,0.002401885,No,NA,NA,NA,NA,NA,NA,regulation of actin filament-based process [GO:0032970],NA,NA,NA
CHOYP_LOC100186070.1.1.m.3415,0.003272639,-0.0199052,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_LOC100186203.1.1.m.7875,0.000974287,-0.024811664,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100186203.1.1.m.7876,0.017757669,-2.35E-05,No,NA,NA,NA,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; aspartyl-tRNA aminoacylation [GO:0006422],NA,NA,NA
CHOYP_LOC100186276.4.5.m.12980,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100186299.6.6.m.52749,-0.005116962,0.006880223,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; dendritic branch [GO:0044307]; extrinsic component of postsynaptic density membrane [GO:0099147]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; neuronal cell body [GO:0043025]; pericentriolar material [GO:0000242]; synaptic membrane [GO:0097060]; potassium channel regulator activity [GO:0015459]; protein kinase A regulatory subunit binding [GO:0034237]; protein-containing complex scaffold activity [GO:0032947]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; regulation of Golgi organization [GO:1903358]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; Sertoli cell development [GO:0060009]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100186360.1.2.m.50759,-0.009145555,-0.006735735,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100186361.3.3.m.66600,0.014698474,-0.006593306,No,NA,NA,NA,NA,NA,NA,A band [GO:0031672]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; 5.8S rRNA binding [GO:1990932]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027],NA,NA,NA
CHOYP_LOC100186692.1.1.m.7600,0.008201035,-0.003321216,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC100186733.1.1.m.7066,-0.004093635,0.006577385,No,NA,NA,NA,NA,NA,NA,cellularization cleavage furrow [GO:0110070]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; mitotic cytokinetic process [GO:1902410]; mitotic nuclear division [GO:0140014]; nuclear chromosome segregation [GO:0098813],NA,NA,NA
CHOYP_LOC100186936.1.2.m.12235,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579],NA,NA,NA
CHOYP_LOC100187037.1.1.m.55673,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100187348.1.1.m.29904,-0.022147626,0.009462017,No,NA,NA,NA,NA,NA,NA,signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100197130.2.2.m.39076,0.022558646,-0.010020232,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100197511.1.1.m.22053,0.004850669,-0.016709979,No,NA,NA,NA,NA,NA,NA,mitochondrial proton-transporting ATP synthase complex [GO:0005753]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex; catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986],NA,NA,NA
CHOYP_LOC100197876.1.1.m.45271,-0.014160924,0.000592085,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood vessel size [GO:0050880]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100198049.1.1.m.13866,-0.008122063,-0.002331074,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA biosynthetic process [GO:0071897]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; positive regulation of endothelial cell proliferation [GO:0001938],NA,NA,NA
CHOYP_LOC100199222.1.1.m.17588,-0.003516455,-0.001661502,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100199246.1.1.m.43478,0.000273065,-0.003608306,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100199379.1.2.m.59875,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_LOC100199379.2.2.m.63866,0.02248671,-0.009266402,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100199505.1.2.m.19947,0.003815666,0.001438765,No,NA,NA,NA,NA,NA,NA,chylomicron [GO:0042627]; chylomicron remnant [GO:0034360]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intermediate-density lipoprotein particle [GO:0034363]; intracellular membrane-bounded organelle [GO:0043231]; low-density lipoprotein particle [GO:0034362]; lysosomal lumen [GO:0043202]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; very-low-density lipoprotein particle [GO:0034361]; cholesterol transporter activity [GO:0017127]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; artery morphogenesis [GO:0048844]; cellular protein metabolic process [GO:0044267]; cellular response to prostaglandin stimulus [GO:0071379]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; chylomicron assembly [GO:0034378]; chylomicron remnant clearance [GO:0034382]; chylomicron remodeling [GO:0034371]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; leukocyte migration [GO:0050900]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; post-translational protein modification [GO:0043687]; receptor-mediated endocytosis [GO:0006898]; regulation of cholesterol biosynthetic process [GO:0045540]; response to carbohydrate [GO:0009743]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to selenium ion [GO:0010269]; response to virus [GO:0009615]; retinoid metabolic process [GO:0001523]; spermatogenesis [GO:0007283]; toll-like receptor signaling pathway [GO:0002224]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642]; very-low-density lipoprotein particle assembly [GO:0034379]; very-low-density lipoprotein particle clearance [GO:0034447],NA,NA,NA
CHOYP_LOC100199505.2.2.m.25542,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100199663.1.1.m.22109,-0.004037776,-0.011296512,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; synapse [GO:0045202]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; cellular response to interleukin-4 [GO:0071353]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100199980.1.2.m.51259,-0.014619798,0.001156338,No,NA,NA,NA,NA,NA,NA,fungal biofilm matrix [GO:0062040]; hyphal cell wall [GO:0030446]; yeast-form cell wall [GO:0030445]; glyoxalase III activity [GO:0019172]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243],NA,NA,NA
CHOYP_LOC100199980.2.2.m.62743,0.014241927,-0.008075945,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100199980.2.2.m.62746,0.015069727,0.005089212,No,NA,NA,NA,NA,NA,NA,fungal biofilm matrix [GO:0062040]; hyphal cell wall [GO:0030446]; yeast-form cell wall [GO:0030445]; glyoxalase III activity [GO:0019172]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243],NA,NA,NA
CHOYP_LOC100200137.1.1.m.23041,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_LOC100200424.1.1.m.16669,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_LOC100201155.1.1.m.58066,-0.017006104,-0.01294806,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100202203.1.1.m.27309,-0.011909097,-0.007856286,No,NA,NA,NA,NA,NA,NA,serine-type endopeptidase activity [GO:0004252],NA,NA,NA
CHOYP_LOC100202812.1.1.m.31203,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100204502.1.2.m.26864,0.016450653,-0.011703185,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100205674.1.1.m.5810,0.002144587,-0.004372169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100206475.1.16.m.4004,0.017901553,0.009384937,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274],NA,NA,NA
CHOYP_LOC100206557.1.1.m.11857,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247],NA,NA,NA
CHOYP_LOC100207121.5.9.m.48175,-0.003983162,-0.007218283,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100207216.2.2.m.28185,-0.022559617,0.010532152,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100208023.1.8.m.8628,0.007177631,7.53E-05,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_LOC100208023.8.8.m.49917,0.002248347,-0.013442173,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of neuron projection development [GO:0010977]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100208544.1.1.m.54499,0.002218464,0.004714944,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665],NA,NA,NA
CHOYP_LOC100210536.1.1.m.18414,-0.005003915,-0.000360492,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; positive regulation by host of symbiont catalytic activity [GO:0043947]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647],NA,NA,NA
CHOYP_LOC100210677.7.8.m.42871,0.022801449,0.005705636,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC100210677.8.8.m.43132,0.01852087,0.009709053,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC100211409.1.1.m.4742,0.010621425,0.011550476,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100211409.1.1.m.4743,0.011555782,-0.01058517,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100212224.1.1.m.37724,0.011915748,0.008590685,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100212386.1.2.m.33906,0.006090613,0.000177605,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063],NA,NA,NA
CHOYP_LOC100212698.1.1.m.5807,-0.012632256,-0.007194963,No,NA,NA,NA,NA,NA,NA,fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; lipase activity [GO:0016298]; sterol esterase activity [GO:0004771]; cell morphogenesis [GO:0000902]; cell proliferation [GO:0008283]; cellular lipid metabolic process [GO:0044255]; cytokine production [GO:0001816]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle clearance [GO:0034383]; lung development [GO:0030324]; sterol metabolic process [GO:0016125]; tissue remodeling [GO:0048771],NA,NA,NA
CHOYP_LOC100213495.2.2.m.51531,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100213558.1.1.m.45753,0.009424176,0.015925091,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100213744.7.19.m.33062,-0.006700884,-0.01036315,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_LOC100213744.9.19.m.37687,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100215454.1.1.m.40627,0.017972246,0.00653591,No,NA,NA,NA,NA,NA,NA,acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of dopamine secretion [GO:0033603]; protein heterooligomerization [GO:0051291]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission; cholinergic [GO:0007271],NA,NA,NA
CHOYP_LOC100217869.1.2.m.29774,-0.001382934,-0.022657505,No,NA,NA,NA,NA,NA,NA,mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789],NA,NA,NA
CHOYP_LOC100218754.1.1.m.60778,0.015491898,-0.011836127,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; beta-catenin binding [GO:0008013]; actin cytoskeleton organization [GO:0030036]; cell proliferation [GO:0008283]; glomerular visceral epithelial cell migration [GO:0090521]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell migration [GO:0030336]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of ruffle assembly [GO:1900028]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of wound healing [GO:0090303]; regulation of establishment of cell polarity [GO:2000114]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_LOC100222629.1.1.m.9927,0.009302994,0.006584118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100222774.1.1.m.56990,-0.011502571,-0.006927657,No,NA,NA,NA,NA,NA,NA,methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]; leucine metabolic process [GO:0006551]; regulation of eclosion [GO:0007563],NA,NA,NA
CHOYP_LOC100222774.1.1.m.56992,0.00520142,-0.004543725,No,NA,NA,NA,NA,NA,NA,cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; response to aldosterone [GO:1904044]; rRNA processing [GO:0006364]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100227090.1.1.m.1313,0.012353555,0.02298547,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; EKC/KEOPS complex [GO:0000408]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; tRNA threonylcarbamoyladenosine modification [GO:0002949],NA,NA,NA
CHOYP_LOC100232142.1.1.m.19194,-0.003175544,0.014715463,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; methylmalonyl-CoA epimerase activity [GO:0004493]; L-methylmalonyl-CoA metabolic process [GO:0046491]; short-chain fatty acid catabolic process [GO:0019626],NA,NA,NA
CHOYP_LOC100232691.1.1.m.15025,-0.006772578,-0.00329256,No,NA,NA,NA,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial ribosome assembly [GO:0061668]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_LOC100261610.1.1.m.6374,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_LOC100313559.1.1.m.47009,0.006862634,-0.020422816,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; bone development [GO:0060348],NA,NA,NA
CHOYP_LOC100313569.1.1.m.15201,-0.010660231,-0.021398721,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; intra-Golgi vesicle-mediated transport [GO:0006891],NA,NA,NA
CHOYP_LOC100313573.1.1.m.62977,-0.0038515,-0.003489623,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; half bridge of spindle pole body [GO:0005825]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; calcium-mediated signaling [GO:0019722]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; microtubule nucleation [GO:0007020]; mitotic spindle pole body duplication [GO:1903087]; spindle pole body duplication [GO:0030474],NA,NA,NA
CHOYP_LOC100313589.1.1.m.31479,-0.008225754,-0.020545455,No,NA,NA,NA,NA,NA,NA,postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; brain development [GO:0007420]; central nervous system projection neuron axonogenesis [GO:0021952]; dendrite morphogenesis [GO:0048813]; forebrain development [GO:0030900]; intracellular signal transduction [GO:0035556]; negative regulation of protein localization to nucleus [GO:1900181]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; response to virus [GO:0009615],NA,NA,NA
CHOYP_LOC100313617.1.1.m.18024,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; animal organ morphogenesis [GO:0009887]; DNA replication preinitiation complex assembly [GO:0071163]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA replication [GO:0008156]; negative regulation of DNA-dependent DNA replication [GO:2000104]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; regulation of DNA replication [GO:0006275],NA,NA,NA
CHOYP_LOC100313636.2.3.m.26350,-0.011124568,-0.00109419,No,NA,NA,NA,NA,NA,NA,apical part of cell [GO:0045177]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; G protein-coupled glutamate receptor binding [GO:0035256]; GKAP/Homer scaffold activity [GO:0030160]; glutamate receptor binding [GO:0035254]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; behavioral response to cocaine [GO:0048148]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; chemical homeostasis within a tissue [GO:0048875]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of store-operated calcium entry [GO:2001256]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_LOC100313649.1.1.m.49801,-0.017073588,-0.011086697,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; cytoplasm [GO:0005737]; motile cilium [GO:0031514],NA,NA,NA
CHOYP_LOC100313653.1.1.m.61188,-0.000371158,-0.010494532,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612],NA,NA,NA
CHOYP_LOC100313655.1.1.m.52035,0.006258154,-0.013254757,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; bone remodeling [GO:0046849]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; cell fate commitment [GO:0045165]; melanocyte differentiation [GO:0030318]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-templated transcription; initiation [GO:2000144]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cell proliferation [GO:0042127]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_LOC100313661.1.1.m.17706,0.006773506,-0.011114183,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; early endosome membrane [GO:0031901]; phosphatidylinositol-3;5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]; phosphatidylinositol dephosphorylation [GO:0046856],NA,NA,NA
CHOYP_LOC100313664.1.1.m.37913,-0.016346237,-0.013605509,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; SH2 domain binding [GO:0042169]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; intracellular signal transduction [GO:0035556]; negative regulation of Wnt signaling pathway [GO:0030178]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; protein stabilization [GO:0050821]; regulation of gene expression [GO:0010468]; regulation of transcription; DNA-templated [GO:0006355]; serine phosphorylation of STAT protein [GO:0042501]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100313668.2.6.m.31487,0.006878148,-0.010753971,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; mesoderm development [GO:0007498]; nervous system development [GO:0007399]; peripheral nervous system development [GO:0007422]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360],NA,NA,NA
CHOYP_LOC100313676.1.2.m.2193,-0.014810946,-0.011654375,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; transcription factor binding [GO:0008134]; antifungal humoral response [GO:0019732]; antimicrobial humoral response [GO:0019730]; defense response [GO:0006952]; dorsal appendage formation [GO:0046843]; dorsal/ventral axis specification [GO:0009950]; hemopoiesis [GO:0030097]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; response to fungus [GO:0009620]; Toll signaling pathway [GO:0008063],NA,NA,NA
CHOYP_LOC100313691.1.1.m.290,0.001493415,-0.003986719,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; germ cell development [GO:0007281]; nematode larval development [GO:0002119]; regulation of cell proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014],NA,NA,NA
CHOYP_LOC100329062.1.2.m.10150,-0.005382027,-0.023307969,No,NA,NA,NA,NA,NA,NA,basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202]; L27 domain binding [GO:0097016]; PDZ domain binding [GO:0030165]; protein domain specific binding [GO:0019904]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100329062.2.2.m.39235,-0.001882345,-0.023808503,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100329078.1.3.m.26927,-0.001148724,-0.015013004,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_LOC100329078.2.3.m.30776,0.015429597,0.008765825,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_LOC100329955.1.1.m.11340,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100330792.1.2.m.48676,0.007802465,0.015648128,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100330792.2.2.m.53521,0.013317377,0.011618096,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100331324.2.3.m.40325,0.007190615,0.009992577,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100332237.1.1.m.18128,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100346427.1.1.m.44592,0.021080398,0.000844001,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; actin filament bundle assembly [GO:0051017]; isotype switching [GO:0045190]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of mast cell chemotaxis [GO:0060754]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_LOC100353582.2.2.m.63483,0.011580721,-0.005115432,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100358262.2.3.m.28381,-0.006123895,0.000589974,No,NA,NA,NA,NA,NA,NA,DNA replication factor A complex [GO:0005662]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697]; base-excision repair [GO:0006284]; DNA damage response; detection of DNA damage [GO:0042769]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; G1/S transition of mitotic cell cycle [GO:0000082]; interstrand cross-link repair [GO:0036297]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair; DNA gap filling [GO:0006297]; nucleotide-excision repair; DNA incision [GO:0033683]; nucleotide-excision repair; DNA incision; 5'-to lesion [GO:0006296]; nucleotide-excision repair; preincision complex assembly [GO:0006294]; nucleotide-excision repair; preincision complex stabilization [GO:0006293]; regulation of cell proliferation [GO:0042127]; regulation of cellular response to heat [GO:1900034]; regulation of mitotic cell cycle [GO:0007346]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985],NA,NA,NA
CHOYP_LOC100366344.1.1.m.7458,-0.010403559,-0.025143922,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; glycine betaine biosynthetic process from choline [GO:0019285],NA,NA,NA
CHOYP_LOC100366380.1.4.m.16838,0.000873782,0.013467778,No,NA,NA,NA,NA,NA,NA,azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosome [GO:0005764]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; RNA binding [GO:0003723]; neutrophil degranulation [GO:0043312]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100366404.1.2.m.22137,-0.001944663,8.32E-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366408.1.1.m.37601,0.008797158,-0.003569362,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; bone resorption [GO:0045453]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731],NA,NA,NA
CHOYP_LOC100366424.1.1.m.29609,-0.003226743,0.008916493,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100366428.1.1.m.3739,-0.012247329,-0.014152551,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],NA,NA,NA
CHOYP_LOC100366428.1.1.m.3740,-0.010689651,0.005388269,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; thiopurine S-methyltransferase activity [GO:0008119],NA,NA,NA
CHOYP_LOC100366442.1.4.m.6288,-0.014090641,-0.009957577,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100366451.1.1.m.10501,0.0106896,-0.001186702,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cell adhesion molecule binding [GO:0050839]; cardiac muscle tissue development [GO:0048738]; cell-matrix adhesion [GO:0007160]; defense response to Gram-negative bacterium [GO:0050829]; integrin-mediated signaling pathway [GO:0007229],NA,NA,NA
CHOYP_LOC100366455.1.3.m.13543,-0.01311855,0.005283343,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity; acting on NAD(P)H; quinone or similar compound as acceptor [GO:0016655]; prostaglandin-E2 9-reductase activity [GO:0050221]; cyclooxygenase pathway [GO:0019371]; drug metabolic process [GO:0017144]; epithelial cell differentiation [GO:0030855]; oxidation-reduction process [GO:0055114]; vitamin K metabolic process [GO:0042373],NA,NA,NA
CHOYP_LOC100366455.2.3.m.25037,0.003533526,7.87E-05,No,NA,NA,NA,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; carbon-sulfur lyase activity [GO:0016846]; ameboidal-type cell migration [GO:0001667]; cell cycle [GO:0007049]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044],NA,NA,NA
CHOYP_LOC100366455.3.3.m.28840,-0.016284806,-0.013618402,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373],NA,NA,NA
CHOYP_LOC100366470.2.2.m.64705,0.014952674,0.013950658,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366482.1.1.m.9777,-0.018824215,0.000960198,No,NA,NA,NA,NA,NA,NA,cell [GO:0005623]; electron transfer activity [GO:0009055]; malate dehydrogenase activity [GO:0016615]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; protein disulfide oxidoreductase activity [GO:0015035]; carbohydrate metabolic process [GO:0005975]; cell redox homeostasis [GO:0045454]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC100366486.1.1.m.15010,-0.008309986,0.020200065,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_LOC100366488.1.1.m.56518,-0.005063787,0.018799362,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100366489.1.1.m.21907,-0.011309306,0.003694715,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100366518.5.6.m.43397,0.002953092,-0.004145692,No,NA,NA,NA,NA,NA,NA,adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; transmembrane signaling receptor activity [GO:0004888]; actin filament organization [GO:0007015]; anterior/posterior pattern specification [GO:0009952]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell adhesion [GO:0007155]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye cone cell fate commitment [GO:0042676]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral lineage restriction; imaginal disc [GO:0007451]; dorsal/ventral pattern formation; imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification; open tracheal system [GO:0035153]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; morphogenesis of follicular epithelium [GO:0016333]; motor neuron axon guidance [GO:0008045]; muscle cell fate determination [GO:0007521]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell fate commitment [GO:0007464]; R7 cell differentiation [GO:0045466]; R8 cell development [GO:0045463]; R8 cell differentiation [GO:0045465]; R8 cell fate commitment [GO:0007460]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of crystal cell differentiation [GO:0042689]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of R8 cell spacing in compound eye [GO:0045468]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; ventral cord development [GO:0007419]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; wing disc proximal/distal pattern formation [GO:0007473],NA,NA,NA
CHOYP_LOC100366536.3.3.m.51739,0.000520868,-0.004067633,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; cellular response to lithium ion [GO:0071285]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; positive regulation of ligase activity [GO:0051351]; response to X-ray [GO:0010165],NA,NA,NA
CHOYP_LOC100366575.1.1.m.29959,-0.016661632,-0.001538191,No,NA,NA,NA,NA,NA,NA,9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; beta-tubulin binding [GO:0048487]; calcium ion binding [GO:0005509]; calcium-dependent outer dynein arm binding [GO:0120152]; dynein heavy chain binding [GO:0045504]; cell chemotaxis [GO:0060326]; negative regulation of ATP-dependent microtubule motor activity; minus-end-directed [GO:2000578]; regulation of flagellated sperm motility [GO:1901317],NA,NA,NA
CHOYP_LOC100366577.1.2.m.17884,-0.007582841,0.000685952,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; fertilization [GO:0009566]; learning [GO:0007612]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; regulation of nucleocytoplasmic transport [GO:0046822]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100366606.1.2.m.47289,-0.022588605,0.010504862,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; negative regulation of cell proliferation [GO:0008285],NA,NA,NA
CHOYP_LOC100366708.1.1.m.19335,0.017628083,0.003185524,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; oxidoreductase activity [GO:0016491]; thiamine metabolic process [GO:0006772],NA,NA,NA
CHOYP_LOC100366728.1.1.m.57449,-0.01191213,0.002917898,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514],NA,NA,NA
CHOYP_LOC100366728.1.1.m.57452,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_LOC100366734.1.1.m.47271,-0.017409487,-0.01816069,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; tubulin binding [GO:0015631]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; multicellular organism development [GO:0007275]; regulation of smoothened signaling pathway [GO:0008589]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100366735.1.1.m.52023,-0.015450932,0.007890653,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network membrane [GO:0032588]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to interferon-gamma [GO:0071346]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; phagosome maturation [GO:0090382]; Rab protein signal transduction [GO:0032482]; retrograde transport; plasma membrane to Golgi [GO:0035526]; toxin transport [GO:1901998]; virion assembly [GO:0019068],NA,NA,NA
CHOYP_LOC100366754.1.1.m.49522,-0.000453671,0.012065525,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin cytoskeleton reorganization [GO:0031532]; cell projection assembly [GO:0030031]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; lamellipodium assembly [GO:0030032]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_LOC100366763.1.1.m.53708,-0.005612215,-0.009818909,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; actin binding [GO:0003779]; GKAP/Homer scaffold activity [GO:0030160]; ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; receptor signaling complex scaffold activity [GO:0030159]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; zinc ion binding [GO:0008270]; adult behavior [GO:0030534]; AMPA glutamate receptor clustering [GO:0097113]; axon guidance [GO:0007411]; brain morphogenesis [GO:0048854]; dendritic spine morphogenesis [GO:0060997]; guanylate kinase-associated protein clustering [GO:0097117]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; memory [GO:0007613]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of cell volume [GO:0045794]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of synapse structural plasticity [GO:0051835]; positive regulation of synaptic transmission; glutamatergic [GO:0051968]; postsynaptic density assembly [GO:0097107]; regulation of AMPA receptor activity [GO:2000311]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of long-term synaptic depression [GO:1900452]; regulation of long-term synaptic potentiation [GO:1900271]; social behavior [GO:0035176]; striatal medium spiny neuron differentiation [GO:0021773]; synapse assembly [GO:0007416]; synaptic growth at neuromuscular junction [GO:0051124]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625],NA,NA,NA
CHOYP_LOC100366763.1.1.m.53709,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366766.1.1.m.56292,0.002495087,0.014298267,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; calcium channel inhibitor activity [GO:0019855]; ion channel binding [GO:0044325]; protein histidine phosphatase activity [GO:0101006]; negative regulation of ATP citrate synthase activity [GO:2000984]; negative regulation of lyase activity [GO:0051350]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-histidine dephosphorylation [GO:0035971]; positive regulation of cell motility [GO:2000147]; regulation of actin cytoskeleton reorganization [GO:2000249],NA,NA,NA
CHOYP_LOC100366770.1.1.m.55784,-0.006720782,-0.009203044,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100366787.1.1.m.65795,-0.017680664,0.003149904,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100366797.1.3.m.20765,0.003425137,-0.005756266,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366797.2.3.m.54046,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366799.1.2.m.37253,0.005573984,-0.003691646,No,NA,NA,NA,NA,NA,NA,ciliary membrane [GO:0060170]; cytosol [GO:0005829]; extracellular space [GO:0005615]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; intramolecular transferase activity [GO:0016866]; monosaccharide binding [GO:0048029]; ubiquitin protein ligase binding [GO:0031625]; erythrocyte homeostasis [GO:0034101]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; in utero embryonic development [GO:0001701]; mesoderm formation [GO:0001707]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin secretion [GO:0051024],NA,NA,NA
CHOYP_LOC100366813.1.6.m.2829,0.006423231,-0.011210212,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC100366813.4.6.m.31116,0.01131309,-0.002301433,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC100366857.1.1.m.38884,0.008474153,-0.018641677,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366862.1.1.m.62455,-0.012304102,-0.014754102,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100366892.2.3.m.51427,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366906.1.1.m.61901,-0.020901451,3.37E-05,No,NA,NA,NA,NA,NA,NA,intracellular [GO:0005622]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384],NA,NA,NA
CHOYP_LOC100366918.1.1.m.31506,-0.011970794,-0.003358558,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; clathrin coat [GO:0030118]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor-activated receptor activity [GO:0005010]; kringle domain binding [GO:0036143]; mannose binding [GO:0005537]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; signaling receptor activity [GO:0038023]; animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; membrane organization [GO:0061024]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; post-Golgi vesicle-mediated transport [GO:0006892]; receptor-mediated endocytosis [GO:0006898]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100366927.1.1.m.6140,-0.001788321,0.013508159,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_LOC100366932.1.1.m.36598,-0.009159912,-0.018638252,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; H2A histone acetyltransferase activity [GO:0043998]; H4 histone acetyltransferase activity [GO:0010485]; peptide-serine-N-acetyltransferase activity [GO:1990189]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; lipid metabolic process [GO:0006629]; N-terminal protein amino acid acetylation [GO:0006474]; regulation of chromatin silencing at rDNA [GO:0061187],NA,NA,NA
CHOYP_LOC100366957.1.1.m.10938,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100366965.1.2.m.40982,-0.001158086,0.011103462,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; Rho GTPase binding [GO:0017048]; cortical actin cytoskeleton organization [GO:0030866]; regulation of cell morphogenesis [GO:0022604],NA,NA,NA
CHOYP_LOC100366987.2.2.m.61972,-0.007755007,-0.005224347,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100367001.1.1.m.55663,-0.009755335,0.013966835,No,NA,NA,NA,NA,NA,NA,activating signal cointegrator 1 complex [GO:0099053]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; estrogen receptor binding [GO:0030331]; histone acetyltransferase binding [GO:0035035]; nuclear receptor binding [GO:0016922]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; ubiquitin-like protein ligase binding [GO:0044389]; zinc ion binding [GO:0008270]; intracellular estrogen receptor signaling pathway [GO:0030520]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of myoblast differentiation [GO:0045661]; regulation of transcription; DNA-templated [GO:0006355]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100367006.2.2.m.17211,-0.000811245,-0.007414224,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse; modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100367014.1.1.m.18505,-0.002972028,0.010736436,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_LOC100367051.1.1.m.13013,-0.011655966,-0.0196301,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; hematopoietic progenitor cell differentiation [GO:0002244]; mRNA cis splicing; via spliceosome [GO:0045292]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_LOC100367053.1.1.m.18595,-0.008318871,-0.007276428,No,NA,NA,NA,NA,NA,NA,CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]; cell proliferation [GO:0008283]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100367064.1.1.m.52280,-0.000278791,-0.02301629,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; regulation of microtubule polymerization [GO:0031113]; regulation of neuron projection development [GO:0010975]; signal transduction [GO:0007165]; zinc ion import across plasma membrane [GO:0071578],NA,NA,NA
CHOYP_LOC100367069.1.1.m.14484,-0.007754751,-0.001729693,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; nucleoplasm [GO:0005654]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100367071.1.1.m.27695,0.002136973,-0.013849536,No,NA,NA,NA,NA,NA,NA,matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858],NA,NA,NA
CHOYP_LOC100367084.12.22.m.48659,-0.022572372,0.010002463,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100367084.3.22.m.29143,0.004251143,-0.013310197,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100367084.6.22.m.31842,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_LOC100367089.1.4.m.1384,0.008244067,-0.004108896,No,NA,NA,NA,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; skeletal muscle tissue development [GO:0007519]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522],NA,NA,NA
CHOYP_LOC100367089.1.4.m.1412,-0.017365323,0.004159454,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100367089.2.4.m.1910,0.009724741,0.01829776,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100367093.1.1.m.63664,0.001944852,-0.021735993,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2B complex [GO:0005851]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; translation initiation factor activity [GO:0003743]; central nervous system development [GO:0007417]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC100367137.1.1.m.23977,-0.003996291,-0.001317429,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein initiator methionine removal [GO:0070084]; protein processing [GO:0016485],NA,NA,NA
CHOYP_LOC100367144.1.1.m.34153,0.005569524,-0.004954989,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931],NA,NA,NA
CHOYP_LOC100367166.1.1.m.1262,-0.011646869,-0.00029853,No,NA,NA,NA,NA,NA,NA,CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of megakaryocyte differentiation [GO:0045652]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100367201.2.2.m.61573,-0.008148056,-0.000732269,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; apoptotic process [GO:0006915]; cellular response to transforming growth factor beta stimulus [GO:0071560]; negative regulation of cell proliferation [GO:0008285]; negative regulation of chaperone-mediated protein folding [GO:1903645]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into mitochondrial outer membrane [GO:1903638]; positive regulation of release of cytochrome c from mitochondria [GO:0090200],NA,NA,NA
CHOYP_LOC100367205.1.1.m.24472,-0.020089982,-0.010692629,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; cilium movement [GO:0003341],NA,NA,NA
CHOYP_LOC100367232.4.5.m.45036,0.006871135,0.012166336,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100367237.1.2.m.43812,-0.020985716,-0.003758755,No,NA,NA,NA,NA,NA,NA,A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC100367237.2.2.m.47349,0.006634957,0.007564264,No,NA,NA,NA,NA,NA,NA,A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC100367242.1.2.m.48297,0.006542335,-0.000351537,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; early endosome [GO:0005769]; common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145],NA,NA,NA
CHOYP_LOC100367266.1.1.m.10803,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNAP receptor activity [GO:0005484]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_LOC100367291.1.1.m.51818,0.007809019,0.015687485,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; presynapse [GO:0098793]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; negative regulation of constitutive secretory pathway [GO:1903434]; protein localization to Golgi apparatus [GO:0034067]; Rab protein signal transduction [GO:0032482]; regulation of Golgi organization [GO:1903358]; regulation of retrograde vesicle-mediated transport; Golgi to ER [GO:2000156]; skeletal system morphogenesis [GO:0048705],NA,NA,NA
CHOYP_LOC100367312.7.13.m.37565,0.00473053,-0.01777811,No,NA,NA,NA,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; regulation of cell cycle [GO:0051726]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100367326.1.1.m.56733,-0.004494568,0.002190416,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715],NA,NA,NA
CHOYP_LOC100367352.1.1.m.27863,-0.02118013,0.006620731,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; cilium [GO:0005929]; calmodulin binding [GO:0005516]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; motile cilium assembly [GO:0044458],NA,NA,NA
CHOYP_LOC100367353.1.1.m.32092,-0.006701631,0.001815667,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; phosphate-containing compound metabolic process [GO:0006796],NA,NA,NA
CHOYP_LOC100367356.1.1.m.29181,-0.020431243,-0.00552105,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100367378.1.1.m.25783,-0.014578794,0.017056276,No,NA,NA,NA,NA,NA,NA,COPII vesicle coat [GO:0030127]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; molecular adaptor activity [GO:0060090]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592],NA,NA,NA
CHOYP_LOC100367394.1.2.m.34992,-0.012497827,0.012558242,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100367405.1.2.m.10570,-0.015667273,0.002376939,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100367414.1.7.m.21233,-0.014630991,0.007799,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_LOC100367421.1.1.m.66338,-0.004166253,0.016481147,No,NA,NA,NA,NA,NA,NA,orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205],NA,NA,NA
CHOYP_LOC100367423.1.1.m.23397,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,adherens junction [GO:0005912]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; cell adhesion [GO:0007155]; determination of left/right symmetry [GO:0007368],NA,NA,NA
CHOYP_LOC100367436.1.1.m.20579,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_LOC100367460.1.1.m.62925,-0.009977012,0.010444095,No,NA,NA,NA,NA,NA,NA,ADP binding [GO:0043531]; sequence-specific DNA binding [GO:0043565],NA,NA,NA
CHOYP_LOC100367470.1.1.m.51904,0.012024979,-0.00771553,No,NA,NA,NA,NA,NA,NA,mitochondrial outer membrane [GO:0005741]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA-guanine transglycosylation [GO:0101030],NA,NA,NA
CHOYP_LOC100367535.1.2.m.4730,0.013773234,0.012101718,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; L-serine catabolic process [GO:0006565]; threonine catabolic process [GO:0006567],NA,NA,NA
CHOYP_LOC100367548.1.1.m.48434,0.014538214,-0.007320105,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677],NA,NA,NA
CHOYP_LOC100367581.3.3.m.56472,-0.018371063,-0.001007252,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; early endosome [GO:0005769]; common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145],NA,NA,NA
CHOYP_LOC100367604.1.1.m.52334,-0.011277343,-0.011674052,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]; protein C-terminus binding [GO:0008022]; cilium assembly [GO:0060271]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; regulation of protein processing [GO:0070613]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_LOC100367612.1.1.m.37487,-0.002295855,-0.005897193,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; histone binding [GO:0042393]; DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337],NA,NA,NA
CHOYP_LOC100367637.1.1.m.55661,-0.014464785,-0.001256419,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; exoribonuclease activity [GO:0004532]; m7G(5')pppN diphosphatase activity [GO:0050072]; RNA 7-methylguanosine cap binding [GO:0000340]; cellular response to menadione [GO:0036245]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; mRNA cis splicing; via spliceosome [GO:0045292]; negative regulation of programmed cell death [GO:0043069]; nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:0000288],NA,NA,NA
CHOYP_LOC100367640.1.1.m.22070,-0.008136899,-0.004933108,No,NA,NA,NA,NA,NA,NA,ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100367645.1.1.m.29695,-0.000853215,-0.0180166,No,NA,NA,NA,NA,NA,NA,mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrion [GO:0005739]; 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; alpha-ketoacid dehydrogenase activity [GO:0003826]; branched-chain amino acid catabolic process [GO:0009083]; response to nutrient [GO:0007584],NA,NA,NA
CHOYP_LOC100367659.1.1.m.9232,0.014878795,-0.015330764,No,NA,NA,NA,NA,NA,NA,extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; mitochondrion [GO:0005739]; (R)-2-hydroxyglutarate dehydrogenase activity [GO:0051990]; D-lactate dehydrogenase (cytochrome) activity [GO:0004458]; FAD binding [GO:0071949]; lactate oxidation [GO:0019516]; respiratory electron transport chain [GO:0022904],NA,NA,NA
CHOYP_LOC100367705.1.1.m.9297,-0.013706783,-0.0013417,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; motile cilium [GO:0031514]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary transport [GO:0042073]; negative regulation of non-motile cilium assembly [GO:1902856]; photoreceptor cell maintenance [GO:0045494]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468],NA,NA,NA
CHOYP_LOC100367718.1.1.m.8839,-0.008054828,-0.015420539,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of mitochondrial outer membrane [GO:0031307]; integral component of peroxisomal membrane [GO:0005779]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; apoptotic process [GO:0006915]; autophagy of mitochondrion [GO:0000422]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipid [GO:0071396]; cellular response to peptide [GO:1901653]; cellular response to thapsigargin [GO:1904579]; cellular response to toxic substance [GO:0097237]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; peroxisome fission [GO:0016559]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein targeting to membrane [GO:0090314]; protein homooligomerization [GO:0051260]; protein targeting to mitochondrion [GO:0006626]; release of cytochrome c from mitochondria [GO:0001836]; response to flavonoid [GO:1905395]; response to fluoride [GO:1902617]; response to hypobaric hypoxia [GO:1990910]; response to muscle activity [GO:0014850]; response to nutrient levels [GO:0031667],NA,NA,NA
CHOYP_LOC100367726.1.2.m.47322,0.010406249,-0.022045153,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]; biotin metabolic process [GO:0006768]; gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral process [GO:0044794]; positive regulation by host of viral release from host cell [GO:0044791]; pyruvate metabolic process [GO:0006090]; viral RNA genome packaging [GO:0019074],NA,NA,NA
CHOYP_LOC100367736.2.2.m.66862,-0.022558474,0.009977651,No,NA,NA,NA,NA,NA,NA,chromaffin granule membrane [GO:0042584]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to salt stress [GO:0009651]; social behavior [GO:0035176],NA,NA,NA
CHOYP_LOC100367739.1.1.m.22741,-0.018270964,0.014320539,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100367787.1.1.m.52250,-0.020546789,-0.004548545,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100367809.2.2.m.44174,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,cell leading edge [GO:0031252]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; cellular protein localization [GO:0034613]; hydrogen peroxide metabolic process [GO:0042743]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of neuron differentiation [GO:0045666]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of inflammatory response [GO:0050727]; regulation of thyroid hormone generation [GO:2000609],NA,NA,NA
CHOYP_LOC100367837.1.1.m.56015,-0.010295582,0.003539542,No,NA,NA,NA,NA,NA,NA,mRNA cleavage stimulating factor complex [GO:0005848]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_LOC100367880.1.1.m.12770,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule [GO:0005874]; organelle membrane [GO:0031090]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]; aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236],NA,NA,NA
CHOYP_LOC100367908.2.2.m.55212,0.016130552,0.006285261,No,NA,NA,NA,NA,NA,NA,early endosome [GO:0005769]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674],NA,NA,NA
CHOYP_LOC100367949.2.3.m.55056,-0.009542739,-0.005494348,No,NA,NA,NA,NA,NA,NA,CCR4-NOT complex [GO:0030014]; nucleus [GO:0005634]; P-body [GO:0000932]; epidermal growth factor receptor binding [GO:0005154]; kinase binding [GO:0019900]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; cytokine-mediated signaling pathway [GO:0019221]; gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100367949.3.3.m.63228,-0.002551902,0.003771843,No,NA,NA,NA,NA,NA,NA,CCR4-NOT complex [GO:0030014]; nucleus [GO:0005634]; P-body [GO:0000932]; epidermal growth factor receptor binding [GO:0005154]; kinase binding [GO:0019900]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; cytokine-mediated signaling pathway [GO:0019221]; gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100367951.1.1.m.38662,0.005049915,0.012455048,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100367954.1.2.m.66390,-0.002723448,0.021352541,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100367954.2.2.m.66596,0.008368506,0.010619594,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100367956.2.2.m.62044,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020]; 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100367974.1.3.m.19352,-0.022728385,-0.003638819,No,NA,NA,NA,NA,NA,NA,early endosome [GO:0005769]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674],NA,NA,NA
CHOYP_LOC100368004.1.1.m.62584,-0.012469868,-0.018541507,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; embryonic camera-type eye development [GO:0031076]; forebrain development [GO:0030900]; gastrulation [GO:0007369]; mesoderm development [GO:0007498]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100368022.1.1.m.55588,-0.022845133,-0.005952765,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motor activity [GO:0003774],NA,NA,NA
CHOYP_LOC100368023.1.1.m.14890,-0.011632267,-0.000971686,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; protein import into mitochondrial inner membrane [GO:0045039],NA,NA,NA
CHOYP_LOC100368053.1.1.m.25224,-0.011845173,-0.002945579,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020]; heart contraction [GO:0060047]; optokinetic behavior [GO:0007634]; signal transduction [GO:0007165]; swimming behavior [GO:0036269],NA,NA,NA
CHOYP_LOC100368071.1.1.m.6755,-0.019832259,-0.000107138,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100368072.1.1.m.52449,-0.008228113,-0.008483938,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100368104.1.1.m.22554,-0.005231471,-0.012093915,No,NA,NA,NA,NA,NA,NA,basal cortex [GO:0045180]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; establishment of protein localization [GO:0045184]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing; spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507],NA,NA,NA
CHOYP_LOC100368109.1.1.m.18734,0.000873892,-0.00339407,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100368117.1.1.m.27153,-0.005691934,0.008769461,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100368128.1.1.m.9893,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; anatomical structure morphogenesis [GO:0009653]; blastocyst development [GO:0001824]; cell differentiation [GO:0030154]; epithelial cell differentiation [GO:0030855]; extracellular matrix organization [GO:0030198]; inflammatory response [GO:0006954]; mammary gland involution [GO:0060056]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC100368178.1.3.m.36490,-0.001470096,-0.010651074,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear receptor transcription coactivator activity [GO:0030374]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lipid metabolic process [GO:0019216],NA,NA,NA
CHOYP_LOC100368194.1.1.m.59989,0.000937454,-0.001440693,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; phosphatase binding [GO:0019902]; protein-containing complex scaffold activity [GO:0032947]; cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial fusion [GO:0008053]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_LOC100368219.2.5.m.38385,-0.022758144,0.005500676,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100368219.4.5.m.58416,0.009337701,0.019622037,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100368228.3.3.m.54183,-0.005320517,0.008890566,No,NA,NA,NA,NA,NA,NA,phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; catalytic activity [GO:0003824]; glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_LOC100368238.1.1.m.7505,0.023279981,-0.007155631,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC100368251.3.6.m.40053,-0.015674673,0.002386187,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; endosomal vesicle fusion [GO:0034058],NA,NA,NA
CHOYP_LOC100368259.1.1.m.39485,0.018620105,-0.010867219,No,NA,NA,NA,NA,NA,NA,autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; glycogen (starch) synthase activity [GO:0004373]; cellular response to starvation [GO:0009267]; cellular response to sucrose stimulus [GO:0071329]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; glycophagy [GO:0061723]; positive regulation of glycogen catabolic process [GO:0045819]; response to sucrose [GO:0009744],NA,NA,NA
CHOYP_LOC100368360.1.1.m.9672,-0.021510986,-0.010031689,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100368376.1.2.m.11023,-0.00254534,-0.004556365,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612],NA,NA,NA
CHOYP_LOC100368394.1.2.m.22888,-0.019689843,-0.000370465,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; extracellular exosome [GO:0070062],NA,NA,NA
CHOYP_LOC100368410.2.2.m.44510,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100368416.1.1.m.58347,-0.003316304,0.001258587,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922]; fucose metabolic process [GO:0006004]; fucosylation [GO:0036065]; mesoderm formation [GO:0001707]; protein O-linked fucosylation [GO:0036066]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of secretion [GO:0051046],NA,NA,NA
CHOYP_LOC100368486.1.1.m.18263,0.009156276,-0.0012207,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; ATPase activator activity [GO:0001671]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; positive regulation of ATPase activity [GO:0032781],NA,NA,NA
CHOYP_LOC100368495.1.1.m.9879,0.00629501,-0.013864556,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100368521.3.3.m.41435,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100368525.1.1.m.62480,-0.008349982,0.010156855,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; cell morphogenesis [GO:0000902]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; cilium assembly [GO:0060271]; digestive system development [GO:0055123]; ear morphogenesis [GO:0042471]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; gonad development [GO:0008406]; in utero embryonic development [GO:0001701]; intraciliary retrograde transport [GO:0035721]; myotome development [GO:0061055]; nervous system process [GO:0050877]; protein localization to cilium [GO:0061512]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831],NA,NA,NA
CHOYP_LOC100368576.1.1.m.45391,-0.014967828,0.008597719,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; motile cilium [GO:0031514]; nucleus [GO:0005634]; cilium-dependent cell motility [GO:0060285],NA,NA,NA
CHOYP_LOC100368627.1.1.m.13820,0.006228612,-0.017085371,No,NA,NA,NA,NA,NA,NA,fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100368636.1.1.m.6631,-0.018352088,0.007398497,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; axoneme assembly [GO:0035082],NA,NA,NA
CHOYP_LOC100368639.1.1.m.56563,0.002662291,-0.01122623,No,NA,NA,NA,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC100368658.1.1.m.16577,-0.013947478,-0.001847387,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular response to DNA damage stimulus [GO:0006974]; inflammatory response [GO:0006954]; macropinocytosis [GO:0044351]; regulation of interleukin-6 production [GO:0032675]; regulation of tumor necrosis factor production [GO:0032680]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224],NA,NA,NA
CHOYP_LOC100368659.1.2.m.15836,0.001390131,0.008910646,No,NA,NA,NA,NA,NA,NA,90S preribosome [GO:0030686]; membrane [GO:0016020]; Noc4p-Nop14p complex [GO:0030692]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000472]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100368661.1.1.m.60830,0.000715001,0.020963953,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100368695.1.1.m.26746,-0.003068632,0.011339271,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100368715.1.3.m.31823,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100368803.1.1.m.12857,-0.015424502,0.000128199,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium organization [GO:0044782]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],NA,NA,NA
CHOYP_LOC100368820.1.1.m.12090,0.009658067,-0.002446369,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; RNA binding [GO:0003723]; ribosome assembly [GO:0042255],NA,NA,NA
CHOYP_LOC100368844.1.1.m.45290,-0.016152539,0.01890757,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100368865.1.1.m.48100,-0.007249513,0.020594534,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100368865.1.1.m.48101,-0.019385654,-0.007992653,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100368866.1.1.m.6804,0.00130478,0.001013332,No,NA,NA,NA,NA,NA,NA,mitochondrial proton-transporting ATP synthase; central stalk [GO:0005756]; mitochondrion [GO:0005739]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_LOC100368907.1.1.m.22004,-0.001847922,0.003318702,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721],NA,NA,NA
CHOYP_LOC100368913.1.1.m.25628,-0.013078854,-0.009470189,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857]; mitochondrial transport [GO:0006839],NA,NA,NA
CHOYP_LOC100368918.1.2.m.6229,0.008356542,0.005475098,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100368924.1.1.m.5031,-0.006785493,0.015928131,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100368926.5.5.m.55016,0.002716009,-0.009691861,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; type II site-specific deoxyribonuclease activity [GO:0009036]; DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition; RNA-mediated [GO:0032197],NA,NA,NA
CHOYP_LOC100368938.2.2.m.53945,-0.020147195,0.00075597,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142],NA,NA,NA
CHOYP_LOC100368976.1.1.m.1873,-0.000735717,-0.006539908,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; 3'-5' exonuclease activity [GO:0008408]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endodeoxyribonuclease activity [GO:0004520]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; single strand break repair [GO:0000012],NA,NA,NA
CHOYP_LOC100368987.1.1.m.6182,0.00046156,0.020750425,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; contractile ring [GO:0070938]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystroglycan complex [GO:0016011]; dystrophin-associated glycoprotein complex [GO:0016010]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; membrane [GO:0016020]; membrane raft [GO:0045121]; node of Ranvier [GO:0033268]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; synapse [GO:0045202]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; calcium ion binding [GO:0005509]; dystroglycan binding [GO:0002162]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; SH2 domain binding [GO:0042169]; structural constituent of muscle [GO:0008307]; tubulin binding [GO:0015631]; vinculin binding [GO:0017166]; aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; axon regeneration [GO:0031103]; basement membrane organization [GO:0071711]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium-dependent cell-matrix adhesion [GO:0016340]; cellular response to cholesterol [GO:0071397]; cellular response to mechanical stimulus [GO:0071260]; commissural neuron axon guidance [GO:0071679]; cytoskeletal anchoring at plasma membrane [GO:0007016]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; membrane protein ectodomain proteolysis [GO:0006509]; microtubule anchoring [GO:0034453]; modulation by virus of host morphology or physiology [GO:0019048]; morphogenesis of an epithelial sheet [GO:0002011]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell migration [GO:0030336]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase B signaling [GO:0051898]; nerve maturation [GO:0021682]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein kinase activity [GO:0045860]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synapse organization [GO:0050807]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to peptide hormone [GO:0043434]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; Schwann cell development [GO:0014044]; skeletal muscle tissue regeneration [GO:0043403],NA,NA,NA
CHOYP_LOC100369014.8.9.m.53287,0.0076513,0.002243305,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369014.9.9.m.53367,-0.007870444,0.023036473,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369017.1.1.m.27033,-0.009903359,0.003030194,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]; patched binding [GO:0005113]; phosphoprotein binding [GO:0051219]; RNA polymerase II repressing transcription factor binding [GO:0001103]; signaling receptor binding [GO:0005102]; smoothened binding [GO:0005119]; adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cellular lipid metabolic process [GO:0044255]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; fat cell differentiation [GO:0045444]; fertilization [GO:0009566]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; hormone metabolic process [GO:0042445]; intraciliary retrograde transport [GO:0035721]; microtubule cytoskeleton organization [GO:0000226]; neural precursor cell proliferation [GO:0061351]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; olfactory behavior [GO:0042048]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; protein localization [GO:0008104]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; retina homeostasis [GO:0001895]; sensory perception of smell [GO:0007608]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100369022.1.1.m.62978,-0.014704168,-0.02102104,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100369031.1.1.m.19197,0.0061084,0.003153875,No,NA,NA,NA,NA,NA,NA,cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle membrane [GO:0030659]; microtubule plus-end [GO:0035371]; ruffle [GO:0001726]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; positive regulation of dendrite development [GO:1900006],NA,NA,NA
CHOYP_LOC100369186.2.9.m.27904,0.006919481,-0.003461646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369194.1.1.m.42345,-0.010297397,0.007510765,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100369232.1.1.m.58420,0.002272163,-0.016830587,No,NA,NA,NA,NA,NA,NA,condensed chromosome [GO:0000793]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleosome [GO:0000786]; pericentric heterochromatin [GO:0005721]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; chromatin organization [GO:0006325]; dosage compensation [GO:0007549]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression; epigenetic [GO:0045814]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of protein localization to chromosome; telomeric region [GO:1904815]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of gene expression; epigenetic [GO:0045815]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; regulation of lipid metabolic process [GO:0019216]; regulation of response to oxidative stress [GO:1902882],NA,NA,NA
CHOYP_LOC100369237.3.3.m.48902,0.005031139,-0.01649259,No,NA,NA,NA,NA,NA,NA,chromatin binding [GO:0003682],NA,NA,NA
CHOYP_LOC100369255.1.3.m.17623,-0.019303818,-0.002269474,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062],NA,NA,NA
CHOYP_LOC100369259.1.1.m.7509,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; thymidylate kinase activity [GO:0004798]; uridylate kinase activity [GO:0009041]; cell proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; myoblast differentiation [GO:0045445]; nucleobase-containing small molecule interconversion [GO:0015949]; response to cadmium ion [GO:0046686]; response to estrogen [GO:0043627],NA,NA,NA
CHOYP_LOC100369270.1.1.m.27019,-0.003253276,0.008926896,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; mitotic spindle pole [GO:0097431]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; kinase regulator activity [GO:0019207]; protein kinase regulator activity [GO:0019887]; tubulin binding [GO:0015631]; cellular response to DNA damage stimulus [GO:0006974]; establishment of mitotic spindle orientation [GO:0000132]; microtubule anchoring [GO:0034453]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of protein kinase activity [GO:0045859]; ribosomal large subunit export from nucleus [GO:0000055],NA,NA,NA
CHOYP_LOC100369290.1.1.m.66929,0.01209226,0.011988054,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; positive regulation of apoptotic process [GO:0043065],NA,NA,NA
CHOYP_LOC100369294.2.6.m.22959,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,integral component of endoplasmic reticulum membrane [GO:0030176]; protein transport [GO:0015031]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100369294.3.6.m.24633,0.015596244,0.001848386,No,NA,NA,NA,NA,NA,NA,integral component of endoplasmic reticulum membrane [GO:0030176]; protein transport [GO:0015031]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100369302.1.3.m.6808,-0.008334979,-0.004580273,No,NA,NA,NA,NA,NA,NA,Rho guanyl-nucleotide exchange factor activity [GO:0005089]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_LOC100369330.1.1.m.48177,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,Atg12-Atg5-Atg16 complex [GO:0034274]; phagophore assembly site membrane [GO:0034045]; Atg8 ligase activity [GO:0019776]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; C-terminal protein lipidation [GO:0006501]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC100369333.14.32.m.32582,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_LOC100369333.22.32.m.39414,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369333.28.32.m.53859,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369340.1.1.m.51639,-0.009021067,0.011037682,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; axonemal dynein complex assembly [GO:0070286]; single fertilization [GO:0007338],NA,NA,NA
CHOYP_LOC100369350.2.6.m.42373,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_LOC100369378.1.1.m.5391,0.022594929,0.008318656,No,NA,NA,NA,NA,NA,NA,actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC100369384.1.1.m.47986,-0.016373098,0.012581878,No,NA,NA,NA,NA,NA,NA,extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; bone development [GO:0060348]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; ossification [GO:0001503]; protein processing [GO:0016485]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100369402.2.2.m.29002,0.004073491,-0.017308084,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100369411.1.1.m.1071,0.006210154,-0.002956518,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin-[acetyl-CoA-carboxylase] ligase activity [GO:0004077]; biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity [GO:0004078]; biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity [GO:0004079]; biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity [GO:0004080]; biotin-protein ligase activity [GO:0018271]; enzyme binding [GO:0019899]; protein homodimerization activity [GO:0042803]; cell proliferation [GO:0008283]; histone biotinylation [GO:0071110]; histone modification [GO:0016570]; protein biotinylation [GO:0009305]; response to biotin [GO:0070781],NA,NA,NA
CHOYP_LOC100369421.1.2.m.17340,-0.017740315,0.006223165,No,NA,NA,NA,NA,NA,NA,axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]; regulation of cilium movement [GO:0003352],NA,NA,NA
CHOYP_LOC100369444.1.1.m.18613,-0.004855003,-0.024057159,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369488.1.1.m.10559,-0.012010935,-0.000843846,No,NA,NA,NA,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475],NA,NA,NA
CHOYP_LOC100369524.1.1.m.8159,-0.008641907,-0.025476504,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659],NA,NA,NA
CHOYP_LOC100369566.1.1.m.41492,-0.020908142,-0.010327721,No,NA,NA,NA,NA,NA,NA,motile cilium [GO:0031514]; radial spoke [GO:0001534]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341],NA,NA,NA
CHOYP_LOC100369570.1.1.m.25302,0.003446619,-0.007513695,No,NA,NA,NA,NA,NA,NA,SCF ubiquitin ligase complex [GO:0019005]; ubiquitin-protein transferase activity [GO:0004842]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],NA,NA,NA
CHOYP_LOC100369596.1.1.m.7021,0.006915016,-0.003430829,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]; 5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; regulation of mRNA stability [GO:0043488]; response to testosterone [GO:0033574]; RNA phosphodiester bond hydrolysis; exonucleolytic [GO:0090503]; rRNA catabolic process [GO:0016075],NA,NA,NA
CHOYP_LOC100369608.1.3.m.11971,-0.00846225,0.006453707,No,NA,NA,NA,NA,NA,NA,stereocilium [GO:0032420]; catalase activity [GO:0004096]; heme binding [GO:0020037]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_LOC100369657.2.2.m.45309,0.020990174,-0.014485951,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524]; cellular response to glucose starvation [GO:0042149]; glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]; negative regulation of apoptotic process [GO:0043066]; positive regulation of mitotic cell cycle [GO:0045931],NA,NA,NA
CHOYP_LOC100369686.2.2.m.30008,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369689.1.1.m.28663,-0.021120635,0.003480227,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369695.1.1.m.26973,-0.015495045,0.005324225,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; thiopurine S-methyltransferase activity [GO:0008119],NA,NA,NA
CHOYP_LOC100369712.1.1.m.64282,-0.012971627,-0.015945056,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; Lsm1-7-Pat1 complex [GO:1990726]; messenger ribonucleoprotein complex [GO:1990124]; mRNA cap binding complex [GO:0005845]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; negative regulation of neuron differentiation [GO:0045665]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; RNA splicing; via transesterification reactions [GO:0000375]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_LOC100369721.1.1.m.17704,0.019720435,0.003381049,No,NA,NA,NA,NA,NA,NA,aspartate dehydrogenase activity [GO:0033735]; NADP binding [GO:0050661]; NAD biosynthetic process [GO:0009435]; NADP catabolic process [GO:0006742],NA,NA,NA
CHOYP_LOC100369745.1.1.m.18815,-0.003130427,-0.02251724,No,NA,NA,NA,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; translation initiation factor activity [GO:0003743]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of RNA-directed 5'-3' RNA polymerase activity [GO:1900260],NA,NA,NA
CHOYP_LOC100369754.6.10.m.53352,0.004241857,-0.013319315,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369791.1.2.m.8271,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; cell junction assembly [GO:0034329]; muscle fiber development [GO:0048747],NA,NA,NA
CHOYP_LOC100369816.1.1.m.23060,-0.017428204,0.005512364,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100369839.2.4.m.27857,-0.020491233,0.011523114,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369879.3.3.m.59095,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC100369901.1.2.m.9586,-0.008593368,-0.004989429,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100369929.1.5.m.32680,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369935.1.1.m.40124,-0.020574358,-0.012587657,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; motile cilium [GO:0031514]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]; cell projection organization [GO:0030030]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142],NA,NA,NA
CHOYP_LOC100369954.1.1.m.22656,-0.005692071,-0.003355579,No,NA,NA,NA,NA,NA,NA,cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100369954.1.1.m.22658,-0.00808039,0.023205832,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; actin binding [GO:0003779]; enzyme binding [GO:0019899]; defense response to fungus [GO:0050832],NA,NA,NA
CHOYP_LOC100369985.1.1.m.35628,-0.009274822,-0.003135074,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100370026.1.1.m.42957,-0.017783676,-0.006292403,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; manganese ion binding [GO:0030145]; RNA binding [GO:0003723]; snoRNA processing [GO:0043144],NA,NA,NA
CHOYP_LOC100370040.1.2.m.55411,0.002815927,0.009899626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370040.2.2.m.55789,0.006893622,-0.009847045,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370046.1.1.m.18329,-0.014912652,-0.004703752,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; tRNA (cytosine-2'-O-)-methyltransferase activity [GO:0052666]; tRNA (guanosine-2'-O-)-methyltransferase activity [GO:0009020]; tRNA methyltransferase activity [GO:0008175]; cytoplasmic translation [GO:0002181]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA nucleoside ribose methylation [GO:0002128],NA,NA,NA
CHOYP_LOC100370061.1.1.m.41505,-0.018895811,0.007335854,No,NA,NA,NA,NA,NA,NA,eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100370071.1.1.m.46123,-0.01365932,0.013981657,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_LOC100370080.1.1.m.14971,-0.001453986,0.010961365,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase inhibitor activity [GO:0005095]; bicellular tight junction assembly [GO:0070830]; centrosome cycle [GO:0007098]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of GTPase activity [GO:0034260]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of microtubule polymerization [GO:0031116]; regulation of insulin secretion [GO:0050796]; regulation of microtubule polymerization [GO:0031113]; tubulin complex assembly [GO:0007021],NA,NA,NA
CHOYP_LOC100370113.2.2.m.56346,0.003742144,0.007525934,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370122.2.2.m.59310,-0.022664283,0.010266439,No,NA,NA,NA,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; electron transport chain [GO:0022900],NA,NA,NA
CHOYP_LOC100370136.1.1.m.2170,0.0007707,-0.02485587,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of collagen binding [GO:0033342]; negative regulation of DNA replication [GO:0008156]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079],NA,NA,NA
CHOYP_LOC100370139.3.4.m.58156,0.007082803,0.018549427,No,NA,NA,NA,NA,NA,NA,cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100370154.1.2.m.27385,-0.013722323,-0.001324694,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network [GO:0005802]; AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; antigen processing and presentation [GO:0019882]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; mitochondrion organization [GO:0007005]; phagosome maturation [GO:0090382]; protein localization to membrane [GO:0072657]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100370167.1.1.m.15539,0.005881661,0.003729362,No,NA,NA,NA,NA,NA,NA,peroxisome [GO:0005777]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062],NA,NA,NA
CHOYP_LOC100370187.1.1.m.8872,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; signaling receptor activity [GO:0038023]; cGMP-mediated signaling [GO:0019934]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100370194.1.1.m.52469,0.003563252,-0.009914016,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; inflammatory response [GO:0006954]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC100370201.1.1.m.974,-0.009768067,-0.013793357,No,NA,NA,NA,NA,NA,NA,COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; molecular adaptor activity [GO:0060090]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592],NA,NA,NA
CHOYP_LOC100370218.1.1.m.36701,-0.018151985,0.01240088,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370236.1.3.m.7766,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; nucleic acid binding [GO:0003676]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100370246.2.2.m.45834,0.001891162,-0.024592121,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100370246.2.2.m.45836,0.012314968,-0.007958976,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; cell proliferation [GO:0008283]; neutrophil degranulation [GO:0043312]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100370269.1.1.m.55713,-0.005251356,0.007412788,No,NA,NA,NA,NA,NA,NA,P-body [GO:0000932]; PAN complex [GO:0031251]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; protein targeting [GO:0006605],NA,NA,NA
CHOYP_LOC100370323.1.1.m.62024,0.000915165,0.014104647,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370330.1.1.m.10944,0.003057268,0.008456164,No,NA,NA,NA,NA,NA,NA,purine nucleotide binding [GO:0017076],NA,NA,NA
CHOYP_LOC100370334.1.1.m.48934,-0.010472704,-0.004822864,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; actin cytoskeleton organization [GO:0030036]; ameboidal-type cell migration [GO:0001667]; carboxylic acid metabolic process [GO:0019752]; cell death [GO:0008219]; cell motility [GO:0048870]; cellular calcium ion homeostasis [GO:0006874]; ceramide metabolic process [GO:0006672]; chemotaxis [GO:0006935]; locomotion [GO:0040011]; negative regulation of aggregate size involved in sorocarp development [GO:0031158]; negative regulation of lateral pseudopodium assembly [GO:0031276]; positive phototaxis [GO:0046956]; regulation of actin filament polymerization [GO:0030833]; sorocarp development [GO:0030587]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665]; sporulation resulting in formation of a cellular spore [GO:0030435],NA,NA,NA
CHOYP_LOC100370358.1.1.m.39703,-0.007656277,-0.0114695,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transporter activity [GO:1902388]; ceramide binding [GO:0097001]; glycolipid binding [GO:0051861]; glycolipid transporter activity [GO:0017089]; intermembrane lipid transfer activity [GO:0120013]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; ceramide transport [GO:0035627]; ER to Golgi ceramide transport [GO:0035621]; intermembrane lipid transfer [GO:0120009]; lipid transport [GO:0006869]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100370401.1.1.m.15416,0.000560275,0.001039356,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_LOC100370403.1.1.m.11269,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; ear development [GO:0043583]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; myelination of posterior lateral line nerve axons [GO:0048932]; ossification [GO:0001503]; peripheral nervous system myelin formation [GO:0032290]; regulation of sprouting angiogenesis [GO:1903670]; Schwann cell differentiation [GO:0014037]; semicircular canal fusion [GO:0060879],NA,NA,NA
CHOYP_LOC100370410.1.1.m.24212,-0.001173189,0.011930269,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; ribulose-phosphate 3-epimerase activity [GO:0004750]; carbohydrate metabolic process [GO:0005975]; cellular carbohydrate metabolic process [GO:0044262]; pentose catabolic process [GO:0019323]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt; non-oxidative branch [GO:0009052],NA,NA,NA
CHOYP_LOC100370453.1.1.m.48521,-0.016583727,0.000412395,No,NA,NA,NA,NA,NA,NA,ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule binding [GO:0008017]; sperm axoneme assembly [GO:0007288],NA,NA,NA
CHOYP_LOC100370463.1.1.m.30276,-0.022664385,0.010339565,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100370478.2.2.m.16291,0.018762232,0.008331577,No,NA,NA,NA,NA,NA,NA,mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; protein-containing complex [GO:0032991]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]; fructose biosynthetic process [GO:0046370]; fructose metabolic process [GO:0006000]; NADH oxidation [GO:0006116]; NADH regeneration [GO:0006735]; sorbitol biosynthetic process [GO:0006061]; sorbitol catabolic process [GO:0006062],NA,NA,NA
CHOYP_LOC100370504.1.2.m.17506,-0.022651245,0.010193983,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100370516.1.1.m.29182,0.007284439,0.004169159,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; Lewy body [GO:0097413]; nuclear body [GO:0016604]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100370520.1.1.m.12258,0.002016653,0.013392714,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623],NA,NA,NA
CHOYP_LOC100370537.1.1.m.10588,-0.015820002,-0.001733482,No,NA,NA,NA,NA,NA,NA,axonemal outer doublet [GO:0097545]; motile cilium [GO:0031514]; dynein complex binding [GO:0070840]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; regulation of microtubule motor activity [GO:2000574],NA,NA,NA
CHOYP_LOC100370537.1.1.m.10589,0.005600816,-0.010874511,No,NA,NA,NA,NA,NA,NA,nucleolar ribonuclease P complex [GO:0005655]; ribonuclease P activity [GO:0004526]; RNA binding [GO:0003723]; tRNA processing [GO:0008033],NA,NA,NA
CHOYP_LOC100370551.1.1.m.64375,-0.021579903,-0.00341358,No,NA,NA,NA,NA,NA,NA,motile cilium [GO:0031514]; cilium assembly [GO:0060271],NA,NA,NA
CHOYP_LOC100370552.2.2.m.59438,0.007471632,-0.002744207,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; ribosomal large subunit export from nucleus [GO:0000055]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100370583.1.1.m.56859,-0.008928354,-0.00276505,No,NA,NA,NA,NA,NA,NA,azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; neutrophil degranulation [GO:0043312]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021],NA,NA,NA
CHOYP_LOC100370588.15.19.m.60881,0.009570016,0.013401926,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370600.1.1.m.29572,-0.017678686,-0.019639509,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],NA,NA,NA
CHOYP_LOC100370603.1.1.m.51092,0.018966414,0.003066636,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166],NA,NA,NA
CHOYP_LOC100370625.2.3.m.26929,-0.012997912,0.002609426,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of RIG-I signaling pathway [GO:1900246]; response to virus [GO:0009615],NA,NA,NA
CHOYP_LOC100370637.1.2.m.12891,-0.00043024,-0.014486041,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; pi-body [GO:0071546]; piP-body [GO:0071547]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; helicase activity [GO:0004386]; nucleic acid binding [GO:0003676]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100370662.1.3.m.5814,0.002847226,-0.008039422,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370665.1.1.m.29815,0.002559911,0.006272057,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle; lid subcomplex [GO:0008541]; structural molecule activity [GO:0005198]; proteasome assembly [GO:0043248]; stem cell differentiation [GO:0048863]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100370672.1.1.m.54509,-0.014888794,0.007087523,No,NA,NA,NA,NA,NA,NA,phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC100370673.1.1.m.13161,-0.022205236,0.003206002,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; podosome [GO:0002102]; vesicle [GO:0031982]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein dimerization activity [GO:0046983]; extracellular matrix disassembly [GO:0022617]; microtubule-based movement [GO:0007018]; organelle disassembly [GO:1903008]; regulation of podosome assembly [GO:0071801],NA,NA,NA
CHOYP_LOC100370684.1.2.m.61027,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; ammonium transmembrane transporter activity [GO:0008519],NA,NA,NA
CHOYP_LOC100370705.1.2.m.30943,0.011351311,0.006315517,No,NA,NA,NA,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleus [GO:0005634]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100370705.2.2.m.55449,0.003674006,-0.01435984,No,NA,NA,NA,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleus [GO:0005634]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100370716.1.1.m.35654,-0.003635962,-0.014468867,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; Sin3-type complex [GO:0070822]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_LOC100370738.1.1.m.30463,-0.021892567,-0.000254846,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_LOC100370747.1.1.m.28315,0.015983079,-0.005166284,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; spermidine synthase activity [GO:0004766]; cellular response to leukemia inhibitory factor [GO:1990830]; polyamine biosynthetic process [GO:0006596]; polyamine metabolic process [GO:0006595]; spermidine biosynthetic process [GO:0008295],NA,NA,NA
CHOYP_LOC100370750.2.2.m.52391,-0.01900343,0.001945275,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159],NA,NA,NA
CHOYP_LOC100370790.1.1.m.9845,0.007592581,0.020603927,No,NA,NA,NA,NA,NA,NA,axonal growth cone [GO:0044295]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; secretory vesicle [GO:0099503]; spindle [GO:0005819]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; protein C-terminus binding [GO:0008022]; axon development [GO:0061564]; cell division [GO:0051301]; dendrite development [GO:0016358]; establishment of mitotic spindle orientation [GO:0000132]; intracellular protein transport [GO:0006886]; intracellular transport of viral protein in host cell [GO:0019060]; negative regulation of cell death [GO:0060548]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of neurogenesis [GO:0050768]; neuron projection morphogenesis [GO:0048812]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cytoskeleton organization [GO:0051493]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_LOC100370821.2.2.m.45409,0.000331682,0.006384043,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100370838.1.1.m.18679,-0.015883125,-0.009820818,No,NA,NA,NA,NA,NA,NA,3'-5' exonuclease activity [GO:0008408]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_LOC100370844.1.2.m.30341,-0.022624887,0.01045768,No,NA,NA,NA,NA,NA,NA,early endosome [GO:0005769],NA,NA,NA
CHOYP_LOC100370879.1.1.m.53699,0.003710775,-0.018798765,No,NA,NA,NA,NA,NA,NA,AP-3 adaptor complex [GO:0030123]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein self-association [GO:0043621]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; regulated exocytosis [GO:0045055]; regulation of SNARE complex assembly [GO:0035542]; vacuole fusion; non-autophagic [GO:0042144],NA,NA,NA
CHOYP_LOC100370896.4.4.m.56380,-0.018295151,0.016978546,No,NA,NA,NA,NA,NA,NA,endocytic vesicle membrane [GO:0030666]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; protein serine/threonine kinase activity [GO:0004674]; Ras GTPase binding [GO:0017016]; actin filament organization [GO:0007015]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; cell-substrate adhesion [GO:0031589]; cellular response to nutrient [GO:0031670]; chemotaxis [GO:0006935]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; positive regulation of gene expression [GO:0010628]; positive regulation of STAT cascade [GO:1904894]; protein phosphorylation [GO:0006468]; regulation of filopodium assembly [GO:0051489]; regulation of sorocarp development [GO:0031156]; tyrosine phosphorylation of STAT protein [GO:0007260],NA,NA,NA
CHOYP_LOC100370897.5.5.m.39218,0.019951587,0.011724954,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370900.1.1.m.20012,-0.02104455,-0.009473392,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062],NA,NA,NA
CHOYP_LOC100370907.1.3.m.3187,0.015555231,-0.013592237,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370907.3.3.m.36832,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral release from host cell [GO:1902187]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_LOC100370909.1.1.m.30849,-0.015980122,-0.014042132,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cell aging [GO:0007569]; cellular response to lipopolysaccharide [GO:0071222]; epithelial to mesenchymal transition involved in cardiac fibroblast development [GO:0060940]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of vascular smooth muscle cell differentiation [GO:1905064]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of inflammatory response [GO:0050729]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of protein metabolic process [GO:0051246],NA,NA,NA
CHOYP_LOC100370910.1.1.m.13897,0.009515127,0.00573911,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; nucleoplasm [GO:0005654]; 3'-5' exonuclease activity [GO:0008408]; exodeoxyribonuclease III activity [GO:0008853]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; meiotic recombination checkpoint [GO:0051598],NA,NA,NA
CHOYP_LOC100370913.1.1.m.19909,-0.001571473,0.005467619,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; COPII vesicle coating [GO:0048208],NA,NA,NA
CHOYP_LOC100370941.1.1.m.59883,-0.003560324,-0.003471456,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; ferric-chelate reductase activity [GO:0000293]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100370957.1.1.m.22435,-0.012105782,-0.000334703,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of signal transduction by p53 class mediator [GO:1901796],NA,NA,NA
CHOYP_LOC100370976.1.2.m.17764,-0.008918399,0.011320447,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; cilium assembly [GO:0060271]; regulation of microtubule cytoskeleton organization [GO:0070507],NA,NA,NA
CHOYP_LOC100370989.2.2.m.37995,0.006989437,-0.019418517,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II; core complex [GO:0005665]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; translation initiation factor binding [GO:0031369]; apoptotic process [GO:0006915]; nuclear-transcribed mRNA catabolic process; exonucleolytic [GO:0000291]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translational initiation [GO:0045948]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_LOC100371005.1.2.m.2526,0.017694553,-0.006373576,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; pyruvate kinase complex [GO:1902912]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; thyroid hormone binding [GO:0070324]; animal organ regeneration [GO:0031100]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; liver development [GO:0001889]; neutrophil degranulation [GO:0043312]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; protein homotetramerization [GO:0051289]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403],NA,NA,NA
CHOYP_LOC100371022.1.1.m.51315,-0.004848222,0.019739279,No,NA,NA,NA,NA,NA,NA,cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; acrosome assembly [GO:0001675]; intermediate filament organization [GO:0045109]; multicellular organism development [GO:0007275]; spermatid nucleus differentiation [GO:0007289],NA,NA,NA
CHOYP_LOC100371039.1.1.m.18908,-0.002029722,-0.020478624,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cyclin D2-CDK6 complex [GO:0097132]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; kinase activity [GO:0016301]; cell cycle [GO:0007049]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; gliogenesis [GO:0042063]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of erythrocyte differentiation [GO:0045646]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323],NA,NA,NA
CHOYP_LOC100371043.3.5.m.24649,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020]; 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100371058.3.3.m.36497,-0.014696302,-0.010916755,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; microtubule binding [GO:0008017]; cell migration [GO:0016477]; cilium-dependent cell motility [GO:0060285]; negative regulation of microtubule depolymerization [GO:0007026],NA,NA,NA
CHOYP_LOC100371059.1.1.m.25395,-0.017899359,-0.011066631,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100371074.1.1.m.36435,-0.011972518,-0.012942379,No,NA,NA,NA,NA,NA,NA,GTP binding [GO:0005525]; GTPase activity [GO:0003924],NA,NA,NA
CHOYP_LOC100371085.1.1.m.44789,2.42E-05,-0.013488443,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100371099.1.1.m.20282,-0.011773846,-0.011828393,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371127.1.1.m.23427,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,early endosome [GO:0005769]; membrane [GO:0016020]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100371143.1.1.m.27046,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cilium assembly [GO:0060271],NA,NA,NA
CHOYP_LOC100371148.1.1.m.47147,-0.016534007,-0.013987003,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225],NA,NA,NA
CHOYP_LOC100371168.1.1.m.54022,-0.015497807,-0.018512008,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371176.1.1.m.33995,-0.005521789,-0.023557099,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC100371209.1.1.m.49090,-0.014333495,0.002167424,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100371218.2.3.m.38221,0.009277062,-0.018704274,No,NA,NA,NA,NA,NA,NA,adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; axonal growth cone [GO:0044295]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; internode region of axon [GO:0033269]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; protein phosphatase binding [GO:0019903]; asymmetric cell division [GO:0008356]; axonogenesis [GO:0007409]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein localization [GO:0008104]; protein targeting to membrane [GO:0006612]; protein-containing complex assembly [GO:0065003]; regulation of cellular localization [GO:0060341]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_LOC100371228.1.4.m.6670,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371232.1.1.m.25817,0.001623599,-0.016193038,No,NA,NA,NA,NA,NA,NA,box C/D snoRNP complex [GO:0031428]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; RNA binding [GO:0003723]; U4atac snRNA binding [GO:0030622]; maturation of LSU-rRNA [GO:0000470]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100371236.1.1.m.62865,0.011022555,-0.013406904,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine metabolic process [GO:0006563]; protein homotetramerization [GO:0051289]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653],NA,NA,NA
CHOYP_LOC100371248.1.2.m.10238,0.016452522,0.001988637,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086],NA,NA,NA
CHOYP_LOC100371248.2.2.m.48460,0.018361429,-0.00389452,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; S-methylmethionine-homocysteine S-methyltransferase activity [GO:0061627]; zinc ion binding [GO:0008270]; L-methionine salvage [GO:0071267]; S-adenosylmethionine metabolic process [GO:0046500]; S-methylmethionine metabolic process [GO:0033477]; sulfur amino acid metabolic process [GO:0000096],NA,NA,NA
CHOYP_LOC100371249.1.1.m.63117,0.020346868,0.014604828,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601],NA,NA,NA
CHOYP_LOC100371249.1.1.m.63118,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC100371254.1.1.m.1838,-0.00256686,-0.011710041,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; syntaxin binding [GO:0019905]; B cell activation [GO:0042113]; exocytosis [GO:0006887],NA,NA,NA
CHOYP_LOC100371275.1.1.m.46896,0.00081227,-0.002988352,No,NA,NA,NA,NA,NA,NA,Cul5-RING ubiquitin ligase complex [GO:0031466]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; calcium channel activity [GO:0005262]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle arrest [GO:0007050]; cell proliferation [GO:0008283]; ERBB2 signaling pathway [GO:0038128]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of cell proliferation [GO:0008285]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100371304.1.1.m.47915,-0.009284629,-0.010517225,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371319.1.1.m.10776,0.010178051,-0.020886881,No,NA,NA,NA,NA,NA,NA,COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; embryo development ending in birth or egg hatching [GO:0009792]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050],NA,NA,NA
CHOYP_LOC100371319.1.1.m.10777,0.010691924,0.001973915,No,NA,NA,NA,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_LOC100371339.1.1.m.4513,-0.019596925,-0.006788225,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_LOC100371354.1.1.m.47130,0.000913823,0.01477192,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_LOC100371361.1.1.m.9282,0.007109924,-0.001802876,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100371374.1.1.m.46502,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228],NA,NA,NA
CHOYP_LOC100371390.1.1.m.8047,0.018172211,0.005463296,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; trans-Golgi network [GO:0005802]; epidermal growth factor receptor binding [GO:0005154]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; cytoplasmic mRNA processing body assembly [GO:0033962]; negative regulation of receptor internalization [GO:0002091]; regulation of cytoplasmic mRNA processing body assembly [GO:0010603]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA transport [GO:0050658]; stress granule assembly [GO:0034063],NA,NA,NA
CHOYP_LOC100371429.1.1.m.13499,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; glycosylceramidase activity [GO:0017042]; lactase activity [GO:0000016]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_LOC100371430.1.1.m.61181,-0.003238457,0.011606428,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313],NA,NA,NA
CHOYP_LOC100371435.1.1.m.6503,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371443.1.1.m.15017,-0.008000126,0.001781984,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]; cell differentiation [GO:0030154]; centrosome localization [GO:0051642]; intraciliary transport [GO:0042073]; protein localization to cilium [GO:0061512]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100371457.1.1.m.12814,-0.004940853,-0.019712314,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome regulatory particle assembly [GO:0070682]; protein deubiquitination [GO:0016579],NA,NA,NA
CHOYP_LOC100371468.2.2.m.53875,-0.002146069,-0.001358447,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; Flemming body [GO:0090543]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]; activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cell proliferation in forebrain [GO:0021846]; cerebellar cortex development [GO:0021695]; cerebellar granular layer structural organization [GO:0021685]; cerebellar Purkinje cell layer structural organization [GO:0021693]; cerebral cortex development [GO:0021987]; establishment of protein localization [GO:0045184]; hippocampus development [GO:0021766]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; negative regulation of apoptotic process [GO:0043066]; negative regulation of integrin activation [GO:0033624]; negative regulation of neuron apoptotic process [GO:0043524]; olfactory bulb development [GO:0021772]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell maturation [GO:1903429]; regulation of cell migration [GO:0030334]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of myelination [GO:0031641]; regulation of neuron apoptotic process [GO:0043523]; regulation of Rap protein signal transduction [GO:0032487]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_LOC100371500.1.7.m.4423,-0.004828222,0.006027057,No,NA,NA,NA,NA,NA,NA,chromosome; centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048],NA,NA,NA
CHOYP_LOC100371503.1.1.m.62767,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371557.1.1.m.57537,0.015431999,-0.004037796,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; GTP binding [GO:0005525]; translation initiation factor activity [GO:0003743]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC100371571.1.1.m.2417,-0.007867228,-0.005097429,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; phosphatase inhibitor activity [GO:0019212]; phosphoprotein binding [GO:0051219]; protein phosphatase inhibitor activity [GO:0004864]; RNA polymerase II complex binding [GO:0000993]; transcription corepressor activity [GO:0003714]; cellular response to growth factor stimulus [GO:0071363]; cellular response to steroid hormone stimulus [GO:0071383]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell growth [GO:0001558]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615],NA,NA,NA
CHOYP_LOC100371575.1.1.m.10551,-0.010752032,-0.013206747,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cotranslational protein targeting to membrane [GO:0006613]; IRE1-mediated unfolded protein response [GO:0036498]; positive regulation of cell proliferation [GO:0008284],NA,NA,NA
CHOYP_LOC100371590.1.1.m.64405,-0.017623207,-0.017078144,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371597.1.1.m.3330,0.00450128,-0.003945425,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; imidazolonepropionase activity [GO:0050480]; metal ion binding [GO:0046872]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557],NA,NA,NA
CHOYP_LOC100371628.1.1.m.35401,-0.014997785,-0.008379394,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100371637.1.1.m.7833,-0.006140148,0.001810982,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum [GO:0005791]; calcium ion binding [GO:0005509]; calcium ion homeostasis [GO:0055074]; endoplasmic reticulum organization [GO:0007029]; ER overload response [GO:0006983]; post-embryonic development [GO:0009791]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_LOC100371650.1.1.m.4398,-0.002908548,0.005666454,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane-bounded organelle [GO:0043227]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; photoreceptor outer segment membrane [GO:0042622]; identical protein binding [GO:0042802]; N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity [GO:0102200]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270]; aging [GO:0007568]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; negative regulation of eating behavior [GO:1903999]; phospholipid catabolic process [GO:0009395]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; response to isolation stress [GO:0035900]; retinoid metabolic process [GO:0001523]; temperature homeostasis [GO:0001659],NA,NA,NA
CHOYP_LOC100371654.1.1.m.14188,-0.022565135,0.009989382,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; kinase activity [GO:0016301]; thiamine binding [GO:0030975]; thiamine diphosphokinase activity [GO:0004788]; thiamine diphosphate biosynthetic process [GO:0009229]; thiamine metabolic process [GO:0006772],NA,NA,NA
CHOYP_LOC100371677.1.1.m.122,0.012774681,0.000317202,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016],NA,NA,NA
CHOYP_LOC100371695.1.1.m.10063,0.013977986,-0.012185027,No,NA,NA,NA,NA,NA,NA,apoplast [GO:0048046]; chloroplast [GO:0009507]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]; adenosine salvage [GO:0006169]; AMP salvage [GO:0044209]; response to cadmium ion [GO:0046686]; response to trehalose-6-phosphate [GO:0080094]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100371721.1.1.m.23143,-0.003248485,-0.001735125,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing; via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100371750.2.2.m.64949,0.000280138,-0.019913444,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; perinuclear region of cytoplasm [GO:0048471]; extracellular matrix structural constituent [GO:0005201]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cellular protein metabolic process [GO:0044267]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; post-translational protein modification [GO:0043687]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_LOC100371756.1.1.m.24048,-0.014576945,-0.00600115,No,NA,NA,NA,NA,NA,NA,kinesin II complex [GO:0016939]; kinesin binding [GO:0019894]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_LOC100371761.1.1.m.57462,-0.001611376,0.017690152,No,NA,NA,NA,NA,NA,NA,late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; Ragulator complex [GO:0071986]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of TOR signaling [GO:0032008]; regulation of cell growth [GO:0001558]; regulation of cholesterol efflux [GO:0010874]; regulation of cholesterol esterification [GO:0010872]; regulation of cholesterol import [GO:0060620]; regulation of receptor recycling [GO:0001919],NA,NA,NA
CHOYP_LOC100371830.5.6.m.55811,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020]; 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100371831.1.1.m.11775,0.000310654,0.019696262,No,NA,NA,NA,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]; Rho protein signal transduction [GO:0007266],NA,NA,NA
CHOYP_LOC100371845.3.3.m.62472,0.00085154,-0.004846852,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intrinsic component of plasma membrane [GO:0031226]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; ion transport [GO:0006811]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; myelination [GO:0042552]; oligodendrocyte differentiation [GO:0048709]; regulation of cardiac conduction [GO:1903779]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; telencephalon development [GO:0021537],NA,NA,NA
CHOYP_LOC100371875.1.1.m.29467,-0.013631558,-0.005644319,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; 6-phosphogluconolactonase activity [GO:0017057]; monosaccharide binding [GO:0048029]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt; oxidative branch [GO:0009051],NA,NA,NA
CHOYP_LOC100371881.1.2.m.3634,0.021396985,-0.009117608,No,NA,NA,NA,NA,NA,NA,chromosome; centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; cell proliferation [GO:0008283]; cholangiocyte proliferation [GO:1990705]; hepatocyte proliferation [GO:0072574]; meiotic cell cycle [GO:0051321]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088],NA,NA,NA
CHOYP_LOC100371885.1.1.m.9427,0.008639723,-0.004884521,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; melanotic encapsulation of foreign target [GO:0035011]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway by establishment of Wnt protein localization to extracellular region [GO:0035593],NA,NA,NA
CHOYP_LOC100371909.1.1.m.30745,-0.022280584,-0.000450771,No,NA,NA,NA,NA,NA,NA,cilium-dependent cell motility [GO:0060285],NA,NA,NA
CHOYP_LOC100371965.3.4.m.28742,-0.006568964,-0.008337352,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100371977.1.1.m.21628,0.006137239,-0.024133716,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100371983.1.3.m.2863,0.017135649,-0.00338875,No,NA,NA,NA,NA,NA,NA,methyl indole-3-acetate esterase activity [GO:0080030]; short-chain carboxylesterase activity [GO:0034338]; catabolic process [GO:0009056],NA,NA,NA
CHOYP_LOC100371983.2.3.m.48879,0.009069598,0.008038443,No,NA,NA,NA,NA,NA,NA,methyl indole-3-acetate esterase activity [GO:0080030]; short-chain carboxylesterase activity [GO:0034338]; catabolic process [GO:0009056],NA,NA,NA
CHOYP_LOC100371994.1.1.m.50098,0.009439989,-0.022581851,No,NA,NA,NA,NA,NA,NA,methionine adenosyltransferase complex [GO:0048269]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; methionine adenosyltransferase regulator activity [GO:0048270]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556],NA,NA,NA
CHOYP_LOC100372012.1.1.m.36569,-0.008303758,-0.004200172,No,NA,NA,NA,NA,NA,NA,microtubule plus-end [GO:0035371]; microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019],NA,NA,NA
CHOYP_LOC100372020.1.1.m.59998,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle pole [GO:0000922],NA,NA,NA
CHOYP_LOC100372028.1.1.m.22341,-0.012368217,0.007970934,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; dense core granule [GO:0031045]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; dense core granule exocytosis [GO:1990504]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; synaptic vesicle exocytosis [GO:0016079],NA,NA,NA
CHOYP_LOC100372071.1.1.m.14107,0.009331467,0.021018193,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; Golgi ribbon formation [GO:0090161]; intracellular protein transport [GO:0006886]; retrograde transport; endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_LOC100372110.1.1.m.11437,0.004351436,0.011153143,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]; BMP signaling pathway [GO:0030509]; SMAD protein signal transduction [GO:0060395]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_LOC100372131.1.2.m.36461,0.01522811,0.006663971,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; amino acid binding [GO:0016597]; dihydropyrimidinase activity [GO:0004157]; phosphoprotein binding [GO:0051219]; thymine binding [GO:0002059]; uracil binding [GO:0002058]; zinc ion binding [GO:0008270]; beta-alanine metabolic process [GO:0019482]; protein homotetramerization [GO:0051289]; pyrimidine nucleobase catabolic process [GO:0006208]; pyrimidine nucleoside catabolic process [GO:0046135]; thymine catabolic process [GO:0006210]; uracil catabolic process [GO:0006212],NA,NA,NA
CHOYP_LOC100372150.1.1.m.7059,0.008492505,0.012928619,No,NA,NA,NA,NA,NA,NA,actin filament [GO:0005884]; cortical cytoskeleton [GO:0030863]; cytosol [GO:0005829]; membrane [GO:0016020]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; tropomyosin binding [GO:0005523]; adult locomotory behavior [GO:0008344]; lens fiber cell development [GO:0070307]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694],NA,NA,NA
CHOYP_LOC100372183.1.1.m.31741,-0.008017434,0.010586872,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; negative regulation of cell proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100372197.3.3.m.56377,-0.003335279,0.00779528,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; protein dimerization activity [GO:0046983]; transmembrane signaling receptor activity [GO:0004888]; anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; cell-cell signaling [GO:0007267]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation with mouth forming second [GO:0001702]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of neurotransmitter secretion [GO:0046928]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100372208.1.1.m.18397,-0.00497951,0.013073074,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]; very-long-chain enoyl-CoA reductase activity [GO:0102758]; very long-chain fatty acid biosynthetic process [GO:0042761],NA,NA,NA
CHOYP_LOC100372219.1.1.m.11590,-0.015469695,-0.011771092,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544],NA,NA,NA
CHOYP_LOC100372221.2.2.m.48004,0.008511819,0.001455513,No,NA,NA,NA,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_LOC100372236.1.4.m.16991,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-1;3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_LOC100372239.1.1.m.50390,-0.02038576,0.003396646,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100372241.1.1.m.9935,-0.008462528,0.012483176,No,NA,NA,NA,NA,NA,NA,chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response; signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of transcription; DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; response to gamma radiation [GO:0010332]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428],NA,NA,NA
CHOYP_LOC100372245.1.1.m.60270,-0.008375446,-0.000363607,No,NA,NA,NA,NA,NA,NA,microtubule [GO:0005874],NA,NA,NA
CHOYP_LOC100372287.1.1.m.10381,-0.013861356,-0.006411615,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100372290.2.2.m.40459,0.009507953,0.007256939,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; cell morphogenesis [GO:0000902]; embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; T cell homeostasis [GO:0043029]; zinc ion transmembrane transport [GO:0071577],NA,NA,NA
CHOYP_LOC100372298.1.1.m.19547,0.010585502,-0.002676122,No,NA,NA,NA,NA,NA,NA,autophagosome [GO:0005776]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of autophagosome maturation [GO:1901098],NA,NA,NA
CHOYP_LOC100372311.1.1.m.6654,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100372339.1.2.m.5168,0.004840287,0.01901802,No,NA,NA,NA,NA,NA,NA,ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex scaffold activity [GO:0032947]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_LOC100372340.1.3.m.9116,-0.005303575,-0.005936802,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_LOC100372340.3.3.m.59986,0.010721262,-0.001171869,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_LOC100372341.1.1.m.46956,-0.010166801,-0.008451198,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301]; miRNA catabolic process [GO:0010587]; nuclear-transcribed mRNA catabolic process; exonucleolytic [GO:0000291]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_LOC100372342.1.1.m.63404,-0.006466038,-0.020031672,No,NA,NA,NA,NA,NA,NA,adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germline ring canal inner rim [GO:0035183]; midbody [GO:0030496]; myosin II complex [GO:0016460]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; actin filament-based movement [GO:0030048]; apical constriction involved in gastrulation [GO:0003384]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compartment boundary maintenance [GO:0060289]; cytoskeleton-dependent cytoplasmic transport; nurse cell to oocyte [GO:0019749]; establishment of planar polarity [GO:0001736]; formation of a compartment boundary [GO:0060288]; imaginal disc-derived wing hair organization [GO:0035317]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; nuclear axial expansion [GO:0035191]; ovarian follicle cell development [GO:0030707]; ovarian nurse cell to oocyte transport [GO:0007300]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of tube length; open tracheal system [GO:0035159]; spiracle morphogenesis; open tracheal system [GO:0035277]; tube formation [GO:0035148]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100372388.1.1.m.26623,-0.015699403,-0.005649833,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100372392.4.8.m.31087,-0.022647995,0.010410347,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100372392.6.8.m.56267,-0.017378755,-0.002324278,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100372393.1.1.m.12043,-0.005645878,0.011384785,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription; DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_LOC100372454.1.1.m.56045,0.02220385,-0.009238959,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467],NA,NA,NA
CHOYP_LOC100372467.1.1.m.42336,-0.004501418,0.015376008,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; SH3 domain binding [GO:0017124]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_LOC100372473.1.5.m.7845,-0.015179604,0.008542019,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100372473.2.5.m.35440,-0.008015492,-0.009981622,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842],NA,NA,NA
CHOYP_LOC100372473.3.5.m.39839,-0.016938341,-0.014219414,No,NA,NA,NA,NA,NA,NA,contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; peptidyl-serine modification [GO:0018209]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288],NA,NA,NA
CHOYP_LOC100372473.4.5.m.48798,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842],NA,NA,NA
CHOYP_LOC100372481.1.1.m.21010,-5.42E-05,-0.012665262,No,NA,NA,NA,NA,NA,NA,cell-cell junction [GO:0005911]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum membrane [GO:1990578]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex; class IA [GO:0005943]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; ErbB-3 class receptor binding [GO:0043125]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; transcription factor binding [GO:0008134]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of glucose import [GO:0046326]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_LOC100372481.1.1.m.21011,0.004297391,0.019473115,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; microtubule [GO:0005874]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; negative regulation of centriole replication [GO:0046600],NA,NA,NA
CHOYP_LOC100372482.1.1.m.61581,0.007020842,0.005492023,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; transport vesicle [GO:0030133]; AP-1 adaptor complex binding [GO:0035650]; kinesin binding [GO:0019894]; cellular protein localization [GO:0034613]; negative regulation of cell motility [GO:2000146]; negative regulation of receptor recycling [GO:0001920]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; vesicle targeting; trans-Golgi to endosome [GO:0048203],NA,NA,NA
CHOYP_LOC100372487.1.1.m.39712,0.006495292,0.007516856,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_LOC100372505.1.2.m.10260,-0.007129365,-0.020955044,No,NA,NA,NA,NA,NA,NA,tRNA-splicing ligase complex [GO:0072669]; protein methyltransferase activity [GO:0008276]; lysosome localization [GO:0032418]; positive regulation of cell proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of ruffle assembly [GO:1900029]; protein methylation [GO:0006479],NA,NA,NA
CHOYP_LOC100372505.1.2.m.10261,-0.011158777,-0.02428467,No,NA,NA,NA,NA,NA,NA,proteasome accessory complex [GO:0022624]; proteasome regulatory particle [GO:0005838]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100372560.1.1.m.25500,0.009852774,0.019236113,No,NA,NA,NA,NA,NA,NA,transferase activity [GO:0016740]; acetyl-CoA metabolic process [GO:0006084],NA,NA,NA
CHOYP_LOC100372582.1.2.m.8558,-0.010819519,-0.001260545,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA cis splicing; via spliceosome [GO:0045292]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_LOC100372601.1.1.m.13567,0.005572217,-0.001264315,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 5'-3' exonuclease activity [GO:0008409]; DNA repair [GO:0006281]; mitotic cell cycle checkpoint [GO:0007093]; protection from non-homologous end joining at telomere [GO:0031848]; telomere maintenance [GO:0000723]; telomeric 3' overhang formation [GO:0031860]; telomeric loop formation [GO:0031627],NA,NA,NA
CHOYP_LOC100372607.1.1.m.49009,-0.018564288,-0.006060321,No,NA,NA,NA,NA,NA,NA,apical part of cell [GO:0045177]; axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; intraciliary transport particle [GO:0030990]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein heavy chain binding [GO:0045504]; determination of left/right symmetry [GO:0007368]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of cilium assembly [GO:1902017],NA,NA,NA
CHOYP_LOC100372616.2.3.m.5692,0.009876763,0.01989006,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; meprin A complex [GO:0017090]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100372626.1.2.m.8346,0.011806635,0.011044157,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100372693.1.1.m.16279,0.003018564,-0.004969939,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539],NA,NA,NA
CHOYP_LOC100372698.1.1.m.18674,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_LOC100372703.1.1.m.29633,-0.018771109,0.004512098,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100372716.5.10.m.31370,0.003203807,0.015052045,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100372803.1.2.m.18615,-0.008339739,-0.010547064,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; cell proliferation [GO:0008283],NA,NA,NA
CHOYP_LOC100372845.1.3.m.7734,-0.020045483,0.004997338,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100372867.1.1.m.18083,0.001972187,-0.006591121,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100372879.1.3.m.18886,0.011670357,-0.011624001,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; esterosome membrane [GO:0033118]; carboxylic ester hydrolase activity [GO:0052689],NA,NA,NA
CHOYP_LOC100372881.1.1.m.4636,-0.007770332,-0.012219654,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; regulation of hippo signaling [GO:0035330],NA,NA,NA
CHOYP_LOC100372889.2.2.m.57965,0.008033057,-0.011322556,No,NA,NA,NA,NA,NA,NA,cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474],NA,NA,NA
CHOYP_LOC100372921.2.2.m.56247,-0.022551558,0.009965751,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; transcription factor binding [GO:0008134]; brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement [GO:0003351]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; regulation of DNA-binding transcription factor activity [GO:0051090],NA,NA,NA
CHOYP_LOC100372922.1.1.m.12888,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; brain development [GO:0007420]; excitatory postsynaptic potential [GO:0060079]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; nuclear export [GO:0051168]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; social behavior [GO:0035176]; visual learning [GO:0008542],NA,NA,NA
CHOYP_LOC100372926.1.3.m.29881,0.008654305,0.01192893,No,NA,NA,NA,NA,NA,NA,cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100372926.2.3.m.61794,0.000967727,-0.012251609,No,NA,NA,NA,NA,NA,NA,cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100372942.1.1.m.31119,-0.007686514,-0.003194553,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; nucleocytoplasmic transport [GO:0006913],NA,NA,NA
CHOYP_LOC100372945.2.2.m.47110,0.008065059,0.004052486,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; macropinosome [GO:0044354]; membrane [GO:0016020]; retromer complex [GO:0030904]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; Rab GTPase binding [GO:0017137]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_LOC100372955.1.1.m.18209,-0.012160245,-0.018241087,No,NA,NA,NA,NA,NA,NA,alpha DNA polymerase:primase complex [GO:0005658]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201],NA,NA,NA
CHOYP_LOC100372966.1.1.m.18755,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; vesicle [GO:0031982]; protein N-terminus binding [GO:0047485]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; early endosome to Golgi transport [GO:0034498]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; regulation of Golgi organization [GO:1903358]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_LOC100372967.1.1.m.16378,-0.003968076,-0.002949232,No,NA,NA,NA,NA,NA,NA,protein carboxyl O-methyltransferase activity [GO:0051998]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259]; regulation of response to DNA damage stimulus [GO:2001020],NA,NA,NA
CHOYP_LOC100372990.1.1.m.15018,-0.014915043,-0.014481678,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784],NA,NA,NA
CHOYP_LOC100373045.1.1.m.16825,-0.014537696,0.007875234,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_LOC100373083.1.2.m.19986,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; lipid transporter activity [GO:0005319]; transporter activity [GO:0005215]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_LOC100373083.1.2.m.19987,0.015264841,-0.00412755,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373083.2.2.m.26841,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; lipid transporter activity [GO:0005319]; transporter activity [GO:0005215]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_LOC100373090.1.1.m.52283,0.015825828,0.005561333,No,NA,NA,NA,NA,NA,NA,lamellipodium [GO:0030027]; directional locomotion [GO:0033058]; negative regulation of actin nucleation [GO:0051126]; negative regulation of cell migration [GO:0030336],NA,NA,NA
CHOYP_LOC100373100.3.4.m.51137,-0.008875592,-0.006052981,No,NA,NA,NA,NA,NA,NA,chromosome; centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048],NA,NA,NA
CHOYP_LOC100373100.4.4.m.65650,-0.009378284,-0.005197816,No,NA,NA,NA,NA,NA,NA,chromosome; centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048],NA,NA,NA
CHOYP_LOC100373136.1.1.m.6977,-0.008594347,-0.006924976,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; multicellular organism development [GO:0007275]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100373138.1.1.m.23491,-0.009040476,-0.002045435,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; membrane organization [GO:0061024]; multivesicular body assembly [GO:0036258]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059],NA,NA,NA
CHOYP_LOC100373141.1.1.m.11194,-0.008317705,-0.022158967,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_LOC100373146.1.2.m.13310,-0.005227289,0.009894388,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373146.2.2.m.27802,-0.016511361,0.007498228,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100373169.1.1.m.15573,-0.018169871,0.002795674,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373170.1.1.m.10994,0.009804259,-0.015579792,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100373178.1.1.m.61012,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]; regulated exocytosis [GO:0045055]; synaptic vesicle membrane organization [GO:0048499],NA,NA,NA
CHOYP_LOC100373186.1.1.m.58981,-0.010083807,-0.006872055,No,NA,NA,NA,NA,NA,NA,BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425],NA,NA,NA
CHOYP_LOC100373240.1.1.m.28382,-0.022522731,0.010559512,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; regulation of cellular defense response [GO:0010185]; regulation of complement activation; lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088],NA,NA,NA
CHOYP_LOC100373287.1.1.m.36226,-0.010452705,0.014836126,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; small nucleolar ribonucleoprotein complex [GO:0005732]; U2-type catalytic step 2 spliceosome [GO:0071007]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_LOC100373289.1.2.m.7904,-1.14E-05,-0.001700524,No,NA,NA,NA,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_LOC100373317.1.1.m.16740,-0.007219377,-0.003152352,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; ribonuclease H2 complex [GO:0032299]; RNA catabolic process [GO:0006401],NA,NA,NA
CHOYP_LOC100373327.1.13.m.13252,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; cell death [GO:0008219]; cellular protein modification process [GO:0006464]; inflammatory response [GO:0006954]; protein ADP-ribosylation [GO:0006471]; regulation of telomerase activity [GO:0051972],NA,NA,NA
CHOYP_LOC100373327.2.13.m.16978,0.007589014,-0.000548924,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; cell death [GO:0008219]; cellular protein modification process [GO:0006464]; inflammatory response [GO:0006954]; protein ADP-ribosylation [GO:0006471]; regulation of telomerase activity [GO:0051972],NA,NA,NA
CHOYP_LOC100373339.1.1.m.5653,0.004293253,0.007974371,No,NA,NA,NA,NA,NA,NA,actomyosin contractile ring [GO:0005826]; cytoplasm [GO:0005737]; GID complex [GO:0034657]; integral component of plasma membrane [GO:0005887]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ubiquitin ligase complex [GO:0000151]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; enucleate erythrocyte development [GO:0048822]; erythrocyte maturation [GO:0043249]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of myeloid cell apoptotic process [GO:0033033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100373351.1.3.m.49572,-0.01874331,-0.010868057,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100373351.2.3.m.58893,-0.003857895,-0.001330847,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100373353.1.1.m.50175,-0.001757249,-0.010577743,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; proteasome binding [GO:0070628]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; innate immune response [GO:0045087]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100373374.1.1.m.7546,-0.003069102,0.019690109,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; trans-Golgi network membrane [GO:0032588]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_LOC100373421.1.1.m.38932,-0.022650793,0.010402472,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813],NA,NA,NA
CHOYP_LOC100373427.1.1.m.49648,0.007260281,0.000716541,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; chemotaxis [GO:0006935]; neutrophil degranulation [GO:0043312]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023],NA,NA,NA
CHOYP_LOC100373429.1.1.m.10007,-0.01536387,0.004131653,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; motile cilium [GO:0031514]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_LOC100373444.22.79.m.26109,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_LOC100373444.23.79.m.27899,-0.009046055,0.00765427,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373444.44.79.m.39021,-0.009263142,0.017442884,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100373444.59.79.m.54129,0.010556707,0.012935784,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373444.63.79.m.59147,0.011711147,0.005765236,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373444.7.79.m.3209,0.002045158,-0.002965948,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373444.72.79.m.60850,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_LOC100373444.8.79.m.3255,0.005943939,0.008493058,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373454.1.1.m.59681,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100373457.1.1.m.27685,-0.007521468,0.008513992,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; phosphodiesterase I activity [GO:0004528]; RNA binding [GO:0003723]; base-excision repair [GO:0006284]; DNA demethylation [GO:0080111]; heart contraction [GO:0060047]; heart looping [GO:0001947]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]; positive regulation of gene expression [GO:0010628],NA,NA,NA
CHOYP_LOC100373461.1.2.m.30015,0.018538605,-0.008063038,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lipoprotein transporter activity [GO:0042954]; cargo loading into COPII-coated vesicle [GO:0090110]; cargo loading into vesicle [GO:0035459]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; lipoprotein transport [GO:0042953]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100373484.1.1.m.8540,-0.005669802,0.005997995,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; TRC complex [GO:0072380]; protein-containing complex scaffold activity [GO:0032947]; positive regulation of chaperone-mediated protein folding [GO:1903646]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_LOC100373488.1.1.m.10129,-0.01164555,0.001142833,No,NA,NA,NA,NA,NA,NA,dioxygenase activity [GO:0051213]; L-ascorbic acid binding [GO:0031418]; metal ion binding [GO:0046872]; 2;4-dichlorophenoxyacetic acid catabolic process [GO:0046300],NA,NA,NA
CHOYP_LOC100373492.1.1.m.24527,0.004051123,-0.018090583,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373522.2.5.m.19698,0.002677776,0.007467491,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020]; binding of sperm to zona pellucida [GO:0007339],NA,NA,NA
CHOYP_LOC100373522.5.5.m.54028,-0.011779672,-0.012200387,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020]; binding of sperm to zona pellucida [GO:0007339],NA,NA,NA
CHOYP_LOC100373569.1.1.m.280,0.003031928,-0.01363663,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein binding; bridging [GO:0030674]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of RNA biosynthetic process [GO:1902680]; ribosomal large subunit export from nucleus [GO:0000055],NA,NA,NA
CHOYP_LOC100373578.1.1.m.478,-0.010235715,0.004921407,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100373584.1.1.m.6647,-0.014680805,-0.01188014,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; double-stranded RNA binding [GO:0003725]; enzyme activator activity [GO:0008047]; production of siRNA involved in RNA interference [GO:0030422],NA,NA,NA
CHOYP_LOC100373590.1.1.m.51920,0.001895525,-0.020215502,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; GTP binding [GO:0005525]; ubiquitin protein ligase binding [GO:0031625],NA,NA,NA
CHOYP_LOC100373606.1.1.m.29757,-0.000309044,-0.007301227,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798]; asparagine catabolic process via L-aspartate [GO:0033345],NA,NA,NA
CHOYP_LOC100373653.3.3.m.56289,0.003394683,-0.005882467,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]; protein domain specific binding [GO:0019904]; neurotransmitter transport [GO:0006836]; regulation of insulin secretion [GO:0050796]; regulation of neurotransmitter secretion [GO:0046928]; regulation of protein homodimerization activity [GO:0043496],NA,NA,NA
CHOYP_LOC100373656.1.1.m.57144,0.004474744,-0.005850545,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100373657.1.1.m.10366,0.004263801,-0.017977665,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; AU-rich element binding [GO:0017091]; identical protein binding [GO:0042802]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; regulation of mRNA stability [GO:0043488]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476],NA,NA,NA
CHOYP_LOC100373670.1.1.m.2427,-0.011044153,0.014955475,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373694.1.1.m.11753,-0.009001893,-0.010087725,No,NA,NA,NA,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; 4 iron; 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial respiratory chain complex I assembly [GO:0032981]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_LOC100373728.1.1.m.59746,-0.011246493,0.002617721,No,NA,NA,NA,NA,NA,NA,ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_LOC100373809.1.2.m.35126,-0.021100429,0.0036034,No,NA,NA,NA,NA,NA,NA,ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; interphase microtubule organizing center [GO:0031021]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium assembly [GO:0060271]; embryonic skeletal system morphogenesis [GO:0048704]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100373842.2.4.m.5139,-0.009642642,-0.012376755,No,NA,NA,NA,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; juxtaparanode region of axon [GO:0044224]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; cytoskeletal anchoring at plasma membrane [GO:0007016]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_LOC100373842.4.4.m.40731,0.018620116,0.007302528,No,NA,NA,NA,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; juxtaparanode region of axon [GO:0044224]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; cytoskeletal anchoring at plasma membrane [GO:0007016]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_LOC100373864.1.2.m.16543,0.003549635,0.007434203,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metallocarboxypeptidase activity [GO:0004181]; proline dipeptidase activity [GO:0102009]; cellular amino acid metabolic process [GO:0006520]; collagen catabolic process [GO:0030574]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100373864.2.2.m.55132,-0.000787691,-0.014421889,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metallocarboxypeptidase activity [GO:0004181]; proline dipeptidase activity [GO:0102009]; cellular amino acid metabolic process [GO:0006520]; collagen catabolic process [GO:0030574]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100373888.8.9.m.60548,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373888.9.9.m.66033,0.010121991,-0.014241616,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; heterochromatin [GO:0000792]; nuclear chromosome; telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]; SUMO binding [GO:0032183]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell cycle arrest [GO:0007050]; cell fate commitment [GO:0045165]; cellular response to interleukin-4 [GO:0071353]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular senescence [GO:0090398]; circadian regulation of gene expression [GO:0032922]; common-partner SMAD protein phosphorylation [GO:0007182]; defense response to virus [GO:0051607]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; entrainment of circadian clock by photoperiod [GO:0043153]; extrinsic apoptotic signaling pathway [GO:0097191]; fibroblast migration [GO:0010761]; innate immune response [GO:0045087]; interferon-gamma-mediated signaling pathway [GO:0060333]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; maintenance of protein location in nucleus [GO:0051457]; myeloid cell differentiation [GO:0030099]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of translation in response to oxidative stress [GO:0032938]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of viral release from host cell [GO:1902187]; PML body organization [GO:0030578]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of protein localization to chromosome; telomeric region [GO:1904816]; positive regulation of telomere maintenance [GO:0032206]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; protein-containing complex assembly [GO:0065003]; regulation of calcium ion transport into cytosol [GO:0010522]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]; regulation of double-strand break repair [GO:2000779]; regulation of protein phosphorylation [GO:0001932]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription; DNA-templated [GO:0006355]; response to cytokine [GO:0034097]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]; retinoic acid receptor signaling pathway [GO:0048384]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100373892.1.2.m.44404,0.001786515,0.003895593,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; dipeptidase activity [GO:0016805]; exocytosis [GO:0006887],NA,NA,NA
CHOYP_LOC100373892.2.2.m.55838,-0.010994091,0.020605196,No,NA,NA,NA,NA,NA,NA,dipeptidase activity [GO:0016805]; exocytosis [GO:0006887],NA,NA,NA
CHOYP_LOC100373898.1.1.m.24900,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; epithelial cilium movement [GO:0003351]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC100373917.1.1.m.43876,-0.015215718,-0.006103208,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100373945.1.1.m.53450,-0.018255375,-0.000534256,No,NA,NA,NA,NA,NA,NA,endosome membrane [GO:0010008],NA,NA,NA
CHOYP_LOC100373956.1.1.m.10987,0.019862043,0.004317733,No,NA,NA,NA,NA,NA,NA,eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_LOC100373985.1.1.m.9302,-0.012078766,0.022785593,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373990.1.1.m.6259,-0.009831345,0.002265618,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nucleus [GO:0005634]; fibroblast growth factor binding [GO:0017134]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; fibroblast growth factor receptor signaling pathway [GO:0008543]; microtubule anchoring [GO:0034453]; protein homooligomerization [GO:0051260]; protein import into nucleus; translocation [GO:0000060]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_LOC100374036.1.1.m.65939,-0.018489437,0.007794175,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100374062.1.1.m.22586,-0.016923336,-0.001308161,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374077.1.1.m.5922,-0.005013825,0.000125944,No,NA,NA,NA,NA,NA,NA,actin filament [GO:0005884]; early endosome [GO:0005769]; growth cone [GO:0030426]; membrane [GO:0016020]; actin binding [GO:0003779]; endocytosis [GO:0006897]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_LOC100374096.1.1.m.8052,-0.022315765,0.000463096,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of receptor recycling [GO:0001919],NA,NA,NA
CHOYP_LOC100374116.1.1.m.37009,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374155.1.1.m.56570,-0.013787472,0.00437638,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100374249.1.1.m.58296,-0.020973568,0.002439722,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement [GO:0003351]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; flagellated sperm motility [GO:0030317]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency [GO:0003356],NA,NA,NA
CHOYP_LOC100374249.1.1.m.58297,-0.007456525,-0.024724245,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; eye development [GO:0001654]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to growth factor [GO:0070848]; response to mechanical stimulus [GO:0009612]; transcription by RNA polymerase II [GO:0006366]; visual learning [GO:0008542],NA,NA,NA
CHOYP_LOC100374254.1.1.m.22199,-0.01692524,-0.010058384,No,NA,NA,NA,NA,NA,NA,cell [GO:0005623]; preribosome; large subunit precursor [GO:0030687]; nucleic acid binding [GO:0003676]; ribosomal large subunit binding [GO:0043023]; zinc ion binding [GO:0008270]; ribosomal large subunit export from nucleus [GO:0000055],NA,NA,NA
CHOYP_LOC100374268.1.1.m.58983,-0.004869876,0.005759691,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle; lid subcomplex [GO:0008541]; endopeptidase activator activity [GO:0061133]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; proteasome assembly [GO:0043248]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100374272.3.6.m.53440,-0.007189829,0.02061372,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of synaptic transmission; glutamatergic [GO:0051966]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100374272.5.6.m.57085,0.017420859,-0.021233746,No,NA,NA,NA,NA,NA,NA,astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; modulation of chemical synaptic transmission [GO:0050804]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic transmission; glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]; synaptic transmission; glutamatergic [GO:0035249],NA,NA,NA
CHOYP_LOC100374272.6.6.m.62213,0.009559322,0.013448465,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]; adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196],NA,NA,NA
CHOYP_LOC100374274.2.3.m.27036,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100374277.1.3.m.16275,0.017906552,0.003714288,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100374277.2.3.m.23204,-0.008213008,0.008551222,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100374280.1.1.m.17385,0.015194411,-0.003336061,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; transferase activity; transferring acyl groups other than amino-acyl groups [GO:0016747]; cysteine biosynthetic process [GO:0019344],NA,NA,NA
CHOYP_LOC100374307.1.1.m.29504,0.002394517,-0.003683217,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; L-gulonate 3-dehydrogenase activity [GO:0050104]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_LOC100374320.1.1.m.54274,-0.017165859,0.018986677,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]; pyridine nucleotide salvage [GO:0019365],NA,NA,NA
CHOYP_LOC100374338.1.1.m.44584,0.015766531,0.010162818,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; oxidoreductase activity; acting on a sulfur group of donors; quinone or similar compound as acceptor [GO:0016672],NA,NA,NA
CHOYP_LOC100374345.1.2.m.11328,-0.011963356,0.00346928,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; pre-mRNA 3'-splice site binding [GO:0030628]; second spliceosomal transesterification activity [GO:0000386]; zinc ion binding [GO:0008270]; alternative mRNA splicing; via spliceosome [GO:0000380]; cellular response to heat [GO:0034605]; intracellular protein transport [GO:0006886]; mRNA 3'-splice site recognition [GO:0000389]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_LOC100374358.1.1.m.59032,0.006192373,0.007250161,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; enzyme binding [GO:0019899]; bone development [GO:0060348]; Golgi organization [GO:0007030],NA,NA,NA
CHOYP_LOC100374370.1.1.m.56335,0.014667585,-0.010841899,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_LOC100374422.1.2.m.26376,-0.021816729,-0.009284706,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100374446.1.1.m.29971,-0.022408668,-0.004379037,No,NA,NA,NA,NA,NA,NA,centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; cilium assembly [GO:0060271],NA,NA,NA
CHOYP_LOC100374467.1.1.m.31786,-0.020443542,-0.009300922,No,NA,NA,NA,NA,NA,NA,ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; motile cilium assembly [GO:0044458],NA,NA,NA
CHOYP_LOC100374491.1.1.m.6498,-0.021162069,0.001075032,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; inner dynein arm assembly [GO:0036159],NA,NA,NA
CHOYP_LOC100374495.1.1.m.55368,-0.022331128,0.00707976,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063]; unfolded protein binding [GO:0051082]; bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of multicellular organism growth [GO:0040018]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC100374522.1.1.m.66943,-0.01496325,-0.001967754,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; cell differentiation [GO:0030154],NA,NA,NA
CHOYP_LOC100374527.1.1.m.55214,-0.017120179,-0.006476165,No,NA,NA,NA,NA,NA,NA,kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314],NA,NA,NA
CHOYP_LOC100374535.2.3.m.26026,0.006798763,0.013177658,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; ATPase binding [GO:0051117]; ATPase inhibitor activity [GO:0042030]; heme biosynthetic process [GO:0006783]; negative regulation of ATPase activity [GO:0032780]; negative regulation of nucleotide metabolic process [GO:0045980],NA,NA,NA
CHOYP_LOC100374535.3.3.m.31001,-0.000673283,0.006749522,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; ATPase binding [GO:0051117]; ATPase inhibitor activity [GO:0042030]; heme biosynthetic process [GO:0006783]; negative regulation of ATPase activity [GO:0032780],NA,NA,NA
CHOYP_LOC100374537.1.1.m.27241,0.006580389,-0.013809902,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100374573.1.1.m.24523,-0.000951289,0.0210703,No,NA,NA,NA,NA,NA,NA,cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; C3HC4-type RING finger domain binding [GO:0055131]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; low-density lipoprotein particle receptor binding [GO:0050750]; metal ion binding [GO:0046872]; Tat protein binding [GO:0030957]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; androgen receptor signaling pathway [GO:0030521]; DNA damage response; detection of DNA damage [GO:0042769]; flagellated sperm motility [GO:0030317]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100374633.1.2.m.21988,0.001370624,-0.004389614,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC100374633.1.2.m.21989,-0.008890763,-0.012714581,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],NA,NA,NA
CHOYP_LOC100374651.1.4.m.28869,-0.011134818,-0.002561471,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100374651.3.4.m.52010,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100374662.1.6.m.7038,-0.020374621,-0.005952047,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100374676.1.1.m.61638,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100374685.1.1.m.16061,-0.006375761,-0.001457878,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; mitochondrion [GO:0005739]; GPI anchor biosynthetic process [GO:0006506],NA,NA,NA
CHOYP_LOC100374693.1.1.m.62043,0.021982051,-0.011698348,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374703.1.1.m.28348,-0.006678753,-0.012138282,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020]; intracellular protein transport [GO:0006886]; response to brefeldin A [GO:0031001],NA,NA,NA
CHOYP_LOC100374741.27.83.m.24541,0.004807877,0.005807111,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100374741.30.83.m.32433,0.002804452,0.003108873,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374741.38.83.m.33463,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374741.49.83.m.42424,0.009356582,-0.001788721,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374741.54.83.m.47294,-0.002972463,0.018288413,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374741.61.83.m.53306,0.007332555,0.004969844,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374741.70.83.m.60164,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_LOC100374741.72.83.m.60196,0.014632468,-0.006148774,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_LOC100374741.79.83.m.63217,0.006593737,-0.004948214,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; regulation of type I interferon production [GO:0032479]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_LOC100374742.1.2.m.209,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374747.1.1.m.54969,0.015164768,-0.014119054,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; intermediate filament [GO:0005882]; nucleus [GO:0005634]; cytoskeletal protein binding [GO:0008092]; SH3 domain binding [GO:0017124]; cytoskeleton organization [GO:0007010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of neuron projection development [GO:0010976]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100374754.1.1.m.32299,0.012177518,-0.02258751,No,NA,NA,NA,NA,NA,NA,condensed chromosome outer kinetochore [GO:0000940]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; nuclear pore distribution [GO:0031081]; nuclear pore organization [GO:0006999]; paraxial mesoderm development [GO:0048339]; protein import into nucleus [GO:0006606]; somite development [GO:0061053],NA,NA,NA
CHOYP_LOC100374772.1.4.m.30631,0.00818015,0.00321358,No,NA,NA,NA,NA,NA,NA,DUBm complex [GO:0071819]; mitochondrion [GO:0005739]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; SAGA complex [GO:0000124]; transcription export complex 2 [GO:0070390]; chromatin binding [GO:0003682]; nuclear receptor transcription coactivator activity [GO:0030374]; transcription coactivator activity [GO:0003713]; histone deubiquitination [GO:0016578]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_LOC100374785.2.3.m.34677,-0.020245118,-0.002675768,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; axoneme assembly [GO:0035082]; cilium movement involved in cell motility [GO:0060294],NA,NA,NA
CHOYP_LOC100374808.1.1.m.29300,-0.014730486,0.020544449,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_LOC100374819.2.7.m.48237,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_LOC100374839.1.1.m.63735,-0.008599332,0.003765646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374845.1.1.m.49323,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374849.1.4.m.16004,-0.006508565,-0.006766692,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374909.1.2.m.4076,0.005602835,-0.015466464,No,NA,NA,NA,NA,NA,NA,glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_LOC100374909.2.2.m.57748,0.010898659,-0.009721895,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_LOC100374912.1.1.m.51922,-0.0019609,0.015922223,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; biliverdin reductase activity [GO:0004074]; riboflavin reductase (NADPH) activity [GO:0042602]; heme catabolic process [GO:0042167],NA,NA,NA
CHOYP_LOC100374960.1.1.m.25267,-0.009354028,-0.020538493,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; Golgi organization [GO:0007030]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_LOC100374962.1.1.m.28954,-0.019306593,-0.004983286,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374974.12.16.m.47308,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374974.15.16.m.58657,0.001302709,-0.013007996,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374981.1.16.m.21258,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374981.4.16.m.24874,0.009869011,0.019454211,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100374995.1.3.m.34198,-0.00433833,-0.019965293,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; P-body [GO:0000932]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087],NA,NA,NA
CHOYP_LOC100374995.2.3.m.59062,-0.016195582,-0.019255121,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; P-body [GO:0000932],NA,NA,NA
CHOYP_LOC100375012.1.1.m.11931,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_LOC100375022.1.1.m.3033,-0.00390974,-0.02282922,No,NA,NA,NA,NA,NA,NA,proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; lid subcomplex [GO:0008541]; enzyme regulator activity [GO:0030234]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100375029.3.10.m.11445,0.005906334,-0.008204363,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015],NA,NA,NA
CHOYP_LOC100375029.6.10.m.36981,0.012985304,0.01775516,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015],NA,NA,NA
CHOYP_LOC100375029.8.10.m.60484,0.002941291,-0.001214061,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015],NA,NA,NA
CHOYP_LOC100375065.1.1.m.7678,-0.004930785,-0.010794636,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; zonula adherens [GO:0005915]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; epithelial cell-cell adhesion [GO:0090136]; Golgi organization [GO:0007030]; microtubule-based movement [GO:0007018]; visual perception [GO:0007601]; zonula adherens maintenance [GO:0045218],NA,NA,NA
CHOYP_LOC100375089.1.1.m.1341,0.006976053,0.012574292,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_LOC100375122.1.1.m.52296,-0.020123204,-0.016161808,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100375141.1.1.m.12655,-0.005794284,0.01827395,No,NA,NA,NA,NA,NA,NA,3-hydroxybutyrate dehydrogenase activity [GO:0003858],NA,NA,NA
CHOYP_LOC100375168.1.1.m.23641,0.002042732,-0.012472195,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; cell proliferation [GO:0008283]; locomotory behavior [GO:0007626]; negative regulation of transcription; DNA-templated [GO:0045892]; neuroblast development [GO:0014019]; neuron development [GO:0048666]; regulation of transcription; DNA-templated [GO:0006355]; wing disc pattern formation [GO:0035222],NA,NA,NA
CHOYP_LOC100375191.1.2.m.9220,-0.012562856,-0.020085893,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; establishment of protein localization [GO:0045184]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; positive regulation of cilium assembly [GO:0045724]; protein localization to cilium [GO:0061512]; regulation of protein binding [GO:0043393]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100375194.5.7.m.46447,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375204.2.2.m.21490,-0.007262989,0.002768447,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100375204.2.2.m.21491,0.00309886,0.000628336,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375219.1.1.m.30268,-0.011967787,-0.001301956,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100375219.1.1.m.30269,-0.015223412,-0.011784349,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100375230.1.1.m.52612,-0.018701905,-0.01540656,No,NA,NA,NA,NA,NA,NA,acrosomal vesicle [GO:0001669]; cell projection [GO:0042995]; cytosol [GO:0005829]; manchette [GO:0002177]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; axoneme assembly [GO:0035082]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100375232.1.2.m.2686,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008],NA,NA,NA
CHOYP_LOC100375265.2.2.m.11396,-0.008728551,-0.007429608,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; cellular nitrogen compound metabolic process [GO:0034641]; dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]; protein complex oligomerization [GO:0051259],NA,NA,NA
CHOYP_LOC100375266.1.1.m.6535,-0.006098469,0.008254162,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; ciliary transition fiber [GO:0097539]; Golgi apparatus [GO:0005794]; cilium assembly [GO:0060271]; establishment of centrosome localization [GO:0051660]; protein localization to centrosome [GO:0071539]; vesicle docking [GO:0048278],NA,NA,NA
CHOYP_LOC100375293.2.2.m.58888,-0.004543563,-0.023803375,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375314.1.1.m.19446,-0.01025956,0.017232444,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; esterosome membrane [GO:0033118]; carboxylic ester hydrolase activity [GO:0052689],NA,NA,NA
CHOYP_LOC100375322.1.1.m.22016,-0.019697094,0.010601977,No,NA,NA,NA,NA,NA,NA,L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; pyridoxal phosphate binding [GO:0030170]; isoleucine biosynthetic process [GO:0009097]; L-serine catabolic process [GO:0006565]; threonine catabolic process [GO:0006567],NA,NA,NA
CHOYP_LOC100375324.1.1.m.45919,-0.014800777,0.014128731,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; EKC/KEOPS complex [GO:0000408]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]; regulation of signal transduction by p53 class mediator [GO:1901796]; tRNA processing [GO:0008033]; tRNA threonylcarbamoyladenosine metabolic process [GO:0070525],NA,NA,NA
CHOYP_LOC100375342.2.3.m.30827,-0.014378606,0.007301944,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375342.3.3.m.40363,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375357.1.1.m.46425,-0.002910259,0.01977403,No,NA,NA,NA,NA,NA,NA,anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616],NA,NA,NA
CHOYP_LOC100375367.1.1.m.10761,-2.38E-06,-0.013488505,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; ATPase activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing; via spliceosome [GO:0000398]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100375395.1.2.m.3613,0.002375655,-0.004347779,No,NA,NA,NA,NA,NA,NA,cell wall [GO:0005618]; extracellular region [GO:0005576]; plant-type cell wall [GO:0009505]; alpha-L-arabinofuranosidase activity [GO:0046556]; xylan 1;4-beta-xylosidase activity [GO:0009044]; arabinan catabolic process [GO:0031222]; xylan catabolic process [GO:0045493],NA,NA,NA
CHOYP_LOC100375405.1.1.m.48387,-0.006307328,0.004588253,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; ephrin receptor binding [GO:0046875]; growth factor binding [GO:0019838]; interleukin-5 receptor binding [GO:0005137]; lipid binding [GO:0008289]; neurexin family protein binding [GO:0042043]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynapse assembly [GO:0099054]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346],NA,NA,NA
CHOYP_LOC100375419.1.1.m.60972,0.015897046,0.007619254,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; lipid droplet [GO:0005811]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; deoxyribonuclease inhibitor activity [GO:0060703]; protein binding involved in protein folding [GO:0044183]; protein domain specific binding [GO:0019904]; apoptotic DNA fragmentation [GO:0006309]; chaperone-mediated protein folding [GO:0061077]; negative regulation of apoptotic DNA fragmentation [GO:1902511]; negative regulation of deoxyribonuclease activity [GO:0032076]; negative regulation of execution phase of apoptosis [GO:1900118]; positive regulation of apoptotic process [GO:0043065]; thymocyte apoptotic process [GO:0070242],NA,NA,NA
CHOYP_LOC100375427.1.1.m.6282,0.022144959,-0.00865821,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; bicarbonate transport [GO:0015701],NA,NA,NA
CHOYP_LOC100375467.1.1.m.42789,0.003636756,-0.000560381,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; hemopoiesis [GO:0030097]; marginal zone B cell differentiation [GO:0002315]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of growth rate [GO:0045967]; nervous system development [GO:0007399]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of Ras protein signal transduction [GO:0046579]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription; DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_LOC100375473.1.1.m.9062,-0.017789518,0.000840213,No,NA,NA,NA,NA,NA,NA,cell projection organization [GO:0030030],NA,NA,NA
CHOYP_LOC100375476.1.1.m.33187,0.001431113,0.002389213,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375481.1.1.m.4496,0.007898983,-0.006830355,No,NA,NA,NA,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100375491.1.1.m.11693,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; transcription corepressor activity [GO:0003714]; fat cell differentiation [GO:0045444]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of DNA binding [GO:0051101]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100375514.2.6.m.12927,0.002987994,0.001076443,No,NA,NA,NA,NA,NA,NA,glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_LOC100375551.1.2.m.27488,-0.010968173,0.002984871,No,NA,NA,NA,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; sperm flagellum [GO:0036126]; axoneme assembly [GO:0035082]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_LOC100375551.1.2.m.27489,-0.000272979,-0.012716596,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100375551.2.2.m.63719,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375622.1.1.m.55637,0.015996391,-0.00329432,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375647.1.2.m.39652,0.00613937,0.000908166,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]; 20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; alkane 1-monooxygenase activity [GO:0018685]; alpha-tocopherol omega-hydroxylase activity [GO:0052871]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; monooxygenase activity [GO:0004497]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen [GO:0016709]; tocotrienol omega-hydroxylase activity [GO:0052872]; arachidonic acid metabolic process [GO:0019369]; blood coagulation [GO:0007596]; drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; negative regulation of icosanoid secretion [GO:0032304]; omega-hydroxylase P450 pathway [GO:0097267]; oxidation-reduction process [GO:0055114]; phylloquinone catabolic process [GO:0042376]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; regulation of blood pressure [GO:0008217]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; vitamin K catabolic process [GO:0042377],NA,NA,NA
CHOYP_LOC100375650.1.1.m.51555,-0.010398092,0.017573257,No,NA,NA,NA,NA,NA,NA,BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; membrane [GO:0016020]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; gastrulation [GO:0007369]; intracellular transport [GO:0046907]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; non-motile cilium assembly [GO:1905515]; pigment granule aggregation in cell center [GO:0051877],NA,NA,NA
CHOYP_LOC100375678.1.1.m.51537,0.007394353,-0.016859924,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2B complex [GO:0005851]; guanyl-nucleotide exchange factor activity [GO:0005085]; nucleotidyltransferase activity [GO:0016779]; translation initiation factor activity [GO:0003743]; hippocampus development [GO:0021766]; oligodendrocyte development [GO:0014003]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translation [GO:0006412]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC100375699.1.2.m.19738,-0.014785307,-0.005191703,No,NA,NA,NA,NA,NA,NA,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cell differentiation [GO:0030154]; cell projection organization [GO:0030030]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100375733.1.1.m.66021,0.014231156,-0.008430366,No,NA,NA,NA,NA,NA,NA,hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; isoprenoid biosynthetic process [GO:0008299]; sterol biosynthetic process [GO:0016126],NA,NA,NA
CHOYP_LOC100375747.1.1.m.36999,-0.012901943,-0.02084996,No,NA,NA,NA,NA,NA,NA,centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; centriole replication [GO:0007099]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; gamma-tubulin complex localization [GO:0033566]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of protein localization to centrosome [GO:1904779]; spindle organization [GO:0007051],NA,NA,NA
CHOYP_LOC100375776.1.3.m.8907,0.011946415,0.020939873,No,NA,NA,NA,NA,NA,NA,cell wall [GO:0005618]; extracellular region [GO:0005576]; S-layer [GO:0030115]; carbohydrate binding [GO:0030246]; polysaccharide catabolic process [GO:0000272],NA,NA,NA
CHOYP_LOC100375784.2.6.m.7640,-0.01849742,-0.016050156,No,NA,NA,NA,NA,NA,NA,axonemal central pair projection [GO:1990718]; axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC100375784.3.6.m.12285,-0.005873335,0.002489614,No,NA,NA,NA,NA,NA,NA,axonemal central pair projection [GO:1990718]; axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC100375784.4.6.m.27594,-0.009895533,0.0166414,No,NA,NA,NA,NA,NA,NA,axonemal central pair projection [GO:1990718]; axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC100375791.1.1.m.18116,0.005264592,-0.0106051,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; nucleus [GO:0005634]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of glycolytic process [GO:0006110]; regulation of pyruvate kinase activity [GO:1903302],NA,NA,NA
CHOYP_LOC100375797.1.3.m.4166,-0.00095864,0.016291423,No,NA,NA,NA,NA,NA,NA,hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; cellular amino acid biosynthetic process [GO:0008652],NA,NA,NA
CHOYP_LOC100375820.1.1.m.62640,0.014514346,0.004892228,No,NA,NA,NA,NA,NA,NA,CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; LUBAC complex [GO:0071797]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; CD40 signaling pathway [GO:0023035]; negative regulation of necroptotic process [GO:0060546]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_LOC100375831.1.1.m.24502,-0.006847546,0.001880634,No,NA,NA,NA,NA,NA,NA,autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; extrinsic component of omegasome membrane [GO:0097629]; Golgi stack [GO:0005795]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; omegasome [GO:1990462]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407]; 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_LOC100375838.1.1.m.39473,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_LOC100375877.1.1.m.16493,-0.000961016,-0.00969133,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020]; midbody [GO:0030496]; nuclear chromosome; telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; negative regulation of telomere maintenance via telomerase [GO:0032211]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391],NA,NA,NA
CHOYP_LOC100375888.1.1.m.18951,-0.005631557,-0.00041759,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; hydrolase activity [GO:0016787]; oxidoreductase activity; acting on the CH-CH group of donors [GO:0016627],NA,NA,NA
CHOYP_LOC100375890.1.1.m.10490,-0.004020319,-0.005714039,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; glycerol-1-phosphatase activity [GO:0000121]; glycerol-3-phosphatase activity [GO:0043136]; magnesium ion binding [GO:0000287]; nucleotide phosphatase activity; acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; phosphoglycolate phosphatase activity [GO:0008967]; protein tyrosine phosphatase activity [GO:0004725]; dephosphorylation [GO:0016311]; glycerol biosynthetic process [GO:0006114]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of gluconeogenesis [GO:0045721]; peptidyl-tyrosine dephosphorylation [GO:0035335],NA,NA,NA
CHOYP_LOC100375897.1.2.m.14439,-0.002658179,-0.012606348,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; mRNA 3'-UTR binding [GO:0003730]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; zinc ion binding [GO:0008270]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; snRNA processing [GO:0016180],NA,NA,NA
CHOYP_LOC100375913.1.1.m.9170,-0.016795303,-0.014667873,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin filament polymerization [GO:0030041]; cilium organization [GO:0044782],NA,NA,NA
CHOYP_LOC100375943.1.1.m.9395,0.004184152,0.016727894,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; selenocysteine insertion sequence binding [GO:0035368]; translation elongation factor activity [GO:0003746]; tRNA binding [GO:0000049]; selenocysteine incorporation [GO:0001514]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_LOC100375954.4.6.m.32949,-0.01973514,0.002292518,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_LOC100375955.1.1.m.9940,0.007846504,0.019411248,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; embryonic brain development [GO:1990403]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_LOC100376045.1.1.m.30010,0.008869415,0.006086762,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_LOC100376049.1.1.m.10489,0.004726317,-0.004134455,No,NA,NA,NA,NA,NA,NA,phosphatidylinositol binding [GO:0035091]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100376067.3.3.m.62990,-0.011062918,0.001638636,No,NA,NA,NA,NA,NA,NA,chromosome; centromeric region [GO:0000775]; cohesin complex [GO:0008278]; nuclear chromosome [GO:0000228]; apoptotic process [GO:0006915]; cell division [GO:0051301]; DNA repair [GO:0006281]; protein localization to chromatin [GO:0071168]; sister chromatid cohesion [GO:0007062],NA,NA,NA
CHOYP_LOC100376096.1.1.m.62366,-0.012360331,-0.000142403,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100376151.1.1.m.21094,-0.012074164,0.007418704,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome; centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; cell division [GO:0051301]; meiotic chromosome segregation [GO:0045132]; mitotic cell cycle [GO:0000278]; negative regulation of chromatin binding [GO:0035562]; negative regulation of DNA replication [GO:0008156]; negative regulation of sister chromatid cohesion [GO:0045875]; positive regulation of fibroblast proliferation [GO:0048146]; protein localization to chromatin [GO:0071168]; regulation of chromosome condensation [GO:0060623]; regulation of cohesin loading [GO:0071922]; response to toxic substance [GO:0009636]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100376162.1.1.m.48261,-0.015289018,-2.14E-05,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1;2-alpha-mannosidase activity [GO:0004571]; glycoprotein metabolic process [GO:0009100]; lung alveolus development [GO:0048286]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; respiratory gaseous exchange [GO:0007585],NA,NA,NA
CHOYP_LOC100376187.1.2.m.22539,-0.007896073,0.012882087,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100376187.1.2.m.22540,0.02065813,-0.005678815,No,NA,NA,NA,NA,NA,NA,aldehyde dehydrogenase (NADP+) activity [GO:0033721]; coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; response to furfural [GO:1901426],NA,NA,NA
CHOYP_LOC100376187.2.2.m.55240,-0.003007346,0.012805347,No,NA,NA,NA,NA,NA,NA,aldehyde dehydrogenase (NADP+) activity [GO:0033721]; coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; response to furfural [GO:1901426],NA,NA,NA
CHOYP_LOC100376200.1.1.m.19157,-0.000797674,-0.007635395,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; SOSS complex [GO:0070876]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; response to ionizing radiation [GO:0010212],NA,NA,NA
CHOYP_LOC100376214.9.11.m.53354,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100376250.1.1.m.46061,-0.007030718,-0.017176869,No,NA,NA,NA,NA,NA,NA,AP-type membrane coat adaptor complex [GO:0030119]; cytosol [GO:0005829]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; endosomal transport [GO:0016197]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100376265.3.4.m.22693,0.00623761,0.001980412,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; galactosylceramidase activity [GO:0004336]; galactosylceramide catabolic process [GO:0006683],NA,NA,NA
CHOYP_LOC100376265.4.4.m.28000,0.002319464,0.012194491,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; galactosylceramidase activity [GO:0004336]; galactosylceramide catabolic process [GO:0006683],NA,NA,NA
CHOYP_LOC100376272.3.4.m.30521,-0.021983218,0.009299006,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; L-ascorbate oxidase activity [GO:0008447],NA,NA,NA
CHOYP_LOC100376272.3.4.m.30522,0.019004948,-0.005266765,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; angiogenesis [GO:0001525]; glutamine biosynthetic process [GO:0006542]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_LOC100376274.7.7.m.64553,-0.006117333,-0.004412986,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159],NA,NA,NA
CHOYP_LOC100376289.1.1.m.60023,-0.019779529,0.003431755,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; cilium assembly [GO:0060271]; photoreceptor cell maintenance [GO:0045494]; pronephros development [GO:0048793]; regulation of TOR signaling [GO:0032006]; retina development in camera-type eye [GO:0060041],NA,NA,NA
CHOYP_LOC100376296.1.1.m.36837,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_LOC100376325.1.2.m.1959,-0.008735098,0.009701827,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; protein homodimerization activity [GO:0042803]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell proliferation [GO:0008284]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100376387.1.1.m.9565,0.014447121,-0.00684929,No,NA,NA,NA,NA,NA,NA,box C/D snoRNP complex [GO:0031428]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; U3 snoRNA binding [GO:0034511]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100376426.3.3.m.65900,-0.00098726,0.014761928,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100376429.1.1.m.24844,-0.013346224,-0.004821783,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; sperm flagellum [GO:0036126]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cell differentiation [GO:0030154]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; Rab protein signal transduction [GO:0032482]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100376442.1.1.m.40651,-0.014321232,0.004646277,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100376457.1.2.m.11537,0.010360528,0.003725182,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693],NA,NA,NA
CHOYP_LOC100376457.2.2.m.51737,0.020906665,0.005697541,No,NA,NA,NA,NA,NA,NA,structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_LOC100376500.1.1.m.36606,-0.006619083,0.006068106,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; lipid droplet [GO:0005811]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; site of double-strand break [GO:0035861]; spindle [GO:0005819]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular protein localization [GO:0034613]; double-strand break repair via nonhomologous end joining [GO:0006303]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; inner cell mass cell proliferation [GO:0001833]; lipid biosynthetic process [GO:0008610]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; proteasomal protein catabolic process [GO:0010498]; protein K63-linked ubiquitination [GO:0070534]; signal transduction involved in DNA damage checkpoint [GO:0072422]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_LOC100376608.2.4.m.47059,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100376608.3.4.m.51379,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100376610.3.3.m.19687,-0.014033559,-0.015988424,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; R-SMAD binding [GO:0070412]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332]; transcription coregulator activity [GO:0003712]; alternative mRNA splicing; via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; circadian rhythm [GO:0007623]; epithelial to mesenchymal transition [GO:0001837]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043517]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of transcription; DNA-templated [GO:0045893]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of protein import into nucleus; translocation [GO:0033158]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral genome replication [GO:0045069],NA,NA,NA
CHOYP_LOC100376688.1.8.m.12067,0.018180731,-0.002080943,No,NA,NA,NA,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; Golgi apparatus [GO:0005794]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100376708.2.2.m.19660,0.019074257,-0.000682927,No,NA,NA,NA,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; metal ion binding [GO:0046872]; proline-tRNA ligase activity [GO:0004827]; RNA binding [GO:0003723]; glutamyl-tRNA aminoacylation [GO:0006424]; prolyl-tRNA aminoacylation [GO:0006433],NA,NA,NA
CHOYP_LOC100376733.1.1.m.12140,0.011241924,0.002769475,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; TOR signaling [GO:0031929],NA,NA,NA
CHOYP_LOC100376749.1.1.m.27252,-0.008384662,0.009576992,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; chordate embryonic development [GO:0043009]; negative regulation of apoptotic process [GO:0043066]; signal transduction [GO:0007165]; TOR signaling [GO:0031929],NA,NA,NA
CHOYP_LOC100376759.2.2.m.59482,-0.015433185,0.009340389,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; actin cytoskeleton reorganization [GO:0031532]; axon extension [GO:0048675]; dendrite extension [GO:0097484]; embryonic viscerocranium morphogenesis [GO:0048703]; forebrain neuron development [GO:0021884]; innate vocalization behavior [GO:0098582]; neuron cellular homeostasis [GO:0070050]; neuron migration [GO:0001764]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H4-K16 acetylation [GO:2000620]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of transcription by RNA polymerase II [GO:0045944]; righting reflex [GO:0060013],NA,NA,NA
CHOYP_LOC100376802.2.2.m.60631,-0.01082368,0.001032403,No,NA,NA,NA,NA,NA,NA,N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; peptidoglycan catabolic process [GO:0009253],NA,NA,NA
CHOYP_LOC100376807.1.1.m.22568,-0.012689407,0.007185279,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514],NA,NA,NA
CHOYP_LOC100376827.1.1.m.60291,-0.014772128,-0.011275226,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; protein N-linked glycosylation [GO:0006487],NA,NA,NA
CHOYP_LOC100376857.1.7.m.30171,-0.018243356,-0.010191458,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; L-ascorbate oxidase activity [GO:0008447],NA,NA,NA
CHOYP_LOC100376857.4.7.m.47467,0.003448577,-0.006079536,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; L-ascorbate oxidase activity [GO:0008447],NA,NA,NA
CHOYP_LOC100376863.1.1.m.65235,0.017515227,-0.010561072,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 1;4-alpha-glucan branching enzyme activity [GO:0003844]; 1;4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; cation binding [GO:0043169]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977],NA,NA,NA
CHOYP_LOC100376864.2.4.m.20389,0.00330482,-0.010919001,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100376880.1.1.m.475,-0.016722845,-0.005757265,No,NA,NA,NA,NA,NA,NA,dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of protein autophosphorylation [GO:0031952]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637],NA,NA,NA
CHOYP_LOC100376902.1.1.m.20390,-0.020406015,-0.014456522,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; radial spoke [GO:0001534]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341],NA,NA,NA
CHOYP_LOC100376908.1.4.m.112,0.008797549,-0.007000647,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; hematopoietic progenitor cell differentiation [GO:0002244]; mRNA cis splicing; via spliceosome [GO:0045292]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_LOC100376932.1.1.m.12642,0.016995527,-0.009791636,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle; base subcomplex [GO:0008540]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; protein catabolic process [GO:0030163],NA,NA,NA
CHOYP_LOC100376984.1.1.m.15840,-0.005527166,-0.018017267,No,NA,NA,NA,NA,NA,NA,nuclear body [GO:0016604]; hydrolase activity; acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100377001.1.2.m.10821,-0.000726033,0.004897038,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; NAD binding [GO:0051287]; oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154],NA,NA,NA
CHOYP_LOC100377001.2.2.m.52324,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; NAD binding [GO:0051287]; oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620]; protein serine/threonine kinase activity [GO:0004674]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; import into nucleus [GO:0051170]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of angiogenesis [GO:0045765],NA,NA,NA
CHOYP_LOC100377034.1.1.m.6251,0.016745132,0.01547683,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; hydroxymethyl-; formyl- and related transferase activity [GO:0016742]; oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620]; 10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; one-carbon metabolic process [GO:0006730],NA,NA,NA
CHOYP_LOC100377054.1.1.m.8489,0.017495364,0.007167946,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; cellular response to interleukin-7 [GO:0098761]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100377058.1.1.m.22299,-0.018648887,-0.007771502,No,NA,NA,NA,NA,NA,NA,intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_LOC100377066.1.2.m.18381,0.000391029,0.009375394,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; steroid dehydrogenase activity [GO:0016229]; androgen catabolic process [GO:0006710]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100377077.1.1.m.9907,-0.016857717,-0.013163612,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377089.1.2.m.5892,0.007416813,0.007083084,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100377100.1.1.m.51994,-0.001167237,-0.016950503,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; D-lactate dehydrogenase (cytochrome) activity [GO:0004458]; D-lactate dehydrogenase activity [GO:0008720]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; lactate catabolic process [GO:1903457],NA,NA,NA
CHOYP_LOC100377119.1.1.m.44037,-0.022519416,0.000516484,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377154.3.4.m.52896,-0.013122677,0.001279543,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100377160.2.2.m.55835,0.018726407,0.004968727,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; cysteine synthase activity [GO:0004124]; L-cysteine desulfhydrase activity [GO:0080146]; pyridoxal phosphate binding [GO:0030170]; cellular amino acid biosynthetic process [GO:0008652]; cysteine biosynthetic process from serine [GO:0006535],NA,NA,NA
CHOYP_LOC100377173.1.2.m.37698,-0.018939538,-0.005864529,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317],NA,NA,NA
CHOYP_LOC100377173.1.2.m.37699,0.008719867,-0.012404741,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377184.1.1.m.16090,-0.005767302,0.000681197,No,NA,NA,NA,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial transcription [GO:0006390]; positive regulation of transcription; DNA-templated [GO:0045893]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100377195.1.2.m.28624,-0.016235308,-0.017577056,No,NA,NA,NA,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_LOC100377200.1.2.m.19811,0.017974402,0.01420505,No,NA,NA,NA,NA,NA,NA,fucose binding [GO:0042806]; L-fucose mutarotase activity [GO:0036373]; racemase and epimerase activity; acting on carbohydrates and derivatives [GO:0016857]; female mating behavior [GO:0060180]; fucose metabolic process [GO:0006004]; fucosylation [GO:0036065]; negative regulation of neuron differentiation [GO:0045665],NA,NA,NA
CHOYP_LOC100377220.1.1.m.36306,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_LOC100377233.1.1.m.30409,-0.012055265,-0.015937623,No,NA,NA,NA,NA,NA,NA,azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body; internal vesicle [GO:0097487]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; cell-matrix adhesion [GO:0007160]; cellular protein localization [GO:0034613]; endosome to melanosome transport [GO:0035646]; neutrophil degranulation [GO:0043312]; pigment granule maturation [GO:0048757]; platelet degranulation [GO:0002576]; positive regulation of endocytosis [GO:0045807]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746],NA,NA,NA
CHOYP_LOC100377235.1.2.m.30935,0.016972612,0.004560695,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; snRNA stem-loop binding [GO:0035614]; U1 snRNA binding [GO:0030619]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100377243.1.1.m.6500,-0.015931157,-0.001603413,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100377244.1.2.m.31458,-0.020855152,-0.000288589,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377267.1.1.m.49876,0.014133581,-0.002346289,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transporter activity [GO:1902388]; intermembrane lipid transfer activity [GO:0120013]; lipid binding [GO:0008289]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009],NA,NA,NA
CHOYP_LOC100377311.6.14.m.34688,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,protein-containing complex binding [GO:0044877],NA,NA,NA
CHOYP_LOC100377323.1.1.m.23683,-0.010380516,-0.001942689,No,NA,NA,NA,NA,NA,NA,dTDP-glucose 4;6-dehydratase activity [GO:0008460]; nucleotide-sugar metabolic process [GO:0009225]; protein glycosylation [GO:0006486]; S-layer organization [GO:0045232],NA,NA,NA
CHOYP_LOC100377347.1.1.m.11235,-0.008800644,0.005783345,No,NA,NA,NA,NA,NA,NA,axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; gamma-tubulin binding [GO:0043015]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein domain specific binding [GO:0019904]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in forebrain [GO:0021846]; cerebellar cortex development [GO:0021695]; cerebral cortex cell migration [GO:0021795]; cerebral cortex radially oriented cell migration [GO:0021799]; forebrain ventricular zone progenitor cell division [GO:0021869]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of axonogenesis [GO:0050772]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microtubule cytoskeleton organization [GO:0070507],NA,NA,NA
CHOYP_LOC100377362.1.1.m.10266,0.008011357,-0.023793605,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cyclin binding [GO:0030332]; MDM2/MDM4 family protein binding [GO:0097371]; mitogen-activated protein kinase binding [GO:0051019]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; ubiquitin-like protein ligase binding [GO:0044389]; apoptotic nuclear changes [GO:0030262]; cell proliferation [GO:0008283]; endoplasmic reticulum unfolded protein response [GO:0030968]; mitotic G2 DNA damage checkpoint [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ufmylation [GO:0071569]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle [GO:0007346]; regulation of phosphatase activity [GO:0010921],NA,NA,NA
CHOYP_LOC100377364.1.2.m.4828,0.007258626,-0.005928657,No,NA,NA,NA,NA,NA,NA,apicolateral plasma membrane [GO:0016327]; axon [GO:0030424]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; photoreceptor cell axon guidance [GO:0072499]; plasma membrane organization [GO:0007009]; regulation of synapse organization [GO:0050807],NA,NA,NA
CHOYP_LOC100377378.1.1.m.64418,-0.01919064,-0.002756917,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100377381.1.2.m.29868,-0.00717791,0.007122973,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite cytoplasm [GO:0032839]; intraciliary transport particle B [GO:0030992]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100377381.2.2.m.49035,-0.021593546,0.006259646,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite cytoplasm [GO:0032839]; intraciliary transport particle B [GO:0030992]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100377392.2.4.m.21904,0.016122472,-0.008999896,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; collagen type II trimer [GO:0005585]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; cartilage development [GO:0051216]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; cellular response to nicotine [GO:0071316]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to retinoic acid [GO:0071300]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin E [GO:0071306]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; growth plate cartilage development [GO:0003417]; notochord development [GO:0030903]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; response to X-ray [GO:0010165]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_LOC100377392.4.4.m.65974,-0.013879865,0.006241449,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100377398.1.1.m.44441,0.004538211,-0.008517332,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; positive regulation of apoptotic process [GO:0043065],NA,NA,NA
CHOYP_LOC100377412.1.1.m.41404,-0.023143952,-0.002570935,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; motile cilium [GO:0031514]; sperm connecting piece [GO:0097224]; sperm flagellum [GO:0036126]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; axonemal central apparatus assembly [GO:1904158]; chaperone cofactor-dependent protein refolding [GO:0051085],NA,NA,NA
CHOYP_LOC100377435.1.1.m.46017,-0.003025048,0.001226023,No,NA,NA,NA,NA,NA,NA,centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; centriole replication [GO:0007099]; protein localization to centrosome [GO:0071539],NA,NA,NA
CHOYP_LOC100377487.1.1.m.27964,-0.000208844,0.003510325,No,NA,NA,NA,NA,NA,NA,citrate lyase complex [GO:0009346]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; cofactor binding [GO:0048037]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107],NA,NA,NA
CHOYP_LOC100377495.1.1.m.17707,0.001909669,0.001934762,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; AT DNA binding [GO:0003680]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; identical protein binding [GO:0042802]; lysine-acetylated histone binding [GO:0070577]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription regulatory region DNA binding [GO:0044212]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; embryonic hemopoiesis [GO:0035162]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; negative regulation of DNA methylation [GO:1905642]; positive regulation of cellular response to drug [GO:2001040]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of transporter activity [GO:0032411]; protein-containing complex assembly [GO:0065003]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of histone H3-K14 acetylation [GO:0071440]; regulation of histone H3-K9 acetylation [GO:2000615]; regulation of megakaryocyte differentiation [GO:0045652]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC100377541.2.4.m.15307,0.007474782,0.007825156,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100377560.1.1.m.66612,-0.002357979,-0.00849756,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC100377596.1.1.m.7350,-0.008823003,-0.009467696,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cell cycle [GO:0007049],NA,NA,NA
CHOYP_LOC100377647.1.2.m.10110,-0.022663599,0.010260004,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100377677.1.2.m.23471,-0.0156859,0.002400244,No,NA,NA,NA,NA,NA,NA,azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; chondroitin sulfate catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; neutrophil degranulation [GO:0043312]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],NA,NA,NA
CHOYP_LOC100377677.2.2.m.27049,-0.006805437,0.003263037,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],NA,NA,NA
CHOYP_LOC100377682.1.1.m.31441,-0.001622007,0.005881985,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminocarboxymuconate-semialdehyde decarboxylase activity [GO:0001760]; hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270]; negative regulation of quinolinate biosynthetic process [GO:1904985]; picolinic acid biosynthetic process [GO:1905004]; protein complex oligomerization [GO:0051259]; regulation of 'de novo' NAD biosynthetic process from tryptophan [GO:1905012]; secondary metabolic process [GO:0019748]; tryptophan catabolic process [GO:0006569],NA,NA,NA
CHOYP_LOC100377736.1.1.m.251,-0.001417133,0.012732297,No,NA,NA,NA,NA,NA,NA,extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 2-octoprenyl-3-methyl-6-methoxy-1;4-benzoquinone hydroxylase activity [GO:0008682]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen [GO:0016709]; age-dependent response to oxidative stress [GO:0001306]; cellular response to oxidative stress [GO:0034599]; determination of adult lifespan [GO:0008340]; in utero embryonic development [GO:0001701]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrion morphogenesis [GO:0070584]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube formation [GO:0001841]; neurogenesis [GO:0022008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of reactive oxygen species metabolic process [GO:2000377]; respiratory electron transport chain [GO:0022904]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_LOC100377751.1.1.m.26359,-0.0225274,-0.008655832,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; motile cilium [GO:0031514]; cilium movement [GO:0003341],NA,NA,NA
CHOYP_LOC100377755.1.1.m.1005,0.016393447,-0.002847926,No,NA,NA,NA,NA,NA,NA,CRD-mediated mRNA stability complex [GO:0070937]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; male gonad development [GO:0008584]; nuclear-transcribed mRNA catabolic process; no-go decay [GO:0070966]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100377755.1.1.m.1006,-0.009155275,0.005058349,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377759.10.15.m.45798,-0.00167126,-0.011561067,No,NA,NA,NA,NA,NA,NA,chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of response to DNA damage stimulus [GO:2001022],NA,NA,NA
CHOYP_LOC100377759.15.15.m.64824,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377771.1.1.m.7044,-0.011898012,-0.005401835,No,NA,NA,NA,NA,NA,NA,cell projection [GO:0042995]; centriole [GO:0005814]; cell projection organization [GO:0030030]; microtubule anchoring [GO:0034453],NA,NA,NA
CHOYP_LOC100377780.8.11.m.53259,-0.015959626,-0.000613115,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955],NA,NA,NA
CHOYP_LOC100377783.1.1.m.14549,0.00532936,0.000566165,No,NA,NA,NA,NA,NA,NA,cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100377801.1.1.m.10929,-0.014320791,-0.022381413,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; preribosome; large subunit precursor [GO:0030687],NA,NA,NA
CHOYP_LOC100377837.2.2.m.7996,-0.004108002,-0.010581788,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730],NA,NA,NA
CHOYP_LOC100377856.1.2.m.13657,0.006866776,-0.012271917,No,NA,NA,NA,NA,NA,NA,outer dense fiber [GO:0001520]; sperm connecting piece [GO:0097224]; cytoskeleton organization [GO:0007010]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100377856.2.2.m.43339,-0.01139163,0.012185346,No,NA,NA,NA,NA,NA,NA,outer dense fiber [GO:0001520]; sperm connecting piece [GO:0097224]; cytoskeleton organization [GO:0007010]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100377864.1.1.m.33298,0.004361353,-0.023082517,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377872.1.1.m.30372,-0.017130748,-0.00206052,No,NA,NA,NA,NA,NA,NA,apical junction complex [GO:0043296]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; GTP-Rho binding [GO:0017049]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100377901.1.1.m.7173,0.018117143,0.007071253,No,NA,NA,NA,NA,NA,NA,cell projection [GO:0042995]; cell-cell junction [GO:0005911]; clathrin-coated vesicle [GO:0030136]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685]; calcium ion binding [GO:0005509]; glutamate receptor binding [GO:0035254]; insulin receptor binding [GO:0005158]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; in utero embryonic development [GO:0001701]; inositol trisphosphate biosynthetic process [GO:0032959]; modulation of chemical synaptic transmission [GO:0050804]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein secretion [GO:0009306]; regulation of store-operated calcium channel activity [GO:1901339]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_LOC100377934.1.1.m.48699,-0.012492999,0.001750086,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377974.1.1.m.6543,-0.010627747,0.000866269,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100377982.1.1.m.43510,-0.012762787,-0.001026944,No,NA,NA,NA,NA,NA,NA,endosome [GO:0005768]; lysosome [GO:0005764]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100378002.1.1.m.47564,-0.006426947,-0.001772637,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; Ski complex [GO:0055087]; transcriptionally active chromatin [GO:0035327]; RNA catabolic process [GO:0006401],NA,NA,NA
CHOYP_LOC100378011.2.2.m.52041,-0.002970093,0.003286119,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842],NA,NA,NA
CHOYP_LOC100378054.4.4.m.63855,0.011401354,0.013269888,No,NA,NA,NA,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; metal ion binding [GO:0046872]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_LOC100378071.1.1.m.40488,-0.023381881,-0.002058273,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motor activity [GO:0003774],NA,NA,NA
CHOYP_LOC100378083.1.3.m.26711,-0.01760653,-0.000861637,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of type I interferon production [GO:0032480]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein deubiquitination [GO:0016579]; protein sumoylation [GO:0016925]; regulation of type III interferon production [GO:0034344]; response to virus [GO:0009615]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100378083.3.3.m.65631,0.006274613,-0.013752281,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_LOC100378099.1.1.m.22676,-0.000388563,-0.004054766,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; antioxidant activity [GO:0016209]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; histone H3-K9 demethylation [GO:0033169]; response to cisplatin [GO:0072718],NA,NA,NA
CHOYP_LOC100378099.1.1.m.22677,0.006935593,0.01023277,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; nucleus [GO:0005634]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_LOC100378116.1.3.m.22707,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100378116.3.3.m.60538,0.005463439,0.008116013,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100378195.1.1.m.46024,-0.011000736,0.002266186,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_LOC100378204.1.1.m.40064,-0.000628451,-0.01933637,No,NA,NA,NA,NA,NA,NA,cofactor binding [GO:0048037]; deoxyhypusine monooxygenase activity [GO:0019135]; iron ion binding [GO:0005506]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612],NA,NA,NA
CHOYP_LOC100378209.1.2.m.7335,-0.013047039,-0.023879502,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; enhancer sequence-specific DNA binding [GO:0001158]; four-way junction DNA binding [GO:0000400]; histone deacetylase binding [GO:0042826]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA binding [GO:0003723]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; anterior/posterior pattern specification [GO:0009952]; camera-type eye morphogenesis [GO:0048593]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100378221.1.1.m.29052,0.005372773,0.0009105,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; Golgi cis cisterna [GO:0000137]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; axonogenesis [GO:0007409]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593],NA,NA,NA
CHOYP_LOC100378252.1.1.m.16877,0.008494553,0.006183448,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100378255.1.1.m.63185,-0.018016109,-0.00741027,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; motile cilium [GO:0031514]; cilium movement [GO:0003341]; cilium organization [GO:0044782],NA,NA,NA
CHOYP_LOC100378269.1.2.m.12226,-0.017256742,0.009060724,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100378295.1.4.m.3278,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_LOC100378322.1.1.m.16268,0.001278717,0.008074655,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100378331.1.1.m.47480,-0.022556364,0.003857331,No,NA,NA,NA,NA,NA,NA,axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100378364.1.1.m.53053,0.01331592,-0.004168929,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]; lysosome [GO:0005764]; multivesicular body membrane [GO:0032585]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; ubiquitin-like protein ligase binding [GO:0044389]; membrane invagination [GO:0010324]; negative regulation of angiogenesis [GO:0016525]; negative regulation of JAK-STAT cascade [GO:0046426]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; regulation of MAP kinase activity [GO:0043405],NA,NA,NA
CHOYP_LOC100378410.1.1.m.18106,-0.012248781,-0.024171888,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; cellular response to estrogen stimulus [GO:0071391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100378414.1.1.m.34038,-0.001948892,-0.021047144,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_LOC100378430.1.1.m.63142,-0.022472245,0.000991266,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793],NA,NA,NA
CHOYP_LOC100378445.1.1.m.7111,0.001307348,-0.004891402,No,NA,NA,NA,NA,NA,NA,nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100378487.1.1.m.64108,-0.003454279,-0.011949192,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; messenger ribonucleoprotein complex [GO:1990124]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; translation factor activity; RNA binding [GO:0008135]; translation repressor activity; mRNA regulatory element binding [GO:0000900]; cellular response to amino acid stimulus [GO:0071230]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; ionotropic glutamate receptor signaling pathway [GO:0035235]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of neuron apoptotic process [GO:0043524]; response to ischemia [GO:0002931],NA,NA,NA
CHOYP_LOC100378510.1.1.m.9865,0.022608252,0.003908953,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; apoptotic process [GO:0006915]; camera-type eye development [GO:0043010]; cell fate specification [GO:0001708]; dorsal/ventral neural tube patterning [GO:0021904]; intracellular signal transduction [GO:0035556]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of BMP signaling pathway [GO:0030513]; smoothened signaling pathway [GO:0007224]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100378526.1.1.m.16747,0.010379257,0.005474472,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; sulfur carrier activity [GO:0097163]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble uridine modification [GO:0002098],NA,NA,NA
CHOYP_LOC100378553.1.1.m.7444,-0.011071503,-0.002373032,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; endochondral bone growth [GO:0003416]; mesenchyme development [GO:0060485]; roof of mouth development [GO:0060021]; tongue development [GO:0043586],NA,NA,NA
CHOYP_LOC100378570.1.1.m.25501,-0.015523415,0.013533345,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; 8-oxo-7;8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; endonuclease activity [GO:0004519]; microtubule binding [GO:0008017]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; acute inflammatory response [GO:0002526]; aging [GO:0007568]; base-excision repair [GO:0006284]; base-excision repair; AP site formation [GO:0006285]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; depurination [GO:0045007]; depyrimidination [GO:0045008]; negative regulation of apoptotic process [GO:0043066]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; nucleotide-excision repair; DNA incision [GO:0033683]; regulation of transcription; DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to light stimulus [GO:0009416]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314],NA,NA,NA
CHOYP_LOC100378584.1.3.m.38091,-0.008795399,7.71E-05,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],NA,NA,NA
CHOYP_LOC100378607.1.2.m.17330,-0.006979845,0.005014435,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100378615.1.2.m.25321,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739],NA,NA,NA
CHOYP_LOC100378618.1.1.m.48704,-0.011161075,-0.012678762,No,NA,NA,NA,NA,NA,NA,centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; spindle pole [GO:0000922]; protein localization [GO:0008104],NA,NA,NA
CHOYP_LOC100378619.1.2.m.21468,-0.001191629,0.010364698,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; nuclear envelope [GO:0005635]; structural molecule activity [GO:0005198]; cell proliferation [GO:0008283],NA,NA,NA
CHOYP_LOC100378619.2.2.m.36047,-0.016901064,-0.019455277,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; nuclear envelope [GO:0005635]; structural molecule activity [GO:0005198]; cell proliferation [GO:0008283],NA,NA,NA
CHOYP_LOC100378642.1.1.m.54868,0.005638462,-0.006005284,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; protein-disulfide reductase activity [GO:0047134]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100378644.2.2.m.58497,-0.014342507,0.006629974,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100378652.1.1.m.5656,-0.01392371,0.005076168,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; intraciliary transport particle B [GO:0030992]; nucleus [GO:0005634]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; epidermis development [GO:0008544]; heart development [GO:0007507]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; keratinocyte development [GO:0003334]; negative regulation of epithelial cell proliferation [GO:0050680]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100378652.1.1.m.5657,-0.005419019,-0.020848112,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anterior/posterior pattern specification [GO:0009952]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cholesterol homeostasis [GO:0042632]; endocytosis [GO:0006897]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; osteoblast development [GO:0002076]; positive regulation of cell proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; retina morphogenesis in camera-type eye [GO:0060042]; retinal blood vessel morphogenesis [GO:0061304]; toxin transport [GO:1901998]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100378652.1.1.m.5658,-0.010594472,0.001967106,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; BMP signaling pathway [GO:0030509]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100378653.1.3.m.42107,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_LOC100378658.1.1.m.38454,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,CAAX-protein geranylgeranyltransferase complex [GO:0005953]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; protein geranylgeranyltransferase activity [GO:0004661]; zinc ion binding [GO:0008270]; protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342],NA,NA,NA
CHOYP_LOC100378676.3.8.m.43012,0.004057431,-0.018000224,No,NA,NA,NA,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; ion channel binding [GO:0044325]; zinc ion binding [GO:0008270]; cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207],NA,NA,NA
CHOYP_LOC100378691.2.2.m.40118,-0.006044689,-0.008936297,No,NA,NA,NA,NA,NA,NA,COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100378714.2.4.m.30802,0.015851196,0.003796382,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100378719.1.1.m.7367,-0.002640221,-0.007716289,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; cAMP response element binding protein binding [GO:0008140]; energy homeostasis [GO:0097009]; entrainment of circadian clock by photoperiod [GO:0043153]; memory [GO:0007613]; negative regulation of membrane hyperpolarization [GO:1902631]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendrite development [GO:1900006]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynapse to nucleus signaling pathway [GO:0099527]; protein homotetramerization [GO:0051289]; rhythmic process [GO:0048511]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100378760.1.1.m.37015,-0.001581422,0.005975758,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activator activity [GO:0097027]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle phase transition [GO:0044770]; cell proliferation [GO:0008283]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription; DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100378816.1.1.m.10997,-0.021255255,-0.001674532,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126]; flagellated sperm motility [GO:0030317],NA,NA,NA
CHOYP_LOC100378818.2.2.m.27217,0.005880014,-0.003804766,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171],NA,NA,NA
CHOYP_LOC100378821.1.1.m.8967,0.004378612,-0.011211612,No,NA,NA,NA,NA,NA,NA,signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100378839.1.1.m.21328,-0.020935457,-0.010938098,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],NA,NA,NA
CHOYP_LOC100378844.1.4.m.7322,-0.021612706,-0.010779759,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100378848.1.1.m.29949,-0.001452109,0.003260714,No,NA,NA,NA,NA,NA,NA,AP-3 adaptor complex [GO:0030123]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; retrograde transport; endosome to plasma membrane [GO:1990126]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100378849.1.1.m.21445,-0.005267333,0.000324613,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100378873.3.3.m.30410,-0.020286175,-0.007435746,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100378881.1.1.m.29212,-0.018086255,0.008647968,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100378892.1.1.m.41502,0.003936146,-0.002320644,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; RNA binding [GO:0003723]; translation activator activity [GO:0008494],NA,NA,NA
CHOYP_LOC100378901.1.2.m.29418,-0.005935038,-0.014036491,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; hemoglobin complex [GO:0005833]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344],NA,NA,NA
CHOYP_LOC100378967.1.1.m.62298,-0.010690019,-0.007735141,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; photoreceptor connecting cilium [GO:0032391]; cilium organization [GO:0044782],NA,NA,NA
CHOYP_LOC100378969.2.2.m.31240,0.017936337,0.001225454,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100378993.1.1.m.13997,0.006431656,0.006772957,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone-lysine N-methyltransferase activity [GO:0018024]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; determination of adult lifespan [GO:0008340]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100378999.1.1.m.36850,-0.02228463,0.009609768,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100379008.4.4.m.54023,-0.000953904,-0.009507271,No,NA,NA,NA,NA,NA,NA,azurophil granule membrane [GO:0035577]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; neutrophil degranulation [GO:0043312]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903],NA,NA,NA
CHOYP_LOC100379049.1.1.m.51860,-0.010088844,-0.01128031,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; phosphatidylinositol binding [GO:0035091]; cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to paclitaxel [GO:1901555]; response to toxic substance [GO:0009636],NA,NA,NA
CHOYP_LOC100402577.1.1.m.44548,0.022868998,0.001126894,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; nematocyst [GO:0042151]; serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729],NA,NA,NA
CHOYP_LOC100459096.3.3.m.45135,0.01964444,0.011252846,No,NA,NA,NA,NA,NA,NA,sulfotransferase activity [GO:0008146]; cellular response to xenobiotic stimulus [GO:0071466],NA,NA,NA
CHOYP_LOC100462678.2.2.m.28619,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100465916.1.1.m.44328,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771],NA,NA,NA
CHOYP_LOC100471656.2.2.m.34266,0.003462605,-0.006693775,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; endoplasmic reticulum unfolded protein response [GO:0030968]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_LOC100472408.1.1.m.17281,0.010104435,-0.022757256,No,NA,NA,NA,NA,NA,NA,RNA binding [GO:0003723]; tRNA (adenine-N6-)-methyltransferase activity [GO:0016430]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_LOC100476601.1.1.m.9343,0.010178138,0.004233411,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; mRNA processing [GO:0006397]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC100485159.1.1.m.30340,-0.016590272,-0.0140104,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100485247.1.1.m.37690,0.016814522,-0.00264753,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100485356.1.1.m.21339,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100485383.1.1.m.52650,-0.016817791,-0.003074558,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100485485.1.1.m.27961,-0.023298677,0.006456361,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_LOC100485536.1.1.m.48204,0.0065316,0.00076789,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; kynureninase activity [GO:0030429]; pyridoxal phosphate binding [GO:0030170]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-kynurenine catabolic process [GO:0097053]; quinolinate biosynthetic process [GO:0019805]; tryptophan catabolic process to kynurenine [GO:0019441],NA,NA,NA
CHOYP_LOC100485604.1.1.m.45268,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,actin filament [GO:0005884]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule binding [GO:0008017]; antral ovarian follicle growth [GO:0001547]; apoptotic process [GO:0006915]; basement membrane organization [GO:0071711]; cell cycle arrest [GO:0007050]; initiation of primordial ovarian follicle growth [GO:0001544]; ovulation [GO:0030728]; regulation of cell shape [GO:0008360]; regulation of Notch signaling pathway [GO:0008593],NA,NA,NA
CHOYP_LOC100486001.1.1.m.6209,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100486063.2.9.m.5918,-0.016909934,0.006689873,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_LOC100486063.5.9.m.39538,0.018671102,-0.005513956,No,NA,NA,NA,NA,NA,NA,collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; sarcolemma [GO:0042383]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; muscle organ development [GO:0007517],NA,NA,NA
CHOYP_LOC100486063.6.9.m.44250,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_LOC100486063.9.9.m.65186,0.022419922,-0.001273415,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_LOC100486357.1.1.m.51050,-0.006850994,-0.007626244,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100486738.1.2.m.63464,0.004402025,0.023874064,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; CARD domain binding [GO:0050700]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein phosphorylation [GO:0001934]; tumor necrosis factor-mediated signaling pathway [GO:0033209],NA,NA,NA
CHOYP_LOC100487213.2.4.m.53374,0.006153768,-0.008521633,No,NA,NA,NA,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; actin monomer binding [GO:0003785]; auditory receptor cell stereocilium organization [GO:0060088]; cilium assembly [GO:0060271]; heart jogging [GO:0003146]; heart looping [GO:0001947],NA,NA,NA
CHOYP_LOC100488715.1.1.m.61241,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100488894.1.5.m.4048,0.000597306,0.003909264,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100489126.1.1.m.18822,0.009558934,0.01344877,No,NA,NA,NA,NA,NA,NA,90S preribosome [GO:0030686]; nucleolus [GO:0005730]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000447],NA,NA,NA
CHOYP_LOC100489926.1.3.m.3642,-0.010559492,0.00774745,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; FHA domain binding [GO:0070975]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; double-strand break repair via nonhomologous end joining [GO:0006303]; intra-S DNA damage checkpoint [GO:0031573],NA,NA,NA
CHOYP_LOC100489929.1.1.m.51437,0.022513687,-0.008949064,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase inhibitor activity [GO:0008191]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100490321.2.2.m.54266,-0.009590919,0.009236984,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100490454.1.1.m.64455,-0.004320389,0.007105692,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]; pantetheine-phosphate adenylyltransferase activity [GO:0004595]; coenzyme A biosynthetic process [GO:0015937],NA,NA,NA
CHOYP_LOC100491753.1.3.m.45589,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100491886.1.1.m.26703,-0.023432022,0.006889799,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; pharyngeal pumping [GO:0043050]; pharynx development [GO:0060465],NA,NA,NA
CHOYP_LOC100492442.1.1.m.16466,-0.017065263,-0.009247536,No,NA,NA,NA,NA,NA,NA,cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; syntaxin binding [GO:0019905]; asymmetric cell division [GO:0008356]; centrosome cycle [GO:0007098]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; negative regulation of autophagy [GO:0010507]; negative regulation of protein binding [GO:0032091]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; spindle assembly involved in meiosis [GO:0090306],NA,NA,NA
CHOYP_LOC100492576.1.1.m.7775,0.019688465,-0.003284483,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; glucosidase II complex [GO:0017177]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; carbohydrate binding [GO:0030246]; glucan 1;3-alpha-glucosidase activity [GO:0033919]; RNA binding [GO:0003723]; carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491],NA,NA,NA
CHOYP_LOC100492683.1.1.m.63753,-0.000835599,-0.007355268,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100493179.5.15.m.32003,-0.008162032,-0.004316377,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100493440.1.2.m.17291,0.006410781,0.006643769,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100493600.1.1.m.58682,-0.016204483,2.25E-07,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; thymidylate kinase activity [GO:0004798]; UMP kinase activity [GO:0033862]; uridylate kinase activity [GO:0009041]; cellular response to lipopolysaccharide [GO:0071222]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142],NA,NA,NA
CHOYP_LOC100495846.1.1.m.11305,-0.017057601,0.007987891,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; base-excision repair [GO:0006284]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of neuron death [GO:1901215]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_LOC100496973.2.8.m.19997,0.00935527,0.020965729,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100496973.4.8.m.55256,-0.017266941,0.013670548,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC100497129.3.8.m.32060,-0.003816729,0.005500853,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC100497129.6.8.m.41866,-0.022527019,0.009925506,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC100497129.7.8.m.41875,0.020195055,-0.009178318,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC100498109.3.3.m.55841,-0.02256496,0.00998907,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100502592.1.1.m.27996,-0.022563231,0.009986001,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100524481.1.1.m.14740,0.013830919,0.016617934,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236],NA,NA,NA
CHOYP_LOC100533218.1.1.m.56993,-0.003314998,-0.018584284,No,NA,NA,NA,NA,NA,NA,cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; 3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; insulin receptor binding [GO:0005158]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase B activity [GO:0032148]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mast cell degranulation [GO:0043304]; type B pancreatic cell development [GO:0003323],NA,NA,NA
CHOYP_LOC100533220.2.2.m.13989,0.008682029,0.005839522,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anatomical structure development [GO:0048856]; astrocyte development [GO:0014002]; inner ear development [GO:0048839]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_LOC100533220.2.2.m.13990,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533220.2.2.m.13991,-0.011391912,0.002093745,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533225.1.2.m.36896,-0.000747587,-0.023757206,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cell projection [GO:0042995]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; neurotransmitter secretion [GO:0007269],NA,NA,NA
CHOYP_LOC100533245.3.6.m.31982,0.006463316,0.007326662,No,NA,NA,NA,NA,NA,NA,acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission; cholinergic [GO:0007271],NA,NA,NA
CHOYP_LOC100533245.3.6.m.31983,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission; cholinergic [GO:0007271],NA,NA,NA
CHOYP_LOC100533258.6.6.m.48142,0.023048556,-0.003329146,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533258.6.6.m.48143,0.023494384,-0.003403831,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533261.1.1.m.36141,0.001239956,-0.010441494,No,NA,NA,NA,NA,NA,NA,astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; antimicrobial humoral response [GO:0019730]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094],NA,NA,NA
CHOYP_LOC100533283.1.1.m.54357,0.018283526,0.003386228,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; neuron projection [GO:0043005]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683],NA,NA,NA
CHOYP_LOC100533284.1.2.m.25143,-0.013522408,-0.016365475,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; Schmidt-Lanterman incisure [GO:0043220]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cell-cell junction organization [GO:0045216]; cellular protein localization [GO:0034613]; cellular response to insulin stimulus [GO:0032869]; establishment of apical/basal cell polarity [GO:0035089]; eye photoreceptor cell development [GO:0042462]; Golgi vesicle budding [GO:0048194]; intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron apoptotic process [GO:0043524]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of glucose import [GO:0046326]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to interleukin-1 [GO:0070555]; response to peptide hormone [GO:0043434],NA,NA,NA
CHOYP_LOC100533289.6.6.m.59221,-0.011595833,-0.003710434,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_LOC100533290.1.1.m.9001,-0.013805695,0.010982613,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; site of DNA damage [GO:0090734]; DNA binding [GO:0003677]; NAD binding [GO:0051287]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; protein ADP-ribosylation [GO:0006471],NA,NA,NA
CHOYP_LOC100533291.4.7.m.29195,-0.021865424,-0.00025061,No,NA,NA,NA,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100533294.1.3.m.35108,0.007667855,-0.009093074,No,NA,NA,NA,NA,NA,NA,sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC100533294.2.3.m.36820,0.008524235,-0.002877055,No,NA,NA,NA,NA,NA,NA,sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC100533315.1.3.m.40003,-0.005207862,0.009899524,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; extracellularly glutamate-gated ion channel activity [GO:0005234]; ionotropic glutamate receptor activity [GO:0004970],NA,NA,NA
CHOYP_LOC100533316.2.2.m.47773,-0.001538257,0.007944666,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100533319.1.2.m.46,-0.002042432,-0.012696234,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431],NA,NA,NA
CHOYP_LOC100533325.1.1.m.55617,-0.007052637,-0.010353216,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485],NA,NA,NA
CHOYP_LOC100533330.1.2.m.2565,-0.015944886,0.004640227,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; endosome [GO:0005768]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cytoskeletal matrix organization at active zone [GO:0048789]; intracellular protein transport [GO:0006886]; maintenance of presynaptic active zone structure [GO:0048790]; neurotransmitter secretion [GO:0007269]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100533341.1.1.m.1846,-2.12E-05,-0.011912571,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; protein C-terminus binding [GO:0008022]; protein transporter activity [GO:0008565]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_LOC100533349.3.5.m.52212,0.006028954,-0.003094706,No,NA,NA,NA,NA,NA,NA,apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; SCAR complex [GO:0031209]; synapse [GO:0045202]; RNA 7-methylguanosine cap binding [GO:0000340]; axon guidance [GO:0007411]; cell adhesion mediated by integrin [GO:0033627]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; centripetally migrating follicle cell migration [GO:0060269]; chaeta development [GO:0022416]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of filopodium assembly [GO:0051491]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100533356.6.6.m.63561,-0.001042944,-0.014523727,No,NA,NA,NA,NA,NA,NA,cell-cell junction [GO:0005911]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; ion transmembrane transport [GO:0034220],NA,NA,NA
CHOYP_LOC100533357.1.2.m.56848,-0.007777543,0.008019527,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; phagocytic vesicle [GO:0045335]; actin filament binding [GO:0051015]; regulation of actin filament polymerization [GO:0030833]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC100533367.1.1.m.49626,-0.010746898,-0.015322843,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533383.1.2.m.10358,0.014579256,0.002881475,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100533384.3.5.m.37350,0.003658687,0.013815484,No,NA,NA,NA,NA,NA,NA,RNA binding [GO:0003723]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC100533384.5.5.m.59082,-0.015883651,0.011482896,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; RNA binding [GO:0003723]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC100533384.5.5.m.59083,-0.008174738,-0.016313563,No,NA,NA,NA,NA,NA,NA,translation initiation factor activity [GO:0003743],NA,NA,NA
CHOYP_LOC100533387.1.1.m.56131,0.000706479,-0.015641621,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; specific granule lumen [GO:0035580]; enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; apoptotic DNA fragmentation [GO:0006309]; astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; intracellular transport of virus [GO:0075733]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; modulation by virus of host process [GO:0019054]; neutrophil degranulation [GO:0043312]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; protein import into nucleus; translocation [GO:0000060]; Ran protein signal transduction [GO:0031291]; regulation of cholesterol biosynthetic process [GO:0045540]; ribosomal protein import into nucleus [GO:0006610],NA,NA,NA
CHOYP_LOC100533388.1.6.m.3716,0.009643491,-0.002173161,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533388.2.6.m.5374,0.02069973,-0.008159256,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533388.4.6.m.45039,0.007800695,0.01563758,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533388.6.6.m.45695,0.000104861,0.005612699,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533400.1.4.m.12300,-0.002856234,0.010537139,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100533400.3.4.m.28214,0.00287504,0.014455846,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100533411.1.1.m.37112,0.00450903,-0.003900157,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533437.1.2.m.4596,-0.008645093,0.018349981,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533444.1.1.m.33578,6.96E-05,0.020159763,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of Wnt signaling pathway [GO:0030178]; negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis [GO:2000057]; non-canonical Wnt signaling pathway [GO:0035567]; regulation of BMP signaling pathway [GO:0030510],NA,NA,NA
CHOYP_LOC100533447.1.3.m.37261,0.010778738,-0.016975952,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198],NA,NA,NA
CHOYP_LOC100533447.2.3.m.44497,-0.004909195,0.013444914,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; postsynaptic density [GO:0014069]; vesicle membrane [GO:0012506]; cytoskeletal adaptor activity [GO:0008093]; phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; receptor signaling complex scaffold activity [GO:0030159]; scaffold protein binding [GO:0097110]; SH3/SH2 adaptor activity [GO:0005070]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; dendritic spine development [GO:0060996]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; immunological synapse formation [GO:0001771]; lamellipodium assembly [GO:0030032]; negative regulation of cell proliferation [GO:0008285]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_LOC100533450.1.1.m.54334,-0.009639567,-0.017235806,No,NA,NA,NA,NA,NA,NA,neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; mRNA binding [GO:0003729]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_LOC100533455.1.9.m.3607,-0.008332987,-0.010106622,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826],NA,NA,NA
CHOYP_LOC100533521.2.2.m.52097,0.01457134,-0.003745244,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289],NA,NA,NA
CHOYP_LOC100533524.1.1.m.33932,-0.013326271,0.000305735,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; NAD+ binding [GO:0070403]; NAD-dependent protein deacetylase activity [GO:0034979]; protein-glutaryllysine deglutarylase activity [GO:0061697]; protein-malonyllysine demalonylase activity [GO:0036054]; protein-succinyllysine desuccinylase activity [GO:0036055]; zinc ion binding [GO:0008270]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; protein demalonylation [GO:0036046]; protein desuccinylation [GO:0036048]; regulation of ketone biosynthetic process [GO:0010566],NA,NA,NA
CHOYP_LOC100533528.2.2.m.26125,0.000556476,0.006693296,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC100533537.1.1.m.36,0.01184089,0.008083999,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; spliceosomal complex [GO:0005681]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of TOR signaling [GO:0032008]; regulation of postsynapse organization [GO:0099175]; regulation of TOR signaling [GO:0032006]; regulation of type B pancreatic cell development [GO:2000074]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_LOC100535066.1.2.m.15640,-0.007075923,0.001245059,No,NA,NA,NA,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_LOC100535716.2.3.m.39162,0.017939658,0.005686096,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100536597.1.1.m.52329,-0.009501042,-0.014951135,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA processing [GO:0008033],NA,NA,NA
CHOYP_LOC100537361.1.1.m.55516,-0.015434737,-0.006432473,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100538313.1.1.m.64152,0.02295875,-0.009889536,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC100538996.1.1.m.14935,-0.015487344,0.01360541,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA-templated transcription; initiation [GO:0006352],NA,NA,NA
CHOYP_LOC100539769.1.1.m.36990,0.008671979,0.008499752,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; signaling receptor binding [GO:0005102]; actin filament organization [GO:0007015]; female gamete generation [GO:0007292]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477],NA,NA,NA
CHOYP_LOC100540539.1.1.m.14519,0.013855907,-0.022107208,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; inner acrosomal membrane [GO:0002079]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; transport vesicle [GO:0030133]; transcription coactivator activity [GO:0003713]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; Golgi organization [GO:0007030]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary transport involved in cilium assembly [GO:0035735]; protein glycosylation [GO:0006486]; transcription by RNA polymerase II [GO:0006366]; ventricular septum development [GO:0003281],NA,NA,NA
CHOYP_LOC100541322.1.1.m.43256,0.009691942,0.01099552,No,NA,NA,NA,NA,NA,NA,cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Grb2-EGFR complex [GO:0070436]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; neurotrophin TRKA receptor binding [GO:0005168]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; SH3 domain binding [GO:0017124]; SH3/SH2 adaptor activity [GO:0005070]; aging [GO:0007568]; anatomical structure formation involved in morphogenesis [GO:0048646]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell differentiation [GO:0030154]; cellular response to ionizing radiation [GO:0071479]; insulin receptor signaling pathway [GO:0008286]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein heterooligomerization [GO:0051291]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; signal transduction in response to DNA damage [GO:0042770],NA,NA,NA
CHOYP_LOC100543236.1.2.m.20322,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; receptor tyrosine kinase binding [GO:0030971]; angiogenesis [GO:0001525],NA,NA,NA
CHOYP_LOC100543709.1.1.m.32086,0.001687722,0.002973704,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; synapse [GO:0045202]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100546924.1.2.m.34506,-0.015504111,-0.006833901,No,NA,NA,NA,NA,NA,NA,snRNA-activating protein complex [GO:0019185]; DNA binding [GO:0003677]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796],NA,NA,NA
CHOYP_LOC100547490.1.1.m.5822,0.014081211,-0.002705474,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100548534.1.1.m.26484,-0.022666178,0.010307852,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100548534.1.1.m.26485,-0.022662709,0.010352785,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; endopeptidase activity [GO:0004175]; enzyme binding [GO:0019899]; kinase binding [GO:0019900]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; labyrinthine layer blood vessel development [GO:0060716]; mononuclear cell migration [GO:0071674]; muscle cell cellular homeostasis [GO:0046716]; myoblast differentiation [GO:0045445]; proteolysis involved in cellular protein catabolic process [GO:0051603]; tissue regeneration [GO:0042246]; tissue remodeling [GO:0048771]; trans-synaptic signaling by BDNF; modulating synaptic transmission [GO:0099183]; trophoblast giant cell differentiation [GO:0060707],NA,NA,NA
CHOYP_LOC100549486.1.1.m.54965,-0.022570747,0.009999495,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; exocytosis [GO:0006887]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of insulin secretion [GO:0032024]; positive regulation of vesicle fusion [GO:0031340]; protein localization [GO:0008104],NA,NA,NA
CHOYP_LOC100552087.1.1.m.26238,-0.013376348,-0.006768915,No,NA,NA,NA,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; lactation [GO:0007595]; late viral transcription [GO:0019086]; lipid homeostasis [GO:0055088]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; regulation of transcription from RNA polymerase II promoter by glucose [GO:0000430]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC100552374.1.1.m.21979,-0.004756965,-0.011240759,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; aryl sulfotransferase activity [GO:0004062]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC100552730.1.1.m.18699,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; heart development [GO:0007507]; negative chemotaxis [GO:0050919]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neuron migration [GO:0001764]; outflow tract septum morphogenesis [GO:0003148]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649],NA,NA,NA
CHOYP_LOC100553519.1.1.m.20707,-0.015506005,-0.007815522,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; response to virus [GO:0009615]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_LOC100553663.1.1.m.58460,-0.00296226,0.010815409,No,NA,NA,NA,NA,NA,NA,lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; alpha-1;4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; maltose alpha-glucosidase activity [GO:0032450]; glycogen catabolic process [GO:0005980],NA,NA,NA
CHOYP_LOC100553687.1.1.m.61663,-0.007107395,-0.006945916,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227],NA,NA,NA
CHOYP_LOC100553809.1.1.m.45965,0.003130517,0.015960637,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100554313.1.1.m.20949,-0.015021884,-0.01703784,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; axon terminus [GO:0043679]; chromaffin granule membrane [GO:0042584]; cytosol [GO:0005829]; dendritic spine neck [GO:0044326]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; T-tubule [GO:0030315]; vesicle [GO:0031982]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; repressing transcription factor binding [GO:0070491]; calcium ion transport [GO:0006816]; cytoplasmic sequestering of transcription factor [GO:0042994]; heart development [GO:0007507]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of heart rate [GO:0010459]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of high voltage-gated calcium channel activity [GO:1901841]; regulation of relaxation of muscle [GO:1901077],NA,NA,NA
CHOYP_LOC100554450.1.1.m.66550,-0.006638681,-0.009315941,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_LOC100554578.1.2.m.7421,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100554670.1.1.m.4865,0.007147862,-0.008029671,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; mRNA binding [GO:0003729]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184],NA,NA,NA
CHOYP_LOC100555223.1.1.m.47612,0.00944645,0.013405271,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100555295.1.1.m.51356,-0.007363945,-0.010284008,No,NA,NA,NA,NA,NA,NA,autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; autophagy [GO:0006914]; protein localization to membrane [GO:0072657],NA,NA,NA
CHOYP_LOC100555755.1.1.m.58711,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],NA,NA,NA
CHOYP_LOC100555907.1.1.m.27452,-0.022212376,0.000144639,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100556034.2.2.m.15378,-0.003879819,0.00698682,No,NA,NA,NA,NA,NA,NA,5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100556517.1.1.m.22221,-0.012565133,0.012263031,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; circadian regulation of gene expression [GO:0032922]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_LOC100558815.1.1.m.30536,-0.003509468,0.004103078,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; positive regulation of exoribonuclease activity [GO:1901919]; regulation of transcription; DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_LOC100558843.1.1.m.14396,-0.010514832,-0.012884472,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; protein depalmitoylation [GO:0002084],NA,NA,NA
CHOYP_LOC100559879.1.1.m.8598,0.000426157,-0.017314548,No,NA,NA,NA,NA,NA,NA,transcriptional repressor complex [GO:0017053],NA,NA,NA
CHOYP_LOC100559941.1.2.m.12240,-0.001032372,-0.022565005,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; protein C-terminus binding [GO:0008022]; hematopoietic progenitor cell differentiation [GO:0002244],NA,NA,NA
CHOYP_LOC100560334.2.3.m.42997,0.014136631,0.0017533,No,NA,NA,NA,NA,NA,NA,acrosomal vesicle [GO:0001669]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; sperm connecting piece [GO:0097224]; binding of sperm to zona pellucida [GO:0007339],NA,NA,NA
CHOYP_LOC100560768.1.1.m.18804,-0.013979954,-0.004818783,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; PAM complex; Tim23 associated import motor [GO:0001405]; ATPase activator activity [GO:0001671]; protein import into mitochondrial matrix [GO:0030150],NA,NA,NA
CHOYP_LOC100561086.1.1.m.13015,-0.012838358,-0.018127819,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; oxidoreductase activity [GO:0016491]; cellular detoxification of aldehyde [GO:0110095],NA,NA,NA
CHOYP_LOC100561262.1.1.m.16846,-0.015204623,-0.013605198,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; glutathione binding [GO:0043295]; glutathione-disulfide reductase activity [GO:0004362]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100561410.1.1.m.58687,-0.003395398,-0.009449713,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; cholesterol homeostasis [GO:0042632]; neutrophil degranulation [GO:0043312]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_LOC100561810.1.1.m.8656,-0.004846888,-0.024837456,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; carnosine N-methyltransferase activity [GO:0030735]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; carnosine metabolic process [GO:0035498],NA,NA,NA
CHOYP_LOC100561894.1.1.m.45814,-0.019741263,0.01079551,No,NA,NA,NA,NA,NA,NA,chromaffin granule membrane [GO:0042584]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to salt stress [GO:0009651]; social behavior [GO:0035176],NA,NA,NA
CHOYP_LOC100562697.1.1.m.27375,-0.001203577,0.019870396,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_LOC100562954.1.1.m.27429,-0.00096981,0.001070851,No,NA,NA,NA,NA,NA,NA,cell leading edge [GO:0031252]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of synaptic membrane [GO:0099699]; integrin alphav-beta5 complex [GO:0034684]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_LOC100563402.1.1.m.5257,0.001156654,0.000912311,No,NA,NA,NA,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_LOC100563554.1.1.m.49953,0.010577318,-0.005755857,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; calcium ion binding [GO:0005509]; calcium:proton antiporter activity [GO:0015369]; ribosome binding [GO:0043022]; calcium export from the mitochondrion [GO:0099093]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_LOC100563867.1.1.m.11836,0.011253362,0.004948166,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100563952.1.1.m.30232,0.00908761,0.022880142,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_LOC100564140.2.2.m.10031,0.000100971,-0.012535077,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_LOC100564354.1.1.m.46361,0.004623304,-0.003452064,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457],NA,NA,NA
CHOYP_LOC100564832.1.1.m.43026,-0.002643288,0.011236205,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; aryl sulfotransferase activity [GO:0004062]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC100565366.1.1.m.49990,0.012468794,-0.0101264,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833],NA,NA,NA
CHOYP_LOC100565534.1.3.m.28075,-0.019230073,-0.012650947,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; spindle pole body organization [GO:0051300],NA,NA,NA
CHOYP_LOC100565534.2.3.m.29570,-0.003469967,-0.014315125,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100566943.1.2.m.35349,-0.003286755,-0.01364267,No,NA,NA,NA,NA,NA,NA,apical cortex [GO:0045179]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; fatty acid binding [GO:0005504]; long-chain fatty acid binding [GO:0036041]; long-chain fatty acid transporter activity [GO:0005324]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; intestinal absorption [GO:0050892]; long-chain fatty acid transport [GO:0015909],NA,NA,NA
CHOYP_LOC100566968.1.1.m.15268,0.008557614,0.005678723,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-protein binding [GO:0017147]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC100567114.1.1.m.39091,0.022034492,-0.011708955,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; response to cytokine [GO:0034097],NA,NA,NA
CHOYP_LOC100567407.1.1.m.8503,-0.005594994,0.002637685,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100567969.1.1.m.26460,-0.009730971,0.010424095,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; tau protein binding [GO:0048156]; mitotic cell cycle [GO:0000278]; peptidyl-serine dephosphorylation [GO:0070262]; response to morphine [GO:0043278],NA,NA,NA
CHOYP_LOC100568234.1.1.m.60837,0.009869314,-0.001060031,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; cupric ion binding [GO:1903135]; Formylglycine-generating oxidase activity [GO:0120147]; protein homodimerization activity [GO:0042803]; post-translational protein modification [GO:0043687]; protein oxidation [GO:0018158],NA,NA,NA
CHOYP_LOC100571875.1.1.m.48861,-0.010447299,0.003511372,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; L-cysteine desulfurase complex [GO:1990221]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; iron chaperone activity [GO:0034986]; adult walking behavior [GO:0007628]; aerobic respiration [GO:0009060]; cellular iron ion homeostasis [GO:0006879]; cellular response to hydrogen peroxide [GO:0070301]; embryo development ending in birth or egg hatching [GO:0009792]; heme biosynthetic process [GO:0006783]; ion transport [GO:0006811]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of organ growth [GO:0046621]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; oxidative phosphorylation [GO:0006119]; positive regulation of aconitate hydratase activity [GO:1904234]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; positive regulation of lyase activity [GO:0051349]; positive regulation of succinate dehydrogenase activity [GO:1904231]; proprioception [GO:0019230]; protein autoprocessing [GO:0016540]; regulation of ferrochelatase activity [GO:0010722]; response to iron ion [GO:0010039]; small molecule metabolic process [GO:0044281],NA,NA,NA
CHOYP_LOC100575377.1.10.m.10592,-0.00476977,-0.011224009,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100576447.2.2.m.55515,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; photoreceptor inner segment [GO:0001917]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100577801.1.1.m.7007,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]; amnioserosa maintenance [GO:0046665]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; dorsal closure; leading edge cell fate determination [GO:0007393]; ectoderm development [GO:0007398]; germ-band shortening [GO:0007390]; head involution [GO:0008258]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; larval lymph gland hemopoiesis [GO:0035167]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; lymph gland plasmatocyte differentiation [GO:0035169]; negative regulation of cell fate specification [GO:0009996]; negative regulation of crystal cell differentiation [GO:0042690]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pigment metabolic process [GO:0042440]; regulation of antimicrobial peptide biosynthetic process [GO:0002805]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100617548.1.1.m.64248,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100618341.1.1.m.42477,-0.000728252,0.002336749,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; axonal fasciculation [GO:0007413]; neuron cell-cell adhesion [GO:0007158]; sensory perception of smell [GO:0007608],NA,NA,NA
CHOYP_LOC100619435.1.2.m.28884,-0.000643014,-0.018043455,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; PAM complex; Tim23 associated import motor [GO:0001405]; adenyl-nucleotide exchange factor activity [GO:0000774]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; protein homodimerization activity [GO:0042803]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150],NA,NA,NA
CHOYP_LOC100631809.1.2.m.30895,-0.013085751,0.015570239,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325],NA,NA,NA
CHOYP_LOC100632370.1.1.m.25156,-0.006197534,-0.014285055,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; metal ion binding [GO:0046872]; xylose isomerase activity [GO:0009045]; D-xylose metabolic process [GO:0042732],NA,NA,NA
CHOYP_LOC100632618.1.3.m.23426,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; histone H3-K9 acetylation [GO:0043970],NA,NA,NA
CHOYP_LOC100632618.2.3.m.30752,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; histone H3-K9 acetylation [GO:0043970],NA,NA,NA
CHOYP_LOC100632738.1.1.m.4911,-0.004558453,0.014475718,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_LOC100632832.1.1.m.45608,-0.01380593,-0.014984946,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; filamentous actin [GO:0031941]; microvillus [GO:0005902]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; actin filament binding [GO:0051015]; SH3 domain binding [GO:0017124]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; locomotory behavior [GO:0007626]; negative regulation of cytoskeleton organization [GO:0051494]; parallel actin filament bundle assembly [GO:0030046]; positive regulation of filopodium assembly [GO:0051491]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_LOC100633041.1.1.m.35428,0.007686882,-0.021492506,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; NADPH regeneration [GO:0006740]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; oxidation-reduction process [GO:0055114]; oxygen homeostasis [GO:0032364]; positive regulation of hydrogen peroxide catabolic process [GO:1903285]; positive regulation of mitochondrial membrane potential [GO:0010918]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; response to vitamin [GO:0033273]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC100633059.1.1.m.20098,-0.004810328,0.02247967,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100633075.1.4.m.4467,0.006462366,0.007321068,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100633077.1.4.m.4444,-0.001367233,-0.002698245,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; protein-disulfide reductase activity [GO:0047134]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100633077.4.4.m.62658,0.004447955,0.018192869,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; protein-disulfide reductase activity [GO:0047134]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100634021.1.1.m.53536,-0.007177632,0.002552188,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861],NA,NA,NA
CHOYP_LOC100634556.1.1.m.45015,0.009458839,-0.008504866,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_LOC100634688.3.6.m.36725,0.009937832,0.013585871,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; cilium assembly [GO:0060271]; immune system development [GO:0002520]; response to UV [GO:0009411]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_LOC100634688.6.6.m.63689,-0.009725341,-0.014785737,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; cilium assembly [GO:0060271]; immune system development [GO:0002520]; response to UV [GO:0009411]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_LOC100634891.1.1.m.11488,-0.005459645,-0.017459018,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; synaptonemal complex [GO:0000795]; Hsp90 protein binding [GO:0051879]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; piRNA metabolic process [GO:0034587]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100635182.1.1.m.5368,0.012045536,0.008556928,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100635245.3.4.m.44747,0.007809338,0.015689409,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; transport vesicle membrane [GO:0030658]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; exocytosis [GO:0006887]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_LOC100635352.1.1.m.9481,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; negative regulation of transcription by RNA polymerase II [GO:0000122]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100635487.1.1.m.21915,0.010240788,0.000974308,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; chitin binding [GO:0008061]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100635694.1.1.m.24761,-0.012689301,-0.020590788,No,NA,NA,NA,NA,NA,NA,actin filament [GO:0005884]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hormone stimulus [GO:0032870]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; cellular response to morphine [GO:0071315]; cerebellum development [GO:0021549]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell proliferation [GO:0048662]; phagocytosis; engulfment [GO:0006911]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of muscle hyperplasia [GO:0014739]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; Rac protein signal transduction [GO:0016601]; response to axon injury [GO:0048678]; response to electrical stimulus [GO:0051602]; response to glucocorticoid [GO:0051384]; ruffle assembly [GO:0097178],NA,NA,NA
CHOYP_LOC100635715.2.9.m.8040,0.017606549,-0.001535397,No,NA,NA,NA,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; chromosome condensation [GO:0030261]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100636110.1.2.m.5041,0.006007844,-0.000323267,No,NA,NA,NA,NA,NA,NA,mannosyl-oligosaccharide glucosidase activity [GO:0004573]; oligosaccharide metabolic process [GO:0009311],NA,NA,NA
CHOYP_LOC100636340.1.4.m.5143,-0.003115914,-0.020926015,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100636340.3.4.m.44279,0.011617709,-0.019202563,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100636340.4.4.m.50991,0.006180314,0.001088244,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100636433.3.4.m.27077,0.021083829,0.003561149,No,NA,NA,NA,NA,NA,NA,extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC100636493.1.1.m.65727,0.019417963,-0.017906227,No,NA,NA,NA,NA,NA,NA,apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],NA,NA,NA
CHOYP_LOC100636568.1.1.m.16013,-0.010630088,0.009245693,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; arginine metabolic process [GO:0006525]; compound eye pigmentation [GO:0048072]; determination of adult lifespan [GO:0008340]; glycerophospholipid metabolic process [GO:0006650]; purine nucleobase metabolic process [GO:0006144]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ethanol [GO:0045471]; tryptophan metabolic process [GO:0006568]; xanthine catabolic process [GO:0009115],NA,NA,NA
CHOYP_LOC100636813.1.1.m.19517,-0.012615438,0.004177589,No,NA,NA,NA,NA,NA,NA,DNA binding [GO:0003677]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100637812.1.1.m.1303,-0.007274087,0.024210058,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100637925.1.4.m.34491,0.009540469,0.006319887,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583],NA,NA,NA
CHOYP_LOC100637925.3.4.m.48236,0.007168761,0.006875836,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100638337.1.1.m.19693,0.012508399,0.009322226,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100638372.1.1.m.60468,-0.006766784,0.002170011,No,NA,NA,NA,NA,NA,NA,COPII vesicle coat [GO:0030127]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; zinc ion binding [GO:0008270]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100638431.10.10.m.59513,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,hydrolase activity; acting on glycosyl bonds [GO:0016798]; metabolic process [GO:0008152],NA,NA,NA
CHOYP_LOC100638431.3.10.m.24462,-0.013239801,-0.006080556,No,NA,NA,NA,NA,NA,NA,hydrolase activity; acting on glycosyl bonds [GO:0016798]; metabolic process [GO:0008152],NA,NA,NA
CHOYP_LOC100638431.4.10.m.48496,-0.002420812,-0.000927264,No,NA,NA,NA,NA,NA,NA,hydrolase activity; acting on glycosyl bonds [GO:0016798]; metabolic process [GO:0008152],NA,NA,NA
CHOYP_LOC100638431.8.10.m.58430,-0.004590267,0.005364919,No,NA,NA,NA,NA,NA,NA,hydrolase activity; acting on glycosyl bonds [GO:0016798]; metabolic process [GO:0008152],NA,NA,NA
CHOYP_LOC100638860.2.2.m.44785,-0.004725213,0.015207723,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100638885.1.4.m.28187,-0.014944905,-0.002455876,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; apoptotic process [GO:0006915]; erythrocyte differentiation [GO:0030218]; keratinocyte differentiation [GO:0030216]; neuron differentiation [GO:0030182]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100639369.1.1.m.23669,-0.000782034,0.010961691,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100639574.1.1.m.40201,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100639626.1.1.m.61641,0.006330158,-0.001959098,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100639879.1.1.m.38832,0.010359119,0.005696111,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100640001.1.2.m.37241,0.014075312,0.008134384,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100640001.2.2.m.62667,0.014723253,0.01456447,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100640206.1.1.m.48266,0.004109012,-0.018834107,No,NA,NA,NA,NA,NA,NA,endosome [GO:0005768]; protein transporter activity [GO:0008565]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_LOC100640260.1.2.m.21931,-0.022531417,0.01055364,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100640618.1.1.m.4378,0.02187768,-0.005732074,No,NA,NA,NA,NA,NA,NA,dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100641267.1.2.m.49206,-0.00917181,-0.004368813,No,NA,NA,NA,NA,NA,NA,iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; antibiotic biosynthetic process [GO:0017000]; antibiotic metabolic process [GO:0016999],NA,NA,NA
CHOYP_LOC100641267.2.2.m.57947,-0.010995045,0.014954266,No,NA,NA,NA,NA,NA,NA,iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; antibiotic biosynthetic process [GO:0017000]; antibiotic metabolic process [GO:0016999],NA,NA,NA
CHOYP_LOC100641892.1.1.m.56601,0.010586142,0.000296515,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; spermidine synthase activity [GO:0004766]; cellular response to leukemia inhibitory factor [GO:1990830]; polyamine biosynthetic process [GO:0006596]; polyamine metabolic process [GO:0006595]; spermidine biosynthetic process [GO:0008295],NA,NA,NA
CHOYP_LOC100641969.1.1.m.7196,0.01613299,-0.007285364,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100642024.1.2.m.38402,-0.005199147,0.022854601,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; actin filament capping [GO:0051693],NA,NA,NA
CHOYP_LOC100642349.1.1.m.53035,0.010801774,-0.01378295,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_LOC100642494.1.1.m.58088,0.00424667,-0.013314807,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; mitochondrial electron transport; cytochrome c to oxygen [GO:0006123]; mitochondrial protein catabolic process [GO:0035694]; mitochondrion organization [GO:0007005],NA,NA,NA
CHOYP_LOC100642680.1.1.m.6611,-0.018176156,-0.011122917,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100642881.1.1.m.14183,0.000714568,-0.002392177,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; [pyruvate dehydrogenase (lipoamide)] phosphatase activity [GO:0004741]; oxidoreductase activity [GO:0016491]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510],NA,NA,NA
CHOYP_LOC100642891.1.1.m.25638,0.007718542,-0.01731074,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; proton-transporting ATP synthase complex assembly [GO:0043461],NA,NA,NA
CHOYP_LOC100642891.1.1.m.25639,-0.004460229,-0.01877216,No,NA,NA,NA,NA,NA,NA,ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_LOC100642984.1.1.m.28915,0.005608758,-0.003744701,No,NA,NA,NA,NA,NA,NA,anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990],NA,NA,NA
CHOYP_LOC100643070.1.1.m.40176,-0.008436934,-0.004736404,No,NA,NA,NA,NA,NA,NA,calcium channel complex [GO:0034704]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; multicellular organism development [GO:0007275]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347],NA,NA,NA
CHOYP_LOC100644321.3.7.m.24037,0.004266423,0.003179192,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266],NA,NA,NA
CHOYP_LOC100644321.6.7.m.56495,-0.005606446,-0.007032588,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266],NA,NA,NA
CHOYP_LOC100644613.1.1.m.55011,0.005405893,-0.010228095,No,NA,NA,NA,NA,NA,NA,dimethylhistidine N-methyltransferase activity [GO:0030745]; protein methyltransferase activity [GO:0008276]; ergothioneine biosynthesis from histidine via N-alpha;N-alpha;N-alpha-trimethyl-L-histidine [GO:0052704]; N-alpha;N-alpha;N-alpha-trimethyl-L-histidine biosynthesis from histidine [GO:0052707],NA,NA,NA
CHOYP_LOC100644701.2.2.m.54959,-0.009091741,-0.001795993,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; negative regulation of mitotic cell cycle [GO:0045930]; respiratory tube development [GO:0030323],NA,NA,NA
CHOYP_LOC100644701.2.2.m.54960,-0.003281777,-0.004274366,No,NA,NA,NA,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; secretory granule [GO:0030141]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_LOC100645183.1.1.m.53488,1.30E-05,-0.015005105,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatase regulator activity [GO:0019208]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_LOC100645380.1.1.m.14246,0.022988168,0.003275468,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal recognition particle binding [GO:0005047]; protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614],NA,NA,NA
CHOYP_LOC100645450.1.1.m.39898,0.010283617,0.000860015,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; hyalurononglucosaminidase activity [GO:0004415]; glycoprotein catabolic process [GO:0006516]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; protein deglycosylation [GO:0006517]; protein O-linked glycosylation [GO:0006493]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100645706.1.1.m.62733,-0.002363861,-0.025133862,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; endocytosis [GO:0006897]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100646524.1.1.m.44445,0.004137219,-0.009688734,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100646535.1.1.m.61774,-0.003861108,-0.009901939,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; protein kinase A binding [GO:0051018]; compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; short-term memory [GO:0007614],NA,NA,NA
CHOYP_LOC100646574.1.1.m.55144,0.017918875,-0.005905978,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; synaptic vesicle membrane [GO:0030672]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; apoptotic mitochondrial changes [GO:0008637]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; peroxisome fission [GO:0016559]; protein complex oligomerization [GO:0051259]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of mitochondrion organization [GO:0010821],NA,NA,NA
CHOYP_LOC100646810.1.1.m.25033,0.006498814,-0.00968542,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; type III intermediate filament [GO:0045098]; identical protein binding [GO:0042802]; uridine phosphorylase activity [GO:0004850]; nucleoside metabolic process [GO:0009116]; nucleotide catabolic process [GO:0009166]; pyrimidine nucleoside catabolic process [GO:0046135]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; uridine metabolic process [GO:0046108],NA,NA,NA
CHOYP_LOC100647135.1.2.m.21531,-0.012670198,0.010050631,No,NA,NA,NA,NA,NA,NA,voltage-gated calcium channel complex [GO:0005891]; calcium ion binding [GO:0005509]; voltage-gated calcium channel activity [GO:0005245]; regulation of ion transmembrane transport [GO:0034765],NA,NA,NA
CHOYP_LOC100647521.2.2.m.59908,0.001048836,0.019675407,No,NA,NA,NA,NA,NA,NA,integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; palmitoleoyltransferase activity [GO:1990698]; carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; circadian rhythm [GO:0007623]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; glucose metabolic process [GO:0006006]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; protein homooligomerization [GO:0051260]; regulation of insulin secretion [GO:0050796]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; triglyceride metabolic process [GO:0006641],NA,NA,NA
CHOYP_LOC100647948.1.1.m.9650,0.00605257,-0.025837185,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cytoplasmic microtubule organization [GO:0031122]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100648051.2.2.m.61174,-0.003329679,-0.01290556,No,NA,NA,NA,NA,NA,NA,plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase; V1 domain [GO:0000221]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; determination of adult lifespan [GO:0008340]; dsRNA transport [GO:0033227],NA,NA,NA
CHOYP_LOC100648516.1.1.m.64902,0.021532522,-0.001264255,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793],NA,NA,NA
CHOYP_LOC100649130.1.1.m.58207,0.021504326,0.012464942,No,NA,NA,NA,NA,NA,NA,actomyosin contractile ring [GO:0005826]; apical cortex [GO:0045179]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; unconventional myosin complex [GO:0016461]; Z disc [GO:0030018]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATPase activity; coupled [GO:0042623]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure; amnioserosa morphology change [GO:0046664]; dorsal closure; leading edge cell differentiation [GO:0046663]; dorsal closure; spreading of leading edge cells [GO:0007395]; establishment of neuroblast polarity [GO:0045200]; establishment of planar polarity [GO:0001736]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; ommatidial rotation [GO:0016318]; ovarian follicle cell migration [GO:0007297]; positive regulation of border follicle cell migration [GO:1903688]; protein complex oligomerization [GO:0051259]; regulation of myoblast fusion [GO:1901739]; regulation of tube length; open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis; open tracheal system [GO:0035277]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100649205.1.1.m.39938,-0.012559358,0.020095616,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; histone exchange [GO:0043486]; regulation of histone deacetylation [GO:0031063],NA,NA,NA
CHOYP_LOC100649375.1.1.m.21222,0.004414323,-0.00484184,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100650469.1.2.m.42139,-0.012813431,-0.017580378,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; activation of protein kinase activity [GO:0032147]; chemical synaptic transmission [GO:0007268]; dendrite morphogenesis [GO:0048813]; MAPK cascade [GO:0000165]; multicellular organism development [GO:0007275]; negative thymic T cell selection [GO:0045060]; neuron cellular homeostasis [GO:0070050]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of AMPA receptor activity [GO:2000311]; regulation of cell migration [GO:0030334]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell-matrix adhesion [GO:0001952]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100650552.1.1.m.44153,-0.00197764,-0.021480895,No,NA,NA,NA,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100650613.1.1.m.10270,0.003549173,0.000110128,No,NA,NA,NA,NA,NA,NA,anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990],NA,NA,NA
CHOYP_LOC100650648.1.2.m.24726,0.003841271,-0.012530061,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; molting cycle process [GO:0022404]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_LOC100650709.1.1.m.12958,-0.011594682,-0.003711722,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100651274.1.1.m.26220,-0.008952872,0.002778271,No,NA,NA,NA,NA,NA,NA,nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; N-acetyltransferase activity [GO:0008080]; nuclear receptor binding [GO:0016922]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription; DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; nucleosome disassembly [GO:0006337],NA,NA,NA
CHOYP_LOC100651327.1.1.m.34619,-0.003282738,0.009004093,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; axon choice point recognition [GO:0016198]; axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; developmental pigmentation [GO:0048066]; habenula development [GO:0021986]; neuromuscular process [GO:0050905]; regulation of axon guidance [GO:1902667]; regulation of pteridine metabolic process [GO:0042068]; retinal ganglion cell axon guidance [GO:0031290],NA,NA,NA
CHOYP_LOC100651687.1.1.m.39884,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; actin cytoskeleton organization [GO:0030036]; protein dephosphorylation [GO:0006470]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of lamellipodium assembly [GO:0010591],NA,NA,NA
CHOYP_LOC100653683.1.1.m.7478,-0.013266323,-0.005144675,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100655005.1.1.m.51334,-0.008505326,-0.004287304,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; blastocyst growth [GO:0001832]; inner cell mass cell proliferation [GO:0001833]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; snRNA processing [GO:0016180]; U2 snRNA 3'-end processing [GO:0034474],NA,NA,NA
CHOYP_LOC100656236.1.1.m.27240,0.004823371,0.013657109,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; adaptive immune response [GO:0002250]; endocytosis [GO:0006897]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC100658481.1.1.m.8712,0.00589176,-0.008722644,No,NA,NA,NA,NA,NA,NA,box C/D snoRNP complex [GO:0031428]; box H/ACA snoRNP complex [GO:0031429]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; box C/D snoRNA binding [GO:0034512]; box C/D snoRNP complex binding [GO:0062064]; box H/ACA snoRNA binding [GO:0034513]; box H/ACA snoRNP complex binding [GO:0062065]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; GTP binding [GO:0005525]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; RNA polymerase I core binding [GO:0001042]; transcription factor binding [GO:0008134]; box H/ACA snoRNA metabolic process [GO:0033979]; mitotic cell cycle [GO:0000278]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; nucleolus organization [GO:0007000]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; regulation of translation [GO:0006417]; response to osmotic stress [GO:0006970]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100659825.1.1.m.62706,-0.006452068,-0.005064129,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; kinetochore [GO:0000776]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TRAPP complex [GO:0030008]; endopeptidase activity [GO:0004175]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; metaphase plate congression [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342]; protein complex oligomerization [GO:0051259]; regulation of kinetochore assembly [GO:0090234],NA,NA,NA
CHOYP_LOC100668913.1.1.m.6819,-0.003880524,0.002309336,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; cell maturation [GO:0048469]; chemokine (C-C motif) ligand 5 production [GO:0071609]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; interleukin-15 production [GO:0032618]; natural killer cell differentiation [GO:0001779]; negative regulation of interleukin-17 production [GO:0032700]; neutrophil mediated killing of gram-negative bacterium [GO:0070945]; phagocytosis [GO:0006909]; positive regulation of interleukin-10 production [GO:0032733]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to defense-related host reactive oxygen species production [GO:0052567],NA,NA,NA
CHOYP_LOC100669963.1.1.m.57300,0.00840012,-0.014738331,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial nucleoid [GO:0042645]; nuclear envelope [GO:0005635]; organelle membrane [GO:0031090],NA,NA,NA
CHOYP_LOC100670231.1.1.m.6369,0.002496203,0.005551953,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; fucose metabolic process [GO:0006004]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_LOC100672555.1.1.m.15827,-0.016846731,-0.00415045,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; dynein complex binding [GO:0070840]; cilium assembly [GO:0060271]; motile cilium assembly [GO:0044458],NA,NA,NA
CHOYP_LOC100677972.1.1.m.12181,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; T-tubule [GO:0030315]; calcium channel inhibitor activity [GO:0019855]; zinc ion transmembrane transporter activity [GO:0005385]; cadmium ion transmembrane transport [GO:0070574]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular zinc ion homeostasis [GO:0006882]; detoxification of cadmium ion [GO:0071585]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion import [GO:0090281]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of zinc ion transmembrane import [GO:0071584]; zinc ion transport [GO:0006829],NA,NA,NA
CHOYP_LOC100678100.1.1.m.14602,-0.011913875,-0.016308732,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; DNA binding [GO:0003677]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100678410.1.1.m.16114,-0.012844991,-0.014933952,No,NA,NA,NA,NA,NA,NA,autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; regulation of autophagosome maturation [GO:1901096],NA,NA,NA
CHOYP_LOC100679233.1.1.m.21455,-0.00982936,0.012083345,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100679608.1.3.m.1597,-0.00130835,0.00783862,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100679620.1.1.m.66367,-0.011535001,-0.013482855,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; mitochondrial respiratory chain complex I assembly [GO:0032981],NA,NA,NA
CHOYP_LOC100680210.1.1.m.5750,0.010445601,0.006388428,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA cis splicing; via spliceosome [GO:0045292]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100681683.1.1.m.60729,-0.007354364,0.005625504,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100689951.1.1.m.56514,0.01193894,-0.009345432,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]; 2-oxoglutarate metabolic process [GO:0006103]; histone succinylation [GO:0106077]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC100690782.1.1.m.26094,0.006496313,-0.012068455,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; 3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]; valine catabolic process [GO:0006574],NA,NA,NA
CHOYP_LOC100690874.1.2.m.62880,0.007863954,0.001097642,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; carboxylic acid binding [GO:0031406]; cofactor binding [GO:0048037]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; phytanoyl-CoA dioxygenase activity [GO:0048244]; 2-oxoglutarate metabolic process [GO:0006103]; fatty acid alpha-oxidation [GO:0001561]; isoprenoid metabolic process [GO:0006720]; methyl-branched fatty acid metabolic process [GO:0097089]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_LOC100691034.1.2.m.10976,-0.003571638,-0.00142352,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; nucleolus [GO:0005730]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; apoptotic process [GO:0006915]; lipid catabolic process [GO:0016042]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100691144.1.1.m.47006,0.010498096,0.010114204,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; alcohol dehydrogenase (NAD) activity [GO:0004022]; hydroxyacid-oxoacid transhydrogenase activity [GO:0047988]; metal ion binding [GO:0046872]; glutamate catabolic process via 2-oxoglutarate [GO:0006539],NA,NA,NA
CHOYP_LOC100691455.1.1.m.3282,0.011826738,0.015465335,No,NA,NA,NA,NA,NA,NA,AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; extracellular space [GO:0005615]; synapse [GO:0045202]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of neuron differentiation [GO:0045666],NA,NA,NA
CHOYP_LOC100691486.1.1.m.24964,0.00781324,0.015713086,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; acyl-CoA metabolic process [GO:0006637],NA,NA,NA
CHOYP_LOC100691486.1.1.m.24965,-0.003716523,-0.00369539,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100691601.2.2.m.40748,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chloride transmembrane transporter activity [GO:0015108]; cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; chloride transmembrane transport [GO:1902476]; cysteine transport [GO:0042883]; D-aspartate import across plasma membrane [GO:0070779]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813],NA,NA,NA
CHOYP_LOC100691676.1.1.m.64226,-0.004860915,0.014911033,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular [GO:0005622]; nucleus [GO:0005634]; 8-oxo-dGDP phosphatase activity [GO:0044715]; ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; snoRNA binding [GO:0030515]; ATP generation from poly-ADP-D-ribose [GO:1990966]; chromatin remodeling [GO:0006338]; D-ribose catabolic process [GO:0019303]; nucleobase-containing small molecule catabolic process [GO:0034656]; nucleoside phosphate metabolic process [GO:0006753]; nucleotide metabolic process [GO:0009117]; ribonucleoside diphosphate catabolic process [GO:0009191]; ribose phosphate metabolic process [GO:0019693],NA,NA,NA
CHOYP_LOC100692139.1.1.m.27787,-0.013073606,-0.008992899,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; 2 iron; 2 sulfur cluster binding [GO:0051537]; ferrochelatase activity [GO:0004325]; metal ion binding [GO:0046872]; heme biosynthetic process [GO:0006783],NA,NA,NA
CHOYP_LOC100692402.2.2.m.49856,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097],NA,NA,NA
CHOYP_LOC100692418.1.1.m.55157,-0.016666907,-0.005507878,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; branched-chain amino acid catabolic process [GO:0009083]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_LOC100692418.1.1.m.55158,-0.006426763,-0.008193814,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_LOC100692795.2.2.m.50682,0.013186278,0.010703468,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100692883.1.1.m.5437,0.00912384,-0.01714639,No,NA,NA,NA,NA,NA,NA,extracellular matrix [GO:0031012]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_LOC100692894.1.1.m.10137,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; citrate transmembrane transporter activity [GO:0015137]; high-affinity sodium:dicarboxylate symporter activity [GO:0015362]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; citrate transport [GO:0015746],NA,NA,NA
CHOYP_LOC100693418.1.2.m.990,-0.018331121,-0.002196361,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; cytidine deaminase activity [GO:0004126]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; cytidine deamination [GO:0009972]; negative regulation of cell growth [GO:0030308]; negative regulation of nucleotide metabolic process [GO:0045980]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_LOC100693418.2.2.m.56971,-0.010658062,-0.006856603,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]; cytidine deaminase activity [GO:0004126]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; cell surface receptor signaling pathway [GO:0007166]; cytidine deamination [GO:0009972]; cytosine metabolic process [GO:0019858]; negative regulation of cell growth [GO:0030308]; negative regulation of nucleotide metabolic process [GO:0045980]; neutrophil degranulation [GO:0043312]; protein homotetramerization [GO:0051289]; pyrimidine nucleoside salvage [GO:0043097]; pyrimidine-containing compound salvage [GO:0008655],NA,NA,NA
CHOYP_LOC100693575.1.1.m.19082,-0.008596846,0.011490203,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; fibrillar center [GO:0001650]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA polyadenylation [GO:0006378],NA,NA,NA
CHOYP_LOC100693708.1.1.m.7688,-0.001955463,-0.017344475,No,NA,NA,NA,NA,NA,NA,extrinsic component of mitochondrial inner membrane [GO:0031314]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphorylation [GO:0016310]; protein phosphorylation [GO:0006468]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_LOC100693867.1.1.m.27278,0.01133177,-0.00553121,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623]; UDP-glucose catabolic process [GO:0006258]; UDP-glucose metabolic process [GO:0006011],NA,NA,NA
CHOYP_LOC100694272.1.1.m.19247,-0.010285329,-0.008170685,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; B cell activation [GO:0042113]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of microtubule-based movement [GO:0060632]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100694623.1.1.m.14876,0.007876933,0.010557033,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cellular response to drug [GO:0035690]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of stress fiber assembly [GO:0051496],NA,NA,NA
CHOYP_LOC100694648.1.1.m.18881,0.002947625,-0.017740738,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; ATPase activity [GO:0016887]; defense response to virus [GO:0051607],NA,NA,NA
CHOYP_LOC100694901.3.3.m.66949,-0.010427088,-0.007877431,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; prefoldin complex [GO:0016272]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082],NA,NA,NA
CHOYP_LOC100695151.2.2.m.30573,0.018463341,-0.01228236,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100695307.1.1.m.51209,-0.010777973,-0.005441751,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; catalytic activity [GO:0003824],NA,NA,NA
CHOYP_LOC100695438.1.1.m.8594,0.006447669,0.006873157,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; gland morphogenesis [GO:0022612]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; organ growth [GO:0035265]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland growth [GO:0060736]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_LOC100696358.1.1.m.27370,-0.005476854,0.005984832,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100696604.1.1.m.40638,0.006118925,0.00283759,No,NA,NA,NA,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; P-body [GO:0000932]; postsynapse [GO:0098794]; RNA binding [GO:0003723]; negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003],NA,NA,NA
CHOYP_LOC100696668.1.1.m.31105,-0.021702956,0.004329331,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100696985.1.1.m.17599,0.005559299,0.014646619,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; regulation of DNA-templated transcription; elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; viral genome replication [GO:0019079],NA,NA,NA
CHOYP_LOC100697247.1.2.m.37588,0.011896998,-0.002333593,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100697247.2.2.m.56896,0.002348107,-0.018041443,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100697720.1.2.m.5790,0.004506946,-0.003912442,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100697793.5.6.m.62286,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100697862.1.1.m.27738,-0.016728246,-0.014369756,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO:0003948]; peptidase activity [GO:0008233],NA,NA,NA
CHOYP_LOC100698013.1.1.m.5420,-0.013837403,0.006119286,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100698240.2.4.m.14964,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; Cul3-RING ubiquitin ligase complex [GO:0031463]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100698638.1.1.m.45171,0.003126629,-0.012839486,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; nuclear membrane [GO:0031965]; carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_LOC100699093.1.1.m.20134,0.0073743,0.019013457,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; betaine-aldehyde dehydrogenase activity [GO:0008802]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; L-aminoadipate-semialdehyde dehydrogenase activity [GO:0004043]; glycine betaine biosynthetic process from choline [GO:0019285],NA,NA,NA
CHOYP_LOC100699161.1.1.m.35139,0.017566548,-0.007290666,No,NA,NA,NA,NA,NA,NA,exocyst [GO:0000145]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; exocytosis [GO:0006887]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100699383.1.1.m.63490,0.014675869,0.01558631,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100699837.1.1.m.54956,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,integral component of endoplasmic reticulum membrane [GO:0030176]; fat cell differentiation [GO:0045444]; lipid catabolic process [GO:0016042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; negative regulation of lipid catabolic process [GO:0050995],NA,NA,NA
CHOYP_LOC100699850.1.3.m.3523,-0.00763703,0.002627639,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_LOC100700188.1.1.m.30931,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100700230.1.1.m.57851,-0.005650908,-0.015561925,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]; tRNA (guanine-N7)-methylation [GO:0106004]; tRNA modification [GO:0006400],NA,NA,NA
CHOYP_LOC100700626.2.2.m.17262,0.003126656,-0.012837715,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_LOC100700757.1.1.m.23394,-0.000177937,0.020036952,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; (3S)-citramalyl-CoA lyase activity [GO:0047777]; magnesium ion binding [GO:0000287]; malate synthase activity [GO:0004474]; protein homotrimerization [GO:0070207]; regulation of cobalamin metabolic process [GO:0106064],NA,NA,NA
CHOYP_LOC100701105.1.1.m.56657,-0.005754768,0.00187311,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; FMN binding [GO:0010181]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; pyridoxamine-phosphate oxidase activity [GO:0004733]; pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615],NA,NA,NA
CHOYP_LOC100701406.1.1.m.23796,-0.01704673,-0.0016781,No,NA,NA,NA,NA,NA,NA,catalytic step 1 spliceosome [GO:0071012]; catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing; via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413],NA,NA,NA
CHOYP_LOC100701551.1.7.m.3948,0.006205382,-0.005998022,No,NA,NA,NA,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; protein N-terminus binding [GO:0047485]; ribosome binding [GO:0043022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000461],NA,NA,NA
CHOYP_LOC100701725.1.1.m.54512,0.014768197,0.002288409,No,NA,NA,NA,NA,NA,NA,cleavage body [GO:0071920]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789],NA,NA,NA
CHOYP_LOC100702367.1.1.m.62543,-0.001484014,-0.00020986,No,NA,NA,NA,NA,NA,NA,ESCRT II complex [GO:0000814]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328],NA,NA,NA
CHOYP_LOC100703090.1.1.m.46433,-0.009124264,-0.021183011,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100703202.1.1.m.10370,0.007856188,-0.014516272,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]; glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515],NA,NA,NA
CHOYP_LOC100703289.1.1.m.53585,0.004669512,-0.004179593,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi stack [GO:0005795]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; endoplasmic reticulum membrane fusion [GO:0016320]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; mitotic cell cycle [GO:0000278]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100703423.1.1.m.940,-0.003733543,-0.009166232,No,NA,NA,NA,NA,NA,NA,mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868],NA,NA,NA
CHOYP_LOC100703423.1.1.m.941,-0.00468851,-0.01099879,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; acetyl-CoA C-acyltransferase activity [GO:0003988]; enoyl-CoA hydratase activity [GO:0004300]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; fatty acid beta-oxidation [GO:0006635],NA,NA,NA
CHOYP_LOC100703585.2.4.m.39510,0.012257642,0.023688357,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100703956.1.1.m.31550,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100704039.1.1.m.21695,0.008122225,0.00613581,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; cation channel activity [GO:0005261]; ligand-gated calcium channel activity [GO:0099604]; manganese ion transmembrane transporter activity [GO:0005384]; sodium channel activity [GO:0005272]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to purine-containing compound [GO:0071415]; cellular response to temperature stimulus [GO:0071502]; dendritic cell chemotaxis [GO:0002407]; dendritic cell differentiation [GO:0097028]; estrous cycle [GO:0044849]; positive regulation of insulin secretion [GO:0032024]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of filopodium assembly [GO:0051489]; release of sequestered calcium ion into cytosol [GO:0051209]; response to heat [GO:0009408]; response to hydroperoxide [GO:0033194]; temperature homeostasis [GO:0001659]; zinc ion transmembrane transport [GO:0071577],NA,NA,NA
CHOYP_LOC100704264.1.1.m.49420,-0.000159432,-0.006024462,No,NA,NA,NA,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; cytokine-mediated signaling pathway [GO:0019221]; enzyme linked receptor protein signaling pathway [GO:0007167]; erythrocyte differentiation [GO:0030218]; innate immune response [GO:0045087]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-21-mediated signaling pathway [GO:0038114]; interleukin-4-mediated signaling pathway [GO:0035771]; interleukin-7-mediated signaling pathway [GO:0038111]; interleukin-9-mediated signaling pathway [GO:0038113]; intracellular signal transduction [GO:0035556]; JAK-STAT cascade involved in growth hormone signaling pathway [GO:0060397]; MAPK cascade [GO:0000165]; negative regulation of dendritic cell cytokine production [GO:0002731]; negative regulation of FasL biosynthetic process [GO:0045221]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of T cell activation [GO:0050868]; negative regulation of T-helper 1 cell differentiation [GO:0045626]; negative regulation of thymocyte apoptotic process [GO:0070244]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of T cell proliferation [GO:0042102]; protein phosphorylation [GO:0006468]; regulation of JAK-STAT cascade [GO:0046425]; regulation of T cell apoptotic process [GO:0070232]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to interleukin-9 [GO:0071104]; T cell homeostasis [GO:0043029]; tyrosine phosphorylation of STAT protein [GO:0007260],NA,NA,NA
CHOYP_LOC100704562.1.1.m.25340,-0.013539693,0.003962957,No,NA,NA,NA,NA,NA,NA,peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; cellular protein modification process [GO:0006464],NA,NA,NA
CHOYP_LOC100704819.1.2.m.14210,0.017170962,0.013244166,No,NA,NA,NA,NA,NA,NA,3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; fatty acid elongation [GO:0030497],NA,NA,NA
CHOYP_LOC100704819.2.2.m.49100,-0.017865129,0.013798236,No,NA,NA,NA,NA,NA,NA,3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; fatty acid elongation [GO:0030497],NA,NA,NA
CHOYP_LOC100705265.3.3.m.40296,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi-associated vesicle [GO:0005798]; ionotropic glutamate receptor complex [GO:0008328]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; channel regulator activity [GO:0016247]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; adult locomotory behavior [GO:0008344]; cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; hyperosmotic response [GO:0006972]; in utero embryonic development [GO:0001701]; positive regulation of synaptic transmission; glutamatergic [GO:0051968]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; regulation of locomotion [GO:0040012]; response to nutrient [GO:0007584]; thigmotaxis [GO:0001966]; vitamin metabolic process [GO:0006766],NA,NA,NA
CHOYP_LOC100705460.1.3.m.4908,-0.001600406,-0.01515392,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of translation [GO:0017148]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000055]; regulation of growth [GO:0040008],NA,NA,NA
CHOYP_LOC100705726.1.1.m.17900,-0.005281023,0.011970584,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; thiamin-triphosphatase activity [GO:0050333]; dephosphorylation [GO:0016311]; thiamine diphosphate metabolic process [GO:0042357]; thiamine metabolic process [GO:0006772],NA,NA,NA
CHOYP_LOC100705966.1.1.m.45957,0.011413674,-0.01133549,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100706133.1.1.m.56708,-0.014667688,0.00462133,No,NA,NA,NA,NA,NA,NA,Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100706374.1.1.m.51988,-0.006858933,0.009394129,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; B cell differentiation [GO:0030183]; immunoglobulin production [GO:0002377]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_LOC100706747.1.1.m.14818,-0.01597642,0.014787287,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; identical protein binding [GO:0042802]; fatty acid beta-oxidation [GO:0006635],NA,NA,NA
CHOYP_LOC100707249.1.1.m.15336,-0.008417043,-0.004105913,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; anatomical structure morphogenesis [GO:0009653]; endocrine pancreas development [GO:0031018]; humoral immune response [GO:0006959]; neuron projection morphogenesis [GO:0048812]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord motor neuron cell fate specification [GO:0021520],NA,NA,NA
CHOYP_LOC100707367.1.1.m.16292,0.005573016,-0.00126171,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; double-stranded DNA binding [GO:0003690]; nucleoside monophosphate kinase activity [GO:0050145]; polynucleotide 3'-phosphatase activity [GO:0046403]; dephosphorylation [GO:0016311]; DNA 3' dephosphorylation involved in DNA repair [GO:0098504]; DNA damage response; detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; negative regulation of protein ADP-ribosylation [GO:0010836]; nucleotide phosphorylation [GO:0046939]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_LOC100707656.1.1.m.10569,-0.010051446,0.00030652,No,NA,NA,NA,NA,NA,NA,chloroplast [GO:0009507]; 8-oxo-dGDP phosphatase activity [GO:0044715]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100707920.1.1.m.27511,0.005855103,0.002604151,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462],NA,NA,NA
CHOYP_LOC100708024.1.2.m.7177,-0.001712679,-0.0044806,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100708054.1.1.m.57813,0.015585141,-0.001225604,No,NA,NA,NA,NA,NA,NA,aggresome [GO:0016235]; AP-2 adaptor complex [GO:0030122]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; ciliary membrane [GO:0060170]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; SH3 domain binding [GO:0017124]; cell proliferation [GO:0008283]; clathrin coat assembly [GO:0048268]; endocytic recycling [GO:0032456]; epidermal growth factor receptor signaling pathway [GO:0007173]; Golgi to endosome transport [GO:0006895]; membrane organization [GO:0061024]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of receptor recycling [GO:0001921]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of cell proliferation [GO:0042127]; vesicle organization [GO:0016050]; viral entry into host cell [GO:0046718],NA,NA,NA
CHOYP_LOC100708199.3.6.m.23799,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100708199.6.6.m.57028,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074],NA,NA,NA
CHOYP_LOC100708329.1.1.m.3319,-0.004550925,-0.020496667,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; zinc ion binding [GO:0008270]; membrane fusion [GO:0061025]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_LOC100708602.1.1.m.65805,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; cell cycle [GO:0007049]; negative regulation of cell proliferation [GO:0008285],NA,NA,NA
CHOYP_LOC100708650.1.3.m.10354,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100708717.1.1.m.5825,-0.009691019,0.002273717,No,NA,NA,NA,NA,NA,NA,acrosomal vesicle [GO:0001669]; azurophil granule [GO:0042582]; azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; astrocyte cell migration [GO:0043615]; cellular calcium ion homeostasis [GO:0006874]; cellular protein metabolic process [GO:0044267]; chondroitin sulfate catabolic process [GO:0030207]; ganglioside catabolic process [GO:0006689]; glycosphingolipid metabolic process [GO:0006687]; hyaluronan catabolic process [GO:0030214]; keratan sulfate catabolic process [GO:0042340]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; male courtship behavior [GO:0008049]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]; oogenesis [GO:0048477]; penetration of zona pellucida [GO:0007341]; phospholipid biosynthetic process [GO:0008654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_LOC100708991.1.5.m.740,-0.005268566,-0.011693448,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100708991.2.5.m.29236,-0.020926433,0.01035953,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_LOC100708991.3.5.m.40072,0.002557317,0.016868543,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100708991.5.5.m.59991,0.022164943,-0.01059376,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100709262.1.2.m.17960,0.002210439,-0.017147294,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC100709316.1.1.m.17221,-0.007660014,-0.009892601,No,NA,NA,NA,NA,NA,NA,axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]; protein peptidyl-prolyl isomerization [GO:0000413],NA,NA,NA
CHOYP_LOC100709493.2.2.m.59425,0.009927321,0.015340881,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; digestion [GO:0007586]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100709538.1.2.m.4299,-0.01249107,-0.022351425,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100709617.1.1.m.10644,-0.016312809,0.019751963,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; cysteine-type peptidase activity [GO:0008234]; pyroglutamyl-peptidase activity [GO:0016920]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100709948.1.1.m.9245,-0.014737786,-0.009546773,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100710392.2.2.m.14004,0.003503424,1.85E-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100710565.1.1.m.5315,-0.00786856,-0.01109218,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; amine sulfotransferase activity [GO:0047685],NA,NA,NA
CHOYP_LOC100710578.1.1.m.62426,-0.006591585,-0.001631827,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629]; mitochondrion organization [GO:0007005]; protein tetramerization [GO:0051262],NA,NA,NA
CHOYP_LOC100710612.1.1.m.5449,-0.00866962,-0.012597076,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100710670.1.2.m.7245,-0.000881558,0.011908606,No,NA,NA,NA,NA,NA,NA,plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; cell morphogenesis [GO:0000902],NA,NA,NA
CHOYP_LOC100710670.2.2.m.45011,0.011835074,0.022122956,No,NA,NA,NA,NA,NA,NA,plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; cell morphogenesis [GO:0000902],NA,NA,NA
CHOYP_LOC100710965.1.1.m.15140,-0.006989272,0.010634714,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; polysome [GO:0005844]; androgen receptor signaling pathway [GO:0030521]; cell aging [GO:0007569]; cellular response to oxidative stress [GO:0034599]; cellular response to testosterone stimulus [GO:0071394]; cytoplasmic translation [GO:0002181]; positive regulation of androgen receptor activity [GO:2000825],NA,NA,NA
CHOYP_LOC100711334.1.1.m.16928,0.007522222,0.007502274,No,NA,NA,NA,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; mRNA binding [GO:0003729]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]; cellular response to UV-B [GO:0071493]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100711559.1.1.m.10313,0.003631002,-0.008746948,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; actin binding [GO:0003779]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; metal ion binding [GO:0046872]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; actin filament polymerization [GO:0030041]; cellular response to oxidative stress [GO:0034599]; protein repair [GO:0030091],NA,NA,NA
CHOYP_LOC100711617.1.1.m.9209,-0.006822044,0.008580171,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II; core complex [GO:0005665]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleotide binding [GO:0000166]; translation initiation factor binding [GO:0031369]; mRNA export from nucleus in response to heat stress [GO:0031990]; nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:0000288]; positive regulation of translational initiation [GO:0045948]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_LOC100713637.1.1.m.16691,-0.017082003,0.00587947,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100714922.1.1.m.39817,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; NAADP-sensitive calcium-release channel activity [GO:0072345]; voltage-gated calcium channel activity [GO:0005245]; regulation of ion transmembrane transport [GO:0034765],NA,NA,NA
CHOYP_LOC100717261.1.1.m.51839,0.016693975,0.004087491,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; sulfotransferase activity [GO:0008146]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC100718468.1.1.m.11334,-0.007421205,0.002135529,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100720440.1.2.m.11473,0.001941457,-0.020371217,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; social behavior [GO:0035176]; vocalization behavior [GO:0071625],NA,NA,NA
CHOYP_LOC100721364.1.1.m.15879,-6.73E-05,0.014056839,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100721584.1.1.m.52602,0.008201909,0.001360353,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; defense response to bacterium [GO:0042742],NA,NA,NA
CHOYP_LOC100723342.1.1.m.58414,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,ELL-EAF complex [GO:0032783]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; transcriptionally active chromatin [GO:0035327]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; spermatid development [GO:0007286]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_LOC100725472.1.2.m.5970,0.005616385,-0.013407369,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100726220.1.1.m.8701,-0.014139687,0.011543895,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of translational initiation [GO:0006446],NA,NA,NA
CHOYP_LOC100726448.1.1.m.26536,-0.004825548,0.001988188,No,NA,NA,NA,NA,NA,NA,hydrolase activity; acting on ester bonds [GO:0016788]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_LOC100727159.1.1.m.60272,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; frizzled binding [GO:0005109]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; limb development [GO:0060173]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of Wnt signaling pathway [GO:0030178]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of Wnt signaling pathway; planar cell polarity pathway [GO:2000095]; stem cell proliferation [GO:0072089]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt receptor catabolic process [GO:0038018]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100727208.1.1.m.9365,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_LOC100727208.1.1.m.9366,0.000231245,0.002782076,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; mRNA 3'-UTR binding [GO:0003730]; regulation of apoptotic process [GO:0042981],NA,NA,NA
CHOYP_LOC100728625.2.2.m.51928,-0.016830967,-0.000430425,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; abscisic acid-activated signaling pathway [GO:0009738]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; response to salicylic acid [GO:0009751],NA,NA,NA
CHOYP_LOC100729623.1.2.m.6310,0.006174609,0.00106279,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100730443.1.1.m.57698,-0.005279333,0.000582864,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100740246.1.1.m.25108,-0.002479091,-0.003920894,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_LOC100740578.1.1.m.65702,-0.009246449,-0.018754557,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; transferase activity [GO:0016740]; negative regulation of protein binding [GO:0032091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_LOC100740873.1.1.m.46472,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; camera-type eye morphogenesis [GO:0048593]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; epithelial cell morphogenesis [GO:0003382]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],NA,NA,NA
CHOYP_LOC100741247.2.2.m.27816,-0.001897239,-0.00269549,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase; V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; vacuolar acidification [GO:0007035],NA,NA,NA
CHOYP_LOC100741250.1.2.m.48951,0.013952346,-0.000320478,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100741406.1.1.m.29038,0.000878223,-0.00386691,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; chromosome; centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; Z disc [GO:0030018]; kinase binding [GO:0019900]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; negative regulation of lipid kinase activity [GO:0090219]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100742152.1.2.m.4504,0.012373213,-0.021144098,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; 2 iron; 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; mitochondrial electron transport; ubiquinol to cytochrome c [GO:0006122],NA,NA,NA
CHOYP_LOC100742289.1.1.m.25180,0.009906477,-0.020198572,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],NA,NA,NA
CHOYP_LOC100743250.1.1.m.12309,-0.007348586,0.013575199,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020]; plasma membrane [GO:0005886]; inositol-1;3;4;5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1;4;5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; PH domain binding [GO:0042731]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; inositol phosphate-mediated signaling [GO:0048016]; phosphatidylinositol dephosphorylation [GO:0046856],NA,NA,NA
CHOYP_LOC100743251.1.1.m.16814,-0.016283608,0.002723155,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]; malate metabolic process [GO:0006108]; oxidation-reduction process [GO:0055114]; pyruvate metabolic process [GO:0006090],NA,NA,NA
CHOYP_LOC100743492.1.1.m.58896,0.018373035,-0.002418611,No,NA,NA,NA,NA,NA,NA,signal recognition particle; endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; SRP-dependent cotranslational protein targeting to membrane; signal sequence recognition [GO:0006617]; SRP-dependent cotranslational protein targeting to membrane; translocation [GO:0006616],NA,NA,NA
CHOYP_LOC100743548.1.2.m.18991,0.017434481,0.006334899,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100743601.1.1.m.37797,-0.0076825,-0.00487946,No,NA,NA,NA,NA,NA,NA,apicolateral plasma membrane [GO:0016327]; axon [GO:0030424]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; photoreceptor cell axon guidance [GO:0072499]; plasma membrane organization [GO:0007009]; regulation of synapse organization [GO:0050807],NA,NA,NA
CHOYP_LOC100743901.1.1.m.4559,0.013791268,-0.013071661,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-R17 specific) [GO:0035642]; histone-arginine N-methyltransferase activity [GO:0008469]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor transcription coactivator activity [GO:0030374]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; histone arginine methylation [GO:0034969]; histone H3-R17 methylation [GO:0034971]; peptidyl-arginine methylation; to asymmetrical-dimethyl arginine [GO:0019919]; positive regulation of fat cell differentiation [GO:0045600]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of skeletal muscle fiber development [GO:0048742]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100744089.1.1.m.58530,-0.007147748,-0.000441945,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; juxtaparanode region of axon [GO:0044224]; meiotic spindle [GO:0072687]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]; histone deacetylase activity [GO:0004407]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; transcription factor binding [GO:0008134]; tubulin deacetylase activity [GO:0042903]; zinc ion binding [GO:0008270]; cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium assembly [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of angiogenesis [GO:0016525]; negative regulation of autophagy [GO:0010507]; negative regulation of cell proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042],NA,NA,NA
CHOYP_LOC100744356.1.1.m.49326,-0.005505565,0.008990781,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; transcription factor complex [GO:0005667]; transcriptional repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212],NA,NA,NA
CHOYP_LOC100744369.1.1.m.56678,-0.00115889,-0.015873298,No,NA,NA,NA,NA,NA,NA,brush border [GO:0005903]; cell cortex [GO:0005938]; cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; actin binding [GO:0003779]; Rac GTPase binding [GO:0048365]; signaling adaptor activity [GO:0035591]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266],NA,NA,NA
CHOYP_LOC100744506.1.1.m.44043,0.017601993,-0.007403481,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016],NA,NA,NA
CHOYP_LOC100745330.1.1.m.65802,0.001902498,0.001924995,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synaptic vesicle [GO:0008021]; tetraspanin-enriched microdomain [GO:0097197]; trans-Golgi network [GO:0005802]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; amyloid-beta formation [GO:0034205]; constitutive protein ectodomain proteolysis [GO:0051089]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; nucleocytoplasmic transport [GO:0006913]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; response to antineoplastic agent [GO:0097327]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100745429.1.1.m.27818,-0.013923071,0.012937949,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; anatomical structure morphogenesis [GO:0009653]; erythrocyte maturation [GO:0043249]; mRNA processing [GO:0006397]; negative regulation of RNA splicing [GO:0033119]; regulation of cell differentiation [GO:0045595]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100745778.1.1.m.27697,0.018288369,-0.003637436,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100748006.1.2.m.19013,0.002267366,0.002234322,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765],NA,NA,NA
CHOYP_LOC100748395.4.7.m.40663,0.003300873,0.012812593,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_LOC100748395.6.7.m.57994,0.012187677,0.021737082,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_LOC100748436.1.1.m.33164,-0.001492023,0.004344273,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; cholesterol metabolic process [GO:0008203]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100748625.1.1.m.24479,-0.00181604,-0.006185114,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; Ran GTPase binding [GO:0008536]; mRNA transport [GO:0051028]; neural tube formation [GO:0001841]; positive regulation of GTPase activity [GO:0043547]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_LOC100749296.1.1.m.45471,0.001447588,0.009993131,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100749463.1.1.m.6770,-0.000719535,-0.004615905,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; ubiquitinyl hydrolase activity [GO:0101005]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; maintenance of DNA methylation [GO:0010216]; monoubiquitinated protein deubiquitination [GO:0035520]; multicellular organism development [GO:0007275]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of protein stability [GO:0031647]; regulation of telomere capping [GO:1904353]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100749506.1.1.m.8950,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinal cone cell fate commitment [GO:0060226]; positive regulation of transcription; DNA-templated [GO:0045893]; retinal bipolar neuron differentiation [GO:0060040]; retinal rod cell fate commitment [GO:0060223],NA,NA,NA
CHOYP_LOC100749506.1.1.m.8951,-0.0230901,0.001758805,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829],NA,NA,NA
CHOYP_LOC100749745.1.1.m.11523,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,external side of plasma membrane [GO:0009897]; T-tubule [GO:0030315]; voltage-gated potassium channel complex [GO:0008076]; G-protein activated inward rectifier potassium channel activity [GO:0015467]; inward rectifier potassium channel activity [GO:0005242]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion import across plasma membrane [GO:1990573]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765],NA,NA,NA
CHOYP_LOC100752270.1.1.m.23081,-0.020330015,0.000570235,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373],NA,NA,NA
CHOYP_LOC100755189.1.1.m.33307,-4.53E-05,0.012151075,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; peroxidase activity [GO:0004601]; protein-disulfide reductase activity [GO:0047134]; tumor necrosis factor-mediated signaling pathway [GO:0033209],NA,NA,NA
CHOYP_LOC100759507.1.1.m.30604,-0.010711239,-0.006187227,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; azurophil granule lumen [GO:0035578]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; beta-N-acetylgalactosaminidase activity [GO:0032428]; lipid transporter activity [GO:0005319]; phospholipase activator activity [GO:0016004]; sphingolipid activator protein activity [GO:0030290]; ganglioside catabolic process [GO:0006689]; glycosphingolipid metabolic process [GO:0006687]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]; positive regulation of hydrolase activity [GO:0051345],NA,NA,NA
CHOYP_LOC100769755.1.1.m.59793,-0.011832679,0.015795207,No,NA,NA,NA,NA,NA,NA,peroxisome [GO:0005777]; copper ion binding [GO:0005507],NA,NA,NA
CHOYP_LOC100770235.1.1.m.2514,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; defense response to bacterium [GO:0042742]; negative regulation of cold-induced thermogenesis [GO:0120163]; tooth eruption [GO:0044691],NA,NA,NA
CHOYP_LOC100770313.1.1.m.3513,0.008488085,-0.005340298,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; catabolic process [GO:0009056]; prostaglandin metabolic process [GO:0006693]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC100808508.1.1.m.59055,-0.006149901,0.016525446,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; enzyme regulator activity [GO:0030234]; glucosinolate catabolic process [GO:0019762]; nitrile biosynthetic process [GO:0080028],NA,NA,NA
CHOYP_LOC100841619.1.1.m.40382,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715],NA,NA,NA
CHOYP_LOC100862999.1.1.m.11759,0.003551653,0.013717619,No,NA,NA,NA,NA,NA,NA,Cul7-RING ubiquitin ligase complex [GO:0031467]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],NA,NA,NA
CHOYP_LOC100863242.1.1.m.9849,0.008075595,-0.019102959,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ribosome binding [GO:0043022]; translation activator activity [GO:0008494]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC100863386.1.1.m.37224,-0.003853457,-0.008406383,No,NA,NA,NA,NA,NA,NA,apical part of cell [GO:0045177]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; very-low-density lipoprotein particle [GO:0034361]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; glycoprotein transporter activity [GO:0034437]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229]; cellular response to hypoxia [GO:0071456]; cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; lipid transport [GO:0006869]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dendrite development [GO:1900006]; positive regulation of protein kinase activity [GO:0045860]; receptor-mediated endocytosis [GO:0006898]; reelin-mediated signaling pathway [GO:0038026]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447],NA,NA,NA
CHOYP_LOC100863781.1.1.m.33751,0.003437738,0.014718818,No,NA,NA,NA,NA,NA,NA,bicellular tight junction [GO:0005923]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_LOC100863920.1.1.m.40408,0.001847973,-0.009352359,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100864134.1.1.m.41690,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ARF protein signal transduction [GO:0032011]; regulation of ARF protein signal transduction [GO:0032012],NA,NA,NA
CHOYP_LOC100864501.1.1.m.7850,-0.017897455,-0.018007827,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; cadherin binding [GO:0045296]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; actin filament organization [GO:0007015]; chitin-based cuticle development [GO:0040003]; dorsal closure [GO:0007391]; epithelial cell migration; open tracheal system [GO:0007427]; epithelium development [GO:0060429]; head involution [GO:0008258]; midgut development [GO:0007494]; protein ubiquitination [GO:0016567]; segmentation [GO:0035282],NA,NA,NA
CHOYP_LOC100864577.1.1.m.8977,-0.007548284,-0.014667203,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of JUN kinase activity [GO:0007257]; activation of protein kinase activity [GO:0032147]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100865129.1.1.m.45329,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100865286.1.1.m.17958,-0.010165271,0.007440481,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]; protein tyrosine phosphatase activity [GO:0004725]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; lipid metabolic process [GO:0006629]; neurotransmitter secretion [GO:0007269],NA,NA,NA
CHOYP_LOC100865976.1.1.m.15403,-0.006168808,-0.003120741,No,NA,NA,NA,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; formation of translation preinitiation complex [GO:0001731]; positive regulation of translational initiation [GO:0045948]; translation reinitiation [GO:0002188],NA,NA,NA
CHOYP_LOC100866180.1.1.m.49582,-0.006716264,0.001115658,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100867381.8.8.m.53059,0.006705201,-0.009781302,No,NA,NA,NA,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-substrate adherens junction [GO:0005924]; centrosome [GO:0005813]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; insulin receptor complex [GO:0005899]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; synapse [GO:0045202]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; SH3/SH2 adaptor activity [GO:0005070]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; acetylcholine receptor signaling pathway [GO:0095500]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; insulin receptor signaling pathway [GO:0008286]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]; stress fiber assembly [GO:0043149],NA,NA,NA
CHOYP_LOC100867487.2.2.m.65146,0.00646183,0.006962604,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_LOC100867628.1.1.m.1331,-0.005978671,0.015751266,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100867962.1.1.m.19193,-0.012101375,-0.011954743,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; histone arginine methylation [GO:0034969]; peptidyl-arginine methylation [GO:0018216]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of transcription; DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LOC100869188.1.1.m.18952,-0.013409221,-0.01862003,No,NA,NA,NA,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735],NA,NA,NA
CHOYP_LOC100869625.1.1.m.52959,-0.007865596,0.008211685,No,NA,NA,NA,NA,NA,NA,CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; gene silencing by RNA [GO:0031047]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:0000288]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606],NA,NA,NA
CHOYP_LOC100870649.1.2.m.13573,-0.01123593,0.004189135,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of chromatin assembly or disassembly [GO:0001672],NA,NA,NA
CHOYP_LOC100872239.1.1.m.53052,-0.012520496,0.003834849,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; endosomal transport [GO:0016197]; endosome transport via multivesicular body sorting pathway [GO:0032509]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058],NA,NA,NA
CHOYP_LOC100872507.1.1.m.21152,0.015417773,0.004151935,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; drug binding [GO:0008144]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731]; immune response [GO:0006955]; inosine catabolic process [GO:0006148]; interleukin-2 secretion [GO:0070970]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; neutrophil degranulation [GO:0043312]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of T cell proliferation [GO:0042102]; purine nucleotide catabolic process [GO:0006195]; purine-containing compound salvage [GO:0043101]; response to drug [GO:0042493]; urate biosynthetic process [GO:0034418],NA,NA,NA
CHOYP_LOC100874620.1.1.m.23782,-0.001879586,0.007455268,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; centrosome [GO:0005813]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; voltage-gated calcium channel complex [GO:0005891]; 3';5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; ATPase binding [GO:0051117]; cAMP binding [GO:0030552]; drug binding [GO:0008144]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; aging [GO:0007568]; cAMP catabolic process [GO:0006198]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; establishment of endothelial barrier [GO:0061028]; leukocyte migration [GO:0050900]; multicellular organism growth [GO:0035264]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of heart contraction [GO:0045822]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-5 production [GO:0032754]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; smooth muscle contraction [GO:0006939]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_LOC100875369.1.1.m.31446,0.003740907,-0.004707109,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; phosphotyrosine residue binding [GO:0001784]; potassium channel inhibitor activity [GO:0019870]; signaling receptor binding [GO:0005102]; blood vessel morphogenesis [GO:0048514]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of RNA metabolic process [GO:0051252]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570],NA,NA,NA
CHOYP_LOC100875390.1.1.m.24780,-0.012533419,-0.002780239,No,NA,NA,NA,NA,NA,NA,ciliary pocket membrane [GO:0020018]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron projection development [GO:0010976]; protein localization to cilium [GO:0061512],NA,NA,NA
CHOYP_LOC100875404.1.1.m.8506,-0.010692911,0.008360533,No,NA,NA,NA,NA,NA,NA,precatalytic spliceosome [GO:0071011]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100875479.1.2.m.42509,-0.012293927,-0.011013449,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100875585.1.1.m.8714,-0.000422652,-0.019368346,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; basement membrane [GO:0005604]; cell junction [GO:0030054]; presynaptic periactive zone [GO:0036062]; synaptic vesicle [GO:0008021]; signaling receptor binding [GO:0005102]; axon guidance [GO:0007411]; cell adhesion mediated by integrin [GO:0033627]; dorsal trunk growth; open tracheal system [GO:0035001]; female meiosis chromosome segregation [GO:0016321]; heart development [GO:0007507]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_LOC100875705.1.1.m.10980,-0.003535325,-0.003113967,No,NA,NA,NA,NA,NA,NA,beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; canonical Wnt signaling pathway [GO:0060070]; chitin-based larval cuticle pattern formation [GO:0035293]; delamination [GO:0060232]; embryonic pattern specification [GO:0009880]; eye-antennal disc development [GO:0035214]; imaginal disc-derived wing expansion [GO:0048526]; positive regulation of transcription by RNA polymerase II [GO:0045944]; segment polarity determination [GO:0007367]; transcription; DNA-templated [GO:0006351]; wing disc morphogenesis [GO:0007472],NA,NA,NA
CHOYP_LOC100875978.1.1.m.34640,-0.022659645,0.010232815,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100875987.1.2.m.7720,-0.011882193,-0.018382103,No,NA,NA,NA,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; 4 iron; 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial respiratory chain complex I assembly [GO:0032981],NA,NA,NA
CHOYP_LOC100876012.1.1.m.8280,-0.009756278,0.020283744,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; uridine phosphorylase activity [GO:0004850]; cellular response to glucose starvation [GO:0042149]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide catabolic process [GO:0009166]; pyrimidine nucleoside catabolic process [GO:0046135]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218],NA,NA,NA
CHOYP_LOC100876515.1.2.m.37063,0.010086143,0.010932963,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100876515.2.2.m.54514,0.003636639,-0.000389401,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100876659.1.1.m.19405,-0.01627937,0.010110311,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100876663.1.1.m.4368,0.007370399,-0.009294898,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide amidation [GO:0001519]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620],NA,NA,NA
CHOYP_LOC100877311.1.1.m.25123,0.002039607,-0.024736801,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC100877335.1.1.m.8851,-0.006391887,0.001703306,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; enzyme binding [GO:0019899]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; circadian regulation of gene expression [GO:0032922]; muscle organ development [GO:0007517]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of cell adhesion [GO:0045785]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of locomotor rhythm [GO:1904059]; regulation of neuron differentiation [GO:0045664]; response to transforming growth factor beta [GO:0071559],NA,NA,NA
CHOYP_LOC100877393.1.1.m.26310,-0.000728331,-0.01410026,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; cardiolipin binding [GO:1901612]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; phosphatidic acid binding [GO:0070300]; apoptotic process [GO:0006915]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; GTP metabolic process [GO:0046039]; membrane fusion [GO:0061025]; membrane tubulation [GO:0097749]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053],NA,NA,NA
CHOYP_LOC100877438.2.2.m.37290,-0.003091037,-0.0060311,No,NA,NA,NA,NA,NA,NA,apicolateral plasma membrane [GO:0016327]; basolateral part of cell [GO:1990794]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; postsynaptic density [GO:0014069]; septate junction [GO:0005918]; synapse [GO:0045202]; ionotropic glutamate receptor binding [GO:0035255]; anterior/posterior axis specification; follicular epithelium [GO:0030714]; basal protein localization [GO:0045175]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; cell proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; Malpighian tubule development [GO:0072002]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of cell proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport; endosome to postsynaptic membrane [GO:0098887]; olfactory behavior [GO:0042048]; ovarian follicle cell development [GO:0030707]; pole plasm protein localization [GO:0007318]; R3/R4 cell fate commitment [GO:0007464]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of JAK-STAT cascade [GO:0046425]; regulation of Notch signaling pathway [GO:0008593]; regulation of synapse structure or activity [GO:0050803]; sensory perception of smell [GO:0007608]; septate junction assembly [GO:0019991]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186],NA,NA,NA
CHOYP_LOC100877549.1.1.m.8321,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; parathyroid hormone secretion [GO:0035898]; protein homotetramerization [GO:0051289]; response to calcium ion [GO:0051592],NA,NA,NA
CHOYP_LOC100877554.2.2.m.34916,0.005696811,-0.013284926,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity; acting on CH-OH group of donors [GO:0016614],NA,NA,NA
CHOYP_LOC100877618.1.1.m.39871,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725],NA,NA,NA
CHOYP_LOC100877689.1.2.m.14376,0.010654376,-0.001492705,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; metal ion binding [GO:0046872]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; intestinal cholesterol absorption [GO:0030299]; negative regulation of actin filament depolymerization [GO:0030835]; ruffle organization [GO:0031529],NA,NA,NA
CHOYP_LOC100877689.2.2.m.26187,0.004476671,0.018081304,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100877728.1.1.m.19879,-0.002232677,0.001350796,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; DNA binding [GO:0003677]; methylated histone binding [GO:0035064]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_LOC100877749.1.1.m.65236,0.002554262,-0.016428507,No,NA,NA,NA,NA,NA,NA,aggresome [GO:0016235]; axon [GO:0030424]; caveola [GO:0005901]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein deacetylase activity [GO:0033558]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; autophagy [GO:0006914]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; mitochondrion localization [GO:0051646]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of protein complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; negative regulation of transcription; DNA-templated [GO:0045892]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of receptor biosynthetic process [GO:0010870]; positive regulation of signal transduction [GO:0009967]; protein deacetylation [GO:0006476]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression; epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; regulation of signaling receptor activity [GO:0010469]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; response to organic substance [GO:0010033]; response to toxic substance [GO:0009636]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],NA,NA,NA
CHOYP_LOC100877947.1.1.m.51907,0.008133468,-0.007863074,No,NA,NA,NA,NA,NA,NA,chromosome; centromeric region [GO:0000775]; chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome; telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion; telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome; telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100877992.1.1.m.1507,-0.00730493,-0.020191338,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100878123.1.1.m.55730,0.017214079,-0.000973336,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; procollagen galactosyltransferase activity [GO:0050211]; positive regulation of collagen fibril organization [GO:1904028],NA,NA,NA
CHOYP_LOC100878391.1.1.m.28644,0.019209847,-0.012558611,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; cardiac muscle cell differentiation [GO:0055007]; intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; response to 3;3';5-triiodo-L-thyronine [GO:1905242],NA,NA,NA
CHOYP_LOC100878601.1.1.m.15486,-0.0082394,0.001245977,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; 7-methylguanosine mRNA capping [GO:0006370]; mRNA transport [GO:0051028],NA,NA,NA
CHOYP_LOC100879052.1.1.m.53743,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cilium assembly [GO:0060271],NA,NA,NA
CHOYP_LOC100879129.1.1.m.44467,0.014266721,0.008771,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235]; protein homooligomerization [GO:0051260]; regulation of G protein-coupled receptor signaling pathway [GO:0008277],NA,NA,NA
CHOYP_LOC100879250.1.1.m.24381,0.005222196,0.016698417,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242],NA,NA,NA
CHOYP_LOC100879339.1.1.m.20204,-0.004770791,-0.011222614,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; phosphatidylethanolamine biosynthetic process [GO:0006646],NA,NA,NA
CHOYP_LOC100879389.2.2.m.63959,-0.007031496,0.006614266,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_LOC100879487.1.3.m.20887,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100879487.2.3.m.32793,0.002056101,-0.000140242,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; eye photoreceptor cell development [GO:0042462]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100879487.3.3.m.33048,-0.010671149,-0.023870412,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100879487.3.3.m.33049,0.006778825,-0.000489695,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; positive regulation of smoothened signaling pathway [GO:0045880]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_LOC100879690.1.1.m.18064,0.005255507,-0.010770672,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; kinase binding [GO:0019900]; protein-containing complex scaffold activity [GO:0032947]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_LOC100879804.1.1.m.59833,-0.002464698,-0.023914495,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100879890.1.1.m.4963,0.022342435,-0.007615678,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; I band [GO:0031674]; lipid tube [GO:0060987]; membrane [GO:0016020]; node of Ranvier [GO:0033268]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; T-tubule [GO:0030315]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; RNA polymerase binding [GO:0070063]; tau protein binding [GO:0048156]; cell proliferation [GO:0008283]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; lipid tube assembly [GO:0060988]; membrane organization [GO:0061024]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of ventricular cardiac muscle cell action potential [GO:1903946]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; regulation of cell cycle arrest [GO:0071156]; regulation of endocytosis [GO:0030100]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of neuron differentiation [GO:0045664]; T-tubule organization [GO:0033292]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100879964.1.1.m.1780,0.009610963,-0.019335667,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]; activation of protein kinase activity [GO:0032147]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; response to UV [GO:0009411]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100879981.1.1.m.57826,0.00208221,-0.016173603,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; metal ion binding [GO:0046872]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100880308.1.1.m.6158,-0.007476216,-0.012945891,No,NA,NA,NA,NA,NA,NA,microfibril [GO:0001527]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100880757.2.2.m.41249,0.012766703,-0.002067588,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_LOC100880815.3.7.m.45911,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; carbohydrate binding [GO:0030246]; CD4 receptor binding [GO:0042609]; IgM binding [GO:0001791]; protein phosphatase binding [GO:0019903]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; B cell activation [GO:0042113]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of immunoglobulin secretion [GO:0051025]; regulation of B cell proliferation [GO:0030888]; regulation of endocytosis [GO:0030100]; regulation of immune response [GO:0050776],NA,NA,NA
CHOYP_LOC100880815.5.7.m.54594,0.008382515,-0.015739744,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC100880948.1.1.m.25232,-0.006406007,0.017546902,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; acute-phase response [GO:0006953]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; JAK-STAT cascade [GO:0007259]; JAK-STAT cascade involved in growth hormone signaling pathway [GO:0060397]; liver development [GO:0001889]; luteinization [GO:0001553]; positive regulation of cellular component movement [GO:0051272]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription; DNA-templated [GO:0006355]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC100881280.1.1.m.39133,-0.010196377,0.005213776,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; endosome membrane [GO:0010008]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cargo loading into vesicle [GO:0035459]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_LOC100881316.1.1.m.51540,0.005877312,0.012674635,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; intracellular signal transduction [GO:0035556]; p38MAPK cascade [GO:0038066]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_LOC100881430.1.1.m.4201,-0.002958199,-0.024271542,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100881900.1.3.m.1852,0.018680578,0.00299547,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; myosin V complex [GO:0031475]; myosin VI complex [GO:0031476]; myosin VII complex [GO:0031477]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]; actin filament-based movement [GO:0030048],NA,NA,NA
CHOYP_LOC100882263.1.1.m.48839,-0.003147917,-0.015856975,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; negative regulation of ribosome biogenesis [GO:0090071]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of translation [GO:0006417]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC100882621.1.2.m.25860,-0.010192885,-0.006339081,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; FACT complex [GO:0035101]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of chromatin assembly or disassembly [GO:0001672]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_LOC100883123.1.1.m.704,-0.006760704,-0.023766892,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100883412.1.1.m.25657,-0.013241791,-0.01687931,No,NA,NA,NA,NA,NA,NA,histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; canonical Wnt signaling pathway [GO:0060070]; cardiovascular system development [GO:0072358]; chromatin remodeling [GO:0006338]; heart morphogenesis [GO:0003007]; histone H3-K4 methylation [GO:0051568]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525],NA,NA,NA
CHOYP_LOC100883571.1.1.m.42323,-0.005972871,-0.014530516,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; postsynapse [GO:0098794]; actin binding [GO:0003779]; actin filament polymerization [GO:0030041]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; modification of postsynaptic actin cytoskeleton [GO:0098885]; oligodendrocyte development [GO:0014003]; positive regulation of myelination [GO:0031643]; protein-containing complex assembly [GO:0065003]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_LOC100883586.1.1.m.268,0.005895698,-0.003213579,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of neuron projection development [GO:0010977]; positive regulation of protein localization to plasma membrane [GO:1903078],NA,NA,NA
CHOYP_LOC100883864.1.1.m.41791,-0.004850061,-0.006560586,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; sarcoplasmic reticulum [GO:0016529]; Z disc [GO:0030018]; AMP binding [GO:0016208]; carbohydrate binding [GO:0030246]; drug binding [GO:0008144]; glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; cellular calcium ion homeostasis [GO:0006874]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; response to cAMP [GO:0051591]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033],NA,NA,NA
CHOYP_LOC100888253.1.1.m.18761,-0.007573971,0.014040774,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_LOC100888299.1.3.m.3738,-0.002437914,0.008862941,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; telomere maintenance [GO:0000723],NA,NA,NA
CHOYP_LOC100888300.1.2.m.10203,-0.00183803,0.003128391,No,NA,NA,NA,NA,NA,NA,acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802],NA,NA,NA
CHOYP_LOC100888608.1.3.m.5445,0.018708443,0.008537788,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100888702.1.1.m.56287,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_LOC100888889.1.1.m.14397,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100888910.1.1.m.64827,0.00987709,0.019879047,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; protein kinase A binding [GO:0051018]; regulation of canonical Wnt signaling pathway [GO:0060828],NA,NA,NA
CHOYP_LOC100888919.1.1.m.1193,-0.003403007,0.018447403,No,NA,NA,NA,NA,NA,NA,cell [GO:0005623]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; entrainment of circadian clock by photoperiod [GO:0043153]; flight behavior [GO:0007629]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; neuron cellular homeostasis [GO:0070050]; regulation of neuromuscular synaptic transmission [GO:1900073],NA,NA,NA
CHOYP_LOC100888944.1.1.m.45112,0.002973477,0.007910959,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100889245.1.2.m.999,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]; cellular response to glial cell derived neurotrophic factor [GO:1990792]; negative regulation of GTP binding [GO:1904425]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phagocytosis [GO:0050766]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_LOC100889318.1.1.m.61506,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; asymmetric neuroblast division [GO:0055059]; axon ensheathment in central nervous system [GO:0032291]; cell cycle [GO:0007049]; cortical actin cytoskeleton organization [GO:0030866]; cytoplasmic transport; nurse cell to oocyte [GO:0007303]; defense response to fungus [GO:0050832]; dorsal/ventral axis specification; ovarian follicular epithelium [GO:0008069]; embryonic axis specification [GO:0000578]; establishment of endothelial blood-brain barrier [GO:0014045]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; glial cell differentiation [GO:0010001]; heart process [GO:0003015]; oocyte dorsal/ventral axis specification [GO:0007310]; regulation of asymmetric cell division [GO:0009786]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419],NA,NA,NA
CHOYP_LOC100889336.1.1.m.18327,-0.018007109,-0.014362869,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100889562.1.1.m.27158,0.003854077,-0.013955803,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; S-methyl-5-thioribose kinase activity [GO:0046522]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284],NA,NA,NA
CHOYP_LOC100889564.1.1.m.17148,0.011250173,-0.012672415,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100889564.1.1.m.17149,-0.005358343,-0.019823918,No,NA,NA,NA,NA,NA,NA,cell projection [GO:0042995]; extrinsic component of mitochondrial inner membrane [GO:0031314]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen [GO:0016709]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced flavin or flavoprotein as one donor; and incorporation of one atom of oxygen [GO:0016712]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_LOC100889738.1.1.m.41184,-0.01693612,-0.002445172,No,NA,NA,NA,NA,NA,NA,RNA polymerase II; holoenzyme [GO:0016591],NA,NA,NA
CHOYP_LOC100889837.1.2.m.2516,0.006312273,-0.003266767,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; (1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC100889837.2.2.m.31074,0.007558637,0.014394252,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; (1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC100889942.1.1.m.57041,0.006207485,-0.000354257,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding; bending [GO:0008301]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nuclear receptor transcription coactivator activity [GO:0030374]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; cholesterol catabolic process [GO:0006707]; homeostatic process [GO:0042592]; multicellular organism development [GO:0007275]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of hormone biosynthetic process [GO:0046885]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100890015.1.1.m.8302,-0.014533289,0.014181814,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100890099.1.1.m.11505,-0.001567524,0.002033283,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100890106.1.1.m.40543,0.016841227,-0.00483747,No,NA,NA,NA,NA,NA,NA,Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; recycling endosome [GO:0055037]; copper ion binding [GO:0005507]; copper ion homeostasis [GO:0055070]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sodium ion transmembrane transport [GO:1902306]; positive regulation of protein ubiquitination [GO:0031398]; protein transport [GO:0015031]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434],NA,NA,NA
CHOYP_LOC100890342.1.1.m.10194,-0.003122904,-0.011907778,No,NA,NA,NA,NA,NA,NA,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]; structural molecule activity [GO:0005198]; actin cytoskeleton organization [GO:0030036]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; ciliary basal body-plasma membrane docking [GO:0097711]; excretion [GO:0007588]; positive regulation of bicellular tight junction assembly [GO:1903348]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; spermatid differentiation [GO:0048515]; visual behavior [GO:0007632],NA,NA,NA
CHOYP_LOC100890433.1.1.m.30609,-0.007055906,0.009504652,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100890512.1.1.m.36422,-0.022178303,-0.008368727,No,NA,NA,NA,NA,NA,NA,axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017]; cell projection organization [GO:0030030]; cellular response to cold [GO:0070417]; cold acclimation [GO:0009631]; microtubule anchoring [GO:0034453]; positive regulation of cilium assembly [GO:0045724]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC100890512.1.1.m.36423,0.007613726,-0.003316344,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100890517.2.2.m.22207,0.00050249,-0.021249888,No,NA,NA,NA,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome; centromeric region [GO:0000780]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; dendrite development [GO:0016358]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_LOC100890554.1.1.m.28894,-0.015567001,-0.010804947,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100890653.1.1.m.13755,-0.01593634,-0.016393393,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100890753.1.3.m.50299,-0.012567673,-0.020410964,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC100890753.2.3.m.53551,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC100890762.1.1.m.31399,-0.00459588,-0.011933165,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100891184.1.1.m.18226,-0.001498612,0.003844058,No,NA,NA,NA,NA,NA,NA,endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; ATPase binding [GO:0051117]; cholesterol binding [GO:0015485]; cholesterol transporter activity [GO:0017127]; high-density lipoprotein particle binding [GO:0008035]; lipid transporter activity [GO:0005319]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; phosphatidylserine-translocating ATPase activity [GO:0090556]; phospholipid binding [GO:0005543]; phospholipid transporter activity [GO:0005548]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; syntaxin binding [GO:0019905]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; phagocytosis; engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691],NA,NA,NA
CHOYP_LOC100891282.1.1.m.41107,-0.016224016,-0.004614428,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; lysosome [GO:0005764]; deoxyribonuclease II activity [GO:0004531]; DNA binding [GO:0003677]; apoptotic DNA fragmentation [GO:0006309]; DNA metabolic process [GO:0006259]; erythrocyte differentiation [GO:0030218]; regulation of immune response [GO:0050776],NA,NA,NA
CHOYP_LOC100891402.2.3.m.27268,-0.002647926,-0.002789123,No,NA,NA,NA,NA,NA,NA,proteasome complex [GO:0000502]; proteasome regulatory particle; lid subcomplex [GO:0008541]; double-strand break repair via homologous recombination [GO:0000724]; mRNA export from nucleus [GO:0006406]; proteasome assembly [GO:0043248],NA,NA,NA
CHOYP_LOC100891466.2.10.m.9752,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100891502.1.1.m.14627,-0.005720107,-0.004396646,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100891594.2.2.m.54602,0.016552847,-0.012677855,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC100891656.1.1.m.62466,-0.019477389,-0.000694388,No,NA,NA,NA,NA,NA,NA,ADP binding [GO:0043531]; sequence-specific DNA binding [GO:0043565],NA,NA,NA
CHOYP_LOC100891888.1.1.m.20756,-0.005838524,-0.007117162,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; inositol monophosphate phosphatase activity [GO:0052834]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; inositol biosynthetic process [GO:0006021]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100892150.1.1.m.10319,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100892181.1.1.m.49777,0.006415558,-0.008487903,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; peptidase inhibitor activity [GO:0030414]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052],NA,NA,NA
CHOYP_LOC100892193.1.5.m.13369,-0.005984745,-0.000421153,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; regulation of apoptotic process [GO:0042981],NA,NA,NA
CHOYP_LOC100892193.2.5.m.28130,0.014390558,0.003781169,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; regulation of apoptotic process [GO:0042981],NA,NA,NA
CHOYP_LOC100892461.2.2.m.55369,0.00962611,0.007277169,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100892516.1.1.m.38152,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100892637.1.1.m.49164,-0.004266342,-0.005850926,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100892743.1.1.m.55850,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; CD27 receptor binding [GO:0005175]; tumor necrosis factor receptor binding [GO:0005164]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; activation-induced cell death of T cells [GO:0006924]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030],NA,NA,NA
CHOYP_LOC100892914.1.1.m.53491,-0.005170771,0.004295871,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100892925.1.2.m.44655,-0.011545352,0.017051168,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008]; TRAPPI protein complex [GO:1990070]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888],NA,NA,NA
CHOYP_LOC100893261.2.3.m.49437,-0.009301306,0.000185675,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; serine-type peptidase activity [GO:0008236],NA,NA,NA
CHOYP_LOC100893889.1.2.m.7738,-0.00510023,0.017469273,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100893889.2.2.m.64935,0.004150413,0.021189684,No,NA,NA,NA,NA,NA,NA,myosin complex [GO:0016459]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100893981.1.1.m.56774,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608],NA,NA,NA
CHOYP_LOC100897892.1.1.m.1462,0.001203599,-0.001541122,No,NA,NA,NA,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; multicellular organism development [GO:0007275]; protein refolding [GO:0042026]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to heat [GO:0009408]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_LOC100898095.9.19.m.32685,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100898860.1.1.m.7386,0.01547354,0.007888803,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; aminoacyl-tRNA hydrolase activity [GO:0004045],NA,NA,NA
CHOYP_LOC100899149.1.2.m.6146,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100899149.2.2.m.29105,-0.020876209,-0.005804671,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100899229.1.1.m.12157,0.00167245,-0.02138143,No,NA,NA,NA,NA,NA,NA,integral component of endoplasmic reticulum membrane [GO:0030176]; adult locomotory behavior [GO:0008344]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; regulation of dendrite development [GO:0050773]; sensory perception of sound [GO:0007605]; sequestering of triglyceride [GO:0030730],NA,NA,NA
CHOYP_LOC100899437.1.1.m.28953,-0.015291,-0.010768949,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100899732.1.1.m.26595,0.012168184,-0.014960653,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100899882.1.3.m.27725,-0.022564823,0.009988827,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100900162.1.1.m.58237,-0.000555323,-0.013167196,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; identical protein binding [GO:0042802]; camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416],NA,NA,NA
CHOYP_LOC100900174.1.1.m.14983,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_LOC100900429.1.1.m.13158,-0.017327211,0.013970607,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; ionotropic glutamate receptor activity [GO:0004970],NA,NA,NA
CHOYP_LOC100900935.1.1.m.56691,-0.012134966,0.013191893,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; vesicle membrane [GO:0012506]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; G protein-coupled receptor signaling pathway [GO:0007186]; glycerolipid metabolic process [GO:0046486]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493],NA,NA,NA
CHOYP_LOC100900939.1.1.m.15284,-0.012965381,0.002285206,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; activating transcription factor binding [GO:0033613]; DNA helicase activity [GO:0003678]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; identical protein binding [GO:0042802]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein homooligomerization [GO:0051260]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395],NA,NA,NA
CHOYP_LOC100901947.1.1.m.7834,-0.013301161,0.002249495,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]; aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100901947.1.1.m.7835,-6.34E-05,-0.001304053,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nuclear chromosome; telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; chromatin silencing at telomere [GO:0006348]; DNA packaging [GO:0006323]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; histone H4 acetylation [GO:0043967]; internal protein amino acid acetylation [GO:0006475]; response to nutrient [GO:0007584],NA,NA,NA
CHOYP_LOC100902046.1.1.m.11187,-0.007530575,0.000211699,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; negative regulation of ribosome biogenesis [GO:0090071]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of translation [GO:0006417]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC100902075.1.1.m.10103,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100902565.1.1.m.19044,0.010463063,-0.000863479,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311],NA,NA,NA
CHOYP_LOC100902628.1.1.m.1200,0.006474012,0.001887529,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_LOC100902807.1.4.m.12152,0.01388263,-0.016924087,No,NA,NA,NA,NA,NA,NA,anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; cell-cell adhesion mediator activity [GO:0098632]; axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991],NA,NA,NA
CHOYP_LOC100902807.4.4.m.59166,-0.001147969,-0.013766102,No,NA,NA,NA,NA,NA,NA,anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; cell-cell adhesion mediator activity [GO:0098632]; axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991],NA,NA,NA
CHOYP_LOC100902912.1.1.m.9008,-0.011894246,-0.021761569,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; NAD+ kinase activity [GO:0003951]; protein homodimerization activity [GO:0042803]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741],NA,NA,NA
CHOYP_LOC100903522.1.3.m.2296,0.014448018,-0.000154524,No,NA,NA,NA,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA-templated transcription; initiation [GO:0006352]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_LOC100903758.1.1.m.43697,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity; acting on CH-OH group of donors [GO:0016614],NA,NA,NA
CHOYP_LOC100903812.1.1.m.65786,0.020778581,0.003464348,No,NA,NA,NA,NA,NA,NA,brush border [GO:0005903]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100903999.1.1.m.16840,-0.00721784,-0.01241827,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein phosphatase regulator activity [GO:0019888],NA,NA,NA
CHOYP_LOC100904232.1.1.m.38777,-0.000582721,0.016768555,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; establishment of natural killer cell polarity [GO:0001770]; intracellular protein transport [GO:0006886]; retrograde transport; endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100904451.3.11.m.13002,0.00344849,-0.013442073,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100904558.2.2.m.26621,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100905188.1.1.m.2446,0.014187421,0.004235202,No,NA,NA,NA,NA,NA,NA,inositol 2-dehydrogenase activity [GO:0050112]; oxidoreductase activity [GO:0016491]; inositol metabolic process [GO:0006020]; NADPH regeneration [GO:0006740],NA,NA,NA
CHOYP_LOC100905387.1.1.m.30579,-0.009734325,0.007092857,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_LOC100905729.1.3.m.13789,-0.002978176,0.009739582,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867],NA,NA,NA
CHOYP_LOC100906408.1.1.m.3002,0.022832584,-0.006964061,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100907253.3.3.m.27327,0.008768326,0.01981881,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100907408.1.1.m.24444,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; ciliary pocket membrane [GO:0020018]; cytoplasmic vesicle [GO:0031410]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; autophagosome maturation [GO:0097352]; cilium assembly [GO:0060271]; exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of synaptic vesicle cycle [GO:0098693]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_LOC100907708.1.1.m.16095,0.02036863,-0.001368849,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665],NA,NA,NA
CHOYP_LOC100907797.3.4.m.54168,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100907841.1.1.m.39986,0.006006794,0.016269122,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC100907845.2.3.m.23111,0.00505969,-0.012379026,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063],NA,NA,NA
CHOYP_LOC100908241.1.1.m.52509,-0.011526175,0.018385569,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; micro-ribonucleoprotein complex [GO:0035068]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter binding [GO:0001047]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity; cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity; cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087],NA,NA,NA
CHOYP_LOC100908688.1.5.m.30293,0.02043117,-0.014329871,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100909243.1.1.m.22728,-0.005132486,0.000777384,No,NA,NA,NA,NA,NA,NA,actin filament [GO:0005884]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; apoptotic process [GO:0006915]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077],NA,NA,NA
CHOYP_LOC100910862.2.2.m.45085,0.000788673,-0.017956295,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100914852.1.1.m.29079,-0.002518443,-0.010081528,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; prominosome [GO:0071914]; cholesterol binding [GO:0015485],NA,NA,NA
CHOYP_LOC100918713.1.1.m.17833,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100922782.1.1.m.5582,-0.007275425,0.020586107,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; trans-permethrin hydrolase activity [GO:0102209],NA,NA,NA
CHOYP_LOC100927475.1.1.m.28390,-0.005675668,-0.008726079,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; lipid droplet [GO:0005811]; carboxylic ester hydrolase activity [GO:0052689]; fatty-acyl-ethyl-ester synthase activity [GO:0030339]; methyl indole-3-acetate esterase activity [GO:0080030]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; acyl-CoA metabolic process [GO:0006637]; acylglycerol catabolic process [GO:0046464]; cholesterol biosynthetic process [GO:0006695]; epithelial cell differentiation [GO:0030855]; lipid catabolic process [GO:0016042]; medium-chain fatty acid metabolic process [GO:0051791]; response to toxic substance [GO:0009636]; short-chain fatty acid catabolic process [GO:0019626]; very-low-density lipoprotein particle assembly [GO:0034379],NA,NA,NA
CHOYP_LOC100929680.1.2.m.17333,0.005661478,0.003239651,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; nuclear chromatin [GO:0000790]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; p53 binding [GO:0002039]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response; signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by competitive promoter binding [GO:0010944]; O-glycan processing [GO:0016266]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],NA,NA,NA
CHOYP_LOC100929680.2.2.m.28318,-0.013880884,0.007361609,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; nuclear chromatin [GO:0000790]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; p53 binding [GO:0002039]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response; signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by competitive promoter binding [GO:0010944]; O-glycan processing [GO:0016266]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],NA,NA,NA
CHOYP_LOC100929997.1.1.m.23658,0.010775567,-0.009497926,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing; via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413],NA,NA,NA
CHOYP_LOC100931580.2.2.m.44310,0.008985986,0.013335333,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; endopeptidase activity [GO:0004175]; apoptotic process [GO:0006915]; cornification [GO:0070268]; epidermis development [GO:0008544]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; keratinization [GO:0031424],NA,NA,NA
CHOYP_LOC100932567.1.1.m.26590,-0.003711961,0.00174742,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]; regulation of microtubule polymerization [GO:0031113],NA,NA,NA
CHOYP_LOC100933241.16.45.m.30626,-0.014801935,-0.0176031,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100933589.3.3.m.59374,-0.004425976,-0.013760431,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100934353.1.1.m.11772,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101020089.1.1.m.9396,0.009555397,0.013450977,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC101033229.1.1.m.38291,-0.021893352,-0.000252082,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101040300.1.2.m.6533,0.016632362,0.013474207,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC101058182.1.1.m.57909,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101060411.1.1.m.54761,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101061101.1.1.m.50165,0.013909459,0.008881439,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101061332.1.1.m.25069,0.022729546,-0.002547364,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631],NA,NA,NA
CHOYP_LOC101061667.1.1.m.8351,0.008114043,0.009102317,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC101062323.1.1.m.15918,-0.004810511,-0.020351181,No,NA,NA,NA,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]; cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LOC101062578.1.1.m.56255,-0.014551971,0.006920158,No,NA,NA,NA,NA,NA,NA,microtubule cytoskeleton [GO:0015630]; microtubule binding [GO:0008017],NA,NA,NA
CHOYP_LOC101063181.1.1.m.12864,-0.005137202,-0.001481097,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]; tRNA (guanine-N7)-methylation [GO:0106004]; tRNA modification [GO:0006400],NA,NA,NA
CHOYP_LOC101063699.1.1.m.18944,-0.012501452,0.001643104,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_LOC101063838.1.1.m.50540,0.003866983,0.001834012,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465],NA,NA,NA
CHOYP_LOC101063890.1.1.m.7895,-0.014086095,0.009026708,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; phagocytosis; recognition [GO:0006910]; photoreceptor cell maintenance [GO:0045494]; positive regulation of phagocytosis [GO:0050766]; protein localization to cilium [GO:0061512]; protein localization to photoreceptor outer segment [GO:1903546]; receptor localization to non-motile cilium [GO:0097500]; response to hormone [GO:0009725]; retina development in camera-type eye [GO:0060041]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_LOC101064182.1.1.m.8320,-4.34E-05,-0.004943838,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483],NA,NA,NA
CHOYP_LOC101064328.2.3.m.57090,-0.015492746,-0.000322884,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; thiopurine S-methyltransferase activity [GO:0008119]; response to organic cyclic compound [GO:0014070]; response to testosterone [GO:0033574],NA,NA,NA
CHOYP_LOC101064384.1.1.m.19175,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,nuclear envelope [GO:0005635]; nuclear lamina [GO:0005652]; nuclear membrane [GO:0031965]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; phospholipid binding [GO:0005543]; single-stranded DNA binding [GO:0003697]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC101064472.1.1.m.66819,0.003752211,-0.004083548,No,NA,NA,NA,NA,NA,NA,collagen type XII trimer [GO:0005595]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC101064693.1.2.m.30288,-0.020863639,-0.001897144,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC101064793.1.1.m.27191,-0.004618285,0.00307047,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription; DNA-templated [GO:0045892]; protein folding [GO:0006457]; regulation of transcription; DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041],NA,NA,NA
CHOYP_LOC101065149.1.1.m.49591,0.011269239,0.014044992,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; ceramidase activity [GO:0102121]; hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; N-acylsphingosine amidohydrolase activity [GO:0017040]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; response to organic substance [GO:0010033],NA,NA,NA
CHOYP_LOC101065571.1.2.m.36430,-0.022558901,0.009978395,No,NA,NA,NA,NA,NA,NA,acylphosphatase activity [GO:0003998],NA,NA,NA
CHOYP_LOC101065647.2.2.m.10863,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; glycine N-acyltransferase activity [GO:0047961],NA,NA,NA
CHOYP_LOC101065695.1.1.m.13611,0.019225411,0.006865868,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; zinc ion binding [GO:0008270]; mitochondrion organization [GO:0007005],NA,NA,NA
CHOYP_LOC101066074.1.1.m.19291,0.01764514,0.01020866,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101066924.1.1.m.16031,-0.01383764,0.004696527,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020]; mitochondrion [GO:0005739]; hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]; negative regulation of neurotransmitter secretion [GO:0046929]; neuromuscular process controlling posture [GO:0050884]; regulation of dopamine metabolic process [GO:0042053]; regulation of synaptic transmission; dopaminergic [GO:0032225],NA,NA,NA
CHOYP_LOC101067075.1.2.m.30552,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; chitin binding [GO:0008061]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC101067281.1.2.m.14666,-0.010630828,-0.015788323,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101067376.1.1.m.40668,0.014252133,0.009116855,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC101067698.2.2.m.27457,-0.022987934,0.001344628,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; hyperosmotic response [GO:0006972]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC101067777.1.1.m.52432,-0.007130715,0.014748605,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; macrophage colony-stimulating factor signaling pathway [GO:0038145]; Ras protein signal transduction [GO:0007265]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC101067857.1.1.m.36995,-0.008295887,0.004458667,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; ATP-dependent RNA helicase activity [GO:0004004]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; positive regulation of translation [GO:0045727]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; RNA secondary structure unwinding [GO:0010501]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784],NA,NA,NA
CHOYP_LOC101067905.1.1.m.42386,0.000908303,0.014388323,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; signaling receptor activity [GO:0038023]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731]; intracellular protein transport [GO:0006886]; IRES-dependent viral translational initiation [GO:0075522]; ribosome disassembly [GO:0032790],NA,NA,NA
CHOYP_LOC101068003.1.1.m.14900,-0.015306421,0.001512535,No,NA,NA,NA,NA,NA,NA,extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2-polyprenyl-6-methoxy-1;4-benzoquinone methyltransferase activity [GO:0008425]; 3-demethylubiquinone-10 3-O-methyltransferase activity [GO:0044596]; 3-demethylubiquinone-9 3-O-methyltransferase activity [GO:0008689]; decaprenyldihydroxybenzoate methyltransferase activity [GO:0044595]; hexaprenyldihydroxybenzoate methyltransferase activity [GO:0004395]; O-methyltransferase activity [GO:0008171]; glycerol metabolic process [GO:0006071]; regulation of ubiquinone biosynthetic process [GO:0010795]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_LOC101068028.1.1.m.48693,0.005697818,-0.013790107,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC101068272.1.3.m.40396,0.02201503,-0.011212945,No,NA,NA,NA,NA,NA,NA,endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; cell adhesion [GO:0007155]; cholesterol catabolic process [GO:0006707]; dendrite development [GO:0016358]; neuron remodeling [GO:0016322]; positive regulation of axon regeneration [GO:0048680]; positive regulation of neuron projection development [GO:0010976]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_LOC101068378.2.3.m.20090,-0.011154559,-0.003509035,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC101068378.3.3.m.29759,0.021281363,-0.011906783,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_LOC101068677.1.1.m.30685,0.009778515,-0.00950892,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine/threonine kinase activity [GO:0004674]; exocytosis [GO:0006887]; growth hormone secretion [GO:0030252]; neuron projection development [GO:0031175]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC101069006.1.2.m.5484,0.018087908,0.015881945,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; beta-N-acetylgalactosaminidase activity [GO:0032428]; beta-N-acetylhexosaminidase activity [GO:0004563]; enzyme activator activity [GO:0008047]; lipid transporter activity [GO:0005319]; phospholipase activator activity [GO:0016004]; ganglioside catabolic process [GO:0006689]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; nervous system process [GO:0050877]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313]; positive regulation of hydrolase activity [GO:0051345],NA,NA,NA
CHOYP_LOC101069440.1.3.m.4206,-0.00751995,-0.016615442,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; L-malate dehydrogenase activity [GO:0030060]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC101069440.2.3.m.16645,0.00436289,-0.007153074,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; L-malate dehydrogenase activity [GO:0030060]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC101069440.3.3.m.28439,0.016826304,-0.002927385,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; L-malate dehydrogenase activity [GO:0030060]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC101069588.1.1.m.34189,0.005523659,0.011964796,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; transketolase activity [GO:0004802]; regulation of growth [GO:0040008],NA,NA,NA
CHOYP_LOC101069759.1.1.m.40708,0.010050349,-0.000272359,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; threonine-type endopeptidase activity [GO:0004298]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_LOC101070424.1.1.m.64148,-0.00712663,0.002431774,No,NA,NA,NA,NA,NA,NA,mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_LOC101070553.1.1.m.9549,-0.010653562,0.000889743,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; cytoplasm [GO:0005737]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3;4;5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-4;5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4;5-bisphosphate phosphatase activity [GO:0106019]; inositol phosphate dephosphorylation [GO:0046855]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of translation [GO:0017148]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488],NA,NA,NA
CHOYP_LOC101070737.2.3.m.11531,-0.017854731,-0.001898051,No,NA,NA,NA,NA,NA,NA,mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_LOC101071050.1.1.m.38421,0.003178902,-0.014851614,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],NA,NA,NA
CHOYP_LOC101071230.1.1.m.22193,0.004428482,-0.004752377,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC101071441.1.1.m.64484,-0.002923634,-0.018584564,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA polymerase II; core complex [GO:0005665]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter [GO:0001193]; mRNA cleavage [GO:0006379]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_LOC101071891.1.2.m.31440,-0.016159547,0.000386674,No,NA,NA,NA,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735],NA,NA,NA
CHOYP_LOC101071902.1.1.m.49967,-0.008759452,-0.016118722,No,NA,NA,NA,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_LOC101072178.1.1.m.65566,0.002360268,0.012521508,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; palmitoyl-(protein) hydrolase activity [GO:0008474],NA,NA,NA
CHOYP_LOC101072591.1.1.m.1861,-0.009451101,-0.007747624,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; gastrulation [GO:0007369]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067]; protein localization to organelle [GO:0033365]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_LOC101072646.1.1.m.8800,0.010125798,-0.018689246,No,NA,NA,NA,NA,NA,NA,mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex; catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex; catalytic core F(1) [GO:0045261]; protein-containing complex binding [GO:0044877]; proton transmembrane transporter activity [GO:0015078]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_LOC101072885.1.1.m.63778,-0.00712988,-0.006160511,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC101072885.1.1.m.63779,-0.01479596,-0.003557542,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC101073830.1.1.m.42117,-0.007914435,-0.018740601,No,NA,NA,NA,NA,NA,NA,mediator complex [GO:0016592]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_LOC101075536.1.1.m.42991,-0.011789253,-0.010676204,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_LOC101075808.1.1.m.17712,-0.012116766,-0.00931201,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC101076145.1.1.m.26253,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101076180.1.1.m.41749,0.000705142,-0.018270237,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_LOC101076498.2.2.m.25096,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930],NA,NA,NA
CHOYP_LOC101076790.1.1.m.45316,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; membrane [GO:0016020]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241],NA,NA,NA
CHOYP_LOC101077059.1.1.m.57292,-0.017445345,-0.002096744,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]; Ras protein signal transduction [GO:0007265],NA,NA,NA
CHOYP_LOC101077542.1.1.m.58180,-0.007484993,0.012539932,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC101077597.2.3.m.25843,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101077787.2.3.m.65668,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nuclear pore [GO:0005643]; nuclear import signal receptor activity [GO:0061608]; RNA cap binding [GO:0000339]; import into nucleus [GO:0051170]; protein import into nucleus [GO:0006606]; snRNA import into nucleus [GO:0061015]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LOC101078033.1.1.m.42470,-0.00093845,0.001743497,No,NA,NA,NA,NA,NA,NA,caveola [GO:0005901]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; TSC1-TSC2 complex [GO:0033596]; GTPase activator activity [GO:0005096]; phosphatase binding [GO:0019902]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; aging [GO:0007568]; cell projection organization [GO:0030030]; establishment of cell polarity [GO:0030010]; establishment of protein localization [GO:0045184]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of macroautophagy [GO:0016242]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of pinocytosis [GO:0048550]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron projection development [GO:0010976]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; protein localization to cell surface [GO:0034394]; regulation of cell cycle [GO:0051726]; regulation of postsynapse organization [GO:0099175]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; social behavior [GO:0035176],NA,NA,NA
CHOYP_LOC101078145.1.1.m.54616,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; cellular response to insulin stimulus [GO:0032869]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of inflammatory response [GO:0050727]; regulation of kinase activity [GO:0043549]; regulation of phosphorylation [GO:0042325]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162]; TOR signaling [GO:0031929],NA,NA,NA
CHOYP_LOC101078252.1.1.m.39219,-0.001043023,-0.014523681,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101078542.1.1.m.44610,0.010479147,0.01568957,No,NA,NA,NA,NA,NA,NA,azurophil granule lumen [GO:0035578]; cortical actin cytoskeleton [GO:0030864]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; actin polymerization or depolymerization [GO:0008154]; activation of adenylate cyclase activity [GO:0007190]; ameboidal-type cell migration [GO:0001667]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; neutrophil degranulation [GO:0043312]; receptor-mediated endocytosis [GO:0006898]; regulation of adenylate cyclase activity [GO:0045761]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC101078914.1.1.m.34199,-0.014844182,-0.003496271,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; proline dehydrogenase activity [GO:0004657]; proline catabolic process to glutamate [GO:0010133],NA,NA,NA
CHOYP_LOC101079138.1.4.m.4320,-0.003490747,0.00346077,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101079642.1.1.m.56374,-0.014378781,-0.010084604,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101107626.1.1.m.1051,-0.008650273,-0.001014695,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to zinc ion [GO:0071294]; negative regulation of transcription; DNA-templated [GO:0045892]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC101154772.1.1.m.55397,-0.014973729,0.005214483,No,NA,NA,NA,NA,NA,NA,inositol-1;4-bisphosphate 1-phosphatase activity [GO:0004441]; metal ion binding [GO:0046872]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854],NA,NA,NA
CHOYP_LOC101155522.1.1.m.45101,-0.005088755,-0.017064042,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]; neuromuscular junction [GO:0031594]; type Ib terminal bouton [GO:0061176]; type Is terminal bouton [GO:0061177]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; chaeta development [GO:0022416]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; terminal button organization [GO:0072553],NA,NA,NA
CHOYP_LOC101155562.1.1.m.51414,-0.008901465,-0.006580485,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; poly(A) binding [GO:0008143]; negative regulation of mRNA polyadenylation [GO:1900364]; regulation of mRNA stability [GO:0043488],NA,NA,NA
CHOYP_LOC101155629.1.1.m.30633,0.009416549,-0.004621151,No,NA,NA,NA,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC101156197.1.1.m.31571,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-dependent DNA replication [GO:0006261]; nucleotide-excision repair; DNA gap filling [GO:0006297],NA,NA,NA
CHOYP_LOC101156767.1.1.m.65605,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; BMP signaling pathway [GO:0030509]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468],NA,NA,NA
CHOYP_LOC101156833.1.1.m.38739,0.018483962,0.003913532,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; lipid binding [GO:0008289],NA,NA,NA
CHOYP_LOC101156914.1.1.m.30383,-0.012533104,0.003928709,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101156984.2.2.m.22956,0.002423947,0.009134185,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457],NA,NA,NA
CHOYP_LOC101157039.2.2.m.54697,0.014139966,0.010805622,No,NA,NA,NA,NA,NA,NA,inosine nucleosidase activity [GO:0047724]; metal ion binding [GO:0046872]; uridine nucleosidase activity [GO:0045437]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_LOC101157079.2.2.m.7067,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; sperm head [GO:0061827]; sperm midpiece [GO:0097225]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of Wnt signaling pathway [GO:0030177]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC101157371.3.3.m.51109,0.019585821,0.005876603,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101157864.1.2.m.9913,-0.001477458,-0.021109756,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101157895.2.2.m.28009,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101158638.1.2.m.5931,0.003097607,0.000625532,No,NA,NA,NA,NA,NA,NA,AMPA glutamate receptor complex [GO:0032281]; basement membrane [GO:0005604]; cell junction [GO:0030054]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614]; synapse [GO:0045202]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of neuron differentiation [GO:0045666],NA,NA,NA
CHOYP_LOC101158638.2.2.m.27400,0.016031455,-0.008790155,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; extracellular region [GO:0005576]; synapse [GO:0045202]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC101158923.1.2.m.27410,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_LOC101159074.1.1.m.29872,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101159300.1.1.m.26609,-0.004109893,-0.007801367,No,NA,NA,NA,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC101159719.1.1.m.21443,-0.002129024,-0.018117577,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_LOC101160004.1.1.m.48946,0.002981509,0.021768805,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101160053.1.1.m.18848,0.003014363,-0.007337554,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC101160063.1.4.m.2465,0.007547409,-0.006077237,No,NA,NA,NA,NA,NA,NA,endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; cell adhesion [GO:0007155]; cholesterol catabolic process [GO:0006707]; dendrite development [GO:0016358]; neuron remodeling [GO:0016322]; positive regulation of axon regeneration [GO:0048680]; positive regulation of neuron projection development [GO:0010976]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_LOC101160163.2.2.m.44944,0.009745725,0.016761092,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; axon guidance receptor activity [GO:0008046]; PDZ domain binding [GO:0030165]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to thyroxine stimulus [GO:0097069]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dopaminergic neuron differentiation [GO:0071542]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; modulation of chemical synaptic transmission [GO:0050804]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to activity [GO:0014823]; response to thyroid hormone [GO:0097066]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_LOC101160363.1.1.m.194,-0.011553842,-0.003757207,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; succinate-hydroxymethylglutarate CoA-transferase activity [GO:0047369],NA,NA,NA
CHOYP_LOC101161108.1.1.m.52561,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; cell differentiation [GO:0030154]; mRNA transport [GO:0051028]; nuclear envelope organization [GO:0006998]; protein transport [GO:0015031]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC101161976.1.1.m.43986,0.005987786,0.023939726,No,NA,NA,NA,NA,NA,NA,3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; fatty acid elongation [GO:0030497],NA,NA,NA
CHOYP_LOC101162206.1.1.m.53261,-0.007330011,0.011310578,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101162499.1.1.m.47400,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867],NA,NA,NA
CHOYP_LOC101162528.1.1.m.17841,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446],NA,NA,NA
CHOYP_LOC101163682.1.1.m.10220,0.004140025,-0.006115629,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_LOC101164168.1.1.m.24728,0.002825019,-0.021508744,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; endosomal transport [GO:0016197]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058],NA,NA,NA
CHOYP_LOC101164444.1.1.m.42364,-0.004180526,-0.016689538,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1;2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1;2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]; lipid catabolic process [GO:0016042]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_LOC101164482.1.1.m.44586,0.005448443,-0.007434075,No,NA,NA,NA,NA,NA,NA,cell [GO:0005623]; clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]; intracellular protein transport [GO:0006886]; negative regulation of mitotic nuclear division [GO:0045839]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC101165304.1.1.m.54576,-0.010420446,-0.001275728,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; nucleolus [GO:0005730]; nucleus [GO:0005634]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptide-glutamate-N-acetyltransferase activity [GO:1990190]; peptide-serine-N-acetyltransferase activity [GO:1990189]; ribosome binding [GO:0043022]; N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; N-terminal peptidyl-serine acetylation [GO:0017198]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of maintenance of mitotic sister chromatid cohesion; centromeric [GO:2000719]; protein acetylation [GO:0006473],NA,NA,NA
CHOYP_LOC101165968.2.7.m.18121,-0.01070904,0.001024696,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955],NA,NA,NA
CHOYP_LOC101165968.3.7.m.49147,0.009615245,0.014482896,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC101165968.5.7.m.54243,-0.01947762,0.001722814,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955],NA,NA,NA
CHOYP_LOC101165968.6.7.m.55758,-0.022564013,0.009987387,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955],NA,NA,NA
CHOYP_LOC101166328.1.1.m.14447,-0.011681237,-0.017649655,No,NA,NA,NA,NA,NA,NA,intracellular [GO:0005622]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC101166335.1.1.m.5463,-0.014192789,-0.001039937,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_LOC101167642.1.1.m.31028,-0.007290958,-0.001091129,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703],NA,NA,NA
CHOYP_LOC101167938.1.1.m.27316,0.012598575,0.015958633,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC101168798.1.1.m.6128,0.006102029,0.000231078,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC101168834.1.1.m.9567,-0.001758838,-0.004008064,No,NA,NA,NA,NA,NA,NA,chromosome; telomeric region [GO:0000781]; condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear chromosome; telomeric region [GO:0000784]; nucleolus [GO:0005730]; spindle [GO:0005819]; protein-containing complex binding [GO:0044877]; telomerase inhibitor activity [GO:0010521]; telomerase RNA binding [GO:0070034]; mitotic metaphase plate congression [GO:0007080]; negative regulation of cell proliferation [GO:0008285]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomeric DNA binding [GO:1904744]; protein localization to chromosome; telomeric region [GO:0070198]; protein localization to nucleolus [GO:1902570]; regulation of protein stability [GO:0031647]; regulation of telomerase activity [GO:0051972]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_LOC101168891.1.1.m.30839,-0.006909395,0.007183474,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; lens development in camera-type eye [GO:0002088],NA,NA,NA
CHOYP_LOC101169131.2.2.m.32499,0.005017118,-0.012619038,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC101169402.1.1.m.7122,0.006157856,0.0061992,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; mRNA binding [GO:0003729],NA,NA,NA
CHOYP_LOC101169524.1.1.m.4630,0.002170332,-0.014310689,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; negative regulation of phosphatase activity [GO:0010923]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing; via transesterification reactions [GO:0000375]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC101169976.1.1.m.55723,-0.008231091,-0.020080503,No,NA,NA,NA,NA,NA,NA,nuclear chromosome; telomeric region [GO:0000784]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; replisome [GO:0030894]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; single-stranded DNA-dependent ATPase activity [GO:0043142]; DNA recombination [GO:0006310]; DNA replication; Okazaki fragment processing [GO:0033567]; DNA strand renaturation [GO:0000733]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-dependent DNA replication [GO:0006261]; innate immune response [GO:0045087]; regulation of DNA repair [GO:0006282]; regulation of DNA-dependent DNA replication initiation [GO:0030174],NA,NA,NA
CHOYP_LOC101170942.1.1.m.47597,0.008506361,0.012631764,No,NA,NA,NA,NA,NA,NA,cell body [GO:0044297]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosolic large ribosomal subunit [GO:0022625]; dendrite [GO:0030425]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC101171340.1.1.m.29474,0.011526493,-0.012760438,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; atrioventricular valve formation [GO:0003190]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in heart formation [GO:0060974]; cell migration to the midline involved in heart development [GO:0003318]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion development [GO:0003197]; heart looping [GO:0001947]; hyaluronan catabolic process [GO:0030214]; muscle attachment [GO:0016203]; muscle tissue morphogenesis [GO:0060415]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_LOC101171379.1.1.m.27459,0.004802622,0.00375501,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; chordate embryonic development [GO:0043009]; mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine methylation; to symmetrical-dimethyl arginine [GO:0019918],NA,NA,NA
CHOYP_LOC101173065.1.1.m.11998,0.008118152,0.00611335,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC101173335.2.4.m.33982,0.022644559,-0.011692624,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC101173335.4.4.m.49816,0.001519526,0.005640766,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC101173404.1.1.m.27554,-0.007321992,0.001424039,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]; kinase binding [GO:0019900]; adenosine salvage [GO:0006169]; AMP salvage [GO:0044209]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC101173869.1.1.m.32090,-0.004490696,-0.002415786,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]; inositol bisphosphate phosphatase activity [GO:0016312]; inositol trisphosphate phosphatase activity [GO:0046030]; inositol-1;3;4;5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1;4;5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol trisphosphate phosphatase activity [GO:0034594]; phosphatidylinositol-3;4;5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4;5-bisphosphate 5-phosphatase activity [GO:0004439]; vasopressin receptor activity [GO:0005000]; cellular response to cAMP [GO:0071320]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to tumor necrosis factor [GO:0071356]; dephosphorylation [GO:0016311]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of dephosphorylation [GO:0035305]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of transcription; DNA-templated [GO:0045892]; neuromuscular junction development; skeletal muscle fiber [GO:0098529]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of renal water transport [GO:2001153]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of urine volume [GO:0035810]; protein localization to plasma membrane [GO:0072659]; regulation of glycogen biosynthetic process [GO:0005979]; response to insulin [GO:0032868]; ruffle assembly [GO:0097178],NA,NA,NA
CHOYP_LOC101174856.1.1.m.47585,-0.001157579,-0.010814895,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC101175128.1.1.m.13811,-0.010060098,0.008914317,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; photoreceptor cell cilium [GO:0097733]; photoreceptor outer segment [GO:0001750]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled [GO:0042623]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix; translocation [GO:0016561]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_LOC101175542.1.1.m.39653,0.006853136,-0.010827364,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; DNA-templated transcription; initiation [GO:0006352]; histone acetylation [GO:0016573]; regulation of signal transduction by p53 class mediator [GO:1901796]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC101175582.1.1.m.59321,-0.009101354,0.010611588,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; mRNA 3'-UTR binding [GO:0003730]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; transcription regulatory region DNA binding [GO:0044212]; cellular response to amino acid starvation [GO:0034198]; circadian rhythm [GO:0007623]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; response to peptide [GO:1901652],NA,NA,NA
CHOYP_LOC101175670.1.1.m.37,-0.003096904,-0.011051322,No,NA,NA,NA,NA,NA,NA,SH3 domain binding [GO:0017124],NA,NA,NA
CHOYP_LOC101234062.1.1.m.27366,-0.01443649,-0.002805931,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; coenzyme binding [GO:0050662]; identical protein binding [GO:0042802]; L-threonine 3-dehydrogenase activity [GO:0008743]; L-threonine catabolic process to glycine [GO:0019518]; threonine catabolic process [GO:0006567],NA,NA,NA
CHOYP_LOC101236385.3.6.m.4348,0.008129644,0.006177735,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC101238350.1.1.m.23002,-0.022562698,0.009985059,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC101242114.1.1.m.13149,0.018110677,-0.008410528,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829],NA,NA,NA
CHOYP_LOC101242248.1.2.m.24785,0.00543066,-0.003684986,No,NA,NA,NA,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC101242430.1.2.m.23519,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101345275.1.1.m.1796,0.004377086,-0.020921083,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101384981.1.1.m.53468,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC101416772.1.1.m.30815,0.018438755,0.014362549,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085],NA,NA,NA
CHOYP_LOC101439509.1.1.m.65851,-0.010753558,-0.024091463,No,NA,NA,NA,NA,NA,NA,blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; female pregnancy [GO:0007565],NA,NA,NA
CHOYP_LOC373223.1.1.m.48226,-0.003069853,0.012645241,No,NA,NA,NA,NA,NA,NA,apical dendrite [GO:0097440]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endosome [GO:0005768]; myelin sheath [GO:0043209]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; smooth endoplasmic reticulum [GO:0005790]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; cellular localization [GO:0051641]; early endosome to recycling endosome transport [GO:0061502]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_LOC373229.2.3.m.43412,0.00140027,-0.00433132,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063],NA,NA,NA
CHOYP_LOC373274.1.1.m.29721,0.021609755,-0.01181845,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; (1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC373275.4.7.m.47547,0.011418251,0.024214727,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; midbody [GO:0030496]; motile cilium [GO:0031514]; septin complex [GO:0031105]; spindle [GO:0005819]; GTP binding [GO:0005525]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cilium assembly [GO:0060271]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC373275.6.7.m.57854,-0.011693891,-0.003735368,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_LOC373275.7.7.m.63851,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_LOC408431.1.1.m.18046,0.009559076,0.01344866,No,NA,NA,NA,NA,NA,NA,adherens junction [GO:0005912]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription factor complex [GO:0005667]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; cytoskeleton organization [GO:0007010]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; ovarian follicle cell development [GO:0030707]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of imaginal disc growth [GO:0045572]; protein localization to centrosome [GO:0071539]; response to hypoxia [GO:0001666],NA,NA,NA
CHOYP_LOC408643.1.1.m.50154,0.007947045,-0.011760192,No,NA,NA,NA,NA,NA,NA,alcohol dehydrogenase (NAD) activity [GO:0004022]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC409619.1.4.m.13984,0.01223136,-0.000858048,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC410403.1.1.m.31535,-0.012415429,-0.009919726,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]; endopeptidase activator activity [GO:0061133]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; p53 binding [GO:0002039]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136],NA,NA,NA
CHOYP_LOC410511.1.2.m.10509,-0.010887635,-0.005357972,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; cellular response to starvation [GO:0009267]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of macroautophagy by TORC1 signaling [GO:1904766]; negative regulation of mitophagy [GO:1901525]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of TORC1 signaling [GO:1904263],NA,NA,NA
CHOYP_LOC411194.1.1.m.8502,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC412116.1.1.m.42829,-0.000222853,-0.004619738,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC413005.1.1.m.63172,-0.00645109,-0.019416534,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC420515.1.1.m.15613,0.004971003,-0.003483377,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_LOC494408.1.1.m.29208,-0.022373438,-0.0017497,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; peptidase inhibitor activity [GO:0030414]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052],NA,NA,NA
CHOYP_LOC496139.1.1.m.39321,-0.005748887,-0.008673036,No,NA,NA,NA,NA,NA,NA,CIA complex [GO:0097361]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428],NA,NA,NA
CHOYP_LOC549476.1.1.m.42388,0.001765901,0.008577911,No,NA,NA,NA,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; erythrocyte differentiation [GO:0030218]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC551931.1.1.m.9934,0.004098383,0.017075742,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phospholipid biosynthetic process [GO:0008654],NA,NA,NA
CHOYP_LOC552012.1.1.m.65224,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; blood coagulation [GO:0007596]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; positive regulation of mitotic nuclear division [GO:0045840]; regulation of DNA biosynthetic process [GO:2000278],NA,NA,NA
CHOYP_LOC552024.1.1.m.5290,0.015602705,-0.013694606,No,NA,NA,NA,NA,NA,NA,oxidoreductase activity [GO:0016491]; NADPH regeneration [GO:0006740],NA,NA,NA
CHOYP_LOC552081.1.1.m.51439,-0.000129213,-0.012399267,No,NA,NA,NA,NA,NA,NA,integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246]; calcium ion binding [GO:0005509]; calcium ion import [GO:0070509]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561],NA,NA,NA
CHOYP_LOC552559.1.2.m.39702,-0.002984085,-0.011911208,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LOC552662.1.1.m.15078,0.009556021,0.013450654,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; carbohydrate homeostasis [GO:0033500]; cell cycle [GO:0007049]; cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; miRNA catabolic process [GO:0010587]; mRNA polyadenylation [GO:0006378]; ncRNA polyadenylation [GO:0043629]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; negative regulation of telomere maintenance via telomerase [GO:0032211]; rRNA processing [GO:0006364]; snoRNA polyadenylation [GO:0071050],NA,NA,NA
CHOYP_LOC557305.1.1.m.18011,0.009683299,0.001126593,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ion channel binding [GO:0044325]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; protein localization to phagophore assembly site [GO:0034497]; protein localization to plasma membrane [GO:0072659]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC558150.4.4.m.53050,-0.007291165,-0.000138386,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750],NA,NA,NA
CHOYP_LOC558213.1.1.m.27293,8.65E-05,0.00054316,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA stem-loop binding [GO:0035613]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; B cell homeostasis [GO:0001782]; cellular response to interleukin-1 [GO:0071347]; cytoplasmic mRNA processing body assembly [GO:0033962]; lymph node development [GO:0048535]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of germinal center formation [GO:0002635]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of T-helper cell differentiation [GO:0045623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:0000288]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; posttranscriptional regulation of gene expression [GO:0010608]; protein polyubiquitination [GO:0000209]; regulation of gene expression [GO:0010468]; regulation of germinal center formation [GO:0002634]; regulation of miRNA metabolic process [GO:2000628]; regulation of mRNA stability [GO:0043488]; regulation of T cell receptor signaling pathway [GO:0050856]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470],NA,NA,NA
CHOYP_LOC559490.1.1.m.44696,-0.004988632,-0.006734577,No,NA,NA,NA,NA,NA,NA,microtubule [GO:0005874]; microtubule bundle [GO:0097427]; perinuclear region of cytoplasm [GO:0048471]; tubulin binding [GO:0015631]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273],NA,NA,NA
CHOYP_LOC562156.1.2.m.16403,-0.019887593,0.002429095,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887],NA,NA,NA
CHOYP_LOC564392.1.1.m.29701,0.004137978,-0.01680958,No,NA,NA,NA,NA,NA,NA,anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685],NA,NA,NA
CHOYP_LOC565211.1.2.m.34982,-0.001029406,-0.014531173,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC565211.2.2.m.55017,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC566621.1.1.m.45550,0.007809552,0.015690702,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446],NA,NA,NA
CHOYP_LOC566887.1.1.m.45765,0.011694035,-0.009390226,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC567383.1.1.m.16245,0.005871303,0.004184626,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]; oxidized purine DNA binding [GO:0032357]; single-stranded DNA binding [GO:0003697]; telomeric D-loop binding [GO:0061821]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA strand renaturation [GO:0000733]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of sister chromatid cohesion [GO:0045875]; pigmentation [GO:0043473]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820],NA,NA,NA
CHOYP_LOC567820.1.1.m.51203,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC569612.1.1.m.18528,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525],NA,NA,NA
CHOYP_LOC571721.1.3.m.36443,0.006967812,-0.005439948,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC571721.2.3.m.53122,-0.012107248,-0.021666959,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC574569.1.1.m.61069,0.000361115,0.012646542,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; plasma membrane [GO:0005886]; exocytosis [GO:0006887]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC574602.1.1.m.44079,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337],NA,NA,NA
CHOYP_LOC574740.1.1.m.29924,-0.015521705,-0.012771669,No,NA,NA,NA,NA,NA,NA,axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium movement [GO:0003341]; hematopoietic progenitor cell differentiation [GO:0002244]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC574855.1.9.m.547,0.011684686,0.011339481,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC574855.4.9.m.22339,0.007812061,0.015705916,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC574855.6.9.m.46549,0.014833893,0.016428237,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC574928.1.2.m.48221,0.012987119,0.000870689,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; cell differentiation [GO:0030154]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; TORC2 signaling [GO:0038203],NA,NA,NA
CHOYP_LOC574943.1.1.m.56446,0.009894838,0.00141235,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; nucleosomal DNA binding [GO:0031492]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; spindle assembly [GO:0051225],NA,NA,NA
CHOYP_LOC575058.1.1.m.9531,0.004661696,-0.005194921,No,NA,NA,NA,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_LOC575132.2.2.m.66125,0.005284279,-0.02306713,No,NA,NA,NA,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex scaffold activity [GO:0032947]; apoptotic process [GO:0006915]; negative regulation of cell proliferation [GO:0008285]; positive regulation of aminoacyl-tRNA ligase activity [GO:1903632]; positive regulation of protein ubiquitination [GO:0031398]; protein-containing complex assembly [GO:0065003]; translation [GO:0006412]; type II pneumocyte differentiation [GO:0060510],NA,NA,NA
CHOYP_LOC575161.4.5.m.42590,0.005367204,-0.004537769,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_LOC575161.5.5.m.55590,0.000182771,-0.016256163,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_LOC575203.2.6.m.6856,0.013619088,0.003627486,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC575203.6.6.m.30705,0.003426559,-0.016257286,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC575264.1.1.m.10111,-0.014897815,-0.006819204,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC575405.1.1.m.18640,0.017831578,-0.008049435,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245],NA,NA,NA
CHOYP_LOC575478.1.1.m.6923,-0.001023624,-0.014534126,No,NA,NA,NA,NA,NA,NA,RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC575509.2.2.m.63548,-0.022805095,0.010520261,No,NA,NA,NA,NA,NA,NA,axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285],NA,NA,NA
CHOYP_LOC575600.1.1.m.27851,-0.012233869,-0.007977221,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_LOC575625.1.2.m.50064,0.003472814,0.001538516,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; serine-type peptidase activity [GO:0008236]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_LOC575793.1.2.m.34690,-0.001926213,-0.014287223,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; preribosome; small subunit precursor [GO:0030688]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; cleavage involved in rRNA processing [GO:0000469]; maturation of SSU-rRNA [GO:0030490],NA,NA,NA
CHOYP_LOC575793.1.2.m.34691,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC575893.1.1.m.62614,0.006752557,-0.005657492,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; 6;7-dihydropteridine reductase activity [GO:0004155]; NADH binding [GO:0070404]; NADPH binding [GO:0070402]; L-phenylalanine catabolic process [GO:0006559]; tetrahydrobiopterin biosynthetic process [GO:0006729],NA,NA,NA
CHOYP_LOC575944.1.5.m.22547,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC575944.3.5.m.24887,0.009877908,0.006754096,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_LOC576041.1.1.m.28220,0.006230477,-0.011658346,No,NA,NA,NA,NA,NA,NA,carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539],NA,NA,NA
CHOYP_LOC576200.3.4.m.38681,-0.004696664,0.013006259,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC576326.1.1.m.49857,0.015192126,0.00018745,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848],NA,NA,NA
CHOYP_LOC576341.1.2.m.9414,-0.01161721,-0.003686435,No,NA,NA,NA,NA,NA,NA,centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; brain development [GO:0007420]; centriole elongation [GO:0061511]; ciliary basal body-plasma membrane docking [GO:0097711]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; neural plate axis specification [GO:0021997]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539]; protein processing [GO:0016485]; regulation of proteolysis [GO:0030162]; regulation of smoothened signaling pathway [GO:0008589],NA,NA,NA
CHOYP_LOC576498.1.1.m.10455,-0.018599321,-0.007649429,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; centriolar satellite [GO:0034451]; cilium [GO:0005929]; metal ion binding [GO:0046872]; inner dynein arm assembly [GO:0036159]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; positive regulation of motile cilium assembly [GO:1905505],NA,NA,NA
CHOYP_LOC576511.1.1.m.53180,-0.009570605,0.012294153,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457],NA,NA,NA
CHOYP_LOC576660.1.1.m.33760,-0.010832998,0.001880193,No,NA,NA,NA,NA,NA,NA,glycerol-3-phosphate dehydrogenase complex [GO:0009331]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [GO:0052591]; camera-type eye development [GO:0043010]; gluconeogenesis [GO:0006094]; glycerol catabolic process [GO:0019563]; glycerol-3-phosphate catabolic process [GO:0046168]; multicellular organism growth [GO:0035264],NA,NA,NA
CHOYP_LOC576665.1.2.m.10867,-0.023412585,0.00228528,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC576665.1.2.m.10868,-0.022792796,0.005553509,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; calmodulin binding [GO:0005516],NA,NA,NA
CHOYP_LOC576698.1.1.m.32335,-0.016800406,-0.020212035,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; NF-kappaB binding [GO:0051059]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092],NA,NA,NA
CHOYP_LOC576797.1.1.m.8986,-0.000730356,0.005735774,No,NA,NA,NA,NA,NA,NA,ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; cytoskeleton organization [GO:0007010]; DNA damage response; detection of DNA damage [GO:0042769]; motile cilium assembly [GO:0044458]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_LOC577063.1.1.m.30814,-0.020097922,-0.002253734,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; aging [GO:0007568]; angiogenesis [GO:0001525]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_LOC577184.1.1.m.62005,0.022391499,-0.009300566,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_LOC577190.1.1.m.18117,-0.007599706,-0.005406247,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K4 specific) [GO:0032453]; iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_LOC577313.2.5.m.45484,-0.018538481,0.010675235,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC577338.1.1.m.9819,-0.015482191,-0.001672109,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; RNA lariat debranching enzyme activity [GO:0008419]; mRNA processing [GO:0006397]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_LOC577351.1.1.m.17664,-0.018908425,-0.001039286,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC577371.1.2.m.46335,-0.018530945,-0.019166084,No,NA,NA,NA,NA,NA,NA,9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_LOC577550.1.1.m.36506,-0.011606832,-0.006663378,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; motile cilium [GO:0031514]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC577551.1.1.m.30278,-0.008231128,0.013496856,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; proteasome complex [GO:0000502]; proteasome binding [GO:0070628]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; negative regulation of proteasomal protein catabolic process [GO:1901799]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC577573.1.1.m.13979,-0.001679226,-0.011557234,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC577730.2.5.m.11065,-0.013877049,-0.015081662,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; Ragulator complex [GO:0071986]; cellular response to amino acid stimulus [GO:0071230]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of TOR signaling [GO:0032008]; protein localization to lysosome [GO:0061462]; regulation of cell size [GO:0008361]; viral genome replication [GO:0019079],NA,NA,NA
CHOYP_LOC577805.1.4.m.9698,-0.019692156,0.004311395,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_LOC577805.3.4.m.46026,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_LOC577905.1.2.m.2598,0.008900231,0.005941586,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; allantoinase activity [GO:0004038]; cobalt ion binding [GO:0050897]; zinc ion binding [GO:0008270]; allantoin catabolic process [GO:0000256],NA,NA,NA
CHOYP_LOC577931.3.3.m.35020,-0.001976811,-0.019730735,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; disordered domain specific binding [GO:0097718]; heparin binding [GO:0008201]; acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_LOC578003.1.1.m.64329,-0.010871735,-0.019433298,No,NA,NA,NA,NA,NA,NA,protein phosphatase 4 complex [GO:0030289]; protein phosphatase regulator activity [GO:0019888],NA,NA,NA
CHOYP_LOC578045.4.5.m.61073,0.007634218,-0.000329331,No,NA,NA,NA,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC578045.5.5.m.65293,-0.001796012,0.023411371,No,NA,NA,NA,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC578169.1.1.m.63470,-0.023329564,0.001639406,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC578260.1.1.m.21677,0.008490557,-0.015492953,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; microtubule binding [GO:0008017]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; peptidyl-cysteine S-nitrosylase activity [GO:0035605]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; microtubule cytoskeleton organization [GO:0000226]; neuron apoptotic process [GO:0051402]; peptidyl-cysteine S-trans-nitrosylation [GO:0035606]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC578280.1.1.m.42277,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],NA,NA,NA
CHOYP_LOC578284.1.1.m.30567,0.002325358,0.004083158,No,NA,NA,NA,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; heterochromatin organization [GO:0070828]; nucleosome assembly [GO:0006334]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC578349.1.1.m.51923,-0.0032917,-0.006383519,No,NA,NA,NA,NA,NA,NA,nonhomologous end joining complex [GO:0070419]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein-containing complex scaffold activity [GO:0032947]; cellular response to DNA damage stimulus [GO:0006974]; DNA ligation involved in DNA repair [GO:0051103]; double-strand break repair via nonhomologous end joining [GO:0006303],NA,NA,NA
CHOYP_LOC578371.1.1.m.56054,-0.023171929,0.000658105,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC578464.1.1.m.46553,0.007775162,-0.005185103,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; flavin adenine dinucleotide binding [GO:0050660]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661],NA,NA,NA
CHOYP_LOC578599.1.8.m.12749,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244],NA,NA,NA
CHOYP_LOC578599.8.8.m.57682,0.006467927,0.007001363,No,NA,NA,NA,NA,NA,NA,caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244],NA,NA,NA
CHOYP_LOC578600.1.1.m.45849,0.006708348,-0.011843281,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; magnesium ion binding [GO:0000287]; phosphatase binding [GO:0019902]; potassium channel inhibitor activity [GO:0019870]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; cellular response to calcium ion [GO:0071277]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; lymphocyte migration into lymph node [GO:0097022]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of GTPase activity [GO:0034260]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of kinase activity [GO:0033673]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of sodium ion transport [GO:0010766]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cellular process [GO:0050794]; regulation of sodium ion transport [GO:0002028]; signal transduction by trans-phosphorylation [GO:0023016]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_LOC578627.1.1.m.61950,-0.005055798,0.011493086,No,NA,NA,NA,NA,NA,NA,early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; lipid droplet [GO:0005811]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_LOC578656.8.15.m.42294,-0.015444965,-0.016797059,No,NA,NA,NA,NA,NA,NA,caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244],NA,NA,NA
CHOYP_LOC578656.9.15.m.53454,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041]; low-density lipoprotein particle receptor binding [GO:0050750]; in utero embryonic development [GO:0001701],NA,NA,NA
CHOYP_LOC578672.1.2.m.29847,-0.005729466,0.007224325,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; response to virus [GO:0009615]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_LOC578672.2.2.m.44884,-0.004139036,-0.01680174,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cell surface [GO:0009986]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic ribonucleoprotein granule [GO:0036464]; dendrite cytoplasm [GO:0032839]; inactive sex chromosome [GO:0098577]; kinetochore [GO:0000776]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; mitotic spindle midzone [GO:1990023]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; spindle pole [GO:0000922]; telomerase holoenzyme complex [GO:0005697]; actin binding [GO:0003779]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(C) RNA binding [GO:0017130]; poly(G) binding [GO:0034046]; pre-mRNA binding [GO:0036002]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; snRNA binding [GO:0017069]; telomerase RNA binding [GO:0070034]; TFIIH-class transcription factor complex binding [GO:0001097]; transcription corepressor activity [GO:0003714]; adaptive thermogenesis [GO:1990845]; cardiac muscle cell development [GO:0055013]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; CRD-mediated mRNA stabilization [GO:0070934]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; dosage compensation by inactivation of X chromosome [GO:0009048]; maintenance of protein location in nucleus [GO:0051457]; mRNA splicing; via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of kinase activity [GO:0033673]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; osteoblast differentiation [GO:0001649]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to spindle microtubule [GO:1902889]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of chromatin organization [GO:1902275]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic spindle assembly [GO:1901673]; RNA localization to chromatin [GO:1990280]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_LOC578680.1.1.m.49370,-0.023173134,-0.003879178,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC578781.1.5.m.2353,-0.001821354,0.003217902,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; actin filament binding [GO:0051015]; cytoskeleton organization [GO:0007010]; positive regulation of cytokinesis [GO:0032467]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_LOC578781.2.5.m.8827,0.012111415,0.004088313,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; actin filament binding [GO:0051015]; cytoskeleton organization [GO:0007010]; positive regulation of cytokinesis [GO:0032467]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_LOC578858.2.2.m.25157,-0.01346561,4.49E-05,No,NA,NA,NA,NA,NA,NA,acrosomal vesicle [GO:0001669]; sperm principal piece [GO:0097228]; calmodulin binding [GO:0005516]; SH3 domain binding [GO:0017124],NA,NA,NA
CHOYP_LOC578881.1.1.m.9743,0.020109215,0.007159866,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]; phosphatidylethanolamine biosynthetic process [GO:0006646],NA,NA,NA
CHOYP_LOC578897.1.1.m.11932,-0.02266496,0.010274019,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC578968.1.2.m.41294,-0.005392118,-0.013535663,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC578968.2.2.m.54316,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC578979.1.1.m.10409,-0.012074758,-0.007566879,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC579012.1.1.m.10830,-0.020356372,-0.010581408,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC579123.1.1.m.65215,0.001490727,-0.019501466,No,NA,NA,NA,NA,NA,NA,nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; circadian rhythm [GO:0007623]; detection of abiotic stimulus [GO:0009582]; DNA repair [GO:0006281]; DNA replication checkpoint [GO:0000076]; lung development [GO:0030324]; morphogenesis of an epithelium [GO:0002009]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of double-strand break repair [GO:2000781]; regulation of circadian rhythm [GO:0042752]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478],NA,NA,NA
CHOYP_LOC579332.1.1.m.41750,0.003215681,-0.02425353,No,NA,NA,NA,NA,NA,NA,cell leading edge [GO:0031252]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; trans-Golgi network [GO:0005802]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; cell activation involved in immune response [GO:0002263]; cellular response to virus [GO:0098586]; COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; establishment of monopolar cell polarity [GO:0061162]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi to endosome transport [GO:0006895]; neutrophil chemotaxis [GO:0030593]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to endoplasmic reticulum tubular network [GO:1903420]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of ARF protein signal transduction [GO:0032012]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport; endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC579381.1.1.m.10900,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC579644.1.1.m.16828,-0.015671193,0.002381836,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; histone kinase activity (H3-T3 specific) [GO:0072354]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore [GO:2000751]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; protein localization to chromosome; centromeric region [GO:0071459]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_LOC579656.3.5.m.41908,0.000951212,0.000672463,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; N-formylglutamate deformylase activity [GO:0050129]; serine-type peptidase activity [GO:0008236]; cellular amino acid biosynthetic process [GO:0008652]; neurotransmitter catabolic process [GO:0042135]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC579681.1.1.m.25827,0.002938033,0.016008155,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC579713.1.1.m.17440,0.000977527,-0.018737266,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC579737.1.1.m.14356,0.009357178,-0.013971679,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; aging [GO:0007568]; astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to lithium ion [GO:0010226]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC579832.2.2.m.47454,-0.013612719,0.001924846,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC579833.1.1.m.23271,0.017480823,-0.007456402,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_LOC579914.1.1.m.13347,-0.015286286,-0.002981935,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; dendritic spine [GO:0043197],NA,NA,NA
CHOYP_LOC579934.1.1.m.59523,-0.012679707,-0.018531487,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; 4-hydroxy-2-oxoglutarate aldolase activity [GO:0008700]; glyoxylate catabolic process [GO:0009436],NA,NA,NA
CHOYP_LOC579946.11.24.m.42367,-0.002766167,0.021384326,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC579946.17.24.m.53406,-0.001586805,0.000419944,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC579946.20.24.m.55163,0.005972204,-0.001484612,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis; engulfment [GO:0006911]; positive regulation of phagocytosis; engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_LOC579946.7.24.m.39737,0.022536608,-0.008604553,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_LOC580197.1.1.m.4591,0.0043282,-0.013103746,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC580207.1.1.m.49071,0.002029672,0.004222142,No,NA,NA,NA,NA,NA,NA,Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; protein transport [GO:0015031]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_LOC580355.1.1.m.29389,0.003109709,-0.006233122,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; peptidyltransferase activity [GO:0000048]; transferase activity; transferring amino-acyl groups [GO:0016755]; aging [GO:0007568]; cellular amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; peptide modification [GO:0031179]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638],NA,NA,NA
CHOYP_LOC580466.1.2.m.18704,0.005914511,-0.00032724,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; endodeoxyribonuclease activity; producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC580666.1.2.m.21929,-0.001805517,0.01151144,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC580669.1.1.m.7758,-0.008420158,-0.004103304,No,NA,NA,NA,NA,NA,NA,90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; ribosomal small subunit biogenesis [GO:0042274]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC580670.1.6.m.4085,-0.001263941,0.011089573,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; cholesterol homeostasis [GO:0042632]; negative regulation of bile acid biosynthetic process [GO:0070858],NA,NA,NA
CHOYP_LOC580670.5.6.m.34028,0.022179418,-0.007268256,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_LOC580670.6.6.m.40875,0.011850549,-0.020710466,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_LOC580675.1.1.m.44042,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_LOC580687.1.1.m.1044,0.013848202,0.003053101,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; DNA binding [GO:0003677]; transcription coregulator activity [GO:0003712]; acrosome assembly [GO:0001675]; cellular response to organic cyclic compound [GO:0071407]; defense response to bacterium [GO:0042742]; flagellated sperm motility [GO:0030317]; Leydig cell differentiation [GO:0033327]; luteinizing hormone secretion [GO:0032275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; positive regulation of cytokine production [GO:0001819]; positive regulation of testosterone secretion [GO:2000845]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of transcription; DNA-templated [GO:0006355]; spermatid nucleus differentiation [GO:0007289]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC580832.1.1.m.66146,-0.007803422,0.000380457,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lysine catabolic process [GO:0006554]; tryptophan metabolic process [GO:0006568],NA,NA,NA
CHOYP_LOC580840.1.1.m.45392,-0.016363655,-0.018233474,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_LOC581113.2.2.m.57598,-0.020156642,-0.009564836,No,NA,NA,NA,NA,NA,NA,apical part of cell [GO:0045177]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; pericentriolar material [GO:0000242]; protein-containing complex [GO:0032991]; centrosome cycle [GO:0007098]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; interkinetic nuclear migration [GO:0022027]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuron migration [GO:0001764]; neuronal stem cell population maintenance [GO:0097150]; non-motile cilium assembly [GO:1905515]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]; social behavior [GO:0035176],NA,NA,NA
CHOYP_LOC581128.1.1.m.46711,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; nucleolus [GO:0005730]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; protein glycosylation [GO:0006486]; protein localization to Golgi apparatus [GO:0034067]; protein localization to organelle [GO:0033365]; protein stabilization [GO:0050821]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_LOC581387.1.1.m.56997,-0.022229224,-0.007402601,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC581447.1.1.m.65782,0.014354161,0.015907582,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; DNA binding [GO:0003677]; oxidoreductase activity; acting on the CH-CH group of donors; NAD or NADP as acceptor [GO:0016628]; sterol biosynthetic process [GO:0016126],NA,NA,NA
CHOYP_LOC581452.2.4.m.25348,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC581452.3.4.m.41000,-0.004760978,-0.011235657,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC581491.1.2.m.56125,-0.0102182,-0.023805714,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; calmodulin binding [GO:0005516]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC581508.1.1.m.26966,0.00136609,-0.004398497,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; Ala-tRNA(Thr) hydrolase activity [GO:0106105]; aminoacyl-tRNA editing activity [GO:0002161]; D-tyrosyl-tRNA(Tyr) deacylase activity [GO:0051500]; tRNA binding [GO:0000049]; aminoacyl-tRNA metabolism involved in translational fidelity [GO:0106074]; tRNA metabolic process [GO:0006399],NA,NA,NA
CHOYP_LOC581594.2.3.m.34837,-0.004165074,-0.00828985,No,NA,NA,NA,NA,NA,NA,mitochondrial respiratory chain complex IV [GO:0005751]; electron transport chain [GO:0022900]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_LOC581711.1.1.m.14276,0.011822407,0.008094627,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein heterodimerization activity [GO:0046982]; rRNA (guanine) methyltransferase activity [GO:0016435]; chromatin organization [GO:0006325]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476],NA,NA,NA
CHOYP_LOC581748.1.1.m.47690,0.003425348,-0.005755378,No,NA,NA,NA,NA,NA,NA,cell septum [GO:0030428]; cell surface [GO:0009986]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; glucan endo-1;3-beta-D-glucosidase activity [GO:0042973]; glucan endo-1;3-beta-glucanase activity; C-3 substituted reducing group [GO:0052861]; glucan endo-1;4-beta-glucanase activity; C-3 substituted reducing group [GO:0052862]; metabolic process [GO:0008152]; septum digestion after cytokinesis [GO:0000920],NA,NA,NA
CHOYP_LOC581773.1.1.m.56865,-0.002856012,-0.005532216,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; intracellular [GO:0005622]; ionotropic glutamate receptor complex [GO:0008328]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; ankyrin repeat binding [GO:0071532]; GKAP/Homer scaffold activity [GO:0030160]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; receptor signaling complex scaffold activity [GO:0030159]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; somatostatin receptor binding [GO:0031877]; adult behavior [GO:0030534]; associative learning [GO:0008306]; brain morphogenesis [GO:0048854]; cytoskeletal anchoring at plasma membrane [GO:0007016]; dendritic spine morphogenesis [GO:0060997]; determination of affect [GO:0050894]; habituation [GO:0046959]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; negative regulation of actin filament bundle assembly [GO:0032232]; neuromuscular process controlling balance [GO:0050885]; olfactory behavior [GO:0042048]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission; glutamatergic [GO:0051968]; postsynaptic density assembly [GO:0097107]; protein localization to synapse [GO:0035418]; protein-containing complex assembly [GO:0065003]; regulation of AMPA receptor activity [GO:2000311]; righting reflex [GO:0060013]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; synaptic growth at neuromuscular junction [GO:0051124]; vocalization behavior [GO:0071625],NA,NA,NA
CHOYP_LOC581886.1.3.m.23639,-0.016989796,0.004154009,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC581927.10.27.m.32671,-0.003640354,-0.016409646,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275],NA,NA,NA
CHOYP_LOC581927.9.27.m.31886,-0.013111935,-0.001896408,No,NA,NA,NA,NA,NA,NA,endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport; endosome to plasma membrane [GO:1990126],NA,NA,NA
CHOYP_LOC582121.1.1.m.30176,-0.005306184,0.005271752,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058],NA,NA,NA
CHOYP_LOC582154.1.1.m.58922,0.023494545,0.002956083,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; 3-hydroxyanthranilate 3;4-dioxygenase activity [GO:0000334]; electron transfer activity [GO:0009055]; ferrous iron binding [GO:0008198]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; NAD biosynthetic process [GO:0009435]; neuron cellular homeostasis [GO:0070050]; quinolinate biosynthetic process [GO:0019805]; quinolinate metabolic process [GO:0046874]; response to cadmium ion [GO:0046686]; response to zinc ion [GO:0010043]; tryptophan catabolic process [GO:0006569],NA,NA,NA
CHOYP_LOC582174.2.16.m.16430,-0.008195233,-0.007406114,No,NA,NA,NA,NA,NA,NA,centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; calmodulin binding [GO:0005516]; protein-containing complex scaffold activity [GO:0032947]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; positive regulation of intracellular protein transport [GO:0090316]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC582178.1.1.m.42729,-0.004581763,-0.019765575,No,NA,NA,NA,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; plasma membrane respiratory chain complex I [GO:0045272]; 2 iron; 2 sulfur cluster binding [GO:0051537]; 4 iron; 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881],NA,NA,NA
CHOYP_LOC582352.1.1.m.30199,-0.019761818,0.00692905,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC582570.1.1.m.65944,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC582626.1.1.m.5567,-0.012085845,-0.02371778,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_LOC582726.1.1.m.29762,0.007950773,-0.013073979,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; ceramide-translocating ATPase activity [GO:0099038]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; phosphatidylethanolamine-translocating ATPase activity [GO:0090555]; transporter activity [GO:0005215]; xenobiotic transmembrane transporting ATPase activity [GO:0008559]; ceramide translocation [GO:0099040]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to drug [GO:0042493]; stem cell proliferation [GO:0072089]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_LOC582782.1.4.m.8110,0.011824133,0.002228483,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_LOC582782.4.4.m.62807,0.0092896,0.006425792,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_LOC582784.1.1.m.53921,-0.00822339,-0.011400087,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of translation [GO:0045727]; RNA export from nucleus [GO:0006405],NA,NA,NA
CHOYP_LOC582874.1.1.m.5135,0.008398693,-0.011944039,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; dipeptidyl-peptidase activity [GO:0008239]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC583072.4.25.m.20255,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC583138.1.1.m.8990,-0.017248143,0.005312041,No,NA,NA,NA,NA,NA,NA,phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_LOC583253.1.1.m.11773,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC583472.1.1.m.25642,-0.007307117,0.007347723,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; Ku70:Ku80 complex [GO:0043564]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome; telomeric region [GO:0000784]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; secretory granule lumen [GO:0034774]; site of DNA damage [GO:0090734]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA end binding [GO:0045027]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; transcription regulatory region DNA binding [GO:0044212]; ubiquitin protein ligase binding [GO:0031625]; activation of innate immune response [GO:0002218]; brain development [GO:0007420]; cell proliferation [GO:0008283]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fatty acid [GO:0071398]; cellular response to gamma radiation [GO:0071480]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; hematopoietic stem cell differentiation [GO:0060218]; innate immune response [GO:0045087]; negative regulation of t-circle formation [GO:1904430]; negative regulation of transcription; DNA-templated [GO:0045892]; neutrophil degranulation [GO:0043312]; positive regulation of catalytic activity [GO:0043085]; positive regulation of neurogenesis [GO:0050769]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of type I interferon production [GO:0032481]; protein localization to chromosome; telomeric region [GO:0070198]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of telomere maintenance [GO:0032204]; response to drug [GO:0042493]; telomere maintenance [GO:0000723],NA,NA,NA
CHOYP_LOC583843.1.1.m.11191,0.008961142,0.007528783,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; HAUS complex [GO:0070652]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225],NA,NA,NA
CHOYP_LOC583865.2.2.m.15485,-0.002250685,-0.004290864,No,NA,NA,NA,NA,NA,NA,histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; non-sequence-specific DNA binding; bending [GO:0044378]; nucleosome binding [GO:0031491]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; zinc ion binding [GO:0008270]; heart looping [GO:0001947]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC583890.1.1.m.14405,0.019780113,0.014328162,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; adenine binding [GO:0002055]; adenine phosphoribosyltransferase activity [GO:0003999]; AMP binding [GO:0016208]; adenine salvage [GO:0006168]; AMP salvage [GO:0044209]; purine ribonucleoside salvage [GO:0006166],NA,NA,NA
CHOYP_LOC583954.1.1.m.777,-0.015525487,-0.005736489,No,NA,NA,NA,NA,NA,NA,glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; amidase activity [GO:0004040]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_LOC584001.1.1.m.46452,-0.001603945,-0.012154281,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC584015.1.1.m.10227,-0.005051204,-0.007214134,No,NA,NA,NA,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]; identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385]; clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_LOC584052.1.1.m.6375,0.009560041,0.013447861,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122],NA,NA,NA
CHOYP_LOC584058.1.1.m.59244,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; mRNA processing [GO:0006397]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RNA processing [GO:0006396]; type I interferon signaling pathway [GO:0060337],NA,NA,NA
CHOYP_LOC584062.1.1.m.62279,-0.016048574,0.003519806,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; quercetin 2;3-dioxygenase activity [GO:0008127]; transcription coregulator activity [GO:0003712]; digestion [GO:0007586]; monocyte differentiation [GO:0030224]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC584095.1.1.m.6815,0.011536679,-0.02164453,No,NA,NA,NA,NA,NA,NA,alpha DNA polymerase:primase complex [GO:0005658]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron; 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleoside binding [GO:0001882]; nucleotide binding [GO:0000166]; cell proliferation [GO:0008283]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication; synthesis of RNA primer [GO:0006269]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via nonhomologous end joining [GO:0006303]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272],NA,NA,NA
CHOYP_LOC584238.1.1.m.30307,0.008336758,-0.019636229,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC584270.1.1.m.49225,0.001047782,0.015877721,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_LOC584281.1.1.m.34958,0.00805961,0.002572554,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; carboxylic acid binding [GO:0031406]; NAD binding [GO:0051287]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; oxidation-reduction process [GO:0055114]; succinate metabolic process [GO:0006105],NA,NA,NA
CHOYP_LOC584318.1.1.m.35309,0.009504352,0.00715678,No,NA,NA,NA,NA,NA,NA,ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; ribonucleoprotein complex binding [GO:0043021]; selenocysteine insertion sequence binding [GO:0035368]; selenocysteine incorporation [GO:0001514],NA,NA,NA
CHOYP_LOC584333.1.1.m.42540,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; L-ascorbate oxidase activity [GO:0008447],NA,NA,NA
CHOYP_LOC584364.2.2.m.57790,-0.003539091,0.005610749,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_LOC584368.1.2.m.10628,0.001882642,0.019054408,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; sarcoplasmic reticulum lumen [GO:0033018]; growth factor activity [GO:0008083]; lipid binding [GO:0008289]; dopaminergic neuron differentiation [GO:0071542]; neuron projection development [GO:0031175]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_LOC584392.1.1.m.24512,-0.011273767,-0.013037304,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484],NA,NA,NA
CHOYP_LOC584416.1.1.m.34286,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC584481.10.10.m.66365,0.003885799,-0.013127838,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; catalase activity [GO:0004096]; heme binding [GO:0020037]; hydroperoxide dehydratase activity [GO:0047987]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; oxylipin biosynthetic process [GO:0031408],NA,NA,NA
CHOYP_LOC584481.5.10.m.52126,0.008730519,-0.020990332,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; catalase activity [GO:0004096]; heme binding [GO:0020037]; hydroperoxide dehydratase activity [GO:0047987]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; oxylipin biosynthetic process [GO:0031408],NA,NA,NA
CHOYP_LOC584481.8.10.m.61433,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; catalase activity [GO:0004096]; heme binding [GO:0020037]; hydroperoxide dehydratase activity [GO:0047987]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; oxylipin biosynthetic process [GO:0031408],NA,NA,NA
CHOYP_LOC584567.1.1.m.29825,0.010577743,-0.001018067,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC584665.1.1.m.28760,-0.0137443,-0.010001548,No,NA,NA,NA,NA,NA,NA,signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC584905.1.1.m.51595,-0.020231587,0.005074835,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; response to X-ray [GO:0010165],NA,NA,NA
CHOYP_LOC585032.1.2.m.1235,0.003121361,-0.012739032,No,NA,NA,NA,NA,NA,NA,early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; membrane fusion [GO:0061025]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC585158.1.2.m.18137,-0.007809881,0.00021183,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; cell redox homeostasis [GO:0045454]; negative regulation of signal transduction [GO:0009968]; protein folding [GO:0006457]; response to pheromone [GO:0019236],NA,NA,NA
CHOYP_LOC585322.1.2.m.8217,-0.010955306,-0.001824767,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC585438.1.1.m.44017,-0.003878628,-0.011537675,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; hematopoietic stem cell homeostasis [GO:0061484]; inner cell mass cell differentiation [GO:0001826]; kidney development [GO:0001822]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of mitotic cell cycle [GO:0045930]; Notch signaling pathway [GO:0007219]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; ribosomal large subunit assembly [GO:0000027]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756],NA,NA,NA
CHOYP_LOC585494.1.1.m.64158,-0.007665872,0.014043323,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; histone deubiquitination [GO:0016578]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic cell cycle [GO:0000278]; mitotic nuclear division [GO:0140014]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of translational elongation [GO:0045901]; protein homotetramerization [GO:0051289]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC585591.1.1.m.62390,-0.013390403,-0.013148271,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC585638.1.1.m.10100,-0.013125297,-0.001882156,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; cell cycle arrest [GO:0007050]; negative regulation of autophagy [GO:0010507]; negative regulation of cell proliferation [GO:0008285],NA,NA,NA
CHOYP_LOC585734.1.1.m.36212,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC585839.1.1.m.51865,-0.015151565,0.001940164,No,NA,NA,NA,NA,NA,NA,axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]; regulation of cilium movement [GO:0003352],NA,NA,NA
CHOYP_LOC585963.1.2.m.36775,-0.009741491,-0.00323382,No,NA,NA,NA,NA,NA,NA,brush border [GO:0005903]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; midbody [GO:0030496]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; polysome [GO:0005844]; spindle [GO:0005819]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; mRNA 5'-UTR binding [GO:0048027]; RNA stem-loop binding [GO:0035613]; actin filament-based movement [GO:0030048]; adult heart development [GO:0007512]; aorta development [GO:0035904]; axon guidance [GO:0007411]; cardiac myofibril assembly [GO:0055003]; cardiac septum development [GO:0003279]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; cerebellar Purkinje cell layer development [GO:0021680]; coronary vasculature development [GO:0060976]; exocytosis [GO:0006887]; fourth ventricle development [GO:0021592]; in utero embryonic development [GO:0001701]; lateral ventricle development [GO:0021670]; mitotic cytokinesis [GO:0000281]; neuromuscular process controlling balance [GO:0050885]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; plasma membrane repair [GO:0001778]; positive regulation of protein secretion [GO:0050714]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of cell shape [GO:0008360]; retina development in camera-type eye [GO:0060041]; substrate-dependent cell migration; cell extension [GO:0006930]; third ventricle development [GO:0021678]; ventricular cardiac muscle cell development [GO:0055015],NA,NA,NA
CHOYP_LOC585972.1.1.m.25356,-0.013620779,-0.001838852,No,NA,NA,NA,NA,NA,NA,extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; 2-octaprenyl-6-methoxy-1;4-benzoquinone methylase activity [GO:0043333]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_LOC586005.1.1.m.63556,0.009491283,0.008206355,No,NA,NA,NA,NA,NA,NA,cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; Golgi-associated vesicle [GO:0005798]; plasma membrane [GO:0005886]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; cell morphogenesis [GO:0000902]; COPII vesicle coating [GO:0048208]; negative regulation of autophagosome assembly [GO:1902902]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein transport [GO:0051223]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_LOC586039.1.1.m.27100,0.00784649,0.007240446,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; N-acetylglucosamine kinase activity [GO:0045127]; N-acetylneuraminate catabolic process [GO:0019262],NA,NA,NA
CHOYP_LOC586044.1.1.m.60359,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311],NA,NA,NA
CHOYP_LOC586122.3.4.m.63155,0.014252955,0.014810314,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC586471.1.1.m.8913,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; ATP binding [GO:0005524]; chloride ion binding [GO:0031404]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; G/U mismatch-specific uracil-DNA glycosylase activity [GO:0043739]; magnesium ion binding [GO:0000287]; mismatched DNA binding [GO:0030983]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein self-association [GO:0043621]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; sodium ion binding [GO:0031402]; SUMO binding [GO:0032183]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]; base-excision repair; AP site formation [GO:0006285]; chromatin organization [GO:0006325]; depyrimidination [GO:0045008]; DNA demethylation [GO:0080111]; mismatch repair [GO:0006298]; negative regulation of chromatin binding [GO:0035562]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidative DNA demethylation [GO:0035511]; regulation of DNA N-glycosylase activity [GO:1902544]; regulation of embryonic development [GO:0045995]; regulation of gene expression; epigenetic [GO:0040029],NA,NA,NA
CHOYP_LOC586494.1.1.m.50214,-0.015523332,0.006421535,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; damaged DNA binding [GO:0003684]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; nucleoside monophosphate kinase activity [GO:0050145]; polynucleotide 3'-phosphatase activity [GO:0046403]; purine nucleotide binding [GO:0017076]; dephosphorylation [GO:0016311]; DNA 3' dephosphorylation involved in DNA repair [GO:0098504]; DNA damage response; detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; negative regulation of protein ADP-ribosylation [GO:0010836]; nucleotide phosphorylation [GO:0046939]; nucleotide-excision repair; DNA damage removal [GO:0000718]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314],NA,NA,NA
CHOYP_LOC586604.1.1.m.30509,-0.003534538,-0.010891286,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC586661.1.1.m.56660,-0.015938792,-0.014805344,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165],NA,NA,NA
CHOYP_LOC586678.1.1.m.35070,0.006595624,-0.024132815,No,NA,NA,NA,NA,NA,NA,MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; cristae formation [GO:0042407]; mitochondrial calcium ion homeostasis [GO:0051560],NA,NA,NA
CHOYP_LOC586835.1.1.m.9967,0.009026663,-0.017308489,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; dosage compensation by inactivation of X chromosome [GO:0009048]; mRNA export from nucleus [GO:0006406]; mRNA splice site selection [GO:0006376]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing; via spliceosome [GO:0048024],NA,NA,NA
CHOYP_LOC586835.1.1.m.9969,-0.018879896,0.004618234,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC586953.1.1.m.19600,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; cytoskeleton organization [GO:0007010]; epithelial cilium movement [GO:0003351]; motile cilium assembly [GO:0044458],NA,NA,NA
CHOYP_LOC587133.1.1.m.61281,0.008391301,0.008646561,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC587136.1.3.m.7607,0.00284189,-0.003153748,No,NA,NA,NA,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC587346.1.1.m.17791,0.007755877,0.001979052,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634]; positive regulation of cell migration [GO:0030335]; tRNA wobble uridine modification [GO:0002098],NA,NA,NA
CHOYP_LOC587439.1.1.m.45707,-0.010362306,-0.002980227,No,NA,NA,NA,NA,NA,NA,cell [GO:0005623]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482],NA,NA,NA
CHOYP_LOC587610.1.3.m.16984,0.020817603,-0.006709444,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; amylase activity [GO:0016160]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404]; carbohydrate catabolic process [GO:0016052]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC587610.3.3.m.27175,0.023366627,-0.006406286,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; amylase activity [GO:0016160]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404]; carbohydrate catabolic process [GO:0016052]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC587700.1.1.m.42534,-0.004620232,-0.024436182,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; isocitrate metabolic process [GO:0006102]; NADH metabolic process [GO:0006734]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC587705.1.2.m.11702,0.013498386,0.013520375,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; oxidoreductase activity [GO:0016491]; thiamine metabolic process [GO:0006772],NA,NA,NA
CHOYP_LOC587705.2.2.m.11817,0.006628734,0.007313569,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; oxidoreductase activity [GO:0016491]; thiamine metabolic process [GO:0006772],NA,NA,NA
CHOYP_LOC587740.1.4.m.22830,0.006565533,0.001611845,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC587752.1.1.m.66173,0.004608867,-0.003167406,No,NA,NA,NA,NA,NA,NA,acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 8-oxo-7;8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7;8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; ATP diphosphatase activity [GO:0047693]; GTP diphosphatase activity [GO:0036219]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; snoRNA binding [GO:0030515]; aging [GO:0007568]; dATP catabolic process [GO:0046061]; dGTP catabolic process [GO:0006203]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; male gonad development [GO:0008584]; purine nucleotide catabolic process [GO:0006195]; response to cadmium ion [GO:0046686],NA,NA,NA
CHOYP_LOC587791.2.3.m.33887,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC587803.1.1.m.9452,-0.006938159,-0.008949066,No,NA,NA,NA,NA,NA,NA,protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; protein C-terminal leucine carboxyl O-methyltransferase activity [GO:0018423]; tRNA methyltransferase activity [GO:0008175]; C-terminal protein methylation [GO:0006481]; tRNA methylation [GO:0030488]; wybutosine biosynthetic process [GO:0031591],NA,NA,NA
CHOYP_LOC587840.1.1.m.10143,-0.013487394,0.00918834,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]; glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311],NA,NA,NA
CHOYP_LOC587946.1.1.m.5037,-0.009661859,0.009259649,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC587966.1.1.m.10698,-0.004788921,0.007950041,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein kinase C binding [GO:0005080]; Rho GTPase binding [GO:0017048]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; regulation of cellular localization [GO:0060341],NA,NA,NA
CHOYP_LOC587972.1.2.m.3283,0.014198749,-0.018837805,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; beta-glucosidase activity [GO:0008422]; glycosylceramidase activity [GO:0017042]; lactase activity [GO:0000016]; carbohydrate metabolic process [GO:0005975]; polysaccharide digestion [GO:0044245],NA,NA,NA
CHOYP_LOC588385.1.2.m.18390,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC588440.1.1.m.4951,0.011254184,0.005857361,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; nucleus [GO:0005634]; signaling receptor binding [GO:0005102]; unfolded protein binding [GO:0051082]; mRNA modification [GO:0016556]; negative regulation of neurogenesis [GO:0050768]; protein folding [GO:0006457]; protein maturation [GO:0051604],NA,NA,NA
CHOYP_LOC588549.1.2.m.1855,0.008920645,-0.023988033,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; nuclear hormone receptor binding [GO:0035257]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region DNA binding [GO:0001012]; sequence-specific DNA binding [GO:0043565]; thyroid hormone receptor binding [GO:0046966]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; circadian rhythm [GO:0007623]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of JNK cascade [GO:0046329]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of fatty acid transport [GO:2000191]; regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter [GO:0072362]; regulation of lipid metabolic process [GO:0019216]; regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter [GO:0072368]; spindle assembly [GO:0051225]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC588572.1.2.m.17892,-0.01584461,-0.005671026,No,NA,NA,NA,NA,NA,NA,nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; mRNA splicing; via spliceosome [GO:0000398]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_LOC588827.1.1.m.11601,0.006524973,-0.008947125,No,NA,NA,NA,NA,NA,NA,anchored component of membrane [GO:0031225]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; proteasome complex [GO:0000502]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein targeting to ER [GO:0045047]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; SRP-dependent cotranslational protein targeting to membrane; translocation [GO:0006616],NA,NA,NA
CHOYP_LOC588883.2.3.m.14590,-0.016009799,-0.014681214,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_LOC588883.3.3.m.38321,0.003733875,-0.017119408,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_LOC588932.3.3.m.35464,0.010252961,-0.009408162,No,NA,NA,NA,NA,NA,NA,AP-1 adaptor complex [GO:0030121]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_LOC589108.1.2.m.9688,-0.01921028,-0.013964123,No,NA,NA,NA,NA,NA,NA,motile cilium [GO:0031514],NA,NA,NA
CHOYP_LOC589108.2.2.m.48073,0.019592203,-0.008949802,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; estrogen receptor binding [GO:0030331]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; cellular response to estrogen stimulus [GO:0071391]; establishment of protein localization [GO:0045184]; positive regulation of gene expression; epigenetic [GO:0045815]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; response to estrogen [GO:0043627]; response to progesterone [GO:0032570],NA,NA,NA
CHOYP_LOC589177.1.1.m.52878,-0.006892162,-0.01178647,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; hydrolase activity [GO:0016787]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_LOC589201.1.1.m.59863,-0.012841559,-0.018788618,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; early phagosome [GO:0032009]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; blood vessel morphogenesis [GO:0048514]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to molecule of fungal origin [GO:0071226]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; leukocyte activation involved in immune response [GO:0002366]; leukocyte cell-cell adhesion [GO:0007159]; lymph vessel development [GO:0001945]; macrophage activation involved in immune response [GO:0002281]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of mast cell degranulation [GO:0043306]; protein phosphorylation [GO:0006468]; regulation of arachidonic acid secretion [GO:0090237]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neutrophil degranulation [GO:0043313]; regulation of phagocytosis [GO:0050764]; regulation of platelet activation [GO:0010543]; regulation of platelet aggregation [GO:0090330]; regulation of superoxide anion generation [GO:0032928]; serotonin secretion by platelet [GO:0002554],NA,NA,NA
CHOYP_LOC589390.1.1.m.11589,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC589479.2.2.m.57247,-0.021381661,-0.005148019,No,NA,NA,NA,NA,NA,NA,axonemal central apparatus [GO:1990716]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; sperm principal piece [GO:0097228]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC589644.2.3.m.21781,-0.003730352,-0.010460109,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC589720.1.1.m.63687,-1.37E-05,-0.017358056,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; positive regulation of cytoskeleton organization [GO:0051495]; protein folding [GO:0006457],NA,NA,NA
CHOYP_LOC589750.3.5.m.42967,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC589839.1.1.m.29309,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ubiquitin-protein transferase activity [GO:0004842]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209],NA,NA,NA
CHOYP_LOC589952.1.5.m.2235,-0.013652244,-0.016085225,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; membrane [GO:0016020]; lipopolysaccharide binding [GO:0001530]; acute-phase response [GO:0006953]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; lipid transport [GO:0006869]; macrophage activation involved in immune response [GO:0002281]; positive regulation of tumor necrosis factor production [GO:0032760],NA,NA,NA
CHOYP_LOC589952.2.5.m.21623,-0.011395983,-0.013595383,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; membrane [GO:0016020]; lipopolysaccharide binding [GO:0001530]; acute-phase response [GO:0006953]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; lipid transport [GO:0006869]; macrophage activation involved in immune response [GO:0002281]; positive regulation of tumor necrosis factor production [GO:0032760],NA,NA,NA
CHOYP_LOC589952.3.5.m.29284,0.000125098,0.001116308,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; extracellular space [GO:0005615]; membrane [GO:0016020]; lipopeptide binding [GO:0071723]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; signaling receptor binding [GO:0005102]; acute-phase response [GO:0006953]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of molecule of bacterial origin [GO:0032490]; innate immune response [GO:0045087]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; lipopolysaccharide transport [GO:0015920]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macromolecule localization [GO:0033036]; macrophage activation involved in immune response [GO:0002281]; negative regulation of growth of symbiont in host [GO:0044130]; negative regulation of tumor necrosis factor production [GO:0032720]; opsonization [GO:0008228]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytolysis [GO:0045919]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of macrophage activation [GO:0043032]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis; engulfment [GO:0060100]; positive regulation of respiratory burst involved in inflammatory response [GO:0060265]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of membrane permeability [GO:0090559]; response to lipopolysaccharide [GO:0032496],NA,NA,NA
CHOYP_LOC589952.4.5.m.31147,-0.016735169,-0.003863404,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; extracellular space [GO:0005615]; membrane [GO:0016020]; lipopeptide binding [GO:0071723]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; signaling receptor binding [GO:0005102]; acute-phase response [GO:0006953]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of molecule of bacterial origin [GO:0032490]; innate immune response [GO:0045087]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; lipopolysaccharide transport [GO:0015920]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macromolecule localization [GO:0033036]; macrophage activation involved in immune response [GO:0002281]; negative regulation of growth of symbiont in host [GO:0044130]; negative regulation of tumor necrosis factor production [GO:0032720]; opsonization [GO:0008228]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytolysis [GO:0045919]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of macrophage activation [GO:0043032]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis; engulfment [GO:0060100]; positive regulation of respiratory burst involved in inflammatory response [GO:0060265]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of membrane permeability [GO:0090559]; response to lipopolysaccharide [GO:0032496],NA,NA,NA
CHOYP_LOC590125.6.7.m.53735,-0.00888825,0.003012329,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_LOC590298.2.3.m.4191,0.002331518,0.021928916,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; glycosylphosphatidylinositol phospholipase D activity [GO:0004621]; sodium channel regulator activity [GO:0017080]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to calcium ion [GO:0071277]; cellular response to cholesterol [GO:0071397]; cellular response to drug [GO:0035690]; cellular response to insulin stimulus [GO:0032869]; cellular response to pH [GO:0071467]; cellular response to triglyceride [GO:0071401]; chondrocyte differentiation [GO:0002062]; complement receptor mediated signaling pathway [GO:0002430]; GPI anchor release [GO:0006507]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell proliferation [GO:0008285]; negative regulation of triglyceride catabolic process [GO:0010897]; ossification [GO:0001503]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytolysis [GO:0045919]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of high-density lipoprotein particle clearance [GO:0010983]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of secretion [GO:0051047]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of cellular response to insulin stimulus [GO:1900076]; response to glucose [GO:0009749]; transepithelial transport [GO:0070633],NA,NA,NA
CHOYP_LOC590567.1.1.m.29483,-0.004856555,0.015069282,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; digestion [GO:0007586]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC590568.2.4.m.38593,0.005262849,-0.006936393,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC590633.1.1.m.32259,-0.008751721,0.000235045,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; tubular endosome [GO:0097422]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rab GTPase binding [GO:0017137]; SNARE binding [GO:0000149]; early endosome to late endosome transport [GO:0045022]; endosome to melanosome transport [GO:0035646]; negative regulation of SNARE complex assembly [GO:0035544]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031]; retrograde transport; endosome to plasma membrane [GO:1990126],NA,NA,NA
CHOYP_LOC590657.1.1.m.633,-0.007049585,0.005018522,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674],NA,NA,NA
CHOYP_LOC590657.1.1.m.634,0.000177444,0.023278436,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_LOC590729.1.1.m.35259,-0.01295259,-0.022715555,No,NA,NA,NA,NA,NA,NA,PeBoW complex [GO:0070545]; preribosome; large subunit precursor [GO:0030687],NA,NA,NA
CHOYP_LOC590756.2.6.m.28777,0.008899941,0.020413628,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC590756.3.6.m.40372,-0.004527447,-0.000500763,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC590756.4.6.m.48555,-0.018250284,-0.011947869,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; cilium assembly [GO:0060271]; determination of ventral identity [GO:0048264]; intraciliary transport [GO:0042073]; pronephros development [GO:0048793]; retina development in camera-type eye [GO:0060041],NA,NA,NA
CHOYP_LOC590931.1.1.m.7446,-0.014642873,-0.010110384,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; microtubule binding [GO:0008017]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; pronephros development [GO:0048793]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization [GO:0031113],NA,NA,NA
CHOYP_LOC590949.1.2.m.13540,-0.01866893,0.004736144,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; inositol-1;4;5-trisphosphate 3-kinase activity [GO:0008440]; cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; common myeloid progenitor cell proliferation [GO:0035726]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate metabolic process [GO:0032957]; MAPK cascade [GO:0000165]; myeloid cell homeostasis [GO:0002262]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neutrophil apoptotic process [GO:0033030]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of Ras protein signal transduction [GO:0046579]; positive thymic T cell selection [GO:0045059]; regulation of protein phosphorylation [GO:0001932]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC590969.1.1.m.15822,-0.003937117,-0.007224369,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC590971.1.1.m.30661,0.015334753,0.008132431,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; electron transfer activity [GO:0009055]; L-malate dehydrogenase activity [GO:0030060]; NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]; brain development [GO:0007420]; cellular amino acid metabolic process [GO:0006520]; G1 to G0 transition [GO:0070314]; gamma-aminobutyric acid metabolic process [GO:0009448]; glial cell development [GO:0021782]; glutamine metabolic process [GO:0006541]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; neural tube development [GO:0021915]; neuron projection development [GO:0031175]; regulation of gene expression [GO:0010468]; spinal cord development [GO:0021510]; taurine metabolic process [GO:0019530]; threonine metabolic process [GO:0006566],NA,NA,NA
CHOYP_LOC590989.3.3.m.32047,0.001101844,0.008985114,No,NA,NA,NA,NA,NA,NA,BRCA1-A complex [GO:0070531]; BRCA1-BARD1 complex [GO:0031436]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; RNA polymerase binding [GO:0070063]; transcription coactivator activity [GO:0003713]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; chordate embryonic development [GO:0043009]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair via homologous recombination [GO:0000724]; fatty acid biosynthetic process [GO:0006633]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of histone acetylation [GO:0035067]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_LOC591073.1.1.m.50375,-0.014713851,-0.006686637,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC591084.2.2.m.59355,-0.009396907,0.008809445,No,NA,NA,NA,NA,NA,NA,histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transferase activity; transferring acyl groups [GO:0016746]; eyelid development in camera-type eye [GO:0061029]; histone methylation [GO:0016571]; multicellular organism growth [GO:0035264]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; single fertilization [GO:0007338],NA,NA,NA
CHOYP_LOC591177.1.1.m.1476,0.003268524,0.019890262,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC591426.1.1.m.19353,0.002233366,-0.007999766,No,NA,NA,NA,NA,NA,NA,nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC591426.1.1.m.19354,0.006878457,0.000651097,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear pore nuclear basket [GO:0044615]; spindle [GO:0005819]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; kinetochore binding [GO:0043515]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538],NA,NA,NA
CHOYP_LOC591441.1.1.m.19965,0.007263811,0.008594228,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_LOC591570.1.1.m.4767,-0.022149911,0.011912756,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_LOC591690.1.1.m.30550,0.005169242,0.007413479,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; intracellular transport [GO:0046907]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC591797.1.3.m.11526,-0.010739855,0.003561716,No,NA,NA,NA,NA,NA,NA,ERCC4-ERCC1 complex [GO:0070522]; nuclear chromatin [GO:0000790]; nuclear chromosome; telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]; base-excision repair [GO:0006284]; cerebellum morphogenesis [GO:0021587]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; positive regulation of DNA ligase activity [GO:1904877]; positive regulation of single strand break repair [GO:1903518]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to drug [GO:0042493]; response to hydroperoxide [GO:0033194]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819]; voluntary musculoskeletal movement [GO:0050882],NA,NA,NA
CHOYP_LOC591797.1.3.m.11527,-0.01298102,-0.011756256,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; histone glutamine methylation [GO:1990258]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC591898.1.2.m.28918,0.010977287,0.006957457,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_LOC591898.2.2.m.29158,0.009212438,-0.009830799,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_LOC591926.1.1.m.27235,0.005065506,-0.021012416,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; rRNA import into mitochondrion [GO:0035928]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC591968.1.1.m.37093,0.004533966,-0.00121168,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; midbody [GO:0030496]; metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; abscission [GO:0009838]; cell division [GO:0051301]; mitotic cytokinesis checkpoint [GO:0044878]; negative regulation of cytokinesis [GO:0032466],NA,NA,NA
CHOYP_LOC592001.1.1.m.43470,-0.001606874,-0.017429776,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC592006.1.1.m.18498,0.004930041,-0.001709075,No,NA,NA,NA,NA,NA,NA,autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; autophagy [GO:0006914]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi ribbon formation [GO:0090161]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein targeting to vacuole [GO:0006623]; retrograde transport; endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280]; voluntary musculoskeletal movement [GO:0050882],NA,NA,NA
CHOYP_LOC592013.1.1.m.20072,-0.006658527,0.013359703,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041],NA,NA,NA
CHOYP_LOC592142.4.9.m.49474,-0.012040151,-0.001195289,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_LOC592142.5.9.m.53066,-0.01033383,0.009331958,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_LOC592142.6.9.m.54976,-0.010399337,0.000595832,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_LOC592142.7.9.m.55467,-0.010551108,0.004623872,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_LOC592209.1.1.m.48009,-0.02174948,-0.00720374,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC592215.1.1.m.34856,0.005665843,-0.01573874,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; oxidoreductase activity; acting on a sulfur group of donors; disulfide as acceptor [GO:0016671]; protein disulfide isomerase activity [GO:0003756]; protein disulfide oxidoreductase activity [GO:0015035]; 4-hydroxyproline metabolic process [GO:0019471]; cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; insulin processing [GO:0030070]; protein folding in endoplasmic reticulum [GO:0034975]; protein maturation by protein folding [GO:0022417],NA,NA,NA
CHOYP_LOC592357.1.1.m.27228,-0.011278656,0.003057898,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC592411.1.1.m.19664,-0.005724651,-0.018270661,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC592528.1.2.m.17290,0.01682483,-0.002092463,No,NA,NA,NA,NA,NA,NA,COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; protein deneddylation [GO:0000338],NA,NA,NA
CHOYP_LOC592585.1.1.m.51309,0.019886287,-0.004510847,No,NA,NA,NA,NA,NA,NA,anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; metalloexopeptidase activity [GO:0008235]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270]; antibiotic metabolic process [GO:0016999]; cellular lactam catabolic process [GO:0072340]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to nitric oxide [GO:0071732]; glutathione metabolic process [GO:0006749]; homocysteine metabolic process [GO:0050667]; leukotriene metabolic process [GO:0006691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC592624.1.1.m.45639,-0.02001136,-8.11E-05,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrion [GO:0005739],NA,NA,NA
CHOYP_LOC592709.1.1.m.22553,-0.011657117,0.00040001,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC592745.1.1.m.47718,0.003051543,0.002990794,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; nucleus [GO:0005634]; 3'-tyrosyl-DNA phosphodiesterase activity [GO:0017005]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284],NA,NA,NA
CHOYP_LOC592825.1.1.m.43751,-0.008873829,-0.016984217,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; SUMO-specific isopeptidase activity [GO:0070140]; protein desumoylation [GO:0016926],NA,NA,NA
CHOYP_LOC592857.1.1.m.62834,-0.019099231,-0.011179772,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC592888.1.1.m.63240,0.009541779,0.012638798,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; cell cycle [GO:0007049],NA,NA,NA
CHOYP_LOC592990.1.1.m.17663,0.007817287,-0.011689934,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_LOC593134.1.1.m.29711,0.000293655,-0.025037772,No,NA,NA,NA,NA,NA,NA,cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; regulation of vesicle targeting; to; from or within Golgi [GO:0048209]; retrograde transport; endosome to Golgi [GO:0042147]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_LOC593247.1.1.m.56872,-0.002829497,0.018704553,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; electron transfer activity [GO:0009055]; glutathione-disulfide reductase activity [GO:0004362]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599],NA,NA,NA
CHOYP_LOC593338.1.2.m.31413,-0.007956256,-0.009285671,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896],NA,NA,NA
CHOYP_LOC593467.2.4.m.66724,0.009768888,0.008902228,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC593522.1.2.m.5381,-0.01323278,-0.013505664,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; dendrite cytoplasm [GO:0032839]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription factor complex [GO:0090575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; activation of innate immune response [GO:0002218]; alternative mRNA splicing; via spliceosome [GO:0000380]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC593522.2.2.m.33858,-0.011252392,-0.00312443,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC593529.1.1.m.59343,-0.001020861,-0.021804578,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233],NA,NA,NA
CHOYP_LOC593558.3.4.m.36843,-0.001175257,-0.003296678,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; zonula adherens [GO:0005915]; delta-catenin binding [GO:0070097]; cardiac muscle cell differentiation [GO:0055007]; epithelial cell-cell adhesion [GO:0090136]; regulation of heart contraction [GO:0008016]; zonula adherens maintenance [GO:0045218],NA,NA,NA
CHOYP_LOC593741.1.1.m.11514,-0.017623572,0.001876591,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC594038.1.1.m.8864,0.006494183,0.001407381,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC594130.1.1.m.48747,-0.011124291,0.018674427,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; 4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572],NA,NA,NA
CHOYP_LOC594151.1.2.m.7270,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC594176.1.1.m.9662,-0.011223757,-0.000892714,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; anoikis [GO:0043276]; cell proliferation [GO:0008283]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; epidermis development [GO:0008544]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of G0 to G1 transition [GO:0070317]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA biosynthetic process [GO:2000278]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083],NA,NA,NA
CHOYP_LOC594315.1.1.m.28047,0.020340356,-0.005477958,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; RISC complex [GO:0016442]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; regulation of cell cycle process [GO:0010564]; RNA catabolic process [GO:0006401],NA,NA,NA
CHOYP_LOC594379.1.1.m.55370,-0.009416062,0.000563248,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC594407.1.1.m.38463,-0.005124527,0.006337513,No,NA,NA,NA,NA,NA,NA,early endosome [GO:0005769]; integral component of membrane [GO:0016021]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC594533.1.1.m.58830,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,cell projection [GO:0042995]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; non-motile cilium assembly [GO:1905515],NA,NA,NA
CHOYP_LOC594590.1.2.m.10772,-0.012818272,-0.014933091,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888],NA,NA,NA
CHOYP_LOC594665.1.1.m.8448,0.019402872,0.002111273,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; cytochrome-b5 reductase activity; acting on NAD(P)H [GO:0004128]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; hydrolase activity [GO:0016787]; iron-cytochrome-c reductase activity [GO:0047726]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric oxide dioxygenase activity [GO:0008941]; oxidoreductase activity [GO:0016491]; carnitine metabolic process [GO:0009437]; cellular organofluorine metabolic process [GO:0090346]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to peptide hormone stimulus [GO:0071375]; demethylation [GO:0070988]; fatty acid oxidation [GO:0019395]; flavonoid metabolic process [GO:0009812]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of lipase activity [GO:0060192]; nitrate catabolic process [GO:0043602]; nitric oxide catabolic process [GO:0046210]; oxidation-reduction process [GO:0055114]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC594665.1.1.m.8449,0.003181456,-0.009725684,No,NA,NA,NA,NA,NA,NA,chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC594676.1.1.m.8936,0.005900234,0.000162552,No,NA,NA,NA,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]; identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385]; clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_LOC654860.3.3.m.63750,-0.010661943,0.006599499,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome to plasma membrane transport vesicle [GO:0070381]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of membrane [GO:0031224]; membrane [GO:0016020]; neurofibrillary tangle [GO:0097418]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; vesicle [GO:0031982]; 1-phosphatidylinositol binding [GO:0005545]; amyloid-beta binding [GO:0001540]; cadherin binding [GO:0045296]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; Rab GTPase binding [GO:0017137]; tau protein binding [GO:0048156]; amyloid-beta clearance by transcytosis [GO:0150093]; axonogenesis [GO:0007409]; cargo loading into vesicle [GO:0035459]; cell proliferation [GO:0008283]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; dendrite morphogenesis [GO:0048813]; endosomal transport [GO:0016197]; hemopoiesis [GO:0030097]; iron ion homeostasis [GO:0055072]; iron ion import across plasma membrane [GO:0098711]; learning or memory [GO:0007611]; membrane bending [GO:0097753]; membrane organization [GO:0061024]; modulation of age-related behavioral decline [GO:0090647]; negative regulation of gene expression [GO:0010629]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron death [GO:1901216]; positive regulation of transcription; DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902959]; regulation of endocytosis [GO:0030100]; regulation of protein localization [GO:0032880]; regulation of vesicle size [GO:0097494]; synaptic vesicle maturation [GO:0016188]; vesicle budding from membrane [GO:0006900]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC654949.1.1.m.9313,-0.014492768,-0.02026407,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase I upstream activating factor complex [GO:0000500]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; transcription initiation from RNA polymerase I promoter [GO:0006361],NA,NA,NA
CHOYP_LOC654994.1.1.m.39461,-0.009989445,-0.011979673,No,NA,NA,NA,NA,NA,NA,histone methyltransferase complex [GO:0035097]; PTW/PP1 phosphatase complex [GO:0072357]; Set1C/COMPASS complex [GO:0048188]; chromatin binding [GO:0003682]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182],NA,NA,NA
CHOYP_LOC655520.2.2.m.14178,-0.005762772,-0.017676988,No,NA,NA,NA,NA,NA,NA,cell projection [GO:0042995]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular [GO:0005622]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; blastocyst formation [GO:0001825]; cardiac epithelial to mesenchymal transition [GO:0060317]; cerebral cortex radial glia guided migration [GO:0021801]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; endoplasmic reticulum tubular network organization [GO:0071786]; negative regulation of axon extension [GO:0030517]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell growth [GO:0030308]; nuclear pore complex assembly [GO:0051292]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERBB3 signaling pathway [GO:1905580]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of cell migration [GO:0030334],NA,NA,NA
CHOYP_LOC655529.1.3.m.1225,0.01018576,-0.00442468,No,NA,NA,NA,NA,NA,NA,intracellular [GO:0005622]; nucleus [GO:0005634]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor transcription coactivator activity [GO:0030374]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC655570.1.2.m.9210,-0.00835697,-0.008386982,No,NA,NA,NA,NA,NA,NA,endosome [GO:0005768]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; pectoral fin development [GO:0033339]; phosphatidylinositol phosphorylation [GO:0046854],NA,NA,NA
CHOYP_LOC656201.1.1.m.8657,-0.012538964,-0.014383518,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded RNA binding [GO:0003727]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC656402.1.1.m.62053,0.007693945,0.011328622,No,NA,NA,NA,NA,NA,NA,glucose binding [GO:0005536]; glycogenin glucosyltransferase activity [GO:0008466]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751]; glycogen biosynthetic process [GO:0005978],NA,NA,NA
CHOYP_LOC656459.1.1.m.34956,-0.016279677,0.009622577,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; glomerular filtration [GO:0003094]; protein processing [GO:0016485],NA,NA,NA
CHOYP_LOC656615.1.1.m.66274,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; GTPase activator activity [GO:0005096]; phosphatidylinositol binding [GO:0035091]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC656702.1.1.m.14425,0.017746014,0.005412936,No,NA,NA,NA,NA,NA,NA,brush border [GO:0005903]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; actin filament severing [GO:0051014]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC656741.1.1.m.19820,0.008790006,-0.018197082,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC656867.1.1.m.28658,0.006171921,0.005170841,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; serine-tRNA ligase activity [GO:0004828]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor production [GO:1904046]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434],NA,NA,NA
CHOYP_LOC656899.1.1.m.15417,-0.007217231,-0.008674174,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235],NA,NA,NA
CHOYP_LOC657235.1.1.m.1711,-0.00403952,0.012841031,No,NA,NA,NA,NA,NA,NA,plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase; V1 domain [GO:0000221]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; determination of adult lifespan [GO:0008340]; dsRNA transport [GO:0033227],NA,NA,NA
CHOYP_LOC657327.1.1.m.54811,-0.004196512,-0.011322662,No,NA,NA,NA,NA,NA,NA,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; tricellular tight junction [GO:0061689]; carbohydrate binding [GO:0030246]; scavenger receptor activity [GO:0005044]; cell-cell junction maintenance [GO:0045217]; establishment of endothelial intestinal barrier [GO:0090557]; liquid clearance; open tracheal system [GO:0035002]; regulation of tube length; open tracheal system [GO:0035159]; response to endoplasmic reticulum stress [GO:0034976]; tricellular tight junction assembly [GO:1904274],NA,NA,NA
CHOYP_LOC657378.1.1.m.14648,0.001773118,-0.017170117,No,NA,NA,NA,NA,NA,NA,brush border [GO:0005903]; cell cortex [GO:0005938]; cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; actin binding [GO:0003779]; Rac GTPase binding [GO:0048365]; signaling adaptor activity [GO:0035591]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266],NA,NA,NA
CHOYP_LOC657466.1.1.m.38710,-0.012542487,0.004485749,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_LOC657473.1.1.m.55374,-0.006298402,-0.016191235,No,NA,NA,NA,NA,NA,NA,cell leading edge [GO:0031252]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription factor complex [GO:0005667]; enzyme binding [GO:0019899]; LIM domain binding [GO:0030274]; RNA polymerase II activating transcription factor binding [GO:0001102]; transcription coregulator activity [GO:0003712]; epithelial structure maintenance [GO:0010669]; hair follicle development [GO:0001942]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of cellular component biogenesis [GO:0044089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of kinase activity [GO:0043549]; somatic stem cell population maintenance [GO:0035019],NA,NA,NA
CHOYP_LOC657674.1.1.m.21821,0.000431918,0.004603881,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; recycling endosome [GO:0055037]; ruffle membrane [GO:0032587]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of protein localization to plasma membrane [GO:1903078]; receptor internalization [GO:0031623]; regulation of collagen catabolic process [GO:0010710],NA,NA,NA
CHOYP_LOC657694.1.1.m.34526,0.003544278,0.006398546,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013],NA,NA,NA
CHOYP_LOC657811.1.1.m.29214,0.008106263,0.006049845,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; nuclear speck [GO:0016607]; Set1C/COMPASS complex [GO:0048188]; histone-lysine N-methyltransferase activity [GO:0018024]; RNA binding [GO:0003723]; histone H3-K4 methylation [GO:0051568],NA,NA,NA
CHOYP_LOC658003.1.1.m.29101,-0.002252864,0.008114096,No,NA,NA,NA,NA,NA,NA,cytoskeleton [GO:0005856],NA,NA,NA
CHOYP_LOC658092.1.2.m.22901,0.005926502,-0.020567342,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle; base subcomplex [GO:0008540]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_LOC658092.2.2.m.60940,-0.004583034,-0.001701468,No,NA,NA,NA,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_LOC658201.1.1.m.42880,0.012946395,-0.01913836,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198],NA,NA,NA
CHOYP_LOC658242.1.1.m.41709,-0.010320253,-0.011495967,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; membrane [GO:0016020]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036],NA,NA,NA
CHOYP_LOC658248.1.1.m.11054,-0.002110633,-0.020381735,No,NA,NA,NA,NA,NA,NA,aryl hydrocarbon receptor complex [GO:0034751]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; aryl hydrocarbon receptor binding [GO:0017162]; GAF domain binding [GO:0036004]; transcription coregulator activity [GO:0003712]; unfolded protein binding [GO:0051082]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; protein maturation by protein folding [GO:0022417]; protein targeting to mitochondrion [GO:0006626]; regulation of protein kinase A signaling [GO:0010738]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC658280.1.1.m.18469,-0.010214949,-0.008694769,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]; ubiquitin binding [GO:0043130]; protein processing [GO:0016485],NA,NA,NA
CHOYP_LOC658414.1.3.m.6219,0.004915557,-0.02178316,No,NA,NA,NA,NA,NA,NA,glutamatergic synapse [GO:0098978]; postsynaptic density; intracellular component [GO:0099092]; in utero embryonic development [GO:0001701],NA,NA,NA
CHOYP_LOC658593.1.1.m.25202,-0.0107795,-0.010977632,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; GTP binding [GO:0005525]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_LOC658611.1.1.m.11239,0.010685031,0.011536083,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_LOC658640.1.2.m.36016,0.005534881,-0.005273177,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC658640.2.2.m.56941,-0.00303204,-0.014123517,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC658895.1.1.m.20262,0.007870936,-0.006294549,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_LOC659024.1.2.m.31136,-0.003321173,0.000332027,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; AU-rich element binding [GO:0017091]; DNA binding [GO:0003677]; apoptotic process [GO:0006915]; germ cell development [GO:0007281]; positive regulation of cell proliferation [GO:0008284]; stem cell division [GO:0017145],NA,NA,NA
CHOYP_LOC659206.1.6.m.3536,0.014256082,-0.007194188,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; ribosome [GO:0005840]; RNA binding [GO:0003723]; selenocysteine insertion sequence binding [GO:0035368]; structural constituent of ribosome [GO:0003735]; liver regeneration [GO:0097421]; positive regulation of selenocysteine incorporation [GO:1904571]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC659206.6.6.m.43541,0.023576838,-0.006399563,No,NA,NA,NA,NA,NA,NA,collagen type I trimer [GO:0005584]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; cellular response to organic substance [GO:0071310]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; extracellular matrix organization [GO:0030198]; response to norepinephrine [GO:0071873],NA,NA,NA
CHOYP_LOC659226.1.3.m.16864,0.000366671,-0.020184043,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC659306.1.1.m.11580,0.009690194,-0.007420311,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC659398.1.1.m.9611,-0.007096352,-0.017440832,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC659409.1.1.m.24437,-0.010409401,-0.016122368,No,NA,NA,NA,NA,NA,NA,cell body [GO:0044297]; cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendrite extension [GO:1903861],NA,NA,NA
CHOYP_LOC659512.1.4.m.6122,-0.00969527,-0.012949459,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_LOC659512.3.4.m.26463,0.023510753,-0.001344681,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_LOC659512.4.4.m.31246,0.013090352,0.000894244,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_LOC659617.1.1.m.23473,-0.005528812,0.013495799,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_LOC659702.1.1.m.7231,-0.004082101,0.001666408,No,NA,NA,NA,NA,NA,NA,AP-type membrane coat adaptor complex [GO:0030119]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular protein transport [GO:0006886]; regulation of defense response to virus by virus [GO:0050690]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC659901.1.1.m.348,-0.013121744,-0.001885952,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274],NA,NA,NA
CHOYP_LOC659964.1.1.m.25995,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; mitotic cell cycle [GO:0000278]; negative regulation of neuroblast proliferation [GO:0007406]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064],NA,NA,NA
CHOYP_LOC660067.1.1.m.20126,0.006526251,-0.018852196,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; preribosome; small subunit precursor [GO:0030688]; rRNA (guanine) methyltransferase activity [GO:0016435]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]; enzyme-directed rRNA 2'-O-methylation [GO:0000453]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463]; rRNA methylation [GO:0031167],NA,NA,NA
CHOYP_LOC660183.1.1.m.8143,0.0027807,-0.024109118,No,NA,NA,NA,NA,NA,NA,COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; mannose binding [GO:0005537]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC660225.1.1.m.35196,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_LOC660225.1.1.m.35197,-0.009037101,0.000551813,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC660338.1.1.m.33595,0.015794036,-0.016789859,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; isomerase activity [GO:0016853]; apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_LOC660381.1.1.m.6379,-0.001354178,0.015268063,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; histone modification [GO:0016570]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; Notch signaling pathway [GO:0007219]; protein monoubiquitination [GO:0006513],NA,NA,NA
CHOYP_LOC660501.1.2.m.5218,-0.020029684,0.00168937,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC660501.2.2.m.19155,-0.018729562,0.010709058,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC660510.1.1.m.56258,0.00845049,0.012213157,No,NA,NA,NA,NA,NA,NA,external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; oxidoreductase activity [GO:0016491]; ultradian rhythm [GO:0007624],NA,NA,NA
CHOYP_LOC660560.1.4.m.31035,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC660560.1.4.m.31036,0.018425088,0.003598931,No,NA,NA,NA,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC660560.4.4.m.54542,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC660590.1.1.m.26950,-0.000328198,-0.012340546,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC660684.1.1.m.28592,-0.009870844,-0.006952157,No,NA,NA,NA,NA,NA,NA,apoplast [GO:0048046]; chloroplast [GO:0009507]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]; response to cadmium ion [GO:0046686],NA,NA,NA
CHOYP_LOC660898.1.1.m.38632,-0.001530359,-0.008483767,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC661043.1.1.m.11553,-0.003765228,-0.012219238,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; cell periphery [GO:0071944]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; proteoglycan binding [GO:0043394]; basement membrane organization [GO:0071711]; cell-matrix adhesion [GO:0007160]; extracellular matrix organization [GO:0030198]; glomerular basement membrane development [GO:0032836]; positive regulation of cell-substrate adhesion [GO:0010811],NA,NA,NA
CHOYP_LOC661226.1.1.m.62936,0.018811383,0.01887142,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; invadopodium [GO:0071437]; lamellipodium [GO:0030027]; microspike [GO:0044393]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; drug binding [GO:0008144]; protein binding; bridging [GO:0030674]; RNA binding [GO:0003723]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cell-cell junction assembly [GO:0007043]; cytokine-mediated signaling pathway [GO:0019221]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of cell polarity [GO:0007163]; microspike assembly [GO:0030035]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of podosome assembly [GO:0071803]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microvillus assembly [GO:0032534],NA,NA,NA
CHOYP_LOC661306.1.3.m.11419,0.01256646,-0.004741679,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; semaphorin receptor binding [GO:0030215]; defasciculation of motor neuron axon [GO:0007415]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; regulation of axonogenesis [GO:0050770]; Rho protein signal transduction [GO:0007266],NA,NA,NA
CHOYP_LOC661626.1.1.m.53878,-0.014883389,0.003163976,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum tubular network [GO:0071782]; perinuclear region of cytoplasm [GO:0048471]; erythropoietin receptor binding [GO:0005128]; interleukin-3 receptor binding [GO:0005135]; protein domain specific binding [GO:0019904]; Ral GTPase binding [GO:0017160]; receptor tyrosine kinase binding [GO:0030971]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of mitophagy [GO:1901525]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; proteasomal protein catabolic process [GO:0010498]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of lymphocyte differentiation [GO:0045619]; regulation of MAPK cascade [GO:0043408]; regulation of myeloid cell differentiation [GO:0045637]; regulation of protein kinase B signaling [GO:0051896]; regulation of reactive oxygen species metabolic process [GO:2000377],NA,NA,NA
CHOYP_LOC661769.1.1.m.10866,0.009797237,-0.002974036,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; negative regulation of translation [GO:0017148]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC661829.1.1.m.64858,-0.013818013,-0.014402731,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear cap binding complex [GO:0005846]; nucleus [GO:0005634]; RNA cap binding [GO:0000339]; 7-methylguanosine mRNA capping [GO:0006370]; gene silencing by RNA [GO:0031047]; mRNA cis splicing; via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC661955.1.1.m.37858,-0.008803787,-0.000894762,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020]; mitochondrion [GO:0005739]; calmodulin binding [GO:0005516]; mitochondrial respiratory chain complex I assembly [GO:0032981],NA,NA,NA
CHOYP_LOC662072.1.1.m.51458,-0.005841359,-0.012042691,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; calcium ion binding [GO:0005509]; calcium ion regulated exocytosis [GO:0017156],NA,NA,NA
CHOYP_LOC662115.2.2.m.15477,0.020313924,-0.000511541,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446],NA,NA,NA
CHOYP_LOC662190.1.3.m.1532,0.001939113,-0.004239105,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; head development [GO:0060322]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC662190.3.3.m.62554,0.011623206,-0.014484203,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; head development [GO:0060322]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC662211.1.1.m.23378,-0.004904529,-0.011280172,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; protein-containing complex [GO:0032991]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rap guanyl-nucleotide exchange factor activity [GO:0017034]; SH3 domain binding [GO:0017124]; activation of GTPase activity [GO:0090630]; activation of MAPKK activity [GO:0000186]; blood vessel development [GO:0001568]; cell-cell adhesion [GO:0098609]; cellular response to cAMP [GO:0071320]; cellular response to nerve growth factor stimulus [GO:1990090]; cytokine-mediated signaling pathway [GO:0019221]; establishment of endothelial barrier [GO:0061028]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of Ras protein signal transduction [GO:0046580]; nerve growth factor signaling pathway [GO:0038180]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Ras protein signal transduction [GO:0046579]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of JNK cascade [GO:0046328]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC662241.1.1.m.66905,0.004315505,-0.012406947,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC662320.1.2.m.18374,-0.008828539,-0.015959289,No,NA,NA,NA,NA,NA,NA,commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; hematopoietic stem cell differentiation [GO:0060218]; mRNA splicing; via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484],NA,NA,NA
CHOYP_LOC662320.2.2.m.19454,-0.004484012,-0.010657876,No,NA,NA,NA,NA,NA,NA,commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; mRNA binding [GO:0003729]; U1 snRNA binding [GO:0030619]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC662357.1.1.m.64851,-0.009118256,-0.0106886,No,NA,NA,NA,NA,NA,NA,beta-catenin-TCF complex [GO:1990907]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; canonical Wnt signaling pathway [GO:0060070]; chitin-based larval cuticle pattern formation [GO:0035293]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; leg disc pattern formation [GO:0035223]; segment polarity determination [GO:0007367]; sternite morphogenesis [GO:0007491]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_LOC662408.1.1.m.44393,-0.013183076,-0.002306571,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017],NA,NA,NA
CHOYP_LOC662543.1.1.m.39811,0.019848941,-0.01343047,No,NA,NA,NA,NA,NA,NA,blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097],NA,NA,NA
CHOYP_LOC662585.2.2.m.7262,0.006418701,0.011778061,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cytoplasmic microtubule organization [GO:0031122]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC663138.1.1.m.7661,-0.001051602,-0.014518569,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803]; adult locomotory behavior [GO:0008344]; cardiac muscle hypertrophy in response to stress [GO:0014898]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of axon regeneration [GO:0048681]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor recycling [GO:0001921]; regulation of cell motility [GO:2000145]; regulation of endocytic recycling [GO:2001135]; regulation of protein kinase B signaling [GO:0051896],NA,NA,NA
CHOYP_LOC663155.1.1.m.62768,-0.013842197,-0.011791108,No,NA,NA,NA,NA,NA,NA,mitochondrial sorting and assembly machinery complex [GO:0001401]; nucleolus [GO:0005730]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC663249.1.1.m.25441,-0.012450058,-0.002631654,No,NA,NA,NA,NA,NA,NA,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; catalytic activity [GO:0003824]; galactoside binding [GO:0016936]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803]; raffinose alpha-galactosidase activity [GO:0052692]; signaling receptor binding [GO:0005102]; glycoside catabolic process [GO:0016139]; glycosphingolipid catabolic process [GO:0046479]; glycosphingolipid metabolic process [GO:0006687]; glycosylceramide catabolic process [GO:0046477]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric-oxide synthase activity [GO:0051001]; neutrophil degranulation [GO:0043312]; oligosaccharide metabolic process [GO:0009311],NA,NA,NA
CHOYP_LOC663261.1.1.m.21784,0.001513532,-0.010782913,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; blastocyst formation [GO:0001825]; positive regulation of cell proliferation [GO:0008284]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; rRNA base methylation [GO:0070475],NA,NA,NA
CHOYP_LOC663375.1.1.m.11969,-0.010440836,-0.017298256,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA polymerase II transcription factor binding [GO:0001085]; female gonad development [GO:0008585]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to gonadotropin [GO:0034698],NA,NA,NA
CHOYP_LOC663422.1.1.m.57246,-0.004507919,-0.019074755,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development; heterochronic [GO:0040034],NA,NA,NA
CHOYP_LOC663424.1.2.m.49957,-0.011272348,0.010849258,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; lamellipodium [GO:0030027]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear speck [GO:0016607]; ruffle membrane [GO:0032587]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; kinase binding [GO:0019900]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; fibroblast migration [GO:0010761]; focal adhesion assembly [GO:0048041]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to plasma membrane [GO:0072659]; ruffle assembly [GO:0097178],NA,NA,NA
CHOYP_LOC663518.1.1.m.11968,-0.001466541,-0.010952613,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; compound eye development [GO:0048749]; mRNA methylation [GO:0080009]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; sex differentiation [GO:0007548]; wing disc pattern formation [GO:0035222],NA,NA,NA
CHOYP_LOC663776.1.1.m.66113,-0.003908021,0.015109701,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; nucleus [GO:0005634]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; histone H4-K20 trimethylation [GO:0034773]; muscle organ development [GO:0007517],NA,NA,NA
CHOYP_LOC663838.2.2.m.43318,-0.005486825,-0.003925343,No,NA,NA,NA,NA,NA,NA,apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC663855.2.5.m.747,0.021100986,-0.001122624,No,NA,NA,NA,NA,NA,NA,Z disc [GO:0030018]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; cardiac muscle thin filament assembly [GO:0071691]; muscle fiber development [GO:0048747],NA,NA,NA
CHOYP_LOC663855.5.5.m.51311,-0.013885933,-0.000501724,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; striated muscle dense body [GO:0055120]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC664087.1.1.m.19351,0.009263636,-0.000256992,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726],NA,NA,NA
CHOYP_LOC664138.1.1.m.26660,-0.022358738,0.000426419,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; zinc ion binding [GO:0008270]; negative regulation of pre-miRNA processing [GO:2000632]; oogenesis [GO:0048477]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of stem cell proliferation [GO:2000648]; regulation of transcription; DNA-templated [GO:0006355]; symmetric stem cell division [GO:0098724],NA,NA,NA
CHOYP_LOC664527.1.1.m.16232,0.001382475,-0.008043535,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC684934.1.1.m.1807,0.004736799,-0.008784851,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC689840.1.1.m.6512,-0.022620205,0.010465034,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC720058.1.1.m.11127,-0.017062414,-0.000384752,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC724172.1.1.m.24081,0.008571721,-0.004284426,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; protein kinase A binding [GO:0051018]; compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; short-term memory [GO:0007614],NA,NA,NA
CHOYP_LOC724467.1.1.m.38548,-0.005519459,0.017481836,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]; protein maturation by iron-sulfur cluster transfer [GO:0097428],NA,NA,NA
CHOYP_LOC725079.1.1.m.66349,-0.009237346,-0.007712073,No,NA,NA,NA,NA,NA,NA,bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; Golgi organization [GO:0007030],NA,NA,NA
CHOYP_LOC725565.1.1.m.19064,0.007110839,-0.007038885,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC725703.1.1.m.31182,-0.021789898,-0.004177718,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC726145.1.1.m.27163,-0.010737039,0.000297762,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524]; proteasome binding [GO:0070628]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209],NA,NA,NA
CHOYP_LOC732900.1.1.m.62814,-0.009810401,-0.025814102,No,NA,NA,NA,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; nucleoplasm [GO:0005654]; 4 iron; 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase activity [GO:0003954]; quinone binding [GO:0048038]; ubiquitin protein ligase binding [GO:0031625]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_LOC732961.1.1.m.29082,-0.012724374,0.008207614,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 7-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0047022]; acetoacetyl-CoA reductase activity [GO:0018454]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; steroid dehydrogenase activity [GO:0016229]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; acyl-CoA metabolic process [GO:0006637]; androgen metabolic process [GO:0008209]; ecdysone metabolic process [GO:0008205]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; mitochondrial tRNA processing [GO:0090646]; RNA phosphodiester bond hydrolysis; endonucleolytic [GO:0090502]; steroid metabolic process [GO:0008202],NA,NA,NA
CHOYP_LOC751836.2.6.m.25437,0.018566192,-0.009140543,No,NA,NA,NA,NA,NA,NA,azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body; internal vesicle [GO:0097487]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; cell-matrix adhesion [GO:0007160]; cellular protein localization [GO:0034613]; endosome to melanosome transport [GO:0035646]; neutrophil degranulation [GO:0043312]; pigment granule maturation [GO:0048757]; platelet degranulation [GO:0002576]; positive regulation of endocytosis [GO:0045807]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746],NA,NA,NA
CHOYP_LOC751836.5.6.m.43257,-0.005695866,0.002255795,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; vesicle [GO:0031982]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of endocytosis [GO:0045807]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC752244.2.2.m.45622,0.008781387,-0.002687157,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_LOC752782.1.1.m.53937,-0.004045632,-0.004930011,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC752782.1.1.m.53938,0.005592026,0.002056244,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC752884.1.1.m.4412,0.008278627,-0.002956385,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; negative regulation of signal transduction [GO:0009968],NA,NA,NA
CHOYP_LOC753176.3.3.m.54259,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_LOC753178.2.2.m.60569,-0.019925692,-0.002204065,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC753709.10.44.m.22246,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; RNA binding [GO:0003723]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC754102.1.1.m.57575,0.021464289,-0.003505876,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC754102.1.1.m.57578,-0.008009707,0.007381042,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_LOC754150.1.1.m.29730,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; modulation of chemical synaptic transmission [GO:0050804]; regulation of protein kinase A signaling [GO:0010738],NA,NA,NA
CHOYP_LOC754355.1.1.m.66745,-0.014967314,-0.002713701,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC754396.1.1.m.39126,0.01256369,-0.003998729,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; isomerase activity [GO:0016853]; L-fuconate dehydratase activity [GO:0050023]; magnesium ion binding [GO:0000287]; cellular carbohydrate catabolic process [GO:0044275],NA,NA,NA
CHOYP_LOC754557.1.2.m.5492,0.023580073,-0.007711987,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848],NA,NA,NA
CHOYP_LOC754557.2.2.m.22904,-0.011921341,-0.003156823,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848],NA,NA,NA
CHOYP_LOC754728.5.6.m.42237,-0.002777518,0.001352304,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275],NA,NA,NA
CHOYP_LOC754820.1.1.m.57329,0.005986179,0.012704507,No,NA,NA,NA,NA,NA,NA,DNA ligase IV complex [GO:0032807]; nonhomologous end joining complex [GO:0070419]; DNA end binding [GO:0045027]; double-strand break repair via nonhomologous end joining [GO:0006303],NA,NA,NA
CHOYP_LOC755229.1.1.m.5006,-0.012383047,-0.012392232,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extrinsic component of external side of plasma membrane [GO:0031232]; carbohydrate binding [GO:0030246]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; sialic acid binding [GO:0033691]; signaling pattern recognition receptor activity [GO:0008329]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation; lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 secretion [GO:2000484]; protein localization to cell surface [GO:0034394]; recognition of apoptotic cell [GO:0043654],NA,NA,NA
CHOYP_LOC755290.2.4.m.31794,-0.003729933,0.001559399,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC755521.5.28.m.32618,0.007846502,0.000395874,No,NA,NA,NA,NA,NA,NA,endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport; endosome to plasma membrane [GO:1990126],NA,NA,NA
CHOYP_LOC755594.2.6.m.51265,0.007636377,0.006631036,No,NA,NA,NA,NA,NA,NA,guanosine tetraphosphate metabolic process [GO:0015969],NA,NA,NA
CHOYP_LOC755594.4.6.m.53187,0.010875,0.012442087,No,NA,NA,NA,NA,NA,NA,guanosine tetraphosphate metabolic process [GO:0015969],NA,NA,NA
CHOYP_LOC755594.5.6.m.54446,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,guanosine tetraphosphate metabolic process [GO:0015969],NA,NA,NA
CHOYP_LOC756222.1.2.m.62,0.016939916,0.005741346,No,NA,NA,NA,NA,NA,NA,contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; I band [GO:0031674]; M band [GO:0031430]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; protein phosphatase 1 binding [GO:0008157]; tropomyosin binding [GO:0005523]; actin cytoskeleton organization [GO:0030036]; negative regulation of blood vessel diameter [GO:0097756]; positive regulation of vasoconstriction [GO:0045907],NA,NA,NA
CHOYP_LOC756760.1.1.m.1259,-0.006118454,0.015863754,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; intracellular [GO:0005622]; mitochondrial matrix [GO:0005759]; adenosine-diphosphatase activity [GO:0043262]; ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144]; ADP catabolic process [GO:0046032]; IDP catabolic process [GO:0046709]; nucleobase-containing small molecule catabolic process [GO:0034656],NA,NA,NA
CHOYP_LOC756946.1.1.m.49284,0.00514954,-0.009294494,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LOC756958.1.2.m.17672,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC757096.1.1.m.9762,-0.022261314,0.005701021,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC762368.1.1.m.8991,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cytoplasm [GO:0005737]; endosome [GO:0005768]; extrinsic component of membrane [GO:0019898]; transport vesicle [GO:0030133]; actin filament binding [GO:0051015]; protein homodimerization activity [GO:0042803]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; blood coagulation [GO:0007596]; endosome to melanosome transport [GO:0035646]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; membrane fusion [GO:0061025]; neuron projection development [GO:0031175]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of pigment cell differentiation [GO:0050942]; secretion of lysosomal enzymes [GO:0033299],NA,NA,NA
CHOYP_LOC762575.1.1.m.54012,-0.014803654,0.00423582,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; NatC complex [GO:0031417]; nucleus [GO:0005634]; polysome [GO:0005844]; negative regulation of apoptotic process [GO:0043066],NA,NA,NA
CHOYP_LOC762961.3.5.m.46330,-0.009642997,0.009253637,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle; wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480],NA,NA,NA
CHOYP_LOC763087.1.1.m.9110,-0.006602543,-0.009869623,No,NA,NA,NA,NA,NA,NA,chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Mre11 complex [GO:0030870]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; shelterin complex [GO:0070187]; G-rich strand telomeric DNA binding [GO:0098505]; phosphatase binding [GO:0019902]; negative regulation of DNA recombination at telomere [GO:0048239]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of telomere maintenance [GO:0032205]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein acetylation [GO:1901985]; protein localization to chromosome; telomeric region [GO:0070198]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription; DNA-templated [GO:0006355]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833],NA,NA,NA
CHOYP_LOC763287.1.1.m.43472,0.012978002,-0.006082731,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; perikaryon [GO:0043204]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344],NA,NA,NA
CHOYP_LOC763308.3.3.m.63145,0.020132875,0.00623105,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; fibronectin binding [GO:0001968]; proteoglycan binding [GO:0043394]; bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; intramembranous ossification [GO:0001957]; negative regulation of cartilage development [GO:0061037]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_LOC763340.1.1.m.60271,-0.003728037,0.007243766,No,NA,NA,NA,NA,NA,NA,endosome [GO:0005768]; focal adhesion [GO:0005925]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC763378.1.1.m.7889,-0.008056902,-0.017103706,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitotic spindle microtubule [GO:1990498]; plasma membrane [GO:0005886]; microtubule binding [GO:0008017]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of protein acetylation [GO:1901985]; regulation of centriole replication [GO:0046599],NA,NA,NA
CHOYP_LOC763463.1.1.m.1366,-0.017831602,0.002415305,No,NA,NA,NA,NA,NA,NA,hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC763793.3.7.m.24306,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC763845.1.1.m.35345,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,unfolded protein binding [GO:0051082]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_LOC763960.1.2.m.17062,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803],NA,NA,NA
CHOYP_LOC764565.1.1.m.3966,-0.009774354,0.019343527,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; peroxisome [GO:0005777]; carbonyl reductase (NADPH) activity [GO:0004090],NA,NA,NA
CHOYP_LOC764722.1.3.m.16471,0.023553251,-0.004766874,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; peptidase activity [GO:0008233],NA,NA,NA
CHOYP_LOC764722.3.3.m.43616,0.015458275,0.012005296,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC764806.1.2.m.17636,0.012843469,-0.013678853,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC764850.1.8.m.5396,0.005434947,-0.011675033,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC764898.1.1.m.28118,-0.011614618,-0.001526869,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; heart development [GO:0007507]; intraciliary transport involved in cilium assembly [GO:0035735]; kidney development [GO:0001822]; left/right axis specification [GO:0070986]; lung development [GO:0030324]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC764949.1.1.m.44351,0.011016753,0.009067015,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC769726.1.1.m.26365,0.00392357,-0.014081235,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; insulin-like growth factor binding [GO:0005520]; serine-type endopeptidase inhibitor activity [GO:0004867]; regulation of cell growth [GO:0001558],NA,NA,NA
CHOYP_LOC778718.1.1.m.29230,-0.00587004,-0.003383734,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA binding; bending [GO:0008301]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; innate immune response [GO:0045087]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_LOC794295.1.1.m.42748,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC797197.1.1.m.49426,0.001761851,-0.019338561,No,NA,NA,NA,NA,NA,NA,central element [GO:0000801]; chiasma assembly [GO:0051026]; fertilization [GO:0009566]; male gonad development [GO:0008584]; male meiosis chromosome segregation [GO:0007060]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; synaptonemal complex assembly [GO:0007130],NA,NA,NA
CHOYP_LONM.1.1.m.7031,0.012471309,-0.01574892,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; ATPase activity [GO:0016887]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; aging [GO:0007568]; cellular protein-containing complex assembly [GO:0034622]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein homooligomerization [GO:0051260]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666],NA,NA,NA
CHOYP_LR16A.1.3.m.9037,-0.006765641,0.012811624,No,NA,NA,NA,NA,NA,NA,cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415],NA,NA,NA
CHOYP_LR16A.3.3.m.59538,0.020819792,-0.009036194,No,NA,NA,NA,NA,NA,NA,cell leading edge [GO:0031252]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415],NA,NA,NA
CHOYP_LR16A.3.3.m.59539,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LRC40.1.2.m.20043,0.001911261,0.004164069,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LRCH2.2.2.m.56149,0.000313124,0.009860575,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576],NA,NA,NA
CHOYP_LRIG1.1.3.m.954,0.014198731,0.016387899,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]; G protein-coupled peptide receptor activity [GO:0008528]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of canonical Wnt signaling pathway [GO:0090263],NA,NA,NA
CHOYP_LRP1.5.5.m.54869,0.003570475,0.002533026,No,NA,NA,NA,NA,NA,NA,basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cardiac septum development [GO:0003279]; cell proliferation [GO:0008283]; cellular response to amyloid-beta [GO:1904646]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of cell death [GO:0010942]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of phospholipase A2 activity [GO:0032429]; transcytosis [GO:0045056],NA,NA,NA
CHOYP_LRP12.1.2.m.30870,0.008762784,-0.011657512,No,NA,NA,NA,NA,NA,NA,clathrin-coated pit [GO:0005905]; integral component of plasma membrane [GO:0005887]; endocytosis [GO:0006897]; neuron migration [GO:0001764]; neuron projection development [GO:0031175],NA,NA,NA
CHOYP_LRP1B.1.2.m.7346,-0.005027092,0.0099462,No,NA,NA,NA,NA,NA,NA,caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244],NA,NA,NA
CHOYP_LRP2.6.7.m.41365,0.007461955,-0.000627742,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766],NA,NA,NA
CHOYP_LRP4.5.5.m.48010,0.007793371,-0.013626531,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; BMP signaling pathway [GO:0030509]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LRP5.1.3.m.18025,0.004077438,-0.002426904,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anterior/posterior pattern specification [GO:0009952]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cholesterol homeostasis [GO:0042632]; endocytosis [GO:0006897]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; osteoblast development [GO:0002076]; positive regulation of cell proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; retina morphogenesis in camera-type eye [GO:0060042]; retinal blood vessel morphogenesis [GO:0061304]; toxin transport [GO:1901998]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LRP6.1.6.m.878,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development [GO:0061310]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:2000151]; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:2000162]; negative regulation of planar cell polarity pathway involved in neural tube closure [GO:2000168]; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis [GO:2000164]; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis [GO:2000166]; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis [GO:2000149]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell proliferation [GO:0042127]; regulation of transcription; DNA-templated [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244],NA,NA,NA
CHOYP_LRRF2.2.2.m.40846,0.000317684,0.004704262,No,NA,NA,NA,NA,NA,NA,regulation of transcription; DNA-templated [GO:0006355]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LS14A.2.3.m.10984,-0.014620403,0.017208458,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; P-body [GO:0000932]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; cytoplasmic mRNA processing body assembly [GO:0033962]; multicellular organism development [GO:0007275]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; regulation of translation [GO:0006417]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_LSAMP.1.1.m.36104,0.009415342,0.020326199,No,NA,NA,NA,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity; open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991],NA,NA,NA
CHOYP_LSDA.1.1.m.28040,0.003361983,-0.019464081,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; flavin adenine dinucleotide binding [GO:0050660]; N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052903]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; thermospermine oxidase activity [GO:1990534]; regulation of timing of transition from vegetative to reproductive phase [GO:0048510]; spermine catabolic process [GO:0046208]; thermospermine catabolic process [GO:1903602],NA,NA,NA
CHOYP_LSG1.1.1.m.14762,0.01115507,0.002434422,No,NA,NA,NA,NA,NA,NA,Cajal body [GO:0015030]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; nuclear export [GO:0051168]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LSM12.1.1.m.24998,0.007546034,0.004838567,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LSM2.1.2.m.54283,0.010610739,0.011679436,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleus [GO:0005634]; P-body [GO:0000932]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; protein kinase binding [GO:0019901]; Ral GTPase binding [GO:0017160]; RNA binding [GO:0003723]; mRNA catabolic process [GO:0006402]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_LSM3.1.1.m.9505,-0.002836142,-0.009001129,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleus [GO:0005634]; P-body [GO:0000932]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; RNA binding [GO:0003723]; U6 snRNA 3'-end binding [GO:0030629]; cytoplasmic mRNA processing body assembly [GO:0033962]; mRNA splicing; via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956],NA,NA,NA
CHOYP_LSM4.1.3.m.2601,0.006335038,-0.00323495,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lsm2-8 complex [GO:0120115]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; PH domain binding [GO:0042731]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]; cytoplasmic mRNA processing body assembly [GO:0033962]; mRNA splicing; via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LSM7.1.1.m.3617,0.005194551,-0.00038593,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; mRNA catabolic process [GO:0006402]; mRNA splicing; via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956],NA,NA,NA
CHOYP_LTN1.1.2.m.7693,0.000726594,-0.003753097,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116],NA,NA,NA
CHOYP_LTOR2.2.2.m.61709,-0.001782796,0.00574146,No,NA,NA,NA,NA,NA,NA,late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; Ragulator complex [GO:0071986]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex scaffold activity [GO:0032947]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; positive regulation of TOR signaling [GO:0032008]; regulation of cell growth [GO:0001558],NA,NA,NA
CHOYP_LTV1.1.1.m.19482,-0.008162714,-0.003280247,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_LYAM3.2.4.m.3333,-0.00857618,0.012601751,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; oligosaccharide binding [GO:0070492]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; leukocyte tethering or rolling [GO:0050901],NA,NA,NA
CHOYP_LYPA2.1.1.m.45740,-0.014901019,0.009312309,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-(protein) hydrolase activity [GO:0008474]; fatty acid metabolic process [GO:0006631]; protein depalmitoylation [GO:0002084],NA,NA,NA
CHOYP_LYRM4.2.3.m.7011,-0.002578982,0.016990335,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LYS3.1.1.m.31221,0.015749589,0.021238388,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; lysozyme activity [GO:0003796]; cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]; metabolic process [GO:0008152],NA,NA,NA
CHOYP_M1I1L.1.1.m.4329,-0.005926554,-0.00815239,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; lipid metabolic process [GO:0006629]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of ligase activity [GO:0051351]; protein polymerization [GO:0051258]; regulation of lipid biosynthetic process [GO:0046890],NA,NA,NA
CHOYP_M2OM.1.1.m.11786,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxoglutarate:malate antiporter activity [GO:0015367],NA,NA,NA
CHOYP_M3K1.1.1.m.7202,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; ATP binding [GO:0005524]; JUN kinase binding [GO:0008432]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein serine/threonine kinase activity [GO:0004674]; sphingolipid binding [GO:0046625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of JNKK activity [GO:0007256]; activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; MAPK cascade [GO:0000165]; negative regulation of actin filament bundle assembly [GO:0032232]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]; protein autophosphorylation [GO:0046777]; protein complex oligomerization [GO:0051259]; protein phosphorylation [GO:0006468]; protein polyubiquitination [GO:0000209]; response to osmotic stress [GO:0006970]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_M3K7.1.4.m.7880,-0.009977598,-0.003754133,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; activation of MAPKK activity [GO:0000186]; apoptotic process [GO:0006915]; I-kappaB phosphorylation [GO:0007252]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JUN kinase activity [GO:0043507]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_M3K7.2.4.m.17369,-0.009197771,-0.011404571,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_M6PR.1.1.m.51635,0.002690401,-0.017668257,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; mannose binding [GO:0005537]; protein domain specific binding [GO:0019904]; retromer complex binding [GO:1905394]; protein targeting to lysosome [GO:0006622]; secretion of lysosomal enzymes [GO:0033299],NA,NA,NA
CHOYP_MA1B1.1.1.m.22675,-0.01367572,-0.008169652,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1;2-alpha-mannosidase activity [GO:0004571]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; trimming of terminal mannose on B branch [GO:0036509]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_MA2A1.1.1.m.19620,-0.00742609,-0.006087857,No,NA,NA,NA,NA,NA,NA,cis-Golgi network [GO:0005801]; extracellular space [GO:0005615]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity; hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1;3-1;6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033],NA,NA,NA
CHOYP_MA2A2.1.1.m.8261,-0.011927468,0.000302323,No,NA,NA,NA,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity; hydrolyzing N-glycosyl compounds [GO:0016799]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1;3-1;6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_MA2C1.1.1.m.46709,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313],NA,NA,NA
CHOYP_MABP1.1.2.m.21698,-0.009083945,-0.005436035,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_MABP1.1.2.m.21699,0.012246692,-0.016483067,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex; eIF3m [GO:0071541]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_MAD1.1.1.m.48542,-0.00016344,-0.023648208,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MAD2L1.1.1.m.10353,-0.012129863,-0.022863955,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of mitotic cell cycle phase transition [GO:1901990],NA,NA,NA
CHOYP_MAGI1.1.1.m.66921,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of postsynaptic membrane [GO:0098890]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; synapse [GO:0045202]; beta-1 adrenergic receptor binding [GO:0031697]; kinesin binding [GO:0019894]; phosphatase binding [GO:0019902]; protein-containing complex binding [GO:0044877]; receptor signaling complex scaffold activity [GO:0030159]; SMAD binding [GO:0046332]; structural constituent of postsynaptic density [GO:0098919]; structural constituent of postsynaptic specialization [GO:0098879]; type II activin receptor binding [GO:0070699]; cellular response to nerve growth factor stimulus [GO:1990090]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; mitotic cell cycle arrest [GO:0071850]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of protein kinase B signaling [GO:0051898]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of receptor internalization [GO:0002092]; protein heterooligomerization [GO:0051291]; receptor clustering [GO:0043113]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synaptic membrane adhesion [GO:0099179]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395],NA,NA,NA
CHOYP_MALT1.1.1.m.53909,0.014317973,0.005642294,No,NA,NA,NA,NA,NA,NA,CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; protein self-association [GO:0043621]; ubiquitin-protein transferase activity [GO:0004842]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; Fc-epsilon receptor signaling pathway [GO:0038095]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; protein complex oligomerization [GO:0051259]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_MAN2B1.1.1.m.38450,-0.007521721,-0.003672844,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; vacuolar membrane [GO:0005774]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; learning or memory [GO:0007611]; mannose metabolic process [GO:0006013]; protein deglycosylation [GO:0006517],NA,NA,NA
CHOYP_MANBA.2.2.m.47433,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,azurophil granule membrane [GO:0035577]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; beta-mannosidase activity [GO:0004567]; mannose binding [GO:0005537]; cellular protein modification process [GO:0006464]; glycoprotein catabolic process [GO:0006516]; mannan catabolic process [GO:0046355]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313],NA,NA,NA
CHOYP_MANL.2.9.m.16934,0.005557855,0.007664842,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_MANL.5.9.m.42622,0.010275962,0.018588673,No,NA,NA,NA,NA,NA,NA,cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_MARE3.1.1.m.30069,0.016465951,0.016710964,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; spindle midzone [GO:0051233]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription; DNA-templated [GO:0045893]; protein localization [GO:0008104]; protein localization to microtubule [GO:0035372]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225],NA,NA,NA
CHOYP_MARH5.1.1.m.45222,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; GTPase binding [GO:0051020]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of cell aging [GO:0090344]; positive regulation of mitochondrial fission [GO:0090141]; protein autoubiquitination [GO:0051865]; protein localization to mitochondrion [GO:0070585]; protein polyubiquitination [GO:0000209]; regulation of mitochondrial fission [GO:0090140],NA,NA,NA
CHOYP_MASP2.1.1.m.3029,0.00642485,0.006730658,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi-associated vesicle [GO:0005798]; ionotropic glutamate receptor complex [GO:0008328]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; channel regulator activity [GO:0016247]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; adult locomotory behavior [GO:0008344]; cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; hyperosmotic response [GO:0006972]; in utero embryonic development [GO:0001701]; positive regulation of synaptic transmission; glutamatergic [GO:0051968]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; regulation of locomotion [GO:0040012]; response to nutrient [GO:0007584]; thigmotaxis [GO:0001966]; vitamin metabolic process [GO:0006766],NA,NA,NA
CHOYP_MAST4.1.1.m.25573,-0.010969359,-0.008682518,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105],NA,NA,NA
CHOYP_MATN1.2.5.m.45361,0.018566186,0.009338398,No,NA,NA,NA,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_MB21L.1.1.m.35723,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MBCDH18.1.1.m.34344,-0.01847166,-0.019273579,No,NA,NA,NA,NA,NA,NA,apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],NA,NA,NA
CHOYP_MBLK1.1.1.m.51933,0.00030714,0.004657124,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; stereocilium tip [GO:0032426]; response to axon injury [GO:0048678],NA,NA,NA
CHOYP_MCA3.1.1.m.5766,0.007209381,0.000280929,No,NA,NA,NA,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; negative regulation of cell proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cellular senescence [GO:2000774]; positive regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043517]; tRNA aminoacylation for protein translation [GO:0006418],NA,NA,NA
CHOYP_MCA3A.1.2.m.24375,-0.000134585,0.010887777,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; cell projection [GO:0042995]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen [GO:0016709]; Rab GTPase binding [GO:0017137]; actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_MCCA.1.1.m.18170,-0.012406605,-0.010042735,No,NA,NA,NA,NA,NA,NA,3-methylcrotonyl-CoA carboxylase complex; mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; biotin metabolic process [GO:0006768]; leucine catabolic process [GO:0006552]; protein heterooligomerization [GO:0051291],NA,NA,NA
CHOYP_MCEE.1.1.m.62224,-0.000949966,0.019560693,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; methylmalonyl-CoA epimerase activity [GO:0004493]; L-methylmalonyl-CoA metabolic process [GO:0046491]; short-chain fatty acid catabolic process [GO:0019626],NA,NA,NA
CHOYP_MCES.1.2.m.15348,-0.011904759,-0.010209851,No,NA,NA,NA,NA,NA,NA,fibrillar center [GO:0001650]; mRNA cap binding complex [GO:0005845]; mRNA cap methyltransferase complex [GO:0031533]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235]; mRNA (guanine-N7-)-methyltransferase activity [GO:0004482]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; cellular response to leukemia inhibitory factor [GO:1990830],NA,NA,NA
CHOYP_MCM2.1.1.m.14569,-0.009019024,-0.01297828,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; negative regulation of DNA helicase activity [GO:1905775]; regulation of DNA-dependent DNA replication initiation [GO:0030174],NA,NA,NA
CHOYP_MCM3.1.1.m.14853,-0.012209213,-0.025011238,No,NA,NA,NA,NA,NA,NA,MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270],NA,NA,NA
CHOYP_MCM4.1.1.m.61253,-0.011385883,-0.018567586,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-dependent DNA replication initiation [GO:0030174],NA,NA,NA
CHOYP_MCM4.1.1.m.61254,0.018575021,-0.011294193,No,NA,NA,NA,NA,NA,NA,sodium:potassium-exchanging ATPase complex [GO:0005890]; ATPase activator activity [GO:0001671]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; potassium ion import across plasma membrane [GO:1990573]; sodium ion export across plasma membrane [GO:0036376],NA,NA,NA
CHOYP_MCM5.1.1.m.48534,-0.010492677,-0.011398121,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; cytosol [GO:0005829]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; helicase activity [GO:0004386]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-dependent DNA replication initiation [GO:0030174],NA,NA,NA
CHOYP_MCM7.1.1.m.50070,-0.013258836,-0.013640898,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-dependent DNA replication initiation [GO:0030174],NA,NA,NA
CHOYP_MCMBP.1.2.m.3994,-0.008259998,-0.009938674,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; DNA-dependent DNA replication [GO:0006261]; sister chromatid cohesion [GO:0007062],NA,NA,NA
CHOYP_MCMBP.2.2.m.18631,0.006643052,-0.021114466,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; DNA-dependent DNA replication [GO:0006261]; sister chromatid cohesion [GO:0007062],NA,NA,NA
CHOYP_MD27A.1.2.m.18338,-0.013046014,-0.009280663,No,NA,NA,NA,NA,NA,NA,mediator complex [GO:0016592],NA,NA,NA
CHOYP_MDHC.1.1.m.57053,0.013545993,0.011668361,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; L-malate dehydrogenase activity [GO:0030060]; carbohydrate metabolic process [GO:0005975]; malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_MDHM.1.1.m.43603,0.012819803,0.001185399,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; L-malate dehydrogenase activity [GO:0030060]; protein homodimerization activity [GO:0042803]; aerobic respiration [GO:0009060]; carbohydrate metabolic process [GO:0005975]; internal protein amino acid acetylation [GO:0006475]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_MDM1.1.2.m.7535,-0.011158379,-0.019122891,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; microtubule [GO:0005874]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; negative regulation of centriole replication [GO:0046600],NA,NA,NA
CHOYP_MDN1.2.8.m.1779,-0.004764016,-0.011231708,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; unfolded protein binding [GO:0051082]; protein-containing complex assembly [GO:0065003]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_MDN1.3.8.m.3846,-0.013812988,-0.018622987,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MDN1.4.8.m.6155,0.0090002,-0.021187822,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; unfolded protein binding [GO:0051082]; protein-containing complex assembly [GO:0065003]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_MDN1.6.8.m.52635,-0.003748905,-0.016283998,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MDN1.7.8.m.63476,0.010725091,-0.00462129,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MDR1A.1.1.m.47026,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; transporter activity [GO:0005215]; establishment of endothelial blood-brain barrier [GO:0014045]; response to drug [GO:0042493]; Sertoli cell barrier remodeling [GO:0061843],NA,NA,NA
CHOYP_MDR1B.1.2.m.12480,-0.005292588,-0.007657044,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; bile acid secretion [GO:0032782]; cellular response to bile acid [GO:1903413]; lipid homeostasis [GO:0055088]; phospholipid translocation [GO:0045332]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of phospholipid transport [GO:2001140]; response to fenofibrate [GO:1901557],NA,NA,NA
CHOYP_MDR3.3.3.m.66641,-0.007875285,-0.007578368,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; ceramide-translocating ATPase activity [GO:0099038]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; phosphatidylethanolamine-translocating ATPase activity [GO:0090555]; transporter activity [GO:0005215]; xenobiotic transmembrane transporting ATPase activity [GO:0008559]; ceramide translocation [GO:0099040]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to drug [GO:0042493]; stem cell proliferation [GO:0072089]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_ME3.1.1.m.58433,-0.006538923,-0.00664169,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948],NA,NA,NA
CHOYP_MEC2.3.4.m.30735,-0.007523899,-0.007577788,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612],NA,NA,NA
CHOYP_MECR.1.1.m.6989,0.003025529,-0.020136699,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_MED17.1.1.m.1678,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_MED18.1.1.m.28719,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]; termination of RNA polymerase II transcription [GO:0006369],NA,NA,NA
CHOYP_MED21.1.1.m.6955,-0.002136981,-0.01064939,No,NA,NA,NA,NA,NA,NA,mediator complex [GO:0016592],NA,NA,NA
CHOYP_MED24.4.10.m.16708,0.006769899,-0.011559354,No,NA,NA,NA,NA,NA,NA,mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; enteric nervous system development [GO:0048484]; interstitial cell of Cajal differentiation [GO:0061453]; retinal cone cell development [GO:0046549]; thymus development [GO:0048538],NA,NA,NA
CHOYP_MED25.2.2.m.42845,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_MED4.1.1.m.12006,-0.007417949,0.005850931,No,NA,NA,NA,NA,NA,NA,core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_MED7.1.1.m.48813,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_MED8B.1.1.m.7004,-0.017808192,0.005176629,No,NA,NA,NA,NA,NA,NA,mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_MEF2A.1.1.m.21731,-0.003927494,0.019458672,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor binding [GO:0001085]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; cardiac conduction [GO:0061337]; cellular response to calcium ion [GO:0071277]; dendrite morphogenesis [GO:0048813]; ERK5 cascade [GO:0070375]; MAPK cascade [GO:0000165]; mitochondrial genome maintenance [GO:0000002]; mitochondrion distribution [GO:0048311]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription; DNA-templated [GO:0006351]; ventricular cardiac myofibril assembly [GO:0055005],NA,NA,NA
CHOYP_MEG10.11.91.m.21604,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis; engulfment [GO:0006911]; positive regulation of phagocytosis; engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_MEG10.19.91.m.24289,-0.017605017,0.003165546,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MEG10.22.91.m.28727,0.008142381,0.006253223,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; negative regulation of Notch signaling pathway [GO:0045746]; phosphatidylinositol 3-kinase signaling [GO:0014065]; platelet aggregation [GO:0070527]; protein kinase B signaling [GO:0043491]; recognition of apoptotic cell [GO:0043654],NA,NA,NA
CHOYP_MEG10.47.91.m.45614,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEG10.50.91.m.46730,-0.022563605,0.009986662,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MEG10.56.91.m.47515,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; negative regulation of Notch signaling pathway [GO:0045746]; phosphatidylinositol 3-kinase signaling [GO:0014065]; platelet aggregation [GO:0070527]; protein kinase B signaling [GO:0043491]; recognition of apoptotic cell [GO:0043654],NA,NA,NA
CHOYP_MEG10.58.91.m.48257,-0.005598615,0.018390375,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis; engulfment [GO:0006911]; positive regulation of phagocytosis; engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_MEG10.61.91.m.50119,0.008714846,0.006520413,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEG10.67.91.m.52967,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],NA,NA,NA
CHOYP_MEG10.70.91.m.54892,0.007965263,0.002445392,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_MEG10.79.91.m.59237,-0.004973353,0.005785327,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_MEG10.80.91.m.60740,0.007435327,0.002558172,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis; engulfment [GO:0006911]; positive regulation of phagocytosis; engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_MEG10.83.91.m.61586,0.004845881,0.011714943,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; negative regulation of insulin receptor signaling pathway [GO:0046627]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_MEG10.9.91.m.20215,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],NA,NA,NA
CHOYP_MEG11.15.25.m.46952,-0.005614323,0.001965148,No,NA,NA,NA,NA,NA,NA,endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; cell adhesion [GO:0007155]; cholesterol catabolic process [GO:0006707]; dendrite development [GO:0016358]; neuron remodeling [GO:0016322]; positive regulation of axon regeneration [GO:0048680]; positive regulation of neuron projection development [GO:0010976]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_MEG11.8.25.m.39826,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEGF10.8.12.m.38635,0.007623958,-0.007995871,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; positive regulation of angiogenesis [GO:0045766]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_MEGF6.1.59.m.1169,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEGF6.11.59.m.24279,-0.001507547,-0.010642693,No,NA,NA,NA,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEGF6.13.59.m.24300,-0.007064385,0.005019369,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MEGF6.15.59.m.24311,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MEGF6.3.59.m.2378,0.009378917,0.020891687,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEGF6.32.59.m.41698,0.009556047,0.01345064,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_MEGF6.35.59.m.42904,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_MEGF6.36.59.m.43203,0.012881993,0.010291569,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MEGF6.44.59.m.47511,-0.012022376,-0.000830663,No,NA,NA,NA,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEGF6.48.59.m.51016,-0.007558899,0.014040312,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MEGF6.52.59.m.54262,-0.001261533,0.005987681,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MEGF6.55.59.m.59497,0.013005868,-0.00120538,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]; dendrite development [GO:0016358]; neuron remodeling [GO:0016322]; positive regulation of axon regeneration [GO:0048680]; positive regulation of neuron projection development [GO:0010976],NA,NA,NA
CHOYP_MEGF6.8.59.m.7292,0.021995325,-0.005020554,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MEGF6A.1.2.m.17795,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MEP50.1.1.m.12931,0.000428567,-0.01797053,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; methyl-CpG binding [GO:0008327],NA,NA,NA
CHOYP_MERL.1.1.m.1067,-0.001286902,0.010712753,No,NA,NA,NA,NA,NA,NA,adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell body [GO:0044297]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; filopodium membrane [GO:0031527]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; cell-cell junction organization [GO:0045216]; ectoderm development [GO:0007398]; hippocampus development [GO:0021766]; lens fiber cell differentiation [GO:0070306]; mesoderm formation [GO:0001707]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of JAK-STAT cascade [GO:0046426]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell differentiation [GO:0045597]; positive regulation of stress fiber assembly [GO:0051496]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of gliogenesis [GO:0014013]; regulation of hippo signaling [GO:0035330]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of stem cell proliferation [GO:0072091]; Schwann cell proliferation [GO:0014010],NA,NA,NA
CHOYP_MESD.1.1.m.52095,0.004927185,-0.016350725,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; protein folding [GO:0006457]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_MESH1.1.3.m.13824,-0.011580408,0.008336881,No,NA,NA,NA,NA,NA,NA,guanosine-3';5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_MEST.2.2.m.55065,-0.021970511,-0.010312474,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; tubulin-glutamic acid ligase activity [GO:0070740]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; protein polyglutamylation [GO:0018095]; protein transport [GO:0015031],NA,NA,NA
CHOYP_MET14.1.1.m.5073,-0.009008937,0.004758887,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; mRNA binding [GO:0003729]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA splicing; via spliceosome [GO:0000398]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_MET14.1.1.m.5074,0.004841296,0.018857331,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634],NA,NA,NA
CHOYP_MET23.1.1.m.14359,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_METEV_0975.1.1.m.28991,-0.01471086,-0.009867906,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198],NA,NA,NA
CHOYP_METH.1.1.m.18095,0.008706389,-0.012063601,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; pteridine-containing compound metabolic process [GO:0042558],NA,NA,NA
CHOYP_METK.1.2.m.3732,0.012712852,-0.00120748,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; methionine catabolic process [GO:0009087]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556],NA,NA,NA
CHOYP_METTL15.1.1.m.14094,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,rRNA (cytosine-N4-)-methyltransferase activity [GO:0071424]; rRNA base methylation [GO:0070475],NA,NA,NA
CHOYP_MF.CPA.1.1.m.3630,0.021092939,-0.006995213,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MFAP4.3.3.m.62664,0.007948361,0.008689072,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; toxin activity [GO:0090729],NA,NA,NA
CHOYP_MGA.2.2.m.66484,-0.000641581,-0.016877066,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MGC154513.1.1.m.20908,-0.008402734,-0.004117888,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982],NA,NA,NA
CHOYP_MGC78792.1.1.m.45233,0.014262543,-0.016020948,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; erythrocyte development [GO:0048821]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of phagocytosis [GO:0050766]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_MGC81574.1.1.m.8983,0.007809368,0.01568959,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_MGC82409.1.1.m.44657,-0.009470592,-0.01046625,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_MGC89016.1.2.m.76,0.017056591,0.006040633,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; aspartic-type endopeptidase activity [GO:0004190],NA,NA,NA
CHOYP_MGN2.1.1.m.9330,0.008499925,0.015150264,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; exon-exon junction complex [GO:0035145]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing; via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_MIB.2.3.m.30418,0.002233396,-0.01744026,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; aging [GO:0007568]; response to virus [GO:0009615],NA,NA,NA
CHOYP_MIB1.3.4.m.57545,-0.006733926,0.010212405,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756],NA,NA,NA
CHOYP_MIB1.4.4.m.64019,-0.009640798,0.009252936,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_MIB2.2.6.m.23029,0.004245992,0.023691561,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_MIB2.4.6.m.43287,-0.003377164,0.003322654,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_MIB2.5.6.m.43978,-0.009060663,0.001003742,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_MICPUCDRAFT_54866.2.4.m.37897,0.011855734,0.010096961,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MICPUCDRAFT_54866.4.4.m.57185,-0.01700738,0.001438741,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MICPUN_58704.1.1.m.54967,-0.018491596,-0.011466828,No,NA,NA,NA,NA,NA,NA,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940],NA,NA,NA
CHOYP_MIF.2.2.m.30795,0.006941294,-0.00505604,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular space [GO:0005615]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; dopachrome isomerase activity [GO:0004167]; identical protein binding [GO:0042802]; phenylpyruvate tautomerase activity [GO:0050178]; protease binding [GO:0002020]; cell aging [GO:0007569]; cell proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; DNA damage response; signal transduction by p53 class mediator [GO:0030330]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of cell aging [GO:0090344]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of macrophage chemotaxis [GO:0010760]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of myeloid cell apoptotic process [GO:0033033]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myeloid leukocyte cytokine production involved in immune response [GO:0061081]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of prostaglandin secretion involved in immune response [GO:0061078]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of tumor necrosis factor production [GO:0032760]; prostaglandin biosynthetic process [GO:0001516]; protein homotrimerization [GO:0070207],NA,NA,NA
CHOYP_MINP1.1.1.m.13284,0.002742531,-0.021450798,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; plasma membrane [GO:0005886]; acid phosphatase activity [GO:0003993]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol hexakisphosphate 2-phosphatase activity [GO:0052826]; inositol phosphate phosphatase activity [GO:0052745]; inositol-1;3;4;5;6-pentakisphosphate 3-phosphatase activity [GO:0030351]; inositol-1;4;5;6-tetrakisphosphate 6-phosphatase activity [GO:0030352],NA,NA,NA
CHOYP_MINT.1.1.m.54605,-0.005561717,-0.010395711,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; axon guidance [GO:0007411]; compound eye development [GO:0048749]; defense response to fungus [GO:0050832]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of thoracic bristle planar orientation [GO:0048106]; glial cell fate determination [GO:0007403]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maintenance of imaginal disc-derived wing hair orientation [GO:0035321]; neuroblast fate determination [GO:0007400]; peripheral nervous system development [GO:0007422]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription; DNA-templated [GO:0006355]; segment specification [GO:0007379]; transcription; DNA-templated [GO:0006351]; wing disc pattern formation [GO:0035222],NA,NA,NA
CHOYP_MK01.1.1.m.48878,0.007173059,-0.01352195,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; mitotic spindle assembly checkpoint [GO:0007094]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of protein stability [GO:0031647]; response to epidermal growth factor [GO:0070849],NA,NA,NA
CHOYP_ML12B.1.1.m.27220,0.021799314,-0.00442002,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; myosin complex [GO:0016459]; calcium ion binding [GO:0005509]; embryonic body morphogenesis [GO:0010172]; establishment of cell polarity [GO:0030010]; meiosis I cytokinesis [GO:0007110]; mitotic cytokinesis [GO:0000281]; nematode larval development [GO:0002119]; protein localization [GO:0008104],NA,NA,NA
CHOYP_MLE.4.9.m.38686,0.019786822,0.004612157,No,NA,NA,NA,NA,NA,NA,myosin complex [GO:0016459]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MLL.1.1.m.33426,0.0061996,0.000710399,No,NA,NA,NA,NA,NA,NA,histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; zinc ion binding [GO:0008270]; gene silencing [GO:0016458]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; histone lysine methylation [GO:0034968]; memory [GO:0007613]; oocyte differentiation [GO:0009994]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_MLL3.2.3.m.25295,-0.013919566,-0.001699546,No,NA,NA,NA,NA,NA,NA,histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transferase activity; transferring acyl groups [GO:0016746]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652],NA,NA,NA
CHOYP_MLP2.4.4.m.62619,0.017113931,0.00531276,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]; muscle organ development [GO:0007517]; muscle tissue development [GO:0060537]; regulation of establishment of planar polarity [GO:0090175]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_MLRA.3.3.m.62296,-0.005957492,0.009649364,No,NA,NA,NA,NA,NA,NA,myosin complex [GO:0016459]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MMAC.1.1.m.8063,-0.013597577,-0.00678129,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cyanocobalamin reductase (cyanide-eliminating) activity [GO:0033787]; demethylase activity [GO:0032451]; FAD binding [GO:0071949]; glutathione binding [GO:0043295]; oxidoreductase activity [GO:0016491]; cobalamin biosynthetic process [GO:0009236]; cobalamin metabolic process [GO:0009235]; demethylation [GO:0070988]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_MMS19.1.1.m.18650,-0.005150965,0.002894555,No,NA,NA,NA,NA,NA,NA,CIA complex [GO:0097361]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; iron-sulfur cluster assembly [GO:0016226]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein maturation by iron-sulfur cluster transfer [GO:0097428],NA,NA,NA
CHOYP_MNB.1.1.m.14023,-0.00464515,0.009311691,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; tau protein binding [GO:0048156]; amyloid-beta formation [GO:0034205]; circadian rhythm [GO:0007623]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of RNA splicing [GO:0033120]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_MO25.1.1.m.62210,-0.000101712,-0.022517662,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; signal transduction by protein phosphorylation [GO:0023014],NA,NA,NA
CHOYP_MO4L1.1.1.m.8106,-0.016372284,0.002750122,No,NA,NA,NA,NA,NA,NA,histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme regulator activity [GO:0030234]; methylated histone binding [GO:0035064]; chromatin silencing [GO:0006342]; chromosome organization [GO:0051276]; chromosome separation [GO:0051304]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K36 methylation [GO:0000416],NA,NA,NA
CHOYP_MOB1.1.1.m.19452,0.006402821,-0.015614053,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; apoptotic process [GO:0006915]; cell proliferation [GO:0008283]; chromosome segregation [GO:0007059]; hippo signaling [GO:0035329]; multicellular organism development [GO:0007275]; ovarian follicle cell development [GO:0030707]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_MON2.1.1.m.65761,-0.006518672,-0.001310394,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031],NA,NA,NA
CHOYP_MONBRDRAFT_34536.1.1.m.30219,0.001825964,-0.014406388,No,NA,NA,NA,NA,NA,NA,L-rhamnonate dehydratase activity [GO:0050032]; magnesium ion binding [GO:0000287]; cellular amino acid catabolic process [GO:0009063],NA,NA,NA
CHOYP_MONBRDRAFT_34989.1.1.m.34385,-0.009074772,0.0041309,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; acyloxyacyl hydrolase activity [GO:0050528]; calcium ion binding [GO:0005509]; fatty acid metabolic process [GO:0006631]; lipopolysaccharide catabolic process [GO:0009104]; negative regulation of inflammatory response [GO:0050728],NA,NA,NA
CHOYP_MORC2.1.1.m.6240,-0.002257282,0.020562818,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; zinc ion binding [GO:0008270]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_MORC3.1.2.m.38178,-0.011726687,-0.007559823,No,NA,NA,NA,NA,NA,NA,nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; PML body [GO:0016605]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cell aging [GO:0007569]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of fibroblast proliferation [GO:0048147]; peptidyl-serine phosphorylation [GO:0018105]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; viral process [GO:0016032],NA,NA,NA
CHOYP_MP2K4.1.1.m.10635,-0.004551871,-0.026049062,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; JUN kinase kinase activity [GO:0008545]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cell growth involved in cardiac muscle cell development [GO:0061049]; cellular response to mechanical stimulus [GO:0071260]; cellular response to sorbitol [GO:0072709]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA replication [GO:0045740]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; protein phosphorylation [GO:0006468]; response to wounding [GO:0009611]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_MP2K5.1.1.m.45311,0.008372999,-0.014432382,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; cellular response to growth factor stimulus [GO:0071363]; cellular response to laminar fluid shear stress [GO:0071499]; ERK5 cascade [GO:0070375]; heart development [GO:0007507]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of interleukin-8 biosynthetic process [GO:0045415]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_MP2K5.1.1.m.45312,0.012259034,0.00845785,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; NAD binding [GO:0051287]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; ATP generation from poly-ADP-D-ribose [GO:1990966]; double-strand break repair [GO:0006302]; peptidyl-serine ADP-ribosylation [GO:0018312]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_MP2K6.1.1.m.38188,0.022027844,0.001993734,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cardiac muscle contraction [GO:0060048]; cell cycle arrest [GO:0007050]; cellular response to sorbitol [GO:0072709]; DNA damage induced protein phosphorylation [GO:0006975]; negative regulation of cold-induced thermogenesis [GO:0120163]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; ovulation cycle process [GO:0022602]; positive regulation of apoptotic process [GO:0043065]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of prostaglandin secretion [GO:0032308]; response to drug [GO:0042493]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_MPDZ.3.3.m.51236,-0.009836781,-0.01474542,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; Schmidt-Lanterman incisure [GO:0043220]; protein C-terminus binding [GO:0008022]; cell adhesion [GO:0007155]; viral process [GO:0016032],NA,NA,NA
CHOYP_MPEG1.4.5.m.49975,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; defense response to bacterium [GO:0042742],NA,NA,NA
CHOYP_MPET_1013.1.2.m.36696,-0.018000797,0.003088039,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951],NA,NA,NA
CHOYP_MPHOSPH9.1.1.m.9795,-0.001094505,-0.005357285,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],NA,NA,NA
CHOYP_MPI.1.1.m.35645,0.01059657,0.009866666,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mannose-6-phosphate isomerase activity [GO:0004476]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; cell wall mannoprotein biosynthetic process [GO:0000032]; GDP-mannose biosynthetic process [GO:0009298]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_MPP2.1.1.m.62101,-0.004744348,0.01785681,No,NA,NA,NA,NA,NA,NA,anchored component of postsynaptic density membrane [GO:0099031]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic shaft [GO:0043198]; dendritic spine membrane [GO:0032591]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; ion channel binding [GO:0044325]; PDZ domain binding [GO:0030165]; structural constituent of postsynaptic density [GO:0098919]; excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_MPPA.2.2.m.18272,0.006926974,-0.015321095,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_MPPA.2.2.m.18273,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MPST.1.1.m.11853,-0.000316293,-0.011151085,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; synapse [GO:0045202]; 3-mercaptopyruvate sulfurtransferase activity [GO:0016784]; identical protein binding [GO:0042802]; thiosulfate sulfurtransferase activity [GO:0004792]; hydrogen sulfide biosynthetic process [GO:0070814]; kidney development [GO:0001822]; liver development [GO:0001889]; spinal cord development [GO:0021510]; transsulfuration [GO:0019346],NA,NA,NA
CHOYP_MROH1.1.1.m.24366,-0.009301243,-0.003621524,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_MRP1.10.10.m.64931,-0.021966962,0.004467566,No,NA,NA,NA,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; drug transmembrane transporter activity [GO:0015238]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; lipid-transporting ATPase activity [GO:0034040]; long-chain fatty acid transporter activity [GO:0005324]; oxidoreductase activity [GO:0016491]; sphingolipid transporter activity [GO:0046624]; xenobiotic transmembrane transporting ATPase activity [GO:0008559]; cell chemotaxis [GO:0060326]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; positive regulation of drug transmembrane export [GO:1905701]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908],NA,NA,NA
CHOYP_MRP1.4.10.m.27993,0.002557941,-0.01622953,No,NA,NA,NA,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_MRP1.5.10.m.34368,-0.01546009,-0.008961609,No,NA,NA,NA,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; drug transmembrane transporter activity [GO:0015238]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; lipid-transporting ATPase activity [GO:0034040]; long-chain fatty acid transporter activity [GO:0005324]; oxidoreductase activity [GO:0016491]; sphingolipid transporter activity [GO:0046624]; xenobiotic transmembrane transporting ATPase activity [GO:0008559]; cell chemotaxis [GO:0060326]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; positive regulation of drug transmembrane export [GO:1905701]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908],NA,NA,NA
CHOYP_MRPL42.1.1.m.61762,0.016450837,-0.006385586,No,NA,NA,NA,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_MRPL45.1.1.m.11763,-0.004620854,0.010455251,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739],NA,NA,NA
CHOYP_MRPL55.1.1.m.1120,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_MRPS28.1.1.m.29259,-0.009084317,0.002104156,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763],NA,NA,NA
CHOYP_MRPS35.1.1.m.20118,-0.00379894,-0.000321249,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_MRRF.1.1.m.16730,0.002176065,0.008634099,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; ribosomal large subunit binding [GO:0043023]; translation [GO:0006412],NA,NA,NA
CHOYP_MRT4.1.1.m.1698,0.007061278,0.0072956,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process [GO:0000956]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_MSH2.1.1.m.18340,-0.002653591,-0.01261029,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; MutSalpha complex [GO:0032301]; ATP binding [GO:0005524]; mismatched DNA binding [GO:0030983]; cell cycle [GO:0007049]; mismatch repair [GO:0006298],NA,NA,NA
CHOYP_MSI2H.3.3.m.35858,-0.01800738,-0.018680515,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; stem cell development [GO:0048864],NA,NA,NA
CHOYP_MSMB.4.5.m.40217,0.00644004,0.003003786,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MSRB3.1.4.m.4844,0.000307865,-0.024134867,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_MSRB3.2.4.m.17278,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; cellular response to oxidative stress [GO:0034599]; protein repair [GO:0030091],NA,NA,NA
CHOYP_MT.10.18.m.44063,-0.001007709,0.002755647,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MTA1.1.1.m.12640,-0.013972091,-0.009247227,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression; epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_MTAP.1.1.m.15433,-0.001873368,-0.007134627,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]; L-methionine salvage from methylthioadenosine [GO:0019509]; purine ribonucleoside salvage [GO:0006166],NA,NA,NA
CHOYP_MTBP.1.1.m.17026,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,cell cycle arrest [GO:0007050]; regulation of protein ubiquitination [GO:0031396],NA,NA,NA
CHOYP_MTHR.1.1.m.54596,0.009859702,-0.024451038,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; FAD binding [GO:0071949]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999],NA,NA,NA
CHOYP_MTIF2.1.1.m.17935,-0.011555987,-0.003754829,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosomal small subunit binding [GO:0043024]; translation factor activity; RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; mitochondrial translational initiation [GO:0070124]; ribosome disassembly [GO:0032790],NA,NA,NA
CHOYP_MTMR9.1.1.m.26430,-0.003763036,0.020298154,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; enzyme regulator activity [GO:0030234]; protein phosphatase binding [GO:0019903]; negative regulation of autophagy [GO:0010507]; positive regulation of phosphatase activity [GO:0010922]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol dephosphorylation [GO:0060304],NA,NA,NA
CHOYP_MTNA.1.1.m.1717,-0.007923068,0.002012809,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; S-methyl-5-thioribose-1-phosphate isomerase activity [GO:0046523]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284],NA,NA,NA
CHOYP_MTNB.1.1.m.16051,0.013581174,0.023589256,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]; negative regulation of apoptotic process [GO:0043066]; protein homotetramerization [GO:0051289]; pyroptosis [GO:0070269]; regulation of ERK1 and ERK2 cascade [GO:0070372],NA,NA,NA
CHOYP_MTND.2.3.m.41824,0.007425576,-0.020925602,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; acireductone dioxygenase [iron(II)-requiring] activity [GO:0010309]; iron ion binding [GO:0005506]; L-methionine salvage from methylthioadenosine [GO:0019509]; methionine metabolic process [GO:0006555],NA,NA,NA
CHOYP_MTOR.2.2.m.51573,-0.013005771,-0.01404452,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphoprotein binding [GO:0051219]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter DNA binding [GO:0001030]; RNA polymerase III type 2 promoter DNA binding [GO:0001031]; RNA polymerase III type 3 promoter DNA binding [GO:0001032]; TFIIIC-class transcription factor complex binding [GO:0001156]; translation regulator activity [GO:0045182]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; activation of protein kinase B activity [GO:0032148]; anoikis [GO:0043276]; brain development [GO:0007420]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell aging [GO:0007569]; cell cycle arrest [GO:0007050]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; long-term memory [GO:0007616]; maternal process involved in female pregnancy [GO:0060135]; mRNA stabilization [GO:0048255]; multicellular organism growth [GO:0035264]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of cholangiocyte apoptotic process [GO:1904193]; negative regulation of iodide transmembrane transport [GO:1904213]; negative regulation of macroautophagy [GO:0016242]; negative regulation of muscle atrophy [GO:0014736]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of eating behavior [GO:1904000]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of granulosa cell proliferation [GO:1904197]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron maturation [GO:0014042]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sensory perception of pain [GO:1904058]; positive regulation of skeletal muscle hypertrophy [GO:1904206]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of wound healing; spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of brown fat cell differentiation [GO:0090335]; regulation of carbohydrate utilization [GO:0043610]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of GTPase activity [GO:0043087]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of response to food [GO:0032095]; regulation of translation at synapse; modulating synaptic transmission [GO:0099547]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to cocaine [GO:0042220]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to nutrient [GO:0007584]; ruffle organization [GO:0031529]; social behavior [GO:0035176]; spinal cord development [GO:0021510]; T-helper 1 cell lineage commitment [GO:0002296]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; visual learning [GO:0008542]; voluntary musculoskeletal movement [GO:0050882]; wound healing [GO:0042060],NA,NA,NA
CHOYP_MTPN.2.2.m.58730,-0.012135452,0.002379198,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex binding [GO:0044877]; actin cytoskeleton organization [GO:0030036]; negative regulation of barbed-end actin filament capping [GO:2000813],NA,NA,NA
CHOYP_MTR_027S0011.1.1.m.29241,-0.010232027,0.010269186,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MTR_7G016900.1.1.m.39323,0.001094664,0.009138696,No,NA,NA,NA,NA,NA,NA,HAUS complex [GO:0070652]; phragmoplast [GO:0009524]; spindle microtubule [GO:0005876]; microtubule minus-end binding [GO:0051011]; cell division [GO:0051301]; spindle assembly [GO:0051225],NA,NA,NA
CHOYP_MTR1.1.1.m.59840,-0.013325173,-0.0084191,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483]; nucleic acid binding [GO:0003676]; 7-methylguanosine mRNA capping [GO:0006370]; cap1 mRNA methylation [GO:0097309]; mRNA methylation [GO:0080009],NA,NA,NA
CHOYP_MTSS1.1.1.1.m.41595,-0.007706616,0.003616555,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; renal tubule morphogenesis [GO:0061333]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_MTX1.1.1.m.43691,0.002678087,-0.016844164,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial sorting and assembly machinery complex [GO:0001401]; protein transport [GO:0015031],NA,NA,NA
CHOYP_MUC1.1.5.m.5910,-0.01741827,-0.010950679,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MUC21.1.1.m.41811,-0.012793075,-0.008469972,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MUC4.1.1.m.41314,0.018178904,-0.011186739,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MUC5A.1.2.m.43407,0.016096245,-0.009538576,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MUC5AC.1.2.m.17430,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; negative chemotaxis [GO:0050919]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; outflow tract septum morphogenesis [GO:0003148]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649],NA,NA,NA
CHOYP_MUC5B.1.1.m.15734,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; extracellular matrix constituent; lubricant activity [GO:0030197]; PDZ domain binding [GO:0030165]; cellular homeostasis [GO:0019725]; O-glycan processing [GO:0016266]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],NA,NA,NA
CHOYP_MUG2.1.1.m.55656,-0.001024067,-0.014533905,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867],NA,NA,NA
CHOYP_MUTA.1.1.m.31799,-0.016335251,-0.008295347,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; cobalamin binding [GO:0031419]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]; modified amino acid binding [GO:0072341]; protein homodimerization activity [GO:0042803]; cobalamin metabolic process [GO:0009235]; homocysteine metabolic process [GO:0050667]; positive regulation of GTPase activity [GO:0043547]; post-embryonic development [GO:0009791],NA,NA,NA
CHOYP_MVD1.1.1.m.28700,-0.009703808,-0.00899821,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; diphosphomevalonate decarboxylase activity [GO:0004163]; Hsp70 protein binding [GO:0030544]; protein homodimerization activity [GO:0042803]; cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process; mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; positive regulation of cell proliferation [GO:0008284],NA,NA,NA
CHOYP_MVP.1.1.m.56230,-0.006458811,0.013853048,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634],NA,NA,NA
CHOYP_MYBA.1.1.m.48052,0.003412855,-0.005807609,No,NA,NA,NA,NA,NA,NA,nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to retinoic acid [GO:0071300]; chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of hepatic stellate cell proliferation [GO:1904899]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T-helper cell differentiation [GO:0045624]; positive regulation of testosterone secretion [GO:2000845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta production [GO:0071636]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of transcription; DNA-templated [GO:0006355]; response to hypoxia [GO:0001666],NA,NA,NA
CHOYP_MYBPP.1.1.m.45264,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_MYBV.1.1.m.62683,0.003420529,-0.000490419,No,NA,NA,NA,NA,NA,NA,cysteine-type peptidase activity [GO:0008234],NA,NA,NA
CHOYP_MYBX.3.4.m.53061,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MYCB2.1.2.m.13017,0.010784392,0.008151784,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein homodimerization activity [GO:0042803]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_MYCBP2.1.1.m.27070,-0.010371292,0.016868531,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MYD88.2.7.m.21423,-0.014123166,0.010571394,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; TIR domain binding [GO:0070976]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123],NA,NA,NA
CHOYP_MYD88.4.7.m.31202,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; TIR domain binding [GO:0070976]; activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; monocyte activation [GO:0042117]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; response to molecule of bacterial origin [GO:0002237],NA,NA,NA
CHOYP_MYD88.5.7.m.41603,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; TIR domain binding [GO:0070976]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of type I interferon production [GO:0032481]; regulation of inflammatory response [GO:0050727]; response to interleukin-1 [GO:0070555]; signal transduction [GO:0007165]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224]; type I interferon signaling pathway [GO:0060337],NA,NA,NA
CHOYP_MYEF2.1.1.m.18999,-0.018103901,0.003365285,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; mRNA binding [GO:0003729]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815],NA,NA,NA
CHOYP_MYG1.1.1.m.4971,0.001528381,-0.008102588,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; locomotory exploration behavior [GO:0035641],NA,NA,NA
CHOYP_MYO15.1.1.m.66281,-0.010329999,-0.019326091,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; stereocilium [GO:0032420]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_MYO16.4.4.m.65831,0.0038804,0.007482238,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; cerebellum development [GO:0021549]; negative regulation of cell proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134],NA,NA,NA
CHOYP_MYO18.1.1.m.3952,0.005939908,0.015714623,No,NA,NA,NA,NA,NA,NA,actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030],NA,NA,NA
CHOYP_MYO1B.1.1.m.53598,-0.010387432,-0.008407904,No,NA,NA,NA,NA,NA,NA,actin filament [GO:0005884]; apical part of cell [GO:0045177]; brush border [GO:0005903]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; filopodium [GO:0030175]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; post-Golgi vesicle-mediated transport [GO:0006892]; transferrin transport [GO:0033572],NA,NA,NA
CHOYP_MYO1E.1.1.m.49109,-0.011344444,-0.003349874,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase activity; coupled [GO:0042623]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; phosphatidylinositol binding [GO:0035091]; actin filament-based movement [GO:0030048]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; in utero embryonic development [GO:0001701]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570],NA,NA,NA
CHOYP_MYO22.2.2.m.24750,0.007513471,0.009265603,No,NA,NA,NA,NA,NA,NA,cell leading edge [GO:0031252]; cytosol [GO:0005829]; filopodium [GO:0030175]; membrane [GO:0016020]; myosin complex [GO:0016459]; phagocytic cup [GO:0001891]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; protein self-association [GO:0043621]; actin filament-based movement [GO:0030048]; cell morphogenesis [GO:0000902]; cell-substrate adhesion [GO:0031589]; filopodium assembly [GO:0046847]; phagocytosis [GO:0006909]; spore germination [GO:0009847],NA,NA,NA
CHOYP_MYO3.2.2.m.59993,0.00488308,-0.011395798,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MYO3AL.1.1.m.8123,-0.01686877,-0.000674663,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; protein serine/threonine kinase activity [GO:0004674]; auditory receptor cell stereocilium organization [GO:0060088]; cochlea morphogenesis [GO:0090103]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of filopodium assembly [GO:0051491]; protein autophosphorylation [GO:0046777]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],NA,NA,NA
CHOYP_MYO5A.2.4.m.11575,0.004972635,0.010987721,No,NA,NA,NA,NA,NA,NA,actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; insulin-responsive compartment [GO:0032593]; intermediate filament [GO:0005882]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule plus-end [GO:0035371]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; postsynapse [GO:0098794]; ruffle [GO:0001726]; smooth endoplasmic reticulum [GO:0005790]; unconventional myosin complex [GO:0016461]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]; RNA binding [GO:0003723]; actin filament-based movement [GO:0030048]; cellular response to insulin stimulus [GO:0032869]; chemical synaptic transmission [GO:0007268]; establishment of endoplasmic reticulum localization to postsynapse [GO:0099089]; exocytosis [GO:0006887]; hair follicle maturation [GO:0048820]; insulin secretion [GO:0030073]; locomotion involved in locomotory behavior [GO:0031987]; long-chain fatty acid biosynthetic process [GO:0042759]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; myelination [GO:0042552]; odontogenesis [GO:0042476]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; regulation of inositol 1;4;5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; secretory granule localization [GO:0032252]; synapse organization [GO:0050808]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601],NA,NA,NA
CHOYP_MYO6.1.1.m.4131,0.002077387,0.007519758,No,NA,NA,NA,NA,NA,NA,actin filament [GO:0005884]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus [GO:0005902]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA polymerase II; holoenzyme [GO:0016591]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; unconventional myosin complex [GO:0016461]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; minus-end directed microfilament motor activity [GO:0060001]; motor activity [GO:0003774]; actin filament-based movement [GO:0030048]; DNA damage response; signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of secretion [GO:0051046]; response to drug [GO:0042493]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_MYO7A.1.3.m.59205,0.003421457,0.002071811,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_MYO7A.2.3.m.63360,0.012533497,0.005716062,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_MYOF.3.3.m.53228,-0.009167462,-0.008994521,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; late endosome [GO:0005770]; membrane microdomain [GO:0098857]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; angiogenesis [GO:0001525]; cellular response to osmotic stress [GO:0071470]; cytokine secretion [GO:0050663]; fat cell differentiation [GO:0045444]; glycerol metabolic process [GO:0006071]; lipid storage [GO:0019915]; macrophage activation involved in immune response [GO:0002281]; monocyte activation involved in immune response [GO:0002280]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein polyubiquitination [GO:1902915]; plasma membrane repair [GO:0001778]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil chemotaxis [GO:0090023]; regulation of calcium ion import [GO:0090279]; skeletal muscle tissue regeneration [GO:0043403]; T-tubule organization [GO:0033292]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_MYPH.1.2.m.36560,0.009222433,0.005524122,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_MYS.1.7.m.433,-0.010034244,0.008061859,No,NA,NA,NA,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS.1.7.m.435,-0.003556855,-0.012280935,No,NA,NA,NA,NA,NA,NA,calyx of Held [GO:0044305]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; regulation of synaptic transmission; glutamatergic [GO:0051966],NA,NA,NA
CHOYP_MYS.2.7.m.2064,0.007821519,0.015763923,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; microtubule organizing center [GO:0005815]; postsynapse [GO:0098794]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; regulation of protein catabolic process at postsynapse; modulating synaptic transmission [GO:0099576]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_MYS.2.7.m.2069,0.003674435,0.00711548,No,NA,NA,NA,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS.2.7.m.2070,-0.002285095,-0.001686445,No,NA,NA,NA,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS.2.7.m.2075,-0.008612494,-0.003223543,No,NA,NA,NA,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS.4.7.m.18188,0.018079923,0.010180173,No,NA,NA,NA,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS.7.7.m.44341,-0.014496042,0.011234465,No,NA,NA,NA,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS3.1.2.m.31829,-0.022001057,0.004503016,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; negative regulation of gene expression; epigenetic [GO:0045814]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of DNA-binding transcription factor activity [GO:0051090]; response to virus [GO:0009615]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_MYSP.1.9.m.1097,0.004595899,0.020233758,No,NA,NA,NA,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYSP.1.9.m.1100,0.016745511,5.30E-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MYSP.4.9.m.2302,0.0047444,-0.021047841,No,NA,NA,NA,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYSP.5.9.m.28124,0.003939413,0.000493589,No,NA,NA,NA,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYSP.8.9.m.44813,-0.003132764,-0.003704888,No,NA,NA,NA,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYSTI_04398.1.1.m.27734,-0.022558217,0.009977204,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_N2F1A.1.1.m.63063,0.012578452,0.020004432,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; atrial cardiac muscle cell differentiation [GO:0055011]; cardiac atrium morphogenesis [GO:0003209]; endothelial cell proliferation [GO:0001935]; vasculature development [GO:0001944],NA,NA,NA
CHOYP_NAA15.1.1.m.34959,0.000918058,-0.002427701,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; NatA complex [GO:0031415]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription; DNA-templated [GO:0045893]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_NAA25.1.1.m.11255,0.00393971,-0.004119305,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; NatB complex [GO:0031416]; N-terminal peptidyl-methionine acetylation [GO:0017196],NA,NA,NA
CHOYP_NAA35.1.1.m.60092,-0.007269074,0.004136981,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; NatC complex [GO:0031417]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; smooth muscle cell proliferation [GO:0048659],NA,NA,NA
CHOYP_NACA.2.9.m.11875,-0.000801319,0.006048344,No,NA,NA,NA,NA,NA,NA,nascent polypeptide-associated complex [GO:0005854]; protein transport [GO:0015031],NA,NA,NA
CHOYP_NAEGRDRAFT_47557.1.1.m.11283,-0.019653519,-0.002047431,No,NA,NA,NA,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_NAEGRDRAFT_49892.1.1.m.10608,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NAEGRDRAFT_71860.1.1.m.2556,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NAF1.1.1.m.13716,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; small nucleolar ribonucleoprotein complex [GO:0005732]; RNA binding [GO:0003723]; box H/ACA snoRNP assembly [GO:0000493]; pseudouridine synthesis [GO:0001522]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_NAGLU.2.2.m.60267,-0.008406919,-0.007328889,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; alpha-N-acetylglucosaminidase activity [GO:0004561]; cerebellar Purkinje cell layer development [GO:0021680]; glycosaminoglycan catabolic process [GO:0006027]; inner ear receptor cell development [GO:0060119]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; middle ear morphogenesis [GO:0042474]; nervous system development [GO:0007399]; retinal rod cell development [GO:0046548],NA,NA,NA
CHOYP_NAGT1.1.1.m.8857,0.00941541,0.020327632,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_NAS13.1.1.m.30415,-0.011580531,-0.003727534,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_NASP.2.4.m.13404,-0.004163011,0.002356501,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_NASP.4.4.m.56613,-0.003450461,-0.016560135,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; histone binding [GO:0042393]; protein-containing complex binding [GO:0044877]; blastocyst development [GO:0001824]; cell proliferation [GO:0008283]; CENP-A containing nucleosome assembly [GO:0034080]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; G1/S transition of mitotic cell cycle [GO:0000082]; histone exchange [GO:0043486]; male gonad development [GO:0008584]; nucleosome assembly [GO:0006334]; protein transport [GO:0015031]; response to testosterone [GO:0033574],NA,NA,NA
CHOYP_NAV2.1.3.m.9737,0.005784556,-0.005682938,No,NA,NA,NA,NA,NA,NA,interstitial matrix [GO:0005614]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; heparin binding [GO:0008201]; glossopharyngeal nerve development [GO:0021563]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; optic nerve development [GO:0021554]; regulation of systemic arterial blood pressure by baroreceptor feedback [GO:0003025]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; vagus nerve development [GO:0021564],NA,NA,NA
CHOYP_NBEL1.1.1.m.33217,0.001623984,-0.01436129,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_NC2A.1.1.m.22786,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_NCAH.1.5.m.8672,-0.006620755,-0.00681681,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NCAH.3.5.m.51972,0.005019464,-6.92E-05,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_NCBP2.1.1.m.60410,-0.010609367,-0.004171981,No,NA,NA,NA,NA,NA,NA,nuclear cap binding complex [GO:0005846]; nucleus [GO:0005634]; RNA cap binding [GO:0000339]; mRNA cis splicing; via spliceosome [GO:0045292]; negative regulation of viral genome replication [GO:0045071]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422],NA,NA,NA
CHOYP_NCDN.1.1.m.58381,-0.006909699,-0.021426961,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; neuron projection development [GO:0031175],NA,NA,NA
CHOYP_NCER_101848.1.1.m.63547,-0.003104834,0.003963539,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NCKP1.1.4.m.24694,-0.000267099,-0.00922092,No,NA,NA,NA,NA,NA,NA,filamentous actin [GO:0031941]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; postsynapse [GO:0098794]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; protein-containing complex binding [GO:0044877]; apical protein localization [GO:0045176]; basal protein localization [GO:0045175]; cell migration [GO:0016477]; cell migration involved in gastrulation [GO:0042074]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; embryonic body morphogenesis [GO:0010172]; embryonic foregut morphogenesis [GO:0048617]; embryonic heart tube development [GO:0035050]; endoderm development [GO:0007492]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; in utero embryonic development [GO:0001701]; lamellipodium assembly [GO:0030032]; mesodermal cell migration [GO:0008078]; neural tube closure [GO:0001843]; neuron projection morphogenesis [GO:0048812]; notochord development [GO:0030903]; notochord morphogenesis [GO:0048570]; paraxial mesoderm development [GO:0048339]; paraxial mesoderm morphogenesis [GO:0048340]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; protein stabilization [GO:0050821]; Rac protein signal transduction [GO:0016601]; regulation of protein localization [GO:0032880]; somitogenesis [GO:0001756]; zygotic determination of anterior/posterior axis; embryo [GO:0007354],NA,NA,NA
CHOYP_NCLIV_053520.1.1.m.8896,-0.001552259,0.009918545,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NCOA4.1.1.m.5549,0.005704298,-0.016217461,No,NA,NA,NA,NA,NA,NA,autolysosome [GO:0044754]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; transcription coactivator activity [GO:0003713]; androgen receptor signaling pathway [GO:0030521]; cellular iron ion homeostasis [GO:0006879]; male gonad development [GO:0008584]; positive regulation of transcription; DNA-templated [GO:0045893]; protein targeting to lysosome [GO:0006622],NA,NA,NA
CHOYP_NCU02236.1.1.m.28628,-0.016985096,-0.015965803,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ND1.2.5.m.36938,0.014390694,0.019225293,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; NAD+ binding [GO:0070403]; fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to insulin [GO:0032868],NA,NA,NA
CHOYP_ND1.4.5.m.42588,-9.75E-05,-0.010967755,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; structural constituent of ribosome [GO:0003735]; apoptotic mitochondrial changes [GO:0008637],NA,NA,NA
CHOYP_ND4.3.5.m.19536,-0.007795074,-0.001128633,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; mRNA 3'-UTR binding [GO:0003730]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; transcription regulatory region DNA binding [GO:0044212]; cellular response to amino acid starvation [GO:0034198]; circadian rhythm [GO:0007623]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; response to peptide [GO:1901652],NA,NA,NA
CHOYP_NDK7.1.1.m.64883,-0.0203783,0.006548664,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228],NA,NA,NA
CHOYP_NDL1A.1.1.m.10230,-0.002463368,0.006046451,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]; spindle pole centrosome [GO:0031616]; synapse [GO:0045202]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; cell division [GO:0051301]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; centrosome localization [GO:0051642]; cerebral cortex development [GO:0021987]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; forebrain development [GO:0030900]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic centrosome separation [GO:0007100]; neuroblast proliferation [GO:0007405]; neuron migration [GO:0001764]; regulation of microtubule motor activity [GO:2000574]; vesicle transport along microtubule [GO:0047496],NA,NA,NA
CHOYP_NDUA5.1.2.m.2750,-0.00430172,0.004711634,No,NA,NA,NA,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120],NA,NA,NA
CHOYP_NDUFA7.2.2.m.57153,0.003077729,0.009088656,No,NA,NA,NA,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; structural constituent of ribosome [GO:0003735]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_NDUFB7.1.1.m.27222,-0.007279353,-0.016755133,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; NADH dehydrogenase (ubiquinone) activity [GO:0008137],NA,NA,NA
CHOYP_NDUFS4.1.1.m.66417,-0.003983942,-0.009016378,No,NA,NA,NA,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; oxidoreductase activity; acting on NAD(P)H [GO:0016651]; brain development [GO:0007420]; cAMP-mediated signaling [GO:0019933]; cellular respiration [GO:0045333]; electron transport chain [GO:0022900]; mitochondrial respiratory chain complex I assembly [GO:0032981]; positive regulation of fibroblast proliferation [GO:0048146]; reactive oxygen species metabolic process [GO:0072593]; response to cAMP [GO:0051591],NA,NA,NA
CHOYP_NEC1.1.1.m.63094,-0.007988166,0.001993405,No,NA,NA,NA,NA,NA,NA,axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]; secretory granule lumen [GO:0034774]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; chaperone binding [GO:0051087]; endopeptidase activity [GO:0004175]; insulin binding [GO:0043559]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; neurogenesis [GO:0022008]; pancreas development [GO:0031016]; peptide hormone processing [GO:0016486]; pituitary gland development [GO:0021983]; positive regulation of protein secretion [GO:0050714]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to axon injury [GO:0048678]; response to calcium ion [GO:0051592]; response to chlorate [GO:0010157]; response to drug [GO:0042493]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to inorganic substance [GO:0010035]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434],NA,NA,NA
CHOYP_NECA3.1.1.m.106,-0.007983361,-0.014043242,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509]; blastocyst hatching [GO:0001835]; regulation of amyloid precursor protein biosynthetic process [GO:0042984],NA,NA,NA
CHOYP_NECX.1.1.m.56979,-0.006014752,0.004472672,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_NED4L.1.1.m.7792,-0.002045011,-0.014573553,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; immune response [GO:0006955]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein catabolic process at postsynapse; modulating synaptic transmission [GO:0099576]; regulation of synapse organization [GO:0050807]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_NEDD1.1.1.m.10741,0.003709242,-0.018790451,No,NA,NA,NA,NA,NA,NA,apical part of cell [GO:0045177]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; gamma-tubulin ring complex; centrosomal [GO:0000924]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule polymerization or depolymerization [GO:0031109]; protein localization to centrosome [GO:0071539]; regulation of establishment of protein localization [GO:0070201],NA,NA,NA
CHOYP_NEFH.1.2.m.59956,0.006342244,-0.006760166,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEK1.1.5.m.9137,-0.015245348,0.013822643,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cilium assembly [GO:0060271]; DNA damage response; detection of DNA damage [GO:0042769]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; protein phosphorylation [GO:0006468]; regulation of DNA damage checkpoint [GO:2000001]; response to ionizing radiation [GO:0010212]; signal transduction by protein phosphorylation [GO:0023014]; spermatogenesis [GO:0007283]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_NEK1.4.5.m.32116,-0.00602889,0.019464087,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cilium assembly [GO:0060271]; DNA damage response; detection of DNA damage [GO:0042769]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; protein phosphorylation [GO:0006468]; regulation of DNA damage checkpoint [GO:2000001]; response to ionizing radiation [GO:0010212]; signal transduction by protein phosphorylation [GO:0023014]; spermatogenesis [GO:0007283]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_NEK9.1.1.m.19497,-0.007553461,-0.001910756,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; mitotic nuclear envelope disassembly [GO:0007077],NA,NA,NA
CHOYP_NELFB.1.2.m.9922,-0.008058176,-0.002887545,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; NELF complex [GO:0032021]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; RNA binding [GO:0003723]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_NEMF.1.1.m.57807,-0.001598323,0.008952657,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; tRNA binding [GO:0000049]; nuclear export [GO:0051168]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G100691.1.2.m.26774,-0.012343654,0.000691412,No,NA,NA,NA,NA,NA,NA,intracellular [GO:0005622]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G100691.2.2.m.65547,-0.004454838,-0.009699445,No,NA,NA,NA,NA,NA,NA,intracellular [GO:0005622]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G106520.1.1.m.14881,-0.004839857,-0.024364878,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein heterodimerization activity [GO:0046982]; cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G114289.1.1.m.17188,0.011500616,0.00715205,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G120119.1.2.m.6082,0.014384557,-0.00166674,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020]; meprin A complex [GO:0017090]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G120526.4.5.m.36926,-0.00943904,-0.010374838,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G122785.1.1.m.57840,-0.013102576,-0.005116649,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis involved in differentiation [GO:0000904]; cell proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; peptide cross-linking [GO:0018149]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length; open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]; Wnt signaling pathway; planar cell polarity pathway [GO:0060071],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G122840.1.2.m.28819,0.008317608,0.00679881,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G135670.1.1.m.18689,-0.01716183,0.015697604,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; cytokine activity [GO:0005125]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; circadian regulation of gene expression [GO:0032922]; NAD biosynthetic process [GO:0009435],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G140878.1.1.m.18069,-0.012310702,-0.003003982,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G141380.2.4.m.8974,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G154303.1.1.m.3521,-0.004499953,-0.017322339,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G154974.1.1.m.44261,0.015908295,-0.003870399,No,NA,NA,NA,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; metal ion binding [GO:0046872]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; chaperone-mediated protein transport [GO:0072321]; protein targeting to mitochondrion [GO:0006626],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G157638.1.1.m.31214,-0.006273,-0.01853289,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; meprin A complex [GO:0017090]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G157950.1.1.m.4584,0.009585757,-0.007819724,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G159364.1.1.m.22912,0.005242408,-0.002124566,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein tag [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]; DNA repair [GO:0006281]; modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G160170.1.1.m.66042,-0.022664809,0.010335254,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G162365.1.1.m.8038,0.009516487,-0.010763442,No,NA,NA,NA,NA,NA,NA,GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]; GDP-mannose biosynthetic process [GO:0009298]; larval lymph gland hemopoiesis [GO:0035167],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G163820.1.1.m.6391,-0.003644935,0.015592555,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; oxidoreductase activity; acting on a sulfur group of donors; disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; protein folding in endoplasmic reticulum [GO:0034975]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G164392.1.3.m.46942,0.016513122,0.01272147,No,NA,NA,NA,NA,NA,NA,hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G164392.3.3.m.59979,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G165338.1.1.m.60296,0.003840906,0.015444411,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cell body [GO:0044297]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; sperm midpiece [GO:0097225]; beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; microtubule cytoskeleton organization [GO:0000226]; protein transport [GO:0015031],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G165649.1.1.m.2893,0.004918887,0.015632042,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; catalytic activity [GO:0003824],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G166546.1.1.m.10454,-0.016793436,-0.005118007,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]; blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; rRNA base methylation [GO:0070475],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G167304.1.1.m.10864,0.004572081,-0.001466781,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; presynaptic active zone [GO:0048786]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; MAP kinase serine/threonine phosphatase activity [GO:1990439]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; ubiquitin protein ligase binding [GO:0031625]; cellular response to osmotic stress [GO:0071470]; negative regulation of axon extension [GO:0030517]; negative regulation of stress-activated MAPK cascade [GO:0032873]; positive regulation of synapse assembly [GO:0051965]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G167758.1.1.m.66572,-0.012504416,0.014106236,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; manchette [GO:0002177]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; calmodulin binding [GO:0005516]; cilium organization [GO:0044782]; sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G167835.1.1.m.6190,-0.008228949,0.008300276,No,NA,NA,NA,NA,NA,NA,cell [GO:0005623]; intraciliary transport particle B [GO:0030992]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G167853.1.2.m.20047,-0.01584582,0.005828713,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G168076.2.2.m.56942,-0.003999251,-0.017206808,No,NA,NA,NA,NA,NA,NA,phosphonopyruvate decarboxylase activity [GO:0033980]; thiamine pyrophosphate binding [GO:0030976]; antibiotic biosynthetic process [GO:0017000]; organic phosphonate biosynthetic process [GO:0032923],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G168163.1.1.m.63148,0.009109626,0.011846398,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex; alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G168923.1.1.m.29344,0.000353959,-0.001802743,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; NADP binding [GO:0050661]; NADPH:quinone reductase activity [GO:0003960]; quinone metabolic process [GO:1901661],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G169195.1.1.m.2476,-0.007128525,0.007852393,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; poly-hydroxybutyrate biosynthetic process [GO:0042619],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G169538.1.2.m.18155,-0.010720067,0.000950374,No,NA,NA,NA,NA,NA,NA,glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; glutathione catabolic process [GO:0006751],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G169538.2.2.m.29703,0.01119086,-0.002724988,No,NA,NA,NA,NA,NA,NA,glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; glutathione catabolic process [GO:0006751],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G171044.1.1.m.44527,0.008841254,0.004305184,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; response to starvation [GO:0042594],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G173323.2.2.m.55211,0.008087137,-0.000277997,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G173435.1.1.m.37344,-0.008412691,0.005413526,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]; NAD+ synthase activity [GO:0008795]; NAD biosynthetic process [GO:0009435],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G173950.1.1.m.13511,0.009320915,0.001350502,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; peroxisome [GO:0005777]; lipid binding [GO:0008289]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; lipid transport [GO:0006869],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G173950.1.1.m.13512,-0.004436275,-0.009410621,No,NA,NA,NA,NA,NA,NA,peroxisome [GO:0005777]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G179696.1.1.m.40556,0.013560471,-0.00121373,No,NA,NA,NA,NA,NA,NA,structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G179716.1.1.m.55972,-0.002098524,-0.003178053,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; protein homotetramerization [GO:0051289]; response to glucocorticoid [GO:0051384]; response to starvation [GO:0042594],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G180651.1.2.m.2808,0.000595083,-0.006562545,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; microvillus [GO:0005902]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; vacuole [GO:0005773]; aminopeptidase activity [GO:0004177]; cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; kininogen binding [GO:0030984]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; autophagic cell death [GO:0048102]; cell communication [GO:0007154]; cellular response to starvation [GO:0009267]; decidualization [GO:0046697]; hair follicle morphogenesis [GO:0031069]; male gonad development [GO:0008584]; multicellular organism aging [GO:0010259]; negative regulation of keratinocyte proliferation [GO:0010839]; nerve development [GO:0021675]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to organic cyclic compound [GO:0014070]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G181421.1.1.m.3106,-0.004817407,0.021972321,No,NA,NA,NA,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068]; ethanol oxidation [GO:0006069],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G182319.1.1.m.5048,-0.006026409,-0.020008068,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; NEDD8 activating enzyme activity [GO:0019781]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G183894.1.1.m.55454,-0.011131223,-0.00541631,No,NA,NA,NA,NA,NA,NA,mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; alpha-ketoacid dehydrogenase activity [GO:0003826]; metal ion binding [GO:0046872]; branched-chain amino acid catabolic process [GO:0009083],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G185623.1.1.m.62696,-0.004795181,-0.002096361,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; negative regulation of asexual reproduction [GO:1903665]; positive regulation of chemorepellent activity [GO:1903669]; protein localization to plasma membrane [GO:0072659]; proteolysis involved in cellular protein catabolic process [GO:0051603]; sorocarp morphogenesis [GO:0031288]; sporulation resulting in formation of a cellular spore [GO:0030435],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G188927.1.1.m.17076,-0.000248956,-0.006167809,No,NA,NA,NA,NA,NA,NA,oxidoreductase activity [GO:0016491]; NADPH regeneration [GO:0006740],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G188942.1.1.m.6629,0.020434664,-0.006240139,No,NA,NA,NA,NA,NA,NA,phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G191841.1.1.m.1745,-0.006994197,-0.00665653,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of collagen fibril organization [GO:1904027]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G192713.1.1.m.16224,0.004728496,-0.015592721,No,NA,NA,NA,NA,NA,NA,endopeptidase Clp complex [GO:0009368]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP-dependent peptidase activity [GO:0004176]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; protein homooligomerization [GO:0051260]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G193373.1.2.m.19292,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral release from host cell [GO:1902187]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G194582.1.2.m.11442,0.014212153,-0.010987111,No,NA,NA,NA,NA,NA,NA,pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity [GO:0036381]; pyridoxal phosphate biosynthetic process [GO:0042823],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G194582.2.2.m.40726,-0.009604191,-0.003035751,No,NA,NA,NA,NA,NA,NA,intrinsic component of membrane [GO:0031224]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; keratinization [GO:0031424]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G197278.1.1.m.45568,0.005091655,0.002021108,No,NA,NA,NA,NA,NA,NA,carboxylic ester hydrolase activity [GO:0052689]; deacetylase activity [GO:0019213]; hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G197314.1.2.m.61420,0.001622543,0.021247663,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G198667.1.15.m.3453,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G198667.12.15.m.51327,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G198667.14.15.m.61843,0.019363507,-0.007062802,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G198846.1.1.m.25649,0.004691836,-0.015140697,No,NA,NA,NA,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G198897.2.6.m.4748,-0.000773442,0.021579611,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G198897.4.6.m.52548,0.006574303,0.001540242,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G199721.1.1.m.64387,0.006379779,-0.024094084,No,NA,NA,NA,NA,NA,NA,acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; ion transmembrane transport [GO:0034220]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G201445.4.5.m.54666,-0.022562798,0.009985234,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G201552.1.6.m.2876,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; polysaccharide binding [GO:0030247]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G201552.4.6.m.22239,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,cell outer membrane [GO:0009279]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; polysaccharide binding [GO:0030247]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G202687.1.1.m.8886,-0.011671311,-0.00260308,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G203842.1.1.m.60812,-0.01494989,-0.004222872,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G203842.1.1.m.60815,0.008142164,0.006251892,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G204928.1.2.m.15590,0.00801963,-0.0098424,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G204928.2.2.m.27972,0.013158226,-0.000460265,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G206150.1.1.m.39762,0.001778079,0.008910034,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G206950.1.1.m.37574,0.006690441,-0.008853047,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G208725.1.1.m.36498,-0.022417136,0.009769485,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G212280.3.3.m.30224,0.011368461,0.007601946,No,NA,NA,NA,NA,NA,NA,P-body [GO:0000932]; miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; embryonic body morphogenesis [GO:0010172]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G212312.2.5.m.45586,-0.002559524,0.01074185,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G214844.22.34.m.54623,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G214844.25.34.m.55918,0.006576433,0.00150807,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G214844.29.34.m.57719,-0.001049689,-0.014519735,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G214844.9.34.m.28637,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G214960.1.1.m.2485,0.015198193,-0.001047108,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G215851.2.2.m.18129,-0.014789528,0.004457953,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G218264.11.14.m.51529,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G218914.4.4.m.62116,0.009556428,0.013450428,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G221088.1.1.m.66380,-0.022203181,0.009520331,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G221688.1.1.m.52819,0.001488585,0.002475572,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G224038.3.5.m.31061,-0.01575134,0.001174646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G224038.4.5.m.31140,-0.019703071,0.00062176,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G224038.5.5.m.50649,0.007299457,0.005773545,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G224392.2.3.m.36325,-0.010347203,-0.002572074,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G226328.1.1.m.11691,0.010836613,-0.014037343,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix structural constituent [GO:0005201]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; immune response [GO:0006955],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G229510.4.4.m.47762,-0.001029309,0.002878678,No,NA,NA,NA,NA,NA,NA,ciliary pocket [GO:0020016]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endocytosis [GO:0006897],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G230495.1.1.m.61211,0.016063686,-0.006836515,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]; D-gluconate metabolic process [GO:0019521]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt; oxidative branch [GO:0009051],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G232294.1.1.m.22465,0.015205336,-0.002554467,No,NA,NA,NA,NA,NA,NA,sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G233184.1.1.m.18285,-0.009867098,-0.018066033,No,NA,NA,NA,NA,NA,NA,dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; nucleotide biosynthetic process [GO:0009165]; pyrimidine nucleotide metabolic process [GO:0006220],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G233709.6.13.m.49823,-0.011604937,-0.003700229,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G233709.8.13.m.55781,0.00459916,0.010962554,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G234225.1.1.m.49490,0.020189454,0.008783693,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; calcium-independent phospholipase A2 activity [GO:0047499]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; phospholipase A2 activity (consuming 1;2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1;2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerophospholipid catabolic process [GO:0046475]; hydrogen peroxide catabolic process [GO:0042744]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G235461.1.1.m.28341,0.011434759,-0.00432902,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G235656.1.1.m.19147,-0.014654207,-0.008388083,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 2;4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; NADPH binding [GO:0070402]; fatty acid beta-oxidation [GO:0006635]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G235656.1.1.m.19149,-0.008325678,0.005454932,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G235970.1.1.m.34141,-0.016033004,-0.013459457,No,NA,NA,NA,NA,NA,NA,allantoicase activity [GO:0004037]; allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G236573.1.2.m.46431,0.008263862,0.00897203,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G236573.2.2.m.47233,-0.006354186,-0.000903209,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G236653.1.1.m.59422,-0.012197801,0.002361776,No,NA,NA,NA,NA,NA,NA,cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; glucose homeostasis [GO:0042593]; intracellular protein transport [GO:0006886]; positive regulation of protein modification process [GO:0031401]; regulation of glucose import [GO:0046324],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G236658.3.6.m.24704,-0.001283325,0.019551611,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G236658.4.6.m.30181,-0.009994388,-0.020598321,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G236658.5.6.m.34525,0.011595194,0.011955057,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G237029.1.1.m.64370,0.000185221,0.003669498,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G237545.1.1.m.34853,0.000529958,0.020528104,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; actin cytoskeleton reorganization [GO:0031532]; cortical actin cytoskeleton organization [GO:0030866]; hematopoietic progenitor cell differentiation [GO:0002244]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of inositol phosphate biosynthetic process [GO:0010920]; phosphatidylinositol metabolic process [GO:0046488]; phospholipase C-inhibiting G protein-coupled receptor signaling pathway [GO:0030845]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of inositol-polyphosphate 5-phosphatase activity [GO:0010925]; positive regulation of integrin activation [GO:0033625]; positive regulation of platelet activation [GO:0010572]; protein kinase C signaling [GO:0070528]; protein secretion by platelet [GO:0070560]; regulation of cell diameter [GO:0060305]; ruffle organization [GO:0031529]; thrombin-activated receptor signaling pathway [GO:0070493]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G237598.1.1.m.11619,0.006706421,-0.011568827,No,NA,NA,NA,NA,NA,NA,transferase activity [GO:0016740]; acetyl-CoA metabolic process [GO:0006084],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G237629.1.1.m.24486,0.018699268,0.003933009,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G237797.1.1.m.40688,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,U2-type catalytic step 1 spliceosome [GO:0071006]; mRNA processing [GO:0006397]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G237881.1.1.m.10098,-0.009962268,-0.012213523,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; (S)-coclaurine-N-methyltransferase activity [GO:0030794],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G238062.3.6.m.5146,0.019316341,-0.01219773,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G238590.1.1.m.49168,-0.005017416,0.017479196,No,NA,NA,NA,NA,NA,NA,mismatch repair complex [GO:0032300]; nucleoplasm [GO:0005654]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA-dependent ATPase activity [GO:0008094]; mismatched DNA binding [GO:0030983]; chiasma assembly [GO:0051026]; female gamete generation [GO:0007292]; homologous chromosome segregation [GO:0045143]; meiosis I [GO:0007127]; mismatch repair [GO:0006298]; reciprocal meiotic recombination [GO:0007131]; synapsis [GO:0007129],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G238593.1.1.m.8407,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; ovarian follicle development [GO:0001541],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G238894.7.11.m.61041,0.011001926,0.019084021,No,NA,NA,NA,NA,NA,NA,voltage-gated calcium channel complex [GO:0005891]; voltage-gated calcium channel activity [GO:0005245],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G239043.2.6.m.4886,-0.00527331,0.006010788,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G240471.1.1.m.10922,-0.022917382,0.005750848,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; rRNA base methylation [GO:0070475],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G240563.1.3.m.5221,-0.002123993,-0.004262816,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G240563.3.3.m.30812,-0.002587744,-0.010579141,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G240887.2.2.m.37649,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; organelle membrane [GO:0031090]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; response to organonitrogen compound [GO:0010243],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G241267.1.1.m.7467,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I transcription factor complex [GO:0000120]; RNA polymerase I CORE element sequence-specific DNA binding [GO:0001164]; transcription by RNA polymerase I [GO:0006360],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G241446.1.2.m.22601,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G241446.2.2.m.47394,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; phosphorylase activity [GO:0004645]; protein homodimerization activity [GO:0042803]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G242065.1.1.m.21817,0.018442076,0.009995106,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G242153.2.4.m.15572,-0.014889895,-0.010508889,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G242153.4.4.m.60071,0.012180874,0.010427007,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G243463.1.1.m.49871,-0.007829226,0.015483474,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G244077.1.1.m.14957,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G244113.1.1.m.22167,-0.012886814,-0.009875218,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G244537.2.3.m.10401,0.001396205,0.009818866,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G244727.1.1.m.35118,0.005024023,-0.02120567,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G244806.2.2.m.52012,0.006222464,0.000829248,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G245101.1.1.m.56451,0.004101972,0.00929958,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone demethylase activity (H3-K36 specific) [GO:0051864]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G245280.11.11.m.63026,0.009540502,-0.002664664,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G245280.2.11.m.22482,-0.00441332,0.016835954,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G245280.5.11.m.34248,-0.003203787,0.017833945,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G245744.1.1.m.36806,-0.015669105,0.002379227,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G245969.1.2.m.347,0.017432449,-0.00649138,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G246111.1.2.m.45249,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cyclic-di-GMP binding [GO:0035438]; cyclic-GMP-AMP binding [GO:0061507]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G246422.1.1.m.1312,-0.011335121,0.001265164,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G246686.1.1.m.53126,-0.022190092,0.009506415,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G247177.1.1.m.63233,-0.017664089,-0.002630052,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G247395.1.8.m.5020,-0.005201953,0.006145475,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G248362.1.1.m.62940,0.005174372,0.014414933,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone-mediated protein complex assembly [GO:0051131]; protein folding [GO:0006457],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G52068.2.3.m.36345,-0.00317523,-0.004643593,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G61368.1.1.m.42775,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G69851.3.4.m.5191,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G73504.1.2.m.17299,0.009088735,-0.016005389,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G73504.2.2.m.38500,0.013491447,-0.011960499,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G79897.1.1.m.52661,0.004883777,0.023471896,No,NA,NA,NA,NA,NA,NA,ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; mitotic cell cycle [GO:0000278]; positive regulation of transcription; DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of cellular senescence [GO:2000772]; regulation of replicative cell aging [GO:1900062]; regulation of response to DNA damage stimulus [GO:2001020]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G80221.1.1.m.12716,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; sulfate binding [GO:0043199]; sulfuric ester hydrolase activity [GO:0008484]; keratan sulfate catabolic process [GO:0042340],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G80846.1.1.m.24713,-0.002956629,-0.009946916,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; protein heterodimerization activity [GO:0046982]; protein methyltransferase activity [GO:0008276]; rRNA (guanine) methyltransferase activity [GO:0016435]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G83869.3.3.m.30283,-0.022657731,0.010378436,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G86312.1.1.m.10844,-0.018367943,-0.009990983,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; pseudophosphatase activity [GO:0001691]; intracellular signal transduction [GO:0035556]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of stress granule assembly [GO:0062030]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron projection development [GO:0010976]; regulation of intrinsic apoptotic signaling pathway [GO:2001242],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G92762.1.1.m.1253,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; D-cysteine desulfhydrase activity [GO:0019148],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G957.1.1.m.27284,0.015394716,0.002754506,No,NA,NA,NA,NA,NA,NA,extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; extracellular matrix organization [GO:0030198],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G96234.1.1.m.27743,-0.01205437,-0.005902576,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G97278.2.2.m.63646,-0.020801898,0.011895638,No,NA,NA,NA,NA,NA,NA,cell-cell adherens junction [GO:0005913]; intrinsic component of membrane [GO:0031224]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; animal organ morphogenesis [GO:0009887]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]; protein metabolic process [GO:0019538],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G97278.2.2.m.63648,0.016053441,-0.011721042,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEO1.3.3.m.61836,0.006457811,0.001917558,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; iron ion homeostasis [GO:0055072]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of neuron death [GO:1901215]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; regulation of axon regeneration [GO:0048679]; regulation of neuron migration [GO:2001222]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_NEUL4.2.2.m.54340,-0.022167458,0.000375071,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814],NA,NA,NA
CHOYP_NF70.1.4.m.31159,0.010884976,0.011590297,No,NA,NA,NA,NA,NA,NA,intermediate filament [GO:0005882]; structural molecule activity [GO:0005198],NA,NA,NA
CHOYP_NF70.4.4.m.63507,-0.004358306,-0.016896474,No,NA,NA,NA,NA,NA,NA,intermediate filament [GO:0005882]; structural molecule activity [GO:0005198],NA,NA,NA
CHOYP_NFH.1.1.m.53607,-0.007380902,0.01074703,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NFIL3.1.1.m.26076,-0.012022347,-0.000830696,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor activity [GO:0003714]; cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; immune response [GO:0006955]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; regulation of transcription; DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_NFKB.1.1.m.51558,-0.01133105,-0.001546531,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; NF-kappaB binding [GO:0051059]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_NFRKB.1.1.m.18027,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,Ino80 complex [GO:0031011]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protease binding [GO:0002020]; DNA recombination [GO:0006310]; DNA repair [GO:0006281],NA,NA,NA
CHOYP_NFRKB.1.1.m.18028,0.002374758,-0.023015463,No,NA,NA,NA,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex; eIF3m [GO:0071541]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; protein deubiquitination [GO:0016579]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_NFS1.1.1.m.1622,-0.010924579,-0.007431823,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]; iron incorporation into metallo-sulfur cluster [GO:0018283]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777],NA,NA,NA
CHOYP_NFX1.1.2.m.13487,0.000181275,-0.012507763,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription by RNA polymerase II [GO:0006366]; viral process [GO:0016032],NA,NA,NA
CHOYP_NGAP.2.2.m.63455,0.007640843,-0.006681851,No,NA,NA,NA,NA,NA,NA,AIP1-IRE1 complex [GO:1990597]; axon [GO:0030424]; cerebellar mossy fiber [GO:0044300]; climbing fiber [GO:0044301]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; parallel fiber [GO:1990032]; plasma membrane [GO:0005886]; 14-3-3 protein binding [GO:0071889]; death receptor binding [GO:0005123]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; activation of JUN kinase activity [GO:0007257]; activation of MAPKKK activity [GO:0000185]; angiogenesis [GO:0001525]; cell cycle [GO:0007049]; cell motility involved in cerebral cortex radial glia guided migration [GO:0021814]; cellular protein catabolic process [GO:0044257]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; I-kappaB phosphorylation [GO:0007252]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; layer formation in cerebral cortex [GO:0021819]; negative regulation of angiogenesis [GO:0016525]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of GTPase activity [GO:0034260]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; neuron projection morphogenesis [GO:0048812]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of synapse maturation [GO:0090129]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reelin-mediated signaling pathway [GO:0038026]; regulation of GTPase activity [GO:0043087]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein complex assembly [GO:0043254]; regulation of protein heterodimerization activity [GO:0043497]; response to unfolded protein [GO:0006986]; tube formation [GO:0035148]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324],NA,NA,NA
CHOYP_NHP2.1.1.m.57624,-0.018140983,0.002115729,No,NA,NA,NA,NA,NA,NA,box H/ACA snoRNP complex [GO:0031429]; small nucleolar ribonucleoprotein complex [GO:0005732]; telomerase holoenzyme complex [GO:0005697]; box H/ACA snoRNA binding [GO:0034513]; RNA binding [GO:0003723]; cleavage involved in rRNA processing [GO:0000469]; maturation of LSU-rRNA [GO:0000470]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]; telomere maintenance via telomerase [GO:0007004]; translation [GO:0006412],NA,NA,NA
CHOYP_NID2.1.2.m.5776,-0.004127381,-0.008881841,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; cysteine-type endopeptidase inhibitor activity [GO:0004869],NA,NA,NA
CHOYP_NIF3L.1.2.m.28817,0.01726079,-0.01035503,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; transcription factor binding [GO:0008134]; negative regulation of nucleic acid-templated transcription [GO:1903507]; neuron differentiation [GO:0030182]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_NIPA.1.1.m.13987,0.007167355,-0.003607288,No,NA,NA,NA,NA,NA,NA,nuclear membrane [GO:0031965]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_NIPLB.1.1.m.11155,-0.003001099,0.004883941,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; integrator complex [GO:0032039]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; brain development [GO:0007420]; cellular protein localization [GO:0034613]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; cognition [GO:0050890]; cohesin loading [GO:0071921]; developmental growth [GO:0048589]; double-strand break repair [GO:0006302]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gall bladder development [GO:0061010]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of mitotic cohesin loading [GO:1905406]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rDNA condensation [GO:0070550]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; transcriptional activation by promoter-enhancer looping [GO:0071733]; uterus morphogenesis [GO:0061038],NA,NA,NA
CHOYP_NIPSNAP3A.B.1.1.m.62397,0.016397533,-0.016420014,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NISCH.1.2.m.17955,-0.008131102,0.009171262,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; glucose metabolic process [GO:0006006]; negative regulation of cell migration [GO:0030336]; norepinephrine secretion [GO:0048243]; Rac protein signal transduction [GO:0016601]; regulation of blood pressure [GO:0008217]; regulation of synaptic transmission; GABAergic [GO:0032228],NA,NA,NA
CHOYP_NIT2B.1.1.m.18389,0.01023579,0.023734836,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; omega-amidase activity [GO:0050152]; nitrogen compound metabolic process [GO:0006807],NA,NA,NA
CHOYP_NKRF.1.1.m.61828,-0.011141583,-0.00352896,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_NKX23.1.1.m.25439,0.005533503,-0.0013897,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; atrial cardiac muscle cell development [GO:0055014]; cell differentiation [GO:0030154]; digestive tract development [GO:0048565]; embryonic heart tube development [GO:0035050]; hypothalamus development [GO:0021854]; negative regulation of apoptotic process [GO:0043066]; pericardium development [GO:0060039]; pharyngeal system development [GO:0060037]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tongue development [GO:0043586]; ventricular cardiac muscle cell development [GO:0055015],NA,NA,NA
CHOYP_NLRC3.1.1.m.57383,-0.006041717,0.010132807,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NMT2.1.2.m.10421,-0.0083693,-0.014497996,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; plasma membrane [GO:0005886]; glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; intracellular transport of virus [GO:0075733]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; regulation of rhodopsin mediated signaling pathway [GO:0022400],NA,NA,NA
CHOYP_NNRE.2.2.m.27199,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; NADHX epimerase activity [GO:0052856]; NADPHX epimerase activity [GO:0052857]; nucleotide binding [GO:0000166],NA,NA,NA
CHOYP_NOC41.1.1.m.53790,-0.009789319,-0.013611089,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_NOG2.1.1.m.41399,0.002140772,-0.003482656,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; GTP binding [GO:0005525]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_NOL10.1.1.m.1606,-0.005595471,-0.020001264,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730],NA,NA,NA
CHOYP_NOL11.1.1.m.6423,0.005869599,-0.015343243,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; maturation of SSU-rRNA [GO:0030490]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838],NA,NA,NA
CHOYP_NOL5.1.1.m.49429,0.010395152,0.005310798,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_NOL9.1.2.m.16473,0.001973791,-0.011115384,No,NA,NA,NA,NA,NA,NA,intermediate filament cytoskeleton [GO:0045111]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460],NA,NA,NA
CHOYP_NOLC1.3.3.m.66629,0.006538684,-0.013026627,No,NA,NA,NA,NA,NA,NA,box C/D snoRNP complex [GO:0031428]; box H/ACA snoRNP complex [GO:0031429]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; box C/D snoRNA binding [GO:0034512]; box C/D snoRNP complex binding [GO:0062064]; box H/ACA snoRNA binding [GO:0034513]; box H/ACA snoRNP complex binding [GO:0062065]; DNA-binding transcription factor activity [GO:0003700]; GTP binding [GO:0005525]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; RNA polymerase I core binding [GO:0001042]; transcription factor binding [GO:0008134]; box H/ACA snoRNA metabolic process [GO:0033979]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; nucleolus organization [GO:0007000]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; regulation of translation [GO:0006417]; response to osmotic stress [GO:0006970],NA,NA,NA
CHOYP_NOMO1.2.2.m.46404,-0.013511161,-0.00253738,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_NOP56.1.1.m.55664,-0.004505511,0.015908901,No,NA,NA,NA,NA,NA,NA,box C/D snoRNP complex [GO:0031428]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; cadherin binding [GO:0045296]; histone methyltransferase binding [GO:1990226]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_NOSC.1.1.m.6346,0.009386781,-0.021676307,No,NA,NA,NA,NA,NA,NA,azurophil granule [GO:0042582]; calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density; intracellular component [GO:0099092]; postsynaptic specialization; intracellular component [GO:0099091]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; T-tubule [GO:0030315]; vesicle membrane [GO:0012506]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cadmium ion binding [GO:0046870]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; ion channel binding [GO:0044325]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080]; arginine catabolic process [GO:0006527]; behavioral response to cocaine [GO:0048148]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to growth factor stimulus [GO:0071363]; cellular response to mechanical stimulus [GO:0071260]; establishment of protein localization [GO:0045184]; exogenous drug catabolic process [GO:0042738]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of heart contraction [GO:0045822]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of insulin secretion [GO:0046676]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of serotonin uptake [GO:0051612]; negative regulation of vasoconstriction [GO:0045906]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140196]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of histone acetylation [GO:0035066]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron death [GO:1901216]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of heart contraction [GO:0008016]; regulation of neurogenesis [GO:0050767]; regulation of sensory perception of pain [GO:0051930]; regulation of sodium ion transport [GO:0002028]; response to estrogen [GO:0043627]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; retrograde trans-synaptic signaling by nitric oxide [GO:0098924]; striated muscle contraction [GO:0006941]; synaptic signaling by nitric oxide [GO:0099163]; vasodilation [GO:0042311],NA,NA,NA
CHOYP_NOTC3.1.1.m.20877,-0.005471952,-0.002651669,No,NA,NA,NA,NA,NA,NA,adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; transmembrane signaling receptor activity [GO:0004888]; actin filament organization [GO:0007015]; anterior/posterior pattern specification [GO:0009952]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell adhesion [GO:0007155]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye cone cell fate commitment [GO:0042676]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral lineage restriction; imaginal disc [GO:0007451]; dorsal/ventral pattern formation; imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification; open tracheal system [GO:0035153]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; morphogenesis of follicular epithelium [GO:0016333]; motor neuron axon guidance [GO:0008045]; muscle cell fate determination [GO:0007521]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell fate commitment [GO:0007464]; R7 cell differentiation [GO:0045466]; R8 cell development [GO:0045463]; R8 cell differentiation [GO:0045465]; R8 cell fate commitment [GO:0007460]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of crystal cell differentiation [GO:0042689]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of R8 cell spacing in compound eye [GO:0045468]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; ventral cord development [GO:0007419]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; wing disc proximal/distal pattern formation [GO:0007473],NA,NA,NA
CHOYP_NPC2.2.7.m.29742,0.019377139,-0.011502135,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol transporter activity [GO:0017127]; enzyme binding [GO:0019899]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; response to virus [GO:0009615],NA,NA,NA
CHOYP_NPC2.4.7.m.30775,-4.90E-05,-0.003088312,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367],NA,NA,NA
CHOYP_NPC2.5.7.m.30911,0.007875711,0.022830371,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol transporter activity [GO:0017127]; enzyme binding [GO:0019899]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; response to virus [GO:0009615],NA,NA,NA
CHOYP_NPC2.6.7.m.31030,0.019722283,-0.016598515,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367],NA,NA,NA
CHOYP_NPL.1.3.m.4064,-0.003608729,-0.017737797,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; N-acetylneuraminate lyase activity [GO:0008747]; carbohydrate metabolic process [GO:0005975]; N-acetylneuraminate catabolic process [GO:0019262],NA,NA,NA
CHOYP_NPL.3.3.m.29352,-0.006292953,0.007515936,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; N-acetylneuraminate lyase activity [GO:0008747]; carbohydrate metabolic process [GO:0005975]; N-acetylneuraminate catabolic process [GO:0019262],NA,NA,NA
CHOYP_NPL4.1.1.m.62114,-0.002068463,0.019786743,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear outer membrane-endoplasmic reticulum membrane network [GO:0042175]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATPase binding [GO:0051117]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; retrograde protein transport; ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_NPTN.1.1.m.50315,0.016967408,-0.004451762,No,NA,NA,NA,NA,NA,NA,acrosomal membrane [GO:0002080]; axon [GO:0030424]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; cadherin binding [GO:0045296]; cell-cell adhesion mediator activity [GO:0098632]; mannose binding [GO:0005537]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; decidualization [GO:0046697]; dendrite self-avoidance [GO:0070593]; embryo implantation [GO:0007566]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; leukocyte migration [GO:0050900]; odontogenesis of dentin-containing tooth [GO:0042475]; protein localization to plasma membrane [GO:0072659]; pyruvate metabolic process [GO:0006090]; response to cAMP [GO:0051591]; response to mercury ion [GO:0046689]; response to peptide hormone [GO:0043434],NA,NA,NA
CHOYP_NR1AA.1.1.m.39226,0.013209979,-0.015567873,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]; acetylcholine receptor binding [GO:0033130]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; learning [GO:0007612]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission; glutamatergic [GO:0051968]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; prepulse inhibition [GO:0060134]; regulation of grooming behavior [GO:2000821]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic vesicle cycle [GO:0098693]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by endocannabinoid [GO:0099542]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625],NA,NA,NA
CHOYP_NRDC.1.1.m.28526,0.001699733,-0.017045111,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548],NA,NA,NA
CHOYP_NRG.1.1.m.10622,-0.005192935,-0.019543602,No,NA,NA,NA,NA,NA,NA,bicellular tight junction [GO:0005923]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_NRP.2.4.m.39720,0.019397344,-0.011096629,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_NRP.4.4.m.44647,0.021759083,-0.008755978,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NRX3A.1.1.m.1705,0.001701001,-0.003718537,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NRX4.1.1.m.8135,0.020498965,-0.007789555,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553],NA,NA,NA
CHOYP_NSF1C.1.1.m.62502,0.008122099,0.012407756,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; spindle pole centrosome [GO:0031616]; VCP-NSFL1C complex [GO:1990730]; ATPase binding [GO:0051117]; phospholipid binding [GO:0005543]; ubiquitin binding [GO:0043130]; autophagosome assembly [GO:0000045]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of protein localization to centrosome [GO:1904780]; nuclear envelope reassembly [GO:0031468]; positive regulation of mitotic centrosome separation [GO:0046604]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_NSUN2.1.1.m.14138,0.00284556,-0.00262137,No,NA,NA,NA,NA,NA,NA,chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; cell division [GO:0051301]; hair follicle maturation [GO:0048820]; meiotic cell cycle checkpoint [GO:0033313]; spermatid development [GO:0007286]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400],NA,NA,NA
CHOYP_NT5M.1.1.m.6188,-0.002683148,-0.012584423,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotidase activity [GO:0008252]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; dUMP catabolic process [GO:0046079]; pyrimidine deoxyribonucleotide catabolic process [GO:0009223]; pyrimidine nucleoside catabolic process [GO:0046135],NA,NA,NA
CHOYP_NTF.2.1.1.m.38498,0.015665313,-0.005444603,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NTM1A.1.1.m.614,0.002702961,-0.00816058,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; N-terminal protein N-methyltransferase activity [GO:0071885]; protein methyltransferase activity [GO:0008276]; chromosome segregation [GO:0007059]; histone methylation [GO:0016571]; N-terminal peptidyl-glycine methylation [GO:0018013]; N-terminal peptidyl-proline dimethylation [GO:0018016]; N-terminal peptidyl-serine dimethylation [GO:0035572]; N-terminal peptidyl-serine trimethylation [GO:0035573]; spindle organization [GO:0007051],NA,NA,NA
CHOYP_NU107.1.2.m.46092,-0.00391779,-0.000152982,No,NA,NA,NA,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; female gonad development [GO:0008585]; mRNA export from nucleus [GO:0006406]; nuclear pore complex assembly [GO:0051292]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_NU160.1.1.m.46155,-0.000612235,0.002377271,No,NA,NA,NA,NA,NA,NA,kinetochore [GO:0000776]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406],NA,NA,NA
CHOYP_NU188.2.2.m.51343,0.012369332,-0.010008974,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; protein import into nucleus [GO:0006606]; viral process [GO:0016032],NA,NA,NA
CHOYP_NUBP1.1.1.m.65721,-0.002151519,0.004981786,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_NUBPL.1.1.m.15123,-0.000273366,0.007146418,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584],NA,NA,NA
CHOYP_NUCB2.2.2.m.55289,0.01809849,-0.013272917,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi medial cisterna [GO:0005797]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; tumor necrosis factor receptor binding [GO:0005164]; insulin metabolic process [GO:1901142]; negative regulation of appetite [GO:0032099]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucagon secretion [GO:0070093]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of testosterone secretion [GO:2000845]; response to glucose [GO:0009749]; response to human chorionic gonadotropin [GO:0044752]; response to melanocyte-stimulating hormone [GO:1990680]; response to starvation [GO:0042594],NA,NA,NA
CHOYP_NUCL.1.2.m.19135,0.003315432,-0.017254357,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; DNA binding [GO:0003677]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_NUCL.2.2.m.21719,0.00493727,-0.005778561,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; DNA binding [GO:0003677]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_NUD16.1.2.m.10250,-0.008719381,-0.008544676,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_NUD17.1.1.m.13156,-0.016015012,0.005537832,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742],NA,NA,NA
CHOYP_NUDT14.1.1.m.64313,-0.01180132,0.007821674,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ADP-ribose diphosphatase activity [GO:0047631]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768]; nucleoside phosphate metabolic process [GO:0006753]; ribose phosphate metabolic process [GO:0019693],NA,NA,NA
CHOYP_NUFIP1.1.1.m.8979,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,cytosolic ribosome [GO:0022626]; fibrillar center [GO:0001650]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; pre-snoRNP complex [GO:0070761]; presynaptic active zone [GO:0048786]; transcription elongation factor complex [GO:0008023]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein binding; bridging [GO:0030674]; snoRNA binding [GO:0030515]; box C/D snoRNP assembly [GO:0000492]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein complex oligomerization [GO:0051259],NA,NA,NA
CHOYP_NUMB.1.1.m.19732,-0.01332411,0.001756167,No,NA,NA,NA,NA,NA,NA,basal cortex [GO:0045180]; basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; asymmetric cell division [GO:0008356]; asymmetric neuroblast division [GO:0055059]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; central nervous system development [GO:0007417]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; glial cell migration [GO:0008347]; heart development [GO:0007507]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; Notch signaling pathway [GO:0007219]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; rhythmic behavior [GO:0007622]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]; ventral cord development [GO:0007419],NA,NA,NA
CHOYP_NUP153.1.1.m.34857,0.000973008,0.007144978,No,NA,NA,NA,NA,NA,NA,nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; protein transport [GO:0015031],NA,NA,NA
CHOYP_NUP205.1.1.m.54932,-0.01427638,-0.021512939,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; viral process [GO:0016032],NA,NA,NA
CHOYP_NUP214.2.3.m.20892,-0.001195523,0.011093113,No,NA,NA,NA,NA,NA,NA,cytoplasmic side of nuclear pore [GO:1990876]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of mRNA stability [GO:0043488]; regulation of nucleocytoplasmic transport [GO:0046822]; viral process [GO:0016032],NA,NA,NA
CHOYP_NUP214.3.3.m.52826,-0.012353771,-0.016238848,No,NA,NA,NA,NA,NA,NA,cytoplasmic side of nuclear pore [GO:1990876]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of mRNA stability [GO:0043488]; regulation of nucleocytoplasmic transport [GO:0046822]; viral process [GO:0016032],NA,NA,NA
CHOYP_NUP50.1.1.m.17104,0.004716678,0.002104124,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Ran GTPase binding [GO:0008536]; mRNA export from nucleus [GO:0006406]; positive regulation of GTPase activity [GO:0043547]; protein import into nucleus [GO:0006606]; viral process [GO:0016032],NA,NA,NA
CHOYP_NUP54.1.1.m.24886,-0.007404015,-0.020212627,No,NA,NA,NA,NA,NA,NA,nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; protein-containing complex [GO:0032991]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein heterooligomerization [GO:0051291]; protein heterotetramerization [GO:0051290]; protein heterotrimerization [GO:0070208]; protein homooligomerization [GO:0051260]; protein localization to nuclear inner membrane [GO:0036228]; protein targeting [GO:0006605]; regulation of protein import into nucleus [GO:0042306],NA,NA,NA
CHOYP_NUP62L.1.1.m.15606,0.005307479,0.006441411,No,NA,NA,NA,NA,NA,NA,annulate lamellae [GO:0005642]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; mitotic spindle [GO:0072686]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; spindle pole [GO:0000922]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinesin binding [GO:0019894]; phospholipid binding [GO:0005543]; PTB domain binding [GO:0051425]; receptor signaling complex scaffold activity [GO:0030159]; SH2 domain binding [GO:0042169]; structural constituent of nuclear pore [GO:0017056]; thyroid hormone receptor binding [GO:0046966]; ubiquitin binding [GO:0043130]; cell aging [GO:0007569]; cell death [GO:0008219]; cell surface receptor signaling pathway [GO:0007166]; centriole assembly [GO:0098534]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic metaphase plate congression [GO:0007080]; mRNA transport [GO:0051028]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of programmed cell death [GO:0043069]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of centriole replication [GO:0046601]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of transcription; DNA-templated [GO:0045893]; protein heterotrimerization [GO:0070208]; protein import into nucleus [GO:0006606]; regulation of mitotic spindle organization [GO:0060236]; regulation of protein import into nucleus [GO:0042306]; spermatogenesis [GO:0007283]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_NUP85.1.1.m.16167,0.010673297,-0.000173004,No,NA,NA,NA,NA,NA,NA,nuclear membrane [GO:0031965]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; positive regulation of transcription; DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_NUP98.1.1.m.8689,-0.01481308,-0.016369614,No,NA,NA,NA,NA,NA,NA,kinetochore [GO:0000776]; nuclear body [GO:0016604]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; peptide binding [GO:0042277]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713]; DNA replication [GO:0006260]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405]; telomere tethering at nuclear periphery [GO:0034398],NA,NA,NA
CHOYP_NUPL2.1.2.m.4693,0.006464194,0.007331834,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]; metal ion binding [GO:0046872]; nuclear export signal receptor activity [GO:0005049]; mRNA transport [GO:0051028]; protein export from nucleus [GO:0006611],NA,NA,NA
CHOYP_NXF1.1.2.m.28017,0.008655465,-0.018834284,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear pore [GO:0005643]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; RNA export from nucleus [GO:0006405]; viral process [GO:0016032],NA,NA,NA
CHOYP_OAT.1.1.m.3069,-0.005717675,0.000256472,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170]; arginine catabolic process to glutamate [GO:0019544]; arginine catabolic process to proline via ornithine [GO:0010121]; L-proline biosynthetic process [GO:0055129]; ornithine metabolic process [GO:0006591],NA,NA,NA
CHOYP_OCDH.1.1.m.1284,0.002358771,0.004918686,No,NA,NA,NA,NA,NA,NA,coenzyme binding [GO:0050662]; D-octopine dehydrogenase activity [GO:0047830]; nucleotide binding [GO:0000166],NA,NA,NA
CHOYP_OCTC.1.1.m.31819,0.008966456,0.010552199,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; carnitine O-octanoyltransferase activity [GO:0008458]; signaling receptor binding [GO:0005102]; carnitine metabolic process [GO:0009437]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; generation of precursor metabolites and energy [GO:0006091]; medium-chain fatty acid metabolic process [GO:0051791]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_ODC1.1.1.m.12032,0.009746594,0.019073774,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_ODH.1.2.m.1327,-0.019629156,0.006779995,No,NA,NA,NA,NA,NA,NA,coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_ODH.2.2.m.16624,-0.018177039,0.005441413,No,NA,NA,NA,NA,NA,NA,coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_ODO1.2.2.m.23540,-0.002367158,-0.023587521,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; 2-oxoglutarate metabolic process [GO:0006103]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; histone succinylation [GO:0106077]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_ODPX.1.1.m.29097,-0.000384734,-0.001299616,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]; transferase activity; transferring acyl groups [GO:0016746]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732],NA,NA,NA
CHOYP_ODPX.1.1.m.29098,-0.001039858,-0.01452549,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_OFD1.1.1.m.29513,-0.008997307,0.005950476,No,NA,NA,NA,NA,NA,NA,centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],NA,NA,NA
CHOYP_OFUT1.1.1.m.41737,-0.001623521,0.007976542,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; fucosyltransferase activity [GO:0008417]; Notch binding [GO:0005112]; peptide-O-fucosyltransferase activity [GO:0046922]; cell-cell adhesion [GO:0098609]; endocytosis [GO:0006897]; fucose metabolic process [GO:0006004]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; O-glycan processing [GO:0016266]; positive regulation of Notch signaling pathway [GO:0045747]; protein catabolic process [GO:0030163]; protein O-linked fucosylation [GO:0036066]; protein O-linked glycosylation [GO:0006493]; regulation of Notch signaling pathway [GO:0008593]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_OGFD1.1.1.m.10563,-0.013125727,-0.001881697,No,NA,NA,NA,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 3-dioxygenase activity [GO:0031544]; peptidyl-proline dioxygenase activity [GO:0031543]; cell proliferation [GO:0008283]; protein hydroxylation [GO:0018126]; regulation of translational termination [GO:0006449]; stress granule assembly [GO:0034063],NA,NA,NA
CHOYP_OGFRL1.1.1.m.44422,-0.003812099,0.011809678,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020]; opioid receptor activity [GO:0004985],NA,NA,NA
CHOYP_OGT1.3.3.m.54325,-0.002329667,-0.020148235,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; zymogen granule [GO:0042588]; monosaccharide binding [GO:0048029]; peptide binding [GO:0042277]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to toxic substance [GO:0097237]; circadian regulation of gene expression [GO:0032922]; forebrain development [GO:0030900]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotrimerization [GO:0070208]; protein homotrimerization [GO:0070207]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110],NA,NA,NA
CHOYP_OLA1.2.2.m.28588,0.01262768,-0.013210351,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; platelet alpha granule lumen [GO:0031093]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; ATP metabolic process [GO:0046034]; platelet degranulation [GO:0002576],NA,NA,NA
CHOYP_ONEC2.1.3.m.22857,-0.018396006,-0.007616822,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cilium assembly [GO:0060271]; endocrine pancreas development [GO:0031018]; epithelial cell development [GO:0002064]; liver development [GO:0001889]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peripheral nervous system neuron development [GO:0048935]; positive regulation of cell migration [GO:0030335]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell-matrix adhesion [GO:0001952],NA,NA,NA
CHOYP_ORC1.1.2.m.17178,-0.010609589,0.003560915,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_OS11G0657400.1.2.m.24816,0.004427198,-0.001682688,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_OSA.1.2.m.6579,0.005722817,0.000868584,No,NA,NA,NA,NA,NA,NA,brahma complex [GO:0035060]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; chromatin remodeling [GO:0006338]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of neuroblast proliferation [GO:0007406]; neuroblast fate commitment [GO:0014017]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; segment specification [GO:0007379]; wing disc dorsal/ventral pattern formation [GO:0048190]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_OSBL6.1.1.m.24967,0.007232813,0.000625241,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699],NA,NA,NA
CHOYP_OSBL8.1.2.m.7583,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204],NA,NA,NA
CHOYP_OSBL9.1.2.m.17667,-0.011955727,-0.014171649,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248],NA,NA,NA
CHOYP_OSBP1.1.1.m.12788,0.013144716,-0.00349245,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; lipid binding [GO:0008289]; oxysterol binding [GO:0008142]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]; intracellular cholesterol transport [GO:0032367]; positive regulation of growth of symbiont in host [GO:0044128]; sterol transport [GO:0015918],NA,NA,NA
CHOYP_OSGEP.1.1.m.29582,-0.005621524,0.002207239,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]; tRNA threonylcarbamoyladenosine modification [GO:0002949],NA,NA,NA
CHOYP_OSGI2.1.1.m.11055,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,growth factor activity [GO:0008083]; meiotic cell cycle [GO:0051321]; negative regulation of cell growth [GO:0030308],NA,NA,NA
CHOYP_OSHV1_GP010.1.2.m.28852,0.006557625,-0.000292119,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_OSHV1_GP010.1.2.m.28853,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_OSHV1_GP010.1.2.m.28854,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_OST48.1.1.m.43513,-0.003176437,0.003198984,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; protein glycosylation [GO:0006486]; protein N-linked glycosylation via asparagine [GO:0018279],NA,NA,NA
CHOYP_OSTA.1.1.m.11011,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; bile acid transmembrane transporter activity [GO:0015125]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transmembrane transporter activity [GO:0022857]; bile acid and bile salt transport [GO:0015721]; bile acid secretion [GO:0032782]; organic substance transport [GO:0071702],NA,NA,NA
CHOYP_OTER_1386.1.1.m.15303,-0.007916321,0.016483856,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_OTU5B.1.1.m.6212,0.001991036,0.017106243,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; NADHX epimerase activity [GO:0052856]; NADPHX epimerase activity [GO:0052857]; nucleotide binding [GO:0000166],NA,NA,NA
CHOYP_OTU6B.1.2.m.31547,-2.28E-05,-0.001704037,No,NA,NA,NA,NA,NA,NA,thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579],NA,NA,NA
CHOYP_OTUB1.1.1.m.29705,0.003696036,-0.011460859,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; NEDD8-specific protease activity [GO:0019784]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; adaptive immune response [GO:0002250]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; protein K48-linked deubiquitination [GO:0071108],NA,NA,NA
CHOYP_OTX5B.1.1.m.10054,-0.02256446,0.009988181,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; eye photoreceptor cell fate commitment [GO:0042706]; positive regulation of rhodopsin gene expression [GO:0045872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_OX2R.3.3.m.44161,0.000751231,-0.004913887,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle; wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480],NA,NA,NA
CHOYP_OXDD.1.4.m.2688,-0.003515301,-0.025501491,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; peroxisome [GO:0005777]; cofactor binding [GO:0048037]; D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]; signaling receptor binding [GO:0005102]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; D-amino acid catabolic process [GO:0019478]; D-amino acid metabolic process [GO:0046416],NA,NA,NA
CHOYP_OXSM.1.1.m.30217,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; acyl-CoA metabolic process [GO:0006637]; medium-chain fatty acid biosynthetic process [GO:0051792]; short-chain fatty acid biosynthetic process [GO:0051790],NA,NA,NA
CHOYP_P121C.1.1.m.57092,0.00398211,-0.014700999,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_P20D2.1.2.m.9005,0.00388855,0.005520832,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268],NA,NA,NA
CHOYP_P20D2.1.2.m.9006,-0.012352922,-0.009393012,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268],NA,NA,NA
CHOYP_P20D2.2.2.m.47191,-0.00739328,0.020547034,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268],NA,NA,NA
CHOYP_P3A2.1.3.m.11560,-0.005163035,-0.013321811,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_P4HA1.4.5.m.59821,-0.022876231,0.005734343,No,NA,NA,NA,NA,NA,NA,cell [GO:0005623]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity; acting on single donors with incorporation of molecular oxygen; incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]; collagen and cuticulin-based cuticle development [GO:0040002]; cuticle development involved in collagen and cuticulin-based cuticle molting cycle [GO:0042338]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic body morphogenesis [GO:0010172]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation [GO:0019511]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of multicellular organism growth [GO:0040018],NA,NA,NA
CHOYP_P4R3A.1.1.m.1043,-0.015086456,-0.016531818,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_P66A.1.1.m.22279,-0.007979805,-0.012348351,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein binding; bridging [GO:0030674]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; DNA methylation [GO:0006306]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_PA1B2.1.2.m.10637,-0.011220349,-0.007065149,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; plasma membrane [GO:0005886]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; platelet-activating factor acetyltransferase activity [GO:0047179]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; brain development [GO:0007420]; lipid catabolic process [GO:0016042]; positive regulation of macroautophagy [GO:0016239]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_PABP2.1.1.m.12768,-0.018155132,-0.015829966,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; mRNA splicing; via spliceosome [GO:0000398]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247]; positive regulation of protein glycosylation [GO:0060050],NA,NA,NA
CHOYP_PABP4.4.6.m.38167,0.002518857,-0.004422906,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; blood coagulation [GO:0007596]; myeloid cell development [GO:0061515]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; translation [GO:0006412],NA,NA,NA
CHOYP_PABP4.5.6.m.38922,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; messenger ribonucleoprotein complex [GO:1990124]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; synapse [GO:0045202]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_PACN2.2.2.m.25018,-0.007198967,0.003032164,No,NA,NA,NA,NA,NA,NA,caveola [GO:0005901]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]; actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; caveolin-mediated endocytosis [GO:0072584]; cell projection morphogenesis [GO:0048858]; cytoskeleton organization [GO:0007010]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PAGR1.1.1.m.18447,-0.000852529,0.004268042,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PAK1.1.1.m.50796,0.006683949,0.014041965,No,NA,NA,NA,NA,NA,NA,actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; actin cytoskeleton reorganization [GO:0031532]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; exocytosis [GO:0006887]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; wound healing [GO:0042060],NA,NA,NA
CHOYP_PAK7.1.1.m.35662,-0.013918911,0.011582015,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; learning [GO:0007612]; locomotory behavior [GO:0007626]; memory [GO:0007613],NA,NA,NA
CHOYP_PAN2.1.1.m.44690,0.006441439,-0.015611972,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; P-body [GO:0000932]; PAN complex [GO:0031251]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606],NA,NA,NA
CHOYP_PAN2.1.1.m.44691,-0.007723684,0.017766615,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_PAN2.1.1.m.44693,-0.007799148,-0.020302551,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_PANG1.1.2.m.10756,-0.009307723,0.003747023,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; beta-catenin binding [GO:0008013]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; kinase binding [GO:0019900]; repressing transcription factor binding [GO:0070491]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; canonical Wnt signaling pathway [GO:0060070]; embryonic pattern specification [GO:0009880]; heart development [GO:0007507]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesodermal cell fate determination [GO:0007500]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; salivary gland morphogenesis [GO:0007435]; segment polarity determination [GO:0007367]; spiracle morphogenesis; open tracheal system [GO:0035277]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_PAPOG.1.2.m.33182,-0.002588381,0.006529002,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631],NA,NA,NA
CHOYP_PAPSS.1.1.m.53055,0.00360796,0.013250118,No,NA,NA,NA,NA,NA,NA,adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfate adenylyltransferase (ATP) activity [GO:0004781]; sulfate assimilation [GO:0000103],NA,NA,NA
CHOYP_PAR14.15.17.m.60687,0.016371634,-0.009030648,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PAR15.2.6.m.21081,0.0023303,-0.007056801,No,NA,NA,NA,NA,NA,NA,signaling receptor binding [GO:0005102]; B cell apoptotic process [GO:0001783]; humoral immune response [GO:0006959]; immunoglobulin secretion [GO:0048305]; intracellular signal transduction [GO:0035556]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123],NA,NA,NA
CHOYP_PAR15.5.6.m.60634,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; cell division [GO:0051301]; kinetochore assembly [GO:0051382]; mitotic sister chromatid cohesion [GO:0007064]; regulation of gene expression [GO:0010468],NA,NA,NA
CHOYP_PARG.1.1.m.24813,-0.009369169,0.018345109,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; ATP generation from poly-ADP-D-ribose [GO:1990966]; carbohydrate metabolic process [GO:0005975]; nucleotide-sugar metabolic process [GO:0009225]; regulation of DNA repair [GO:0006282],NA,NA,NA
CHOYP_PARN.1.1.m.19023,-0.003532453,-0.009526695,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; cation binding [GO:0043169]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; meiotic cell cycle [GO:0051321]; mRNA catabolic process [GO:0006402],NA,NA,NA
CHOYP_PARP12.1.2.m.42887,-0.013014491,0.005580916,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_PARP14.14.22.m.52621,-0.001272308,0.003957231,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_PARP16.1.1.m.1294,0.007620893,0.002287407,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; kinase binding [GO:0019900]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein serine/threonine kinase activator activity [GO:0043539]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein ADP-ribosylation [GO:0006471],NA,NA,NA
CHOYP_PARP8.1.1.m.55346,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,intracellular [GO:0005622]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylation [GO:0006471],NA,NA,NA
CHOYP_PAT3.1.4.m.21678,-0.00098169,-0.016682539,No,NA,NA,NA,NA,NA,NA,basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; M band [GO:0031430]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; striated muscle dense body [GO:0055120]; integrin binding [GO:0005178]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of locomotion [GO:0040017]; positive regulation of myosin II filament organization [GO:1904901]; positive regulation of ovulation [GO:0060279]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of smooth muscle contraction [GO:0045987]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of distal tip cell migration [GO:1903354]; regulation of vulval development [GO:0040028]; striated muscle cell development [GO:0055002]; vulval cell fate specification [GO:0072327],NA,NA,NA
CHOYP_PAT3.4.4.m.54228,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; M band [GO:0031430]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; striated muscle dense body [GO:0055120]; integrin binding [GO:0005178]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of locomotion [GO:0040017]; positive regulation of myosin II filament organization [GO:1904901]; positive regulation of ovulation [GO:0060279]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of smooth muscle contraction [GO:0045987]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of distal tip cell migration [GO:1903354]; regulation of vulval development [GO:0040028]; striated muscle cell development [GO:0055002]; vulval cell fate specification [GO:0072327],NA,NA,NA
CHOYP_PAX2A.1.2.m.10577,-0.010502173,-0.008563247,No,NA,NA,NA,NA,NA,NA,centriolar satellite [GO:0034451]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; proximal promoter sequence-specific DNA binding [GO:0000987]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; aging [GO:0007568]; axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye development [GO:0043010]; cell fate determination [GO:0001709]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to retinoic acid [GO:0071300]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; glial cell differentiation [GO:0010001]; inner ear morphogenesis [GO:0042472]; mesenchymal to epithelial transition [GO:0060231]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesodermal cell fate specification [GO:0007501]; mesonephros development [GO:0001823]; metanephric collecting duct development [GO:0072205]; metanephric distal convoluted tubule development [GO:0072221]; metanephric epithelium development [GO:0072207]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric mesenchyme development [GO:0072075]; metanephric nephron tubule formation [GO:0072289]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process involved in metanephric collecting duct development [GO:1900215]; negative regulation of apoptotic process involved in metanephric nephron tubule development [GO:1900218]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of cytolysis [GO:0045918]; negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis [GO:0072305]; negative regulation of mesenchymal cell apoptotic process involved in metanephros development [GO:1900212]; negative regulation of programmed cell death [GO:0043069]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription; DNA-templated [GO:0045892]; nephric duct formation [GO:0072179]; neural tube closure [GO:0001843]; optic chiasma development [GO:0061360]; optic cup morphogenesis involved in camera-type eye development [GO:0002072]; optic nerve development [GO:0021554]; optic nerve morphogenesis [GO:0021631]; optic nerve structural organization [GO:0021633]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of metanephric DCT cell differentiation [GO:2000594]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of optic nerve formation [GO:2000597]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; pronephric field specification [GO:0039003]; pronephros development [GO:0048793]; protein kinase B signaling [GO:0043491]; reactive oxygen species metabolic process [GO:0072593]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of metanephros size [GO:0035566]; response to nutrient levels [GO:0031667]; retinal pigment epithelium development [GO:0003406]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366]; transcription; DNA-templated [GO:0006351]; ureter development [GO:0072189]; ureter maturation [GO:0035799]; urogenital system development [GO:0001655]; vestibulocochlear nerve formation [GO:0021650]; visual perception [GO:0007601],NA,NA,NA
CHOYP_PAXB1.1.2.m.42816,0.002371389,0.007616821,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; maintenance of lens transparency [GO:0036438]; negative regulation of creatine transmembrane transporter activity [GO:1905408]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; signal transduction by protein phosphorylation [GO:0023014]; signal transduction by trans-phosphorylation [GO:0023016]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_PB1.2.6.m.11467,0.004844024,0.007933925,No,NA,NA,NA,NA,NA,NA,RSC-type complex [GO:0016586]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; ATP-dependent chromatin remodeling [GO:0043044]; nucleosome disassembly [GO:0006337]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_PC11X.1.2.m.24796,-0.003065914,-0.005964454,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; ADP-dependent NAD(P)H-hydrate dehydratase activity [GO:0052855]; ATP binding [GO:0005524]; ATP-dependent NAD(P)H-hydrate dehydratase activity [GO:0047453]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356],NA,NA,NA
CHOYP_PC2.1.2.m.34944,-0.007402395,-0.020061984,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865],NA,NA,NA
CHOYP_PC2.1.2.m.34945,-0.001150667,-0.022529918,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; transport vesicle [GO:0030133]; serine-type endopeptidase activity [GO:0004252]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485],NA,NA,NA
CHOYP_PCCA.2.2.m.45684,-0.00472212,-0.011499637,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658],NA,NA,NA
CHOYP_PCCB.1.2.m.3057,-0.014353465,-0.015302865,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_PCCB.1.2.m.3058,-0.009914847,0.006158579,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]; biotin metabolic process [GO:0006768],NA,NA,NA
CHOYP_PCDH1.2.3.m.8055,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,cell-cell contact zone [GO:0044291]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],NA,NA,NA
CHOYP_PCDH1.3.3.m.63887,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PCDH7.1.3.m.6236,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_PCDH9.2.5.m.34196,-0.00156256,-0.007717863,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_PCDH9.4.5.m.58558,0.011002527,0.007446594,No,NA,NA,NA,NA,NA,NA,cell-cell contact zone [GO:0044291]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],NA,NA,NA
CHOYP_PCDH9.5.5.m.59488,0.005345205,-0.007956393,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; cation binding [GO:0043169]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; nuclease activity [GO:0004518]; poly(A)-specific ribonuclease activity [GO:0004535]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; box H/ACA snoRNA 3'-end processing [GO:0000495]; female gamete generation [GO:0007292]; miRNA catabolic process [GO:0010587]; ncRNA deadenylation [GO:0110008]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of mRNA stability [GO:0043488]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; RNA modification [GO:0009451]; RNA phosphodiester bond hydrolysis; exonucleolytic [GO:0090503]; telomerase RNA stabilization [GO:0090669],NA,NA,NA
CHOYP_PCF11.1.1.m.49191,0.006039626,0.006668054,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; RNA polymerase II complex binding [GO:0000993]; mRNA 3'-end processing [GO:0031124]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; mRNA splicing; via spliceosome [GO:0000398]; termination of RNA polymerase II transcription [GO:0006369],NA,NA,NA
CHOYP_PCH2.1.1.m.7113,0.003568481,0.000148929,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; nucleus [GO:0005634]; ATP binding [GO:0005524]; double-strand break repair [GO:0006302]; meiotic recombination checkpoint [GO:0051598]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130],NA,NA,NA
CHOYP_PCID2.1.1.m.28679,-0.004933467,-0.013081256,No,NA,NA,NA,NA,NA,NA,transcription export complex 2 [GO:0070390]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; nuclear retention of pre-mRNA at the site of transcription [GO:0071033]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of transcription; DNA-templated [GO:0045893]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; regulation of mRNA stability [GO:0043488]; spleen development [GO:0048536]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_PCKG.1.2.m.43784,0.001885538,0.009919109,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; DBD domain binding [GO:0050692]; epinephrine binding [GO:0051379]; GTP binding [GO:0005525]; inosine kinase activity [GO:0008906]; malate oxidase activity [GO:0019157]; manganese ion binding [GO:0030145]; mRNA binding [GO:0003729]; nucleoside diphosphate kinase activity [GO:0004550]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; protein-disulfide reductase activity [GO:0047134]; sequence-specific DNA binding [GO:0043565]; adult feeding behavior [GO:0008343]; aging [GO:0007568]; alanine metabolic process [GO:0006522]; aspartate metabolic process [GO:0006531]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to fructose stimulus [GO:0071332]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-1 [GO:0071347]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to retinoic acid [GO:0071300]; cellular response to tumor necrosis factor [GO:0071356]; developmental growth [GO:0048589]; digestion [GO:0007586]; eggshell formation [GO:0030703]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic organ morphogenesis [GO:0048562]; gluconeogenesis [GO:0006094]; glutamate metabolic process [GO:0006536]; glutamine metabolic process [GO:0006541]; glycerol biosynthetic process from pyruvate [GO:0046327]; glycerol catabolic process [GO:0019563]; glycine metabolic process [GO:0006544]; hepatocyte differentiation [GO:0070365]; intestinal absorption [GO:0050892]; kidney interstitial fibroblast differentiation [GO:0072071]; lactate metabolic process [GO:0006089]; lipid catabolic process [GO:0016042]; malate transport [GO:0015743]; NADH regeneration [GO:0006735]; negative regulation of carbohydrate metabolic process [GO:0045912]; oviposition [GO:0018991]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of carbohydrate metabolic process [GO:0045913]; positive regulation of gluconeogenesis [GO:0045722]; proline metabolic process [GO:0006560]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; regulation of feeding behavior [GO:0060259]; regulation of gluconeogenesis [GO:0006111]; regulation of transcription by glucose [GO:0046015]; response to cAMP [GO:0051591]; response to cycloheximide [GO:0046898]; response to glucocorticoid [GO:0051384]; response to interleukin-6 [GO:0070741]; response to lipid [GO:0033993]; response to lipopolysaccharide [GO:0032496]; response to methionine [GO:1904640]; response to starvation [GO:0042594]; serine family amino acid metabolic process [GO:0009069]; sexual reproduction [GO:0019953]; vitellogenesis [GO:0007296],NA,NA,NA
CHOYP_PCKG.1.2.m.43785,0.007399899,0.014494902,No,NA,NA,NA,NA,NA,NA,GTP binding [GO:0005525]; metal ion binding [GO:0046872]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; gluconeogenesis [GO:0006094],NA,NA,NA
CHOYP_PCKG.2.2.m.50139,-0.005105191,0.018142198,No,NA,NA,NA,NA,NA,NA,GTP binding [GO:0005525]; metal ion binding [GO:0046872]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; gluconeogenesis [GO:0006094],NA,NA,NA
CHOYP_PCP.1.1.m.59309,-0.010407196,0.009974691,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; carboxypeptidase activity [GO:0004180]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; angiogenesis involved in wound healing [GO:0060055]; negative regulation of systemic arterial blood pressure [GO:0003085]; proteolysis [GO:0006508]; regulation of blood vessel endothelial cell migration [GO:0043535],NA,NA,NA
CHOYP_PCS.1.1.1.m.8305,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PCX1.1.1.m.55309,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_PCYB_062570.1.1.m.58917,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PDCD2L.1.1.m.43699,0.002132545,-0.013858864,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_PDCL3.1.1.m.7323,0.017090719,-0.007860965,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; viral process [GO:0016032],NA,NA,NA
CHOYP_PDDC1.1.1.m.16484,-0.00168386,-0.006346376,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_PDE11.1.3.m.8788,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; 3';5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]; cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PDE2A.3.3.m.60225,-0.002118755,-0.004546457,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; 3';5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; drug binding [GO:0008144]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to drug [GO:0035690]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; establishment of endothelial barrier [GO:0061028]; GMP catabolic process [GO:0046038]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of protein import into nucleus; translocation [GO:0033159]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PDE3A.1.3.m.22256,0.007951615,0.008695978,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; 3';5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; metal ion binding [GO:0046872]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of vascular permeability [GO:0043116]; oocyte maturation [GO:0001556]; positive regulation of oocyte development [GO:0060282]; positive regulation of vascular permeability [GO:0043117]; regulation of meiotic nuclear division [GO:0040020]; response to drug [GO:0042493],NA,NA,NA
CHOYP_PDE6D.1.2.m.6439,-0.010186484,-0.020119858,No,NA,NA,NA,NA,NA,NA,cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; 3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; GTPase inhibitor activity [GO:0005095]; Rab GTPase binding [GO:0017137]; phototransduction [GO:0007602]; visual perception [GO:0007601],NA,NA,NA
CHOYP_PDHA.1.1.1.m.67024,-0.00948436,-0.015725784,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PDHA1.1.1.m.42807,0.007024482,-0.004488962,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_PDIA1.1.1.m.5297,0.018062107,-0.016642151,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; melanosome [GO:0042470]; procollagen-proline 4-dioxygenase complex [GO:0016222]; enzyme binding [GO:0019899]; integrin binding [GO:0005178]; peptide disulfide oxidoreductase activity [GO:0015037]; procollagen-proline 4-dioxygenase activity [GO:0004656]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]; cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-7 [GO:0098761]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_PDIA3.1.1.m.60223,0.001046898,-0.001886423,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; MHC class I peptide loading complex [GO:0042824]; myelin sheath [GO:0043209]; identical protein binding [GO:0042802]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; cellular response to interleukin-7 [GO:0098761]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_PDIA4.1.1.m.54958,0.014446442,0.000203101,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]; cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_PDIA6.1.2.m.9012,0.015485936,0.008165937,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527],NA,NA,NA
CHOYP_PDIA6.2.2.m.58490,-0.021074323,-0.00117718,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_PDLI1.2.2.m.2094,0.01888708,0.011374866,No,NA,NA,NA,NA,NA,NA,cytoskeleton [GO:0005856]; transcription factor complex [GO:0005667]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_PDS5B.1.1.m.16690,0.011538126,-0.01814752,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell division [GO:0051301]; DNA repair [GO:0006281]; enteric nervous system development [GO:0048484]; lens development in camera-type eye [GO:0002088]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of cell proliferation [GO:0008285]; neuroblast migration [GO:0097402]; regulation of cell proliferation [GO:0042127],NA,NA,NA
CHOYP_PDXDC1.1.1.m.11298,-0.004943716,-0.021720635,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; ameboidal-type cell migration [GO:0001667]; carboxylic acid metabolic process [GO:0019752]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665],NA,NA,NA
CHOYP_PDXK.1.1.m.14904,0.0062745,0.016780183,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; pyridoxal kinase activity [GO:0008478]; pyridoxal 5'-phosphate salvage [GO:0009443],NA,NA,NA
CHOYP_PDZRN3.1.1.m.18229,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neuromuscular junction development [GO:0007528]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_PE2R3.2.2.m.61863,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; nervous system development [GO:0007399]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_PEAR1.10.16.m.42850,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_PEAR1.6.16.m.37314,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157],NA,NA,NA
CHOYP_PEAR1.8.16.m.41400,-0.016628133,-0.019916732,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PECR.1.1.m.58859,-0.00380177,0.006076293,No,NA,NA,NA,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]; fatty acid biosynthetic process [GO:0006633]; oxidation-reduction process [GO:0055114]; phytol metabolic process [GO:0033306],NA,NA,NA
CHOYP_PELO.1.1.m.14458,0.002983684,0.000477457,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; Dom34-Hbs1 complex [GO:1990533]; nucleus [GO:0005634]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; compound eye morphogenesis [GO:0001745]; female germ-line stem cell asymmetric division [GO:0048132]; G2/MI transition of meiotic cell cycle [GO:0008315]; germ-line stem cell population maintenance [GO:0030718]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; meiotic nuclear envelope disassembly [GO:0051078]; meiotic spindle organization [GO:0000212]; nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process; no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process; non-stop decay [GO:0070481]; posttranscriptional gene silencing [GO:0016441]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]; spermatocyte division [GO:0048137],NA,NA,NA
CHOYP_PEO1.1.1.m.14775,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PEPM.1.1.m.14235,-0.002722135,-0.01528951,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; phosphoenolpyruvate mutase activity [GO:0050188]; organic phosphonate biosynthetic process [GO:0032923],NA,NA,NA
CHOYP_PERMA_0370.1.1.m.41998,0.000363164,0.000551159,No,NA,NA,NA,NA,NA,NA,ubiquitin-protein transferase activity [GO:0004842]; regulation of ubiquitin-protein transferase activity [GO:0051438],NA,NA,NA
CHOYP_PERQ2.2.2.m.40796,-0.016350351,-0.012567949,No,NA,NA,NA,NA,NA,NA,protein-containing complex [GO:0032991]; insulin-like growth factor receptor signaling pathway [GO:0048009],NA,NA,NA
CHOYP_PESC.1.1.m.16875,0.016442108,-0.020157968,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome; large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; cell proliferation [GO:0008283]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463],NA,NA,NA
CHOYP_PEX2.2.2.m.26981,-0.002150675,-0.02430893,No,NA,NA,NA,NA,NA,NA,brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; ATPase binding [GO:0051117]; peroxisome membrane class-1 targeting sequence binding [GO:0036105]; protein N-terminus binding [GO:0047485]; chaperone-mediated protein folding [GO:0061077]; chaperone-mediated protein transport [GO:0072321]; establishment of protein localization to peroxisome [GO:0072663]; negative regulation of lipid binding [GO:1900131]; peroxisome fission [GO:0016559]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein import into peroxisome membrane [GO:0045046]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_PF10_0308.1.1.m.43529,0.015722483,-0.000285733,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PFB0115W.2.2.m.65461,-0.006950676,0.00198109,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PFD3.1.1.m.56418,0.006079034,-0.002454132,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; protein folding [GO:0006457],NA,NA,NA
CHOYP_PGBM.2.3.m.44777,0.015407624,-0.007600957,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; axon initial segment [GO:0043194]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; myelin sheath [GO:0043209]; node of Ranvier [GO:0033268]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; Schwann cell microvillus [GO:0097454]; septate junction [GO:0005918]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; protein domain specific binding [GO:0019904]; axon guidance [GO:0007411]; clustering of voltage-gated sodium channels [GO:0045162]; paranodal junction assembly [GO:0030913]; peripheral nervous system development [GO:0007422]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; synapse organization [GO:0050808]; transmission of nerve impulse [GO:0019226],NA,NA,NA
CHOYP_PGDH.3.5.m.36973,-0.011281838,0.017818396,No,NA,NA,NA,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_PGDH.5.5.m.66725,0.012508869,-0.01054002,No,NA,NA,NA,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_PGK1.1.1.m.27254,0.010631767,0.016339211,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; protein-disulfide reductase activity [GO:0047134]; cellular response to hypoxia [GO:0071456]; chemical synaptic transmission [GO:0007268]; epithelial cell differentiation [GO:0030855]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; muscle cell cellular homeostasis [GO:0046716]; myoblast fusion [GO:0007520]; negative regulation of angiogenesis [GO:0016525]; plasminogen activation [GO:0031639]; positive regulation of oxidative phosphorylation [GO:1903862]; response to hypoxia [GO:0001666]; somatic muscle development [GO:0007525],NA,NA,NA
CHOYP_PGM1.1.1.m.38482,0.00639594,-0.009594411,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; galactose catabolic process [GO:0019388]; gluconeogenesis [GO:0006094]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312],NA,NA,NA
CHOYP_PGM2.1.1.m.65095,0.007362215,0.000128505,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; phosphopentomutase activity [GO:0008973]; deoxyribose phosphate catabolic process [GO:0046386]; galactose catabolic process [GO:0019388]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; neutrophil degranulation [GO:0043312]; pentose-phosphate shunt [GO:0006098],NA,NA,NA
CHOYP_PGPS1.1.1.m.10148,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [GO:0008444]; cardiolipin biosynthetic process [GO:0032049],NA,NA,NA
CHOYP_PGRMC1.1.1.m.38547,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; steroid binding [GO:0005496],NA,NA,NA
CHOYP_PGTA.1.1.m.43418,0.019066658,-0.001642521,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; Rab-protein geranylgeranyltransferase complex [GO:0005968]; Rab geranylgeranyltransferase activity [GO:0004663]; Rab GTPase binding [GO:0017137]; zinc ion binding [GO:0008270]; protein geranylgeranylation [GO:0018344],NA,NA,NA
CHOYP_PGTG_12376.1.2.m.43330,0.006866006,-0.000146178,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; actin binding [GO:0003779]; actin filament depolymerization [GO:0030042],NA,NA,NA
CHOYP_PHATRDRAFT_43152.1.1.m.15003,0.00649355,0.018986199,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_PHC2.1.1.m.48379,-0.011982018,0.008014202,No,NA,NA,NA,NA,NA,NA,PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_PHF10.1.1.m.6981,0.005134264,0.021065654,No,NA,NA,NA,NA,NA,NA,histone acetyltransferase complex [GO:0000123]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_PHF14.1.1.m.27257,0.003088772,0.000605771,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; lung alveolus development [GO:0048286]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_PHF5A.1.1.m.32389,-0.008365705,-0.015931687,No,NA,NA,NA,NA,NA,NA,nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_PHLP.1.1.m.25742,9.87E-05,-0.019111274,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex binding [GO:0044877]; cell projection organization [GO:0030030]; heterotrimeric G-protein complex assembly [GO:1902605]; negative regulation of protein refolding [GO:0061084]; positive regulation of smoothened signaling pathway [GO:0045880]; protein folding [GO:0006457]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]; visual perception [GO:0007601],NA,NA,NA
CHOYP_PHOCN.1.1.m.40660,-0.014481961,-0.013232216,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; vesicle budding from membrane [GO:0006900],NA,NA,NA
CHOYP_PHR.1.1.m.7664,-0.021573895,-0.003978486,No,NA,NA,NA,NA,NA,NA,deoxyribodipyrimidine photo-lyase activity [GO:0003904]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; protein-chromophore linkage [GO:0018298],NA,NA,NA
CHOYP_PHT4.1.1.m.18841,-0.008763551,-0.000620866,No,NA,NA,NA,NA,NA,NA,oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_PHUM_PHUM009400.1.1.m.35298,-0.015985064,-0.017550084,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_PHUM_PHUM035190.1.1.m.16675,0.005721452,-0.001840983,No,NA,NA,NA,NA,NA,NA,synaptic vesicle [GO:0008021]; hematopoietic progenitor cell differentiation [GO:0002244],NA,NA,NA
CHOYP_PHUM_PHUM049590.1.4.m.14204,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM060390.1.1.m.12993,-0.000430444,0.016471426,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; G protein-coupled receptor signaling pathway [GO:0007186],NA,NA,NA
CHOYP_PHUM_PHUM066670.2.3.m.42178,-0.006074532,-0.019019015,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_PHUM_PHUM068980.4.5.m.56739,-0.00552393,0.001757925,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_PHUM_PHUM071280.1.1.m.25507,-0.006088742,0.002689714,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cellular response to starvation [GO:0009267]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; MAPK cascade [GO:0000165]; negative regulation of cell migration [GO:0030336]; neuron projection morphogenesis [GO:0048812]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_PHUM_PHUM075600.1.1.m.35072,0.004434851,-0.013980554,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxidoreductase activity; acting on NAD(P)H [GO:0016651]; innate immune response [GO:0045087]; regulation of oxidoreductase activity [GO:0051341],NA,NA,NA
CHOYP_PHUM_PHUM076810.1.1.m.24070,0.020645519,-0.007760288,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; actin cytoskeleton organization [GO:0030036]; cellular response to interferon-gamma [GO:0071346]; cytoskeletal anchoring at plasma membrane [GO:0007016]; epithelial cell morphogenesis [GO:0003382]; keratinocyte development [GO:0003334]; signal transduction [GO:0007165]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_PHUM_PHUM092120.1.1.m.33493,0.000474356,-0.012449312,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031],NA,NA,NA
CHOYP_PHUM_PHUM122670.1.1.m.38346,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; amyloid-beta binding [GO:0001540]; transcription factor binding [GO:0008134]; embryo development ending in birth or egg hatching [GO:0009792]; feeding behavior [GO:0007631]; nematode larval development [GO:0002119]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_PHUM_PHUM125580.1.1.m.47466,0.001478162,-0.02036437,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_PHUM_PHUM128460.1.7.m.3477,-0.001531485,-0.01461752,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; SH3/SH2 adaptor activity [GO:0005070]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; B cell differentiation [GO:0030183]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PHUM_PHUM128460.3.7.m.27983,-0.016250074,-0.011038474,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; SH3/SH2 adaptor activity [GO:0005070]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; B cell differentiation [GO:0030183]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PHUM_PHUM128460.4.7.m.38295,-0.001748006,-0.000416421,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; plasma membrane [GO:0005886]; SH3/SH2 adaptor activity [GO:0005070]; B cell activation [GO:0042113]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PHUM_PHUM128460.6.7.m.60989,0.005067136,0.017076885,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; plasma membrane [GO:0005886]; SH3/SH2 adaptor activity [GO:0005070]; B cell activation [GO:0042113]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PHUM_PHUM135440.1.1.m.40573,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; peptide hormone processing [GO:0016486],NA,NA,NA
CHOYP_PHUM_PHUM137710.1.1.m.19548,0.007573414,-0.022082828,No,NA,NA,NA,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sarcomere [GO:0030017],NA,NA,NA
CHOYP_PHUM_PHUM169900.2.2.m.61606,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_PHUM_PHUM174810.1.1.m.31029,-0.010818914,0.008091187,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126],NA,NA,NA
CHOYP_PHUM_PHUM174820.1.1.m.57391,-0.003581584,0.013085946,No,NA,NA,NA,NA,NA,NA,mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; signaling receptor activity [GO:0038023]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; androgen receptor signaling pathway [GO:0030521]; cholesterol homeostasis [GO:0042632]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]; triglyceride homeostasis [GO:0070328],NA,NA,NA
CHOYP_PHUM_PHUM176650.1.1.m.13332,-0.012961774,0.004575303,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; myelination [GO:0042552]; phosphatidylinositol phosphorylation [GO:0046854]; protein localization to plasma membrane [GO:0072659],NA,NA,NA
CHOYP_PHUM_PHUM184790.1.1.m.41715,-0.022009002,0.003412083,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; interleukin-1 receptor antagonist activity [GO:0005152]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_PHUM_PHUM215460.1.1.m.33815,0.005138757,-0.009356852,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytoskeletal adaptor activity [GO:0008093]; microtubule binding [GO:0008017]; thyroid hormone receptor binding [GO:0046966]; cell cycle arrest [GO:0007050]; cellular response to starvation [GO:0009267]; cellular response to thyroid hormone stimulus [GO:0097067]; microtubule bundle formation [GO:0001578]; negative regulation of cell growth [GO:0030308]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of gene expression [GO:0010629]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of cell cycle [GO:0051726],NA,NA,NA
CHOYP_PHUM_PHUM226120.1.7.m.673,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_PHUM_PHUM226120.2.7.m.2274,0.010892067,0.002004432,No,NA,NA,NA,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_PHUM_PHUM226120.3.7.m.20773,-0.017657959,0.009570462,No,NA,NA,NA,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_PHUM_PHUM226120.5.7.m.43551,-0.003066242,0.003432456,No,NA,NA,NA,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_PHUM_PHUM226120.6.7.m.48915,0.013572558,-0.003886046,No,NA,NA,NA,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_PHUM_PHUM226120.7.7.m.54053,0.001329394,0.002980966,No,NA,NA,NA,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_PHUM_PHUM228480.1.1.m.498,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM229210.1.1.m.50089,0.008563114,0.01092475,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_PHUM_PHUM233260.1.1.m.6315,-0.000232021,-0.017771749,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial crista [GO:0030061]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; postsynaptic membrane [GO:0045211]; beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; protein phosphatase binding [GO:0019903]; protein-containing complex scaffold activity [GO:0032947]; RNA binding [GO:0003723]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of protein dephosphorylation [GO:0035308]; negative regulation of protein import into nucleus [GO:0042308]; regulation of protein kinase A signaling [GO:0010738],NA,NA,NA
CHOYP_PHUM_PHUM234540.1.1.m.9211,0.005102235,-0.000798426,No,NA,NA,NA,NA,NA,NA,chaperone complex [GO:0101031]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]; TPR domain binding [GO:0030911]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579],NA,NA,NA
CHOYP_PHUM_PHUM241330.1.3.m.29132,-0.005051051,-0.003180511,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing; via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_PHUM_PHUM244880.1.2.m.691,-0.01305827,-0.001952975,No,NA,NA,NA,NA,NA,NA,cation channel complex [GO:0034703]; cation channel activity [GO:0005261]; cation homeostasis [GO:0055080]; locomotor rhythm [GO:0045475],NA,NA,NA
CHOYP_PHUM_PHUM244880.2.2.m.41653,-0.000809117,-0.019928184,No,NA,NA,NA,NA,NA,NA,cation channel complex [GO:0034703]; cation channel activity [GO:0005261]; cation homeostasis [GO:0055080]; locomotor rhythm [GO:0045475],NA,NA,NA
CHOYP_PHUM_PHUM268120.1.1.m.23332,0.011172079,0.014144136,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_PHUM_PHUM278110.1.1.m.17560,-0.001504521,0.002945436,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_PHUM_PHUM289860.1.1.m.44778,-0.010929817,0.006088329,No,NA,NA,NA,NA,NA,NA,anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616],NA,NA,NA
CHOYP_PHUM_PHUM289860.1.1.m.44779,0.016041814,0.002395612,No,NA,NA,NA,NA,NA,NA,actin filament [GO:0005884]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; protein binding; bridging [GO:0030674]; actomyosin structure organization [GO:0031032]; epithelial cell differentiation [GO:0030855]; negative regulation of ATPase activity [GO:0032780],NA,NA,NA
CHOYP_PHUM_PHUM305910.1.2.m.58404,0.016519978,-0.00605457,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; growth cone lamellipodium [GO:1990761]; lamellipodium [GO:0030027]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; actin filament binding [GO:0051015]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; protein-containing complex binding [GO:0044877]; actin filament organization [GO:0007015]; aging [GO:0007568]; calcium-mediated signaling [GO:0019722]; cellular response to toxic substance [GO:0097237]; excitatory postsynaptic potential [GO:0060079]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of stress fiber assembly [GO:0051497]; neuron development [GO:0048666]; neuron projection development [GO:0031175]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein kinase activity [GO:0045860]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of filopodium assembly [GO:0051489]; regulation of synapse assembly [GO:0051963]; regulation of synapse structural plasticity [GO:0051823],NA,NA,NA
CHOYP_PHUM_PHUM310360.1.1.m.21767,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; symbiont-containing vacuole [GO:0020003]; trans-Golgi network [GO:0005802]; dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinesin binding [GO:0019894]; Rab GTPase binding [GO:0017137]; Golgi organization [GO:0007030]; mitochondrion organization [GO:0007005]; multi-organism toxin transport [GO:1990967]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to membrane [GO:0072657]; protein transport [GO:0015031]; response to bacterium [GO:0009617]; retrograde transport; endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]; viral RNA genome replication [GO:0039694],NA,NA,NA
CHOYP_PHUM_PHUM317840.1.2.m.29476,-0.014533795,-0.009953109,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; oxidoreductase activity [GO:0016491]; retinal dehydrogenase activity [GO:0001758]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_PHUM_PHUM317840.2.2.m.36471,-0.011373364,0.011669599,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; oxidoreductase activity [GO:0016491]; retinal dehydrogenase activity [GO:0001758]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_PHUM_PHUM319040.1.1.m.54919,0.001359873,0.008671525,No,NA,NA,NA,NA,NA,NA,mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731]; IRES-dependent viral translational initiation [GO:0075522]; ribosome disassembly [GO:0032790]; translation reinitiation [GO:0002188],NA,NA,NA
CHOYP_PHUM_PHUM328150.1.1.m.8592,0.012304381,0.022336668,No,NA,NA,NA,NA,NA,NA,bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; nucleotide binding [GO:0000166]; nucleobase-containing compound metabolic process [GO:0006139],NA,NA,NA
CHOYP_PHUM_PHUM332570.1.1.m.56283,-0.010000554,0.012615624,No,NA,NA,NA,NA,NA,NA,receptor tyrosine kinase binding [GO:0030971]; border follicle cell migration [GO:0007298]; ephrin receptor signaling pathway [GO:0048013]; imaginal disc fusion; thorax closure [GO:0046529]; myoblast fusion [GO:0007520]; phagocytosis; engulfment [GO:0006911]; positive regulation of JNK cascade [GO:0046330]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_PHUM_PHUM349810.1.2.m.7707,-0.002123615,0.000554284,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; (S)-2-hydroxy-acid oxidase activity [GO:0003973]; 2-hydroxyglutarate dehydrogenase activity [GO:0047545],NA,NA,NA
CHOYP_PHUM_PHUM350510.1.1.m.44180,0.000146545,-0.01782437,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell proliferation [GO:0008283]; development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription; DNA-templated [GO:0006355]; respiratory gaseous exchange [GO:0007585]; suckling behavior [GO:0001967],NA,NA,NA
CHOYP_PHUM_PHUM353470.1.1.m.63458,0.001487087,0.00647071,No,NA,NA,NA,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; ribose-5-phosphate isomerase activity [GO:0004751]; D-ribose metabolic process [GO:0006014]; pentose-phosphate shunt; non-oxidative branch [GO:0009052],NA,NA,NA
CHOYP_PHUM_PHUM361660.1.1.m.63423,-0.012497246,-0.023298015,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_PHUM_PHUM370970.1.2.m.40102,-0.007317477,0.003993037,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931],NA,NA,NA
CHOYP_PHUM_PHUM375280.1.2.m.23797,0.013553234,0.001850722,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-templated transcription; initiation [GO:0006352]; embryo development ending in birth or egg hatching [GO:0009792]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_PHUM_PHUM377430.1.2.m.29459,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM378040.1.1.m.15341,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; Tat protein binding [GO:0030957]; TFIIF-class transcription factor complex binding [GO:0001096]; cell division [GO:0051301]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; exit from mitosis [GO:0010458]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation by host of viral transcription [GO:0043923]; protein dephosphorylation [GO:0006470]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_PHUM_PHUM411900.1.1.m.50272,-0.01586498,0.00336075,No,NA,NA,NA,NA,NA,NA,oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_PHUM_PHUM423190.1.1.m.18351,-0.008881402,-0.005366215,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA methyltransferase activity [GO:0008173]; S-adenosyl-L-methionine binding [GO:1904047]; adenosine to inosine editing [GO:0006382]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; dosage compensation by inactivation of X chromosome [GO:0009048]; endothelial to hematopoietic transition [GO:0098508]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of cap-independent translational initiation [GO:1903679]; primary miRNA methylation [GO:1990744]; primary miRNA processing [GO:0031053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of T cell differentiation [GO:0045580]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_PHUM_PHUM427190.1.1.m.57126,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; carbohydrate binding [GO:0030246]; CD4 receptor binding [GO:0042609]; IgM binding [GO:0001791]; protein phosphatase binding [GO:0019903]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; B cell activation [GO:0042113]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of immunoglobulin secretion [GO:0051025]; regulation of B cell proliferation [GO:0030888]; regulation of endocytosis [GO:0030100]; regulation of immune response [GO:0050776],NA,NA,NA
CHOYP_PHUM_PHUM445570.1.1.m.18708,0.014950479,0.001534106,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; electron transfer activity [GO:0009055]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity; acting on single donors with incorporation of molecular oxygen; incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401],NA,NA,NA
CHOYP_PHUM_PHUM450820.1.1.m.40803,-0.009655698,-0.016840925,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; extrinsic component of postsynaptic membrane [GO:0098890]; extrinsic component of presynaptic membrane [GO:0098888]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density; intracellular component [GO:0099092]; presynaptic active zone cytoplasmic component [GO:0098831]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; cell-cell adhesion [GO:0098609]; dendrite morphogenesis [GO:0048813]; modification of postsynaptic actin cytoskeleton [GO:0098885]; prepulse inhibition [GO:0060134]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of synapse structural plasticity [GO:0051823],NA,NA,NA
CHOYP_PHUM_PHUM454570.1.1.m.28665,0.012087715,0.00106813,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; lateral plasma membrane [GO:0016328]; microtubule bundle [GO:0097427]; midbody [GO:0030496]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule bundle formation [GO:0001578]; positive regulation of microtubule motor activity [GO:2000576]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of autophagy [GO:0010506],NA,NA,NA
CHOYP_PHUM_PHUM465390.1.1.m.21142,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM470230.1.1.m.29432,0.0009653,0.00180661,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766],NA,NA,NA
CHOYP_PHUM_PHUM477110.1.1.m.53813,-0.008210561,0.007700848,No,NA,NA,NA,NA,NA,NA,bicellular tight junction [GO:0005923]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_PHUM_PHUM477570.1.1.m.2101,0.016358928,0.016797544,No,NA,NA,NA,NA,NA,NA,mitochondrial respiratory chain complex IV [GO:0005751]; myelin sheath [GO:0043209]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]; mitochondrial electron transport; cytochrome c to oxygen [GO:0006123],NA,NA,NA
CHOYP_PHUM_PHUM477850.1.1.m.19067,-0.015432475,-0.010915198,No,NA,NA,NA,NA,NA,NA,annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; transferase activity [GO:0016740]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]; protein sumoylation [GO:0016925],NA,NA,NA
CHOYP_PHUM_PHUM479110.1.1.m.54103,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; identical protein binding [GO:0042802]; malonyl-CoA decarboxylase activity [GO:0050080]; signaling receptor binding [GO:0005102]; acetyl-CoA biosynthetic process [GO:0006085]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; fatty acid oxidation [GO:0019395]; malonyl-CoA catabolic process [GO:2001294]; positive regulation of fatty acid oxidation [GO:0046321]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glucose metabolic process [GO:0010906]; response to ischemia [GO:0002931],NA,NA,NA
CHOYP_PHUM_PHUM494500.1.1.m.9430,0.014352882,-0.010586441,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; insulin binding [GO:0043559]; insulin-like growth factor binding [GO:0005520]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; determination of adult lifespan [GO:0008340]; entry into reproductive diapause [GO:0055116]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lipid storage [GO:0010888]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; positive regulation of insulin receptor signaling pathway [GO:0046628]; response to starvation [GO:0042594],NA,NA,NA
CHOYP_PHUM_PHUM498110.1.1.m.60692,0.004359625,0.02327193,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM498130.1.1.m.12138,-0.010111871,0.008937569,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM500930.1.1.m.21562,0.002705241,-0.016708221,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; basement membrane assembly [GO:0070831]; cell adhesion mediated by integrin [GO:0033627]; endodermal digestive tract morphogenesis [GO:0061031]; extracellular matrix assembly [GO:0085029]; midgut development [GO:0007494]; salivary gland morphogenesis [GO:0007435]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_PHUM_PHUM516040.1.1.m.55603,-0.008737681,0.0002083,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_PHUM_PHUM519460.1.1.m.3701,-0.009445429,-0.012595388,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_PHUM_PHUM536560.1.2.m.12360,-0.005895079,-0.00993338,No,NA,NA,NA,NA,NA,NA,amino acid binding [GO:0016597]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; cellular response to insulin stimulus [GO:0032869]; circadian regulation of gene expression [GO:0032922]; fructose 6-phosphate metabolic process [GO:0006002]; glucosamine biosynthetic process [GO:0006042]; glutamine metabolic process [GO:0006541]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein homotetramerization [GO:0051289]; protein N-linked glycosylation [GO:0006487]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047],NA,NA,NA
CHOYP_PHUM_PHUM537100.1.1.m.62217,-0.01114968,-0.004532711,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport; plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068],NA,NA,NA
CHOYP_PHUM_PHUM538050.1.1.m.56205,-0.010460698,-0.017323231,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM538580.1.1.m.43268,0.009432828,0.005783081,No,NA,NA,NA,NA,NA,NA,aggresome [GO:0016235]; axon [GO:0030424]; caveola [GO:0005901]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein deacetylase activity [GO:0033558]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; autophagy [GO:0006914]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; mitochondrion localization [GO:0051646]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of protein complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; negative regulation of transcription; DNA-templated [GO:0045892]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of receptor biosynthetic process [GO:0010870]; positive regulation of signal transduction [GO:0009967]; protein deacetylation [GO:0006476]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression; epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; regulation of signaling receptor activity [GO:0010469]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; response to organic substance [GO:0010033]; response to toxic substance [GO:0009636]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],NA,NA,NA
CHOYP_PHUM_PHUM544530.1.1.m.38469,0.007057205,-0.01369901,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of neuron projection development [GO:0010976]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_PHUM_PHUM547410.1.1.m.10964,-0.022666069,0.010294788,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_PHUM_PHUM549040.1.1.m.10284,0.007073174,0.010782874,No,NA,NA,NA,NA,NA,NA,ISWI-type complex [GO:0031010]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; chaeta development [GO:0022416]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ precursor cell fate determination [GO:0016360]; wing disc development [GO:0035220],NA,NA,NA
CHOYP_PHUM_PHUM559420.1.1.m.8620,0.00990705,-0.005917061,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_PHUM_PHUM562900.1.1.m.43674,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; intracellular sodium activated potassium channel activity [GO:0005228]; outward rectifier potassium channel activity [GO:0015271]; regulation of membrane potential [GO:0042391],NA,NA,NA
CHOYP_PHUM_PHUM563970.1.1.m.13515,0.009945644,-0.017082214,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; preribosome binding [GO:1990275]; RNA binding [GO:0003723]; positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_PHUM_PHUM574190.1.1.m.24768,-0.006735026,0.012740944,No,NA,NA,NA,NA,NA,NA,cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; podosome [GO:0002102]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; cellular response to cytokine stimulus [GO:0071345]; cellular response to epidermal growth factor stimulus [GO:0071364]; ERBB2 signaling pathway [GO:0038128]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_PHUM_PHUM574550.1.1.m.59401,-0.003520324,-0.005478722,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; Golgi membrane [GO:0000139]; positive regulation of macroautophagy [GO:0016239]; regulation of protein complex stability [GO:0061635],NA,NA,NA
CHOYP_PHUM_PHUM579670.1.1.m.63016,-0.003426823,0.002074515,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Ras GTPase binding [GO:0017016]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to L-glutamate [GO:1905232]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to manganese ion [GO:0071287]; cellular response to mercaptoethanol [GO:0072705]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to testosterone stimulus [GO:0071394]; intracellular distribution of mitochondria [GO:0048312]; male gonad development [GO:0008584]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial membrane organization [GO:0007006]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; mitotic cell cycle [GO:0000278]; mitotic cell cycle arrest [GO:0071850]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell death [GO:0060548]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of neuron death [GO:1901215]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of sarcomere organization [GO:0060299]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; positive regulation of cellular respiration [GO:1901857]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of estradiol secretion [GO:2000866]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of progesterone secretion [GO:2000872]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; protein targeting to mitochondrion [GO:0006626]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to calcium ion [GO:0051592]; response to D-galactose [GO:1905377]; response to electrical stimulus [GO:0051602]; response to fatty acid [GO:0070542]; response to flavonoid [GO:1905395]; response to hypobaric hypoxia [GO:1990910]; response to L-arginine [GO:1903576]; response to muscle activity [GO:0014850]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_PHUM_PHUM596890.1.1.m.10989,0.009560557,-0.020193988,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],NA,NA,NA
CHOYP_PHUM_PHUM596940.1.1.m.2151,-0.015856636,0.016235119,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018]; 14-3-3 protein binding [GO:0071889]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; filamin binding [GO:0031005]; muscle alpha-actinin binding [GO:0051371]; autophagosome assembly [GO:0000045]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000298],NA,NA,NA
CHOYP_PHUM_PHUM600390.1.1.m.6641,-0.013186238,-0.009442536,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II complex binding [GO:0000993]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; termination of RNA polymerase II transcription [GO:0006369]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_PHUM_PHUM602670.1.1.m.52487,-0.012631618,0.001291159,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; microvillus [GO:0005902]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; homologous chromosome movement towards spindle pole involved in homologous chromosome segregation [GO:0051758]; intracellular signal transduction [GO:0035556]; intracellular transport [GO:0046907]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_PHUM_PHUM616130.1.1.m.47653,-0.000498954,0.00945385,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; NELF complex [GO:0032021]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; transcriptional repressor complex [GO:0017053]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; negative regulation of DNA-templated transcription; elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_PHYD1.1.2.m.17822,-0.012600185,0.013693138,No,NA,NA,NA,NA,NA,NA,dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_PI4KB.1.1.m.8669,-0.001543918,-0.014331374,No,NA,NA,NA,NA,NA,NA,Golgi membrane [GO:0000139]; mitochondrial outer membrane [GO:0005741]; rough endoplasmic reticulum membrane [GO:0030867]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; phosphatidylinositol-mediated signaling [GO:0048015],NA,NA,NA
CHOYP_PIDD.1.1.m.54294,-0.022611952,0.010082495,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PIF.3.6.m.18904,0.022843032,-0.009640654,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitin metabolic process [GO:0006030],NA,NA,NA
CHOYP_PIF.6.6.m.44699,0.009818302,-0.004821934,No,NA,NA,NA,NA,NA,NA,collagen type XII trimer [GO:0005595]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_PIGS.1.1.m.18959,-0.012774941,0.013150517,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; acetylpyruvate hydrolase activity [GO:0018773]; acylpyruvate hydrolase activity [GO:0047621]; fumarylpyruvate hydrolase activity [GO:0034545]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948],NA,NA,NA
CHOYP_PININ.1.1.m.56667,-0.010932037,-0.004894767,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cell-cell junction [GO:0005911]; desmosome [GO:0030057]; exon-exon junction complex [GO:0035145]; intermediate filament [GO:0005882]; membrane [GO:0016020]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_PIPNA.1.1.m.37750,0.001730313,-0.018301983,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; myelin sheath [GO:0043209]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transporter activity [GO:0008526]; phospholipid binding [GO:0005543]; stearic acid binding [GO:0070540]; axonogenesis [GO:0007409]; phospholipid transport [GO:0015914],NA,NA,NA
CHOYP_PIR.1.1.m.48663,-0.000700088,0.000393027,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; quercetin 2;3-dioxygenase activity [GO:0008127]; transcription coregulator activity [GO:0003712]; digestion [GO:0007586]; monocyte differentiation [GO:0030224]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_PISD.2.2.m.30086,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,integral component of mitochondrial inner membrane [GO:0031305]; nucleus [GO:0005634]; phosphatidylserine decarboxylase activity [GO:0004609]; phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540],NA,NA,NA
CHOYP_PITG_07096.1.1.m.4922,0.007755593,-0.011241239,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PK1IP.1.1.m.49466,0.01149055,0.006854395,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; tRNA binding [GO:0000049]; selenocysteine incorporation [GO:0001514],NA,NA,NA
CHOYP_PK3C3.1.1.m.13959,-0.009230686,-0.00541238,No,NA,NA,NA,NA,NA,NA,midbody [GO:0030496]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; autophagy [GO:0006914]; cell cycle [GO:0007049]; cell division [GO:0051301]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_PKH_082300.1.1.m.29388,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PKH_143120.1.1.m.6777,-0.018393933,-0.006019165,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PKHL1.3.3.m.42452,-0.021529285,0.009979112,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_PLB1.1.1.m.16558,0.000237607,0.002222545,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1;2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1;2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644],NA,NA,NA
CHOYP_PLC.2.5.m.5277,-0.011172607,0.008220386,No,NA,NA,NA,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_PLC.3.5.m.7658,0.004386643,-0.012377552,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_PLCB4.1.2.m.1637,-0.021303183,-0.00103907,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density [GO:0014069]; smooth endoplasmic reticulum [GO:0005790]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate metabolic process [GO:0043647]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PLCD1.1.1.m.63908,0.006288274,0.00709069,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; inositol 1;4;5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; phospholipid binding [GO:0005543]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of norepinephrine secretion [GO:0010701]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of phospholipase C activity [GO:1900274]; response to aluminum ion [GO:0010044]; response to calcium ion [GO:0051592]; response to hyperoxia [GO:0055093]; response to organonitrogen compound [GO:0010243]; response to peptide hormone [GO:0043434]; response to prostaglandin F [GO:0034696],NA,NA,NA
CHOYP_PLCL2.1.1.m.62311,-0.001109539,0.012409856,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; GABA receptor binding [GO:0050811]; inositol 1;4;5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]; B cell proliferation involved in immune response [GO:0002322]; B-1a B cell differentiation [GO:0002337]; gamma-aminobutyric acid signaling pathway [GO:0007214]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of receptor binding [GO:1900122]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of synaptic transmission; GABAergic [GO:0032228],NA,NA,NA
CHOYP_PLEKHA1.2.2.m.21816,0.000830649,0.010651382,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of cell-matrix adhesion [GO:0001954],NA,NA,NA
CHOYP_PLIN2.1.1.m.23758,0.012230441,-0.023651666,No,NA,NA,NA,NA,NA,NA,intracellular [GO:0005622]; lipid droplet [GO:0005811]; membrane [GO:0016020],NA,NA,NA
CHOYP_PLK1.1.2.m.26371,0.010985029,-0.007129131,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; mitotic cell cycle [GO:0000278]; protein localization to chromatin [GO:0071168]; protein phosphorylation [GO:0006468]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425],NA,NA,NA
CHOYP_PLMN.1.11.m.5524,-0.008968335,-0.025571829,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586],NA,NA,NA
CHOYP_PLMN.4.11.m.29150,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; interaction with symbiont via secreted substance involved in symbiotic interaction [GO:0052213]; tissue remodeling [GO:0048771],NA,NA,NA
CHOYP_PLOD3.1.1.m.41788,0.019908604,-0.002786691,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; basement membrane assembly [GO:0070831]; cellular response to hormone stimulus [GO:0032870]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endothelial cell morphogenesis [GO:0001886]; epidermis morphogenesis [GO:0048730]; hydroxylysine biosynthetic process [GO:0046947]; in utero embryonic development [GO:0001701]; lung morphogenesis [GO:0060425]; neural tube development [GO:0021915]; peptidyl-lysine hydroxylation [GO:0017185]; protein localization [GO:0008104]; protein O-linked glycosylation [GO:0006493]; vasodilation [GO:0042311],NA,NA,NA
CHOYP_PLRG1.1.1.m.65600,-0.00426262,-0.01860323,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; DNA replication factor A complex [GO:0005662]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504],NA,NA,NA
CHOYP_PLSP.4.5.m.44386,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; heme binding [GO:0020037]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_PLXA3.1.1.m.51322,-0.001471769,-0.010650716,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; brain development [GO:0007420]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; neural tube closure [GO:0001843]; neuroblast proliferation [GO:0007405]; positive regulation of axonogenesis [GO:0050772]; positive regulation of neuron projection development [GO:0010976]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of neuron migration [GO:2001222]; regulation of protein phosphorylation [GO:0001932]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287],NA,NA,NA
CHOYP_PLXB2.2.2.m.47843,-0.01506842,-0.010680204,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PM20D2.1.1.m.27186,0.019887798,-0.006253358,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268],NA,NA,NA
CHOYP_PMAA_001770.1.1.m.11519,0.011389972,0.001359216,No,NA,NA,NA,NA,NA,NA,dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_PMAR_PMAR003946.2.2.m.31102,-0.009174522,-0.016461646,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; electron transfer activity [GO:0009055]; glutathione-disulfide reductase activity [GO:0004362]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599],NA,NA,NA
CHOYP_PMAR_PMAR009545.1.1.m.28734,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PMAR_PMAR019172.1.1.m.2563,-0.008040361,0.002848753,No,NA,NA,NA,NA,NA,NA,magnesium ion binding [GO:0000287]; phosphonoacetaldehyde hydrolase activity [GO:0050194]; organic phosphonate catabolic process [GO:0019700],NA,NA,NA
CHOYP_PMS2.1.1.m.16450,0.010700848,0.012273882,No,NA,NA,NA,NA,NA,NA,cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; single base insertion or deletion binding [GO:0032138]; mismatch repair [GO:0006298]; response to drug [GO:0042493]; somatic hypermutation of immunoglobulin genes [GO:0016446],NA,NA,NA
CHOYP_PMTR.1.1.m.46450,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PNCB.1.1.m.57201,-0.017034022,-0.009370432,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; metal ion binding [GO:0046872]; nicotinate phosphoribosyltransferase activity [GO:0004516]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; NAD biosynthetic process [GO:0009435]; NAD salvage [GO:0034355]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_PNO1.1.3.m.2044,-0.007218745,-0.015437654,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_PNO1.2.3.m.47801,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,KICSTOR complex [GO:0140007]; lamellipodium [GO:0030027]; lysosomal membrane [GO:0005765]; postsynaptic actin cytoskeleton [GO:0098871]; stereocilium [GO:0032420]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462],NA,NA,NA
CHOYP_PNP5B.1.1.m.21997,-0.001001714,0.024171575,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; drug binding [GO:0008144]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731]; immune response [GO:0006955]; inosine catabolic process [GO:0006148]; interleukin-2 secretion [GO:0070970]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; neutrophil degranulation [GO:0043312]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of T cell proliferation [GO:0042102]; purine nucleotide catabolic process [GO:0006195]; purine-containing compound salvage [GO:0043101]; response to drug [GO:0042493]; urate biosynthetic process [GO:0034418],NA,NA,NA
CHOYP_PO2F1.1.1.m.11428,-0.003980444,-0.012357707,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; epidermis development [GO:0008544]; negative regulation by host of viral transcription [GO:0043922]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_POGLUT1.1.1.m.45796,0.001385961,0.019377808,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; glucosyltransferase activity [GO:0046527]; protein xylosyltransferase activity [GO:0030158]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]; gastrulation [GO:0007369]; muscle tissue development [GO:0060537]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; regulation of gastrulation [GO:0010470],NA,NA,NA
CHOYP_POLD1.1.1.m.61169,-0.004081537,0.014834081,No,NA,NA,NA,NA,NA,NA,aggresome [GO:0016235]; cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron; 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; base-excision repair; gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA damage response; detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-dependent DNA replication [GO:0006261]; fatty acid homeostasis [GO:0055089]; nucleotide-excision repair; DNA gap filling [GO:0006297]; nucleotide-excision repair; DNA incision [GO:0033683]; nucleotide-excision repair; DNA incision; 5'-to lesion [GO:0006296]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985],NA,NA,NA
CHOYP_POLR3K.1.1.m.8423,-0.003634001,-0.01737934,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; termination of RNA polymerase III transcription [GO:0006386]; transcription by RNA polymerase III [GO:0006383]; tRNA 3'-trailer cleavage [GO:0042779],NA,NA,NA
CHOYP_POMGNT1.1.1.m.33377,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; beta-1;3-galactosyl-O-glycosyl-glycoprotein beta-1;3-N-acetylglucosaminyltransferase activity [GO:0047223]; manganese ion binding [GO:0030145]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493],NA,NA,NA
CHOYP_POPTRDRAFT_1091519.1.1.m.56854,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; carboxylic acid binding [GO:0031406]; NAD binding [GO:0051287]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; acetate metabolic process [GO:0006083]; central nervous system development [GO:0007417]; galactosylceramide metabolic process [GO:0006681]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; glucose metabolic process [GO:0006006]; glucosylceramide metabolic process [GO:0006678]; glutamate metabolic process [GO:0006536]; glutamine metabolic process [GO:0006541]; glutathione metabolic process [GO:0006749]; glycerophospholipid metabolic process [GO:0006650]; neurotransmitter catabolic process [GO:0042135]; oxidation-reduction process [GO:0055114]; post-embryonic development [GO:0009791]; protein homotetramerization [GO:0051289]; respiratory electron transport chain [GO:0022904]; short-chain fatty acid metabolic process [GO:0046459]; succinate metabolic process [GO:0006105],NA,NA,NA
CHOYP_POPTRDRAFT_655879.1.1.m.46190,0.006090542,-0.001895385,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PP1A.1.1.m.25950,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; glycogen granule [GO:0042587]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear chromosome; telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; ribonucleoprotein complex binding [GO:0043021]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981]; response to lead ion [GO:0010288],NA,NA,NA
CHOYP_PP1B.2.3.m.22075,0.005103264,-0.000605019,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; metal ion binding [GO:0046872]; myosin-light-chain-phosphatase activity [GO:0050115]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; glycogen metabolic process [GO:0005977]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752],NA,NA,NA
CHOYP_PP1RA.1.1.m.9915,-0.007057883,0.008377102,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein phosphatase inhibitor activity [GO:0004864],NA,NA,NA
CHOYP_PP4C.1.1.m.10112,-0.008159155,-0.023216555,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; regulation of double-strand break repair via homologous recombination [GO:0010569],NA,NA,NA
CHOYP_PP4R1.1.1.m.11682,0.00568665,-0.021697354,No,NA,NA,NA,NA,NA,NA,protein phosphatase 4 complex [GO:0030289]; protein phosphatase regulator activity [GO:0019888]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PP6R3.1.1.m.43072,-0.009934384,-0.020699094,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein phosphatase binding [GO:0019903]; regulation of phosphoprotein phosphatase activity [GO:0043666],NA,NA,NA
CHOYP_PPA5.1.1.m.36087,-0.008170264,0.004123922,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; acid phosphatase activity [GO:0003993]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; bone morphogenesis [GO:0060349]; bone resorption [GO:0045453]; defense response to Gram-positive bacterium [GO:0050830]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of superoxide anion generation [GO:0032929]; negative regulation of tumor necrosis factor production [GO:0032720]; ossification [GO:0001503]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496],NA,NA,NA
CHOYP_PPAC1.1.1.m.51347,-0.001697611,0.000101466,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; acid phosphatase activity [GO:0003993]; protein tyrosine phosphatase activity [GO:0004725]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_PPAL.2.2.m.32405,-0.01165406,-0.011081064,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; acid phosphatase activity [GO:0003993]; lysosome organization [GO:0007040]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_PPAN.B.1.1.m.2112,-0.003640194,-0.013896099,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PPBT.1.4.m.5115,-0.003289998,-0.021937066,No,NA,NA,NA,NA,NA,NA,anchored component of plasma membrane [GO:0046658]; alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]; dephosphorylation [GO:0016311],NA,NA,NA
CHOYP_PPIB.2.4.m.40019,-0.022557861,0.009976585,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; Golgi apparatus [GO:0005794]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; protein folding in endoplasmic reticulum [GO:0034975]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_PPID.1.1.m.55261,-0.003241551,-0.012915483,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; apoptotic process [GO:0006915]; cellular response to UV-A [GO:0071492]; chaperone-mediated protein folding [GO:0061077]; lipid droplet organization [GO:0034389]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003],NA,NA,NA
CHOYP_PPIE.1.1.m.18580,-0.003182326,-2.64E-05,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; cyclosporin A binding [GO:0016018]; mRNA binding [GO:0003729]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; poly(A) binding [GO:0008143]; mRNA splicing; via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413],NA,NA,NA
CHOYP_PPIG.1.1.m.63308,0.006040331,-0.012067699,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_PPIH.1.1.m.18923,0.012065517,-0.001795039,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ribonucleoprotein complex binding [GO:0043021]; unfolded protein binding [GO:0051082]; angiogenesis [GO:0001525]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein-containing complex assembly [GO:0065003],NA,NA,NA
CHOYP_PPIL2.1.1.m.55184,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209],NA,NA,NA
CHOYP_PPM1H.1.1.m.24782,-0.007695439,0.016332119,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722],NA,NA,NA
CHOYP_PPME1.1.1.m.56260,-0.014082356,0.008000442,No,NA,NA,NA,NA,NA,NA,protein C-terminal methylesterase activity [GO:0051722]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]; protein demethylation [GO:0006482],NA,NA,NA
CHOYP_PPN.2.4.m.44929,0.000750921,-0.007907535,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_PPN.3.4.m.50209,-0.005764982,0.004145293,No,NA,NA,NA,NA,NA,NA,basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_PPOX.1.1.m.45234,-0.009330927,-0.017495093,No,NA,NA,NA,NA,NA,NA,intrinsic component of mitochondrial inner membrane [GO:0031304]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; oxygen-dependent protoporphyrinogen oxidase activity [GO:0004729]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782],NA,NA,NA
CHOYP_PPP1CC.1.1.m.13937,-1.79E-05,-0.008249438,No,NA,NA,NA,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; glycogen granule [GO:0042587]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear chromosome; telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; ribonucleoprotein complex binding [GO:0043021]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981]; response to lead ion [GO:0010288],NA,NA,NA
CHOYP_PPP1R7.1.1.m.37778,0.015690698,0.000760423,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_PPP6.1.1.m.16278,0.007683183,-0.021884418,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; innate immune response [GO:0045087]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_PPR27.1.1.m.10278,0.009798621,0.002964021,No,NA,NA,NA,NA,NA,NA,phosphatase binding [GO:0019902]; protein phosphatase inhibitor activity [GO:0004864]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_PPR37.1.1.m.27483,-0.001599681,-0.007805765,No,NA,NA,NA,NA,NA,NA,protein phosphatase inhibitor activity [GO:0004864]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_PPT2A.1.2.m.30339,0.007462878,-0.020536646,No,NA,NA,NA,NA,NA,NA,lysosome [GO:0005764]; palmitoyl-(protein) hydrolase activity [GO:0008474],NA,NA,NA
CHOYP_PPUTW619_2764.1.1.m.44946,0.021873905,-0.012835745,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PPWD1.1.1.m.48713,0.007480294,-0.010609883,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA processing [GO:0006397]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_PRB2.2.2.m.41331,0.007606374,-0.0082363,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_PRCC.2.2.m.58572,-0.001418034,-0.004955165,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mitotic cell cycle checkpoint [GO:0007093]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_PRG4.1.2.m.7441,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PRIM.1.1.m.30784,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,DNA primase activity [GO:0003896],NA,NA,NA
CHOYP_PRKAB1B.1.3.m.19788,-0.010260463,0.012680579,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PRKAB1B.2.3.m.31228,0.020645364,-0.004609034,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PRKAB2.1.1.m.12513,0.014513494,0.00155087,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; cell cycle arrest [GO:0007050]; fatty acid biosynthetic process [GO:0006633]; macroautophagy [GO:0016236]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid biosynthetic process [GO:0042304]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PRKCSH.1.1.m.28109,0.013195071,-0.008889673,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular [GO:0005622]; intracellular membrane-bounded organelle [GO:0043231]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]; cellular protein metabolic process [GO:0044267]; intracellular signal transduction [GO:0035556]; N-glycan processing [GO:0006491]; post-translational protein modification [GO:0043687],NA,NA,NA
CHOYP_PRKDC.1.1.m.47256,-0.01887672,-0.00419583,No,NA,NA,NA,NA,NA,NA,nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]; telomere maintenance [GO:0000723],NA,NA,NA
CHOYP_PRKN2.1.1.m.54903,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,aggresome [GO:0016235]; axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; F-box domain binding [GO:1990444]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; adult locomotory behavior [GO:0008344]; aggresome assembly [GO:0070842]; autophagy of mitochondrion [GO:0000422]; brain development [GO:0007420]; cellular protein modification process [GO:0006464]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to L-glutamate [GO:1905232]; cellular response to L-glutamine [GO:1904845]; cellular response to manganese ion [GO:0071287]; cellular response to toxic substance [GO:0097237]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of insulin secretion [GO:0046676]; negative regulation of JNK cascade [GO:0046329]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of synaptic transmission; glutamatergic [GO:0051967]; neuron cellular homeostasis [GO:0070050]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of DNA binding [GO:0043388]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitophagy [GO:1901526]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein localization to mitochondrion [GO:0070585]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; response to corticosterone [GO:0051412]; response to curcumin [GO:1904643]; response to drug [GO:0042493]; response to endoplasmic reticulum stress [GO:0034976]; response to muscle activity [GO:0014850]; response to oxidative stress [GO:0006979]; response to unfolded protein [GO:0006986]; ubiquitin-dependent protein catabolic process [GO:0006511]; zinc ion homeostasis [GO:0055069],NA,NA,NA
CHOYP_PROF.2.2.m.41295,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PROM1.3.3.m.58805,0.016655957,0.011284032,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840],NA,NA,NA
CHOYP_PRP16.1.1.m.19094,0.004477555,-0.004077482,No,NA,NA,NA,NA,NA,NA,spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_PRP18.1.1.m.2214,-0.009559373,0.019007992,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; U2-type post-spliceosomal complex [GO:0071021]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; generation of catalytic spliceosome for second transesterification step [GO:0000350]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048],NA,NA,NA
CHOYP_PRP31.3.6.m.8812,-0.0054185,-0.010326416,No,NA,NA,NA,NA,NA,NA,Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; U4atac snRNA binding [GO:0030622]; mRNA splicing; via spliceosome [GO:0000398]; retina development in camera-type eye [GO:0060041]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_PRP4B.1.1.m.28423,-0.013464776,-0.007534102,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; mRNA processing [GO:0006397]; protein phosphorylation [GO:0006468]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_PRP6.1.2.m.28600,-0.010127266,-0.018014803,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_PRP6.2.2.m.34365,-0.01777079,-0.011194049,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_PRP8.1.1.m.51584,-0.018581664,-0.011311369,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; second spliceosomal transesterification activity [GO:0000386]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_PRPF3.1.1.m.736,-0.003862285,-0.003125535,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_PRPF4.1.1.m.62194,-0.004099167,-0.006338036,No,NA,NA,NA,NA,NA,NA,Cajal body [GO:0015030]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; spliceosomal snRNP complex [GO:0097525]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; mRNA splicing; via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_PRPS1.1.1.m.10083,-0.007825163,0.006700429,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; ribose phosphate diphosphokinase complex [GO:0002189]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; carbohydrate binding [GO:0030246]; GDP binding [GO:0019003]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; AMP biosynthetic process [GO:0006167]; animal organ regeneration [GO:0031100]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribose phosphate metabolic process [GO:0019693],NA,NA,NA
CHOYP_PRRC1.1.1.m.6820,0.010984142,0.00166022,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794],NA,NA,NA
CHOYP_PRRT1.2.5.m.28553,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020],NA,NA,NA
CHOYP_PRS4.1.1.m.45626,0.005016022,-0.000533019,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; proteasome-activating ATPase activity [GO:0036402]; TBP-class protein binding [GO:0017025]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_PRS6B.1.1.m.66735,-0.009763006,0.001559053,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; blastocyst development [GO:0001824]; protein catabolic process [GO:0030163],NA,NA,NA
CHOYP_PRS7.1.1.m.31825,-0.007011144,0.005770623,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; proteasome-activating ATPase activity [GO:0036402]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_PRS8.1.1.m.40757,0.001434479,0.008983561,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; protein catabolic process [GO:0030163],NA,NA,NA
CHOYP_PRTG.2.3.m.27411,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_PRUN2.1.1.m.38759,-0.00340024,0.005448137,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; exopolyphosphatase activity [GO:0004309]; apoptotic process [GO:0006915]; polyphosphate catabolic process [GO:0006798],NA,NA,NA
CHOYP_PSA.1.1.m.27259,0.021335029,0.002512535,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_PSA1.1.1.m.44276,0.008589612,0.014958862,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysome [GO:0005844]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex; alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; RNA binding [GO:0003723]; threonine-type endopeptidase activity [GO:0004298]; immune system process [GO:0002376]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579],NA,NA,NA
CHOYP_PSA2.1.1.m.57091,0.018178901,-0.000156536,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex; alpha-subunit complex [GO:0019773]; secretory granule lumen [GO:0034774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; neutrophil degranulation [GO:0043312]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; response to virus [GO:0009615],NA,NA,NA
CHOYP_PSA4.1.1.m.19303,0.009671899,0.014729861,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex; alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; viral process [GO:0016032],NA,NA,NA
CHOYP_PSA6.1.1.m.30357,-0.004908915,0.004639487,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; myofibril [GO:0030016]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; proteasome core complex [GO:0005839]; proteasome core complex; alpha-subunit complex [GO:0019773]; sarcomere [GO:0030017]; endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; threonine-type endopeptidase activity [GO:0004298]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_PSB1.2.2.m.63827,0.003441081,0.014560773,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_PSD7.1.1.m.19729,0.016954734,-0.008723616,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; lid subcomplex [GO:0008541]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_PSDE.1.1.m.38562,0.002392977,0.024247936,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; lid subcomplex [GO:0008541]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579],NA,NA,NA
CHOYP_PSIP1.1.1.m.61157,-0.011873767,-0.016785337,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; growth factor activity [GO:0008083]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]; cell proliferation [GO:0008283]; microtubule polymerization [GO:0046785]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175],NA,NA,NA
CHOYP_PSMB2.1.1.m.62965,0.016445392,-0.00627847,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243],NA,NA,NA
CHOYP_PSMC6.1.1.m.13888,0.018549341,-0.00431232,No,NA,NA,NA,NA,NA,NA,cytosolic proteasome complex [GO:0031597]; inclusion body [GO:0016234]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle; base subcomplex [GO:0008540]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; proteasome-activating ATPase activity [GO:0036402]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_PSMD1.1.1.m.21682,0.001941715,-0.022014587,No,NA,NA,NA,NA,NA,NA,azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; ubiquitin protein ligase binding [GO:0031625]; neutrophil degranulation [GO:0043312]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; regulation of protein catabolic process [GO:0042176],NA,NA,NA
CHOYP_PSMD1.1.1.m.21683,-0.013127616,-0.010409253,No,NA,NA,NA,NA,NA,NA,endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; protein localization to membrane [GO:0072657],NA,NA,NA
CHOYP_PSMD2.1.3.m.13362,0.010067557,0.006263496,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle; base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176],NA,NA,NA
CHOYP_PSMD2.3.3.m.59657,-0.006358871,-0.019862812,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; meiotic cell cycle [GO:0051321]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_PSMD2.3.3.m.59658,-0.006827002,-0.007808126,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; secretory granule lumen [GO:0034774]; enzyme regulator activity [GO:0030234]; neutrophil degranulation [GO:0043312]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; regulation of protein catabolic process [GO:0042176],NA,NA,NA
CHOYP_PSMD6.1.1.m.60839,-0.007969838,-0.025135676,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]; ATPase activity [GO:0016887]; enzyme regulator activity [GO:0030234]; neutrophil degranulation [GO:0043312]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_PSMD9.1.1.m.5055,-0.000101595,-0.008136214,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome regulatory particle; base subcomplex [GO:0008540]; proteasome regulatory particle assembly [GO:0070682],NA,NA,NA
CHOYP_PSME4.1.1.m.18992,-0.005704134,-0.011225025,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spermatoproteasome complex [GO:1990111]; lysine-acetylated histone binding [GO:0070577]; peptidase activator activity [GO:0016504]; proteasome binding [GO:0070628]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; spermatogenesis; exchange of chromosomal proteins [GO:0035093],NA,NA,NA
CHOYP_PSMG2.1.1.m.66279,-0.003551961,-0.003820798,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome assembly [GO:0043248],NA,NA,NA
CHOYP_PSTA_4372.1.1.m.39115,0.005484755,-0.005391259,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PSTA.1.2.m.4739,0.017676579,0.005208384,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PSTA.2.2.m.9655,-0.018662299,-0.005648893,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PSTPIP1.1.1.m.39114,-0.003404154,0.018870378,No,NA,NA,NA,NA,NA,NA,actin filament [GO:0005884]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931]; actin filament binding [GO:0051015]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; actin filament polymerization [GO:0030041]; cell adhesion [GO:0007155]; endocytosis [GO:0006897]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PTCD3.1.1.m.24655,-0.010557532,-0.011131399,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; ribosome [GO:0005840]; ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_PTEN.1.1.m.5408,-0.011575429,-0.011840988,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; myelin sheath adaxonal region [GO:0035749]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; Schmidt-Lanterman incisure [GO:0043220]; anaphase-promoting complex binding [GO:0010997]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; inositol-1;3;4;5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; ionotropic glutamate receptor binding [GO:0035255]; lipid binding [GO:0008289]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3;4;5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3;4-bisphosphate 3-phosphatase activity [GO:0051800]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; platelet-derived growth factor receptor binding [GO:0005161]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; ubiquitin-specific protease binding [GO:1990381]; adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to electrical stimulus [GO:0071257]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to leptin stimulus [GO:0044320]; cellular response to nerve growth factor stimulus [GO:1990090]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon regeneration [GO:0048681]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of synaptic vesicle clustering [GO:2000808]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; negative regulation of wound healing; spreading of epidermal cells [GO:1903690]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein deubiquitination [GO:0016579]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission; GABAergic [GO:0032228]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to estradiol [GO:0032355]; response to glucose [GO:0009749]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_PTER.1.2.m.28985,0.012994476,0.007284236,No,NA,NA,NA,NA,NA,NA,hydrolase activity; acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270]; catabolic process [GO:0009056],NA,NA,NA
CHOYP_PTGR1.1.1.m.29812,0.004169721,0.016290796,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase [NAD(P)] activity [GO:0032440],NA,NA,NA
CHOYP_PTH1R.4.4.m.65130,0.005823211,-0.003590673,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; parathyroid hormone receptor activity [GO:0004991]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166],NA,NA,NA
CHOYP_PTHB1.1.1.m.35678,-0.011790134,-0.012773845,No,NA,NA,NA,NA,NA,NA,BBSome [GO:0034464]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815],NA,NA,NA
CHOYP_PTN11.4.4.m.62827,0.005350088,0.000576428,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cell adhesion molecule binding [GO:0050839]; insulin receptor binding [GO:0005158]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; peptide hormone receptor binding [GO:0051428]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; SH3/SH2 adaptor activity [GO:0005070]; abortive mitotic cell cycle [GO:0033277]; activation of MAPK activity [GO:0000187]; atrioventricular canal development [GO:0036302]; axonogenesis [GO:0007409]; Bergmann glial cell differentiation [GO:0060020]; cellular response to epidermal growth factor stimulus [GO:0071364]; cerebellar cortex formation [GO:0021697]; DNA damage checkpoint [GO:0000077]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; face morphogenesis [GO:0060325]; genitalia development [GO:0048806]; glucose homeostasis [GO:0042593]; homeostasis of number of cells within a tissue [GO:0048873]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; intestinal epithelial cell migration [GO:0061582]; megakaryocyte development [GO:0035855]; microvillus organization [GO:0032528]; multicellular organism growth [GO:0035264]; multicellular organismal reproductive process [GO:0048609]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cortisol secretion [GO:0051463]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of insulin secretion [GO:0046676]; neurotrophin TRK receptor signaling pathway [GO:0048011]; organ growth [GO:0035265]; platelet formation [GO:0030220]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose import [GO:0046326]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of multicellular organism growth [GO:0040014]; regulation of protein complex assembly [GO:0043254]; regulation of protein export from nucleus [GO:0046825]; triglyceride metabolic process [GO:0006641],NA,NA,NA
CHOYP_PTN11.4.4.m.62828,-0.020375459,0.003323374,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_PTP10.3.3.m.46720,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311],NA,NA,NA
CHOYP_PTPA.1.1.m.18579,-0.002321909,-0.014043065,No,NA,NA,NA,NA,NA,NA,calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activator activity [GO:0008160]; signaling receptor binding [GO:0005102]; mitotic spindle organization [GO:0007052]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; positive regulation of apoptotic process [GO:0043065]; positive regulation of phosphoprotein phosphatase activity [GO:0032516],NA,NA,NA
CHOYP_PTPN23.1.1.m.16408,-0.006379604,-0.005212384,No,NA,NA,NA,NA,NA,NA,ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],NA,NA,NA
CHOYP_PTPRA.19.22.m.59233,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPRA.2.22.m.3118,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRA.9.22.m.46545,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRA.9.22.m.46547,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PTPRB.1.4.m.21615,0.00369025,0.00511544,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311],NA,NA,NA
CHOYP_PTPRB.3.4.m.52977,0.002980327,-0.00575549,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311],NA,NA,NA
CHOYP_PTPRB.4.4.m.66782,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_PTPRC.5.14.m.34957,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRE.7.19.m.34309,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPREA.1.2.m.4823,0.011164854,-0.001114897,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic density membrane [GO:0099061]; intrinsic component of plasma membrane [GO:0031226]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perineuronal net [GO:0072534]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; fibroblast growth factor binding [GO:0017134]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of dendrite development [GO:2000171]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite development [GO:1900006]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Schwann cell migration [GO:1900149]; protein dephosphorylation [GO:0006470]; regulation of dendrite morphogenesis [GO:0048814]; regulation of oligodendrocyte progenitor proliferation [GO:0070445],NA,NA,NA
CHOYP_PTPRF.2.6.m.17540,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PTPRF.3.6.m.28841,0.003171596,0.0103362,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725]; SAM domain binding [GO:0032093]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; peptidyl-tyrosine dephosphorylation [GO:0035335]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic growth at neuromuscular junction [GO:0051124],NA,NA,NA
CHOYP_PTPRG.1.3.m.56419,-0.004420881,-0.011387264,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPRG.2.3.m.61939,0.005338476,0.00027429,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPRG.3.3.m.65311,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRK.10.20.m.31769,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRK.13.20.m.40023,0.009506975,0.007138353,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPRK.17.20.m.60780,0.004324457,-0.012409213,No,NA,NA,NA,NA,NA,NA,adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription; DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_PTPRK.18.20.m.62712,0.000285551,-0.000524494,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; cytokine-mediated signaling pathway [GO:0019221]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of oligodendrocyte progenitor proliferation [GO:0070445],NA,NA,NA
CHOYP_PTPRK.4.20.m.2624,0.010265194,0.012490675,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRK.6.20.m.6291,0.007963597,0.008721636,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRK.8.20.m.8333,0.006346897,-0.006722335,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRM.11.15.m.52054,0.006577079,0.000365944,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; negative regulation of insulin receptor signaling pathway [GO:0046627]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_PTPRM.14.15.m.57240,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription; DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_PTPRQ.6.8.m.45809,0.006588986,0.00040845,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; stereocilium bundle [GO:0032421]; protein tyrosine phosphatase activity [GO:0004725]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; regulation of fat cell differentiation [GO:0045598]; vestibular receptor cell morphogenesis [GO:0060116],NA,NA,NA
CHOYP_PTPRT.11.45.m.39468,9.12E-05,0.008197247,No,NA,NA,NA,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PTPRT.12.45.m.39573,-0.007532332,0.012499919,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRT.17.45.m.42361,0.008648262,0.001518938,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRT.22.45.m.47112,0.012209221,-0.018594969,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRT.26.45.m.52045,-0.007901479,-0.003470648,No,NA,NA,NA,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PTPRT.30.45.m.53464,-0.000100518,-0.005427298,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPRT.38.45.m.60044,0.003156309,0.000757238,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRT.40.45.m.61584,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPRT.6.45.m.24275,-0.007533593,0.014039508,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRU.2.2.m.58388,0.003550887,0.007558926,No,NA,NA,NA,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PTPRZ.1.9.m.12735,0.012353559,0.022987074,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; cytokine-mediated signaling pathway [GO:0019221]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of oligodendrocyte progenitor proliferation [GO:0070445],NA,NA,NA
CHOYP_PTPRZ.4.9.m.21524,-0.002693012,-0.012575538,No,NA,NA,NA,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PUA1A.1.1.m.6287,-0.011760975,-0.00179488,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; adenylosuccinate synthase activity [GO:0004019]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; 'de novo' AMP biosynthetic process [GO:0044208],NA,NA,NA
CHOYP_PUM1.1.1.m.8674,-0.01272226,-0.017305577,No,NA,NA,NA,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; stress granule assembly [GO:0034063],NA,NA,NA
CHOYP_PUR2.1.1.m.17810,0.021319291,-0.007985539,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; ribonucleoside monophosphate biosynthetic process [GO:0009156]; tetrahydrofolate biosynthetic process [GO:0046654],NA,NA,NA
CHOYP_PUR8.1.1.m.2748,-0.005948826,0.010904299,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity [GO:0070626]; N6-(1;2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity [GO:0004018]; 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189],NA,NA,NA
CHOYP_PUS3.1.1.m.9880,-0.012446293,-0.004821866,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine synthase activity [GO:0106029]; mRNA pseudouridine synthesis [GO:1990481]; tRNA modification [GO:0006400]; tRNA pseudouridine synthesis [GO:0031119],NA,NA,NA
CHOYP_PUS7.1.1.m.53798,0.010506632,0.008615074,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; tRNA pseudouridine synthesis [GO:0031119],NA,NA,NA
CHOYP_PVX_111155.1.1.m.25208,0.016507829,0.002275917,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PWAP.1.1.m.44818,0.022845413,-0.00146105,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PWP2.1.1.m.7530,-0.004434092,-0.010060511,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730],NA,NA,NA
CHOYP_PXK.1.1.m.27815,0.008749207,0.011012594,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; inflammatory response [GO:0006954]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATPase activity [GO:0032780]; negative regulation of ion transport [GO:0043271]; regulation of membrane potential [GO:0042391],NA,NA,NA
CHOYP_PY03350.1.1.m.8097,0.004394321,-0.010700855,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PY03697.1.1.m.58980,0.000765184,-0.003236507,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PY04960.1.1.m.26352,-0.022621939,0.010462369,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PYR1.1.1.m.61565,-0.003474397,-0.01182638,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; zinc ion binding [GO:0008270]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541],NA,NA,NA
CHOYP_PYRD2.1.1.m.26691,-0.010628296,0.003380358,No,NA,NA,NA,NA,NA,NA,oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_PYRG1.1.1.m.13552,-0.007391842,-0.017075582,No,NA,NA,NA,NA,NA,NA,cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]; 'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; pyrimidine nucleobase biosynthetic process [GO:0019856],NA,NA,NA
CHOYP_QARS.2.2.m.18038,0.005942049,-0.016038802,No,NA,NA,NA,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; brain development [GO:0007420]; glutaminyl-tRNA aminoacylation [GO:0006425]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription; DNA-templated [GO:0045892]; tRNA aminoacylation for protein translation [GO:0006418],NA,NA,NA
CHOYP_QCR2.1.1.m.35612,-0.007343298,-0.019017788,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein-containing complex binding [GO:0044877]; aerobic respiration [GO:0009060]; oxidative phosphorylation [GO:0006119]; protein processing involved in protein targeting to mitochondrion [GO:0006627],NA,NA,NA
CHOYP_QCR2.1.1.m.35613,-0.018633986,-0.013951558,No,NA,NA,NA,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; sperm flagellum [GO:0036126]; axoneme assembly [GO:0035082]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_QPCT.1.1.m.38977,0.012195613,0.008400743,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270]; cellular protein modification process [GO:0006464]; neutrophil degranulation [GO:0043312]; peptidyl-pyroglutamic acid biosynthetic process; using glutaminyl-peptide cyclotransferase [GO:0017186],NA,NA,NA
CHOYP_QTRTD1.1.1.m.19041,0.007517792,0.008437154,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA-guanine transglycosylation [GO:0101030],NA,NA,NA
CHOYP_R3HDM1.1.1.m.36018,0.003060129,-0.00598325,No,NA,NA,NA,NA,NA,NA,RNA binding [GO:0003723],NA,NA,NA
CHOYP_RAB1A.1.3.m.10036,0.001353225,-0.012977682,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_RAB21.1.1.m.56542,0.005295901,-0.006244813,No,NA,NA,NA,NA,NA,NA,axon cytoplasm [GO:1904115]; cleavage furrow [GO:0032154]; cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi cisterna membrane [GO:0032580]; neuron projection [GO:0043005]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle membrane [GO:0012506]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; anterograde axonal transport [GO:0008089]; intracellular protein transport [GO:0006886]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of receptor-mediated endocytosis [GO:0048260]; Rab protein signal transduction [GO:0032482]; regulation of axon extension [GO:0030516]; regulation of exocytosis [GO:0017157],NA,NA,NA
CHOYP_RAB35.1.1.m.8277,0.011179779,0.015230097,No,NA,NA,NA,NA,NA,NA,anchored component of synaptic vesicle membrane [GO:0098993]; cell projection membrane [GO:0031253]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; antigen processing and presentation [GO:0019882]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; neuron projection development [GO:0031175]; plasma membrane to endosome transport [GO:0048227]; protein localization to endosome [GO:0036010]; Rab protein signal transduction [GO:0032482],NA,NA,NA
CHOYP_RAB35.1.1.m.8278,0.014651305,0.011840121,No,NA,NA,NA,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; membrane [GO:0016020]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; osteoblast differentiation [GO:0001649]; translation [GO:0006412],NA,NA,NA
CHOYP_RAB4B.1.1.m.55402,-0.008956809,0.005219727,No,NA,NA,NA,NA,NA,NA,endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_RAB7A.1.2.m.23789,0.001405987,0.006959957,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine methylation [GO:0018022],NA,NA,NA
CHOYP_RAB7A.1.2.m.23790,-0.009426893,0.00906866,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; lipid catabolic process [GO:0016042]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral process [GO:0048524]; protein targeting to lysosome [GO:0006622]; viral process [GO:0016032],NA,NA,NA
CHOYP_RAB8A.2.3.m.33866,-0.005477619,-0.008070167,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; Golgi vesicle fusion to target membrane [GO:0048210]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; regulation of autophagy [GO:0010506]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_RABGAP1.1.1.m.50532,-3.41E-05,0.002390067,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_RABP2.1.1.m.29597,0.008032776,0.002829327,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin binding [GO:0030332]; retinal binding [GO:0016918]; retinoic acid binding [GO:0001972]; retinol binding [GO:0019841]; embryonic forelimb morphogenesis [GO:0035115]; positive regulation of collateral sprouting [GO:0048672]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; retinoic acid biosynthetic process [GO:0002138]; retinoic acid metabolic process [GO:0042573],NA,NA,NA
CHOYP_RABX5.1.2.m.26033,-0.001509547,-0.010642223,No,NA,NA,NA,NA,NA,NA,early endosome [GO:0005769]; recycling endosome [GO:0055037]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; protein transport [GO:0015031],NA,NA,NA
CHOYP_RAC1.1.3.m.20870,0.02184431,-0.009744837,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119]; drug metabolic process [GO:0017144],NA,NA,NA
CHOYP_RAC1.1.3.m.20871,-0.004592029,0.014545171,No,NA,NA,NA,NA,NA,NA,actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]; ATPase binding [GO:0051117]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; Rho GDP-dissociation inhibitor binding [GO:0051022]; thioesterase binding [GO:0031996]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell motility [GO:0048870]; cell projection assembly [GO:0030031]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; chemotaxis [GO:0006935]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of respiratory burst [GO:0060263]; Rho protein signal transduction [GO:0007266]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_RAC1.2.3.m.23406,-0.022665871,0.010319441,No,NA,NA,NA,NA,NA,NA,actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]; ATPase binding [GO:0051117]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; Rho GDP-dissociation inhibitor binding [GO:0051022]; thioesterase binding [GO:0031996]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell motility [GO:0048870]; cell projection assembly [GO:0030031]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; chemotaxis [GO:0006935]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of respiratory burst [GO:0060263]; Rho protein signal transduction [GO:0007266]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_RADI.1.2.m.2373,0.013736528,0.008126141,No,NA,NA,NA,NA,NA,NA,apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell tip [GO:0051286]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; midbody [GO:0030496]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stereocilium [GO:0032420]; T-tubule [GO:0030315]; actin binding [GO:0003779]; ATPase binding [GO:0051117]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; apical protein localization [GO:0045176]; barbed-end actin filament capping [GO:0051016]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of organelle assembly [GO:1902115]; regulation of ruffle assembly [GO:1900027],NA,NA,NA
CHOYP_RADI.2.2.m.22446,-0.011503072,-0.003438039,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein localization to plasma membrane [GO:0072659],NA,NA,NA
CHOYP_RAEL1.1.1.m.40419,0.002099745,-0.018254316,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; mitotic spindle pole [GO:0097431]; nuclear pore [GO:0005643]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to organic cyclic compound [GO:0071407]; mRNA export from nucleus [GO:0006406]; regulation of mitotic spindle organization [GO:0060236]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972],NA,NA,NA
CHOYP_RAGP1.1.1.m.64037,-0.016369696,-0.005046208,No,NA,NA,NA,NA,NA,NA,aggresome [GO:0016235]; axon cytoplasm [GO:1904115]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; activation of GTPase activity [GO:0090630]; cellular response to vasopressin [GO:1904117]; negative regulation of protein export from nucleus [GO:0046826]; response to axon injury [GO:0048678]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_RALA.1.4.m.8443,-0.012005238,0.021217503,No,NA,NA,NA,NA,NA,NA,cleavage furrow [GO:0032154]; Flemming body [GO:0090543]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; PDZ domain binding [GO:0030165]; border follicle cell migration [GO:0007298]; defense response to Gram-negative bacterium [GO:0050829]; dorsal closure [GO:0007391]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of JNK cascade [GO:0046329]; R3/R4 cell fate commitment [GO:0007464]; Ras protein signal transduction [GO:0007265]; regulation of cell morphogenesis [GO:0022604]; regulation of Notch signaling pathway [GO:0008593],NA,NA,NA
CHOYP_RALA.4.4.m.26414,-0.005137125,0.009742964,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RAN.1.3.m.3468,-0.016324453,0.001597771,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; electron transfer activity [GO:0009055]; protein-disulfide reductase (glutathione) activity [GO:0019153]; cell redox homeostasis [GO:0045454]; defense response to virus [GO:0051607]; oxidation-reduction process [GO:0055114]; viral process [GO:0016032],NA,NA,NA
CHOYP_RAN.3.3.m.59027,-0.017200027,0.004877714,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; axonal growth cone [GO:0044295]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; actin filament binding [GO:0051015]; cell adhesion molecule binding [GO:0050839]; actin filament bundle retrograde transport [GO:0061573]; axonogenesis [GO:0007409]; Cdc42 protein signal transduction [GO:0032488]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; endoplasmic reticulum polarization [GO:0061163]; netrin-activated signaling pathway [GO:0038007]; positive regulation of axon extension [GO:0045773]; positive regulation of neuron migration [GO:2001224]; Ras protein signal transduction [GO:0007265]; regulation of establishment of cell polarity [GO:2000114]; substrate-dependent cell migration; cell extension [GO:0006930],NA,NA,NA
CHOYP_RANB9.1.2.m.40766,-0.007242102,-0.004878945,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; retina development in camera-type eye [GO:0060041],NA,NA,NA
CHOYP_RANGRF.1.2.m.18930,-0.013946354,-0.002934157,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; heart contraction [GO:0060047]; heart looping [GO:0001947]; protein transport [GO:0015031],NA,NA,NA
CHOYP_RAS.1.1.m.57089,-0.010513855,0.010921783,No,NA,NA,NA,NA,NA,NA,host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_RAS3.1.1.m.15706,-0.007160949,0.011602816,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Rap protein signal transduction [GO:0032486],NA,NA,NA
CHOYP_RAVR1.1.1.m.62572,-0.019252611,-0.007073457,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_RB3GP.1.2.m.53902,0.010562612,0.004999671,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096],NA,NA,NA
CHOYP_RB6I2.2.2.m.65652,-0.008674156,0.005923374,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; IkappaB kinase complex [GO:0008385]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; presynaptic active zone cytoplasmic component [GO:0098831]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; PDZ domain binding [GO:0030165]; Rab GTPase binding [GO:0017137]; structural constituent of presynaptic active zone [GO:0098882]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635]; I-kappaB phosphorylation [GO:0007252]; protein transport [GO:0015031]; retrograde transport; endosome to Golgi [GO:0042147]; synaptic vesicle priming [GO:0016082],NA,NA,NA
CHOYP_RBBP4.1.1.m.62913,0.006774003,0.000412665,No,NA,NA,NA,NA,NA,NA,CAF-1 complex [GO:0033186]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; NURF complex [GO:0016589]; protein-containing complex [GO:0032991]; DNA-dependent ATPase activity [GO:0008094]; histone deacetylase binding [GO:0042826]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336],NA,NA,NA
CHOYP_RBCC1.1.2.m.7288,-0.00142971,-0.009173184,No,NA,NA,NA,NA,NA,NA,Atg1/ULK1 kinase complex [GO:1990316]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; protein kinase binding [GO:0019901]; protein-containing complex scaffold activity [GO:0032947]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; glycophagy [GO:0061723]; heart development [GO:0007507]; liver development [GO:0001889]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of cell size [GO:0045793]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; reticulophagy [GO:0061709],NA,NA,NA
CHOYP_RBEL1.1.1.m.174,-0.00227229,-0.019469269,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525],NA,NA,NA
CHOYP_RBM10.2.2.m.59955,-0.003598061,-0.009061286,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_RBM19.1.2.m.28228,0.001905816,0.001929514,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA cis splicing; via spliceosome [GO:0045292]; multicellular organism development [GO:0007275]; positive regulation of embryonic development [GO:0040019]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_RBM20.1.2.m.2222,-0.009760717,0.006331421,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; zinc ion binding [GO:0008270]; activation of innate immune response [GO:0002218]; blastocyst formation [GO:0001825]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; posttranscriptional regulation of gene expression [GO:0010608]; ventricular septum development [GO:0003281],NA,NA,NA
CHOYP_RBM22.1.1.m.43645,-0.005628642,0.001683038,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; metal ion binding [GO:0046872]; pre-mRNA binding [GO:0036002]; U6 snRNA binding [GO:0017070]; cellular response to drug [GO:0035690]; mRNA cis splicing; via spliceosome [GO:0045292]; positive regulation of RNA splicing [GO:0033120]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_RBM25.1.2.m.41094,-0.013510048,-0.009015353,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; mRNA binding [GO:0003729]; apoptotic process [GO:0006915]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_RBM39.1.1.m.19427,-0.008056762,0.009910298,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_RBMX.1.1.m.26723,-0.002564047,0.001049323,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; extracellular exosome [GO:0070062]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splicing; via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_RBP6.1.2.m.6061,0.020069424,-0.011019442,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; stem cell development [GO:0048864],NA,NA,NA
CHOYP_RBSK.1.1.m.17187,0.014136476,0.009322371,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]; carbohydrate phosphorylation [GO:0046835]; D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098],NA,NA,NA
CHOYP_RBX1A.1.1.m.63168,-0.001321647,-0.009228367,No,NA,NA,NA,NA,NA,NA,anaphase-promoting complex [GO:0005680]; Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul5-RING ubiquitin ligase complex [GO:0031466]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nuclear SCF ubiquitin ligase complex [GO:0043224]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; VCB complex [GO:0030891]; cullin family protein binding [GO:0097602]; eukaryotic initiation factor 4E binding [GO:0008190]; NEDD8 transferase activity [GO:0019788]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein monoubiquitination [GO:0006513]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RCC1.1.1.m.15249,0.007167945,-0.00443982,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; Ran GTPase binding [GO:0008536]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; sulfate binding [GO:0043199]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic spindle organization [GO:0007052]; protein heterotetramerization [GO:0051290]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225]; viral process [GO:0016032],NA,NA,NA
CHOYP_RCL1.1.1.m.7474,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; endoribonuclease activity [GO:0004521]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000447]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_RCOM_1886900.1.1.m.11248,-0.022186776,0.000124008,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RD23B.1.1.m.38952,-0.015213803,-0.017217554,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; XPC complex [GO:0071942]; damaged DNA binding [GO:0003684]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]; cellular response to interleukin-7 [GO:0098761]; embryonic organ development [GO:0048568]; global genome nucleotide-excision repair [GO:0070911]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair; DNA damage recognition [GO:0000715]; nucleotide-excision repair; preincision complex assembly [GO:0006294]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein folding [GO:0006457]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_RDH13.1.3.m.10433,0.002433126,-0.023628537,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; NADP-retinol dehydrogenase activity [GO:0052650]; eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574],NA,NA,NA
CHOYP_RED.1.2.m.8931,-0.008473641,-0.013454817,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nuclear chromosome [GO:0000228]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; identical protein binding [GO:0042802]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing; via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501],NA,NA,NA
CHOYP_RED1.1.2.m.60684,-0.010787334,-0.003080447,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RED1.2.2.m.61084,-0.005170738,0.005432306,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of mRNA processing [GO:0050685]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965],NA,NA,NA
CHOYP_RELN.3.4.m.48195,0.010983139,-5.52E-05,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to dexamethasone stimulus [GO:0071549]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dentate gyrus development [GO:0021542]; glial cell differentiation [GO:0010001]; hypothalamus development [GO:0021854]; locomotory behavior [GO:0007626]; memory [GO:0007613]; midgut development [GO:0007494]; neuron migration [GO:0001764]; orbitofrontal cortex development [GO:0021769]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hormone [GO:0009725]; response to insecticide [GO:0017085]; response to lithium ion [GO:0010226]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; social behavior [GO:0035176]; spinal cord patterning [GO:0021511],NA,NA,NA
CHOYP_RENT1.1.1.m.44133,-0.003602355,-0.010033441,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nuclear chromosome; telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; supraspliceosomal complex [GO:0044530]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process; endonucleolytic cleavage-dependent decay [GO:0000294]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201],NA,NA,NA
CHOYP_RENT2.1.1.m.50589,0.002817164,0.01265208,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; animal organ regeneration [GO:0031100]; liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184],NA,NA,NA
CHOYP_REPS1.1.2.m.35334,0.005549765,-0.001369349,No,NA,NA,NA,NA,NA,NA,clathrin-coated pit [GO:0005905]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; SH3 domain binding [GO:0017124]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_RER1.1.1.m.49089,-0.014260728,-0.021966255,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of Golgi membrane [GO:0030173]; protein retention in ER lumen [GO:0006621]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_RFA1.1.1.m.16020,-0.006210006,-0.019683071,No,NA,NA,NA,NA,NA,NA,DNA replication factor A complex [GO:0005662]; nuclear chromosome; telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; damaged DNA binding [GO:0003684]; G-rich strand telomeric DNA binding [GO:0098505]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response; detection of DNA damage [GO:0042769]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; G1/S transition of mitotic cell cycle [GO:0000082]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair; DNA gap filling [GO:0006297]; nucleotide-excision repair; DNA incision [GO:0033683]; nucleotide-excision repair; DNA incision; 5'-to lesion [GO:0006296]; nucleotide-excision repair; preincision complex assembly [GO:0006294]; nucleotide-excision repair; preincision complex stabilization [GO:0006293]; protein localization to chromosome [GO:0034502]; regulation of cellular response to heat [GO:1900034]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomere maintenance via telomerase [GO:0007004]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985],NA,NA,NA
CHOYP_RFA2.1.1.m.6290,0.002142427,0.011809992,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; chromosome; telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; DNA replication factor A complex [GO:0005662]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; G-rich strand telomeric DNA binding [GO:0098505]; protein N-terminus binding [GO:0047485]; protein phosphatase binding [GO:0019903]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; base-excision repair [GO:0006284]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; heteroduplex formation [GO:0030491]; mismatch repair [GO:0006298]; mitotic G1 DNA damage checkpoint [GO:0031571]; mitotic recombination [GO:0006312]; nucleotide-excision repair [GO:0006289]; positive regulation of helicase activity [GO:0051096]; protein localization to chromosome [GO:0034502]; reciprocal meiotic recombination [GO:0007131]; regulation of DNA damage checkpoint [GO:2000001]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_RFC1.1.3.m.8918,0.009442182,-0.018285819,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]; DNA clamp unloader activity [GO:0061860]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]; DNA clamp unloading [GO:0090618]; DNA damage response; detection of DNA damage [GO:0042769]; DNA-dependent DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleotide-excision repair; DNA gap filling [GO:0006297]; nucleotide-excision repair; DNA incision [GO:0033683]; nucleotide-excision repair; DNA incision; 5'-to lesion [GO:0006296]; positive regulation of transcription; DNA-templated [GO:0045893]; telomere maintenance via semi-conservative replication [GO:0032201]; telomere maintenance via telomerase [GO:0007004]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985],NA,NA,NA
CHOYP_RFC2.1.2.m.12862,-0.010600549,-0.018079656,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_RFC2.1.2.m.12863,-0.011622738,-0.001594772,No,NA,NA,NA,NA,NA,NA,Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA-dependent ATPase activity [GO:0043142]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264],NA,NA,NA
CHOYP_RFC3.1.1.m.48357,-0.006485344,-0.00734251,No,NA,NA,NA,NA,NA,NA,Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; DNA clamp loader activity [GO:0003689]; single-stranded DNA-dependent ATPase activity [GO:0043142]; DNA replication [GO:0006260]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; response to organophosphorus [GO:0046683],NA,NA,NA
CHOYP_RFIP4.1.2.m.976,0.008631823,-0.007366709,No,NA,NA,NA,NA,NA,NA,cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; midbody [GO:0030496]; recycling endosome membrane [GO:0055038]; ADP-ribosylation factor binding [GO:0030306]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; cell cycle [GO:0007049]; cell division [GO:0051301]; endocytic recycling [GO:0032456]; eye morphogenesis [GO:0048592]; regulation of cell cycle [GO:0051726]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_RFOX2.1.2.m.24118,-0.020525883,-0.001124898,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; dendrite morphogenesis [GO:0048813]; fibroblast growth factor receptor signaling pathway [GO:0008543]; intracellular estrogen receptor signaling pathway [GO:0030520]; mRNA processing [GO:0006397]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of cell proliferation [GO:0042127]; regulation of definitive erythrocyte differentiation [GO:0010724]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_RFX3.1.1.m.55790,-0.008676282,0.004034042,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; cell differentiation [GO:0030154]; cilium-dependent cell motility [GO:0060285]; endocrine pancreas development [GO:0031018]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_RGD1309762.1.1.m.47917,0.019212944,0.009454914,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; ubiquitin-protein transferase activity [GO:0004842]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_RGD1310712.1.1.m.16487,0.002362137,-0.011855963,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_RGD1561408.1.2.m.4308,0.018976012,-0.014114029,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; nuclear chromatin [GO:0000790]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; p53 binding [GO:0002039]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response; signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by competitive promoter binding [GO:0010944]; O-glycan processing [GO:0016266]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],NA,NA,NA
CHOYP_RGN.1.1.m.30406,-0.015756822,0.006273801,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848],NA,NA,NA
CHOYP_RGPA1.1.1.m.50924,0.002141882,-0.013838746,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_RHDF1.2.3.m.45435,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; negative regulation of protein secretion [GO:0050709]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein secretion [GO:0050708],NA,NA,NA
CHOYP_RHDF1.3.3.m.54744,-0.001501978,0.008103652,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth factor binding [GO:0019838]; negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of protein secretion [GO:0050708],NA,NA,NA
CHOYP_RHG07.1.1.m.14019,-0.009913835,-0.01142423,No,NA,NA,NA,NA,NA,NA,lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]; cell cycle [GO:0007049]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of sprouting angiogenesis [GO:1903671]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_RHG17.1.2.m.32099,0.000817901,-0.004651352,No,NA,NA,NA,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; endoplasmic reticulum [GO:0005783]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; 5S rRNA binding [GO:0008097]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000447]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic metaphase plate congression [GO:0007080]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055],NA,NA,NA
CHOYP_RHG18.1.1.m.24618,-0.005896786,0.016430096,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_RHG44.1.1.m.982,-0.000560534,0.004279127,No,NA,NA,NA,NA,NA,NA,bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; calcium ion regulated exocytosis [GO:0017156]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_RHO.1.1.m.2313,-0.009293491,-0.019471329,No,NA,NA,NA,NA,NA,NA,plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_RHO1.3.3.m.44337,0.007242647,0.017176871,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; unfolded protein binding [GO:0051082]; cell cycle [GO:0007049]; cell division [GO:0051301]; developmental process [GO:0032502]; protein folding [GO:0006457],NA,NA,NA
CHOYP_RHO1.3.3.m.44338,-0.004962096,0.016165761,No,NA,NA,NA,NA,NA,NA,apical cortex [GO:0045179]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cell hair [GO:0070451]; cell-cell contact zone [GO:0044291]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin-mediated cell contraction [GO:0070252]; adherens junction maintenance [GO:0034334]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell migration [GO:0016477]; cellular protein localization [GO:0034613]; cellularization [GO:0007349]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; determination of left/right symmetry [GO:0007368]; dorsal closure [GO:0007391]; dorsal closure; leading edge cell differentiation [GO:0046663]; dorsal closure; spreading of leading edge cells [GO:0007395]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of planar polarity of embryonic epithelium [GO:0042249]; establishment of protein localization [GO:0045184]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; gastrulation involving germ band extension [GO:0010004]; germ-band extension [GO:0007377]; glial cell migration [GO:0008347]; hemocyte migration [GO:0035099]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing hair organization [GO:0035317]; lumen formation; open tracheal system [GO:0035149]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; melanization defense response [GO:0035006]; mitotic actomyosin contractile ring assembly [GO:1903475]; mitotic cytokinesis [GO:0000281]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neuroblast proliferation [GO:0007405]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; posterior midgut invagination [GO:0007374]; protein localization involved in establishment of planar polarity [GO:0090251]; protein localization to adherens junction [GO:0071896]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; regulation of locomotor rhythm [GO:1904059]; regulation of Malpighian tubule size [GO:0035298]; regulation of myoblast fusion [GO:1901739]; regulation of tube length; open tracheal system [GO:0035159]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]; salivary gland morphogenesis [GO:0007435]; spiracle morphogenesis; open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]; ventral furrow formation [GO:0007370]; visual perception [GO:0007601]; wound healing [GO:0042060],NA,NA,NA
CHOYP_RHOM172_0471.1.1.m.60636,0.009876065,0.01991058,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_RIF1.1.1.m.13682,-0.004443444,-0.003107331,No,NA,NA,NA,NA,NA,NA,chromosome; telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; spindle midzone [GO:0051233]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing at telomere [GO:0006348]; DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of isotype switching [GO:0045830]; stem cell population maintenance [GO:0019827]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247],NA,NA,NA
CHOYP_RIMB2.3.5.m.17363,-0.014431045,-0.02119072,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; plasma membrane [GO:0005886]; synapse [GO:0045202]; negative regulation of phosphatase activity [GO:0010923]; neuromuscular synaptic transmission [GO:0007274],NA,NA,NA
CHOYP_RINT1.1.1.m.9402,-0.002156555,-0.000882667,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; cell cycle [GO:0007049]; Golgi organization [GO:0007030]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of signal transduction involved in mitotic G2 DNA damage checkpoint [GO:1902504]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_RIOK3.1.1.m.54195,0.001232723,-0.016678418,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; preribosome; small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein homooligomerization [GO:0032463]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728],NA,NA,NA
CHOYP_RIPL1.1.1.m.59984,0.007041284,0.008153961,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; dynein light intermediate chain binding [GO:0051959]; protein dimerization activity [GO:0046983]; small GTPase binding [GO:0031267]; cilium assembly [GO:0060271]; epithelial cell morphogenesis [GO:0003382]; protein transport from ciliary membrane to plasma membrane [GO:1903445]; regulation of neuron death [GO:1901214],NA,NA,NA
CHOYP_RIR1.2.2.m.30556,0.001176822,-0.004766024,No,NA,NA,NA,NA,NA,NA,cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; purine nucleotide binding [GO:0017076]; ribonucleoside-diphosphate reductase activity; thioredoxin disulfide as acceptor [GO:0004748]; cell proliferation in forebrain [GO:0021846]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; male gonad development [GO:0008584]; mitotic cell cycle [GO:0000278]; protein complex oligomerization [GO:0051259]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ionizing radiation [GO:0010212]; retina development in camera-type eye [GO:0060041],NA,NA,NA
CHOYP_RIR2.1.1.m.19831,0.002750948,-0.019879054,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity; thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_RL10.1.3.m.11695,0.014246984,-0.002850501,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027],NA,NA,NA
CHOYP_RL10A.1.2.m.7633,-0.014120175,-0.003155251,No,NA,NA,NA,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412],NA,NA,NA
CHOYP_RL11.2.7.m.12991,0.010020771,0.00882904,No,NA,NA,NA,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; peroxisome proliferator activated receptor binding [GO:0042975]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein localization to nucleus [GO:0034504]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_RL14.2.9.m.10151,0.020285161,0.006018603,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RL17.2.7.m.34420,0.008644942,0.004814554,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; positive regulation by host of viral process [GO:0044794]; positive regulation by host of viral release from host cell [GO:0044791],NA,NA,NA
CHOYP_RL17.7.7.m.57535,-0.001469425,-0.018703013,No,NA,NA,NA,NA,NA,NA,large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RL18A.1.8.m.12900,0.01372204,-0.014645098,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; response to antineoplastic agent [GO:0097327]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_RL18A.6.8.m.61646,0.007789082,0.013479703,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; response to antineoplastic agent [GO:0097327]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_RL21.1.4.m.19435,0.002096917,0.008741002,No,NA,NA,NA,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RL22.4.4.m.37418,0.017154617,0.009992893,No,NA,NA,NA,NA,NA,NA,cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; glutamatergic synapse [GO:0098978]; large ribosomal subunit [GO:0015934]; presynapse [GO:0098793]; heparin binding [GO:0008201]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; alpha-beta T cell differentiation [GO:0046632]; regulation of translation at presynapse; modulating synaptic transmission [GO:0099577]; translation [GO:0006412],NA,NA,NA
CHOYP_RL23.1.11.m.2901,0.012539509,0.020440665,No,NA,NA,NA,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_RL23.4.11.m.13922,0.022305386,0.008353031,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RL23A.3.6.m.31005,0.018320166,0.010622268,No,NA,NA,NA,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; TORC2 complex binding [GO:1904841]; cell proliferation [GO:0008283]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_RL23A.6.6.m.63333,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; TORC2 complex binding [GO:1904841]; cell proliferation [GO:0008283]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_RL24.6.9.m.43123,0.019470016,-0.01174069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RL24.6.9.m.43124,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840],NA,NA,NA
CHOYP_RL39.1.2.m.5372,0.006519748,-0.00875722,No,NA,NA,NA,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; mitochondrion organization [GO:0007005]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cellular response to hypoxia [GO:1900037],NA,NA,NA
CHOYP_RL39.2.2.m.64898,-0.007912617,0.00618472,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RL4.2.6.m.4480,-0.00090946,-0.009749035,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RL4.2.6.m.4481,0.010564412,-0.006375263,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RL4.6.6.m.66341,-0.009413759,0.011164311,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RL40.1.7.m.3623,0.006885699,-0.016118259,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RL44.1.2.m.28788,0.00537538,-0.006394786,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RL7A.2.6.m.5689,-0.001833514,-0.002851035,No,NA,NA,NA,NA,NA,NA,anchored component of plasma membrane [GO:0046658]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of sodium ion transport [GO:0010765]; transepithelial transport [GO:0070633],NA,NA,NA
CHOYP_RL8.10.10.m.65636,-0.001012604,-0.020874981,No,NA,NA,NA,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_RL8.3.10.m.22753,-0.004230646,0.012874607,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; protein localization to nucleus [GO:0034504]; translation [GO:0006412],NA,NA,NA
CHOYP_RL9.4.6.m.43062,0.012342963,0.005297548,No,NA,NA,NA,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_RL9.5.6.m.63453,0.001371775,0.007270464,No,NA,NA,NA,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_RLA0.3.7.m.42195,-0.010482885,-0.015457178,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; inositol 1;3;4;5 tetrakisphosphate binding [GO:0043533]; metal ion binding [GO:0046872]; phosphatidylinositol bisphosphate binding [GO:1902936]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; cell surface receptor signaling pathway [GO:0007166]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_RLA0.3.7.m.42196,0.01676451,-0.00470608,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_RLA0.5.7.m.56220,0.009096266,-0.000906344,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RLA1.3.12.m.12071,0.002768279,0.009562926,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_RLA1.5.12.m.15482,0.006940668,-0.020028866,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_RLA1.8.12.m.25631,0.006156385,0.000982274,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_RLP24.2.2.m.51354,0.001170423,-0.020824766,No,NA,NA,NA,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; assembly of large subunit precursor of preribosome [GO:1902626]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_RM10.1.2.m.26850,0.00775154,0.007807266,No,NA,NA,NA,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; ribonucleoprotein complex [GO:1990904]; structural constituent of ribosome [GO:0003735]; ribosome biogenesis [GO:0042254]; translation [GO:0006412],NA,NA,NA
CHOYP_RM11.1.1.m.9390,0.000920026,-0.008428726,No,NA,NA,NA,NA,NA,NA,large ribosomal subunit [GO:0015934]; mitochondrial large ribosomal subunit [GO:0005762]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; gene silencing by RNA [GO:0031047]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_RM22.1.1.m.63127,0.004233413,-0.013326179,No,NA,NA,NA,NA,NA,NA,large ribosomal subunit [GO:0015934]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; ribosome assembly [GO:0042255]; translation [GO:0006412],NA,NA,NA
CHOYP_RM23.1.1.m.173,-0.022562075,0.009983958,No,NA,NA,NA,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_RM37.1.1.m.14517,-0.009671441,-0.011081087,No,NA,NA,NA,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RM49.1.1.m.1644,-0.005229646,-0.000365372,No,NA,NA,NA,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RM51.1.1.m.12099,0.003894111,-0.018243618,No,NA,NA,NA,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412],NA,NA,NA
CHOYP_RMI1.1.1.m.17246,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; RecQ helicase-Topo III complex [GO:0031422]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; glucose homeostasis [GO:0042593]; multicellular organism growth [GO:0035264]; reduction of food intake in response to dietary excess [GO:0002023]; resolution of meiotic recombination intermediates [GO:0000712]; response to glucose [GO:0009749],NA,NA,NA
CHOYP_RN19A.1.1.m.35894,-0.01515372,0.007918037,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RN213.11.13.m.59720,-0.005363783,-0.004390147,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN213.12.13.m.60577,-0.01573805,-0.012110095,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN213.4.13.m.27716,0.001108396,-0.018744943,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN213.6.13.m.42268,0.006833302,0.005138909,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN213.7.13.m.45975,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN213.7.13.m.45976,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN213.8.13.m.52889,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN45S.2.5.m.14111,0.017219832,0.001616704,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_RN45S.4.5.m.43162,0.007084068,-0.003445965,No,NA,NA,NA,NA,NA,NA,troponin complex [GO:0005861]; actin binding [GO:0003779]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_RNF17.1.1.m.17312,-0.013104591,-0.001904212,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; multicellular organism development [GO:0007275]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_RNF213.1.4.m.3458,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RNOY.1.3.m.4495,-0.015462885,-0.013129708,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; ribonuclease T2 activity [GO:0033897]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_RNOY.3.3.m.58342,-0.01174629,-0.016515508,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; ribonuclease T2 activity [GO:0033897]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_RNP1B.1.1.m.59888,-0.006198052,0.014093836,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_RNZ1.1.1.m.29553,0.002257705,0.003594116,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; 3'-tRNA processing endoribonuclease activity [GO:0042781]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_RO60.1.6.m.24126,-0.012256464,-0.001045703,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; misfolded RNA binding [GO:0034336]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; cilium assembly [GO:0060271]; immune system development [GO:0002520]; response to UV [GO:0009411]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_ROA3.2.2.m.11068,-0.010830775,-0.00591465,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_ROAA.3.6.m.39522,-0.008382503,-0.003115916,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription factor complex [GO:0090575]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; epithelial to mesenchymal transition [GO:0001837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_ROCK2.1.1.m.26830,0.011973823,0.004501005,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]; positive regulation of centrosome duplication [GO:0010825]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of circadian rhythm [GO:0042752]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939],NA,NA,NA
CHOYP_RORA.1.2.m.59037,0.006475094,0.007396306,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; retinoic acid receptor signaling pathway [GO:0048384],NA,NA,NA
CHOYP_RPA1.1.2.m.3320,0.001510755,-0.014887421,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RPA1.2.2.m.6583,0.000920465,0.000845568,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA polymerase I activity [GO:0001054]; zinc ion binding [GO:0008270]; negative regulation of protein localization to nucleolus [GO:1904750]; rRNA transcription [GO:0009303],NA,NA,NA
CHOYP_RPA12.1.1.m.48818,-0.005034725,-0.003894211,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; protein heterodimerization activity [GO:0046982]; protein methyltransferase activity [GO:0008276]; rRNA (guanine) methyltransferase activity [GO:0016435]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_RPAB1.1.1.m.11586,-0.011256872,-0.005282546,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II; core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_RPAB3.2.4.m.30639,0.011318959,-0.012855426,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase I complex [GO:0005736]; RNA polymerase II; core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; single-stranded DNA binding [GO:0003697]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_RPAC1.1.1.m.36389,0.003619682,-0.000276453,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_RPB1.1.1.m.36612,-0.001754408,-0.024475541,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II; core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_RPB2.1.1.m.38872,0.003564161,0.001637638,No,NA,NA,NA,NA,NA,NA,membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II; core complex [GO:0005665]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing; via spliceosome [GO:0000398]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_RPB3.1.1.m.45705,-0.009847673,0.004633891,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II; core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_RPC1.1.1.m.16568,-0.01706646,0.006024096,No,NA,NA,NA,NA,NA,NA,nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840]; spliceosomal complex [GO:0005681]; identical protein binding [GO:0042802]; pre-mRNA branch point binding [GO:0045131]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; Leydig cell differentiation [GO:0033327]; male sex determination [GO:0030238]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nuclear body organization [GO:0030575]; regulation of steroid biosynthetic process [GO:0050810]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_RPF2.2.2.m.27891,0.000294956,-0.01342008,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; 5S rRNA binding [GO:0008097]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; rRNA binding [GO:0019843]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_RPGRB.1.1.m.59104,0.01063138,-0.013419197,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; sperm flagellum [GO:0036126]; guanyl-nucleotide exchange factor activity [GO:0005085]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; response to stimulus [GO:0050896]; visual perception [GO:0007601],NA,NA,NA
CHOYP_RPL36.1.1.m.57199,0.008807392,0.007999999,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_RPOC1.1.1.m.34397,-0.015470909,-0.013914986,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RPS24.1.8.m.571,0.009877283,0.019871994,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RPS27L.1.1.m.21535,-0.009586314,-0.0243297,No,NA,NA,NA,NA,NA,NA,mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial electron transport; ubiquinol to cytochrome c [GO:0006122],NA,NA,NA
CHOYP_RPZ3.1.1.m.26308,-0.016275493,0.004844718,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RRAGA.1.1.m.41224,-0.008703369,0.01246979,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; EGO complex [GO:0034448]; GATOR1 complex [GO:1990130]; Gtr1-Gtr2 GTPase complex [GO:1990131]; lysosome [GO:0005764]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphoprotein binding [GO:0051219]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; modulation by virus of host morphology or physiology [GO:0019048]; negative regulation of autophagy [GO:0010507]; positive regulation of cytolysis [GO:0045919]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagy [GO:0010506]; regulation of TORC1 signaling [GO:1903432]; response to amino acid [GO:0043200],NA,NA,NA
CHOYP_RREB1.1.1.m.11945,-0.013647716,-0.004524678,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_RRP1B.1.1.m.21811,0.004959423,-0.007826642,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; euchromatin [GO:0000791]; granular component [GO:0001652]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; preribosome; small subunit precursor [GO:0030688]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; cellular response to virus [GO:0098586]; mRNA processing [GO:0006397]; negative regulation of GTPase activity [GO:0034260]; negative regulation of phosphatase activity [GO:0010923]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_RS14.3.6.m.23056,-0.015054474,-0.000219169,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]; ATP metabolic process [GO:0046034]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142],NA,NA,NA
CHOYP_RS15A.5.11.m.18785,0.01027654,0.011249697,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS15A.6.11.m.23616,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS16.1.5.m.29365,0.000195619,0.013520225,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS17.10.11.m.58728,-0.003652913,0.008446669,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; respirasome [GO:0070469]; acyl binding [GO:0000035]; acyl carrier activity [GO:0000036]; phosphopantetheine binding [GO:0031177]; fatty acid biosynthetic process [GO:0006633]; lipid A biosynthetic process [GO:0009245]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120],NA,NA,NA
CHOYP_RS19.3.12.m.15295,0.022221903,-0.001185659,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS2.2.10.m.5562,0.017192172,-0.006399956,No,NA,NA,NA,NA,NA,NA,small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS2.7.10.m.39920,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS21.1.4.m.13400,0.014612322,0.00249341,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; antioxidant activity [GO:0016209]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; cellular detoxification of hydrogen peroxide [GO:0061692]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine salvage from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; sulfate assimilation; phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379],NA,NA,NA
CHOYP_RS23.1.9.m.12948,-0.001432035,-0.014162434,No,NA,NA,NA,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_RS23.4.9.m.24810,-0.003936601,0.011429835,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RS26.14.15.m.57342,0.009101981,0.021155828,No,NA,NA,NA,NA,NA,NA,cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_RS27L.1.4.m.9354,0.016847899,0.00353065,No,NA,NA,NA,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],NA,NA,NA
CHOYP_RS27L.3.4.m.33064,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RS3.2.7.m.23037,0.017241564,-0.008495758,No,NA,NA,NA,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; kinase binding [GO:0019900]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to nerve growth factor stimulus [GO:1990090]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of DNA repair [GO:0045739]; regulation of apoptotic process [GO:0042981]; regulation of translation [GO:0006417]; translation [GO:0006412],NA,NA,NA
CHOYP_RS3.4.7.m.42801,0.00982296,0.018954342,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RS32.1.1.m.57158,-0.006447204,-0.010979996,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular [GO:0005622]; intracellular membrane-bounded organelle [GO:0043231]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]; cellular protein metabolic process [GO:0044267]; intracellular signal transduction [GO:0035556]; N-glycan processing [GO:0006491]; post-translational protein modification [GO:0043687],NA,NA,NA
CHOYP_RS3A.14.15.m.57763,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS3A.2.15.m.2682,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS3A.4.15.m.15366,-0.007348041,0.013575175,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; hematopoietic progenitor cell differentiation [GO:0002244]; mRNA cis splicing; via spliceosome [GO:0045292]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_RS3A.4.15.m.15367,-0.004993081,-0.001544432,No,NA,NA,NA,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS3A.8.15.m.27207,-0.001254502,-0.014302939,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RS4.10.11.m.60432,-0.000317569,-0.002567088,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS4.11.11.m.63584,-0.017063162,0.007927329,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RS4.3.11.m.15465,0.015576986,0.002789837,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS5.1.2.m.146,0.017816914,-0.000434577,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_RS6.10.12.m.44863,0.020469493,-0.009872327,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS6.5.12.m.23146,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS6.8.12.m.36342,-0.000991548,0.00789747,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS7.5.9.m.38700,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; riboflavin kinase activity [GO:0008531]; apoptotic process [GO:0006915]; FMN biosynthetic process [GO:0009398]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; reactive oxygen species metabolic process [GO:0072593]; riboflavin biosynthetic process [GO:0009231]; riboflavin metabolic process [GO:0006771],NA,NA,NA
CHOYP_RS7.6.9.m.44704,0.017225887,0.016171866,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS8.12.14.m.59492,0.006792012,0.005790075,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607],NA,NA,NA
CHOYP_RS8.8.14.m.44842,0.003330514,0.001152344,No,NA,NA,NA,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS9.11.13.m.49921,0.016203061,-0.003265839,No,NA,NA,NA,NA,NA,NA,nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS9.8.13.m.41198,0.015350448,-0.008310912,No,NA,NA,NA,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; 5.8S rRNA binding [GO:1990932]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; positive regulation of cell proliferation [GO:0008284]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412],NA,NA,NA
CHOYP_RS9.9.13.m.44486,0.022568973,-0.010191423,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_RSMB.1.2.m.12400,-0.0042359,-0.003317038,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U7 snRNP [GO:0005683]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_RSPH4A.1.1.m.15217,0.004412349,-0.004854019,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; radial spoke [GO:0001534]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341],NA,NA,NA
CHOYP_RSRC2.1.1.m.14844,-0.008978179,0.018774855,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_RSSA.1.10.m.2054,0.008599436,0.006193931,No,NA,NA,NA,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],NA,NA,NA
CHOYP_RSSA.3.10.m.22114,0.008962742,0.007584942,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RSU1.1.1.m.44138,0.00353128,0.00601854,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_RT10.2.4.m.12766,0.008912021,-0.022502294,No,NA,NA,NA,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412],NA,NA,NA
CHOYP_RT16.1.1.m.16545,0.006730828,-0.008921423,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_RTCB.1.2.m.27510,-0.005335917,-0.02087274,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; RNA ligase (ATP) activity [GO:0003972]; tRNA exon ligation utilizing 2';3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_RTEL1.1.1.m.16665,-0.008674689,-0.013032968,No,NA,NA,NA,NA,NA,NA,chromosome; telomeric region [GO:0000781]; nucleus [GO:0005634]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of DNA recombination [GO:0045910]; negative regulation of t-circle formation [GO:1904430]; negative regulation of telomere maintenance in response to DNA damage [GO:1904506]; positive regulation of telomeric loop disassembly [GO:1904535]; regulation of double-strand break repair via homologous recombination [GO:0010569]; replication fork processing [GO:0031297]; strand displacement [GO:0000732]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]; telomeric loop disassembly [GO:0090657],NA,NA,NA
CHOYP_RTF1.1.1.m.10685,-0.007375015,0.004581226,No,NA,NA,NA,NA,NA,NA,Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; single-stranded DNA binding [GO:0003697]; blastocyst growth [GO:0001832]; endodermal cell fate commitment [GO:0001711]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_RTTN.1.3.m.9025,-0.014509767,-0.009701792,No,NA,NA,NA,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; ciliary basal body organization [GO:0032053]; determination of left/right symmetry [GO:0007368],NA,NA,NA
CHOYP_RTTN.1.3.m.9026,0.004581564,-0.004637448,No,NA,NA,NA,NA,NA,NA,glycine cleavage complex [GO:0005960]; mitochondrion [GO:0005739]; aminomethyltransferase activity [GO:0004047]; enzyme binding [GO:0019899]; glycine decarboxylation via glycine cleavage system [GO:0019464]; protein lipoylation [GO:0009249],NA,NA,NA
CHOYP_RU1C.1.2.m.50387,-0.009144445,0.005932162,No,NA,NA,NA,NA,NA,NA,commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; pre-mRNA 5'-splice site binding [GO:0030627]; U1 snRNA binding [GO:0030619]; zinc ion binding [GO:0008270]; mRNA 5'-splice site recognition [GO:0000395]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_RU2A.1.1.m.20848,-0.01679182,-0.018137358,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2 snRNA binding [GO:0030620]; mRNA splicing; via spliceosome [GO:0000398]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_RUNX1.1.1.m.49526,0.00511349,-0.000756134,No,NA,NA,NA,NA,NA,NA,core-binding factor complex [GO:0016513]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; myeloid cell differentiation [GO:0030099]; negative regulation of CD4-positive; alpha-beta T cell differentiation [GO:0043371]; negative regulation of gene expression [GO:0010629]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; peripheral nervous system neuron development [GO:0048935]; positive regulation of angiogenesis [GO:0045766]; positive regulation of CD8-positive; alpha-beta T cell differentiation [GO:0043378]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cytokine-mediated signaling pathway [GO:0001959]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of keratinocyte differentiation [GO:0045616]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of myeloid cell differentiation [GO:0045637]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of Wnt signaling pathway [GO:0030111],NA,NA,NA
CHOYP_RUVB1.1.1.m.25669,0.00273462,0.018973125,No,NA,NA,NA,NA,NA,NA,Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; R2TP complex [GO:0097255]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATP-dependent 5'-3' DNA helicase activity [GO:0043141]; DNA recombination [GO:0006310]; DNA repair [GO:0006281],NA,NA,NA
CHOYP_RUVB2.1.1.m.19005,-0.004392294,-0.017212946,No,NA,NA,NA,NA,NA,NA,Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; R2TP complex [GO:0097255]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATP-dependent 5'-3' DNA helicase activity [GO:0043141]; DNA recombination [GO:0006310]; DNA repair [GO:0006281],NA,NA,NA
CHOYP_RXR.1.2.m.45987,-0.002506296,0.016357797,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; retinal binding [GO:0016918]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_S12A2.1.2.m.32137,0.007835569,-0.001334626,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; cation:chloride symporter activity [GO:0015377]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_S12A2.2.2.m.39394,0.011163306,-0.005631127,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; cation:chloride symporter activity [GO:0015377]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_S26A5.2.2.m.9883,0.017758447,0.000114601,No,NA,NA,NA,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; protein homodimerization activity [GO:0042803]; secondary active sulfate transmembrane transporter activity [GO:0008271]; spectrin binding [GO:0030507]; sulfate transmembrane transporter activity [GO:0015116]; transcription factor binding [GO:0008134]; cochlea development [GO:0090102]; fructose transmembrane transport [GO:0015755]; negative regulation of ion transmembrane transport [GO:0034766]; positive regulation of cell motility [GO:2000147]; positive regulation of cell size [GO:0045793]; protein tetramerization [GO:0051262]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996]; response to ischemia [GO:0002931]; response to potassium ion [GO:0035864]; response to salicylic acid [GO:0009751]; response to salt [GO:1902074]; response to thyroid hormone [GO:0097066]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_S28A3.2.3.m.7477,-0.010605082,0.000845687,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337],NA,NA,NA
CHOYP_S30BP.1.1.m.62845,0.00131577,-0.010433411,No,NA,NA,NA,NA,NA,NA,intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; positive regulation of cell death [GO:0010942]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_S4A10.3.4.m.28397,0.021638951,0.003332812,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453],NA,NA,NA
CHOYP_S4A8.1.1.m.28334,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; antiporter activity [GO:0015297]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453],NA,NA,NA
CHOYP_SAC1.1.1.m.40164,-0.008828398,0.011488923,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; phosphatase activity [GO:0016791]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; phosphatidylinositol dephosphorylation [GO:0046856],NA,NA,NA
CHOYP_SACS.11.17.m.53250,-0.018573253,0.010886031,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750],NA,NA,NA
CHOYP_SACS.12.17.m.53659,-0.006331873,-0.004482143,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750],NA,NA,NA
CHOYP_SACS.14.17.m.61817,-0.004640673,-0.003303112,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],NA,NA,NA
CHOYP_SACS.4.17.m.32398,-0.010988356,0.013783065,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],NA,NA,NA
CHOYP_SACS.6.17.m.35149,-0.000285825,-0.002531669,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750],NA,NA,NA
CHOYP_SACS.9.17.m.52781,0.007823246,-0.006389441,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750],NA,NA,NA
CHOYP_SAE1.1.1.m.46861,-0.000609349,-0.017367276,No,NA,NA,NA,NA,NA,NA,SUMO activating enzyme complex [GO:0031510]; ubiquitin-like modifier activating enzyme activity [GO:0008641]; protein sumoylation [GO:0016925],NA,NA,NA
CHOYP_SAE2.1.1.m.59765,0.00154444,0.014515,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; SUMO activating enzyme complex [GO:0031510]; acid-amino acid ligase activity [GO:0016881]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; SUMO activating enzyme activity [GO:0019948]; transferase activity [GO:0016740]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925],NA,NA,NA
CHOYP_SAFB2.2.3.m.30765,-0.006387107,-0.019661353,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008],NA,NA,NA
CHOYP_SAFB2.3.3.m.33384,-0.018715218,0.014168427,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008],NA,NA,NA
CHOYP_SAHH3.2.2.m.51221,0.00918085,-0.017188437,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005]; hydrolase activity [GO:0016787]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353],NA,NA,NA
CHOYP_SAHHA.1.1.m.62610,0.02015658,-0.008309475,No,NA,NA,NA,NA,NA,NA,adenosylhomocysteinase activity [GO:0004013]; NAD binding [GO:0051287]; one-carbon metabolic process [GO:0006730]; S-adenosylhomocysteine catabolic process [GO:0019510],NA,NA,NA
CHOYP_SALIVA_1456.1.1.m.19330,-0.011598294,-0.003707678,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SAM9L.1.2.m.51914,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; endosomal vesicle fusion [GO:0034058],NA,NA,NA
CHOYP_SAMD15.1.1.m.27733,-0.006483431,0.008631691,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_SAMH1.10.12.m.55275,-0.014699631,-0.0013425,No,NA,NA,NA,NA,NA,NA,intracellular [GO:0005622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; immune response [GO:0006955]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; somatic hypermutation of immunoglobulin genes [GO:0016446]; type I interferon signaling pathway [GO:0060337],NA,NA,NA
CHOYP_SAMH1.12.12.m.66249,-0.012603419,0.003938868,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446],NA,NA,NA
CHOYP_SAP.1.2.m.13958,0.016282482,-0.015200792,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; intercalated disc [GO:0014704]; lateral loop [GO:0043219]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; MPP7-DLG1-LIN7 complex [GO:0097025]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; sarcolemma [GO:0042383]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; guanylate kinase activity [GO:0004385]; ion channel binding [GO:0044325]; ionotropic glutamate receptor binding [GO:0035255]; L27 domain binding [GO:0097016]; mitogen-activated protein kinase kinase binding [GO:0031434]; phosphatase binding [GO:0019902]; phosphoprotein phosphatase activity [GO:0004721]; potassium channel regulator activity [GO:0015459]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein-containing complex scaffold activity [GO:0032947]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; structural constituent of postsynaptic density [GO:0098919]; actin filament organization [GO:0007015]; activation of protein kinase activity [GO:0032147]; amyloid precursor protein metabolic process [GO:0042982]; astral microtubule organization [GO:0030953]; bicellular tight junction assembly [GO:0070830]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cellular protein-containing complex localization [GO:0034629]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell proliferation [GO:0001935]; establishment of centrosome localization [GO:0051660]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; hard palate development [GO:0060022]; immunological synapse formation [GO:0001771]; lens development in camera-type eye [GO:0002088]; MAPK cascade [GO:0000165]; membrane raft organization [GO:0031579]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; peristalsis [GO:0030432]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell proliferation [GO:0008284]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; regulation of myelination [GO:0031641]; regulation of potassium ion export across plasma membrane [GO:1903764]; regulation of potassium ion import [GO:1903286]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903760]; reproductive structure development [GO:0048608]; smooth muscle tissue development [GO:0048745]; T cell activation [GO:0042110]; T cell cytokine production [GO:0002369]; viral process [GO:0016032],NA,NA,NA
CHOYP_SARM1.1.1.m.377,-0.010789304,0.003393802,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; signaling adaptor activity [GO:0035591]; innate immune response [GO:0045087]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_SARNP.1.1.m.46095,-0.008151689,-0.011831695,No,NA,NA,NA,NA,NA,NA,cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription export complex [GO:0000346]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RS domain binding [GO:0050733]; mRNA export from nucleus [GO:0006406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_SART1.1.1.m.14398,0.009397152,0.009290604,No,NA,NA,NA,NA,NA,NA,Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; RNA binding [GO:0003723]; maturation of 5S rRNA [GO:0000481]; mRNA cis splicing; via spliceosome [GO:0045292]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of cytotoxic T cell differentiation [GO:0045585]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_SASB.2.3.m.37538,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,asymmetric; glutamatergic; excitatory synapse [GO:0098985]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric; GABA-ergic; inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625],NA,NA,NA
CHOYP_SASB.3.3.m.51787,0.007022816,-0.019388698,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity; acting on ester bonds [GO:0016788]; methyl indole-3-acetate esterase activity [GO:0080030]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_SBDS.1.1.m.27786,-0.010880556,0.020468682,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; ribosome binding [GO:0043022]; rRNA binding [GO:0019843]; bone marrow development [GO:0048539]; bone mineralization [GO:0030282]; cell proliferation [GO:0008283]; inner cell mass cell proliferation [GO:0001833]; leukocyte chemotaxis [GO:0030595]; mature ribosome assembly [GO:0042256]; mitotic spindle organization [GO:0007052]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_SBNO1.1.1.m.7257,-0.006207821,-0.009653818,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_SBP1.1.2.m.2083,0.021132461,-0.006699933,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430]; protein transport [GO:0015031],NA,NA,NA
CHOYP_SBP1.2.2.m.49372,0.013694173,0.018594798,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430]; protein transport [GO:0015031],NA,NA,NA
CHOYP_SC22B.1.1.m.62900,0.010667726,-0.008529504,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; vesicle fusion with Golgi apparatus [GO:0048280],NA,NA,NA
CHOYP_SC24B.2.2.m.54667,-0.008684962,-0.000832657,No,NA,NA,NA,NA,NA,NA,COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; aorta morphogenesis [GO:0035909]; auditory receptor cell stereocilium organization [GO:0060088]; cargo loading into COPII-coated vesicle [GO:0090110]; cochlear nucleus development [GO:0021747]; COPII vesicle coating [GO:0048208]; coronary artery morphogenesis [GO:0060982]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lung lobe morphogenesis [GO:0060463]; neural tube closure [GO:0001843]; outflow tract morphogenesis [GO:0003151]; pulmonary artery morphogenesis [GO:0061156]; regulation of cargo loading into COPII-coated vesicle [GO:1901301]; regulation of establishment of planar polarity involved in neural tube closure [GO:0090178],NA,NA,NA
CHOYP_SC24C.1.1.m.9387,0.016982922,-0.010032639,No,NA,NA,NA,NA,NA,NA,COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; cargo loading into COPII-coated vesicle [GO:0090110]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_SC31A.1.2.m.8240,0.015618164,-0.009567075,No,NA,NA,NA,NA,NA,NA,COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; structural molecule activity [GO:0005198]; cargo loading into COPII-coated vesicle [GO:0090110]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_SC31A.1.2.m.8241,-0.007579223,-0.004652282,No,NA,NA,NA,NA,NA,NA,aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; unfolded protein binding [GO:0051082]; blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transforming growth factor beta activation [GO:1901389]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; regulation of cellular protein localization [GO:1903827]; response to estrogen [GO:0043627],NA,NA,NA
CHOYP_SC5A9.3.5.m.27017,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412],NA,NA,NA
CHOYP_SC6A5.3.7.m.20491,0.017734454,-0.006552692,No,NA,NA,NA,NA,NA,NA,glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_SC6A5.5.7.m.49357,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_SC6A5.7.7.m.62985,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328],NA,NA,NA
CHOYP_SC6A6.2.2.m.37040,0.003048526,-0.02162641,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]; neurotransmitter transport [GO:0006836],NA,NA,NA
CHOYP_SC6A9.4.6.m.26535,0.017312824,-0.005448981,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SC6A9.6.6.m.57818,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328],NA,NA,NA
CHOYP_SCAM1.1.1.m.5509,-0.013628092,-0.016543245,No,NA,NA,NA,NA,NA,NA,clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; zymogen granule membrane [GO:0042589]; protein domain specific binding [GO:0019904]; endocytosis [GO:0006897]; exocytosis [GO:0006887]; protein transport [GO:0015031],NA,NA,NA
CHOYP_SCAPER.1.1.m.34551,-0.006863304,-0.010016635,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_SCE4070.1.1.m.29642,0.017237522,0.005424215,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SCMH1.1.1.m.1166,-0.01793208,0.002561532,No,NA,NA,NA,NA,NA,NA,chromocenter [GO:0010369]; nucleoplasm [GO:0005654]; anterior/posterior pattern specification [GO:0009952]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; negative regulation of transcription; DNA-templated [GO:0045892]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SCN1.1.2.m.28878,0.002739556,0.008955672,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; cation transport [GO:0006812]; choline transport [GO:0015871]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_SCOT1.1.1.m.59655,-0.014926396,0.004021372,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-oxoacid CoA-transferase activity [GO:0008260]; protein homodimerization activity [GO:0042803]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594],NA,NA,NA
CHOYP_SCP.3.12.m.27952,-0.019703016,-0.001127076,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_SCP.6.12.m.50694,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_SCP.8.12.m.57173,0.023167748,-0.006318952,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_SCP.9.12.m.62606,0.02184512,-0.00415369,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_SCPDL.1.1.m.55687,-0.017006381,0.002875339,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; oxidoreductase activity [GO:0016491]; glycolipid biosynthetic process [GO:0009247]; platelet degranulation [GO:0002576],NA,NA,NA
CHOYP_SDA1.1.1.m.12704,0.000876929,-0.017814366,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; actin cytoskeleton organization [GO:0030036]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055],NA,NA,NA
CHOYP_SDHC.1.1.m.31276,0.001043773,-0.014007953,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II; succinate dehydrogenase complex (ubiquinone) [GO:0005749]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; succinate dehydrogenase activity [GO:0000104]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_SDR16C5.1.1.m.7423,0.00147682,0.002839424,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; DNA-binding transcription factor activity [GO:0003700]; retinol dehydrogenase activity [GO:0004745]; transcription factor binding [GO:0008134]; keratinocyte proliferation [GO:0043616]; negative regulation of histone acetylation [GO:0035067]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572],NA,NA,NA
CHOYP_SEC13.1.1.m.20714,0.001261435,-0.006531335,No,NA,NA,NA,NA,NA,NA,COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; protein-containing complex [GO:0032991]; structural molecule activity [GO:0005198]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mRNA transport [GO:0051028]; positive regulation of TORC1 signaling [GO:1904263]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to plasma membrane [GO:0072659],NA,NA,NA
CHOYP_SEC23B.1.1.m.12147,0.006469543,-0.01850306,No,NA,NA,NA,NA,NA,NA,COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]; cargo loading into COPII-coated vesicle [GO:0090110]; cartilage development [GO:0051216]; embryonic neurocranium morphogenesis [GO:0048702]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; pectoral fin morphogenesis [GO:0035138]; regulation of cell shape [GO:0008360]; regulation of COPII vesicle coating [GO:0003400],NA,NA,NA
CHOYP_SEC23IP.1.1.m.41425,-0.004587613,-0.020605581,No,NA,NA,NA,NA,NA,NA,cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum exit site [GO:0070971]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; acrosome assembly [GO:0001675]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; single fertilization [GO:0007338]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_SEH1.1.1.m.55025,-0.005757269,0.02086358,No,NA,NA,NA,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; lysosomal membrane [GO:0005765]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859]; structural molecule activity [GO:0005198]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular protein-containing complex localization [GO:0034629]; cellular response to amino acid starvation [GO:0034198]; mitotic metaphase plate congression [GO:0007080]; mRNA transport [GO:0051028]; nuclear pore organization [GO:0006999]; positive regulation of TORC1 signaling [GO:1904263]; protein transport [GO:0015031],NA,NA,NA
CHOYP_SELD.1.2.m.8600,0.006628378,-0.021031818,No,NA,NA,NA,NA,NA,NA,chromosome; centromeric region [GO:0000775]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; spindle pole [GO:0000922]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]; apoptotic mitochondrial changes [GO:0008637]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of microtubule binding [GO:1904528]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; regulation of gene expression [GO:0010468]; response to endoplasmic reticulum stress [GO:0034976]; response to hydrogen peroxide [GO:0042542]; response to lead ion [GO:0010288],NA,NA,NA
CHOYP_SELJ.1.1.m.21559,-0.004287919,0.0029828,No,NA,NA,NA,NA,NA,NA,structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_SEM1A.1.2.m.57703,0.008841026,-0.010779464,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_SEM2A.1.1.m.43497,0.016236879,-0.008632122,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_SEP11.1.2.m.19430,0.016822333,0.003419732,No,NA,NA,NA,NA,NA,NA,microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; protein-containing complex scaffold activity [GO:0032947]; cellularization [GO:0007349]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; growth of a germarium-derived egg chamber [GO:0007295]; imaginal disc development [GO:0007444]; mitotic cytokinesis [GO:0000281]; regulation of cell cycle [GO:0051726],NA,NA,NA
CHOYP_SEPT2.1.1.m.40428,0.002802152,0.01933794,No,NA,NA,NA,NA,NA,NA,ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle [GO:0005819]; GTP binding [GO:0005525]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_SEPT5.1.2.m.11458,0.005076421,0.009942271,No,NA,NA,NA,NA,NA,NA,microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex scaffold activity [GO:0032947]; structural molecule activity [GO:0005198]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]; synaptic vesicle targeting [GO:0016080],NA,NA,NA
CHOYP_SEPT7.1.1.m.59134,0.005954427,-0.002434108,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; midbody [GO:0030496]; motile cilium [GO:0031514]; septin complex [GO:0031105]; spindle [GO:0005819]; GTP binding [GO:0005525]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cilium assembly [GO:0060271]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SERB.1.1.m.7242,0.01189074,-0.005804881,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; phosphoserine phosphatase activity [GO:0004647]; protein homodimerization activity [GO:0042803]; dephosphorylation [GO:0016311]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563],NA,NA,NA
CHOYP_SETD2.1.1.m.25547,0.002397193,0.010465856,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; alpha-tubulin binding [GO:0043014]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of interferon-alpha production [GO:0032727]; regulation of cytokinesis [GO:0032465]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription; DNA-templated [GO:0006355]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_SETD3.1.1.m.42582,0.009109609,-0.016555242,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; transcription coactivator activity [GO:0003713]; histone H3-K36 methylation [GO:0010452]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_SETD6.1.1.m.14704,0.001303955,-0.003548335,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; NF-kappaB binding [GO:0051059]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; peptidyl-lysine monomethylation [GO:0018026]; regulation of inflammatory response [GO:0050727]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_SF3A1.1.3.m.41531,-0.011682398,-0.016399697,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_SF3A3.1.1.m.50392,0.015392891,-0.014933261,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_SF3B1.1.3.m.24001,-0.010151254,-0.023340074,No,NA,NA,NA,NA,NA,NA,spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_SF3B3.1.1.m.45473,-0.009811035,-0.016663149,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_SF3B4.1.1.m.14985,0.007395002,0.00027165,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; RNA binding [GO:0003723]; mRNA cis splicing; via spliceosome [GO:0045292]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_SF3B5.1.1.m.12205,-0.014550301,-0.00907907,No,NA,NA,NA,NA,NA,NA,precatalytic spliceosome [GO:0071011]; SAGA complex [GO:0000124]; U2 snRNP [GO:0005686]; mRNA splicing; via spliceosome [GO:0000398]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SGPL1.1.1.m.42223,-0.003925493,0.00290737,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; ameboidal-type cell migration [GO:0001667]; androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665]; vasculogenesis [GO:0001570],NA,NA,NA
CHOYP_SGPP1.1.1.m.5606,-0.008089997,-0.00768013,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_SH3KBP1.1.1.m.30545,-0.008775038,0.007383348,No,NA,NA,NA,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cell-cell signaling [GO:0007267]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_SH3L1.2.5.m.9176,-0.009441249,-0.005451659,No,NA,NA,NA,NA,NA,NA,SH3 domain binding [GO:0017124],NA,NA,NA
CHOYP_SHD.1.1.m.20907,0.007815876,0.015729183,No,NA,NA,NA,NA,NA,NA,phosphotyrosine residue binding [GO:0001784]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_SHEP.1.1.m.27990,0.012959861,-0.010408568,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_SHLB1.2.2.m.54016,-0.012982323,-0.015286648,No,NA,NA,NA,NA,NA,NA,Golgi membrane [GO:0000139]; mitochondrial outer membrane [GO:0005741]; lipid binding [GO:0008289]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_SHMT2.1.1.m.10572,-0.015801286,-0.008844107,No,NA,NA,NA,NA,NA,NA,BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; chromatin binding [GO:0003682]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; zinc ion binding [GO:0008270]; cellular response to tetrahydrofolate [GO:1904482]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653],NA,NA,NA
CHOYP_SHROOM3.1.1.m.15543,0.007634707,-0.004392315,No,NA,NA,NA,NA,NA,NA,adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; apical protein localization [GO:0045176]; cell morphogenesis [GO:0000902]; cellular pigment accumulation [GO:0043482]; epithelial cell development [GO:0002064]; neural tube closure [GO:0001843]; pattern specification process [GO:0007389]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_SI_CH211.197G15.10.6.7.m.50389,-0.014177682,-0.009342029,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SI_CH211.197G15.7.3.3.m.61063,0.014640418,0.001051765,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SI_CH211.250G4.3.1.2.m.7118,0.008539837,0.003767804,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SI_DKEY.21N12.1.1.1.m.65205,-0.008654732,-0.008768676,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SI_DKEY.5N18.1.1.2.m.5489,-0.008535233,-0.019069206,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SI_DKEYP.75B4.10.2.2.m.54469,-0.012118447,-0.00386928,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SI1L1.1.2.m.7671,-0.009657027,-0.003499237,No,NA,NA,NA,NA,NA,NA,GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_SIK3.1.1.m.8214,0.015930999,-0.00096936,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; endochondral ossification [GO:0001958]; intracellular signal transduction [GO:0035556]; limb morphogenesis [GO:0035108]; microtubule cytoskeleton organization [GO:0000226]; multicellular organism growth [GO:0035264]; protein phosphorylation [GO:0006468]; regulation of protein localization [GO:0032880]; skeletal system morphogenesis [GO:0048705],NA,NA,NA
CHOYP_SIP.1.1.m.5724,-0.007289314,0.016656169,No,NA,NA,NA,NA,NA,NA,beta-catenin destruction complex [GO:0030877]; cytosol [GO:0005829]; nuclear envelope lumen [GO:0005641]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; S100 protein binding [GO:0044548]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]; cellular response to leukemia inhibitory factor [GO:1990830]; heart development [GO:0007507],NA,NA,NA
CHOYP_SIP.1.1.m.5725,-0.016458212,-0.01982504,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SIRT1.1.1.m.9844,0.008529429,-0.013758984,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; growth cone [GO:0030426]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nuclear envelope [GO:0005635]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; rDNA heterochromatin [GO:0033553]; bHLH transcription factor binding [GO:0043425]; deacetylase activity [GO:0019213]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; NAD-dependent protein deacetylase activity [GO:0034979]; nuclear hormone receptor binding [GO:0035257]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; protein deacetylase activity [GO:0033558]; protein domain specific binding [GO:0019904]; protein kinase B binding [GO:0043422]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; angiogenesis [GO:0001525]; behavioral response to starvation [GO:0042595]; cellular glucose homeostasis [GO:0001678]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; chromatin silencing at rDNA [GO:0000183]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA synthesis involved in DNA repair [GO:0000731]; energy homeostasis [GO:0097009]; establishment of chromatin silencing [GO:0006343]; fatty acid homeostasis [GO:0055089]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage cytokine production [GO:0010934]; macrophage differentiation [GO:0030225]; maintenance of chromatin silencing [GO:0006344]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of helicase activity [GO:0051097]; negative regulation of histone H3-K14 acetylation [GO:0071441]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of tumor necrosis factor production [GO:0032720]; ovulation from ovarian follicle [GO:0001542]; peptidyl-lysine acetylation [GO:0018394]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA repair [GO:0045739]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of heart rate [GO:0010460]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of thyroid-stimulating hormone secretion [GO:2000614]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell proliferation [GO:0042127]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of protein import into nucleus; translocation [GO:0033158]; regulation of protein serine/threonine kinase activity [GO:0071900]; regulation of smooth muscle cell apoptotic process [GO:0034391]; response to ethanol [GO:0045471]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to leptin [GO:0044321]; response to oxidative stress [GO:0006979]; rRNA processing [GO:0006364]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; transforming growth factor beta receptor signaling pathway [GO:0007179]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; white fat cell differentiation [GO:0050872],NA,NA,NA
CHOYP_SIX1.1.2.m.49270,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; anatomical structure development [GO:0048856]; Bolwig's organ morphogenesis [GO:0001746]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; entrainment of circadian clock [GO:0009649]; eye-antennal disc morphogenesis [GO:0007455]; glial cell migration [GO:0008347]; negative regulation of transcription; DNA-templated [GO:0045892]; optic lobe placode formation [GO:0001744]; positive regulation of transcription by RNA polymerase II [GO:0045944]; ring gland development [GO:0035271]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SK2L2.1.1.m.35679,0.010036313,-0.006644135,No,NA,NA,NA,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; maturation of 5.8S rRNA [GO:0000460]; mRNA splicing; via spliceosome [GO:0000398]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_SKAP2.1.1.m.63022,-0.000937875,0.023680934,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; B cell activation [GO:0042113],NA,NA,NA
CHOYP_SKIV2L.3.4.m.25390,-0.00310012,-0.006210131,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; Ski complex [GO:0055087]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; nuclear-transcribed mRNA catabolic process; 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; RNA catabolic process [GO:0006401],NA,NA,NA
CHOYP_SLAI2.1.2.m.8777,-0.014476154,-0.001038047,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; cytoplasmic microtubule organization [GO:0031122]; microtubule nucleation [GO:0007020]; positive regulation of microtubule polymerization [GO:0031116],NA,NA,NA
CHOYP_SLC31.5.5.m.57886,-0.007358262,-0.005053758,No,NA,NA,NA,NA,NA,NA,brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; amino acid transport [GO:0006865]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_SLC34A2.1.2.m.9501,-0.002720705,-0.007802142,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; phosphate ion binding [GO:0042301]; protein domain specific binding [GO:0019904]; sodium ion binding [GO:0031402]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]; sodium:phosphate symporter activity [GO:0005436]; cellular phosphate ion homeostasis [GO:0030643]; in utero embryonic development [GO:0001701]; phosphate ion transport [GO:0006817]; response to estrogen [GO:0043627]; sodium-dependent phosphate transport [GO:0044341],NA,NA,NA
CHOYP_SLC3A1.1.1.m.14892,-0.014310429,0.003093593,No,NA,NA,NA,NA,NA,NA,brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; amino acid transport [GO:0006865]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_SLC40A1.1.1.m.55100,0.003126325,-0.012849206,No,NA,NA,NA,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; ferrous iron transmembrane transporter activity [GO:0015093]; identical protein binding [GO:0042802]; iron channel activity [GO:0097689]; iron ion transmembrane transporter activity [GO:0005381]; peptide hormone binding [GO:0017046]; cellular iron ion homeostasis [GO:0006879]; endothelium development [GO:0003158]; iron ion export across plasma membrane [GO:1903988]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; lymphocyte homeostasis [GO:0002260]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; spleen development [GO:0048536]; spleen trabecula formation [GO:0060345],NA,NA,NA
CHOYP_SLC6A14.1.1.m.43828,-0.014538196,0.003858289,No,NA,NA,NA,NA,NA,NA,glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_SLK.1.1.m.59382,0.0122736,-0.017315629,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; protein autophosphorylation [GO:0046777]; regulation of lymphocyte migration [GO:2000401]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_SLMAP.2.8.m.897,-0.008161942,0.004976168,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]; muscle contraction [GO:0006936]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150],NA,NA,NA
CHOYP_SLX4.1.1.m.278,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; chromosome; telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Slx1-Slx4 complex [GO:0033557]; 5'-flap endonuclease activity [GO:0017108]; endodeoxyribonuclease activity [GO:0004520]; enzyme activator activity [GO:0008047]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic DNA double-strand break processing [GO:0000706]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; positive regulation of t-circle formation [GO:1904431]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429]; t-circle formation [GO:0090656]; telomeric D-loop disassembly [GO:0061820],NA,NA,NA
CHOYP_SMAD1.2.2.m.60397,-0.013974579,-0.012049492,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; transcription factor complex [GO:0005667]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; cardiac muscle contraction [GO:0060048]; cartilage development [GO:0051216]; cellular response to organic cyclic compound [GO:0071407]; embryonic pattern specification [GO:0009880]; erythrocyte differentiation [GO:0030218]; germ cell development [GO:0007281]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast fate commitment [GO:0002051]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; protein phosphorylation [GO:0006468]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657],NA,NA,NA
CHOYP_SMAD3.1.1.m.51679,0.001110013,0.007491275,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; SMAD protein complex [GO:0071141]; transcription factor complex [GO:0005667]; beta-catenin binding [GO:0008013]; bHLH transcription factor binding [GO:0043425]; chromatin DNA binding [GO:0031490]; co-SMAD binding [GO:0070410]; collagen binding [GO:0005518]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; enzyme binding [GO:0019899]; glucocorticoid receptor binding [GO:0035259]; mineralocorticoid receptor binding [GO:0031962]; phosphatase binding [GO:0019902]; primary miRNA binding [GO:0070878]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; proximal promoter sequence-specific DNA binding [GO:0000987]; R-SMAD binding [GO:0070412]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; transforming growth factor beta receptor binding [GO:0005160]; transforming growth factor beta receptor; pathway-specific cytoplasmic mediator activity [GO:0030618]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; adrenal gland development [GO:0030325]; cell cycle arrest [GO:0007050]; cell-cell junction organization [GO:0045216]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endoderm development [GO:0007492]; evasion or tolerance of host defenses by virus [GO:0019049]; extrinsic apoptotic signaling pathway [GO:0097191]; heart looping [GO:0001947]; immune response [GO:0006955]; immune system development [GO:0002520]; in utero embryonic development [GO:0001701]; lens fiber cell differentiation [GO:0070306]; liver development [GO:0001889]; mesoderm formation [GO:0001707]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lung blood pressure [GO:0061767]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of wound healing [GO:0061045]; nodal signaling pathway [GO:0038092]; osteoblast development [GO:0002076]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta3 production [GO:0032916]; protein stabilization [GO:0050821]; regulation of binding [GO:0051098]; regulation of epithelial cell proliferation [GO:0050678]; regulation of immune response [GO:0050776]; regulation of striated muscle tissue development [GO:0016202]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somitogenesis [GO:0001756]; T cell activation [GO:0042110]; thyroid gland development [GO:0030878]; transdifferentiation [GO:0060290]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657],NA,NA,NA
CHOYP_SMAD4.3.4.m.13408,-0.005806044,-0.0075736,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_SMARCA5.1.1.m.31708,-0.015166347,-0.021420213,No,NA,NA,NA,NA,NA,NA,chromatin silencing complex [GO:0005677]; condensed chromosome [GO:0000793]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; RSF complex [GO:0031213]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]; ATP-dependent chromatin remodeling [GO:0043044]; cellular response to leukemia inhibitory factor [GO:1990830]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; chromatin silencing at rDNA [GO:0000183]; DNA-templated transcription; initiation [GO:0006352]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of gene expression; epigenetic [GO:0045815]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_SMC.3.5.m.51502,-0.007653241,0.014043,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMC2.1.4.m.17836,-0.007403145,-0.009226584,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome condensation [GO:0030261],NA,NA,NA
CHOYP_SMC2.1.4.m.17837,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of MAPKKK activity [GO:0000185]; apoptotic process [GO:0006915]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; protein ubiquitination [GO:0016567]; ribosomal large subunit assembly [GO:0000027],NA,NA,NA
CHOYP_SMC3.1.1.m.65133,-0.013764468,0.004332208,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; chromosome; centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275],NA,NA,NA
CHOYP_SMCA4.1.1.m.54020,-0.001731343,-0.011289665,No,NA,NA,NA,NA,NA,NA,nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; histone binding [GO:0042393]; RNA binding [GO:0003723]; ATP-dependent chromatin remodeling [GO:0043044]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_SMG1.1.1.m.46694,0.014736734,-0.000639572,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; telomeric DNA binding [GO:0042162]; DNA repair [GO:0006281]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphorylation [GO:0046854]; protein autophosphorylation [GO:0046777]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204],NA,NA,NA
CHOYP_SMG5.1.1.m.21320,0.007964335,0.008723231,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; histone deacetylase binding [GO:0042826]; protein phosphatase 2A binding [GO:0051721]; ribonuclease activity [GO:0004540]; ribonucleoprotein complex binding [GO:0043021]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; ubiquitin protein ligase binding [GO:0031625]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of RNA stability [GO:0043487]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_SMG7.1.1.m.21983,-0.006812319,-0.004210938,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; protein phosphatase 2A binding [GO:0051721]; ribonuclease activity [GO:0004540]; ribonucleoprotein complex binding [GO:0043021]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of RNA stability [GO:0043487]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_SMG9.1.1.m.2906,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184],NA,NA,NA
CHOYP_SMHD1.1.1.m.47344,0.003287248,0.000767757,No,NA,NA,NA,NA,NA,NA,Barr body [GO:0001740]; nuclear chromosome; telomeric region [GO:0000784]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; heterochromatin organization involved in chromatin silencing [GO:0070868]; inactivation of X chromosome by DNA methylation [GO:0060821]; inactivation of X chromosome by heterochromatin assembly [GO:0060820]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034],NA,NA,NA
CHOYP_SMOX.1.2.m.3830,-0.003898357,-0.025448444,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208],NA,NA,NA
CHOYP_SMP_001000.1.1.m.39561,-0.019762758,0.004363541,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_005500.1.1.m.34627,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243],NA,NA,NA
CHOYP_SMP_006860.2.1.4.m.8660,0.016532371,0.019077362,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952],NA,NA,NA
CHOYP_SMP_006860.2.2.4.m.24582,-0.002973741,0.006538626,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_006860.2.3.4.m.63036,-0.01842481,0.000435019,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952],NA,NA,NA
CHOYP_SMP_012720.1.2.m.31152,0.00600844,0.013442345,No,NA,NA,NA,NA,NA,NA,actin filament [GO:0005884]; cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein kinase C signaling [GO:0070528]; protein localization to cell leading edge [GO:1902463]; ruffle organization [GO:0031529]; wound healing [GO:0042060],NA,NA,NA
CHOYP_SMP_012720.2.2.m.34968,0.010074228,0.011679049,No,NA,NA,NA,NA,NA,NA,actin filament [GO:0005884]; cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein kinase C signaling [GO:0070528]; protein localization to cell leading edge [GO:1902463]; ruffle organization [GO:0031529]; wound healing [GO:0042060],NA,NA,NA
CHOYP_SMP_039300.1.1.m.1202,0.010414786,-0.002038806,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_SMP_043120.1.1.m.12494,-0.011192662,0.006475639,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_SMP_045300.1.1.m.927,-0.009487136,0.003721011,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952],NA,NA,NA
CHOYP_SMP_048560.1.2.m.58825,-0.01556262,-0.011047296,No,NA,NA,NA,NA,NA,NA,M band [GO:0031430]; nucleus [GO:0005634]; Z disc [GO:0030018]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015],NA,NA,NA
CHOYP_SMP_051990.1.7.m.327,-0.001236675,0.014261199,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_051990.2.7.m.611,-0.000841167,0.010154059,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_051990.4.7.m.9424,0.019021333,0.004280398,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_SMP_051990.5.7.m.43424,0.001017971,-0.00400529,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_SMP_051990.7.7.m.57569,0.015078838,0.007314397,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_076400.2.2.m.49169,-0.000987688,-0.006874203,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_078690.3.5.m.2272,0.021657897,0.007657559,No,NA,NA,NA,NA,NA,NA,actin filament [GO:0005884]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; protein binding; bridging [GO:0030674]; actomyosin structure organization [GO:0031032]; epithelial cell differentiation [GO:0030855]; negative regulation of ATPase activity [GO:0032780],NA,NA,NA
CHOYP_SMP_078690.4.5.m.41580,-0.005219542,0.009896439,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_SMP_082940.1.1.m.3343,-0.013808757,-0.009975603,No,NA,NA,NA,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_SMP_087250.2.2.m.25167,0.018757842,0.017431986,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_SMP_089460.1.1.1.m.34779,0.013865255,-0.009705513,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_SMP_102490.1.2.m.22219,0.006612772,-0.002581078,No,NA,NA,NA,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_SMP_105540.1.1.m.40275,-0.005858771,-0.01639422,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211],NA,NA,NA
CHOYP_SMP_137640.1.2.m.40559,0.011201434,0.005155476,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_SMP_140370.1.1.m.35365,-0.017895927,-0.016570483,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_143090.1.1.m.6805,-0.022570302,-0.001715659,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_147320.1.1.m.27463,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; cAMP binding [GO:0030552]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SMP_148160.1.1.m.11635,-0.017061412,-0.01841338,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; sperm connecting piece [GO:0097224]; myosin light chain binding [GO:0032027]; cell differentiation [GO:0030154]; motile cilium assembly [GO:0044458]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SMP_148530.1.1.m.18051,0.018591174,0.006637612,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_SMP_149390.1.1.m.8819,-0.013204356,-0.005698595,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186]; protein localization to plasma membrane [GO:0072659],NA,NA,NA
CHOYP_SMP_149990.1.1.1.m.44960,-0.000433967,-0.021563812,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_SMP_158990.1.1.m.28205,-0.016395057,0.003953279,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_SMP_159010.1.1.1.m.56000,-0.004117667,0.010084332,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_SMP_159780.1.2.m.41665,0.000428074,0.005786594,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_168770.1.1.m.18618,-0.01964584,-0.001925688,No,NA,NA,NA,NA,NA,NA,TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; instar larval development [GO:0002168]; protein import into mitochondrial matrix [GO:0030150],NA,NA,NA
CHOYP_SMP_171550.1.1.m.44645,-0.014904636,-0.016338027,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_173720.2.3.m.52988,0.005537261,0.013830228,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; metal ion transport [GO:0030001]; protein tetramerization [GO:0051262]; response to toxic substance [GO:0009636],NA,NA,NA
CHOYP_SMP_176410.1.1.m.18565,0.000539361,0.009506628,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; cell division [GO:0051301]; cell proliferation [GO:0008283]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_SMP_194720.1.1.m.53496,0.017605089,0.009335361,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_SMRC2.2.2.m.49912,-0.005728573,0.006024139,No,NA,NA,NA,NA,NA,NA,nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_SMRD1.1.2.m.1725,-0.002607478,0.01335998,No,NA,NA,NA,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; protein-containing complex scaffold activity [GO:0032947]; signaling receptor binding [GO:0005102]; cellular response to fatty acid [GO:0071398]; chromatin remodeling [GO:0006338]; chromatin-mediated maintenance of transcription [GO:0048096]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337],NA,NA,NA
CHOYP_SMU1.1.1.m.58635,-0.015783254,-0.004392795,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing; via spliceosome [GO:0000398]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_SMYD5.1.1.m.27234,0.002098025,0.005270513,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_SNF1A.1.1.m.52779,0.005954955,-0.015771946,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; [acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell cycle arrest [GO:0007050]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; macroautophagy [GO:0016236]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of TOR signaling [GO:0032007]; negative regulation of tubulin deacetylation [GO:1904428]; positive regulation of autophagy [GO:0010508]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of glycolytic process [GO:0045821]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stress granule assembly [GO:0062028]; response to muscle activity [GO:0014850]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_SNUT2.1.1.m.19264,-0.015923558,-0.014296923,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing; via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_SNW1.2.2.m.19563,0.001809501,-0.0183629,No,NA,NA,NA,NA,NA,NA,nuclear matrix [GO:0016363]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; nuclear hormone receptor binding [GO:0035257]; retinoic acid receptor binding [GO:0042974]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; vitamin D receptor binding [GO:0042809]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinoic acid receptor signaling pathway [GO:0048384],NA,NA,NA
CHOYP_SNX2.1.1.m.25425,0.001395398,-0.011748923,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer; tubulation complex [GO:0030905]; cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]; early endosome to Golgi transport [GO:0034498]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; protein complex oligomerization [GO:0051259]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_SODM.1.2.m.45531,0.014756461,-0.004532329,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]; age-dependent response to reactive oxygen species [GO:0001315]; aging [GO:0007568]; regulation of transcription by RNA polymerase II [GO:0006357]; superoxide metabolic process [GO:0006801],NA,NA,NA
CHOYP_SODM.2.2.m.62946,0.013135729,-0.008602588,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body; internal vesicle [GO:0097487]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; pigment granule maturation [GO:0048757]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746],NA,NA,NA
CHOYP_SON.1.3.m.26634,0.001855673,-0.003387431,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SORBIDRAFT_04G037735.1.1.m.52863,0.005782164,-0.010049743,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SORBIDRAFT_06G032450.1.1.m.16356,0.005600935,-0.003498204,No,NA,NA,NA,NA,NA,NA,peroxisome [GO:0005777]; flavin adenine dinucleotide binding [GO:0050660]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]; thermospermine catabolic process [GO:1903602],NA,NA,NA
CHOYP_SORL.1.3.m.4531,0.006601478,-0.011135264,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766],NA,NA,NA
CHOYP_SORL.3.3.m.58779,-0.004382837,0.002224623,No,NA,NA,NA,NA,NA,NA,early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; integral component of membrane [GO:0016021]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; multivesicular body [GO:0005771]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; ADP-ribosylation factor binding [GO:0030306]; amyloid-beta binding [GO:0001540]; low-density lipoprotein particle binding [GO:0030169]; cell migration [GO:0016477]; cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]; lipid transport [GO:0006869]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of protein binding [GO:0032091]; negative regulation of protein oligomerization [GO:0032460]; negative regulation of tau-protein kinase activity [GO:1902948]; positive regulation of choline O-acetyltransferase activity [GO:1902771]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein maturation [GO:0051604]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; regulation of smooth muscle cell migration [GO:0014910],NA,NA,NA
CHOYP_SOS1.1.1.m.52801,0.010545796,0.016056237,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_SOSB1.1.2.m.1668,-0.008540296,0.011340698,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; SOSS complex [GO:0070876]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle checkpoint [GO:0007093]; response to ionizing radiation [GO:0010212],NA,NA,NA
CHOYP_SOX2.1.2.m.31411,-0.013866452,-0.017230785,No,NA,NA,NA,NA,NA,NA,cell [GO:0005623]; cytosol [GO:0005829]; nuclear transcription factor complex [GO:0044798]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; miRNA binding [GO:0035198]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; central nervous system development [GO:0007417]; endodermal cell fate specification [GO:0001714]; eye development [GO:0001654]; forebrain development [GO:0030900]; inner ear development [GO:0048839]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; osteoblast differentiation [GO:0001649]; pituitary gland development [GO:0021983]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of transcription; DNA-templated [GO:0006355]; response to growth factor [GO:0070848]; response to wounding [GO:0009611]; sensory organ precursor cell fate determination [GO:0016360]; somatic stem cell population maintenance [GO:0035019],NA,NA,NA
CHOYP_SP3.1.1.m.9839,0.004862634,-0.012384173,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_SPAG16.1.1.m.51927,-0.02023553,0.00368364,No,NA,NA,NA,NA,NA,NA,axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; sperm flagellum [GO:0036126]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; sperm axoneme assembly [GO:0007288],NA,NA,NA
CHOYP_SPAG7.1.1.m.66661,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_SPAT6.1.1.m.11699,-0.006914196,0.013587587,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; sperm connecting piece [GO:0097224]; myosin light chain binding [GO:0032027]; cell differentiation [GO:0030154]; motile cilium assembly [GO:0044458]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SPB3.1.1.m.31072,-0.017545714,-0.016871727,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; epithelial cell-cell adhesion [GO:0090136]; negative regulation of endopeptidase activity [GO:0010951],NA,NA,NA
CHOYP_SPCA.1.1.m.6746,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-transporting ATPase activity [GO:0005388]; manganese ion binding [GO:0030145]; manganese-transporting ATPase activity [GO:0015410]; metal ion binding [GO:0046872]; proton-exporting ATPase activity; phosphorylative mechanism [GO:0008553]; actin cytoskeleton reorganization [GO:0031532]; ATP hydrolysis coupled cation transmembrane transport [GO:0099132]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; manganese ion transport [GO:0006828]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123],NA,NA,NA
CHOYP_SPCS.1.1.m.65784,-0.012726928,0.015090164,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; transferase activity; transferring selenium-containing groups [GO:0016785]; tRNA binding [GO:0000049]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; translation [GO:0006412],NA,NA,NA
CHOYP_SPF45.1.1.m.22111,-0.006169945,0.007229487,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; alternative mRNA splicing; via spliceosome [GO:0000380]; DNA repair [GO:0006281]; mRNA splicing; via spliceosome [GO:0000398]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_SPH127.1.1.m.56840,0.017114064,-0.005681737,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SPI2.16.37.m.16200,-0.001615787,0.017393551,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SPI2.25.37.m.28547,0.003475878,-0.025487622,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SPI2.29.37.m.30551,0.009441234,-0.016981935,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SPI2.30.37.m.30616,-0.012632357,-0.007195749,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SPI2.8.37.m.4837,-0.001812592,-0.011366851,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SPR.1.3.m.17978,-0.012037286,-0.00917517,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; sepiapterin reductase activity [GO:0004757]; tetrahydrobiopterin biosynthetic process [GO:0006729],NA,NA,NA
CHOYP_SPR.2.3.m.21888,0.006128035,-0.006273765,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity; post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042],NA,NA,NA
CHOYP_SPT20.1.1.m.35908,0.007164321,-0.012058745,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; catalytic activity [GO:0003824]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SPT4H.1.1.m.40744,0.001002862,-0.012822466,No,NA,NA,NA,NA,NA,NA,DSIF complex [GO:0032044]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription; elongation [GO:0032786],NA,NA,NA
CHOYP_SPT5H.1.1.m.60053,0.002594863,-0.017498214,No,NA,NA,NA,NA,NA,NA,DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; negative regulation of DNA-templated transcription; elongation [GO:0032785]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_SPT6H.1.1.m.55595,0.008460566,-0.011635744,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; transcriptionally active chromatin [GO:0035327]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; blastocyst formation [GO:0001825]; chromatin maintenance [GO:0070827]; chromatin remodeling [GO:0006338]; mRNA processing [GO:0006397]; mRNA transcription by RNA polymerase II [GO:0042789]; mRNA transport [GO:0051028]; negative regulation of histone H3-K27 methylation [GO:0061086]; nucleosome organization [GO:0034728]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of isotype switching [GO:0045191]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription; DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032],NA,NA,NA
CHOYP_SPTCA.1.2.m.1905,0.00018116,-0.00026037,No,NA,NA,NA,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807],NA,NA,NA
CHOYP_SPTCA.2.2.m.25615,-0.007869251,0.007605209,No,NA,NA,NA,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807],NA,NA,NA
CHOYP_SQPA.2.2.m.61080,0.006494574,0.007512541,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SR140.1.2.m.11983,0.003437036,0.011742733,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_SRA1.1.1.m.56432,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; steroid hormone aporeceptor complex [GO:0005831]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; nuclear receptor transcription coactivator activity [GO:0030374]; steroid receptor RNA activator RNA binding [GO:0002153]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of myoblast differentiation [GO:0045662]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_SRAP.10.18.m.43353,0.00615674,-0.019152516,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874],NA,NA,NA
CHOYP_SRAP.14.18.m.50950,-0.016713105,0.010390021,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; regulation of type I interferon production [GO:0032479]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_SRAP.16.18.m.58654,0.018962688,-0.007005327,No,NA,NA,NA,NA,NA,NA,anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; extracellular region [GO:0005576]; cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226],NA,NA,NA
CHOYP_SRC.1.2.m.2503,0.022656763,-0.007874377,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cell projection [GO:0042995]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; actin binding [GO:0003779]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]; axo-dendritic transport [GO:0008088]; axonogenesis [GO:0007409]; compound eye development [GO:0048749]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; nervous system development [GO:0007399]; neurofilament cytoskeleton organization [GO:0060052]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; regulation of microtubule depolymerization [GO:0031114]; regulation of synaptic growth at neuromuscular junction [GO:0008582],NA,NA,NA
CHOYP_SRC1.1.1.m.63625,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,actin filament [GO:0005884]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glucose transmembrane transport [GO:0010827]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_SRC2.1.1.m.6537,0.00656027,0.001271706,No,NA,NA,NA,NA,NA,NA,adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure; spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc fusion; thorax closure [GO:0046529]; imaginal disc-derived wing morphogenesis [GO:0007476]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; protein phosphorylation [GO:0006468]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_SRCR12.1.1.m.53668,0.003126372,-0.012848167,No,NA,NA,NA,NA,NA,NA,external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044],NA,NA,NA
CHOYP_SREC2.7.9.m.44662,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SREC2.9.9.m.66799,0.007844787,0.000660544,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SRFB1.1.2.m.18320,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,90S preribosome [GO:0030686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; maturation of SSU-rRNA [GO:0030490],NA,NA,NA
CHOYP_SRP54.1.2.m.21986,0.005897053,-0.009638249,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; signal recognition particle; endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; drug binding [GO:0008144]; endoplasmic reticulum signal peptide binding [GO:0030942]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614],NA,NA,NA
CHOYP_SRP68.1.1.m.61852,0.0034918,-0.020451979,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; ribosome [GO:0005840]; signal recognition particle [GO:0048500]; signal recognition particle; endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]; response to drug [GO:0042493]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614],NA,NA,NA
CHOYP_SRP72.1.1.m.60789,-0.002240808,-0.00670661,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; signal recognition particle [GO:0048500]; signal recognition particle; endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]; TPR domain binding [GO:0030911]; response to drug [GO:0042493]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; SRP-dependent cotranslational protein targeting to membrane; translocation [GO:0006616],NA,NA,NA
CHOYP_SRPK2.1.1.m.5002,0.014433775,-0.005776523,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cell differentiation [GO:0030154]; chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_SRPX2.1.1.m.37317,0.002237388,-0.001407587,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_SRSF4.6.6.m.44673,-0.010321318,0.015121027,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SSPO.1.14.m.962,-0.004653505,0.00705361,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_SSPO.11.14.m.53093,-0.011845762,0.002345823,No,NA,NA,NA,NA,NA,NA,cell wall [GO:0005618]; extracellular region [GO:0005576]; S-layer [GO:0030115]; carbohydrate binding [GO:0030246]; polysaccharide catabolic process [GO:0000272],NA,NA,NA
CHOYP_SSPO.12.14.m.53188,-0.020096253,0.006925054,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; binding of sperm to zona pellucida [GO:0007339]; cell-cell adhesion [GO:0098609],NA,NA,NA
CHOYP_SSPO.2.14.m.3787,0.004450467,-0.006027275,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; platelet alpha granule [GO:0031091]; sarcoplasmic reticulum [GO:0016529]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_SSPO.6.14.m.26542,-0.012274552,0.000926308,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_SSRB.1.2.m.5816,-0.008482355,-0.013770732,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_SSRP1.1.1.m.19377,-0.011919906,-0.015045211,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_SSSCA1.1.2.m.25666,-0.000254584,0.011301829,No,NA,NA,NA,NA,NA,NA,identical protein binding [GO:0042802]; cell division [GO:0051301]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_SSU72.1.1.m.2079,0.001478533,0.008009627,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA polyadenylation [GO:0006378]; termination of RNA polymerase II transcription [GO:0006369],NA,NA,NA
CHOYP_ST1C1.1.1.m.45503,-0.001799648,0.011183471,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923],NA,NA,NA
CHOYP_ST1C4.2.3.m.14628,-0.011008028,0.000630922,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923],NA,NA,NA
CHOYP_ST5.1.1.m.54184,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,Rab guanyl-nucleotide exchange factor activity [GO:0017112]; positive regulation of ERK1 and ERK2 cascade [GO:0070374],NA,NA,NA
CHOYP_STAB2.1.1.m.64132,0.005386299,0.000473423,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897],NA,NA,NA
CHOYP_STAR5.2.2.m.39352,0.018148516,0.00776346,No,NA,NA,NA,NA,NA,NA,bile acid binding [GO:0032052]; cholesterol binding [GO:0015485]; cholesterol transporter activity [GO:0017127]; cholesterol import [GO:0070508],NA,NA,NA
CHOYP_STAT1.1.2.m.1003,-0.000679565,0.011613823,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; glucocorticoid receptor binding [GO:0035259]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; acute-phase response [GO:0006953]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; JAK-STAT cascade [GO:0007259]; JAK-STAT cascade involved in growth hormone signaling pathway [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; liver development [GO:0001889]; luteinization [GO:0001553]; mast cell migration [GO:0097531]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; regulation of cell adhesion [GO:0030155]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; sex differentiation [GO:0007548]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_STERM_3136.1.1.m.53971,-0.004768912,-0.011225176,No,NA,NA,NA,NA,NA,NA,hydrolase activity; acting on glycosyl bonds [GO:0016798]; metabolic process [GO:0008152],NA,NA,NA
CHOYP_STIM1.1.1.m.13316,0.008512102,-0.008509136,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum membrane [GO:0033017]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; microtubule plus-end binding [GO:0051010]; store-operated calcium channel activity [GO:0015279]; activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; detection of calcium ion [GO:0005513]; enamel mineralization [GO:0070166]; myotube differentiation [GO:0014902]; positive regulation of adenylate cyclase activity [GO:0045762]; regulation of calcium ion transport [GO:0051924]; regulation of store-operated calcium entry [GO:2001256]; store-operated calcium entry [GO:0002115],NA,NA,NA
CHOYP_STING.3.3.m.61083,-0.00450421,0.013320112,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; cyclic-di-GMP binding [GO:0035438]; cyclic-GMP-AMP binding [GO:0061507]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; activation of innate immune response [GO:0002218]; apoptotic process [GO:0006915]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-beta [GO:0035458]; cellular response to organic cyclic compound [GO:0071407]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; neutrophil degranulation [GO:0043312]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import into nucleus; translocation [GO:0033160]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; regulation of inflammatory response [GO:0050727]; regulation of type I interferon production [GO:0032479]; viral process [GO:0016032],NA,NA,NA
CHOYP_STIP1.1.2.m.12856,0.00383421,-0.00390916,No,NA,NA,NA,NA,NA,NA,chaperone complex [GO:0101031]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; cellular response to interleukin-7 [GO:0098761],NA,NA,NA
CHOYP_STIP1.2.2.m.54723,0.001986655,-0.000107298,No,NA,NA,NA,NA,NA,NA,chaperone complex [GO:0101031]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; cellular response to interleukin-7 [GO:0098761],NA,NA,NA
CHOYP_STK17A.1.1.m.24446,0.021707797,-0.006493581,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fibroblast apoptotic process [GO:2000271]; protein phosphorylation [GO:0006468]; regulation of reactive oxygen species metabolic process [GO:2000377],NA,NA,NA
CHOYP_STK31.1.1.m.16297,0.001697512,-0.014144753,No,NA,NA,NA,NA,NA,NA,acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nuclease activity [GO:0004518]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA catabolic process [GO:0006401],NA,NA,NA
CHOYP_STK33.1.1.m.8044,-0.01389684,-0.000196564,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; mitotic DNA damage checkpoint [GO:0044773]; protein autophosphorylation [GO:0046777]; signal transduction in response to DNA damage [GO:0042770],NA,NA,NA
CHOYP_STRN.MLCK.2.3.m.9348,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_STRN3.3.5.m.25133,-0.006300835,-0.000362599,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; DNA-binding transcription factor activity [GO:0003700]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; Rho GTPase binding [GO:0017048]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_STRUM.1.1.m.42335,-0.008113461,-0.024782562,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; WASH complex [GO:0071203]; protein transport [GO:0015031],NA,NA,NA
CHOYP_STT3A.1.1.m.40532,-0.009315315,-0.012477152,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; oligosaccharyltransferase III complex [GO:0035000]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; co-translational protein modification [GO:0043686]; protein N-linked glycosylation via asparagine [GO:0018279],NA,NA,NA
CHOYP_STX.1.1.m.30392,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,cell [GO:0005623]; integral component of membrane [GO:0016021]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; intracellular protein transport [GO:0006886]; neurotransmitter transport [GO:0006836]; regulation of exocytosis [GO:0017157]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_STX12.1.1.m.34092,-0.022663495,0.010347139,No,NA,NA,NA,NA,NA,NA,early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; membrane raft [GO:0045121]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; autophagosome assembly [GO:0000045]; cholesterol efflux [GO:0033344]; intracellular protein transport [GO:0006886]; protein stabilization [GO:0050821]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_STXB1.1.1.m.56878,-0.010091991,-0.012598558,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; axon target recognition [GO:0007412]; cellular response to interferon-gamma [GO:0071346]; developmental process involved in reproduction [GO:0003006]; long-term synaptic depression [GO:0060292]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of SNARE complex assembly [GO:0035544]; negative regulation of synaptic transmission; GABAergic [GO:0032229]; neuromuscular synaptic transmission [GO:0007274]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of exocytosis [GO:0045921]; positive regulation of glutamate secretion; neurotransmission [GO:1903296]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of vesicle docking [GO:0106022]; presynaptic dense core vesicle exocytosis [GO:0099525]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of synaptic vesicle priming [GO:0010807]; regulation of vesicle fusion [GO:0031338]; response to estradiol [GO:0032355]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_STXB5.1.2.m.50466,-0.003187695,0.00628549,No,NA,NA,NA,NA,NA,NA,acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of presynaptic membrane [GO:0098888]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]; Schaffer collateral - CA1 synapse [GO:0098685]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; synaptic vesicle cycle [GO:0099504],NA,NA,NA
CHOYP_SUCB1.1.1.m.41299,0.010761764,-0.007969223,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase activity [GO:0004774]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_SUCB2.1.1.m.7164,-0.004169153,-0.022403982,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_SUDX.1.1.m.4577,-0.00845315,0.010169725,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; lung development [GO:0030324]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; T cell differentiation [GO:0030217]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_SUIS.2.2.m.16063,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; alpha-1;4-glucosidase activity [GO:0004558]; amylase activity [GO:0016160]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; glucan 1;4-alpha-glucosidase activity [GO:0004339]; maltose alpha-glucosidase activity [GO:0032450]; neutrophil degranulation [GO:0043312]; polysaccharide digestion [GO:0044245]; starch catabolic process [GO:0005983],NA,NA,NA
CHOYP_SUOX.1.1.m.32255,0.008768901,-0.002464909,No,NA,NA,NA,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482]; nitrate assimilation [GO:0042128]; sulfur compound metabolic process [GO:0006790],NA,NA,NA
CHOYP_SUV3.1.1.m.14574,0.008130016,0.006179872,No,NA,NA,NA,NA,NA,NA,mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA duplex unwinding [GO:0032508]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA processing [GO:0000963]; mitochondrial tRNA processing [GO:0090646]; oxidative phosphorylation [GO:0006119]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]; respiratory electron transport chain [GO:0022904]; RNA catabolic process [GO:0006401],NA,NA,NA
CHOYP_SVEP1.2.8.m.26503,0.023220421,-0.000162535,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_SVIL.1.1.m.1136,-0.019026018,-0.002301704,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SYAC.2.2.m.18500,0.010252265,0.001102572,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; translation regulator activity [GO:0045182]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]; cerebellar Purkinje cell layer development [GO:0021680]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA modification [GO:0006400],NA,NA,NA
CHOYP_SYB.1.3.m.25801,-0.008598913,-0.004086176,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; synaptic vesicle membrane [GO:0030672]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_SYCC.1.1.m.11415,0.001946251,0.001484494,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; cysteinyl-tRNA aminoacylation [GO:0006423],NA,NA,NA
CHOYP_SYCP2.1.2.m.47476,-0.007262891,-0.01068727,No,NA,NA,NA,NA,NA,NA,lateral element [GO:0000800]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; animal organ morphogenesis [GO:0009887]; cell division [GO:0051301]; female meiotic nuclear division [GO:0007143]; fertilization [GO:0009566]; male genitalia morphogenesis [GO:0048808]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066],NA,NA,NA
CHOYP_SYFA.1.1.m.53256,0.007760378,0.012470761,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290],NA,NA,NA
CHOYP_SYFA.1.1.m.53257,-0.013617391,-0.015829163,No,NA,NA,NA,NA,NA,NA,calcium channel complex [GO:0034704]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; uniplex complex [GO:1990246]; calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; uniporter activity [GO:0015292]; actin filament organization [GO:0007015]; calcium import into the mitochondrion [GO:0036444]; calcium-mediated signaling [GO:0019722]; chordate embryonic development [GO:0043009]; convergent extension involved in gastrulation [GO:0060027]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein complex oligomerization [GO:0051259]; regulation of heart contraction [GO:0008016],NA,NA,NA
CHOYP_SYHC.1.1.m.65924,0.009658849,-0.008695795,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]; histidyl-tRNA aminoacylation [GO:0006427]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_SYMC.1.1.m.18367,0.013097476,0.002395783,No,NA,NA,NA,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to starvation [GO:0009267]; methionyl-tRNA aminoacylation [GO:0006431]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; rRNA transcription [GO:0009303]; tRNA aminoacylation for protein translation [GO:0006418],NA,NA,NA
CHOYP_SYMPK.1.1.m.1791,0.004955819,-0.015084567,No,NA,NA,NA,NA,NA,NA,bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of protein binding [GO:0032091]; positive regulation of protein dephosphorylation [GO:0035307]; termination of RNA polymerase II transcription [GO:0006369],NA,NA,NA
CHOYP_SYNE1.1.1.m.51183,-0.000320426,0.004664027,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SYNJ1.1.1.m.42275,0.012520175,0.019115964,No,NA,NA,NA,NA,NA,NA,clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; membrane coat [GO:0030117]; neuron projection [GO:0043005]; parallel fiber to Purkinje cell synapse [GO:0098688]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; terminal bouton [GO:0043195]; vesicle membrane [GO:0012506]; EH domain binding [GO:1990175]; inositol-1;4;5-trisphosphate 5-phosphatase activity [GO:0052658]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4;5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; brain development [GO:0007420]; inositol phosphate dephosphorylation [GO:0046855]; learning [GO:0007612]; neurotransmitter transport [GO:0006836]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of endosome organization [GO:1904980]; positive regulation of gliogenesis [GO:0014015]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of synaptic vesicle recycling [GO:1903423]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; response to cytokine [GO:0034097]; response to retinoic acid [GO:0032526]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; synaptic vesicle uncoating [GO:0016191],NA,NA,NA
CHOYP_SYPL1.1.1.m.49654,-0.003369845,-0.024524807,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; melanosome [GO:0042470]; secretory granule [GO:0030141]; chemical synaptic transmission [GO:0007268],NA,NA,NA
CHOYP_SYRC.1.2.m.36309,-0.006190997,0.014168234,No,NA,NA,NA,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; arginyl-tRNA aminoacylation [GO:0006420],NA,NA,NA
CHOYP_SYTC.1.1.m.35709,0.020221526,0.003209837,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; threonine-tRNA ligase activity [GO:0004829]; threonyl-tRNA aminoacylation [GO:0006435],NA,NA,NA
CHOYP_SYWC.3.5.m.26200,0.016420651,0.003309925,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]; angiogenesis [GO:0001525]; negative regulation of cell proliferation [GO:0008285]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]; tryptophanyl-tRNA aminoacylation [GO:0006436],NA,NA,NA
CHOYP_SYWC.4.5.m.36166,0.00721207,0.020774704,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of gene expression [GO:0010628]; positive regulation of protein complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; tryptophanyl-tRNA aminoacylation [GO:0006436],NA,NA,NA
CHOYP_SYWC.5.5.m.54889,0.020016178,0.008938404,No,NA,NA,NA,NA,NA,NA,cell projection [GO:0042995]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular [GO:0005622]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; blastocyst formation [GO:0001825]; cardiac epithelial to mesenchymal transition [GO:0060317]; cerebral cortex radial glia guided migration [GO:0021801]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; endoplasmic reticulum tubular network organization [GO:0071786]; negative regulation of axon extension [GO:0030517]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell growth [GO:0030308]; nuclear pore complex assembly [GO:0051292]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERBB3 signaling pathway [GO:1905580]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of cell migration [GO:0030334],NA,NA,NA
CHOYP_SYYC.1.2.m.23460,-0.002556116,-0.009398809,No,NA,NA,NA,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; methionyl glutamyl tRNA synthetase complex [GO:0017102]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; tyrosine-tRNA ligase activity [GO:0004831]; cellular response to DNA damage stimulus [GO:0006974]; tRNA aminoacylation for protein translation [GO:0006418]; tyrosyl-tRNA aminoacylation [GO:0006437],NA,NA,NA
CHOYP_SYYC.2.2.m.58390,0.012356229,0.022998321,No,NA,NA,NA,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; methionyl glutamyl tRNA synthetase complex [GO:0017102]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; tyrosine-tRNA ligase activity [GO:0004831]; cellular response to DNA damage stimulus [GO:0006974]; tRNA aminoacylation for protein translation [GO:0006418]; tyrosyl-tRNA aminoacylation [GO:0006437],NA,NA,NA
CHOYP_T23O.5.6.m.52216,0.007805222,0.015664625,No,NA,NA,NA,NA,NA,NA,heme binding [GO:0020037]; metal ion binding [GO:0046872]; tryptophan 2;3-dioxygenase activity [GO:0004833]; protein homotetramerization [GO:0051289]; tryptophan catabolic process to kynurenine [GO:0019441],NA,NA,NA
CHOYP_T24B8.5.1.2.m.5660,-0.004552587,-0.011378089,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_T24B8.5.2.2.m.46909,0.001771157,-0.009042746,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_T3HPD.1.2.m.24627,0.011319703,0.000757134,No,NA,NA,NA,NA,NA,NA,hydro-lyase activity [GO:0016836]; trans-L-3-hydroxyproline dehydratase activity [GO:0050346],NA,NA,NA
CHOYP_TAB3.1.1.m.25766,0.003385243,-0.000599917,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; heart development [GO:0007507]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein kinase activity [GO:0045860],NA,NA,NA
CHOYP_TACC1.2.2.m.53512,0.014421894,-0.005900888,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; cell division [GO:0051301]; cell proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neurogenesis [GO:0022008]; regulation of microtubule-based process [GO:0032886],NA,NA,NA
CHOYP_TACC3.3.3.m.16099,0.010083643,-0.005189965,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; translation initiation factor binding [GO:0031369]; cell division [GO:0051301]; mitotic spindle organization [GO:0007052]; negative regulation of translation [GO:0017148],NA,NA,NA
CHOYP_TAD2A.1.1.m.27478,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; unfolded protein binding [GO:0051082]; developmental process [GO:0032502]; protein folding [GO:0006457],NA,NA,NA
CHOYP_TAF1.1.1.m.31656,0.009427677,-0.002788716,No,NA,NA,NA,NA,NA,NA,MLL1 complex [GO:0071339]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; transcription factor TFIID complex [GO:0005669]; ATP binding [GO:0005524]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone acetyltransferase activity [GO:0004402]; kinase activity [GO:0016301]; lysine-acetylated histone binding [GO:0070577]; nuclear hormone receptor binding [GO:0035257]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II sequence-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; TBP-class protein binding [GO:0017025]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; ubiquitin conjugating enzyme activity [GO:0061631]; cell cycle [GO:0007049]; cellular response to ATP [GO:0071318]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA-templated transcription; initiation [GO:0006352]; midbrain development [GO:0030901]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of protein autoubiquitination [GO:1905524]; negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903026]; negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [GO:0010768]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription initiation from RNA polymerase II promoter [GO:0060260]; regulation of transcription; DNA-templated [GO:0006355]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription factor catabolic process [GO:0036369]; transcription initiation from RNA polymerase II promoter [GO:0006367]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_TAF13.1.3.m.20331,-0.012168688,0.019511457,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_TAF9.1.1.m.10395,0.00159036,-0.021564713,No,NA,NA,NA,NA,NA,NA,Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887],NA,NA,NA
CHOYP_TAGL3.1.1.m.31031,0.009466714,0.022681373,No,NA,NA,NA,NA,NA,NA,actin filament binding [GO:0051015],NA,NA,NA
CHOYP_TALDO.2.2.m.43331,0.003086985,-0.017376313,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; monosaccharide binding [GO:0048029]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; interleukin-12-mediated signaling pathway [GO:0035722]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt; non-oxidative branch [GO:0009052]; xylulose biosynthetic process [GO:0005999],NA,NA,NA
CHOYP_TBA.1.6.m.12217,-0.010126724,-0.005424778,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBA.3.6.m.29936,-0.022773568,0.000991343,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TBA.3.6.m.29937,-0.022496816,0.005282842,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TBA.5.6.m.37448,0.000144202,0.010492192,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBA1.2.9.m.9962,0.001444763,-0.008389558,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281],NA,NA,NA
CHOYP_TBA1.7.9.m.44107,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; antimicrobial humoral response [GO:0019730]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094],NA,NA,NA
CHOYP_TBA1A.2.4.m.19573,-0.011553199,-0.003757919,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_TBA2.1.1.m.955,-0.015521576,-0.003240303,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; membrane raft [GO:0045121]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; regulation of synapse organization [GO:0050807],NA,NA,NA
CHOYP_TBA3.1.1.m.5111,0.000165904,-0.003582542,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_TBB.2.7.m.37919,0.01926793,-0.009298696,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764],NA,NA,NA
CHOYP_TBB.5.7.m.60062,0.003940886,-0.000604341,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; carbohydrate binding [GO:0030246]; galactoside binding [GO:0016936],NA,NA,NA
CHOYP_TBB2.1.2.m.45096,-0.011708167,-0.019930766,No,NA,NA,NA,NA,NA,NA,axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_TBB2.2.2.m.53000,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBB2.2.2.m.53001,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_TBB2.2.2.m.53003,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBB4.1.1.m.40048,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBB4B.1.7.m.12262,0.00784516,-0.0027244,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBB4B.3.7.m.22777,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; anion transmembrane transporter activity [GO:0008509]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; adult behavior [GO:0030534]; anion transmembrane transport [GO:0098656]; cellular response to extracellular stimulus [GO:0031668]; D-aspartate import across plasma membrane [GO:0070779]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neurotransmitter reuptake [GO:0098810]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; telencephalon development [GO:0021537]; visual behavior [GO:0007632],NA,NA,NA
CHOYP_TBB4B.7.7.m.63980,-0.016151106,0.004833697,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBC13.1.1.m.24396,-0.001399759,0.010020078,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_TBC15.1.1.m.4226,0.010805744,-0.019631214,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_TBC1D22A.1.1.m.24510,-0.01089822,-0.003787779,No,NA,NA,NA,NA,NA,NA,cell [GO:0005623]; 14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_TBCA.1.1.m.12075,0.006716338,-0.006161509,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; RNA binding [GO:0003723]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021],NA,NA,NA
CHOYP_TBCD.1.2.m.35202,-0.017789999,-0.002444966,No,NA,NA,NA,NA,NA,NA,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; GTPase activator activity [GO:0005096]; adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis involved in neuron differentiation [GO:0048667]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of microtubule polymerization [GO:0031115]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021],NA,NA,NA
CHOYP_TBCD1.1.1.m.14806,-0.003879986,-0.015429302,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cellular response to insulin stimulus [GO:0032869]; intracellular protein transport [GO:0006886]; negative regulation of vesicle fusion [GO:0031339]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_TBCE.1.1.m.14005,0.001395725,0.011562118,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; post-chaperonin tubulin folding pathway [GO:0007023],NA,NA,NA
CHOYP_TBCEL.2.2.m.26805,-0.005661796,-0.008732932,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],NA,NA,NA
CHOYP_TBG1.1.1.m.28190,-0.015404542,-0.011439981,No,NA,NA,NA,NA,NA,NA,apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; G2/M transition of mitotic cell cycle [GO:0000086]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],NA,NA,NA
CHOYP_TBL2.1.1.m.29917,0.00703201,-0.003000761,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; translation initiation factor binding [GO:0031369]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; endoplasmic reticulum unfolded protein response [GO:0030968],NA,NA,NA
CHOYP_TBRG4.1.1.m.48213,0.000121769,-0.02214667,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein kinase activity [GO:0004672]; cellular respiration [GO:0045333]; mitochondrial mRNA processing [GO:0090615]; mRNA metabolic process [GO:0016071]; regulation of mitochondrial mRNA stability [GO:0044528],NA,NA,NA
CHOYP_TC1DB.1.1.m.22354,-0.022788529,0.001040693,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_TCF25.1.1.m.28509,0.000686233,-0.010733133,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_TCFAP2B.2.2.m.11727,-0.022096466,0.009409904,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; anterior neuropore closure [GO:0021506]; basement membrane organization [GO:0071711]; bone morphogenesis [GO:0060349]; cellular response to iron ion [GO:0071281]; cornea development in camera-type eye [GO:0061303]; embryonic body morphogenesis [GO:0010172]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; embryonic pattern specification [GO:0009880]; epidermis morphogenesis [GO:0048730]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; forebrain neuron development [GO:0021884]; forelimb morphogenesis [GO:0035136]; inner ear morphogenesis [GO:0042472]; keratinocyte development [GO:0003334]; kidney development [GO:0001822]; lens induction in camera-type eye [GO:0060235]; lens morphogenesis in camera-type eye [GO:0002089]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neural tube closure [GO:0001843]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; outflow tract morphogenesis [GO:0003151]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of cell differentiation [GO:0045595]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; response to lipopolysaccharide [GO:0032496]; roof of mouth development [GO:0060021]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; sympathetic nervous system development [GO:0048485]; trigeminal nerve development [GO:0021559],NA,NA,NA
CHOYP_TCPB.1.1.m.6398,0.002598638,-0.009671832,No,NA,NA,NA,NA,NA,NA,cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; protein binding involved in protein folding [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone mediated protein folding independent of cofactor [GO:0051086]; chaperone-mediated protein complex assembly [GO:0051131]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_TCPD.1.1.m.13556,0.003377823,-0.007404643,No,NA,NA,NA,NA,NA,NA,chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; melanosome [GO:0042470]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457],NA,NA,NA
CHOYP_TCPG.1.1.m.30926,-0.007680766,0.001794403,No,NA,NA,NA,NA,NA,NA,chaperonin-containing T-complex [GO:0005832]; ATP binding [GO:0005524]; ATPase activity; coupled [GO:0042623]; unfolded protein binding [GO:0051082]; lumen formation; open tracheal system [GO:0035149]; protein folding [GO:0006457]; terminal branching; open tracheal system [GO:0007430],NA,NA,NA
CHOYP_TCPH.1.1.m.7312,-0.005522781,-0.013346754,No,NA,NA,NA,NA,NA,NA,chaperonin-containing T-complex [GO:0005832]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457],NA,NA,NA
CHOYP_TCPQ.1.1.m.57792,0.010063007,-0.013031673,No,NA,NA,NA,NA,NA,NA,cell projection [GO:0042995]; chaperonin-containing T-complex [GO:0005832]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457],NA,NA,NA
CHOYP_TCRG1.1.1.m.1150,-0.006307327,-0.010622515,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA polymerase binding [GO:0070063]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_TDRD1.1.1.m.34821,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TDRD3.1.2.m.3301,-0.001932028,0.0100771,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_TDRD3.2.2.m.8522,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TEFF2.1.1.m.26857,0.008658014,0.003514773,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TEKT3.1.1.m.37281,-0.022125243,0.002572007,No,NA,NA,NA,NA,NA,NA,acrosomal membrane [GO:0002080]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378],NA,NA,NA
CHOYP_TEKT5.1.1.m.60031,-0.009944647,0.00681217,No,NA,NA,NA,NA,NA,NA,acrosomal membrane [GO:0002080]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378],NA,NA,NA
CHOYP_TEKT5.1.1.m.60033,-0.01876424,-0.003301008,No,NA,NA,NA,NA,NA,NA,acrosomal membrane [GO:0002080]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378],NA,NA,NA
CHOYP_TEMPT.1.3.m.4934,0.023188151,0.002936875,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_TEMPT.2.3.m.39578,0.017697961,0.002146146,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TEMPT.3.3.m.40304,0.008155843,-0.023478181,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_TEN2.1.2.m.44821,-0.005763117,-0.014468603,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499],NA,NA,NA
CHOYP_TENA.5.5.m.43448,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TENS3.2.4.m.45659,0.009775823,0.006647753,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; RNA binding [GO:0003723]; cell-substrate junction assembly [GO:0007044]; fibroblast migration [GO:0010761],NA,NA,NA
CHOYP_TENS3.3.4.m.52970,0.01062526,-0.001207875,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; RNA binding [GO:0003723]; cell-substrate junction assembly [GO:0007044]; fibroblast migration [GO:0010761],NA,NA,NA
CHOYP_TENS3.4.4.m.60095,0.009070757,0.011085109,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; RNA binding [GO:0003723]; cell-substrate junction assembly [GO:0007044]; fibroblast migration [GO:0010761],NA,NA,NA
CHOYP_TENX.1.2.m.12929,0.01789049,0.002926351,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TERA.1.1.m.29200,0.010647702,0.009703073,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein hexamerization [GO:0034214]; protein N-linked glycosylation via asparagine [GO:0018279]; protein ubiquitination [GO:0016567]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_TEX10.2.3.m.28279,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; Rix1 complex [GO:0097344],NA,NA,NA
CHOYP_TF2AA.1.1.m.50726,-0.005019567,-0.018997907,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II repressing transcription factor binding [GO:0001103]; TBP-class protein binding [GO:0017025]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_TFCP2.1.2.m.11029,-0.02056849,0.001538509,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein C-terminus binding [GO:0008022]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; mRNA transcription by RNA polymerase II [GO:0042789]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_TFG.1.1.m.8487,0.020933694,0.006126217,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; Golgi membrane [GO:0000139]; identical protein binding [GO:0042802]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123],NA,NA,NA
CHOYP_TFP11.1.1.m.65838,-0.00787346,0.006166038,No,NA,NA,NA,NA,NA,NA,spliceosomal complex [GO:0005681]; nucleic acid binding [GO:0003676]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_TGM1.1.2.m.5148,0.016093336,-0.003500643,No,NA,NA,NA,NA,NA,NA,plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149],NA,NA,NA
CHOYP_TGME49_066610.1.1.m.2678,0.010353846,-0.000496239,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819],NA,NA,NA
CHOYP_THERJR_2510.1.1.m.38407,0.010086205,-0.018257487,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_THIKA.1.1.m.13333,0.001921134,0.009294432,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; peroxisome [GO:0005777]; acetyl-CoA C-acyltransferase activity [GO:0003988]; palmitoyl-CoA oxidase activity [GO:0016401]; fatty acid beta-oxidation [GO:0006635]; phenylacetate catabolic process [GO:0010124]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; response to steroid hormone [GO:0048545],NA,NA,NA
CHOYP_THNS1.1.1.m.28661,0.012234173,-0.002556448,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_THNS2.1.1.m.27131,0.002287461,0.012454877,No,NA,NA,NA,NA,NA,NA,lyase activity [GO:0016829],NA,NA,NA
CHOYP_THOC1.1.1.m.62740,-0.005835824,-0.017616732,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nuclear chromosome; telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; negative regulation of isotype switching to IgA isotypes [GO:0048297]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; regulation of DNA-templated transcription; elongation [GO:0032784]; replication fork processing [GO:0031297]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; viral mRNA export from host cell nucleus [GO:0046784],NA,NA,NA
CHOYP_THOC2.1.2.m.9631,0.004607459,-0.01723123,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; THO complex [GO:0000347]; RNA binding [GO:0003723]; generation of neurons [GO:0048699]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; neuron development [GO:0048666]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_THOC2.2.2.m.19049,0.006453581,-0.007380351,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; THO complex [GO:0000347]; RNA binding [GO:0003723]; generation of neurons [GO:0048699]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; neuron development [GO:0048666]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_THOC5.1.1.m.12880,-0.002638179,-0.006243657,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; THO complex part of transcription export complex [GO:0000445]; mRNA binding [GO:0003729]; cell differentiation [GO:0030154]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_THOC7.1.1.m.6771,0.00179916,-0.013624808,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; THO complex part of transcription export complex [GO:0000445]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_THOP1.1.1.m.18269,0.007470312,-0.004283849,No,NA,NA,NA,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; intracellular signal transduction [GO:0035556]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_THSD4.1.2.m.36522,0.004159008,-0.008751511,No,NA,NA,NA,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; microfibril [GO:0001527]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_THSD4.2.2.m.57001,0.006160607,-0.013469597,No,NA,NA,NA,NA,NA,NA,extracellular matrix [GO:0031012]; microfibril [GO:0001527]; peptidase activity [GO:0008233]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_THTR.1.1.m.25923,0.013955552,-0.01404823,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; 5S rRNA binding [GO:0008097]; thiosulfate sulfurtransferase activity [GO:0004792]; rRNA import into mitochondrion [GO:0035928]; rRNA transport [GO:0051029],NA,NA,NA
CHOYP_THTR.1.1.m.25924,-0.012678128,-0.022948614,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; apoptotic signaling pathway [GO:0097190]; cellular response to interferon-beta [GO:0035458]; cellular response to retinoic acid [GO:0071300]; extrinsic apoptotic signaling pathway [GO:0097191]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of protein catabolic process [GO:0045732]; protein import into mitochondrial inner membrane [GO:0045039]; reactive oxygen species metabolic process [GO:0072593],NA,NA,NA
CHOYP_THUM1.1.1.m.47876,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,RNA binding [GO:0003723]; tRNA modification [GO:0006400],NA,NA,NA
CHOYP_THUM3.1.1.m.17928,0.014116015,-0.007839786,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_TIAP2.12.13.m.62840,-0.012201335,0.002892057,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865],NA,NA,NA
CHOYP_TIF1A.3.8.m.12841,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TIF1A.4.8.m.23900,-0.017507423,0.01051679,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TIF1A.5.8.m.32570,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TIM8A.1.1.m.4787,0.00418695,-0.017598202,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; metal ion binding [GO:0046872]; chaperone-mediated protein transport [GO:0072321],NA,NA,NA
CHOYP_TIMP2B.1.1.m.29629,-0.01806077,0.018409604,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TIMP3.4.9.m.28669,-0.020778112,-0.005534584,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TIMP3.5.9.m.39776,0.018787234,-0.012960731,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TITIN.1.19.m.2116,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TITIN.19.19.m.66288,0.009968019,-0.005300962,No,NA,NA,NA,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_TITIN.4.19.m.19569,0.006432704,0.00677948,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; carbohydrate binding [GO:0030246]; CD4 receptor binding [GO:0042609]; IgM binding [GO:0001791]; protein phosphatase binding [GO:0019903]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; B cell activation [GO:0042113]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of immunoglobulin secretion [GO:0051025]; regulation of B cell proliferation [GO:0030888]; regulation of endocytosis [GO:0030100]; regulation of immune response [GO:0050776],NA,NA,NA
CHOYP_TITIN.6.19.m.31591,0.012942607,0.003180362,No,NA,NA,NA,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_TITIN.8.19.m.35861,-0.011778016,0.001677895,No,NA,NA,NA,NA,NA,NA,A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_TLE4.1.1.m.19069,-0.014692722,0.001672951,No,NA,NA,NA,NA,NA,NA,beta-catenin-TCF complex [GO:1990907]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_TLN1.4.4.m.33719,0.020434155,0.009832787,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeletal anchoring at plasma membrane [GO:0007016]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032],NA,NA,NA
CHOYP_TLN2.1.2.m.5591,-0.008387277,-0.00525211,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cell-cell junction assembly [GO:0007043]; cytoskeletal anchoring at plasma membrane [GO:0007016],NA,NA,NA
CHOYP_TLR1.1.3.m.1564,-0.002629139,0.008843395,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular [GO:0005622]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Toll-like receptor 2-Toll-like receptor 6 protein complex [GO:0035355]; amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; cell activation [GO:0001775]; cellular response to amyloid-beta [GO:1904646]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to bacterium [GO:0042742]; detection of diacyl bacterial lipopeptide [GO:0042496]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1 beta secretion [GO:0050702]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of interleukin-8 secretion [GO:2000483]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; nitric oxide metabolic process [GO:0046209]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-6 biosynthetic process [GO:0045410]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macrophage activation [GO:0043032]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; signal transduction [GO:0007165]; toll-like receptor 6 signaling pathway [GO:0034150]; toll-like receptor signaling pathway [GO:0002224]; toll-like receptor TLR6:TLR2 signaling pathway [GO:0038124]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666],NA,NA,NA
CHOYP_TM9S4.1.1.m.23520,-0.014062302,-0.003816302,No,NA,NA,NA,NA,NA,NA,early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072],NA,NA,NA
CHOYP_TMC3.1.1.m.4078,0.002064731,-0.00505612,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; ion channel activity [GO:0005216]; mechanosensitive ion channel activity [GO:0008381],NA,NA,NA
CHOYP_TMCO4.1.1.m.378,-0.011614311,-0.008947667,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_TMED7.1.3.m.6189,0.01097713,-0.023029926,No,NA,NA,NA,NA,NA,NA,COPI-coated vesicle membrane [GO:0030663]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_TMED7.2.3.m.28259,0.016684949,-0.002748933,No,NA,NA,NA,NA,NA,NA,COPI-coated vesicle membrane [GO:0030663]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_TMEDA.1.2.m.42794,0.020104054,-0.005092786,No,NA,NA,NA,NA,NA,NA,cis-Golgi network [GO:0005801]; COPI-coated vesicle [GO:0030137]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; COPI-coated vesicle budding [GO:0035964]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; protein complex oligomerization [GO:0051259]; regulated exocytosis [GO:0045055]; regulation of amyloid-beta formation [GO:1902003]; response to alkaloid [GO:0043279]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; vesicle targeting; to; from or within Golgi [GO:0048199],NA,NA,NA
CHOYP_TMEDA.1.2.m.42795,-0.004758704,-0.011238565,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TMEL_0889.1.2.m.168,0.015004182,0.01809075,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TMEM16.2.2.m.41752,0.003404019,-0.005844172,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; detection of mechanical stimulus [GO:0050982]; detection of temperature stimulus [GO:0016048],NA,NA,NA
CHOYP_TMEM2.1.4.m.6314,-0.009537576,-0.024515577,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; atrioventricular valve formation [GO:0003190]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in heart formation [GO:0060974]; cell migration to the midline involved in heart development [GO:0003318]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion development [GO:0003197]; heart looping [GO:0001947]; hyaluronan catabolic process [GO:0030214]; muscle attachment [GO:0016203]; muscle tissue morphogenesis [GO:0060415]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_TMEM2.2.4.m.8174,-0.02004808,0.000293179,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_TMEM2.3.4.m.10491,-0.022312172,0.006924822,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_TMEM2.4.4.m.28440,0.00573382,0.001713898,No,NA,NA,NA,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; atrioventricular valve formation [GO:0003190]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in heart formation [GO:0060974]; cell migration to the midline involved in heart development [GO:0003318]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion development [GO:0003197]; heart looping [GO:0001947]; hyaluronan catabolic process [GO:0030214]; muscle attachment [GO:0016203]; muscle tissue morphogenesis [GO:0060415]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_TMM98.1.1.m.51750,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_TMO_0856.1.3.m.5045,-0.004849864,0.018914388,No,NA,NA,NA,NA,NA,NA,3-hydroxybutyrate dehydrogenase activity [GO:0003858],NA,NA,NA
CHOYP_TNNC.1.1.m.66691,0.004665148,0.007999057,No,NA,NA,NA,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_TNNI.3.3.m.56962,-0.002014217,-0.001452791,No,NA,NA,NA,NA,NA,NA,troponin complex [GO:0005861]; actin binding [GO:0003779]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_TNPO1.1.1.m.8874,0.007589898,-0.018092553,No,NA,NA,NA,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nucleus [GO:0005634]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; intraciliary transport involved in cilium assembly [GO:0035735]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus; translocation [GO:0000060]; regulation of mRNA stability [GO:0043488]; ribosomal protein import into nucleus [GO:0006610]; viral process [GO:0016032],NA,NA,NA
CHOYP_TNPO3.1.1.m.11099,-0.003284819,-0.014193606,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; signaling receptor activity [GO:0038023]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_TNRC6A.1.2.m.16253,-0.010913411,0.005707423,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; micro-ribonucleoprotein complex [GO:0035068]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RNA binding [GO:0003723]; gene silencing by miRNA [GO:0035195]; miRNA mediated inhibition of translation [GO:0035278]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; posttranscriptional gene silencing by RNA [GO:0035194]; regulation of megakaryocyte differentiation [GO:0045652]; Wnt signaling pathway; calcium modulating pathway [GO:0007223],NA,NA,NA
CHOYP_TNRC6A.2.2.m.59802,-0.007229881,0.003940004,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; micro-ribonucleoprotein complex [GO:0035068]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RNA binding [GO:0003723]; gene silencing by miRNA [GO:0035195]; miRNA mediated inhibition of translation [GO:0035278]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; posttranscriptional gene silencing by RNA [GO:0035194]; regulation of megakaryocyte differentiation [GO:0045652]; Wnt signaling pathway; calcium modulating pathway [GO:0007223],NA,NA,NA
CHOYP_TOL2_C08810.1.1.m.6377,-0.015452697,-0.003177882,No,NA,NA,NA,NA,NA,NA,carboxyl-O-methyltransferase activity [GO:0010340]; malonyl-CoA methyltransferase activity [GO:0102130]; methyl indole-3-acetate esterase activity [GO:0080030]; biotin biosynthetic process [GO:0009102],NA,NA,NA
CHOYP_TOLIP.1.1.m.57590,0.016695005,0.008956353,No,NA,NA,NA,NA,NA,NA,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; interleukin-1 receptor complex [GO:0045323]; interleukin-18 receptor complex [GO:0045092]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; specific granule lumen [GO:0035580]; interleukin-1; type I receptor binding [GO:0005150]; kinase binding [GO:0019900]; SUMO binding [GO:0032183]; Toll-like receptor binding [GO:0035325]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; autophagy [GO:0006914]; cell-cell signaling [GO:0007267]; epithelial cell differentiation [GO:0030855]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; leukocyte activation [GO:0045321]; neutrophil degranulation [GO:0043312]; phosphorylation [GO:0016310]; positive regulation of protein sumoylation [GO:0033235]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_TOLL.1.1.1.m.37581,0.001563246,-0.017905026,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TOM20.1.1.m.11207,0.011193358,-0.004989535,No,NA,NA,NA,NA,NA,NA,integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion targeting sequence binding [GO:0030943]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; mitochondrial outer membrane translocase complex assembly [GO:0070096]; protein import into mitochondrial matrix [GO:0030150]; tRNA import into mitochondrion [GO:0016031],NA,NA,NA
CHOYP_TOMM70A.1.1.m.42370,0.02160293,-0.007648296,No,NA,NA,NA,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; protein transmembrane transporter activity [GO:0008320]; protein targeting to mitochondrion [GO:0006626],NA,NA,NA
CHOYP_TONSL.1.1.m.18360,-0.003258129,-0.000934259,No,NA,NA,NA,NA,NA,NA,nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_TOP1.5.5.m.61515,-0.009552052,-0.016602571,No,NA,NA,NA,NA,NA,NA,DNA topoisomerase complex (ATP-hydrolyzing) [GO:0009330]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perikaryon [GO:0043204]; protein-DNA complex [GO:0032993]; replication fork protection complex [GO:0031298]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type I activity [GO:0003917]; double-stranded DNA binding [GO:0003690]; protein domain specific binding [GO:0019904]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]; chromatin remodeling [GO:0006338]; chromosome segregation [GO:0007059]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; programmed cell death [GO:0012501]; response to drug [GO:0042493]; viral process [GO:0016032],NA,NA,NA
CHOYP_TOP2B.1.1.m.6674,0.008721328,-0.018812152,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; viral integration complex [GO:0019035]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type II (ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase C binding [GO:0005080]; ribonucleoprotein complex binding [GO:0043021]; axonogenesis [GO:0007409]; cell aging [GO:0007569]; cellular response to ATP [GO:0071318]; cellular response to hydrogen peroxide [GO:0070301]; DNA topological change [GO:0006265]; forebrain development [GO:0030900]; mitotic DNA integrity checkpoint [GO:0044774]; neuron migration [GO:0001764]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; resolution of meiotic recombination intermediates [GO:0000712]; sister chromatid segregation [GO:0000819],NA,NA,NA
CHOYP_TOP3B.1.1.m.1654,-0.003339325,-0.012241595,No,NA,NA,NA,NA,NA,NA,condensed chromosome [GO:0000793]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I activity [GO:0003917]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; DNA topological change [GO:0006265],NA,NA,NA
CHOYP_TPC2.1.2.m.19378,-0.007790629,-0.006624536,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; NAADP-sensitive calcium-release channel activity [GO:0072345]; voltage-gated calcium channel activity [GO:0005245]; calcium-mediated signaling [GO:0019722]; regulation of ion transmembrane transport [GO:0034765]; regulation of myotome development [GO:2000290]; skeletal myofibril assembly [GO:0014866]; smooth muscle contraction [GO:0006939],NA,NA,NA
CHOYP_TPM.15.19.m.50851,-0.007240823,0.010723091,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_TPM.17.19.m.63919,0.015942777,0.000640495,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_TPM.18.19.m.66023,-0.014164574,0.000172128,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_TPM.19.19.m.66623,0.020585348,-0.014152716,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_TPM.6.19.m.12415,0.013304459,0.021817218,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_TPM.7.19.m.15554,-0.008357585,-0.015293329,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription factor complex [GO:0090575]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; epithelial to mesenchymal transition [GO:0001837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_TPM2.8.8.m.50799,-0.00506796,0.002030653,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_TPP2.1.1.m.24017,0.016778478,0.001402918,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_TPPC3.1.1.m.58563,0.007795346,-0.017697783,No,NA,NA,NA,NA,NA,NA,cis-Golgi network membrane [GO:0033106]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; TRAPP complex [GO:0030008]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891],NA,NA,NA
CHOYP_TPPC8.1.1.m.6302,0.011425541,0.008990261,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; autophagosome assembly [GO:0000045]; autophagy of peroxisome [GO:0030242]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein localization by the Cvt pathway [GO:0032258]; protein localization to phagophore assembly site [GO:0034497],NA,NA,NA
CHOYP_TPR.1.2.m.29645,0.009803789,0.011385171,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; chromatin binding [GO:0003682]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; structural constituent of nuclear pore [GO:0017056]; cell division [GO:0051301]; cellular response to heat [GO:0034605]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404],NA,NA,NA
CHOYP_TPR.2.2.m.46877,0.009898224,-0.013933949,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631]; cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404],NA,NA,NA
CHOYP_TR12A.1.2.m.32633,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRA2A.1.1.m.21305,-0.009348209,-0.008464819,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; response to reactive oxygen species [GO:0000302],NA,NA,NA
CHOYP_TRAP1.1.1.m.60651,0.011500307,-0.02107971,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; translational attenuation [GO:0009386],NA,NA,NA
CHOYP_TRD7B.1.1.m.56981,-0.010070173,-0.004168917,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ribonucleoprotein granule [GO:0035770]; mRNA binding [GO:0003729]; lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; posttranscriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_TRI10.1.1.m.35702,-0.00989846,0.0026633,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRI33.5.8.m.56889,0.014038845,0.017861019,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRI45.13.23.m.35793,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral release from host cell [GO:1902187]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_TRI45.18.23.m.48495,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRI46.2.3.m.61659,-0.008353797,-0.00415869,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_TRI56.4.4.m.61739,-0.007579055,-0.015589809,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_TRIADDRAFT_19804.1.1.m.8993,-0.00247786,0.013240694,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_TRIADDRAFT_21078.2.2.m.64279,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,deoxyribonuclease IV (phage-T4-induced) activity [GO:0008833]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284],NA,NA,NA
CHOYP_TRIADDRAFT_21752.1.1.m.62548,-0.011597256,-0.003708839,No,NA,NA,NA,NA,NA,NA,3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3';5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542],NA,NA,NA
CHOYP_TRIADDRAFT_23075.1.1.m.48886,0.00709811,0.012399085,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; molybdopterin synthase activity [GO:0030366]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324],NA,NA,NA
CHOYP_TRIADDRAFT_25769.1.1.m.25945,-0.00876149,0.003444285,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031],NA,NA,NA
CHOYP_TRIADDRAFT_26208.1.1.m.10460,-0.008311364,0.007989163,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; peroxisomal matrix [GO:0005782]; alanine-glyoxylate transaminase activity [GO:0008453]; amino acid binding [GO:0016597]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; pyridoxal phosphate binding [GO:0030170]; serine-pyruvate transaminase activity [GO:0004760]; signaling receptor binding [GO:0005102]; glycine biosynthetic process; by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process [GO:0042853]; L-cysteine catabolic process [GO:0019448]; Notch signaling pathway [GO:0007219]; oxalic acid secretion [GO:0046724],NA,NA,NA
CHOYP_TRIADDRAFT_26518.1.1.m.16475,-2.10E-05,-0.013487841,No,NA,NA,NA,NA,NA,NA,Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_TRIADDRAFT_26633.4.6.m.50465,0.005302164,-0.021106303,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_TRIADDRAFT_29967.1.1.m.56654,-0.00710377,0.000911483,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; ceramidase activity [GO:0102121]; N-acylsphingosine amidohydrolase activity [GO:0017040]; ceramide catabolic process [GO:0046514]; ceramide metabolic process [GO:0006672]; long-chain fatty acid biosynthetic process [GO:0042759]; sphingosine biosynthetic process [GO:0046512],NA,NA,NA
CHOYP_TRIADDRAFT_29994.1.1.m.48948,-0.014735756,-0.017030119,No,NA,NA,NA,NA,NA,NA,defense response [GO:0006952]; response to biotic stimulus [GO:0009607],NA,NA,NA
CHOYP_TRIADDRAFT_32712.2.4.m.28430,-0.022662609,0.010251994,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_TRIADDRAFT_32712.3.4.m.44104,-0.018784715,-0.0002622,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_TRIADDRAFT_32712.4.4.m.44519,0.022068668,-0.011144548,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_TRIADDRAFT_37121.1.1.m.51940,-0.005637793,-0.012609513,No,NA,NA,NA,NA,NA,NA,intracellular [GO:0005622]; photoreceptor inner segment [GO:0001917]; retinol dehydrogenase activity [GO:0004745]; response to stimulus [GO:0050896]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601],NA,NA,NA
CHOYP_TRIADDRAFT_38448.1.1.m.27929,0.022851396,0.000727691,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_TRIADDRAFT_49883.1.1.m.29857,-0.022452673,-0.005660489,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; angiogenesis [GO:0001525]; glutamine biosynthetic process [GO:0006542]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_TRIADDRAFT_50333.1.1.m.59774,-0.020068353,-0.007898068,No,NA,NA,NA,NA,NA,NA,basal plasma membrane [GO:0009925],NA,NA,NA
CHOYP_TRIADDRAFT_51343.2.2.m.65118,0.005589563,-0.005802205,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_TRIADDRAFT_52608.1.2.m.25467,-0.001473669,0.003872621,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_TRIADDRAFT_53531.1.2.m.12127,-0.004379591,-0.013277704,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_TRIADDRAFT_53596.1.1.m.47642,-0.002642544,-0.012619669,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; acrosome reaction [GO:0007340]; detection of mechanical stimulus [GO:0050982],NA,NA,NA
CHOYP_TRIADDRAFT_53677.1.1.m.35290,0.001727369,-0.014275555,No,NA,NA,NA,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; lipid transporter activity [GO:0005319]; cholesterol efflux [GO:0033344]; high-density lipoprotein particle remodeling [GO:0034375]; lipid transport [GO:0006869]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; reverse cholesterol transport [GO:0043691]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_TRIADDRAFT_55241.1.1.m.41679,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; rough endoplasmic reticulum [GO:0005791]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; inositol 1;4;5 trisphosphate binding [GO:0070679]; inositol 1;4;5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; release of sequestered calcium ion into cytosol [GO:0051209],NA,NA,NA
CHOYP_TRIADDRAFT_55525.1.1.m.53631,-0.019007671,-0.009985637,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; drug binding [GO:0008144]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731]; immune response [GO:0006955]; inosine catabolic process [GO:0006148]; interleukin-2 secretion [GO:0070970]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; neutrophil degranulation [GO:0043312]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of T cell proliferation [GO:0042102]; purine nucleotide catabolic process [GO:0006195]; purine-containing compound salvage [GO:0043101]; response to drug [GO:0042493]; urate biosynthetic process [GO:0034418],NA,NA,NA
CHOYP_TRIADDRAFT_55768.1.2.m.4473,-0.001664718,0.015951145,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase inhibitor activity [GO:0004867]; eye development [GO:0001654],NA,NA,NA
CHOYP_TRIADDRAFT_55768.2.2.m.14361,0.019161054,-0.015366518,No,NA,NA,NA,NA,NA,NA,anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616],NA,NA,NA
CHOYP_TRIADDRAFT_57018.1.2.m.10706,-0.004701448,-0.001687049,No,NA,NA,NA,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide catabolic process [GO:0009166],NA,NA,NA
CHOYP_TRIADDRAFT_57086.1.1.m.25271,-0.00500068,-0.009267346,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; actin binding [GO:0003779]; actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301],NA,NA,NA
CHOYP_TRIADDRAFT_57945.3.3.m.55640,0.000394976,-0.021798007,No,NA,NA,NA,NA,NA,NA,actomyosin [GO:0042641]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_TRIADDRAFT_60787.1.1.m.6621,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,RNA polymerase I core factor complex [GO:0070860]; metal ion binding [GO:0046872]; RNA polymerase I CORE element sequence-specific DNA binding [GO:0001164]; RNA polymerase I preinitiation complex assembly [GO:0001188],NA,NA,NA
CHOYP_TRIADDRAFT_61434.1.1.m.8434,0.004053209,-0.017940191,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIADDRAFT_62546.1.2.m.5483,0.018022787,-0.00215671,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIADDRAFT_62546.2.2.m.56798,0.007594635,0.01456187,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIADDRAFT_63204.1.2.m.30701,0.018808784,0.015739375,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; (R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; pyridoxal phosphate binding [GO:0030170]; glycine biosynthetic process; by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; L-alanine catabolic process; by transamination [GO:0019481]; positive regulation of nitric oxide biosynthetic process [GO:0045429],NA,NA,NA
CHOYP_TRIADDRAFT_63204.2.2.m.38038,0.017211888,-0.010670472,No,NA,NA,NA,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; (R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; pyridoxal phosphate binding [GO:0030170]; glycine biosynthetic process; by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; L-alanine catabolic process; by transamination [GO:0019481]; positive regulation of nitric oxide biosynthetic process [GO:0045429],NA,NA,NA
CHOYP_TRIADDRAFT_63666.3.3.m.57696,-0.00672057,-0.012055041,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIADDRAFT_64314.1.2.m.9124,0.004272208,-0.022618132,No,NA,NA,NA,NA,NA,NA,NAD(P)H dehydrogenase (quinone) activity [GO:0003955],NA,NA,NA
CHOYP_TRIADDRAFT_64314.2.2.m.54695,-0.005409658,0.011818275,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIADDRAFT_64367.1.1.m.42126,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815],NA,NA,NA
CHOYP_TRIB2.1.1.m.226,0.008133093,0.00619771,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIM2.16.59.m.31979,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIM2.42.59.m.43682,-0.012585876,0.007893821,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIM33.1.1.m.36639,0.005445341,-0.007080601,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015],NA,NA,NA
CHOYP_TRIM5.1.2.m.60878,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIM56.2.2.m.59948,-0.020313208,0.003477062,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_TRIO.1.1.m.49282,-0.003764533,-0.023572126,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; negative regulation of fat cell differentiation [GO:0045599]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_TRIPC.1.1.m.6424,-0.014665364,0.00448921,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; thyroid hormone receptor binding [GO:0046966]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_TRM13.1.1.m.16853,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872]; tRNA 2'-O-methyltransferase activity [GO:0106050]; tRNA methyltransferase activity [GO:0008175]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_TRM5.1.1.m.24347,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; tRNA (guanine(37)-N(1))-methyltransferase activity [GO:0052906]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA methyltransferase activity [GO:0008175]; mitochondrial tRNA methylation [GO:0070901]; tRNA methylation [GO:0030488]; tRNA N1-guanine methylation [GO:0002939],NA,NA,NA
CHOYP_TRMT2A.1.1.m.17768,0.002725055,-0.010882596,No,NA,NA,NA,NA,NA,NA,RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_TRMT6.1.1.m.8062,0.000284902,-0.014962374,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]; mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_TRNT1.1.1.m.1512,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity [GO:0052929]; CTP:3'-cytidine-tRNA cytidylyltransferase activity [GO:0052928]; CTP:tRNA cytidylyltransferase activity [GO:0052927]; tRNA binding [GO:0000049]; tRNA nucleotidyltransferase activity [GO:0009022]; mitochondrial tRNA 3'-end processing [GO:1990180]; tRNA 3'-terminal CCA addition [GO:0001680]; tRNA processing [GO:0008033],NA,NA,NA
CHOYP_TRPM3.1.7.m.9000,-0.009203479,0.008096433,No,NA,NA,NA,NA,NA,NA,cation channel complex [GO:0034703]; divalent inorganic cation transmembrane transporter activity [GO:0072509]; intracellular phosphatidylinositol-3;5-bisphosphate-sensitive cation channel activity [GO:0097682]; zinc ion transmembrane transporter activity [GO:0005385]; cation transmembrane transport [GO:0098655]; divalent metal ion transport [GO:0070838]; magnesium ion homeostasis [GO:0010960]; protein tetramerization [GO:0051262]; zinc ion homeostasis [GO:0055069],NA,NA,NA
CHOYP_TRPM3.3.7.m.16169,0.005295246,-0.006800783,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; detection of temperature stimulus [GO:0016048]; protein tetramerization [GO:0051262]; sensory perception of temperature stimulus [GO:0050951],NA,NA,NA
CHOYP_TRPM3.7.7.m.59826,0.00535421,-0.006220338,No,NA,NA,NA,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; detection of temperature stimulus [GO:0016048]; protein tetramerization [GO:0051262]; sensory perception of temperature stimulus [GO:0050951],NA,NA,NA
CHOYP_TRRAP.1.2.m.339,0.008596482,-0.012500172,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; SAGA complex [GO:0000124]; transcription coregulator activity [GO:0003712]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H3 acetylation [GO:0043966]; mitotic cytokinesis [GO:0000281]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351]; wing disc pattern formation [GO:0035222],NA,NA,NA
CHOYP_TRXR2.1.1.m.10443,-0.006236654,0.003368479,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; protein homodimerization activity [GO:0042803]; thioredoxin-disulfide reductase activity [GO:0004791]; cell redox homeostasis [GO:0045454]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; response to oxygen radical [GO:0000305],NA,NA,NA
CHOYP_TS101.4.4.m.57290,-0.00237167,0.004270203,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; nuclear receptor transcription coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; negative regulation of cell proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral process [GO:0048524]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; regulation of viral budding via host ESCRT complex [GO:1903772]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755],NA,NA,NA
CHOYP_TSC1.1.1.m.5136,0.007570409,-0.007753655,No,NA,NA,NA,NA,NA,NA,actin filament [GO:0005884]; cell cortex [GO:0005938]; cell projection [GO:0042995]; chaperone complex [GO:0101031]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; TSC1-TSC2 complex [GO:0033596]; ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]; GTPase activating protein binding [GO:0032794]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein N-terminus binding [GO:0047485]; activation of GTPase activity [GO:0090630]; adaptive immune response [GO:0002250]; adult locomotory behavior [GO:0008344]; cardiac muscle cell differentiation [GO:0055007]; cell projection organization [GO:0030030]; cell-matrix adhesion [GO:0007160]; cellular response to oxygen-glucose deprivation [GO:0090650]; cerebral cortex development [GO:0021987]; glucose import [GO:0046323]; hippocampus development [GO:0021766]; kidney development [GO:0001822]; memory T cell differentiation [GO:0043379]; myelination [GO:0042552]; negative regulation of ATPase activity [GO:0032780]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of TOR signaling [GO:0032007]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of macroautophagy [GO:0016239]; positive regulation of stress fiber assembly [GO:0051496]; potassium ion transport [GO:0006813]; protein heterooligomerization [GO:0051291]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of focal adhesion assembly [GO:0051893]; regulation of neuron death [GO:1901214]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of protein kinase activity [GO:0045859]; response to insulin [GO:0032868]; rRNA export from nucleus [GO:0006407]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_TSIB_0893.1.1.m.10314,-0.008214332,0.000115312,No,NA,NA,NA,NA,NA,NA,L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; nucleotide binding [GO:0000166]; pyridoxal phosphate binding [GO:0030170]; L-threonine catabolic process to propionate [GO:0070689],NA,NA,NA
CHOYP_TSN3.1.1.m.57074,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166]; multicellular organism development [GO:0007275]; pigmentation [GO:0043473],NA,NA,NA
CHOYP_TSP_00320.1.1.m.7280,-0.006362012,0.003935175,No,NA,NA,NA,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear speck [GO:0016607]; double-stranded DNA binding [GO:0003690]; ribonucleoprotein complex binding [GO:0043021]; activation of innate immune response [GO:0002218]; alternative mRNA splicing; via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; neuron projection development [GO:0031175]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of dendrite morphogenesis [GO:0048814]; regulation of RNA splicing [GO:0043484],NA,NA,NA
CHOYP_TSP_02835.1.1.m.26375,-0.015502091,-0.009918618,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; fatty acid binding [GO:0005504],NA,NA,NA
CHOYP_TSP_03740.1.1.m.61194,0.02107834,-0.008515159,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of collagen fibril organization [GO:1904027]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_TSP_06726.1.1.m.7470,-0.00799576,-0.002368768,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; chaperone complex [GO:0101031]; dendritic microtubule [GO:1901588]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; tau protein binding [GO:0048156]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of protein binding [GO:0032091]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein processing [GO:0010954]; protein metabolic process [GO:0019538]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_TSP_07884.1.1.m.41175,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; neurogenesis [GO:0022008]; post-translational protein modification [GO:0043687],NA,NA,NA
CHOYP_TSP_09282.1.1.m.18814,-0.012858071,-0.005634091,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TSP_10783.1.2.m.5651,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TSP_10831.1.1.m.47028,-0.022639641,0.010154264,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; molting cycle; collagen and cuticulin-based cuticle [GO:0018996]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_TSP1.1.1.m.43967,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_TSPAN18A.2.2.m.50689,0.007038896,-0.004154923,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TSSC1.1.1.m.66470,-0.001565297,-0.00774132,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_TT30A.1.1.m.28332,-0.014077714,-0.001475305,No,NA,NA,NA,NA,NA,NA,axonemal microtubule [GO:0005879]; cilium [GO:0005929]; transporter activity [GO:0005215]; intraciliary transport [GO:0042073]; protein polyglutamylation [GO:0018095],NA,NA,NA
CHOYP_TT39C.1.1.m.6317,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_TTC1.1.2.m.53162,-0.000326727,-0.016358822,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829],NA,NA,NA
CHOYP_TTC12.1.1.m.14571,0.000112308,-0.012531798,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813],NA,NA,NA
CHOYP_TTC14.1.1.m.54084,-0.00225318,0.000789325,No,NA,NA,NA,NA,NA,NA,nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_TTC28.1.1.m.51607,0.00879795,0.007239654,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; kinase binding [GO:0019900]; cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346],NA,NA,NA
CHOYP_TTC38.1.1.m.27111,0.015379025,-0.010592588,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_TTC4.1.1.m.16365,0.002721999,-0.015093341,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_TTC8.1.1.m.35457,-0.011704562,0.015189396,No,NA,NA,NA,NA,NA,NA,BBSome [GO:0034464]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytosol [GO:0005829]; non-motile cilium [GO:0097730]; RNA polymerase II repressing transcription factor binding [GO:0001103]; cilium assembly [GO:0060271]; establishment of anatomical structure orientation [GO:0048560]; non-motile cilium assembly [GO:1905515]; protein transport [GO:0015031]; sensory processing [GO:0050893],NA,NA,NA
CHOYP_TTHERM_00599920.1.1.m.38926,0.00491589,-0.000600715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TTL11.1.1.m.51011,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_TTL12.1.1.m.6226,0.015311181,-0.002588761,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; cellular protein modification process [GO:0006464],NA,NA,NA
CHOYP_TTN.2.9.m.17508,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_TUT4.2.2.m.35505,-0.007968453,0.013012557,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; zinc ion binding [GO:0008270]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; negative regulation of transposition; RNA-mediated [GO:0010526]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_TVAG_008910.1.4.m.27225,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_008910.2.4.m.37672,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_012450.7.8.m.63509,-0.012006385,-0.000849085,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_020440.14.21.m.33137,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_TVAG_087170.4.8.m.31291,0.004815594,0.007830696,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_087170.6.8.m.41156,-0.004177313,-0.016591245,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_087500.3.4.m.52917,-0.007755135,0.006109488,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_087500.4.4.m.60594,0.006539723,-0.000361627,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_098350.1.1.m.14015,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_106580.1.1.m.44429,0.019778002,-0.013735282,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_TVAG_110290.2.8.m.6221,-0.005131204,0.008972586,No,NA,NA,NA,NA,NA,NA,cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; chromosome [GO:0005694]; cortical microtubule [GO:0055028]; cytoplasm [GO:0005737]; cytoplasmic microtubule bundle [GO:1905720]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; Golgi membrane [GO:0000139]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; microtubule bundle [GO:0097427]; microtubule minus-end [GO:0036449]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; spindle pole centrosome [GO:0031616]; disordered domain specific binding [GO:0097718]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; microtubule plus-end binding [GO:0051010]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; tubulin binding [GO:0015631]; anastral spindle assembly [GO:0055048]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; meiotic cell cycle [GO:0051321]; microtubule bundle formation [GO:0001578]; nucleus organization [GO:0006997]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; positive regulation of hair follicle development [GO:0051798]; positive regulation of intracellular transport [GO:0032388]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of mitotic spindle elongation [GO:1902846]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of protein localization to spindle pole body [GO:1902365]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236],NA,NA,NA
CHOYP_TVAG_117920.1.1.m.65694,0.008586697,-0.002577675,No,NA,NA,NA,NA,NA,NA,guanosine tetraphosphate metabolic process [GO:0015969],NA,NA,NA
CHOYP_TVAG_127540.1.10.m.21803,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_166520.1.2.m.37665,0.005205659,0.002579464,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_168130.1.2.m.10205,-0.022271812,0.01065478,No,NA,NA,NA,NA,NA,NA,cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133],NA,NA,NA
CHOYP_TVAG_193760.1.4.m.10065,0.008875235,-0.009413593,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_199400.1.1.m.52426,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_216960.2.4.m.29368,-0.009936273,-0.015081596,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_268110.1.13.m.574,0.010990916,-0.006526443,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; transcription regulatory region DNA binding [GO:0044212]; tubulin binding [GO:0015631]; brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664],NA,NA,NA
CHOYP_TVAG_268110.13.13.m.65590,0.012319292,0.023331731,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_283050.1.1.m.65542,0.003625266,0.000263477,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome regulatory particle assembly [GO:0070682]; protein deubiquitination [GO:0016579],NA,NA,NA
CHOYP_TVAG_286470.1.2.m.41541,-0.01050012,0.001692439,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_313830.1.4.m.32667,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; antimicrobial humoral response [GO:0019730]; compound eye photoreceptor cell differentiation [GO:0001751]; flight [GO:0060361]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy of mitochondrion [GO:1903147]; sarcomere organization [GO:0045214]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_TVAG_355490.1.22.m.8202,0.011868292,0.00322256,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.12.22.m.45126,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.15.22.m.47579,-0.01506804,-0.017392104,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.16.22.m.50235,-0.004342837,-0.008164521,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.19.22.m.56184,-0.004055705,0.010248414,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.2.22.m.9582,-0.001236671,-0.007729229,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; centrosome [GO:0005813]; chromosome; centromeric region [GO:0000775]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; condensed chromosome outer kinetochore [GO:0000940]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; transcription factor binding [GO:0008134]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cell proliferation [GO:0008283]; chromosome segregation [GO:0007059]; DNA biosynthetic process [GO:0071897]; kidney development [GO:0001822]; kinetochore assembly [GO:0051382]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; muscle organ development [GO:0007517]; negative regulation of transcription; DNA-templated [GO:0045892]; protein transport [GO:0015031]; regulation of cell cycle [GO:0051726]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of striated muscle tissue development [GO:0016202]; response to drug [GO:0042493]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_TVAG_355490.3.22.m.9919,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.4.22.m.10865,0.000336712,-0.018739658,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.5.22.m.11608,-0.008848644,-0.011655636,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.6.22.m.13410,-0.016920473,-0.00358143,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.7.22.m.16997,0.004313197,0.00420767,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_399490.1.3.m.7885,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_399490.2.3.m.26257,-0.006144623,0.019550752,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_407710.2.4.m.6401,-0.014167404,0.011244385,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_407710.4.4.m.62673,0.020316862,0.001978945,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_410100.4.6.m.41037,-0.016630266,-0.004971376,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_417100.1.2.m.19129,0.004795043,-0.009869172,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_480920.2.3.m.38258,0.005611508,-0.003966829,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TWF1.1.1.m.62154,0.004886907,0.010096431,No,NA,NA,NA,NA,NA,NA,actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; myofibril [GO:0030016]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; actin filament depolymerization [GO:0030042]; barbed-end actin filament capping [GO:0051016]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of neuron projection development [GO:0010976]; regulation of actin phosphorylation [GO:0043538]; regulation of lamellipodium assembly [GO:0010591]; sequestering of actin monomers [GO:0042989],NA,NA,NA
CHOYP_TXN4A.1.2.m.59542,-0.000922399,0.005598916,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_TXND3.1.4.m.3505,-0.019097214,0.003730813,No,NA,NA,NA,NA,NA,NA,cell [GO:0005623]; nucleoside diphosphate kinase activity [GO:0004550]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228],NA,NA,NA
CHOYP_TXND3.2.4.m.21415,-0.017535882,0.014112824,No,NA,NA,NA,NA,NA,NA,cell [GO:0005623]; nucleoside diphosphate kinase activity [GO:0004550]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228],NA,NA,NA
CHOYP_TXND3.4.4.m.64014,0.021350151,-0.011504353,No,NA,NA,NA,NA,NA,NA,cell [GO:0005623]; nucleoside diphosphate kinase activity [GO:0004550]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228],NA,NA,NA
CHOYP_TXNDC9.1.1.m.22863,-0.018557825,0.000182747,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_TYRO.1.1.m.38876,0.020389604,-0.010824984,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_TYRO1.2.6.m.42960,0.005849371,-0.025960031,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_TYRO1.5.6.m.44175,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_TYRO1.6.6.m.44318,0.02219701,-0.013206488,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_U2AF2.1.1.m.30416,0.002937257,-0.006628476,No,NA,NA,NA,NA,NA,NA,commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF [GO:0089701]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_U5S1.1.1.m.49230,-0.008316752,-0.024482675,No,NA,NA,NA,NA,NA,NA,Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U5 snRNA binding [GO:0030623]; cellular response to drug [GO:0035690]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; response to cocaine [GO:0042220]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_U728.1.1.m.63184,-0.015546314,-0.013459353,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_UAFA.3.8.m.34702,-0.000761423,0.012536173,No,NA,NA,NA,NA,NA,NA,apical distal dendrite [GO:0150014]; axon hillock [GO:0043203]; axon initial segment [GO:0043194]; basal dendrite [GO:0097441]; CA3 pyramidal cell dendrite [GO:0097442]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic branch [GO:0044307]; dendritic filopodium [GO:1902737]; dendritic growth cone [GO:0044294]; dendritic shaft [GO:0043198]; distal dendrite [GO:0150002]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; primary dendrite [GO:0150001]; proximal dendrite [GO:1990635]; proximal neuron projection [GO:1990769]; calmodulin binding [GO:0005516]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; axonogenesis [GO:0007409]; cellular response to organic substance [GO:0071310]; central nervous system neuron development [GO:0021954]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; establishment of cell polarity [GO:0030010]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of axon extension [GO:0030517]; negative regulation of microtubule binding [GO:1904527]; negative regulation of microtubule motor activity [GO:2000575]; negative regulation of microtubule polymerization [GO:0031115]; neuron projection development [GO:0031175]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of anterograde synaptic vesicle transport [GO:1903744]; regulation of cellular protein localization [GO:1903827]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle transport along microtubule [GO:1902513],NA,NA,NA
CHOYP_UAFA.6.8.m.45002,-0.010864532,-0.004494266,No,NA,NA,NA,NA,NA,NA,apical distal dendrite [GO:0150014]; axon hillock [GO:0043203]; axon initial segment [GO:0043194]; basal dendrite [GO:0097441]; CA3 pyramidal cell dendrite [GO:0097442]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic branch [GO:0044307]; dendritic filopodium [GO:1902737]; dendritic growth cone [GO:0044294]; dendritic shaft [GO:0043198]; distal dendrite [GO:0150002]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; primary dendrite [GO:0150001]; proximal dendrite [GO:1990635]; proximal neuron projection [GO:1990769]; calmodulin binding [GO:0005516]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; axonogenesis [GO:0007409]; cellular response to organic substance [GO:0071310]; central nervous system neuron development [GO:0021954]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; establishment of cell polarity [GO:0030010]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of axon extension [GO:0030517]; negative regulation of microtubule binding [GO:1904527]; negative regulation of microtubule motor activity [GO:2000575]; negative regulation of microtubule polymerization [GO:0031115]; neuron projection development [GO:0031175]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of anterograde synaptic vesicle transport [GO:1903744]; regulation of cellular protein localization [GO:1903827]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle transport along microtubule [GO:1902513],NA,NA,NA
CHOYP_UB2D2.1.1.m.56387,0.006113486,-0.010052585,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; transferase activity [GO:0016740]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_UB2G2.1.1.m.7534,-0.011276194,0.001242259,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936]; protein N-linked glycosylation via asparagine [GO:0018279]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_UB2R2.1.1.m.18979,-0.008566737,0.002963277,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cellular response to interferon-beta [GO:0035458]; negative regulation of cAMP-mediated signaling [GO:0043951]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of neuron apoptotic process [GO:0043525]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBA1.2.2.m.30036,0.002883128,0.019791642,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; desmosome [GO:0030057]; endosome membrane [GO:0010008]; heterochromatin [GO:0000792]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]; ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]; cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_UBA3.1.1.m.59856,0.003711165,-0.009034881,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; acid-amino acid ligase activity [GO:0016881]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NEDD8 activating enzyme activity [GO:0019781]; nuclear receptor binding [GO:0016922]; protein heterodimerization activity [GO:0046982]; endomitotic cell cycle [GO:0007113]; mitotic cell cycle [GO:0000278]; negative regulation of transcription; DNA-templated [GO:0045892]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]; regulation of cell cycle [GO:0051726],NA,NA,NA
CHOYP_UBA5.1.2.m.8624,0.013688825,-0.01365463,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; UFM1 activating enzyme activity [GO:0071566]; neuromuscular process [GO:0050905]; protein K69-linked ufmylation [GO:1990592]; protein modification by small protein conjugation [GO:0032446]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_UBA6.3.4.m.53927,0.009618013,-0.009344404,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; ubiquitin activating enzyme activity [GO:0004839]; amygdala development [GO:0021764]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBA6.4.4.m.63770,-0.001145045,-0.007357062,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; ubiquitin activating enzyme activity [GO:0004839]; amygdala development [GO:0021764]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBC12.1.1.m.51806,0.001410184,-0.01135762,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; NEDD8 transferase activity [GO:0019788]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; protein neddylation [GO:0045116],NA,NA,NA
CHOYP_UBC2.1.3.m.24138,0.003072466,0.011864523,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBC9B.1.1.m.10688,0.001749093,0.021817827,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524]; SUMO conjugating enzyme activity [GO:0061656]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; definitive hemopoiesis [GO:0060216]; embryonic heart tube elongation [GO:0036306]; heart looping [GO:0001947]; protein sumoylation [GO:0016925],NA,NA,NA
CHOYP_UBCD1.1.2.m.50237,-0.006889426,-0.001324305,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; transferase activity [GO:0016740]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_UBCD2.1.1.m.54558,-0.01211559,-0.009015353,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; lipid storage [GO:0019915]; protein polyubiquitination [GO:0000209],NA,NA,NA
CHOYP_UBCP1.1.1.m.7721,-0.010153529,-0.009360545,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; phosphoprotein phosphatase activity [GO:0004721],NA,NA,NA
CHOYP_UBD2A.1.1.m.63050,-0.009588224,0.00923612,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_UBE2A.1.1.m.48761,0.003947669,-0.013804273,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; HULC complex [GO:0033503]; nuclear chromatin [GO:0000790]; XY body [GO:0001741]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; blastocyst hatching [GO:0001835]; DNA repair [GO:0006281]; histone H2A ubiquitination [GO:0033522]; in utero embryonic development [GO:0001701]; maternal process involved in female pregnancy [GO:0060135]; positive regulation of cell proliferation [GO:0008284]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411],NA,NA,NA
CHOYP_UBE2C.1.1.m.55757,-0.001973102,-0.02025982,No,NA,NA,NA,NA,NA,NA,anaphase-promoting complex [GO:0005680]; ATP binding [GO:0005524]; transferase activity [GO:0016740]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; protein K11-linked ubiquitination [GO:0070979]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBE2H.1.1.m.49863,-0.018669742,-0.000668584,No,NA,NA,NA,NA,NA,NA,ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBE2N.1.1.m.62056,-0.006000586,-0.006612285,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; UBC13-MMS2 complex [GO:0031372]; UBC13-UEV1A complex [GO:0035370]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; DNA double-strand break processing [GO:0000729]; double-strand break repair via homologous recombination [GO:0000724]; histone ubiquitination [GO:0016574]; positive regulation of DNA repair [GO:0045739]; positive regulation of histone modification [GO:0031058]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]; regulation of histone ubiquitination [GO:0033182]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBE2Z.1.1.m.61760,-0.013572558,0.003886046,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBE4A.2.2.m.59113,0.002102237,-0.008953053,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_UBE4B.1.1.m.11223,-0.003380178,0.002326656,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; unfolded protein binding [GO:0051082]; cellular protein catabolic process [GO:0044257]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; neuron projection development [GO:0031175]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein folding [GO:0006457]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; response to UV [GO:0009411]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular trabecula myocardium morphogenesis [GO:0003222],NA,NA,NA
CHOYP_UBL4A.2.2.m.18059,0.002536901,0.004202714,No,NA,NA,NA,NA,NA,NA,BAT3 complex [GO:0071818]; cytosol [GO:0005829]; nucleus [GO:0005634]; tail-anchored membrane protein insertion into ER membrane [GO:0071816],NA,NA,NA
CHOYP_UBL5.3.5.m.41673,-0.007552808,0.004046293,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cellular protein modification process [GO:0006464],NA,NA,NA
CHOYP_UBP10.1.1.m.10603,0.00017835,-0.021615979,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; ion channel binding [GO:0044325]; p53 binding [GO:0002039]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; DNA damage response; signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; protein deubiquitination [GO:0016579]; regulation of autophagy [GO:0010506]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP15.4.4.m.56615,0.01509847,-0.000403491,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein deubiquitination [GO:0016579]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP19.1.1.m.55642,-0.000604189,-0.014400915,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Hsp90 protein binding [GO:0051879]; Lys48-specific deubiquitinase activity [GO:1990380]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of cell cycle process [GO:0090068]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of cellular response to hypoxia [GO:1900037]; regulation of ERAD pathway [GO:1904292]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_UBP20.2.2.m.51412,-0.010256491,-0.023155839,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type endopeptidase activity [GO:0004197]; G protein-coupled receptor binding [GO:0001664]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP24.1.1.m.54945,0.015585696,-0.018487582,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP25.1.1.m.61531,-0.004859478,-0.014472037,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; ATPase binding [GO:0051117]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of ERAD pathway [GO:1904293]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP32.1.1.m.56373,0.004472206,-0.004106016,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP34.1.1.m.55124,-0.018605301,-0.009523013,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_UBP47.1.2.m.66121,-0.014735433,-0.00889007,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]; WD40-repeat domain binding [GO:0071987]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; response to drug [GO:0042493]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP47.2.2.m.66754,-0.002140639,-0.021491112,No,NA,NA,NA,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex; eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex; eIF3m [GO:0071541]; multi-eIF complex [GO:0043614]; mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translation reinitiation [GO:0002188],NA,NA,NA
CHOYP_UBP48.1.1.m.25564,-0.004961015,-0.005473208,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBQL4.1.1.m.37426,0.000340596,-0.025256487,No,NA,NA,NA,NA,NA,NA,aggresome [GO:0016235]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein domain specific binding [GO:0019904]; signaling receptor binding [GO:0005102]; aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_UBQL4.1.1.m.37429,-0.019445684,-0.00533373,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; phosphatase inhibitor activity [GO:0019212]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_UBR2.2.2.m.54412,-0.014574221,-0.009669846,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leucine [GO:0071233]; chromatin silencing [GO:0006342]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],NA,NA,NA
CHOYP_UBR3.1.1.m.43346,0.003193624,-0.013563003,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; embryo development ending in birth or egg hatching [GO:0009792]; in utero embryonic development [GO:0001701]; olfactory behavior [GO:0042048]; protein ubiquitination [GO:0016567]; sensory perception of smell [GO:0007608]; suckling behavior [GO:0001967]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],NA,NA,NA
CHOYP_UBR4.1.1.m.34997,-0.00519091,0.005741845,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calmodulin binding [GO:0005516]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_UBR5.1.1.m.44200,-0.009421794,-0.015569161,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; negative regulation of interleukin-17 secretion [GO:1905077]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus; translocation [GO:0033160]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of protein stability [GO:0031647],NA,NA,NA
CHOYP_UBR7.1.1.m.7300,-0.010238937,-0.001884324,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_UBS3B.1.1.m.43636,0.00471462,-0.010523328,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; phosphatase activity [GO:0016791]; phosphoprotein binding [GO:0051219]; protein tyrosine phosphatase activity [GO:0004725]; ubiquitin protein ligase binding [GO:0031625]; collagen-activated signaling pathway [GO:0038065]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; negative regulation of bone resorption [GO:0045779]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of signal transduction [GO:0009968]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet aggregation [GO:0070527]; regulation of osteoclast differentiation [GO:0045670]; regulation of protein binding [GO:0043393]; regulation of release of sequestered calcium ion into cytosol [GO:0051279],NA,NA,NA
CHOYP_UBXN4.1.1.m.22642,0.00956003,0.012601488,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_UBXN7.1.1.m.64349,-0.00549454,0.001219989,No,NA,NA,NA,NA,NA,NA,nuclear body [GO:0016604]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; transcription factor binding [GO:0008134]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625],NA,NA,NA
CHOYP_UCHL.1.1.m.29303,-0.001633168,0.006459002,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UCHL5.2.2.m.46419,-0.006136404,0.008924549,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; Ino80 complex [GO:0031011]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; forebrain morphogenesis [GO:0048853]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; protein deubiquitination [GO:0016579]; regulation of proteasomal protein catabolic process [GO:0061136]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UCK2.1.1.m.6328,-0.002777088,-0.000372318,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; uridine kinase activity [GO:0004849]; CMP salvage [GO:0006238]; CTP salvage [GO:0044211]; UMP salvage [GO:0044206],NA,NA,NA
CHOYP_UFC1.1.2.m.6917,0.003695219,0.0051299,No,NA,NA,NA,NA,NA,NA,UFM1 transferase activity [GO:0071568]; protein K69-linked ufmylation [GO:1990592],NA,NA,NA
CHOYP_UFD1L.1.1.m.43606,-0.008430484,-0.002358513,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ER-associated misfolded protein catabolic process [GO:0071712]; error-free translesion synthesis [GO:0070987]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; retrograde protein transport; ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UFL1.1.1.m.20000,0.015552919,-0.004770886,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; UFM1 transferase activity [GO:0071568]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein ubiquitination [GO:0031397]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146],NA,NA,NA
CHOYP_UFSP2.1.1.m.36906,0.012972262,-0.021897699,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; thiolester hydrolase activity [GO:0016790]; UFM1 hydrolase activity [GO:0071567]; proteolysis [GO:0006508]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146],NA,NA,NA
CHOYP_UGGG1.1.1.m.59266,0.00273829,-0.024369737,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]; 'de novo' posttranslational protein folding [GO:0051084]; ER-associated misfolded protein catabolic process [GO:0071712]; protein folding [GO:0006457]; protein N-linked glycosylation via asparagine [GO:0018279],NA,NA,NA
CHOYP_UGPA.1.1.m.49579,0.014250653,-0.003280853,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; UTP:glucose-1-phosphate uridylyltransferase activity [GO:0003983]; glycogen metabolic process [GO:0005977]; UDP-glucose metabolic process [GO:0006011],NA,NA,NA
CHOYP_UHRF1.1.1.m.10935,0.007665939,0.007578078,No,NA,NA,NA,NA,NA,NA,euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear chromatin [GO:0000790]; replication fork [GO:0005657]; hemi-methylated DNA-binding [GO:0044729]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; histone ubiquitination [GO:0016574]; maintenance of DNA methylation [GO:0010216]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UN45B.1.1.m.19072,-0.002199355,-0.004243492,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; Z disc [GO:0030018]; Hsp90 protein binding [GO:0051879]; cardiac muscle tissue development [GO:0048738]; chaperone-mediated protein folding [GO:0061077]; lens development in camera-type eye [GO:0002088]; muscle fiber development [GO:0048747]; myofibril assembly [GO:0030239]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_UNC.89.1.2.m.1625,0.003126344,-0.012848794,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_UNC22.2.2.m.50516,0.004875417,-0.008153976,No,NA,NA,NA,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_UNC89.1.19.m.7848,-0.00115345,-0.01497788,No,NA,NA,NA,NA,NA,NA,cortical actin cytoskeleton [GO:0030864]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle [GO:0030133]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; Rab GTPase binding [GO:0017137]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_UNC89.15.19.m.55545,0.01106301,0.004004265,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_UNC89.16.19.m.57422,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_URIC.1.2.m.35940,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; urate oxidase activity [GO:0004846]; purine nucleobase catabolic process [GO:0006145]; urate catabolic process [GO:0019628],NA,NA,NA
CHOYP_URIC.2.2.m.54754,-0.00305327,-0.017455839,No,NA,NA,NA,NA,NA,NA,peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; urate oxidase activity [GO:0004846]; purine nucleobase catabolic process [GO:0006145]; urate catabolic process [GO:0019628],NA,NA,NA
CHOYP_USH1C.1.1.m.30582,0.01259244,0.01759078,No,NA,NA,NA,NA,NA,NA,apical part of cell [GO:0045177]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; actin filament binding [GO:0051015]; spectrin binding [GO:0030507]; actin filament bundle assembly [GO:0051017]; brush border assembly [GO:1904970]; cellular protein-containing complex assembly [GO:0034622]; equilibrioception [GO:0050957]; G2/M transition of mitotic cell cycle [GO:0000086]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; parallel actin filament bundle assembly [GO:0030046]; photoreceptor cell maintenance [GO:0045494]; protein localization to microvillus [GO:1904106]; regulation of microvillus length [GO:0032532]; retinal cone cell development [GO:0046549]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_USO1.1.11.m.6354,0.021389029,-0.004760931,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471]; protein transporter activity [GO:0008565]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi vesicle docking [GO:0048211]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; transcytosis [GO:0045056]; vesicle fusion with Golgi apparatus [GO:0048280],NA,NA,NA
CHOYP_USO1.11.11.m.64787,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_USO1.2.11.m.12785,-0.00693356,0.002565124,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_USP2.1.1.m.44411,0.012994775,-0.013688658,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_USP36.1.2.m.17402,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; histone deubiquitination [GO:0016578]; negative regulation of macroautophagy [GO:0016242]; nucleolus organization [GO:0007000]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of rRNA processing [GO:2000232]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UT14A.1.1.m.44047,0.007049973,0.023625409,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_UTP20.2.4.m.1508,-0.004308943,-0.006315407,No,NA,NA,NA,NA,NA,NA,90S preribosome [GO:0030686]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; preribosome; small subunit precursor [GO:0030688]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000472]; negative regulation of cell proliferation [GO:0008285]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_UUR10_0415.1.1.m.64919,0.022977361,-0.008398371,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743],NA,NA,NA
CHOYP_VA0D1.1.2.m.31117,-0.007961958,0.002011027,No,NA,NA,NA,NA,NA,NA,plasma membrane [GO:0005886]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase; V0 domain [GO:0000220]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; regulation of Notch signaling pathway [GO:0008593]; terminal branching; open tracheal system [GO:0007430]; vacuolar acidification [GO:0007035],NA,NA,NA
CHOYP_VAC14.1.1.m.31290,0.004487099,-0.004025477,No,NA,NA,NA,NA,NA,NA,endosome membrane [GO:0010008]; extrinsic component of vacuolar membrane [GO:0000306]; PAS complex [GO:0070772]; phosphatidylinositol biosynthetic process [GO:0006661],NA,NA,NA
CHOYP_VASP.1.1.m.15245,0.002902519,-0.001868406,No,NA,NA,NA,NA,NA,NA,bicellular tight junction [GO:0005923]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; lamellipodium membrane [GO:0031258]; actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; actin polymerization or depolymerization [GO:0008154]; axon guidance [GO:0007411]; neural tube closure [GO:0001843]; positive regulation of actin filament polymerization [GO:0030838]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_VATA.1.1.m.44460,-0.002770684,-0.008043277,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting V-type ATPase; V1 domain [GO:0033180]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; ATP metabolic process [GO:0046034]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572],NA,NA,NA
CHOYP_VATB.1.2.m.33785,0.017786864,0.000292851,No,NA,NA,NA,NA,NA,NA,proton-transporting V-type ATPase; V1 domain [GO:0033180]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; ATP hydrolysis coupled proton transport [GO:0015991]; ATP metabolic process [GO:0046034],NA,NA,NA
CHOYP_VATB.2.2.m.62084,-0.019209905,-0.017609381,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_VATC1.1.1.m.38693,-0.012894244,0.000518602,No,NA,NA,NA,NA,NA,NA,proton-transporting V-type ATPase; V1 domain [GO:0033180]; proton transmembrane transporter activity [GO:0015078]; ATP hydrolysis coupled proton transport [GO:0015991],NA,NA,NA
CHOYP_VATD.2.2.m.64245,-0.007930754,-0.006747429,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cilium [GO:0005929]; proton-transporting V-type ATPase complex [GO:0033176]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; cilium assembly [GO:0060271]; ion transport [GO:0006811]; protein localization to cilium [GO:0061512],NA,NA,NA
CHOYP_VATE.1.1.m.21420,-0.002928655,0.005995886,No,NA,NA,NA,NA,NA,NA,plasma membrane [GO:0005886]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase; V1 domain [GO:0000221]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; apical protein localization [GO:0045176]; ATP hydrolysis coupled proton transport [GO:0015991]; liquid clearance; open tracheal system [GO:0035002]; terminal branching; open tracheal system [GO:0007430],NA,NA,NA
CHOYP_VATG.1.2.m.4407,0.002608949,0.011058373,No,NA,NA,NA,NA,NA,NA,apical plasma membrane [GO:0016324]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_VAV2.1.3.m.40262,-0.009783968,0.013058103,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphotyrosine residue binding [GO:0001784]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; ephrin receptor signaling pathway [GO:0048013]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; G protein-coupled receptor signaling pathway [GO:0007186]; lamellipodium assembly [GO:0030032]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_VAV2.3.3.m.62875,0.00667394,-0.007947228,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphotyrosine residue binding [GO:0001784]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; ephrin receptor signaling pathway [GO:0048013]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; G protein-coupled receptor signaling pathway [GO:0007186]; lamellipodium assembly [GO:0030032]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_VDE.1.1.m.30310,-0.006540145,0.014525485,No,NA,NA,NA,NA,NA,NA,chloroplast thylakoid membrane [GO:0009535]; violaxanthin de-epoxidase activity [GO:0046422],NA,NA,NA
CHOYP_VIGLN.1.2.m.34766,0.016719657,0.0058394,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; lipid binding [GO:0008289]; RNA binding [GO:0003723]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle clearance [GO:0034384]; lipid transport [GO:0006869],NA,NA,NA
CHOYP_VIGLN.2.2.m.61191,-0.004667388,-0.022029209,No,NA,NA,NA,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; protein domain specific binding [GO:0019904]; structural constituent of ribosome [GO:0003735],NA,NA,NA
CHOYP_VIP2.1.1.m.54883,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; 5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1;3;4;5;6-pentakisphosphate kinase activity [GO:0000827]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958],NA,NA,NA
CHOYP_VIR.1.1.m.51105,0.003159384,-0.000659693,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA alternative polyadenylation [GO:0110104]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_VMA5A.1.1.m.24860,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634],NA,NA,NA
CHOYP_VMP1.1.1.m.34831,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774],NA,NA,NA
CHOYP_VOLCADRAFT_121426.1.1.m.43175,-0.008322074,0.00536142,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]; ADP biosynthetic process [GO:0006172]; ATP metabolic process [GO:0046034]; dADP biosynthetic process [GO:0006173]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine ribonucleotide biosynthetic process [GO:0009220],NA,NA,NA
CHOYP_VOLCADRAFT_89567.1.1.m.27272,-0.019697856,-0.013003207,No,NA,NA,NA,NA,NA,NA,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940],NA,NA,NA
CHOYP_VOLCADRAFT_93060.1.2.m.3949,0.011764845,0.001907272,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819],NA,NA,NA
CHOYP_VOLCADRAFT_93060.2.2.m.26741,-0.023267397,0.006945162,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819],NA,NA,NA
CHOYP_VP13D.2.3.m.58593,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_VP33.1.2.m.1058,0.01550314,0.01995281,No,NA,NA,NA,NA,NA,NA,cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; synapse [GO:0045202],NA,NA,NA
CHOYP_VP33A.1.1.m.58311,-0.006550991,0.006914733,No,NA,NA,NA,NA,NA,NA,autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; protein-containing complex binding [GO:0044877]; protein transport [GO:0015031]; regulation of lysosomal lumen pH [GO:0035751]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_VPP1.2.2.m.13421,-0.0003031,-0.002550952,No,NA,NA,NA,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150],NA,NA,NA
CHOYP_VPRBP.1.1.m.15849,-0.001242724,-0.014320769,No,NA,NA,NA,NA,NA,NA,Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; histone kinase activity (H2A-T120 specific) [GO:1990244]; B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; histone H2A-T120 phosphorylation [GO:1990245]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]; viral process [GO:0016032],NA,NA,NA
CHOYP_VPS11.3.3.m.17579,-0.010056547,-0.017877404,No,NA,NA,NA,NA,NA,NA,autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein binding; bridging [GO:0030674]; protein domain specific binding [GO:0019904]; syntaxin binding [GO:0019905]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein targeting to mitochondrion [GO:1903955]; regulation of organelle assembly [GO:1902115]; regulation of protein stability [GO:0031647]; regulation of SNARE complex assembly [GO:0035542]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_VPS18.1.1.m.38708,-0.001351669,-0.01090629,No,NA,NA,NA,NA,NA,NA,endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; metal ion binding [GO:0046872]; protein binding; bridging [GO:0030674]; apical protein localization [GO:0045176]; bile acid and bile salt transport [GO:0015721]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; endosome to pigment granule transport [GO:0043485]; eye pigmentation [GO:0048069]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; notochord cell vacuolation [GO:0060036]; optokinetic behavior [GO:0007634]; pigment granule maturation [GO:0048757]; regulation of SNARE complex assembly [GO:0035542]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_VPS25.1.1.m.66093,0.004655031,0.016078082,No,NA,NA,NA,NA,NA,NA,ESCRT II complex [GO:0000814]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328],NA,NA,NA
CHOYP_VPS35.1.1.m.55447,0.010278357,0.000857455,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer; cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422]; D1 dopamine receptor binding [GO:0031748]; protein transporter activity [GO:0008565]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport; endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to organelle [GO:0033365]; regulation of dendritic spine maintenance [GO:1902950]; regulation of terminal button organization [GO:2000331]; retrograde transport; endosome to Golgi [GO:0042147]; retrograde transport; endosome to plasma membrane [GO:1990126]; synapse assembly [GO:0007416]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882],NA,NA,NA
CHOYP_VPS36.1.1.m.27030,-0.011686451,0.008034205,No,NA,NA,NA,NA,NA,NA,endosome [GO:0005768]; ESCRT II complex [GO:0000814]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; phosphatidylinositol-3-phosphate binding [GO:0032266]; ubiquitin binding [GO:0043130]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328],NA,NA,NA
CHOYP_VPS45.1.1.m.8023,-0.000647855,-0.007015933,No,NA,NA,NA,NA,NA,NA,endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; synaptic vesicle [GO:0008021]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_VPS4B.2.2.m.30053,0.021854227,0.007261059,No,NA,NA,NA,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled [GO:0042623]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; cholesterol transport [GO:0030301]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; late endosomal microautophagy [GO:0061738]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nucleus organization [GO:0006997]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of viral release from host cell [GO:1902188]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076],NA,NA,NA
CHOYP_VPS51.1.1.m.43266,-0.006297703,-0.007494048,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; EARP complex [GO:1990745]; GARP complex [GO:0000938]; membrane [GO:0016020]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; ADP-ribosylation factor binding [GO:0030306]; endocytic recycling [GO:0032456]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; lipid digestion [GO:0044241]; lipid transport [GO:0006869]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; regulation of phospholipase activity [GO:0010517]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_VPS53.1.1.m.51625,0.010024347,-0.004596696,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; endocytic recycling [GO:0032456]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_VPS8.1.1.m.51272,0.005212215,-0.015178589,No,NA,NA,NA,NA,NA,NA,CORVET complex [GO:0033263]; early endosome [GO:0005769]; metal ion binding [GO:0046872]; endosomal vesicle fusion [GO:0034058],NA,NA,NA
CHOYP_VRK1.1.1.m.10917,0.006009112,-0.023058589,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; Golgi disassembly [GO:0090166]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_VRP.2.4.m.18914,0.015137986,-0.020693613,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_VTA1.1.1.m.36056,0.006778395,0.006903868,No,NA,NA,NA,NA,NA,NA,endosome membrane [GO:0010008]; protein transport [GO:0015031],NA,NA,NA
CHOYP_VWA8.2.3.m.28001,0.000484904,-0.010536831,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887],NA,NA,NA
CHOYP_VWCE.1.3.m.5007,0.013943084,0.018685249,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_VWDE.5.13.m.28163,0.011409875,0.010051911,No,NA,NA,NA,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_VWDE.8.13.m.38775,0.004027525,-0.021219192,No,NA,NA,NA,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; cytochrome-c oxidase activity [GO:0004129],NA,NA,NA
CHOYP_WASP.1.1.m.35786,0.00325434,0.00389726,No,NA,NA,NA,NA,NA,NA,actin cortical patch [GO:0030479]; actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; site of double-strand break [GO:0035861]; vesicle membrane [GO:0012506]; actin filament binding [GO:0051015]; GTPase regulator activity [GO:0030695]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; actin cortical patch assembly [GO:0000147]; actin cortical patch localization [GO:0051666]; actin filament polymerization [GO:0030041]; actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; blood coagulation [GO:0007596]; Cdc42 protein signal transduction [GO:0032488]; cellular response to interferon-gamma [GO:0071346]; defense response [GO:0006952]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; epidermis development [GO:0008544]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immune response [GO:0006955]; negative regulation of cell motility [GO:2000146]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of actin nucleation [GO:0051127]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of lamellipodium assembly [GO:0010591]; regulation of stress fiber assembly [GO:0051492]; regulation of T cell antigen processing and presentation [GO:0002625]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_WBP11.1.1.m.12849,-0.003183906,0.00987764,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase regulator activity [GO:0019888]; WW domain binding [GO:0050699]; mRNA cis splicing; via spliceosome [GO:0045292]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_WDHD1.1.1.m.23505,-0.001459028,-0.010653402,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677],NA,NA,NA
CHOYP_WDR1.1.1.m.29076,0.009227168,0.009872057,No,NA,NA,NA,NA,NA,NA,actomyosin; actin portion [GO:0042643]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; border follicle cell migration [GO:0007298]; establishment of planar polarity [GO:0001736]; imaginal disc-derived wing hair organization [GO:0035317]; locomotion [GO:0040011]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of actin filament depolymerization [GO:0030836]; regulation of actin filament depolymerization [GO:0030834]; regulation of actin filament polymerization [GO:0030833]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_WDR11.2.2.m.58625,0.004153694,-0.014698408,No,NA,NA,NA,NA,NA,NA,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041],NA,NA,NA
CHOYP_WDR12.1.1.m.13380,-0.009694018,-0.007909728,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome; large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463],NA,NA,NA
CHOYP_WDR17.1.1.m.17546,3.59E-05,-0.002985319,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_WDR26.1.1.m.43030,0.003962282,-0.002658868,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; nucleus [GO:0005634],NA,NA,NA
CHOYP_WDR31.2.2.m.65613,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_WDR37.1.1.m.57561,0.006743436,-0.016047791,No,NA,NA,NA,NA,NA,NA,PeBoW complex [GO:0070545]; preribosome; large subunit precursor [GO:0030687],NA,NA,NA
CHOYP_WDR5.2.3.m.6293,-0.008177531,0.011326701,No,NA,NA,NA,NA,NA,NA,histone acetyltransferase complex [GO:0000123]; MLL1 complex [GO:0071339]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; histone binding [GO:0042393]; histone H3-K4 methylation [GO:0051568]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982],NA,NA,NA
CHOYP_WDR52.1.1.m.21751,-0.021737273,-0.000754622,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; cilium-dependent cell motility [GO:0060285]; sperm axoneme assembly [GO:0007288],NA,NA,NA
CHOYP_WDR59.4.5.m.55404,-0.000577243,0.010025788,No,NA,NA,NA,NA,NA,NA,GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008],NA,NA,NA
CHOYP_WDR61.1.2.m.7565,-0.010799523,0.013057583,No,NA,NA,NA,NA,NA,NA,Cdc73/Paf1 complex [GO:0016593]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; Ski complex [GO:0055087]; transcriptionally active chromatin [GO:0035327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968],NA,NA,NA
CHOYP_WDR63.1.1.m.21743,-0.020757805,-0.001263291,No,NA,NA,NA,NA,NA,NA,dynein complex [GO:0030286]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_WDR70.1.1.m.7199,0.009413652,0.011946132,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; site of double-strand break [GO:0035861]; regulation of DNA double-strand break processing [GO:1903775]; regulation of histone H2B conserved C-terminal lysine ubiquitination [GO:2001173],NA,NA,NA
CHOYP_WDR74.1.1.m.19017,-0.003956099,0.001793242,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; blastocyst formation [GO:0001825]; ribosomal large subunit biogenesis [GO:0042273]; RNA metabolic process [GO:0016070]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_WDR75.1.1.m.9234,-0.002757984,0.006275771,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_WDR89.1.1.m.30861,0.010064112,-0.001805853,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_WDR92.1.1.m.12560,-0.011808475,-0.007665503,No,NA,NA,NA,NA,NA,NA,ubiquitin binding [GO:0043130]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_WFIKKN1.1.1.m.28942,-0.022868616,0.006681205,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867],NA,NA,NA
CHOYP_WHITE.1.1.m.38819,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; 3';5'-cyclic GMP transmembrane-transporting ATPase activity [GO:1905948]; amine transmembrane transporter activity [GO:0005275]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; eye pigment precursor transporter activity [GO:0005395]; guanine-transporting ATPase activity [GO:0008558]; pigment binding [GO:0031409]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_WHSC1.1.1.m.15308,-0.007027869,0.007250775,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; estrogen receptor binding [GO:0030331]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; thyroid hormone receptor binding [GO:0046966]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; gastrulation with mouth forming second [GO:0001702]; histone methylation [GO:0016571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of histone H3-K36 methylation [GO:0000414]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_WIBG.1.1.m.11521,-0.002231596,-0.001378977,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome binding [GO:0043022]; exon-exon junction complex disassembly [GO:1903259]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727],NA,NA,NA
CHOYP_WIPI2.1.2.m.9192,-0.006952803,0.003670015,No,NA,NA,NA,NA,NA,NA,autophagosome [GO:0005776]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792],NA,NA,NA
CHOYP_WIPI3.1.1.m.13956,-0.000185137,0.003508792,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; TSC1-TSC2 complex binding [GO:0062078]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497],NA,NA,NA
CHOYP_WKK_06610.2.2.m.50131,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_WN10A.1.1.m.28564,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; frizzled binding [GO:0005109]; camera-type eye photoreceptor cell differentiation [GO:0060219]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cell proliferation [GO:0008283]; cornea development in camera-type eye [GO:0061303]; embryonic camera-type eye formation [GO:0060900]; embryonic forelimb morphogenesis [GO:0035115]; iris morphogenesis [GO:0061072]; lens development in camera-type eye [GO:0002088]; limb development [GO:0060173]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of glial cell differentiation [GO:0045686]; negative regulation of neuron differentiation [GO:0045665]; neural retina development [GO:0003407]; neuron differentiation [GO:0030182]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of fibroblast growth factor production [GO:0090270]; retina layer formation [GO:0010842]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_WNK2.1.2.m.38552,0.00709391,-0.005381363,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; magnesium ion binding [GO:0000287]; phosphatase binding [GO:0019902]; potassium channel inhibitor activity [GO:0019870]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; cellular response to calcium ion [GO:0071277]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; lymphocyte migration into lymph node [GO:0097022]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of GTPase activity [GO:0034260]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of kinase activity [GO:0033673]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of sodium ion transport [GO:0010766]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cellular process [GO:0050794]; regulation of sodium ion transport [GO:0002028]; signal transduction by trans-phosphorylation [GO:0023016]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_WNT7B.1.2.m.36042,0.004985908,-0.012197618,No,NA,NA,NA,NA,NA,NA,extracellular space [GO:0005615]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; fibroblast proliferation [GO:0048144]; forebrain regionalization [GO:0021871]; lens fiber cell development [GO:0070307]; neuron differentiation [GO:0030182]; positive regulation of JNK cascade [GO:0046330]; stem cell proliferation [GO:0072089]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_WRI_006090.1.1.m.34650,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_XCASPASE.7.1.4.m.26576,-0.011842595,0.006584082,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_XDH.1.3.m.46824,-0.014352149,-0.021688809,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115],NA,NA,NA
CHOYP_XDH.2.3.m.53113,-9.10E-05,-0.004349323,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115],NA,NA,NA
CHOYP_XDH.3.3.m.55146,-0.00244755,0.0020573,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; purine nucleotide catabolic process [GO:0006195]; xanthine catabolic process [GO:0009115],NA,NA,NA
CHOYP_XFIN.1.4.m.606,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; multicellular organism development [GO:0007275]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of gene expression [GO:0010468],NA,NA,NA
CHOYP_XIAP.1.7.m.6021,-0.019742845,-0.010070584,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_XPF.1.1.m.14801,-0.006033917,-0.021901766,No,NA,NA,NA,NA,NA,NA,nucleolus [GO:0005730]; apoptotic process [GO:0006915]; cell cycle [GO:0007049],NA,NA,NA
CHOYP_XPO1.1.1.m.31560,-0.011064613,-0.013631058,No,NA,NA,NA,NA,NA,NA,annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056],NA,NA,NA
CHOYP_XPO2.1.1.m.50289,0.000376022,-0.019471376,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; Ran GTPase binding [GO:0008536]; body fluid secretion [GO:0007589]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_XPO5.1.1.m.14207,-0.00159301,-0.025044195,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; micro-ribonucleoprotein complex [GO:0035068]; nuclear RNA export factor complex [GO:0042272]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA nuclear export complex [GO:0042565]; mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; miRNA metabolic process [GO:0010586]; positive regulation of RNA interference [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; regulation of protein export from nucleus [GO:0046825],NA,NA,NA
CHOYP_XPO6.1.1.m.15288,-0.000800461,-0.008687176,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; protein export from nucleus [GO:0006611],NA,NA,NA
CHOYP_XPP1.1.2.m.16748,0.013615788,-0.011243865,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_XPP1.2.2.m.38696,-0.005380491,0.002177835,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_XRN2.1.1.m.13943,-0.010687852,-0.011967095,No,NA,NA,NA,NA,NA,NA,aggresome [GO:0016235]; nucleolus [GO:0005730]; 5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; metal ion binding [GO:0046872]; transcription termination site sequence-specific DNA binding [GO:0001147]; DNA catabolic process; exonucleolytic [GO:0000738]; DNA-templated transcription; termination [GO:0006353]; mRNA processing [GO:0006397]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_Y003.1.1.m.31014,0.008038755,0.001776372,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_Y022.1.1.m.30669,0.006345083,-0.006737393,No,NA,NA,NA,NA,NA,NA,host cell membrane [GO:0033644]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_Y0417.2.2.m.29395,-0.001008663,-0.015163864,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049],NA,NA,NA
CHOYP_Y045.1.1.m.43767,0.021013951,-0.002994353,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_Y054.1.1.m.9666,-0.005669005,0.00360818,No,NA,NA,NA,NA,NA,NA,host cell membrane [GO:0033644]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_Y061.1.1.m.29896,0.007515533,0.00653197,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_Y071.1.1.m.29248,0.006588326,0.018093163,No,NA,NA,NA,NA,NA,NA,host cell membrane [GO:0033644]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_Y077.1.1.m.27629,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,host cell membrane [GO:0033644]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_Y0777.3.3.m.60141,0.008436967,-0.001893043,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_Y1004.1.1.m.18927,-0.004582887,0.009397777,No,NA,NA,NA,NA,NA,NA,cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_Y118.1.1.m.30002,-0.007739649,0.014045033,No,NA,NA,NA,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_Y7557.3.3.m.42713,0.014917915,0.018514597,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_YAHB.1.1.m.25422,0.00184732,0.022474884,No,NA,NA,NA,NA,NA,NA,,NA,NA,NA
CHOYP_YAP.1.2.m.23386,-0.003127759,-0.013064373,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; cartilage development [GO:0051216]; cilium assembly [GO:0060271]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; endoderm development [GO:0007492]; fin regeneration [GO:0031101]; heart formation [GO:0060914]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; pancreas development [GO:0031016]; positive regulation of glutamate-ammonia ligase activity [GO:1905480]; posterior lateral line development [GO:0048916]; pronephric duct development [GO:0039022]; regulation of organ growth [GO:0046620]; retinal pigment epithelium development [GO:0003406],NA,NA,NA
CHOYP_YAP.2.2.m.62060,0.002274702,0.007843394,No,NA,NA,NA,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; cartilage development [GO:0051216]; cilium assembly [GO:0060271]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; endoderm development [GO:0007492]; fin regeneration [GO:0031101]; heart formation [GO:0060914]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; pancreas development [GO:0031016]; positive regulation of glutamate-ammonia ligase activity [GO:1905480]; posterior lateral line development [GO:0048916]; pronephric duct development [GO:0039022]; regulation of organ growth [GO:0046620]; retinal pigment epithelium development [GO:0003406],NA,NA,NA
CHOYP_YBOXH.2.4.m.3352,-0.008443445,-0.01988297,No,NA,NA,NA,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_YDJC.1.1.m.4244,0.00823405,-0.014051528,No,NA,NA,NA,NA,NA,NA,hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_YETS2.1.1.m.302,-0.00254837,-0.014714435,No,NA,NA,NA,NA,NA,NA,Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; mitotic spindle [GO:0072686]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone binding [GO:0042393]; modification-dependent protein binding [GO:0140030]; TBP-class protein binding [GO:0017025]; histone H3 acetylation [GO:0043966]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_YG31B.1.3.m.6174,-0.008875524,-0.006764303,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition; RNA-mediated [GO:0032197],NA,NA,NA
CHOYP_YG31B.2.3.m.9011,-0.00699852,0.005015545,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_YL086.1.1.m.33481,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_YL58.1.1.m.35411,0.00205195,-0.009341169,No,NA,NA,NA,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; intracellular mRNA localization [GO:0008298]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_YL8A.1.1.m.29604,-0.012904961,-0.020380341,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; trans-aconitate 3-methyltransferase activity [GO:0046547]; cellular detoxification [GO:1990748],NA,NA,NA
CHOYP_YLPM1.1.2.m.17086,-0.003907705,-0.008125527,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227],NA,NA,NA
CHOYP_YMS5.1.1.m.5494,0.009092904,-0.02586208,No,NA,NA,NA,NA,NA,NA,cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_YNY5.2.4.m.50761,0.008375271,0.005081391,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_YQK4.2.2.m.31850,-0.014791155,0.008016958,No,NA,NA,NA,NA,NA,NA,defense response to Gram-negative bacterium [GO:0050829]; regulation of antimicrobial humoral response [GO:0002759]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_YS11.1.1.m.30657,-0.005907044,-0.009117962,No,NA,NA,NA,NA,NA,NA,gamma-glutamylaminecyclotransferase activity [GO:0061929]; transferase activity; transferring acyl groups [GO:0016746]; cellular modified amino acid catabolic process [GO:0042219],NA,NA,NA
CHOYP_YTDC1.1.2.m.56405,0.006159669,0.009419646,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; insulin receptor signaling pathway [GO:0008286],NA,NA,NA
CHOYP_ZADH2.1.3.m.13137,0.00405747,0.005042536,No,NA,NA,NA,NA,NA,NA,mitochondrion [GO:0005739]; peroxisome [GO:0005777]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; zinc ion binding [GO:0008270]; negative regulation of fat cell differentiation [GO:0045599],NA,NA,NA
CHOYP_ZBTB5.4.4.m.42642,0.004056269,0.006120542,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZC11A.1.1.m.60722,0.009555318,0.013451016,No,NA,NA,NA,NA,NA,NA,cell [GO:0005623]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; poly(A)+ mRNA export from nucleus [GO:0016973],NA,NA,NA
CHOYP_ZC3H18.1.1.m.8085,-0.002268653,-0.005515078,No,NA,NA,NA,NA,NA,NA,nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_ZC3H4.1.1.m.57516,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_ZC3HA.1.1.m.27569,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_ZC3HDC1L.1.1.m.44413,-0.00845083,-0.01172743,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_ZCCHC8.1.1.m.18098,-0.012971459,-0.012671963,No,NA,NA,NA,NA,NA,NA,nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_ZDHHC17.1.1.m.29726,-0.016959105,0.009602069,No,NA,NA,NA,NA,NA,NA,aggresome [GO:0016235]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; presynaptic membrane [GO:0042734]; identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; lipoprotein transport [GO:0042953]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein palmitoylation [GO:0018345],NA,NA,NA
CHOYP_ZEB2.1.1.m.29733,-0.014139232,0.000564794,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ZF_BBOX_RING_.1.3.10.m.29555,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZF_BBOX_RING_.1.5.10.m.34434,0.012463813,0.018383027,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZF_U1LIKE_.10.1.1.m.18971,-0.011674269,0.002725785,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZFP37.1.4.m.10878,-0.022284027,0.000493371,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZFP37.3.4.m.48467,0.009041537,0.001250011,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZFR.1.1.m.57469,-0.000218147,-0.000993748,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_ZFY27.1.1.m.31417,0.003647786,-0.008720528,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network [GO:0071782]; growth cone membrane [GO:0032584]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; recycling endosome membrane [GO:0055038]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; endoplasmic reticulum tubular network formation [GO:0071787]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of axon extension [GO:0045773]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_ZGC_113208.1.1.m.15618,0.004501496,-0.003944182,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZGC_113625.1.2.m.2855,-0.000632842,-0.009694484,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; GTP metabolic process [GO:0046039],NA,NA,NA
CHOYP_ZGC_136858.1.1.m.51274,0.013459706,0.007780347,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; pseudouridine kinase activity [GO:0050225]; pseudouridylate synthase activity [GO:0004730]; pseudouridine synthesis [GO:0001522]; pyrimidine nucleoside metabolic process [GO:0006213],NA,NA,NA
CHOYP_ZGC_171566.1.1.m.22181,-0.019151752,0.002023476,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; vacuole [GO:0005773]; gamma-glutamyl-peptidase activity [GO:0034722]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to zinc ion [GO:0010043]; tetrahydrofolylpolyglutamate metabolic process [GO:0046900],NA,NA,NA
CHOYP_ZGC_73273.1.1.m.18633,-0.003758024,-0.007235403,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; dCTP diphosphatase activity [GO:0047840]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; pyrimidine deoxyribonucleotide binding [GO:0032556]; pyrophosphatase activity [GO:0016462]; dCTP catabolic process [GO:0006253]; DNA protection [GO:0042262]; nucleoside triphosphate catabolic process [GO:0009143]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_ZGC_92203.1.1.m.55468,0.009223758,-0.001123072,No,NA,NA,NA,NA,NA,NA,endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; GTPase binding [GO:0051020]; guanyl-nucleotide exchange factor activity [GO:0005085]; Sar guanyl-nucleotide exchange factor activity [GO:0005090]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; protein exit from endoplasmic reticulum [GO:0032527]; protein secretion [GO:0009306]; regulation of COPII vesicle coating [GO:0003400],NA,NA,NA
CHOYP_ZIP.1.1.m.15785,0.000247192,0.017464441,No,NA,NA,NA,NA,NA,NA,actomyosin contractile ring [GO:0005826]; apical cortex [GO:0045179]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; unconventional myosin complex [GO:0016461]; Z disc [GO:0030018]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATPase activity; coupled [GO:0042623]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure; amnioserosa morphology change [GO:0046664]; dorsal closure; leading edge cell differentiation [GO:0046663]; dorsal closure; spreading of leading edge cells [GO:0007395]; establishment of neuroblast polarity [GO:0045200]; establishment of planar polarity [GO:0001736]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; ommatidial rotation [GO:0016318]; ovarian follicle cell migration [GO:0007297]; positive regulation of border follicle cell migration [GO:1903688]; protein complex oligomerization [GO:0051259]; regulation of myoblast fusion [GO:1901739]; regulation of tube length; open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis; open tracheal system [GO:0035277]; wound healing [GO:0042060],NA,NA,NA
CHOYP_ZMY11.1.1.m.3621,-0.005376762,-0.007878842,No,NA,NA,NA,NA,NA,NA,chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243],NA,NA,NA
CHOYP_ZN207.1.1.m.6909,-0.007755007,0.009137785,No,NA,NA,NA,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; nucleic acid binding [GO:0003676]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983],NA,NA,NA
CHOYP_ZN330.1.2.m.7843,0.005309471,-0.004304342,No,NA,NA,NA,NA,NA,NA,chromosome; centromeric region [GO:0000775]; midbody [GO:0030496]; nucleolus [GO:0005730]; zinc ion binding [GO:0008270]; larval lymph gland hemopoiesis [GO:0035167],NA,NA,NA
CHOYP_ZN521.2.3.m.13584,0.003126219,-0.012851312,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZN568.1.1.m.61611,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZN609.1.1.m.44387,-0.010600817,0.000841816,No,NA,NA,NA,NA,NA,NA,integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; muscle organ development [GO:0007517]; positive regulation of neuron migration [GO:2001224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of myoblast proliferation [GO:2000291]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_ZN622.1.1.m.2103,-0.004595444,-0.001575074,No,NA,NA,NA,NA,NA,NA,cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_ZN706.1.2.m.11926,0.00843766,-0.017046691,No,NA,NA,NA,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_ZN729.1.1.m.13702,0.007480438,-0.002204771,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZNF184.1.1.m.59420,-0.013606352,-0.002645204,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZNF259.1.1.m.10424,-0.001920096,-0.008810078,No,NA,NA,NA,NA,NA,NA,axon [GO:0030424]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; Gemini of coiled bodies [GO:0097504]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; SMN complex [GO:0032797]; receptor tyrosine kinase binding [GO:0030971]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]; apoptotic process involved in development [GO:1902742]; axon development [GO:0061564]; Cajal body organization [GO:0030576]; cellular response to epidermal growth factor stimulus [GO:0071364]; DNA endoreduplication [GO:0042023]; inner cell mass cell proliferation [GO:0001833]; microtubule cytoskeleton organization [GO:0000226]; mRNA processing [GO:0006397]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; pre-mRNA catabolic process [GO:1990261]; regulation of myelination [GO:0031641]; RNA splicing [GO:0008380]; spinal cord development [GO:0021510]; trophectodermal cell proliferation [GO:0001834],NA,NA,NA
CHOYP_ZNF382.1.1.m.21527,-0.003233272,0.013064971,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZNF43.1.1.m.6773,0.002179971,-0.008072714,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZNF510.1.1.m.10853,0.003945368,0.002913697,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZNF624.1.1.m.45743,0.00030866,0.00069952,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZNF85.1.1.m.65738,-0.000167789,-0.011337469,No,NA,NA,NA,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ZNRD1.1.2.m.7107,-0.00838306,-0.004134319,No,NA,NA,NA,NA,NA,NA,RNA polymerase I complex [GO:0005736]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; mRNA cleavage [GO:0006379]; termination of RNA polymerase I transcription [GO:0006363],NA,NA,NA
CHOYP_ZW10.1.1.m.35287,0.005136091,-0.021708744,No,NA,NA,NA,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; nucleus [GO:0005634]; RZZ complex [GO:1990423]; spindle pole [GO:0000922]; cell division [GO:0051301]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; mitotic cell cycle checkpoint [GO:0007093]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; protein localization to kinetochore [GO:0034501]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulation of exit from mitosis [GO:0007096],NA,NA,NA
CHOYP_ZYRO0F11880G.1.1.m.7082,-0.01513535,-0.019168224,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
K1C10_HUMAN,-0.012791618,-0.017970269,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
K1C15_SHEEP,-0.012481275,-0.006738075,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
K1C9_HUMAN,-0.016003875,-0.016935212,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
K1M1_SHEEP,-0.002120788,-0.008918373,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
K22E_HUMAN,-0.01221523,-0.019381692,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
K2C1_HUMAN,-0.018652578,-0.010200538,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
KRUC_SHEEP,-0.000342808,-0.011144685,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
LYSC_CHICK,-0.01316047,-0.001844314,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
LYSC_HUMAN,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
NEDD8_HUMAN,0.006219324,0.005933154,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
TRFL_HUMAN,0.006786201,0.008787418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
TRYP_PIG,0.01314841,-0.003387122,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA